Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Behavioral & Substance Use Disorder Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:glucose
go back to main search page
Accession:CHEBI:17234 term browser browse the term
Definition:An aldohexose used as a source of energy and metabolic intermediate.
Synonyms:related_synonym: DL-glucose;   Glc;   Glukose;   gluco-hexose
 alt_id: CHEBI:14313;   CHEBI:24277;   CHEBI:33929;   CHEBI:5418
 xref: CAS:50-99-7
 xref_mesh: MESH:D005947
 xref: kegg.compound:C00293;   wikipedia.en:Glucose
 chemrof_formula: C6H12O6


show annotations for term's descendants           Sort by:
glucose term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A2m alpha-2-macroglobulin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of A2M mRNA CTD PMID:37567420 NCBI chr 4:156,570,163...156,619,870
Ensembl chr 4:156,569,860...156,619,868 		JBrowse link
G Abca1 ATP binding cassette subfamily A member 1 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of ABCA1 mRNA; Glucose results in decreased expression of ABCA1 protein
morroniside inhibits the reaction [Glucose results in decreased expression of ABCA1 mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of ABCA1 protein] 		CTD PMID:34485530 NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473 		JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A decreases expression ISO Glucose results in decreased expression of ABCB1 protein CTD PMID:22363694 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135 		JBrowse link
G Abcb4 ATP binding cassette subfamily B member 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of ABCB4 mRNA CTD PMID:37567420 NCBI chr 4:26,106,895...26,164,440 JBrowse link
G Abcb7 ATP binding cassette subfamily B member 7 decreases expression ISO Glucose results in decreased expression of ABCB7 mRNA CTD PMID:17178593 NCBI chr  X:73,361,296...73,502,464
Ensembl chr  X:73,361,310...73,502,547 		JBrowse link
G Abcc1 ATP binding cassette subfamily C member 1 multiple interactions ISO Glucose inhibits the reaction [Sodium Azide inhibits the reaction [ABCC1 protein results in decreased uptake of Daunorubicin]]; Glucose inhibits the reaction [Sodium Azide inhibits the reaction [ABCC1 protein results in decreased uptake of Etoposide]] CTD PMID:10856430 NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 multiple interactions EXP [Benzbromarone results in decreased activity of ABCC2 protein] inhibits the reaction [Glucose results in increased secretion of S-(2,4-dinitrophenyl)glutathione]; [Furosemide results in increased activity of ABCC2 protein] promotes the reaction [Glucose results in increased secretion of S-(2,4-dinitrophenyl)glutathione]; [sulfanitran results in increased activity of ABCC2 protein] promotes the reaction [Glucose results in increased secretion of S-(2,4-dinitrophenyl)glutathione] CTD PMID:19782883 NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471 		JBrowse link
G Abcd2 ATP binding cassette subfamily D member 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ABCD2 mRNA CTD PMID:37567420 NCBI chr 7:124,142,597...124,191,202
Ensembl chr 7:124,142,595...124,191,202 		JBrowse link
G Abcg1 ATP binding cassette subfamily G member 1 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of ABCG1 mRNA; Glucose results in decreased expression of ABCG1 protein
morroniside inhibits the reaction [Glucose results in decreased expression of ABCG1 mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of ABCG1 protein] 		CTD PMID:34485530 NCBI chr20:9,128,056...9,184,312
Ensembl chr20:9,127,803...9,186,563 		JBrowse link
G Abcg4 ATP binding cassette subfamily G member 4 increases expression ISO Glucose results in increased expression of ABCG4 mRNA CTD PMID:39922521 NCBI chr 8:53,508,005...53,525,314
Ensembl chr 8:53,508,005...53,523,571 		JBrowse link
G Acaca acetyl-CoA carboxylase alpha increases expression
decreases expression
multiple interactions
decreases phosphorylation 		ISO
EXP 		Glucose results in increased expression of ACACA mRNA
Glucose results in decreased expression of ACACA protein modified form
[INS protein co-treated with Glucose] results in increased expression of ACACA mRNA; [Pyruvic Acid co-treated with Glucose] results in increased phosphorylation of ACACA protein; PRKAA2 protein promotes the reaction [SIRT1 protein inhibits the reaction [Glucose results in decreased phosphorylation of ACACA protein]]; SIRT1 protein inhibits the reaction [Glucose results in decreased phosphorylation of ACACA protein]; SRT1720 inhibits the reaction [[INS protein co-treated with Glucose] results in increased expression of ACACA mRNA] 		CTD PMID:15066988 PMID:18482975 PMID:19071085 PMID:19724016 PMID:24349266 More... NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888 		JBrowse link
G Acacb acetyl-CoA carboxylase beta decreases phosphorylation
multiple interactions 		ISO Glucose results in decreased phosphorylation of ACACB protein
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [ACACB protein affects the reaction [Glucose results in decreased expression of PPARGC1A protein]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [ACACB protein affects the reaction [Glucose results in decreased expression of SIRT1 protein]]; ACACB protein affects the reaction [Glucose results in decreased expression of NPHS1 protein]; ACACB protein affects the reaction [Glucose results in decreased expression of PPARGC1A protein]; ACACB protein affects the reaction [Glucose results in decreased expression of SIRT1 protein]; ACACB protein affects the reaction [Glucose results in decreased expression of SLC2A4 protein]; ACACB protein affects the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; ACACB protein affects the reaction [Glucose results in decreased phosphorylation of IRS1 protein] 		CTD PMID:33957017 NCBI chr12:48,026,394...48,138,214
Ensembl chr12:48,026,394...48,138,214 		JBrowse link
G Acadl acyl-CoA dehydrogenase, long chain multiple interactions ISO [Glucose co-treated with Palmitic Acid] results in decreased expression of ACADL mRNA CTD PMID:39265716 NCBI chr 9:75,783,689...75,822,077
Ensembl chr 9:75,783,689...75,822,164 		JBrowse link
G Acadsb acyl-CoA dehydrogenase, short/branched chain multiple interactions ISO 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA] CTD PMID:32613381 NCBI chr 1:195,619,088...195,660,564
Ensembl chr 1:195,619,038...195,660,561 		JBrowse link
G Acat2 acetyl-CoA acetyltransferase 2 decreases expression ISO Glucose results in decreased expression of ACAT2 mRNA CTD PMID:39613055 NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:50,100,817...50,135,095 		JBrowse link
G Ace angiotensin I converting enzyme multiple interactions
increases expression
decreases expression 		ISO
EXP 		Enalaprilat inhibits the reaction [Glucose results in increased expression of ACE protein]
Glucose results in increased expression of ACE mRNA
CEBPB protein inhibits the reaction [Glucose results in increased expression of ACE protein]
NFE2L2 protein affects the reaction [Glucose results in increased expression of ACE mRNA]; oltipraz inhibits the reaction [trigonelline inhibits the reaction [Glucose results in increased expression of ACE mRNA]]; trigonelline inhibits the reaction [Glucose results in increased expression of ACE mRNA]
Glucose results in decreased expression of ACE mRNA 		CTD PMID:16452552 PMID:29211853 PMID:29266779 PMID:31655124 NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942 		JBrowse link
G Ace2 angiotensin converting enzyme 2 decreases expression
multiple interactions 		EXP
ISO 		Glucose results in decreased expression of ACE2 mRNA
Glucose results in decreased expression of ACE2 protein
CEBPB protein inhibits the reaction [Glucose results in decreased expression of ACE2 protein]; Glucose inhibits the reaction [CEBPB protein binds to ACE2 promoter]; Valsartan inhibits the reaction [Glucose results in decreased expression of ACE2 protein]
NFE2L2 protein affects the reaction [Glucose results in decreased expression of ACE2 mRNA]; oltipraz inhibits the reaction [trigonelline inhibits the reaction [Glucose results in decreased expression of ACE2 mRNA]]; trigonelline inhibits the reaction [Glucose results in decreased expression of ACE2 mRNA] 		CTD PMID:29211853 PMID:29266779 NCBI chr  X:33,925,458...33,972,851
Ensembl chr  X:33,925,458...33,971,596 		JBrowse link
G Ache acetylcholinesterase multiple interactions
increases expression
decreases activity 		ISO Ascorbic Acid inhibits the reaction [Glucose results in decreased activity of ACHE protein]
Glucose results in increased expression of ACHE mRNA 		CTD PMID:26163454 PMID:39922521 NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410 		JBrowse link
G Acly ATP citrate lyase increases expression EXP
ISO 		Glucose results in increased expression of ACLY mRNA
Glucose deficiency results in increased expression of ACLY mRNA; Glucose deficiency results in increased expression of ACLY protein 		CTD PMID:24349266 PMID:26811028 NCBI chr10:85,912,402...85,964,605
Ensembl chr10:85,912,402...85,963,631 		JBrowse link
G Aco1 aconitase 1 multiple interactions
increases expression 		EXP
ISO 		[Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein; Oxygen inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein]
Glucose results in increased expression of ACO1 protein 		CTD PMID:16135072 PMID:38483099 NCBI chr 5:60,055,895...60,111,920
Ensembl chr 5:60,055,866...60,112,600 		JBrowse link
G Aco2 aconitase 2 multiple interactions EXP [Glucose co-treated with Oxygen] affects the activity of ACO2 protein; Glucose results in decreased expression of and results in decreased activity of ACO2 protein; LONP1 protein affects the reaction [SRT1720 inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of ACO2 protein]]; manganese tetrakis-(N-ethyl-2 pyridyl) porphyrin inhibits the reaction [[Glucose co-treated with Oxygen] affects the activity of ACO2 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[Glucose co-treated with Oxygen] affects the activity of ACO2 protein]; SRT1720 inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of ACO2 protein] CTD PMID:11520895 PMID:31639451 NCBI chr 7:115,265,816...115,308,931
Ensembl chr 7:115,265,791...115,308,892 		JBrowse link
G Acot1 acyl-CoA thioesterase 1 increases expression
multiple interactions 		ISO Glucose results in increased expression of ACOT1 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of ACOT1 mRNA 		CTD PMID:17178593 PMID:37567420 NCBI chr 6:109,367,274...109,375,268
Ensembl chr 6:109,367,268...109,380,749 		JBrowse link
G Acox1 acyl-CoA oxidase 1 increases expression
decreases expression
multiple interactions 		ISO Glucose results in increased expression of ACOX1 mRNA
Glucose results in decreased expression of ACOX1 protein
[Glucose co-treated with Palmitic Acid] results in decreased expression of ACOX1 mRNA; Ditiocarb inhibits the reaction [YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of ACOX1 protein]]]]; Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of ACOX1 protein]; jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of ACOX1 protein]]; YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of ACOX1 protein]]] 		CTD PMID:36156098 PMID:39059604 PMID:39265716 NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,905,083...101,930,136 		JBrowse link
G Acox2 acyl-CoA oxidase 2 decreases expression ISO Glucose results in decreased expression of ACOX2 mRNA CTD PMID:17178593 NCBI chr15:19,090,820...19,122,392
Ensembl chr15:19,090,926...19,122,392 		JBrowse link
G Acp5 acid phosphatase 5, tartrate resistant increases expression ISO Glucose results in increased expression of ACP5 mRNA CTD PMID:39922521 NCBI chr 8:28,939,984...28,946,639
Ensembl chr 8:28,939,985...28,943,929 		JBrowse link
G Acrbp acrosin binding protein increases expression ISO Glucose results in increased expression of ACRBP mRNA CTD PMID:39922521 NCBI chr 4:159,537,395...159,550,454
Ensembl chr 4:159,537,391...159,550,454 		JBrowse link
G Acsbg1 acyl-CoA synthetase bubblegum family member 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of ACSBG1 mRNA CTD PMID:37567420 NCBI chr 8:63,887,433...63,943,486
Ensembl chr 8:63,887,435...63,984,178 		JBrowse link
G Acsbg3 acyl-CoA synthetase bubblegum family member 3 increases expression ISO Glucose results in increased expression of ACSBG3 mRNA CTD PMID:39922521 NCBI chr 9:1,802,729...1,814,761
Ensembl chr 9:1,802,744...1,814,761 		JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 multiple interactions ISO [Glucose co-treated with Palmitic Acid] results in decreased expression of ACSL1 mRNA CTD PMID:39265716 NCBI chr16:52,487,870...52,554,110
Ensembl chr16:52,487,870...52,554,023 		JBrowse link
G Acsl4 acyl-CoA synthetase long-chain family member 4 multiple interactions EXP [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of ACSL4 protein; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of ACSL4 protein] CTD PMID:36806343 NCBI chr  X:110,739,633...110,803,416
Ensembl chr  X:110,739,648...110,803,261 		JBrowse link
G Acsm2 acyl-CoA synthetase medium-chain family member 2 increases expression ISO Glucose results in increased expression of ACSM2 mRNA CTD PMID:31525975 NCBI chr 1:183,347,705...183,386,453
Ensembl chr 1:183,347,705...183,386,453 		JBrowse link
G Acsm3 acyl-CoA synthetase medium-chain family member 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ACSM3 mRNA CTD PMID:37567420 NCBI chr 1:183,564,652...183,591,328
Ensembl chr 1:183,564,635...183,591,437 		JBrowse link
G Acss1 acyl-CoA synthetase short-chain family member 1 increases expression ISO Glucose results in increased expression of ACSS1 mRNA CTD PMID:36156098 NCBI chr 3:159,910,809...159,960,748
Ensembl chr 3:159,910,809...159,960,748 		JBrowse link
G Acss2 acyl-CoA synthetase short-chain family member 2 increases expression ISO Glucose results in increased expression of ACSS2 mRNA CTD PMID:36156098 PMID:39613055 NCBI chr 3:164,464,124...164,507,607
Ensembl chr 3:164,464,055...164,519,830 		JBrowse link
G Acta1 actin, alpha 1, skeletal muscle increases expression
multiple interactions
decreases expression 		EXP
ISO 		Glucose results in increased expression of ACTA1 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ACTA1 mRNA; fucoxanthin inhibits the reaction [Glucose results in decreased expression of ACTA1 mRNA]
HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]]; Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]] 		CTD PMID:24810525 PMID:33448797 PMID:37567420 NCBI chr19:68,781,168...68,784,194
Ensembl chr19:68,781,168...68,786,178 		JBrowse link
G Acta2 actin alpha 2, smooth muscle multiple interactions
increases expression 		ISO
EXP 		4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [Glucose results in increased expression of ACTA2 protein]; [Glucose co-treated with TGFB1 protein] results in increased expression of ACTA2 protein; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of ACTA2 protein]; DKK1 protein inhibits the reaction [Glucose results in increased expression of ACTA2 mRNA]; DKK1 protein inhibits the reaction [Glucose results in increased expression of ACTA2 protein]; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of ACTA2 protein]; MAPK14 protein promotes the reaction [Glucose results in increased expression of ACTA2 protein]
Dichloroacetic Acid inhibits the reaction [Glucose results in increased expression of ACTA2 protein]; Oxamic Acid inhibits the reaction [Glucose results in increased expression of ACTA2 protein]
Glucose results in increased expression of ACTA2 mRNA; Glucose results in increased expression of ACTA2 protein
cinnamaldehyde inhibits the reaction [Glucose results in increased expression of ACTA2 protein] 		CTD PMID:20060012 PMID:21829520 PMID:26045780 PMID:29163160 PMID:35961541 More... NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503 		JBrowse link
G Actb actin, beta decreases expression ISO Glucose deficiency results in decreased expression of ACTB protein CTD PMID:22314686 NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242 		JBrowse link
G Actg1 actin, gamma 1 multiple interactions EXP ACTG1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr10:106,118,106...106,120,951
Ensembl chr10:106,118,108...106,120,951 		JBrowse link
G Actr2 actin related protein 2 multiple interactions
decreases expression 		ISO Eucalyptol inhibits the reaction [Glucose results in decreased expression of ACTR2 protein] CTD PMID:31483951 NCBI chr14:98,500,119...98,535,092
Ensembl chr14:98,500,138...98,541,998 		JBrowse link
G Acvr2b activin A receptor type 2B increases expression ISO Glucose results in increased expression of ACVR2B mRNA CTD PMID:39922521 NCBI chr 8:128,016,589...128,056,193
Ensembl chr 8:128,016,526...128,048,171 		JBrowse link
G Adam17 ADAM metallopeptidase domain 17 decreases expression ISO Glucose results in decreased expression of ADAM17 mRNA CTD PMID:31655124 NCBI chr 6:46,601,583...46,663,690
Ensembl chr 6:46,601,583...46,649,344 		JBrowse link
G Adam19 ADAM metallopeptidase domain 19 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of ADAM19 mRNA CTD PMID:37567420 NCBI chr10:30,992,713...31,084,455
Ensembl chr10:30,992,754...31,084,455 		JBrowse link
G Adam32 ADAM metallopeptidase domain 32 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of ADAM32 mRNA CTD PMID:37567420 NCBI chr16:73,805,023...73,914,787
Ensembl chr16:73,805,052...73,914,785 		JBrowse link
G Adam7 ADAM metallopeptidase domain 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of ADAM7 mRNA CTD PMID:37567420 NCBI chr15:47,009,176...47,057,581
Ensembl chr15:47,009,176...47,057,581 		JBrowse link
G Adam8 ADAM metallopeptidase domain 8 increases expression
multiple interactions 		ISO Glucose results in increased expression of ADAM8 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADAM8 mRNA 		CTD PMID:17178593 PMID:37567420 NCBI chr 1:204,206,206...204,218,988
Ensembl chr 1:204,206,199...204,218,485 		JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 increases expression ISO Glucose results in increased expression of ADAMTS1 mRNA CTD PMID:17178593 NCBI chr11:38,418,565...38,427,384
Ensembl chr11:38,418,101...38,427,390 		JBrowse link
G Adamts3 ADAM metallopeptidase with thrombospondin type 1, motif 3 increases expression ISO Glucose results in increased expression of ADAMTS3 mRNA CTD PMID:39922521 NCBI chr14:18,515,249...18,721,887
Ensembl chr14:18,515,249...18,721,887 		JBrowse link
G Adamtsl2 ADAMTS-like 2 increases expression ISO Glucose results in increased expression of ADAMTSL2 mRNA CTD PMID:39922521 NCBI chr 3:30,795,882...30,832,635
Ensembl chr 3:30,802,700...30,832,635 		JBrowse link
G Adcy7 adenylate cyclase 7 increases expression
decreases methylation
multiple interactions 		ISO Glucose results in increased expression of ADCY7 mRNA
Glucose results in decreased methylation of ADCY7 gene
fucoxanthin inhibits the reaction [Glucose results in decreased methylation of ADCY7 gene]; fucoxanthin inhibits the reaction [Glucose results in increased expression of ADCY7 mRNA] 		CTD PMID:33448797 NCBI chr19:34,913,154...34,972,366
Ensembl chr19:34,914,322...34,936,743 		JBrowse link
G Adgra1 adhesion G protein-coupled receptor A1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADGRA1 mRNA CTD PMID:37567420 NCBI chr 1:204,059,218...204,102,869
Ensembl chr 1:204,059,367...204,102,869 		JBrowse link
G Adgrb1 adhesion G protein-coupled receptor B1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADGRB1 mRNA CTD PMID:37567420 NCBI chr 7:108,293,681...108,365,892
Ensembl chr 7:108,293,818...108,365,870 		JBrowse link
G Adgre4 adhesion G protein-coupled receptor E4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADGRE4 mRNA CTD PMID:37567420 NCBI chr 9:10,085,258...10,240,346
Ensembl chr 9:10,085,352...10,240,229 		JBrowse link
G Adgrf4 adhesion G protein-coupled receptor F4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ADGRF4 mRNA CTD PMID:37567420 NCBI chr 9:25,769,265...25,800,438
Ensembl chr 9:25,769,265...25,800,438 		JBrowse link
G Adgrg4 adhesion G protein-coupled receptor G4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of ADGRG4 mRNA CTD PMID:37567420 NCBI chr  X:139,771,962...139,901,771 JBrowse link
G Adgrg5 adhesion G protein-coupled receptor G5 increases expression ISO Glucose results in increased expression of ADGRG5 mRNA CTD PMID:39922521 NCBI chr19:10,080,800...10,104,659
Ensembl chr19:10,085,388...10,103,220 		JBrowse link
G Adhfe1 alcohol dehydrogenase, iron containing, 1 decreases expression ISO Glucose results in decreased expression of ADHFE1 mRNA CTD PMID:17178593 NCBI chr 5:14,488,784...14,515,405
Ensembl chr 5:14,488,788...14,515,835 		JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing multiple interactions
increases expression
increases secretion
decreases expression 		EXP
ISO 		ADIPOQ protein inhibits the reaction [Glucose results in decreased expression of ADIPOR2 protein]; argan oil promotes the reaction [Glucose results in increased expression of ADIPOQ protein]; Corn Oil promotes the reaction [Glucose results in increased expression of ADIPOQ protein]
[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; [Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; butylbenzyl phthalate promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; Diethylhexyl Phthalate promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; Pioglitazone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; tributyltin promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]
Glucose deficiency results in increased secretion of ADIPOQ protein
Glucose results in decreased expression of ADIPOQ protein 		CTD PMID:21912612 PMID:24802182 PMID:29165388 PMID:32407875 NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169 		JBrowse link
G Adipor1 adiponectin receptor 1 multiple interactions
decreases expression 		EXP FOXO1 protein inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]; FOXO1 protein inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]; FOXO1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]]; FOXO1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]]; resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]; resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]
Glucose results in decreased expression of ADIPOR1 mRNA; Glucose results in decreased expression of ADIPOR1 protein 		CTD PMID:24413998 NCBI chr13:48,411,438...48,431,251
Ensembl chr13:48,411,826...48,431,255 		JBrowse link
G Adipor2 adiponectin receptor 2 multiple interactions
decreases expression 		EXP ADIPOQ protein inhibits the reaction [Glucose results in decreased expression of ADIPOR2 protein] CTD PMID:21912612 NCBI chr 4:154,195,440...154,261,141
Ensembl chr 4:154,172,567...154,231,666 		JBrowse link
G Adra1a adrenoceptor alpha 1A multiple interactions EXP 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose]; 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose]; 2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose]; [cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose; [Phenylephrine results in increased activity of ADRA1A protein] which results in increased transport of Glucose; Prazosin inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose] CTD PMID:15550506 NCBI chr15:45,005,648...45,111,416
Ensembl chr15:45,005,799...45,102,534 		JBrowse link
G Adrb2 adrenoceptor beta 2 multiple interactions ISO [BRL 37344 binds to and results in increased activity of ADRB2 protein] which results in increased uptake of Glucose; [Clenbuterol binds to and results in increased activity of ADRB2 protein] which results in decreased uptake of Glucose; ICI 118551 inhibits the reaction [[BRL 37344 binds to and results in increased activity of ADRB2 protein] which results in increased uptake of Glucose]; ICI 118551 inhibits the reaction [[Clenbuterol binds to and results in increased activity of ADRB2 protein] which results in decreased uptake of Glucose] CTD PMID:18552870 NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803 		JBrowse link
G Adrb3 adrenoceptor beta 3 multiple interactions ISO [BRL 37344 binds to and results in increased activity of ADRB3 protein] which results in decreased abundance of Glucose; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADRB3 mRNA CTD PMID:20930473 PMID:37567420 NCBI chr16:71,544,603...71,547,410
Ensembl chr16:71,542,567...71,547,420 		JBrowse link
G Afg2b AFG2 AAA ATPase homolog B increases expression ISO Glucose results in increased expression of AFG2B mRNA CTD PMID:39922521 NCBI chr 3:130,148,061...130,162,458
Ensembl chr 3:130,148,301...130,162,112 		JBrowse link
G Afp alpha-fetoprotein increases expression ISO Glucose results in increased expression of AFP mRNA CTD PMID:17178593 NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,857,584...17,875,649 		JBrowse link
G Agbl4 AGBL carboxypeptidase 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of AGBL4 mRNA CTD PMID:37567420 NCBI chr 5:130,483,551...131,762,906 JBrowse link
G Ager advanced glycosylation end product-specific receptor multiple interactions
increases expression 		ISO
EXP 		GLO1 inhibits the reaction [Glucose promotes the reaction [RELA protein binds to AGER promoter]]; GLO1 inhibits the reaction [Glucose results in increased expression of AGER mRNA]; GLO1 inhibits the reaction [Glucose results in increased expression of AGER protein]; Glucose promotes the reaction [RELA protein binds to AGER promoter]; Luteolin inhibits the reaction [Glucose results in increased expression of AGER mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of AGER mRNA]; RELA promotes the reaction [Glucose results in increased expression of AGER mRNA]; Rutin inhibits the reaction [Glucose results in increased expression of AGER mRNA]; SOD2 inhibits the reaction [Glucose results in increased expression of AGER mRNA]; SOD2 inhibits the reaction [Glucose results in increased expression of AGER protein]; UCP1 inhibits the reaction [Glucose results in increased expression of AGER mRNA]; UCP1 inhibits the reaction [Glucose results in increased expression of AGER protein]
[Ribose co-treated with Glucose] results in increased expression of AGER protein; AGER protein affects the reaction [Ribose promotes the reaction [Glucose results in increased phosphorylation of RELA protein]]
Glucose results in increased expression of AGER mRNA; Glucose results in increased expression of AGER protein
AGER protein results in increased susceptibility to [Azoxymethane co-treated with Glucose co-treated with Linoleic Acid]; Glucose promotes the reaction [Azoxymethane results in increased expression of AGER protein]; Glucose promotes the reaction [Linoleic Acid promotes the reaction [Azoxymethane results in increased expression of AGER protein]]; Linoleic Acid promotes the reaction [Glucose promotes the reaction [Azoxymethane results in increased expression of AGER protein]]; Losartan inhibits the reaction [Glucose promotes the reaction [Linoleic Acid promotes the reaction [Azoxymethane results in increased expression of AGER protein]]]; Losartan inhibits the reaction [Linoleic Acid promotes the reaction [Glucose promotes the reaction [Azoxymethane results in increased expression of AGER protein]]]; Metformin inhibits the reaction [Glucose promotes the reaction [Linoleic Acid promotes the reaction [Azoxymethane results in increased expression of AGER protein]]]; Metformin inhibits the reaction [Linoleic Acid promotes the reaction [Glucose promotes the reaction [Azoxymethane results in increased expression of AGER protein]]] 		CTD PMID:19557821 PMID:19759273 PMID:19833897 PMID:22467055 PMID:30101366 More... NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685 		JBrowse link
G Agl amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase increases uptake ISO AGL protein results in increased uptake of Glucose CTD PMID:24700805 NCBI chr 2:207,389,949...207,445,959
Ensembl chr 2:207,389,949...207,445,724 		JBrowse link
G Agt angiotensinogen multiple interactions
increases expression
affects metabolic processing 		ISO
EXP 		(3,4-dihydroxyphenylamino)-2-imidazoline inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]; 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]; [Valsartan co-treated with Simvastatin] inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]]; [Valsartan co-treated with Simvastatin] inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of LIF mRNA]]; acetovanillone inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]; Enalaprilat inhibits the reaction [Glucose results in increased expression of AGT protein]; Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]; Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA]; Glucose promotes the reaction [AGT protein results in increased expression of FOSL1 mRNA]; Glucose promotes the reaction [AGT protein results in increased expression of KLF10 mRNA]; Glucose promotes the reaction [AGT protein results in increased expression of LIF mRNA]; Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]; Rotenone inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]; Simvastatin promotes the reaction [Glucose promotes the reaction [AGT protein results in increased expression of PTGS2 mRNA]]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA]]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of KLF10 mRNA]]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of LIF mRNA]]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]
Glucose results in increased expression of AGT mRNA; Glucose results in increased expression of AGT protein
AGT protein affects the metabolism of Glucose
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Glucose results in increased expression of AGT mRNA]; 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Glucose results in increased expression of AGT protein]; alpha-cyano-4-hydroxycinnamate inhibits the reaction [Glucose results in increased expression of AGT mRNA]; alpha-cyano-4-hydroxycinnamate inhibits the reaction [Glucose results in increased expression of AGT protein]; Carbonyl Cyanide m-Chlorophenyl Hydrazone inhibits the reaction [Glucose results in increased expression of AGT mRNA]; Carbonyl Cyanide m-Chlorophenyl Hydrazone inhibits the reaction [Glucose results in increased expression of AGT protein]; CAT protein inhibits the reaction [Glucose results in increased expression of AGT mRNA]; CAT protein inhibits the reaction [Glucose results in increased expression of AGT protein]; Hydrogen Peroxide promotes the reaction [Glucose results in increased expression of AGT mRNA]; Hydrogen Peroxide promotes the reaction [Glucose results in increased expression of AGT protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of AGT mRNA]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of AGT protein]; NFE2L2 protein affects the reaction [Glucose results in increased expression of AGT mRNA]; oltipraz inhibits the reaction [trigonelline inhibits the reaction [Glucose results in increased expression of AGT mRNA]]; Rotenone inhibits the reaction [Glucose results in increased expression of AGT mRNA]; Rotenone inhibits the reaction [Glucose results in increased expression of AGT protein]; SB 203580 inhibits the reaction [Glucose results in increased expression of AGT mRNA]; SB 203580 inhibits the reaction [Glucose results in increased expression of AGT protein]; Taurine inhibits the reaction [Glucose results in increased expression of AGT mRNA]; Taurine inhibits the reaction [Glucose results in increased expression of AGT protein]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of AGT mRNA]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of AGT protein]; trigonelline inhibits the reaction [Glucose results in increased expression of AGT mRNA]; Valsartan promotes the reaction [Glucose results in increased expression of AGT protein] 		CTD PMID:11115780 PMID:12130563 PMID:15677497 PMID:16452552 PMID:19225232 More... NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944 		JBrowse link
G Agtr1a angiotensin II receptor, type 1a multiple interactions
increases expression 		ISO Enalaprilat inhibits the reaction [Glucose results in increased expression of AGTR1 protein]
CEBPB protein inhibits the reaction [Glucose results in increased expression of AGTR1 protein]
Glucose results in increased expression of AGTR1 mRNA; Glucose results in increased expression of AGTR1 protein 		CTD PMID:16452552 PMID:29266779 PMID:31655124 PMID:34464088 NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660 		JBrowse link
G Agtr2 angiotensin II receptor, type 2 multiple interactions
increases expression 		ISO CEBPB protein inhibits the reaction [Glucose results in increased expression of AGTR2 protein] CTD PMID:29266779 NCBI chr  X:116,914,320...116,918,504
Ensembl chr  X:116,913,656...116,918,745 		JBrowse link
G Ahr aryl hydrocarbon receptor increases response to substance
multiple interactions 		ISO AHR results in increased susceptibility to Glucose
AHR protein promotes the reaction [Tetrachlorodibenzodioxin affects the susceptibility to Glucose]
4,7-phenanthroline inhibits the reaction [AHR promotes the reaction [Tetrachlorodibenzodioxin results in decreased uptake of Glucose]]; AHR promotes the reaction [Tetrachlorodibenzodioxin results in decreased uptake of Glucose]; alpha-naphthoflavone inhibits the reaction [AHR promotes the reaction [Tetrachlorodibenzodioxin results in decreased uptake of Glucose]] 		CTD PMID:8738555 PMID:19623578 PMID:21849270 NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901 		JBrowse link
G Aif1 allograft inflammatory factor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of AIF1 mRNA CTD PMID:37567420 NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,652,243...3,657,339 		JBrowse link
G Aifm1 apoptosis inducing factor, mitochondria associated 1 affects localization
multiple interactions 		EXP Glucose affects the localization of AIFM1 protein
[Oxygen co-treated with Glucose] results in decreased expression of AIFM1 protein; protosappanin A inhibits the reaction [[Oxygen co-treated with Glucose] results in decreased expression of AIFM1 protein]; Quercetin affects the reaction [Glucose affects the localization of AIFM1 protein]; sesamin affects the reaction [Glucose affects the localization of AIFM1 protein] 		CTD PMID:19146853 PMID:22524206 PMID:33225685 NCBI chr  X:132,528,107...132,567,237
Ensembl chr  X:132,528,107...132,567,237 		JBrowse link
G Aim2 absent in melanoma 2 increases expression ISO Glucose results in increased expression of AIM2 mRNA CTD PMID:39613055 NCBI chr13:88,397,516...88,439,325
Ensembl chr13:88,404,048...88,439,318 		JBrowse link
G Ak7 adenylate kinase 7 increases expression ISO Glucose results in increased expression of AK7 mRNA CTD PMID:39922521 NCBI chr 6:130,376,499...130,444,674
Ensembl chr 6:130,376,550...130,444,677 		JBrowse link
G Ak8 adenylate kinase 8 multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of AK8 mRNA] CTD PMID:33448797 NCBI chr 3:32,426,892...32,542,432
Ensembl chr 3:32,426,421...32,542,431 		JBrowse link
G Akap5 A-kinase anchoring protein 5 increases expression ISO Glucose results in increased expression of AKAP5 mRNA CTD PMID:31525975 NCBI chr 6:100,787,169...100,796,712
Ensembl chr 6:100,790,148...100,796,620 		JBrowse link
G Akr1a1 aldo-keto reductase family 1 member A1 multiple interactions
decreases expression 		ISO fidarestat inhibits the reaction [Glucose results in decreased expression of AKR1A1 mRNA] CTD PMID:16805838 NCBI chr 5:135,329,605...135,367,037
Ensembl chr 5:135,329,606...135,367,035 		JBrowse link
G Akr1b1 aldo-keto reductase family 1 member B1 multiple interactions
increases expression 		ISO AKR1B1 protein promotes the reaction [Glucose results in increased abundance of Sorbitol]
Glucose results in increased expression of AKR1B1 mRNA; Glucose results in increased expression of AKR1B1 protein 		CTD PMID:16805838 PMID:25451566 NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:63,899,222...63,913,315 		JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of AKR1C6 mRNA CTD PMID:37567420 NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247 		JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of AKR1C18 mRNA CTD PMID:37567420 NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions
increases expression
decreases phosphorylation
increases phosphorylation
increases response to substance
decreases expression 		ISO
EXP 		2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; [Glucose affects the susceptibility to INS protein] which affects the phosphorylation of AKT1 protein; [Glucose co-treated with Cadmium] results in increased phosphorylation of AKT1 protein; [Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT1 protein; [Palmitic Acid co-treated with Glucose] results in increased phosphorylation of AKT1 protein; ACACB protein affects the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; albiflorin inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased phosphorylation of AKT1 protein]; Berberine inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Captopril inhibits the reaction [Glucose results in increased expression of AKT1 mRNA]; Fluorometholone inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; Glucose inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]; HAGLR protein affects the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; HAGLR protein inhibits the reaction [MIR106B inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; huai qi huang inhibits the reaction [Glucose results in increased expression of AKT1 mRNA]; Metformin inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; MIR106B inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]]; nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT1 protein]; PTEN protein affects the reaction [HAGLR protein affects the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Rosiglitazone inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; spiraeoside inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Wortmannin inhibits the reaction [nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT1 protein]]; zhenwu decoction inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased phosphorylation of AKT1 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [deuterohemin-alanyl-histidyl-threonyl-valyl-glutamyl-lysine inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [diallyl trisulfide inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein]; 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; [3,4-Dihydroxyphenylacetic Acid co-treated with Glucose] results in increased phosphorylation of AKT1 protein; [Catechin co-treated with Glucose] results in increased phosphorylation of AKT1 protein; [Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein; Acetylcysteine inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; deuterohemin-alanyl-histidyl-threonyl-valyl-glutamyl-lysine inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; diallyl trisulfide inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; Simvastatin inhibits the reaction [Glucose results in decreased expression of AKT1 protein modified form]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Glucose co-treated with Calcitriol] results in increased phosphorylation of AKT1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; [AKT1 protein mutant form results in increased susceptibility to Glucose deficiency] which results in increased phosphorylation of EIF4EBP1 protein; [Glucose co-treated with Calcitriol] results in increased phosphorylation of AKT1 protein; AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form results in increased susceptibility to Glucose deficiency]; AKT1 protein modified form inhibits the reaction [arsenite inhibits the reaction [INS1 protein results in increased uptake of Glucose]]; AKT1 protein modified form inhibits the reaction [monomethylarsonous acid inhibits the reaction [INS1 protein results in increased uptake of Glucose]]; AKT1 protein promotes the reaction [Glucose affects the phosphorylation of and affects the activity of FOXO3 protein]; Bezafibrate inhibits the reaction [AKT1 protein mutant form results in increased susceptibility to Glucose deficiency]; Glucose affects the phosphorylation of and affects the activity of AKT1 protein; methyl pyruvate inhibits the reaction [AKT1 protein mutant form results in increased susceptibility to Glucose deficiency]; PRKAA2 protein affects the reaction [AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form affects the susceptibility to Glucose deficiency]]; SMARCA4A protein inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein] 		CTD PMID:15806154 PMID:16385087 PMID:17520061 PMID:18004065 PMID:20370652 More... NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610 		JBrowse link
G Akt2 AKT serine/threonine kinase 2 affects response to substance
multiple interactions 		ISO AKT2 protein affects the susceptibility to Glucose
[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT2 protein; nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT2 protein]; Wortmannin inhibits the reaction [nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT2 protein]] 		CTD PMID:21964073 PMID:38528077 NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:92,014,859...92,061,420 		JBrowse link
G Akt3 AKT serine/threonine kinase 3 multiple interactions ISO [Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT3 protein; nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT3 protein]; Wortmannin inhibits the reaction [nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT3 protein]] CTD PMID:38528077 NCBI chr13:91,475,839...91,758,060
Ensembl chr13:91,475,839...91,748,020 		JBrowse link
G Alb albumin decreases uptake
multiple interactions
increases metabolic processing 		ISO
EXP 		Glucose results in decreased uptake of ALB protein
ALB protein modified form inhibits the reaction [Glucose results in increased phosphorylation of RELA protein]; ALB protein modified form inhibits the reaction [Glucose results in increased secretion of INS1 protein]; MK615 extract inhibits the reaction [ALB protein modified form inhibits the reaction [Glucose results in increased phosphorylation of RELA protein]]; MK615 extract inhibits the reaction [ALB protein modified form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]
Glucose results in increased metabolism of ALB protein
[Glucose deficiency co-treated with ALB protein] results in decreased expression of FABP4 mRNA; [Glucose deficiency co-treated with ALB protein] results in decreased expression of PCK1 mRNA
[Fructose co-treated with Glucose] results in increased glycation of ALB protein; [Peroxynitrous Acid co-treated with Glucose] results in increased glycation of ALB protein; Phlorhizin inhibits the reaction [Glucose results in decreased uptake of ALB protein]; pimagedine inhibits the reaction [[Fructose co-treated with Glucose] results in increased glycation of ALB protein]; pimagedine inhibits the reaction [[Peroxynitrous Acid co-treated with Glucose] results in increased glycation of ALB protein]; ursonic acid inhibits the reaction [[Fructose co-treated with Glucose] results in increased glycation of ALB protein] 		CTD PMID:8536680 PMID:12196478 PMID:12434198 PMID:16313995 PMID:27415824 More... NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865 		JBrowse link
G Alcam activated leukocyte cell adhesion molecule increases expression
multiple interactions 		ISO Glucose results in increased expression of ALCAM mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of ALCAM mRNA] 		CTD PMID:33448797 NCBI chr11:61,804,932...62,005,250
Ensembl chr11:61,805,049...62,006,876 		JBrowse link
G Aldh1b1 aldehyde dehydrogenase 1 family, member B1 increases expression ISO Glucose deficiency results in increased expression of ALDH1B1 protein CTD PMID:22314686 NCBI chr 5:64,859,000...64,864,008
Ensembl chr 5:64,858,934...64,864,365 		JBrowse link
G Aldh1l2 aldehyde dehydrogenase 1 family, member L2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of ALDH1L2 mRNA CTD PMID:37567420 NCBI chr 7:22,141,872...22,193,403
Ensembl chr 7:22,141,842...22,193,398 		JBrowse link
G Aldh2 aldehyde dehydrogenase 2 family member multiple interactions
decreases expression 		EXP N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of ALDH2 protein] CTD PMID:29128638 NCBI chr12:40,610,244...40,643,220
Ensembl chr12:40,610,224...40,643,219 		JBrowse link
G Aldh3a1 aldehyde dehydrogenase 3 family, member A1 decreases expression ISO Glucose results in decreased expression of ALDH3A1 mRNA CTD PMID:39613055 NCBI chr10:46,392,464...46,402,151
Ensembl chr10:46,392,411...46,402,151 		JBrowse link
G Aldh3b3 aldehyde dehydrogenase 3 family, member B3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ALDH3B3 mRNA CTD PMID:37567420 NCBI chr 1:210,617,090...210,629,886
Ensembl chr 1:210,622,639...210,629,879 		JBrowse link
G Aldh6a1 aldehyde dehydrogenase 6 family, member A1 decreases expression ISO Glucose results in decreased expression of ALDH6A1 mRNA CTD PMID:17178593 NCBI chr 6:109,809,092...109,829,725
Ensembl chr 6:109,809,122...109,829,743 		JBrowse link
G Alg12 ALG12, alpha-1,6-mannosyltransferase decreases expression ISO Glucose results in decreased expression of ALG12 mRNA CTD PMID:17178593 NCBI chr 7:121,774,796...121,789,175
Ensembl chr 7:121,768,234...121,788,983 		JBrowse link
G Alk ALK receptor tyrosine kinase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ALK mRNA CTD PMID:37567420 NCBI chr 6:28,631,431...29,351,321
Ensembl chr 6:28,632,197...29,349,721 		JBrowse link
G Alox12 arachidonate 12-lipoxygenase, 12S type increases expression ISO Glucose results in increased expression of ALOX12 mRNA CTD PMID:32942007 NCBI chr10:55,456,923...55,469,239
Ensembl chr10:55,456,928...55,469,199 		JBrowse link
G Alox12b arachidonate 12-lipoxygenase, 12R type increases expression ISO Glucose results in increased expression of ALOX12B mRNA CTD PMID:39922521 NCBI chr10:54,361,898...54,373,776
Ensembl chr10:54,361,898...54,373,776 		JBrowse link
G Alox5 arachidonate 5-lipoxygenase multiple interactions
increases expression 		EXP
ISO 		[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein; caffeic acid inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein]; Edaravone inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein]; SB 203580 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein]
Glucose results in increased expression of ALOX5 mRNA 		CTD PMID:18951527 PMID:31655124 NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:151,203,949...151,251,126 		JBrowse link
G Aloxe3 arachidonate epidermal lipoxygenase 3 increases expression ISO Glucose results in increased expression of ALOXE3 mRNA CTD PMID:39922521 NCBI chr10:54,329,224...54,353,167
Ensembl chr10:54,329,043...54,353,166 		JBrowse link
G Alpk3 alpha-kinase 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ALPK3 mRNA CTD PMID:37567420 NCBI chr 1:144,423,690...144,471,534
Ensembl chr 1:144,423,726...144,490,309 		JBrowse link
G Alpl alkaline phosphatase, biomineralization associated multiple interactions
decreases expression 		ISO
EXP 		2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL protein]]; Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL mRNA]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL mRNA]]; Sirolimus inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL mRNA]]
morroniside inhibits the reaction [Glucose results in decreased expression of ALPL mRNA] 		CTD PMID:32643284 PMID:33450223 NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167 		JBrowse link
G Amer2 APC membrane recruitment protein 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of AMER2 mRNA CTD PMID:37567420 NCBI chr15:38,701,509...38,711,817
Ensembl chr15:38,701,657...38,705,633 		JBrowse link
G Amot angiomotin decreases expression ISO Glucose results in decreased expression of AMOT mRNA CTD PMID:17178593 NCBI chr  X:113,778,990...113,837,846
Ensembl chr  X:113,781,526...113,837,482 		JBrowse link
G Angptl4 angiopoietin-like 4 increases expression ISO Glucose results in increased expression of ANGPTL4 mRNA CTD PMID:16805838 NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681 		JBrowse link
G Ankrd53 ankyrin repeat domain 53 increases expression ISO Glucose results in increased expression of ANKRD53 mRNA CTD PMID:39922521 NCBI chr 4:117,804,702...117,810,650
Ensembl chr 4:117,804,548...117,810,645 		JBrowse link
G Ankrd61 ankyrin repeat domain 61 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of ANKRD61 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of ANKRD61 mRNA] 		CTD PMID:31525975 PMID:33448797 NCBI chr12:15,832,567...15,836,925
Ensembl chr12:15,832,108...15,836,923 		JBrowse link
G Anks1b ankyrin repeat and sterile alpha motif domain containing 1B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ANKS1B mRNA CTD PMID:37567420 NCBI chr 7:26,200,649...27,366,552
Ensembl chr 7:26,201,240...27,364,943 		JBrowse link
G Anp32e acidic nuclear phosphoprotein 32 family member E increases expression ISO Glucose results in increased expression of ANP32E mRNA CTD PMID:39922521 NCBI chr 2:186,161,520...186,177,984
Ensembl chr 2:186,161,532...186,177,986 		JBrowse link
G Anxa5 annexin A5 decreases expression ISO Glucose results in decreased expression of ANXA5 mRNA CTD PMID:31655124 NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:121,242,136...121,281,400 		JBrowse link
G Aoc1 amine oxidase, copper containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of AOC1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of AOC1 mRNA CTD PMID:37567420 NCBI chr 4:79,143,126...79,162,705
Ensembl chr 4:79,143,126...79,162,704 		JBrowse link
G Aoc2-ps1 amine oxidase, copper containing 2, pseudogene 1 increases expression ISO Glucose results in increased expression of AOC2 mRNA CTD PMID:39922521 NCBI chr10:86,767,268...86,768,734 JBrowse link
G Apaf1 apoptotic peptidase activating factor 1 multiple interactions ISO [Glucose co-treated with Deferoxamine] results in increased expression of APAF1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of APAF1 mRNA] CTD PMID:33962019 NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772 		JBrowse link
G Apba1 amyloid beta precursor protein binding family A member 1 increases expression ISO Glucose results in increased expression of APBA1 mRNA CTD PMID:39922521 NCBI chr 1:230,790,297...230,995,986
Ensembl chr 1:230,790,297...230,995,986 		JBrowse link
G Apc APC regulator of WNT signaling pathway decreases expression EXP Glucose results in decreased expression of APC mRNA CTD PMID:21818840 NCBI chr18:26,138,382...26,196,021
Ensembl chr18:26,102,679...26,197,022 		JBrowse link
G Apcs amyloid P component, serum multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of APCS mRNA CTD PMID:37567420 NCBI chr13:87,905,532...87,906,508
Ensembl chr13:87,905,532...87,928,824 		JBrowse link
G Apoa1 apolipoprotein A1 decreases expression
increases expression 		EXP Glucose results in decreased expression of APOA1 mRNA
Glucose results in increased expression of APOA1 mRNA; Glucose results in increased expression of APOA1 protein 		CTD PMID:9322794 PMID:9668074 NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:55,423,825...55,425,729 		JBrowse link
G Apob apolipoprotein B multiple interactions ISO Glucose promotes the reaction [Copper Sulfate results in increased cleavage of APOB protein] CTD PMID:19489629 NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:36,563,704...36,611,814 		JBrowse link
G Apobec2 apolipoprotein B mRNA editing enzyme catalytic subunit 2 increases expression ISO Glucose results in increased expression of APOBEC2 mRNA CTD PMID:39922521 NCBI chr 9:20,062,561...20,076,074
Ensembl chr 9:20,062,526...20,076,071 		JBrowse link
G Apoe apolipoprotein E affects secretion
decreases expression
multiple interactions 		ISO Glucose deficiency affects the secretion of APOE protein
Glucose results in decreased expression of APOE mRNA; Glucose results in decreased expression of APOE protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of APOE mRNA; morroniside inhibits the reaction [Glucose results in decreased expression of APOE mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of APOE protein] 		CTD PMID:24802182 PMID:34485530 PMID:37567420 NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855 		JBrowse link
G Apol9a apolipoprotein L9a multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of APOL9A mRNA CTD PMID:37567420 NCBI chr 7:111,021,452...111,030,380
Ensembl chr 7:111,021,453...111,028,213 		JBrowse link
G Apold1 apolipoprotein L domain containing 1 increases expression ISO Glucose results in increased expression of APOLD1 mRNA CTD PMID:39922521 NCBI chr 4:169,499,728...169,557,075
Ensembl chr 4:169,549,679...169,559,176 		JBrowse link
G App amyloid beta precursor protein increases abundance
multiple interactions 		ISO APP protein mutant form results in increased abundance of Glucose
PF-06840003 inhibits the reaction [APP protein mutant form results in increased abundance of Glucose]
[APP protein mutant form co-treated with PSEN1 protein mutant form co-treated with PF-06840003] results in decreased abundance of Glucose; [APP protein mutant form co-treated with PSEN1 protein mutant form] results in increased abundance of Glucose; IDO1 protein affects the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in increased abundance of Glucose] 		CTD PMID:39172838 NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971 		JBrowse link
G Aqp1 aquaporin 1 multiple interactions
increases expression 		EXP benazepril inhibits the reaction [Glucose results in increased expression of AQP1 mRNA]; Valsartan inhibits the reaction [Glucose results in increased expression of AQP1 mRNA] CTD PMID:11510275 NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504 		JBrowse link
G Aqp3 aquaporin 3 (Gill blood group) multiple interactions
increases expression 		ISO Glucose promotes the reaction [AQP3 protein results in increased transport of Glycerol]
Glucose results in increased expression of AQP3 mRNA; Glucose results in increased expression of AQP3 protein 		CTD PMID:12234316 NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:61,035,166...61,040,685 		JBrowse link
G Aqp4 aquaporin 4 multiple interactions
increases expression 		EXP benazepril inhibits the reaction [Glucose results in increased expression of AQP4 mRNA]; valsartan inhibits the reaction [Glucose results in increased expression of AQP4 mRNA] CTD PMID:11510275 NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,782,389...6,799,098 		JBrowse link
G Aqp5 aquaporin 5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of AQP5 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of AQP5 mRNA CTD PMID:37567420 NCBI chr 7:132,601,528...132,605,060
Ensembl chr 7:132,601,059...132,605,062 		JBrowse link
G Aqp7 aquaporin 7 multiple interactions ISO [Arsenic Trioxide co-treated with Glucose] results in increased expression of AQP7 mRNA; [Arsenic Trioxide co-treated with Glucose] results in increased expression of AQP7 protein; INS protein inhibits the reaction [[Arsenic Trioxide co-treated with Glucose] results in increased expression of AQP7 mRNA]; INS protein inhibits the reaction [[Arsenic Trioxide co-treated with Glucose] results in increased expression of AQP7 protein] CTD PMID:37146668 NCBI chr 5:60,968,495...60,982,618
Ensembl chr 5:60,967,558...60,982,618 		JBrowse link
G Aqp8 aquaporin 8 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of AQP8 mRNA CTD PMID:37567420 NCBI chr 1:187,424,314...187,430,243
Ensembl chr 1:187,424,417...187,430,242 		JBrowse link
G Ar androgen receptor multiple interactions EXP
ISO 		[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of AR mRNA; tetrahydropalmatine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of AR mRNA]
[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate co-treated with lard co-treated with Cholesterol co-treated with Glucose co-treated with Sucrose co-treated with Fructose] results in decreased expression of AR protein 		CTD PMID:37606869 PMID:37615203 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Areg amphiregulin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of AREG mRNA CTD PMID:37567420 NCBI chr14:17,256,384...17,265,641
Ensembl chr14:17,256,384...17,265,641 		JBrowse link
G Arg2 arginase 2 increases expression
decreases expression 		ISO Glucose results in increased expression of ARG2 mRNA
Glucose results in decreased expression of ARG2 mRNA 		CTD PMID:17178593 PMID:39613055 NCBI chr 6:103,669,001...103,694,375
Ensembl chr 6:103,668,988...103,694,375 		JBrowse link
G Arhgap6 Rho GTPase activating protein 6 increases expression ISO Glucose results in increased expression of ARHGAP6 mRNA CTD PMID:31525975 NCBI chr  X:28,525,912...29,062,344
Ensembl chr  X:28,525,917...29,061,244 		JBrowse link
G Arhgdib Rho GDP dissociation inhibitor beta decreases expression
multiple interactions 		ISO Glucose results in decreased expression of ARHGDIB mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of ARHGDIB mRNA] 		CTD PMID:33448797 NCBI chr 4:171,554,139...171,573,057
Ensembl chr 4:171,554,140...171,573,068 		JBrowse link
G Arl4d ARF like GTPase 4D multiple interactions EXP [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of ARL4D mRNA; ARL4D protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr10:87,092,276...87,103,079
Ensembl chr10:87,077,523...87,106,199 		JBrowse link
G Arl5b ARF like GTPase 5B increases expression ISO Glucose results in increased expression of ARL5B mRNA CTD PMID:17178593 NCBI chr17:82,864,315...82,888,458
Ensembl chr17:82,864,287...82,890,646 		JBrowse link
G Arl5c ARF like GTPase 5C multiple interactions
increases expression 		ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of ARL5C mRNA
Glucose results in increased expression of ARL5C mRNA 		CTD PMID:37567420 PMID:39922521 NCBI chr10:83,481,540...83,492,915
Ensembl chr10:83,481,540...83,488,406 		JBrowse link
G Arl9 ARF like GTPase 9 increases expression ISO Glucose results in increased expression of ARL9 mRNA CTD PMID:39922521 NCBI chr14:31,511,845...31,521,038
Ensembl chr14:31,511,330...31,520,988 		JBrowse link
G Armcx6 armadillo repeat containing, X-linked 6 multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of ARMCX6 mRNA] CTD PMID:33448797 NCBI chr  X:102,222,288...102,229,871
Ensembl chr  X:102,222,220...102,240,052 		JBrowse link
G Armt1 acidic residue methyltransferase 1 increases expression ISO Glucose results in increased expression of ARMT1 mRNA CTD PMID:39922521 NCBI chr 1:43,299,916...43,323,675
Ensembl chr 1:43,299,826...43,323,670 		JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator multiple interactions
increases activity 		ISO [Glucose co-treated with Deferoxamine] results in increased expression of ARNT mRNA; Glucose promotes the reaction [[ARNT protein binds to G6PC1 promoter] which results in increased expression of G6PC1 mRNA]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of ARNT mRNA]
[Glucose co-treated with Oxygen deficiency] inhibits the reaction [ARNT protein binds to HIF1A protein]
Glucose results in increased activity of ARNT protein 		CTD PMID:15767253 PMID:18227068 PMID:33962019 NCBI chr 2:185,686,703...185,745,546
Ensembl chr 2:185,680,683...185,745,546 		JBrowse link
G Arsj arylsulfatase family, member J multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of ARSJ mRNA CTD PMID:37567420 NCBI chr 2:217,449,147...217,529,142
Ensembl chr 2:217,449,147...217,529,142 		JBrowse link
G Ascl1 achaete-scute family bHLH transcription factor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ASCL1 mRNA CTD PMID:37567420 NCBI chr 7:23,790,642...23,793,509
Ensembl chr 7:23,790,360...23,798,231 		JBrowse link
G Asic3 acid sensing ion channel subunit 3 increases expression ISO Glucose results in increased expression of ASIC3 mRNA CTD PMID:39922521 NCBI chr 4:11,652,946...11,657,415
Ensembl chr 4:11,652,946...11,657,367 		JBrowse link
G Asip agouti signaling protein multiple interactions
affects response to substance 		ISO [[imeglimin co-treated with Sitagliptin Phosphate] affects the reaction [A mutant form affects the susceptibility to Glucose]] which affects the expression of GCG protein; [[imeglimin co-treated with Sitagliptin Phosphate] affects the reaction [A mutant form affects the susceptibility to Glucose]] which affects the expression of INS1 protein; [imeglimin affects the reaction [A mutant form affects the susceptibility to Glucose]] which affects the expression of GCG protein; [imeglimin affects the reaction [A mutant form affects the susceptibility to Glucose]] which affects the expression of GIP protein; [imeglimin affects the reaction [A mutant form affects the susceptibility to Glucose]] which affects the expression of INS1 protein; [Sitagliptin Phosphate co-treated with imeglimin] affects the reaction [A mutant form affects the susceptibility to Glucose]; imeglimin affects the reaction [A mutant form affects the susceptibility to Glucose] CTD PMID:36977210 NCBI chr 3:163,933,768...164,021,377
Ensembl chr 3:164,015,903...164,021,378 		JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) affects expression ISO Glucose affects the expression of ASNS mRNA CTD PMID:17409444 NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050 		JBrowse link
G Aspg asparaginase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ASPG mRNA CTD PMID:37567420 NCBI chr 6:136,997,832...137,017,417
Ensembl chr 6:136,998,023...137,017,417 		JBrowse link
G Aspn asporin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of ASPN mRNA CTD PMID:37567420 NCBI chr17:15,286,338...15,310,567
Ensembl chr17:15,287,065...15,310,632 		JBrowse link
G Atad1 ATPase family, AAA domain containing 1 multiple interactions EXP ATAD1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 1:239,957,329...240,023,792
Ensembl chr 1:239,957,882...240,009,822 		JBrowse link
G Atf3 activating transcription factor 3 multiple interactions
increases expression 		ISO [imeglimin co-treated with Glucose] results in increased expression of ATF3 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ATF3 mRNA
[imeglimin co-treated with Glucose] promotes the reaction [Thapsigargin results in increased expression of ATF3 mRNA]
Glucose results in increased expression of ATF3 mRNA 		CTD PMID:34588186 PMID:37567420 PMID:39613055 NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750 		JBrowse link
G Atf4 activating transcription factor 4 increases expression
increases response to substance
multiple interactions 		ISO
EXP 		Glucose deficiency results in increased expression of ATF4 mRNA
ATF4 protein results in increased susceptibility to Glucose
Glucose results in increased expression of ATF4 protein
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of ATF4 protein]
Glucose deficiency results in increased expression of ATF4 protein; Glucose results in increased expression of ATF4 protein
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in increased expression of ATF4 protein]]; 4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of ATF4 protein]; [Galactose co-treated with Glucose deficiency] promotes the reaction [Leflunomide results in increased expression of ATF4 protein]; [imeglimin co-treated with Glucose] promotes the reaction [Thapsigargin results in increased expression of ATF4 mRNA]; Acetylcysteine inhibits the reaction [Glucose results in increased expression of ATF4 protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in increased expression of ATF4 protein]; ginsenoside Rg3 promotes the reaction [Acetylcysteine inhibits the reaction [Glucose results in increased expression of ATF4 protein]]; salubrinal inhibits the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of ATF4 protein]] 		CTD PMID:27226639 PMID:27278863 PMID:29427785 PMID:31022492 PMID:34588186 More... NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739 		JBrowse link
G Atf6 activating transcription factor 6 increases expression
multiple interactions 		ISO
EXP 		Glucose deficiency results in increased expression of ATF6 protein; Glucose results in increased expression of ATF6 mRNA; Glucose results in increased expression of ATF6 protein
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of ATF6 protein]; Glucose results in increased expression of and affects the localization of ATF6 protein; Metformin inhibits the reaction [Glucose results in increased expression of and affects the localization of ATF6 protein]
4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of ATF6 protein]; ATF6 protein modified form promotes the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 mRNA]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 protein]]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 mRNA]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 protein] 		CTD PMID:31022492 PMID:34801538 PMID:39798073 NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033 		JBrowse link
G Atg10 autophagy related 10 increases expression
multiple interactions 		ISO Glucose results in increased expression of ATG10 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of ATG10 mRNA] 		CTD PMID:33448797 NCBI chr 2:23,843,695...24,133,459
Ensembl chr 2:23,844,482...24,133,368 		JBrowse link
G Atg3 autophagy related 3 increases expression
multiple interactions
decreases expression 		EXP Glucose results in increased expression of ATG3 mRNA
Berberine inhibits the reaction [Glucose results in decreased expression of ATG3 protein] 		CTD PMID:38444079 PMID:39127087 NCBI chr11:69,130,948...69,159,280
Ensembl chr11:69,121,952...69,159,280 		JBrowse link
G Atg5 autophagy related 5 multiple interactions
increases expression
decreases expression 		EXP 3-methyladenine inhibits the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of ATG5 protein]]; [Glucose co-treated with Lycopene] results in increased expression of ATG5 mRNA; Berberine inhibits the reaction [Glucose results in decreased expression of ATG5 protein]; N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of ATG5 protein]; Sirolimus promotes the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of ATG5 protein]]; SRT1720 inhibits the reaction [Glucose results in decreased expression of ATG5 protein]; ULK1 protein affects the reaction [Glucose results in decreased expression of ATG5 protein]; ULK1 protein affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of ATG5 protein]]
Glucose results in increased expression of ATG5 mRNA 		CTD PMID:29128638 PMID:38444079 PMID:39127087 NCBI chr20:49,380,835...49,471,826
Ensembl chr20:49,380,813...49,471,821 		JBrowse link
G Atg7 autophagy related 7 decreases expression
multiple interactions 		EXP Glucose results in decreased expression of ATG7 protein
Berberine inhibits the reaction [Glucose results in decreased expression of ATG7 protein]; Inositol inhibits the reaction [Glucose results in decreased expression of ATG7 protein]; SRT1720 inhibits the reaction [Glucose results in decreased expression of ATG7 protein] 		CTD PMID:35243728 PMID:39127087 NCBI chr 4:149,390,000...149,597,534
Ensembl chr 4:149,391,390...149,598,319 		JBrowse link
G Atl1 atlastin GTPase 1 multiple interactions EXP ATL1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 6:94,113,149...94,210,955
Ensembl chr 6:94,112,877...94,211,219 		JBrowse link
G Atoh8 atonal bHLH transcription factor 8 decreases expression ISO Glucose results in decreased expression of ATOH8 mRNA CTD PMID:39613055 NCBI chr 4:105,818,203...105,850,379
Ensembl chr 4:105,818,203...105,850,379 		JBrowse link
G Atox1 antioxidant 1 copper chaperone increases expression ISO Glucose results in increased expression of ATOX1 mRNA CTD PMID:32942007 NCBI chr10:40,065,525...40,080,627
Ensembl chr10:40,065,527...40,080,585 		JBrowse link
G Atp1a1 ATPase Na+/K+ transporting subunit alpha 1 multiple interactions ISO
EXP 		Glucose results in decreased expression of and results in decreased activity of ATP1A1 protein; INS protein inhibits the reaction [Glucose results in decreased expression of ATP1A1 protein]
[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of and affects the localization of ATP1A1 protein; Antigen-Antibody Complex inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of and affects the localization of ATP1A1 protein] 		CTD PMID:22162761 PMID:29702141 NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:191,709,311...191,737,425 		JBrowse link
G Atp2a1 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of ATP2A1 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of ATP2A1 mRNA] 		CTD PMID:31525975 PMID:33448797 NCBI chr 1:190,457,198...190,475,410
Ensembl chr 1:190,457,198...190,475,423 		JBrowse link
G Atp5f1a ATP synthase F1 subunit alpha multiple interactions EXP [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of ATP5F1A protein CTD PMID:25997894 NCBI chr18:73,567,537...73,575,473
Ensembl chr18:73,567,526...73,575,922 		JBrowse link
G Atp5f1d ATP synthase F1 subunit delta multiple interactions EXP 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid inhibits the reaction [notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of ATP5F1D protein]]; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of ATP5F1D protein; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of ATP5F1D protein]; Y 27632 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of ATP5F1D protein] CTD PMID:25305180 NCBI chr 7:10,211,260...10,218,989
Ensembl chr 7:10,211,262...10,216,583 		JBrowse link
G Atp6ap2 ATPase H+ transporting accessory protein 2 increases expression
multiple interactions 		EXP Glucose results in increased expression of ATP6AP2 mRNA; Glucose results in increased expression of ATP6AP2 protein
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Glucose results in increased expression of ATP6AP2 mRNA]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Glucose results in increased expression of ATP6AP2 protein] 		CTD PMID:19861503 NCBI chr  X:12,856,708...12,883,670
Ensembl chr  X:12,855,859...12,905,875 		JBrowse link
G Atp7b ATPase copper transporting beta increases expression ISO Glucose results in increased expression of ATP7B mRNA CTD PMID:39922521 NCBI chr16:76,654,725...76,726,092
Ensembl chr16:76,653,660...76,728,801 		JBrowse link
G Aurka aurora kinase A increases expression ISO Glucose results in increased expression of AURKA mRNA CTD PMID:17178593 NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:181,546,742...181,562,771 		JBrowse link
G Azgp1 alpha-2-glycoprotein 1, zinc-binding affects secretion ISO Glucose deficiency affects the secretion of AZGP1 protein CTD PMID:24802182 NCBI chr12:22,044,685...22,051,248
Ensembl chr12:22,044,751...22,053,020 		JBrowse link
G B2m beta-2 microglobulin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of B2M mRNA CTD PMID:37567420 NCBI chr 3:129,549,236...129,555,354
Ensembl chr 3:129,549,318...129,555,356 		JBrowse link
G B3gat3 beta-1,3-glucuronyltransferase 3 multiple interactions
increases expression 		EXP [XDH protein co-treated with Hypoxanthine] inhibits the reaction [Glucose results in increased expression of B3GAT3 mRNA]; IL1B protein inhibits the reaction [Glucose results in increased expression of B3GAT3 mRNA] CTD PMID:11801247 NCBI chr 1:215,246,453...215,253,033
Ensembl chr 1:215,246,482...215,266,876 		JBrowse link
G B3gnt6 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 multiple interactions
increases expression 		ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of B3GNT6 mRNA
Glucose results in increased expression of B3GNT6 mRNA 		CTD PMID:37567420 PMID:39922521 NCBI chr 1:161,897,504...161,915,046
Ensembl chr 1:161,898,323...161,903,354 		JBrowse link
G B4galnt4 beta-1,4-N-acetyl-galactosaminyl transferase 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of B4GALNT4 mRNA CTD PMID:37567420 NCBI chr 1:205,600,989...205,611,889
Ensembl chr 1:205,600,989...205,611,889 		JBrowse link
G Baat bile acid CoA:amino acid N-acyltransferase increases expression ISO Glucose results in increased expression of BAAT mRNA CTD PMID:39922521 NCBI chr 5:68,647,166...68,656,137
Ensembl chr 5:68,646,203...68,656,181 		JBrowse link
G Bad BCL2-associated agonist of cell death multiple interactions
increases expression 		ISO
EXP 		[resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of BAD protein]; Glucose results in decreased phosphorylation of and results in decreased activity of BAD protein
Glucose results in increased expression of BAD mRNA
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAD protein 		CTD PMID:17293559 PMID:20370652 PMID:38444079 NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034 		JBrowse link
G Bak1 BCL2-antagonist/killer 1 multiple interactions
increases expression 		EXP
ISO 		[[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Carvedilol] which results in decreased expression of BAK1 mRNA
Glucose results in increased expression of BAK1 mRNA
[Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA] 		CTD PMID:29122578 PMID:33962019 PMID:38444079 NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,102,335...5,110,974 		JBrowse link
G Bambi BMP and activin membrane-bound inhibitor increases expression
multiple interactions 		ISO Glucose results in increased expression of BAMBI mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of BAMBI mRNA] 		CTD PMID:33448797 NCBI chr17:58,816,438...58,821,003
Ensembl chr17:58,816,442...58,821,247 		JBrowse link
G Barx2 BARX homeobox 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of BARX2 mRNA CTD PMID:37567420 NCBI chr 8:38,509,277...38,576,978
Ensembl chr 8:38,509,277...38,576,978 		JBrowse link
G Batf2 basic leucine zipper ATF-like transcription factor 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of BATF2 mRNA CTD PMID:37567420 NCBI chr 1:212,897,076...212,905,740
Ensembl chr 1:212,875,148...212,905,831 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression
affects expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of BAX mRNA; Glucose results in increased expression of BAX protein
Glucose affects the expression of BAX protein
3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Glucose results in increased expression of BAX protein]; [Dithionite co-treated with Glucose deficiency] results in increased expression of BAX protein; [morroniside co-treated with Diosgenin] inhibits the reaction [Glucose results in increased expression of BAX protein]; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased expression of BAX protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein; Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of BAX protein]]; cinnamic acid inhibits the reaction [Glucose results in increased expression of BAX protein]; Diosgenin inhibits the reaction [Glucose results in increased expression of BAX protein]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of BAX protein]]; gastrodin inhibits the reaction [Glucose results in increased expression of BAX protein]; Metformin inhibits the reaction [Glucose results in increased expression of BAX protein]; morroniside inhibits the reaction [Glucose results in increased expression of BAX protein]; naringenin inhibits the reaction [Glucose results in increased expression of BAX mRNA]; naringenin inhibits the reaction [Glucose results in increased expression of BAX protein]; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased expression of BAX protein]; protosappanin A inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; Quercetin affects the reaction [Glucose affects the expression of BAX protein]; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in increased expression of BAX protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of BAX protein]; Scopoletin inhibits the reaction [Glucose results in increased expression of BAX protein]; sesamin affects the reaction [Glucose affects the expression of BAX protein]; STIM1 protein affects the reaction [Glucose results in increased expression of BAX protein]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX mRNA]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX mRNA]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; 8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one promotes the reaction [[Glucose co-treated with Bupivacaine] results in increased expression of BAX protein]; [Glucose co-treated with Bupivacaine] results in increased expression of BAX protein; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX mRNA; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein modified form; atractylenolide III inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of BAX protein]; Edaravone inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; gastrodin inhibits the reaction [Glucose results in increased expression of BAX protein]; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX mRNA]]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX mRNA]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; Valsartan inhibits the reaction [Glucose results in increased expression of BAX protein]
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in increased expression of BAX protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in increased expression of BAX protein]]; [Carnosine co-treated with asiatic acid] inhibits the reaction [Glucose results in increased expression of BAX mRNA]; [Glucose co-treated with Deferoxamine] results in increased expression of BAX mRNA; [Glucose co-treated with Deferoxamine] results in increased expression of BAX protein; asiatic acid inhibits the reaction [Glucose results in increased expression of BAX mRNA]; Carnosine inhibits the reaction [Glucose results in increased expression of BAX mRNA]; DDIT3 protein inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of BAX protein]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of BAX protein]]; diallyl trisulfide inhibits the reaction [Glucose results in increased expression of BAX protein]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of BAX protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in increased expression of BAX protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BAX mRNA]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BAX protein]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of BAX protein]]; MIR142 inhibits the reaction [Glucose results in increased expression of BAX protein]; MitoTEMPO inhibits the reaction [Glucose results in increased expression of BAX protein]; NDRG2 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; polyethylene glycol loxenatide inhibits the reaction [Glucose results in increased expression of BAX protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of BAX protein]; salvianolic acid inhibits the reaction [Glucose results in increased expression of BAX protein]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased expression of BAX protein]]; spiraeoside inhibits the reaction [Glucose results in increased expression of BAX protein]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of BAX protein] 		CTD PMID:21803128 PMID:22524206 PMID:23192364 PMID:23451161 PMID:24218232 More... NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Bbc3 Bcl-2 binding component 3 multiple interactions ISO [Glucose co-treated with Deferoxamine] results in increased expression of BBC3 mRNA; [Palmitic Acid co-treated with Glucose] results in increased expression of BBC3 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BBC3 mRNA]; SIRT1 protein mutant form inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased expression of BBC3 mRNA]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BBC3 protein modified form; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BBC3 protein] 		CTD PMID:24451382 PMID:28675767 PMID:33962019 NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:86,141,603...86,150,666 		JBrowse link
G Bcan brevican increases expression ISO Glucose results in increased expression of BCAN mRNA CTD PMID:39922521 NCBI chr 2:175,752,333...175,765,766
Ensembl chr 2:175,752,336...175,765,314 		JBrowse link
G Bche butyrylcholinesterase increases expression
multiple interactions 		ISO Glucose results in increased expression of BCHE mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of BCHE mRNA] 		CTD PMID:33448797 NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760 		JBrowse link
G Bcl11a BCL11 transcription factor A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of BCL11A mRNA CTD PMID:37567420 NCBI chr14:102,230,147...102,325,289
Ensembl chr14:102,231,113...102,325,623 		JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions
decreases expression
affects expression 		ISO
EXP 		2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; [Glucose co-treated with Deferoxamine] results in decreased expression of BCL2 mRNA; [Glucose co-treated with Deferoxamine] results in decreased expression of BCL2 protein; [Resveratrol co-treated with Glucose] results in increased expression of BCL2 protein; asiatic acid inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]; asiatic acid promotes the reaction [Carnosine inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]]; Berberine inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Carnosine inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]; Carnosine promotes the reaction [asiatic acid inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]]; Catechin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]; DDIT3 protein inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; diallyl trisulfide inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; epigallocatechin gallate inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]; ginsenoside Re inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Gliclazide inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]; Glucose results in increased degradation of and results in decreased expression of BCL2 protein; Luteolin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in decreased expression of BCL2 mRNA]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in decreased expression of BCL2 protein]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in decreased expression of BCL2 protein]]; MIR142 inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; MitoTEMPO inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; NS 1619 inhibits the reaction [Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]]; polyethylene glycol loxenatide inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Quercetin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]; Rutin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]; salvianolic acid inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; spiraeoside inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Tamoxifen inhibits the reaction [Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]]; TAOK1 mRNA alternative form affects the reaction [Glucose results in decreased expression of BCL2 protein]
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 mRNA]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 mRNA]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; 8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one promotes the reaction [[Glucose co-treated with Bupivacaine] results in decreased expression of BCL2 protein]; [Glucose co-treated with Bupivacaine] results in decreased expression of BCL2 protein; [Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 mRNA; [Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA; atractylenolide III inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]]; gastrodin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 mRNA]]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 mRNA]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; linderalactone inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; MIR210 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 mRNA]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]; U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid inhibits the reaction [notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of BCL2 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]; 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; [Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein; [Glucose co-treated with Lycopene] results in increased expression of BCL2 mRNA; [Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of BCL2 protein]; [morroniside co-treated with Diosgenin] inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of BCL2 protein; [Oxygen deficiency co-treated with Glucose deficiency] affects the expression of BCL2 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein; Chlorogenic Acid inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; cinnamic acid inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Diosgenin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; gastrodin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Metformin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; morroniside inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; naringenin inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]; naringenin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of BCL2 protein]; Quercetin affects the reaction [Glucose affects the expression of BCL2 protein]; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Scopoletin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; sesamin affects the reaction [Glucose affects the expression of BCL2 protein]; STIM1 protein affects the reaction [Glucose results in decreased expression of BCL2 protein]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]
Glucose results in decreased expression of BCL2 mRNA; Glucose results in decreased expression of BCL2 protein
Glucose affects the expression of BCL2 mRNA; Glucose affects the expression of BCL2 protein 		CTD PMID:18088078 PMID:19557821 PMID:21413024 PMID:21803128 PMID:21818840 More... NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Bcl2l1 Bcl2-like 1 multiple interactions EXP BCL2L1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907
Ensembl chr 1:161,745,540...161,764,907 		JBrowse link
G Bcl2l11 Bcl2-like 11 multiple interactions
increases expression 		EXP 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein]]; resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein] CTD PMID:25471227 NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:135,817,562...135,960,695 		JBrowse link
G Bcl2l15 Bcl2-like 15 multiple interactions ISO [Glucose co-treated with Deferoxamine] results in increased expression of BCL2L15 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BCL2L15 mRNA] CTD PMID:33962019 NCBI chr 2:194,019,158...194,032,516
Ensembl chr 2:194,027,397...194,032,516 		JBrowse link
G Bcl3 BCL3, transcription coactivator decreases expression ISO Glucose results in decreased expression of BCL3 mRNA CTD PMID:39613055 NCBI chr 1:88,599,321...88,613,555
Ensembl chr 1:88,599,321...88,614,368 		JBrowse link
G Bco1 beta-carotene oxygenase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of BCO1 mRNA CTD PMID:37567420 NCBI chr19:62,058,061...62,094,923
Ensembl chr19:62,058,089...62,094,917 		JBrowse link
G Bdkrb1 bradykinin receptor B1 increases expression
multiple interactions 		EXP Glucose results in increased expression of BDKRB1 protein
argan oil inhibits the reaction [Glucose results in increased expression of BDKRB1 protein]; Corn Oil inhibits the reaction [Glucose results in increased expression of BDKRB1 protein] 		CTD PMID:29165388 NCBI chr 6:130,275,631...130,284,968
Ensembl chr 6:130,275,478...130,280,973 		JBrowse link
G Becn1 beclin 1 multiple interactions
increases expression
decreases expression 		EXP
ISO 		[Glucose co-treated with Lycopene] results in increased expression of BECN1 mRNA; [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in decreased expression of BECN1 protein]; [Resveratrol co-treated with Glucose] results in increased expression of BECN1 protein; Inositol inhibits the reaction [Glucose results in decreased expression of BECN1 protein]; SRT1720 inhibits the reaction [Glucose results in decreased expression of BECN1 protein]
Glucose results in increased expression of BECN1 mRNA
Glucose results in increased expression of BECN1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in increased expression of BECN1 protein]]; Calcitriol inhibits the reaction [Glucose results in increased expression of BECN1 protein]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in increased expression of BECN1 protein]]; HU 308 inhibits the reaction [Glucose results in decreased expression of BECN1 protein] 		CTD PMID:25997894 PMID:28713934 PMID:30459625 PMID:33450223 PMID:35243728 More... NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002 		JBrowse link
G Begain brain-enriched guanylate kinase-associated multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of BEGAIN mRNA CTD PMID:37567420 NCBI chr 6:133,708,010...133,744,264
Ensembl chr 6:133,708,007...133,744,526 		JBrowse link
G Bglap bone gamma-carboxyglutamate protein multiple interactions
decreases expression 		ISO
EXP 		2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP protein]]; Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP mRNA]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP mRNA]]; Sirolimus inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP mRNA]]
Glucose results in decreased expression of BGLAP mRNA; Glucose results in decreased expression of BGLAP protein
morroniside inhibits the reaction [Glucose results in decreased expression of BGLAP mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of BGLAP protein] 		CTD PMID:32643284 PMID:33450223 NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:176,136,341...176,137,318 		JBrowse link
G Bhlha15 basic helix-loop-helix family, member a15 affects expression ISO Glucose affects the expression of BHLHA15 mRNA CTD PMID:39613055 NCBI chr12:15,534,123...15,538,299
Ensembl chr12:15,534,123...15,538,515 		JBrowse link
G Bhmt betaine-homocysteine S-methyltransferase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of BHMT mRNA CTD PMID:37567420 NCBI chr 2:26,594,852...26,614,429
Ensembl chr 2:26,594,854...26,614,715 		JBrowse link
G Bid BH3 interacting domain death agonist multiple interactions ISO [Glucose co-treated with Deferoxamine] results in increased expression of BID mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BID mRNA] CTD PMID:33962019 NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275 		JBrowse link
G Bmp2 bone morphogenetic protein 2 multiple interactions
decreases expression 		ISO
EXP 		cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of BMP2 mRNA]; tin mesoporphyrin promotes the reaction [Glucose results in decreased expression of BMP2 mRNA]
morroniside inhibits the reaction [Glucose results in decreased expression of BMP2 mRNA] 		CTD PMID:19924377 PMID:32643284 NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:141,264,646...141,274,760 		JBrowse link
G Bmper BMP-binding endothelial regulator multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of BMPER mRNA CTD PMID:37567420 NCBI chr 8:30,008,049...30,253,201
Ensembl chr 8:30,008,148...30,434,359 		JBrowse link
G Bnip3 BCL2 interacting protein 3 multiple interactions
decreases expression 		ISO
EXP 		[Glucose co-treated with Deferoxamine] results in increased expression of BNIP3 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BNIP3 mRNA]
Berberine inhibits the reaction [Glucose results in decreased expression of BNIP3 protein]; SRT1720 inhibits the reaction [Glucose results in decreased expression of BNIP3 protein] 		CTD PMID:33962019 PMID:39127087 NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962 		JBrowse link
G Bnip3l BCL2 interacting protein 3 like multiple interactions
decreases expression 		ISO
EXP 		[Glucose co-treated with Deferoxamine] results in increased expression of BNIP3L mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BNIP3L mRNA]
Glucose results in decreased expression of BNIP3L protein
Inositol inhibits the reaction [Glucose results in decreased expression of BNIP3L protein] 		CTD PMID:33962019 PMID:35243728 NCBI chr15:45,350,081...45,373,213
Ensembl chr15:45,334,537...45,373,282 		JBrowse link
G Bop1 BOP1 ribosomal biogenesis factor increases expression ISO Glucose results in increased expression of BOP1 mRNA CTD PMID:39613055 NCBI chr 7:110,052,716...110,076,529
Ensembl chr 7:110,052,720...110,076,529 		JBrowse link
G Bspry B-box and SPRY domain containing increases expression ISO Glucose results in increased expression of BSPRY mRNA CTD PMID:39922521 NCBI chr 5:80,942,974...80,965,157
Ensembl chr 5:80,942,979...80,988,154 		JBrowse link
G Bst2 bone marrow stromal cell antigen 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of BST2 mRNA CTD PMID:37567420 NCBI chr16:18,250,593...18,254,967
Ensembl chr16:18,251,847...18,254,967 		JBrowse link
G Btbd17 BTB domain containing 17 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of BTBD17 mRNA CTD PMID:37567420 NCBI chr10:100,325,177...100,331,669
Ensembl chr10:100,325,177...100,331,771 		JBrowse link
G Btn1a1 butyrophilin, subfamily 1, member A1 increases expression ISO Glucose results in increased expression of BTN1A1 mRNA CTD PMID:39922521 NCBI chr17:42,080,217...42,092,286
Ensembl chr17:42,081,527...42,092,276 		JBrowse link
G C1qtnf3 C1q and TNF related 3 decreases expression ISO Glucose results in decreased expression of C1QTNF3 mRNA CTD PMID:31525975 NCBI chr 2:61,644,225...61,666,640
Ensembl chr 2:61,644,276...61,666,559 		JBrowse link
G C1r complement C1r decreases secretion ISO Glucose deficiency results in decreased secretion of C1R protein CTD PMID:24802182 NCBI chr 4:159,099,013...159,109,770
Ensembl chr 4:159,098,918...159,109,714 		JBrowse link
G C1s complement C1s affects secretion ISO Glucose deficiency affects the secretion of C1S protein CTD PMID:24802182 NCBI chr 4:159,116,549...159,128,736
Ensembl chr 4:159,116,549...159,128,736 		JBrowse link
G C3 complement C3 increases expression
multiple interactions 		ISO Glucose results in increased expression of C3 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of C3 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of C3 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of C3 mRNA 		CTD PMID:17178593 PMID:23199288 PMID:37567420 NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339 		JBrowse link
G C4b complement C4B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of C4B mRNA CTD PMID:37567420 NCBI chr20:4,201,979...4,216,292
Ensembl chr20:4,201,961...4,216,289 		JBrowse link
G C5 complement C5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of HC mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of HC mRNA CTD PMID:37567420 NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:38,668,174...38,759,468 		JBrowse link
G C5ar1 complement C5a receptor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of C5AR1 mRNA CTD PMID:37567420 NCBI chr 1:86,077,309...86,088,001 JBrowse link
G Ca14 carbonic anhydrase 14 increases expression ISO Glucose results in increased expression of CAR14 mRNA CTD PMID:39922521 NCBI chr 2:186,131,196...186,138,164
Ensembl chr 2:186,129,341...186,138,863 		JBrowse link
G Ca3 carbonic anhydrase 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CAR3 mRNA CTD PMID:37567420 NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:88,491,670...88,500,524 		JBrowse link
G Cabp4 calcium binding protein 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of CABP4 mRNA CTD PMID:37567420 NCBI chr 1:210,857,223...210,872,431
Ensembl chr 1:210,858,133...210,862,632 		JBrowse link
G Cacna1s calcium voltage-gated channel subunit alpha1 S multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CACNA1S mRNA CTD PMID:37567420 NCBI chr13:50,045,668...50,115,903
Ensembl chr13:50,045,668...50,115,903 		JBrowse link
G Calca calcitonin-related polypeptide alpha increases expression
multiple interactions 		ISO Glucose results in increased expression of CALCA mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CALCA mRNA 		CTD PMID:31655124 PMID:37567420 NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529 		JBrowse link
G Calm2 calmodulin 2 multiple interactions EXP CALM2 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 6:12,845,170...12,857,830
Ensembl chr15:64,519,554...64,520,657
Ensembl chr 6:64,519,554...64,520,657 		JBrowse link
G Calr calreticulin decreases expression ISO Glucose results in decreased expression of CALR mRNA CTD PMID:17178593 NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236 		JBrowse link
G Calu calumenin decreases secretion ISO Glucose deficiency results in decreased secretion of CALU protein CTD PMID:24802182 NCBI chr 4:58,914,456...58,941,957
Ensembl chr 4:58,914,421...58,941,956 		JBrowse link
G Caly calcyon neuron-specific vesicular protein multiple interactions EXP CALY protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 1:204,292,317...204,303,506
Ensembl chr 1:204,292,318...204,303,196 		JBrowse link
G Canx calnexin decreases expression
increases expression
multiple interactions 		ISO
EXP 		Glucose results in decreased expression of CANX mRNA
Glucose results in increased expression of CANX protein
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of CANX protein] 		CTD PMID:17178593 PMID:34801538 NCBI chr10:35,124,941...35,157,954
Ensembl chr10:35,124,941...35,157,857 		JBrowse link
G Capn1 calpain 1 multiple interactions
increases expression 		EXP
ISO 		2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside inhibits the reaction [[Oxygen co-treated with Glucose deficiency] results in increased expression of CAPN1 protein]; [Oxygen co-treated with Glucose deficiency] results in increased expression of CAPN1 protein
Glucose results in increased expression of CAPN1 protein
Furans analog inhibits the reaction [Glucose results in increased expression of CAPN1 protein] 		CTD PMID:24726522 PMID:28911973 NCBI chr 1:212,705,219...212,736,134
Ensembl chr 1:212,705,222...212,729,445 		JBrowse link
G Card14 caspase recruitment domain family, member 14 increases expression ISO Glucose results in increased expression of CARD14 mRNA CTD PMID:39922521 NCBI chr10:105,064,941...105,100,132
Ensembl chr10:105,064,941...105,100,132 		JBrowse link
G Casp1 caspase 1 increases activity
increases cleavage
increases expression
multiple interactions 		EXP
ISO 		Glucose results in increased activity of CASP1 mRNA; Glucose results in increased activity of CASP1 protein
Glucose results in increased cleavage of CASP1 protein
Glucose results in increased expression of CASP1 mRNA
Glucose results in increased expression of CASP1 protein
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP1 protein modified form; Allopurinol inhibits the reaction [Glucose results in increased expression of CASP1 protein]; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP1 protein modified form]; L 709049 analog inhibits the reaction [Glucose results in increased expression of CASP1 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of CASP1 protein]; rhodioloside inhibits the reaction [Glucose results in increased expression of CASP1 protein]; Suramin inhibits the reaction [Glucose results in increased activity of CASP1 protein]; TXNIP mRNA promotes the reaction [Glucose results in increased expression of CASP1 protein]
[Glucose co-treated with TGFB1 protein] results in increased cleavage of CASP1 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP1 protein; Allopurinol inhibits the reaction [Glucose results in increased expression of CASP1 protein]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased cleavage of CASP1 protein]; bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP1 protein]; Glucose results in increased expression of and results in increased cleavage of CASP1 protein; HAGLR protein affects the reaction [Glucose results in increased expression of and results in increased cleavage of CASP1 protein]; HAGLR protein promotes the reaction [Glucose results in increased expression of and results in increased cleavage of CASP1 protein]; L 709049 analog inhibits the reaction [Glucose results in increased expression of CASP1 protein]; Lipopolysaccharides inhibits the reaction [swietenine inhibits the reaction [Glucose results in increased expression of CASP1 protein]]; Lipopolysaccharides promotes the reaction [Glucose results in increased expression of CASP1 protein]; loganin inhibits the reaction [Glucose results in increased expression of CASP1 mRNA]; loganin inhibits the reaction [Glucose results in increased expression of CASP1 protein]; MIR200C mRNA affects the reaction [Glucose results in increased cleavage of CASP1 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Glucose results in increased expression of CASP1 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide promotes the reaction [swietenine inhibits the reaction [Glucose results in increased expression of CASP1 protein]]; PTEN protein affects the reaction [HAGLR protein affects the reaction [Glucose results in increased expression of and results in increased cleavage of CASP1 protein]]; Quercetin inhibits the reaction [Glucose results in increased expression of CASP1 protein]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased cleavage of CASP1 protein]]; swietenine inhibits the reaction [Glucose results in increased expression of CASP1 protein]; TXNIP mRNA promotes the reaction [Glucose results in increased expression of CASP1 protein]
Glucose results in increased expression of CASP1 mRNA; Glucose results in increased expression of CASP1 protein
Acetylcysteine inhibits the reaction [Glucose results in increased cleavage of CASP1 protein]; FOXO3 protein promotes the reaction [Glucose results in increased cleavage of and results in increased activity of CASP1 protein]; Glucose results in increased cleavage of and results in increased activity of CASP1 protein; Glucose results in increased expression of and results in increased cleavage of CASP1 protein 		CTD PMID:20370652 PMID:21832250 PMID:23647015 PMID:27783111 PMID:29031534 More... NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275 		JBrowse link
G Casp12 caspase 12 multiple interactions
increases cleavage
increases expression 		ISO
EXP 		TRPM7 protein affects the reaction [Glucose results in increased cleavage of CASP12 protein]; waixenicin A inhibits the reaction [Glucose results in increased cleavage of CASP12 protein]
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in increased cleavage of CASP12 protein]]; Acetylcysteine inhibits the reaction [Glucose results in increased cleavage of CASP12 protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in increased cleavage of CASP12 protein]; ginsenoside Rg3 promotes the reaction [Acetylcysteine inhibits the reaction [Glucose results in increased cleavage of CASP12 protein]]
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of CASP12 protein] 		CTD PMID:30076216 PMID:34801538 PMID:39579577 NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:10,926,994...10,954,442 		JBrowse link
G Casp3 caspase 3 multiple interactions
decreases expression
increases cleavage
increases expression
increases activity 		ISO
EXP 		2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; [Carnosine co-treated with asiatic acid] inhibits the reaction [Glucose results in increased activity of CASP3 protein]; [Glucose co-treated with Deferoxamine] results in increased expression of CASP3 mRNA; [Glucose co-treated with Deferoxamine] results in increased expression of CASP3 protein; [Glucose co-treated with Deferoxamine] results in increased expression of CASP3 protein modified form; [Glucose deficiency co-treated with Acetylcysteine] results in increased activity of CASP3 protein; [Glucose deficiency co-treated with CAT] results in increased activity of CASP3 protein; [Glucose deficiency co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP3 protein; [Palmitic Acid co-treated with Glucose] results in increased cleavage of CASP3 protein; asiatic acid inhibits the reaction [Glucose results in increased activity of CASP3 protein]; Captopril inhibits the reaction [Glucose results in increased expression of CASP3 mRNA]; Carnosine inhibits the reaction [Glucose results in increased activity of CASP3 protein]; DDIT3 protein inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; diallyl trisulfide inhibits the reaction [Glucose results in increased activity of CASP3 protein]; Fluorometholone inhibits the reaction [Glucose results in increased activity of CASP3 protein]; ginsenoside Re inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Gliclazide inhibits the reaction [Glucose results in increased expression of CASP3 protein]; huai qi huang inhibits the reaction [Glucose results in increased expression of CASP3 mRNA]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of CASP3 protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CASP3 mRNA]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CASP3 protein modified form]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CASP3 protein]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased cleavage of CASP3 protein]]; MIR142 inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; MitoTEMPO inhibits the reaction [Glucose results in increased activity of CASP3 protein]; polyethylene glycol loxenatide inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Rosiglitazone inhibits the reaction [Glucose results in increased activity of CASP3 protein]; rutecarpine inhibits the reaction [Glucose results in increased activity of CASP3 protein]; salvianolic acid inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; SIRT1 protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased cleavage of CASP3 protein]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased cleavage of CASP3 protein]
Glucose results in decreased expression of CASP3 mRNA
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid inhibits the reaction [notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased cleavage of CASP3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [2-chloro-N(6)cyclopentyladenosine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [LY 379268 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; 2-chloro-N(6)cyclopentyladenosine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; [Dithionite co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein; [Glucose co-treated with Lycopene] results in increased expression of CASP3 mRNA; [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]; [morroniside co-treated with Diosgenin] inhibits the reaction [Glucose results in increased expression of and results in increased activity of CASP3 protein]; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased activity of CASP3 protein; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased cleavage of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] affects the expression of and affects the activity of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of and results in increased cleavage of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form; Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP3]; Antigen-Antibody Complex inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; Chlorogenic Acid inhibits the reaction [Glucose results in increased activity of CASP3 protein]; cinnamic acid inhibits the reaction [Glucose results in increased activity of CASP3 protein]; cobaltiprotoporphyrin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]; diallyl trisulfide inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Diosgenin inhibits the reaction [Glucose results in increased expression of and results in increased activity of CASP3 protein]; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]; gastrodin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Glucose results in increased expression of and results in increased activity of CASP3 protein; Glucose results in increased expression of and results in increased cleavage of CASP3 protein; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; HMOX1 protein promotes the reaction [diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; IGF2R protein modified form inhibits the reaction [Glucose results in increased expression of CASP3 protein modified form]; IGF2R protein modified form inhibits the reaction [Glucose results in increased expression of CASP3 protein]; KEAP1 protein inhibits the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; LY 379268 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; Metformin inhibits the reaction [Glucose results in increased activity of CASP3 protein]; Metformin inhibits the reaction [Glucose results in increased expression of and results in increased activity of CASP3 protein]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; morroniside inhibits the reaction [Glucose results in increased expression of and results in increased activity of CASP3 protein]; naringenin inhibits the reaction [Glucose results in increased activity of CASP3 protein]; naringenin inhibits the reaction [Glucose results in increased expression of and results in increased cleavage of CASP3 protein]; naringenin inhibits the reaction [Glucose results in increased expression of CASP3 mRNA]; NFE2L2 mutant form inhibits the reaction [diallyl trisulfide inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; NFE2L2 protein mutant form affects the reaction [plumbagin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; NFE2L2 protein promotes the reaction [diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; NFE2L2 protein promotes the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased activity of CASP3 protein]; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased cleavage of CASP3 protein]; plumbagin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; protosappanin A inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of and results in increased cleavage of CASP3 protein]; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in increased expression of CASP3 protein]; Quercetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein]; Quercetin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of CASP3 mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of CASP3 protein modified form]; Scopoletin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; sesamin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Simvastatin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; STIM1 protein affects the reaction [Glucose results in increased cleavage of CASP3 protein]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; U 0126 inhibits the reaction [2-chloro-N(6)cyclopentyladenosine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; U 0126 inhibits the reaction [LY 379268 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; WDR35 protein affects the reaction [Glucose results in increased activity of CASP3 protein]; Y 27632 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased cleavage of CASP3 protein]
Glucose results in increased expression of CASP3 mRNA; Glucose results in increased expression of CASP3 protein; Glucose results in increased expression of CASP3 protein modified form
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CASP3 mRNA]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CASP3 mRNA]; [Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CASP3 mRNA; [Glucose deficiency co-treated with Simvastatin] results in increased cleavage of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein; atractylenolide III inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein]; Edaravone inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein]; FOXO3 protein promotes the reaction [Glucose results in increased cleavage of and results in increased activity of CASP3 protein]; gastrodin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Glucose deficiency inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein modified form]; Glucose results in increased cleavage of and results in increased activity of CASP3 protein; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]]; imeglimin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; INO 1001 inhibits the reaction [Glucose results in increased activity of CASP3 protein]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CASP3 mRNA]]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CASP3 mRNA]; linderalactone inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; MIR144 mRNA promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; MIR322 affects the reaction [Glucose results in increased cleavage of CASP3 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; TRAF3 affects the reaction [Glucose results in increased cleavage of CASP3 protein]; TRPM7 protein affects the reaction [Glucose results in increased cleavage of CASP3 protein]; U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein]; VDAC1 protein inhibits the reaction [Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; VDAC1 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; waixenicin A inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; zinc protoporphyrin inhibits the reaction [[Glucose deficiency co-treated with Simvastatin] results in increased cleavage of CASP3 protein]
Glucose results in increased activity of CASP3; Glucose results in increased activity of CASP3 protein 		CTD PMID:15322300 PMID:16135072 PMID:17065336 PMID:17293559 PMID:17309078 More... NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Casp8 caspase 8 increases activity
increases expression
multiple interactions 		ISO
EXP 		Glucose results in increased activity of CASP8 protein
Glucose results in increased expression of CASP8 mRNA
[Glucose co-treated with Deferoxamine] results in increased expression of CASP8 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CASP8 mRNA]
[Glucose co-treated with Lycopene] results in increased expression of CASP8 mRNA; Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP8] 		CTD PMID:18791325 PMID:18973755 PMID:33962019 PMID:38444079 NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699 		JBrowse link
G Casp9 caspase 9 multiple interactions
increases cleavage
increases expression
increases activity 		ISO
EXP 		2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in increased cleavage of CASP9 protein]]; [Glucose deficiency co-treated with Acetylcysteine] results in increased activity of CASP9 protein; [Glucose deficiency co-treated with CAT] results in increased activity of CASP9 protein; [Glucose deficiency co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP9 protein; ginsenoside Rg3 inhibits the reaction [Glucose results in increased cleavage of CASP9 protein]; salvianolic acid inhibits the reaction [Glucose results in increased cleavage of CASP9 protein]
Glucose results in increased expression of CASP9 mRNA; Glucose results in increased expression of CASP9 protein
Glucose results in increased activity of CASP9
[Glucose co-treated with IGF2R protein modified form] results in increased expression of CASP9 protein; [Glucose co-treated with Lycopene] results in increased expression of CASP9 mRNA; [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of and results in increased cleavage of CASP9 protein; Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP9]; Glucose results in increased expression of and results in increased cleavage of CASP9 protein; naringenin inhibits the reaction [Glucose results in increased expression of and results in increased cleavage of CASP9 protein]; naringenin inhibits the reaction [Glucose results in increased expression of CASP9 mRNA]; protosappanin A inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of and results in increased cleavage of CASP9 protein]; Scopoletin inhibits the reaction [Glucose results in increased expression of CASP9 protein] 		CTD PMID:17309078 PMID:18791325 PMID:23192364 PMID:25997894 PMID:30431688 More... Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Casz1 castor zinc finger 1 increases expression
multiple interactions 		ISO Glucose results in increased expression of CASZ1 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of CASZ1 mRNA] 		CTD PMID:33448797 NCBI chr 5:164,527,083...164,677,037
Ensembl chr 5:164,527,112...164,677,014 		JBrowse link
G Cat catalase multiple interactions
decreases expression
decreases activity
increases activity
increases expression 		ISO
EXP 		2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in increased activity of CAT protein]]; [Glucose deficiency co-treated with CAT] affects the localization of ENDOG protein; [Glucose deficiency co-treated with CAT] results in increased activity of CASP3 protein; [Glucose deficiency co-treated with CAT] results in increased activity of CASP9 protein; [Glucose deficiency co-treated with CAT] results in increased cleavage of PARP1 protein; CAT inhibits the reaction [Glucose deficiency affects the folding of SOD2 protein]; CAT inhibits the reaction [Glucose deficiency results in increased activity of MAPK1 protein]; CAT inhibits the reaction [Glucose deficiency results in increased activity of MAPK14 protein]; CAT inhibits the reaction [Glucose deficiency results in increased activity of MAPK3 protein]; CAT inhibits the reaction [Glucose deficiency results in increased degradation of SOD1 protein]; CAT protein inhibits the reaction [Glucose promotes the reaction [EDN1 protein results in increased chemical synthesis of Inositol 1,4,5-Trisphosphate]]; cyclopamine inhibits the reaction [SHH protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]]; Furans analog inhibits the reaction [Glucose results in decreased activity of CAT protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in decreased expression of CAT protein]; SHH protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]; SIRT3 protein inhibits the reaction [Glucose results in increased expression of CAT protein]; solanesol inhibits the reaction [Glucose results in decreased activity of CAT protein]; spiraeoside inhibits the reaction [Glucose results in increased activity of CAT protein]
4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits the reaction [gastrodin inhibits the reaction [Glucose results in decreased activity of CAT protein]]; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein; cyclopamine inhibits the reaction [polydatin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]]; cyclopamine promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]; gastrodin inhibits the reaction [Glucose results in decreased activity of CAT protein]; NFE2L2 protein affects the reaction [gastrodin inhibits the reaction [Glucose results in decreased activity of CAT protein]]; polydatin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]
Glucose deficiency results in increased expression of CAT protein; Glucose results in increased expression of CAT protein
4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits the reaction [gastrodin inhibits the reaction [Glucose results in decreased activity of CAT protein]]; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in decreased activity of CAT protein; CAT protein inhibits the reaction [Glucose results in increased expression of AGT mRNA]; CAT protein inhibits the reaction [Glucose results in increased expression of AGT protein]; CAT protein inhibits the reaction [Glucose results in increased expression of GNA11 protein]; CAT protein inhibits the reaction [Glucose results in increased expression of GNAQ protein]; CAT protein inhibits the reaction [Glucose results in increased expression of PLCB1 protein]; CAT protein inhibits the reaction [Glucose results in increased expression of PLCB2 protein]; gastrodin inhibits the reaction [Glucose results in decreased activity of CAT protein]; naringenin inhibits the reaction [Glucose results in decreased activity of CAT protein]; NFE2L2 protein affects the reaction [gastrodin inhibits the reaction [Glucose results in decreased activity of CAT protein]]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [Glucose results in decreased activity of CAT protein]
Glucose results in decreased expression of CAT mRNA 		CTD PMID:12130563 PMID:17309078 PMID:20691780 PMID:21818840 PMID:23192364 More... NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Cav1 caveolin 1 multiple interactions
decreases expression 		ISO EGF protein inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA]; Simvastatin inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA]
Glucose results in decreased expression of CAV1 mRNA; Glucose results in decreased expression of CAV1 protein 		CTD PMID:19816600 PMID:31655124 NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740 		JBrowse link
G Cbr3 carbonyl reductase 3 increases expression ISO Glucose results in increased expression of CBR3 mRNA CTD PMID:17178593 NCBI chr11:46,478,295...46,486,555
Ensembl chr11:46,478,274...46,486,558 		JBrowse link
G Cbs cystathionine beta synthase increases expression
decreases expression 		ISO
EXP 		Glucose results in increased expression of CBS mRNA
Glucose deficiency results in decreased expression of CBS mRNA 		CTD PMID:17178593 PMID:35577173 NCBI chr20:9,709,394...9,733,925
Ensembl chr20:9,709,395...9,734,066 		JBrowse link
G Ccdc116 coiled-coil domain containing 116 multiple interactions
decreases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of CCDC116 mRNA] CTD PMID:33448797 NCBI chr11:97,346,927...97,354,827
Ensembl chr11:97,346,675...97,354,824 		JBrowse link
G Ccdc146 coiled-coil domain containing 146 increases expression ISO Glucose results in increased expression of CCDC146 mRNA CTD PMID:39922521 NCBI chr 4:14,554,966...14,703,801
Ensembl chr 4:14,554,966...14,703,799 		JBrowse link
G Ccdc169 coiled-coil domain containing 169 multiple interactions
increases expression 		ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CCDC169 mRNA
Glucose results in increased expression of CCDC169 mRNA 		CTD PMID:37567420 PMID:39922521 NCBI chr 2:141,471,762...141,501,325
Ensembl chr 2:141,471,810...141,501,325 		JBrowse link
G Ccdc190 coiled-coil domain containing 190 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of CCDC190 mRNA CTD PMID:37567420 NCBI chr13:84,679,959...84,687,661
Ensembl chr13:84,679,986...84,687,658 		JBrowse link
G Ccdc73 coiled-coil domain containing 73 increases expression ISO Glucose results in increased expression of CCDC73 mRNA CTD PMID:39922521 NCBI chr 3:111,737,771...111,879,588
Ensembl chr 3:111,737,730...111,880,105 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 increases expression
multiple interactions
increases secretion 		ISO
EXP 		Glucose results in increased expression of CCL2 mRNA; Glucose results in increased expression of CCL2 protein
(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CCL2 protein]; [Glucose co-treated with fatostatin] results in increased expression of CCL2 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL2 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of CCL2 protein]; [Valsartan co-treated with Simvastatin] inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]]; aspalathin inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; aspalathin inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Aspirin inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Aspirin inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Aspirin inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; CCL2 mRNA affects the reaction [Glucose results in increased expression of CCN2 protein]; chromic chloride inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; chromium nicotinic acid complex inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Clofibrate inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Clofibrate inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Clofibrate inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; diphenyleneiodonium inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; diphenyleneiodonium inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Fenofibrate inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Fenofibrate inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Fenofibrate inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Glucose inhibits the reaction [Fructose results in increased secretion of CCL2 protein]; Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]; HTS 466284 inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; isoangustone A inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; manganese chloride inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; nothofagin inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; nothofagin inhibits the reaction [Glucose results in increased expression of CCL2 protein]; picolinic acid inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; psicose inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; psicose inhibits the reaction [Glucose results in increased expression of CCL2 protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of MCP1 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; SB 203580 inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; SB 203580 inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Selenium inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]]
Glucose results in increased expression of CCL2 mRNA; Glucose results in increased expression of CCL2 protein; Glucose results in increased expression of MCP1 mRNA
duanbanhuain A inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; duanbanhuain B inhibits the reaction [Glucose results in increased secretion of CCL2 protein]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CCL2 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CCL2 mRNA; manganese chloride inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; MIR27B mRNA affects the reaction [Glucose results in increased expression of CCL2 protein]; SNHG1 affects the reaction [Glucose results in increased expression of CCL2 mRNA]; SNHG1 affects the reaction [Glucose results in increased expression of CCL2 protein]; SNHG1 affects the reaction [MIR27B mRNA affects the reaction [Glucose results in increased expression of CCL2 protein]] 		CTD PMID:16143069 PMID:16600694 PMID:17178593 PMID:17607302 PMID:17655880 More... NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Ccl28 C-C motif chemokine ligand 28 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CCL28 mRNA CTD PMID:37567420 NCBI chr 2:53,334,071...53,358,709
Ensembl chr 2:53,334,071...53,358,709 		JBrowse link
G Ccl5 C-C motif chemokine ligand 5 increases expression
multiple interactions
decreases expression 		ISO Glucose results in increased expression of CCL5 mRNA
[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA
Glucose results in decreased expression of CCL5 mRNA 		CTD PMID:17178593 PMID:31655124 PMID:32613381 PMID:32942007 NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884 		JBrowse link
G Ccl7 C-C motif chemokine ligand 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CCL7 mRNA CTD PMID:37567420 NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,514,091...67,515,947 		JBrowse link
G Ccn1 cellular communication network factor 1 increases expression ISO Glucose results in increased expression of CCN1 mRNA CTD PMID:17178593 NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883 		JBrowse link
G Ccn2 cellular communication network factor 2 increases expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of CCN2 mRNA; Glucose results in increased expression of CCN2 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [Glucose results in increased expression of CCN2 mRNA]]; SMARCA4A protein inhibits the reaction [Glucose results in increased expression of CCN2 mRNA]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CCN2 protein]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of CCN2 mRNA]; Cadmium inhibits the reaction [Glucose results in increased expression of CCN2 protein]; CCL2 mRNA affects the reaction [Glucose results in increased expression of CCN2 protein]; SB 203580 inhibits the reaction [Glucose results in increased expression of CCN2 protein]; Zinc inhibits the reaction [Glucose results in increased expression of CCN2 protein]
Aspirin inhibits the reaction [Glucose results in increased expression of CCN2 mRNA]; CCN2 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]; fatostatin inhibits the reaction [Glucose results in increased expression of CCN2 protein]; HIF1A protein affects the reaction [Glucose results in increased expression of CCN2 protein]; MIR217 mRNA affects the reaction [Glucose results in increased expression of CCN2 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of CCN2 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CCN2 protein]] 		CTD PMID:10026205 PMID:14586741 PMID:19369054 PMID:21124846 PMID:21367880 More... NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976 		JBrowse link
G Ccna1 cyclin A1 multiple interactions ISO [imeglimin co-treated with Glucose] results in increased expression of CCNA1 mRNA CTD PMID:34588186 NCBI chr 2:141,383,352...141,428,205
Ensembl chr 2:141,382,468...141,393,300 		JBrowse link
G Ccnb1 cyclin B1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CCNB1 mRNA CTD PMID:37567420 NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225 		JBrowse link
G Ccnd1 cyclin D1 increases expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of CCND1; Glucose results in increased expression of CCND1 mRNA
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND1 mRNA; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND1 mRNA]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND1 mRNA]]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND1 mRNA]
resveratrol inhibits the reaction [Glucose results in increased expression of CCND1 protein]
[Glucose co-treated with resveratrol] results in decreased expression of CCND1 mRNA; resveratrol inhibits the reaction [Glucose results in increased expression of CCND1 mRNA] 		CTD PMID:23690508 PMID:24064760 PMID:24971582 PMID:27049278 PMID:27481074 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Ccnd2 cyclin D2 multiple interactions
increases expression 		ISO [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND2 mRNA; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND2 mRNA]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND2 mRNA]]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND2 mRNA]
Glucose results in increased expression of CCND2 mRNA 		CTD PMID:27481074 PMID:34588186 NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:161,653,048...161,680,301
Ensembl chr 4:161,653,048...161,680,301 		JBrowse link
G Ccne1 cyclin E1 increases expression
multiple interactions 		EXP Glucose results in increased expression of CCNE1 protein
resveratrol inhibits the reaction [Glucose results in increased expression of CCNE1 protein] 		CTD PMID:24971582 NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822 		JBrowse link
G Ccnl1 cyclin L1 increases expression ISO Glucose results in increased expression of CCNL1 mRNA CTD PMID:17178593 NCBI chr 2:152,495,169...152,508,855
Ensembl chr 2:152,495,172...152,507,468 		JBrowse link
G Ccr10 C-C motif chemokine receptor 10 multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of CCR10 mRNA] CTD PMID:33448797 NCBI chr10:86,608,836...86,611,273
Ensembl chr10:86,608,836...86,611,273 		JBrowse link
G Ccr6 C-C motif chemokine receptor 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CCR6 mRNA CTD PMID:37567420 NCBI chr 1:55,022,037...55,055,857
Ensembl chr 1:55,021,833...55,046,059 		JBrowse link
G Ccr7 C-C motif chemokine receptor 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CCR7 mRNA CTD PMID:37567420 NCBI chr10:84,594,399...84,604,514
Ensembl chr10:84,593,594...84,604,501 		JBrowse link
G Ccs copper chaperone for superoxide dismutase multiple interactions EXP [Glucose co-treated with Lycopene] results in increased expression of CCS mRNA CTD PMID:38444079 NCBI chr 1:211,543,192...211,564,354
Ensembl chr 1:211,542,701...211,564,260 		JBrowse link
G Cd14 CD14 molecule multiple interactions ISO CD14 protein affects the reaction [Glucose promotes the reaction [Lipopolysaccharides results in increased secretion of MMP1 protein]]; Curcumin inhibits the reaction [Glucose promotes the reaction [Lipopolysaccharides results in increased expression of CD14 protein]]; Glucose promotes the reaction [Lipopolysaccharides results in increased expression of CD14 protein] CTD PMID:18180316 NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292 		JBrowse link
G Cd151 CD151 molecule (Raph blood group) multiple interactions EXP CD151 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 1:205,994,300...205,998,307
Ensembl chr 1:205,994,738...205,998,784 		JBrowse link
G Cd160 CD160 molecule decreases expression ISO Glucose results in decreased expression of CD160 mRNA CTD PMID:31525975 NCBI chr 2:187,029,654...187,042,447
Ensembl chr 2:187,033,140...187,064,587 		JBrowse link
G Cd163 CD163 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CD163 mRNA CTD PMID:37567420 NCBI chr 4:158,770,751...158,804,146
Ensembl chr 4:158,770,749...158,804,146 		JBrowse link
G Cd164l2 CD164 molecule like 2 increases expression ISO Glucose results in increased expression of CD164L2 mRNA CTD PMID:39922521 NCBI chr 5:150,698,662...150,711,622
Ensembl chr 5:150,707,667...150,711,631 		JBrowse link
G Cd19 CD19 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of CD19 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CD19 mRNA CTD PMID:37567420 NCBI chr 1:190,417,853...190,424,494
Ensembl chr 1:190,417,853...190,424,355 		JBrowse link
G Cd1d1 CD1d1 molecule multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of CD1D1 mRNA] CTD PMID:33448797 NCBI chr 2:174,721,522...174,725,029
Ensembl chr 2:174,721,522...174,725,029 		JBrowse link
G Cd226 CD226 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CD226 mRNA CTD PMID:37567420 NCBI chr18:84,723,330...84,819,836
Ensembl chr18:84,725,242...84,819,835 		JBrowse link
G Cd247 Cd247 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CD247 mRNA CTD PMID:37567420 NCBI chr13:80,576,264...80,651,422
Ensembl chr13:80,576,202...80,655,248 		JBrowse link
G Cd300a Cd300a molecule increases expression
multiple interactions 		ISO Glucose results in increased expression of CD300A mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CD300A mRNA 		CTD PMID:31525975 PMID:37567420 NCBI chr10:100,428,826...100,441,693
Ensembl chr10:100,428,826...100,442,958 		JBrowse link
G Cd300lb CD300 molecule-like family member b multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CD300LB mRNA CTD PMID:37567420 NCBI chr10:100,463,815...100,473,804
Ensembl chr10:100,463,815...100,473,804 		JBrowse link
G Cd36 CD36 molecule multiple interactions
increases expression 		ISO (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]
Glucose results in increased expression of CD36 mRNA 		CTD PMID:32613381 PMID:36156098 NCBI chr 4:18,209,088...18,302,142 JBrowse link
G Cd3e CD3 epsilon subunit of T-cell receptor complex multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CD3E mRNA CTD PMID:37567420 NCBI chr 8:54,200,617...54,211,770
Ensembl chr 8:54,200,617...54,211,876 		JBrowse link
G Cd40lg CD40 ligand multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CD40LG mRNA CTD PMID:37567420 NCBI chr  X:140,164,341...140,176,057
Ensembl chr  X:140,164,302...140,176,475 		JBrowse link
G Cd44 CD44 molecule increases expression
multiple interactions 		ISO Glucose results in increased expression of CD44 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CD44 mRNA 		CTD PMID:17178593 PMID:37567420 NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424 		JBrowse link
G Cd48 Cd48 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CD48 mRNA CTD PMID:37567420 NCBI chr13:86,717,960...86,741,540
Ensembl chr13:86,717,961...86,742,942 		JBrowse link
G Cd5 Cd5 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CD5 mRNA CTD PMID:37567420 NCBI chr 1:216,790,245...216,811,209
Ensembl chr 1:216,790,245...216,811,209 		JBrowse link
G Cd52 CD52 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CD52 mRNA CTD PMID:37567420 NCBI chr 5:151,603,537...151,605,096
Ensembl chr 5:151,603,524...151,605,086 		JBrowse link
G Cd6 Cd6 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CD6 mRNA CTD PMID:37567420 NCBI chr 1:216,867,767...216,906,642
Ensembl chr 1:216,867,771...216,879,432 		JBrowse link
G Cd74 CD74 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CD74 mRNA CTD PMID:37567420 NCBI chr18:56,527,071...56,536,406
Ensembl chr18:56,527,132...56,536,410 		JBrowse link
G Cd8b CD8 subunit beta multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CD8B1 mRNA CTD PMID:37567420 NCBI chr 4:104,870,911...104,886,838
Ensembl chr 4:104,870,893...104,886,868 		JBrowse link
G Cd96 CD96 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CD96 mRNA CTD PMID:37567420 NCBI chr11:68,164,926...68,239,266
Ensembl chr11:68,164,872...68,241,937 		JBrowse link
G Cdc42 cell division cycle 42 increases expression
multiple interactions 		ISO Glucose results in increased expression of CDC42 mRNA; Glucose results in increased expression of CDC42 protein
Eucalyptol inhibits the reaction [Glucose results in increased expression of CDC42 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of CDC42 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of CDC42 protein] 		CTD PMID:24659233 PMID:31483951 NCBI chr 5:154,838,478...154,876,629
Ensembl chr 5:154,839,631...154,876,627 		JBrowse link
G Cdc7 cell division cycle 7 increases expression ISO Glucose results in increased expression of CDC7 mRNA CTD PMID:39922521 NCBI chr14:2,949,538...2,969,656
Ensembl chr14:2,949,539...2,969,656 		JBrowse link
G Cdh1 cadherin 1 multiple interactions
decreases expression 		ISO 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [Glucose results in decreased expression of CDH1 protein]; [Glucose co-treated with TGFB1 protein] results in decreased expression of CDH1 protein; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in decreased expression of CDH1 protein]; DKK1 protein inhibits the reaction [Glucose results in decreased expression of CDH1 mRNA]; DKK1 protein inhibits the reaction [Glucose results in decreased expression of CDH1 protein]; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in decreased expression of CDH1 protein]; MAPK14 protein promotes the reaction [Glucose results in decreased expression of CDH1 protein]
Glucose results in decreased expression of CDH1 mRNA; Glucose results in decreased expression of CDH1 protein 		CTD PMID:21829520 PMID:26045780 PMID:29163160 PMID:33992720 PMID:35445903 More... NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565 		JBrowse link
G Cdh5 cadherin 5 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of CDH5 mRNA
[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of and affects the localization of CDH5 protein; [Glucose deficiency co-treated with Oxygen deficiency] results in increased localization of CDH5 protein; nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased localization of CDH5 protein]; Wortmannin inhibits the reaction [nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased localization of CDH5 protein]] 		CTD PMID:31655124 PMID:38528077 NCBI chr19:821,875...860,931
Ensembl chr19:822,464...860,822 		JBrowse link
G Cdk1 cyclin-dependent kinase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CDK1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CDK1 mRNA CTD PMID:37567420 NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455 		JBrowse link
G Cdk9 cyclin-dependent kinase 9 multiple interactions
increases phosphorylation 		ISO 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased phosphorylation of CDK9 protein]; CDK9 protein affects the reaction [Glucose results in increased expression of COL4A4 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of IL1B mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of IL6 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of NOS2 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of TGFB1 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of TNF mRNA]; CDK9 protein affects the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; CDK9 protein affects the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; CDK9 protein affects the reaction [Glucose results in increased secretion of IL6 protein]; CDK9 protein affects the reaction [Glucose results in increased secretion of TNF protein] CTD PMID:33631230 NCBI chr 3:36,394,168...36,399,016
Ensembl chr 3:36,394,169...36,399,528 		JBrowse link
G Cdkl5 cyclin-dependent kinase-like 5 increases expression ISO Glucose results in increased expression of CDKL5 mRNA CTD PMID:39922521 NCBI chr  X:37,566,320...37,796,766
Ensembl chr  X:37,566,378...37,796,760 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression
multiple interactions
decreases expression 		ISO
EXP 		Glucose results in increased expression of CDKN1A mRNA
[imeglimin co-treated with Glucose] results in increased expression of CDKN1A mRNA
Glucose results in decreased expression of CDKN1A protein
Glucose promotes the reaction [SETD7 protein binds to CDKN1A promoter]; NAD inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; Niacinamide inhibits the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; Resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; SIRT1 protein promotes the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; TGFB1 protein promotes the reaction [Glucose promotes the reaction [SETD7 protein binds to CDKN1A promoter]]; TGFB1 protein promotes the reaction [Glucose results in increased expression of CDKN1A mRNA]
Glucose results in increased expression of CDKN1A mRNA; Glucose results in increased expression of CDKN1A protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased expression of CDKN1A mRNA]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; [Glucose co-treated with Deferoxamine] results in increased expression of CDKN1A mRNA; [Palmitic Acid co-treated with Glucose] results in increased expression of CDKN1A mRNA; CDKN1A protein affects the reaction [Glucose results in increased expression of GLB1 protein]; Fluorometholone inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CDKN1A mRNA]; Melatonin inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; Phytic Acid inhibits the reaction [Glucose results in increased expression of CDKN1A mRNA]; Phytic Acid inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1A mRNA]; SIRT1 protein mutant form inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased expression of CDKN1A mRNA]; TAS1R1 protein affects the reaction [Glucose results in decreased expression of CDKN1A protein] 		CTD PMID:17178593 PMID:22561310 PMID:24451382 PMID:27049278 PMID:27652271 More... NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B increases expression
multiple interactions 		EXP
ISO 		Glucose results in increased expression of CDKN1B protein
[Glucose co-treated with Deferoxamine] results in increased expression of CDKN1B mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CDKN1B mRNA]
NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein]; Niacinamide inhibits the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein]]; resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1B protein]; Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein]; SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein]]; SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1B protein]]; SIRT1 protein promotes the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein]] 		CTD PMID:22561310 PMID:33962019 PMID:33992720 NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498 		JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A increases expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of CDKN2A protein; Glucose results in increased expression of CDKN2A protein alternative form
CDKN2A protein affects the reaction [Glucose results in increased expression of GLB1 protein]; SIRT3 protein inhibits the reaction [Glucose results in increased expression of CDKN2A protein alternative form] 		CTD PMID:23494737 PMID:38483099 NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248 		JBrowse link
G Ceacam1 CEA cell adhesion molecule 1 multiple interactions
decreases secretion
decreases expression 		ISO cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of CEACAM1 mRNA]; cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased secretion of CEACAM1 protein] CTD PMID:19924377 NCBI chr 1:90,171,401...90,187,810
Ensembl chr 1:90,171,401...90,187,798 		JBrowse link
G Ceacam19 CEA cell adhesion molecule 19 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CEACAM19 mRNA CTD PMID:37567420 NCBI chr 1:88,670,054...88,678,900
Ensembl chr 1:88,670,054...88,678,874 		JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha multiple interactions ISO CEBPA protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]; CEBPA protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]; Glucose promotes the reaction [CEBPA protein binds to EDN1 promoter]; Glucose results in increased localization of and results in increased activity of CEBPA protein; pyrazolanthrone inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPA protein]; SB 203580 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPA protein]; U 0126 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPA protein] CTD PMID:24376792 NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309 		JBrowse link
G Cebpb CCAAT/enhancer binding protein beta multiple interactions
decreases expression 		ISO CEBPB protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]; CEBPB protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]; Glucose promotes the reaction [CEBPB protein binds to EDN1 promoter]; Glucose results in increased localization of and results in increased activity of CEBPB protein; pyrazolanthrone inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPB protein]; SB 203580 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPB protein]; U 0126 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPB protein]
Glucose results in decreased expression of CEBPB protein
CEBPB protein inhibits the reaction [Glucose results in decreased expression of ACE2 protein]; CEBPB protein inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of MMP2 protein]; CEBPB protein inhibits the reaction [Glucose results in decreased expression of MAS1 protein]; CEBPB protein inhibits the reaction [Glucose results in decreased expression of PPARGC1A protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of ACE protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of AGTR1 protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of AGTR2 protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of BAX protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of COL3A1 protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; Glucose inhibits the reaction [CEBPB protein binds to ACE2 promoter] 		CTD PMID:24376792 PMID:28482072 PMID:29266779 NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072 		JBrowse link
G Cebpd CCAAT/enhancer binding protein delta multiple interactions ISO CEBPD protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]; CEBPD protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]; Glucose promotes the reaction [CEBPD protein binds to EDN1 promoter]; Glucose results in increased localization of and results in increased activity of CEBPD protein; pyrazolanthrone inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPD protein]; SB 203580 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPD protein]; U 0126 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPD protein] CTD PMID:24376792 NCBI chr11:98,268,856...98,269,994
Ensembl chr11:98,265,651...98,280,824 		JBrowse link
G Celf3 CUGBP, Elav-like family member 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of CELF3 mRNA CTD PMID:37567420 NCBI chr 2:184,805,078...184,819,189
Ensembl chr 2:184,805,081...184,819,187 		JBrowse link
G Celf4 CUGBP, Elav-like family member 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CELF4 mRNA CTD PMID:37567420 NCBI chr18:17,061,284...17,339,747
Ensembl chr18:17,061,293...17,339,571 		JBrowse link
G Celsr1 cadherin, EGF LAG seven-pass G-type receptor 1 increases expression
multiple interactions 		ISO Glucose results in increased expression of CELSR1 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of CELSR1 mRNA] 		CTD PMID:33448797 NCBI chr 7:118,867,450...119,004,859
Ensembl chr 7:118,867,450...119,004,856 		JBrowse link
G Celsr2 cadherin, EGF LAG seven-pass G-type receptor 2 increases expression ISO Glucose results in increased expression of CELSR2 mRNA CTD PMID:39922521 NCBI chr 2:198,717,333...198,741,689
Ensembl chr 2:198,717,896...198,741,581 		JBrowse link
G Celsr3 cadherin, EGF LAG seven-pass G-type receptor 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of CELSR3 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CELSR3 mRNA CTD PMID:37567420 NCBI chr 8:118,409,136...118,438,593
Ensembl chr 8:118,409,136...118,436,847 		JBrowse link
G Cemip cell migration inducing hyaluronidase 1 multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of CEMIP mRNA] CTD PMID:33448797 NCBI chr 1:147,316,052...147,471,552
Ensembl chr 1:147,316,052...147,471,768 		JBrowse link
G Cenpa centromere protein A multiple interactions ISO [imeglimin co-treated with Glucose] results in increased expression of CENPA mRNA CTD PMID:34588186 NCBI chr 6:31,420,062...31,431,703 JBrowse link
G Cenpf centromere protein F multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CENPF mRNA CTD PMID:37567420 NCBI chr13:103,715,344...103,760,931
Ensembl chr13:103,715,344...103,760,886 		JBrowse link
G Cert1 ceramide transporter 1 multiple interactions
increases expression 		EXP rhodioloside inhibits the reaction [Glucose results in increased expression of CERT1 mRNA]; TXNIP protein affects the reaction [Glucose results in increased expression of CERT1 mRNA] CTD PMID:29031534 NCBI chr 2:29,617,202...29,721,734
Ensembl chr 2:29,617,023...29,721,729 		JBrowse link
G Ces2f carboxylesterase 2F increases expression ISO Glucose results in increased expression of CES2F mRNA CTD PMID:31525975 NCBI chr19:11,245...21,395
Ensembl chr19:13,987...21,358 		JBrowse link
G Ces2h carboxylesterase 2H multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CES2H mRNA CTD PMID:37567420 NCBI chr19:49,884,164...49,898,764
Ensembl chr19:49,884,164...49,898,752 		JBrowse link
G Cfap45 cilia and flagella associated protein 45 increases expression ISO Glucose results in increased expression of CFAP45 mRNA CTD PMID:31525975 NCBI chr13:87,521,831...87,545,236
Ensembl chr13:87,521,518...87,545,234 		JBrowse link
G Cfap74 cilia and flagella associated protein 74 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CFAP74 mRNA CTD PMID:37567420 NCBI chr 5:171,252,907...171,328,351
Ensembl chr 5:171,262,113...171,328,349 		JBrowse link
G Cfap97d1 CFAP97 domain containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CFAP97D1 mRNA CTD PMID:37567420 NCBI chr10:87,432,559...87,444,711
Ensembl chr10:87,434,008...87,441,577 		JBrowse link
G Cfd complement factor D decreases expression
multiple interactions 		EXP
ISO 		Glucose results in decreased expression of CFD mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CFD mRNA 		CTD PMID:3299706 PMID:37567420 NCBI chr 7:10,463,773...10,465,496
Ensembl chr 7:10,463,775...10,465,572 		JBrowse link
G Cfl1 cofilin 1 increases secretion ISO Glucose deficiency results in increased secretion of CFL1 protein CTD PMID:24802182 NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:212,226,121...212,231,353 		JBrowse link
G Cfp complement factor properdin decreases expression
multiple interactions 		ISO Glucose results in decreased expression of CFP mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of CFP mRNA] 		CTD PMID:33448797 NCBI chr  X:3,715,551...3,721,113
Ensembl chr  X:3,710,425...3,721,112 		JBrowse link
G Chac1 ChaC glutathione-specific gamma-glutamylcyclotransferase 1 multiple interactions
decreases expression 		EXP
ISO 		CHAC1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
Glucose results in decreased expression of CHAC1 mRNA 		CTD PMID:21124846 PMID:39613055 NCBI chr 3:126,796,131...126,799,352
Ensembl chr 3:126,796,024...126,799,361 		JBrowse link
G Chd2 chromodomain helicase DNA binding protein 2 multiple interactions ISO Glucose promotes the reaction [TCF19 protein binds to CHD2 protein] CTD PMID:29042441 NCBI chr 1:136,597,993...136,726,874
Ensembl chr 1:136,599,900...136,710,335 		JBrowse link
G Chgb chromogranin B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CHGB mRNA CTD PMID:37567420 NCBI chr 3:140,496,712...140,510,057
Ensembl chr 3:140,495,951...140,510,054 		JBrowse link
G Chkb choline kinase beta multiple interactions EXP CHKB protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 7:122,380,592...122,385,102
Ensembl chr 7:122,380,594...122,383,949 		JBrowse link
G Chn1 chimerin 1 increases expression ISO Glucose results in increased expression of CHN1 mRNA CTD PMID:39922521 NCBI chr 3:78,917,329...79,084,040
Ensembl chr 3:78,917,329...79,084,197 		JBrowse link
G Chrdl2 chordin-like 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CHRDL2 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CHRDL2 mRNA CTD PMID:37567420 NCBI chr 1:163,755,316...163,782,758
Ensembl chr 1:163,755,316...163,782,757 		JBrowse link
G Chrm2 cholinergic receptor, muscarinic 2 increases expression EXP Glucose results in increased expression of CHRM2 mRNA CTD PMID:18715473 NCBI chr 4:65,981,136...66,116,128
Ensembl chr 4:65,981,006...66,126,464 		JBrowse link
G Chrna2 cholinergic receptor nicotinic alpha 2 subunit multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CHRNA2 mRNA CTD PMID:37567420 NCBI chr15:44,517,862...44,534,144
Ensembl chr15:44,517,862...44,534,144 		JBrowse link
G Cidea cell death-inducing DFFA-like effector a increases expression ISO Glucose results in increased expression of CIDEA mRNA CTD PMID:39922521 NCBI chr18:63,164,817...63,190,384
Ensembl chr18:63,164,099...63,190,382 		JBrowse link
G Cimap1c ciliary microtubule associated protein 1C multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of CIMAP1C mRNA CTD PMID:37567420 NCBI chr 8:66,144,726...66,176,985
Ensembl chr 8:66,144,726...66,181,546 		JBrowse link
G Ckap2 cytoskeleton associated protein 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CKAP2 mRNA CTD PMID:37567420 NCBI chr16:76,542,114...76,567,297
Ensembl chr16:76,542,104...76,567,352 		JBrowse link
G Ckb creatine kinase B multiple interactions
increases activity 		ISO Glucose inhibits the reaction [daidzein results in increased activity of CKB protein]; Glucose inhibits the reaction [Dihydrotestosterone results in increased activity of CKB protein]; Glucose inhibits the reaction [Estradiol results in increased activity of CKB protein]; Glucose inhibits the reaction [Genistein results in increased activity of CKB protein]
Glucose results in increased activity of CKB protein 		CTD PMID:16621514 NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478 		JBrowse link
G Ckm creatine kinase, M-type increases expression ISO Glucose results in increased expression of CKM mRNA CTD PMID:39922521 NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:88,189,485...88,199,719 		JBrowse link
G Cks2 CDC28 protein kinase regulatory subunit 2 increases expression ISO Glucose results in increased expression of CKS2 mRNA CTD PMID:17178593 NCBI chr17:13,722,360...13,727,519
Ensembl chr17:13,722,361...13,727,519 		JBrowse link
G Clcnkb chloride voltage-gated channel Kb increases expression ISO Glucose results in increased expression of CLCNKB mRNA CTD PMID:39922521 NCBI chr 5:158,993,073...159,005,618
Ensembl chr 5:158,993,074...159,004,900 		JBrowse link
G Cldn4 claudin 4 increases expression ISO Glucose results in increased expression of CLDN4 mRNA CTD PMID:39922521 NCBI chr12:27,388,160...27,389,958
Ensembl chr12:27,387,981...27,389,958 		JBrowse link
G Clec4a C-type lectin domain family 4, member A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CLEC4N mRNA CTD PMID:37567420 NCBI chr 4:158,026,138...158,119,904
Ensembl chr 4:158,100,615...158,118,094 		JBrowse link
G Clec4e C-type lectin domain family 4, member E multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CLEC4E mRNA CTD PMID:37567420 NCBI chr 4:158,292,624...158,298,607
Ensembl chr 4:158,293,311...158,298,467 		JBrowse link
G Clec7a C-type lectin domain containing 7A increases expression ISO Glucose results in increased expression of CLEC7A mRNA CTD PMID:39922521 NCBI chr 4:164,588,737...164,599,953
Ensembl chr 4:164,588,754...164,599,919 		JBrowse link
G Clhc1 clathrin heavy chain linker domain containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CLHC1 mRNA CTD PMID:37567420 NCBI chr14:107,488,983...107,529,667
Ensembl chr14:107,488,643...107,529,669 		JBrowse link
G Clic6 chloride intracellular channel 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CLIC6 mRNA CTD PMID:37567420 NCBI chr11:45,223,715...45,266,261
Ensembl chr11:45,223,669...45,267,344 		JBrowse link
G Clspn claspin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CLSPN mRNA CTD PMID:37567420 NCBI chr 5:144,134,619...144,169,531
Ensembl chr 5:144,134,632...144,169,530 		JBrowse link
G Clstn3 calsyntenin 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CLSTN3 mRNA CTD PMID:37567420 NCBI chr 4:159,017,795...159,051,069
Ensembl chr 4:159,017,795...159,051,069 		JBrowse link
G Cma1 chymase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CMA1 mRNA CTD PMID:37567420 NCBI chr15:33,387,351...33,390,133
Ensembl chr15:33,387,351...33,390,133 		JBrowse link
G Cnga3 cyclic nucleotide gated channel subunit alpha 3 increases expression ISO Glucose results in increased expression of CNGA3 mRNA CTD PMID:39922521 NCBI chr 9:46,943,353...46,989,862
Ensembl chr 9:46,928,810...46,989,862 		JBrowse link
G Cnga4 cyclic nucleotide gated channel subunit alpha 4 increases expression ISO Glucose results in increased expression of CNGA4 mRNA CTD PMID:39922521 NCBI chr 1:169,134,332...169,168,317
Ensembl chr 1:169,164,206...169,168,224 		JBrowse link
G Cnih2 cornichon family AMPA receptor auxiliary protein 2 increases expression ISO Glucose results in increased expression of CNIH2 mRNA CTD PMID:17178593 NCBI chr 1:211,828,791...211,834,474
Ensembl chr 1:211,828,794...211,834,437 		JBrowse link
G Cnn1 calponin 1 increases methylation
multiple interactions
decreases expression 		ISO Glucose results in increased methylation of CNN1 gene
fucoxanthin inhibits the reaction [Glucose results in decreased expression of CNN1 mRNA] 		CTD PMID:33448797 NCBI chr 8:28,908,437...28,917,099
Ensembl chr 8:28,908,330...28,919,482 		JBrowse link
G Cnr1 cannabinoid receptor 1 decreases expression
increases expression
multiple interactions 		EXP Glucose results in decreased expression of CNR1 mRNA
Glucose results in increased expression of CNR1 mRNA; Glucose results in increased expression of CNR1 protein
MIR29A mRNA inhibits the reaction [Glucose results in increased expression of CNR1 mRNA]; MIR29A mRNA inhibits the reaction [Glucose results in increased expression of CNR1 protein] 		CTD PMID:19501110 PMID:30642005 NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:53,204,260...53,239,252 		JBrowse link
G Cntn4 contactin 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CNTN4 mRNA CTD PMID:37567420 NCBI chr 4:140,180,696...141,177,771
Ensembl chr 4:140,596,284...141,177,766 		JBrowse link
G Cntnap2 contactin associated protein 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CNTNAP2 mRNA CTD PMID:37567420 NCBI chr 4:75,109,358...77,366,258
Ensembl chr 4:75,109,858...77,366,258 		JBrowse link
G Cntnap5b contactin associated protein family member 5B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CNTNAP5A mRNA CTD PMID:37567420 NCBI chr13:18,378,255...19,281,711
Ensembl chr13:18,378,368...19,281,711 		JBrowse link
G Col11a2 collagen type XI alpha 2 chain increases expression ISO Glucose results in increased expression of COL11A2 mRNA CTD PMID:39922521 NCBI chr20:4,788,829...4,818,492
Ensembl chr20:4,788,829...4,817,648 		JBrowse link
G Col19a1 collagen type XIX alpha 1 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of COL19A1 mRNA CTD PMID:37567420 NCBI chr 9:34,170,248...34,518,478
Ensembl chr 9:34,170,248...34,518,350 		JBrowse link
G Col1a1 collagen type I alpha 1 chain affects secretion
decreases expression
increases expression
multiple interactions 		ISO
EXP 		Glucose deficiency affects the secretion of COL1A1 protein
Glucose results in decreased expression of COL1A1 mRNA
Glucose results in increased expression of COL1A1 mRNA
Curcumin analog inhibits the reaction [Glucose results in increased expression of COL1A1 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of COL1A1 mRNA]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in decreased expression of COL1A1 mRNA]]; DKK1 protein inhibits the reaction [Glucose results in increased expression of COL1A1 mRNA]; Melatonin inhibits the reaction [Glucose results in decreased expression of COL1A1 mRNA]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of COL1A1 protein]]; MIR142 inhibits the reaction [Glucose results in increased expression of COL1A1 protein]; Phytic Acid inhibits the reaction [Glucose results in decreased expression of COL1A1 mRNA]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased expression of COL1A1 protein]]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of COL1A1 protein]
Glucose results in increased expression of COL1A1 mRNA; Glucose results in increased expression of COL1A1 protein 		CTD PMID:24802182 PMID:28700904 PMID:29163160 PMID:38000455 PMID:38124441 NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460 		JBrowse link
G Col1a2 collagen type I alpha 2 chain increases expression
increases secretion
multiple interactions 		ISO Glucose results in increased expression of COL1A2 mRNA
Glucose deficiency results in increased secretion of COL1A2 protein
troglitazone inhibits the reaction [Glucose results in increased expression of COL1A2 mRNA] 		CTD PMID:17199790 PMID:24802182 NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995 		JBrowse link
G Col20a1 collagen type XX alpha 1 chain increases expression ISO Glucose results in increased expression of COL20A1 mRNA CTD PMID:39922521 NCBI chr 3:188,477,663...188,512,326
Ensembl chr 3:188,465,648...188,511,078 		JBrowse link
G Col27a1 collagen type XXVII alpha 1 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of COL27A1 mRNA CTD PMID:37567420 NCBI chr 5:81,662,822...81,781,502
Ensembl chr 5:81,661,685...81,781,502 		JBrowse link
G Col3a1 collagen type III alpha 1 chain affects secretion
multiple interactions
increases expression 		ISO Glucose deficiency affects the secretion of COL3A1 protein
CEBPB protein inhibits the reaction [Glucose results in increased expression of COL3A1 protein]; Valsartan inhibits the reaction [Glucose results in increased expression of COL3A1 protein] 		CTD PMID:24802182 PMID:29266779 NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232 		JBrowse link
G Col4a1 collagen type IV alpha 1 chain multiple interactions
increases expression 		EXP
ISO 		[eplerenone co-treated with Enalapril] inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of COL4A1 mRNA]]; Aldosterone promotes the reaction [Glucose results in increased expression of COL4A1 mRNA]; Curcumin analog inhibits the reaction [Glucose results in increased expression of COL4A1 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of COL4A1 mRNA]; Enalapril inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of COL4A1 mRNA]]; eplerenone inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of COL4A1 mRNA]]
Glucose results in increased expression of COL4A1 protein
MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of COL4A1 protein]]; MIR142 inhibits the reaction [Glucose results in increased expression of COL4A1 protein]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased expression of COL4A1 protein]]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of COL4A1 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [Glucose results in increased expression of COL4A1 mRNA]]; SMARCA4A protein inhibits the reaction [Glucose results in increased expression of COL4A1 mRNA] 		CTD PMID:18682491 PMID:28700904 PMID:33270355 PMID:38124441 NCBI chr16:84,885,597...84,996,482
Ensembl chr16:84,885,597...84,996,482 		JBrowse link
G Col4a2 collagen type IV alpha 2 chain affects secretion ISO Glucose deficiency affects the secretion of COL4A2 protein CTD PMID:24802182 NCBI chr16:84,749,672...84,885,520
Ensembl chr16:84,749,672...84,885,520 		JBrowse link
G Col4a4 collagen type IV alpha 4 chain increases expression
multiple interactions 		ISO Glucose results in increased expression of COL4A4 mRNA
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased expression of COL4A4 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of COL4A4 mRNA] 		CTD PMID:33631230 NCBI chr 9:91,281,324...91,323,577
Ensembl chr 9:91,203,670...91,323,577 		JBrowse link
G Col5a1 collagen type V alpha 1 chain affects secretion ISO Glucose deficiency affects the secretion of COL5A1 protein CTD PMID:24802182 NCBI chr 3:31,606,475...31,755,097
Ensembl chr 3:31,606,486...31,753,020 		JBrowse link
G Col5a2 collagen type V alpha 2 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of COL5A2 mRNA CTD PMID:37567420 NCBI chr 9:54,940,768...55,090,151
Ensembl chr 9:54,940,764...55,090,150 		JBrowse link
G Col6a1 collagen type VI alpha 1 chain affects secretion ISO Glucose deficiency affects the secretion of COL6A1 protein CTD PMID:24802182 NCBI chr20:11,905,690...11,924,111
Ensembl chr20:11,905,457...11,924,107 		JBrowse link
G Col6a2 collagen type VI alpha 2 chain affects secretion ISO Glucose deficiency affects the secretion of COL6A2 protein CTD PMID:24802182 NCBI chr20:12,021,182...12,048,932
Ensembl chr20:12,021,265...12,057,042 		JBrowse link
G Col6a5 collagen type VI alpha 5 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of COL6A5 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of COL6A5 mRNA CTD PMID:37567420 NCBI chr 8:115,362,532...115,462,844
Ensembl chr 8:115,361,906...115,462,859 		JBrowse link
G Col6a6 collagen type VI alpha 6 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of COL6A6 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of COL6A6 mRNA CTD PMID:37567420 NCBI chr 8:115,196,833...115,352,161
Ensembl chr 8:115,197,464...115,352,136 		JBrowse link
G Col7a1 collagen type VII alpha 1 chain decreases expression
multiple interactions 		ISO Glucose results in decreased expression of COL7A1 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of COL7A1 mRNA] 		CTD PMID:33448797 NCBI chr 8:118,483,364...118,515,736
Ensembl chr 8:118,483,364...118,517,439 		JBrowse link
G Col8a2 collagen type VIII alpha 2 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of COL8A2 mRNA CTD PMID:37567420 NCBI chr 5:143,870,754...143,897,372
Ensembl chr 5:143,870,742...143,897,884 		JBrowse link
G Commd9 COMM domain containing 9 multiple interactions EXP COMMD9 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 3:108,630,903...108,645,427
Ensembl chr 3:108,630,980...108,666,091 		JBrowse link
G Coq8a coenzyme Q8A increases expression ISO Glucose results in increased expression of COQ8A mRNA CTD PMID:39922521 NCBI chr13:94,436,680...94,465,535
Ensembl chr13:94,436,546...94,463,378 		JBrowse link
G Cox4i1 cytochrome c oxidase subunit 4i1 increases expression
multiple interactions 		ISO Glucose deficiency results in increased expression of COX4I1 mRNA
[Glucose co-treated with Palmitic Acid] results in decreased expression of COX4I1 mRNA 		CTD PMID:26811028 PMID:39265716 NCBI chr19:65,630,383...65,636,623
Ensembl chr19:65,630,432...65,636,624 		JBrowse link
G Cox5b cytochrome c oxidase subunit 5B multiple interactions EXP COX5B protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 9:46,417,735...46,419,664
Ensembl chr 9:46,417,838...46,420,403 		JBrowse link
G Cox6a2 cytochrome c oxidase subunit 6A2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of COX6A2 mRNA CTD PMID:37567420 NCBI chr 1:192,218,970...192,221,188
Ensembl chr 1:192,218,970...192,219,716 		JBrowse link
G Cpe carboxypeptidase E multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CPE mRNA CTD PMID:37567420 NCBI chr16:29,796,707...29,908,647
Ensembl chr16:29,796,689...29,909,524 		JBrowse link
G Cpeb2 cytoplasmic polyadenylation element binding protein 2 increases expression ISO Glucose results in increased expression of CPEB2 mRNA CTD PMID:39922521 NCBI chr14:71,999,958...72,056,012
Ensembl chr14:72,002,072...72,052,263 		JBrowse link
G Cpne7 copine 7 increases expression ISO Glucose results in increased expression of CPNE7 mRNA CTD PMID:39922521 NCBI chr19:68,072,165...68,091,197
Ensembl chr19:68,074,545...68,091,197 		JBrowse link
G Cpne9 copine family member 9 increases expression ISO Glucose results in increased expression of CPNE9 mRNA CTD PMID:39922521 NCBI chr 4:147,985,900...148,009,987
Ensembl chr 4:147,986,452...148,009,986 		JBrowse link
G Cpq carboxypeptidase Q decreases expression
multiple interactions 		ISO Glucose results in decreased expression of CPQ mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of CPQ mRNA] 		CTD PMID:33448797 NCBI chr 7:66,148,973...66,719,189
Ensembl chr 7:66,149,377...66,716,137 		JBrowse link
G Cpt1a carnitine palmitoyltransferase 1A decreases expression
multiple interactions 		ISO Glucose results in decreased expression of CPT1A protein
Glucose results in decreased expression of CPT1A mRNA; Glucose results in decreased expression of CPT1A protein
(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Ditiocarb inhibits the reaction [YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of CPT1A protein]]]]; Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of CPT1A protein]; Fenofibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of CPT1A protein]]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of CPT1A protein]]] 		CTD PMID:23090186 PMID:32613381 PMID:36156098 PMID:39059604 NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326 		JBrowse link
G Cpt2 carnitine palmitoyltransferase 2 affects expression
multiple interactions 		EXP
ISO 		Glucose affects the expression of CPT2 mRNA
[Glucose co-treated with Palmitic Acid] results in decreased expression of CPT2 mRNA 		CTD PMID:24349266 PMID:39265716 NCBI chr 5:127,893,450...127,911,347
Ensembl chr 5:127,893,207...127,910,818 		JBrowse link
G Crabp2 cellular retinoic acid binding protein 2 increases expression ISO Glucose results in increased expression of CRABP2 mRNA CTD PMID:39922521 NCBI chr 2:175,714,862...175,719,208
Ensembl chr 2:175,707,312...175,728,385 		JBrowse link
G Creb1 cAMP responsive element binding protein 1 increases activity
multiple interactions 		ISO
EXP 		Glucose results in increased activity of CREB1 protein
[Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased phosphorylation of CREB1 protein; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased phosphorylation of CREB1 protein] 		CTD PMID:15767253 PMID:24726522 NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339 		JBrowse link
G Creb3l3 cAMP responsive element binding protein 3-like 3 multiple interactions
increases expression 		ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CREB3L3 mRNA
Glucose results in increased expression of CREB3L3 mRNA 		CTD PMID:37567420 PMID:39922521 NCBI chr 7:9,273,320...9,281,755
Ensembl chr 7:9,273,338...9,281,778 		JBrowse link
G Crlf1 cytokine receptor-like factor 1 increases expression
multiple interactions 		ISO Glucose results in increased expression of CRLF1 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of CRLF1 mRNA] 		CTD PMID:33448797 NCBI chr16:18,958,695...18,970,026
Ensembl chr16:18,957,956...18,969,970 		JBrowse link
G Crmp1 collapsin response mediator protein 1 multiple interactions EXP CRMP1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr14:77,734,675...77,780,916
Ensembl chr14:77,734,675...77,780,916 		JBrowse link
G Crtac1 cartilage acidic protein 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CRTAC1 mRNA CTD PMID:37567420 NCBI chr 1:251,040,963...251,182,920
Ensembl chr 1:251,028,143...251,182,689 		JBrowse link
G Cryaa crystallin, alpha A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CRYAA mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CRYAA mRNA CTD PMID:37567420 NCBI chr20:9,784,872...9,788,656
Ensembl chr20:9,784,857...9,788,654 		JBrowse link
G Crybg2 crystallin beta-gamma domain containing 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CRYBG2 mRNA CTD PMID:37567420 NCBI chr 5:151,570,154...151,602,164
Ensembl chr 5:151,570,540...151,602,163 		JBrowse link
G Cs citrate synthase increases activity
multiple interactions 		ISO Glucose results in increased activity of CS protein
Desipramine inhibits the reaction [Glucose results in increased activity of CS protein] 		CTD PMID:32481596 NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:1,342,942...1,375,938 		JBrowse link
G Csn3 casein kappa increases expression
multiple interactions 		ISO Glucose results in increased expression of CSN3 mRNA
Dichloroacetic Acid inhibits the reaction [Glucose results in increased expression of CSN3 mRNA]; Oxamic Acid inhibits the reaction [Glucose results in increased expression of CSN3 mRNA] 		CTD PMID:39922521 NCBI chr14:20,433,277...20,439,830
Ensembl chr14:20,433,277...20,439,832 		JBrowse link
G Csrnp1 cysteine and serine rich nuclear protein 1 increases expression ISO Glucose results in increased expression of CSRNP1 mRNA CTD PMID:17178593 NCBI chr 8:128,582,364...128,594,163
Ensembl chr 8:128,582,365...128,588,469 		JBrowse link
G Cst6 cystatin E/M multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of CST6 mRNA CTD PMID:37567420 NCBI chr 1:212,084,676...212,086,384
Ensembl chr 1:212,084,676...212,086,384 		JBrowse link
G Cth cystathionine gamma-lyase decreases expression
increases expression 		EXP
ISO 		Glucose deficiency results in decreased expression of CTH mRNA; Glucose deficiency results in decreased expression of CTH protein
Glucose results in increased expression of CTH mRNA 		CTD PMID:35577173 PMID:39613055 NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:249,634,731...249,661,066 		JBrowse link
G Ctnnb1 catenin beta 1 decreases expression
affects localization
increases expression
multiple interactions 		EXP
ISO 		Glucose results in decreased expression of CTNNB1 mRNA; Glucose results in decreased expression of CTNNB1 protein
Glucose affects the localization of CTNNB1 protein
Glucose results in increased expression of CTNNB1 mRNA; Glucose results in increased expression of CTNNB1 protein
[Glucose co-treated with ICG 001] results in decreased expression of CTNNB1 protein; [ICG 001 co-treated with Glucose] affects the localization of CTNNB1 protein; DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 mRNA]; DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 protein]; Panax notoginseng extract inhibits the reaction [[Glucose co-treated with ICG 001] results in decreased expression of CTNNB1 protein]; Panax notoginseng extract inhibits the reaction [[ICG 001 co-treated with Glucose] affects the localization of CTNNB1 protein]; Panax notoginseng extract inhibits the reaction [Glucose affects the localization of CTNNB1 protein]; Panax notoginseng extract inhibits the reaction [Glucose results in decreased expression of CTNNB1 protein]
Simvastatin inhibits the reaction [Glucose results in decreased expression of CTNNB1 protein] 		CTD PMID:18004065 PMID:21818840 PMID:29163160 PMID:35385194 NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662 		JBrowse link
G Ctsb cathepsin B multiple interactions
increases expression 		ISO [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CTSB protein; Melatonin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CTSB protein]
Glucose results in increased expression of CTSB mRNA 		CTD PMID:17178593 PMID:21392095 NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478 		JBrowse link
G Ctsl cathepsin L increases secretion ISO Glucose deficiency results in increased secretion of CTSL protein CTD PMID:24802182 NCBI chr17:770,104...776,266
Ensembl chr17:770,093...777,113 		JBrowse link
G Ctsw cathepsin W multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CTSW mRNA CTD PMID:37567420 NCBI chr 1:212,201,904...212,208,028
Ensembl chr 1:212,201,904...212,205,292 		JBrowse link
G Cttn cortactin decreases expression
multiple interactions 		ISO Glucose results in decreased expression of CTTN protein
Eucalyptol inhibits the reaction [Glucose results in decreased expression of CTTN protein] 		CTD PMID:31483951 NCBI chr 1:209,029,048...209,064,577
Ensembl chr 1:209,029,048...209,058,211 		JBrowse link
G Ctu1 cytosolic thiouridylase subunit 1 decreases expression ISO Glucose results in decreased expression of CTU1 mRNA CTD PMID:39613055 NCBI chr 1:103,251,983...103,257,778
Ensembl chr 1:103,251,995...103,257,775 		JBrowse link
G Cuzd1 CUB and zona pellucida-like domains 1 increases expression ISO Glucose results in increased expression of CUZD1 mRNA CTD PMID:39922521 NCBI chr 1:195,519,609...195,532,733
Ensembl chr 1:195,519,609...195,532,733 		JBrowse link
G Cx3cl1 C-X3-C motif chemokine ligand 1 multiple interactions
increases expression 		ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CX3CL1 protein]; Clofibrate inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA]; Clofibrate inhibits the reaction [Glucose results in increased expression of CX3CL1 protein]; Fenofibrate inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA]; Fenofibrate inhibits the reaction [Glucose results in increased expression of CX3CL1 protein]; SB 203580 inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA]; SB 203580 inhibits the reaction [Glucose results in increased expression of CX3CL1 protein]
Glucose results in increased expression of CX3CL1 mRNA; Glucose results in increased expression of CX3CL1 protein 		CTD PMID:19132243 PMID:31655124 NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,233,329...10,242,999 		JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 increases expression
multiple interactions 		ISO Glucose results in increased expression of CXCL10 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CXCL10 mRNA 		CTD PMID:17178593 PMID:37567420 NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261 		JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 increases expression ISO Glucose results in increased expression of CXCL2 mRNA CTD PMID:17178593 NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255 		JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 increases expression
multiple interactions 		ISO Glucose results in increased expression of CXCL1 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CXCL1 mRNA 		CTD PMID:17178593 PMID:37567420 NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624 		JBrowse link
G Cxcl9 C-X-C motif chemokine ligand 9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CXCL9 mRNA CTD PMID:37567420 NCBI chr14:16,007,166...16,012,077
Ensembl chr14:16,007,204...16,014,299 		JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 multiple interactions ISO [Glucose co-treated with Oxygen deficiency] results in decreased expression of CXCR4 mRNA; [Glucose co-treated with Oxygen deficiency] results in decreased expression of CXCR4 protein CTD PMID:18227068 NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459 		JBrowse link
G Cyba cytochrome b-245 alpha chain increases expression
decreases expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of CYBA protein
Glucose results in decreased expression of CYBA mRNA
Glucose results in increased expression of CYBA mRNA; Glucose results in increased expression of CYBA protein
[[[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1 protein; [[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species; CYBA protein promotes the reaction [Glucose results in increased chemical synthesis of Reactive Oxygen Species]; CYBA protein promotes the reaction [Glucose results in increased expression of FN1 protein]; farrerol inhibits the reaction [Glucose results in increased expression of CYBA mRNA]; farrerol inhibits the reaction [Glucose results in increased expression of CYBA protein]; pyrazolanthrone inhibits the reaction [Glucose results in increased expression of CYBA protein]; Resveratrol inhibits the reaction [[[[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of CYBA mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of CYBA protein]
dorsomorphin inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in increased expression of CYBA protein]]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of CYBA protein]; Rosiglitazone inhibits the reaction [Glucose results in increased expression of CYBA protein] 		CTD PMID:17916771 PMID:18088078 PMID:22245600 PMID:31838053 PMID:32942007 NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214 		JBrowse link
G Cybb cytochrome b-245 beta chain multiple interactions
increases expression
increases localization 		ISO
EXP 		[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CYBB protein; Prodigiosin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CYBB protein]; prolinedithiocarbamate inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CYBB protein]
Glucose results in increased expression of CYBB mRNA; Glucose results in increased expression of CYBB protein
dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CYBB protein]]; Resveratrol inhibits the reaction [Glucose results in increased expression of CYBB protein]
acetovanillone inhibits the reaction [Glucose results in increased expression of and results in increased activity of CYBB protein]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of CYBB protein]; Glucose results in increased expression of and results in increased activity of CYBB protein; Telmisartan inhibits the reaction [Glucose results in increased expression of CYBB mRNA]; Telmisartan inhibits the reaction [Glucose results in increased expression of CYBB protein]
Glucose results in increased localization of CYBB protein 		CTD PMID:19878672 PMID:21925195 PMID:22253932 PMID:26054749 PMID:31494106 More... NCBI chr  X:16,030,596...16,065,065
Ensembl chr  X:16,030,596...16,065,065 		JBrowse link
G Cycs cytochrome c, somatic affects localization
increases expression
multiple interactions 		EXP
ISO 		Glucose affects the localization of CYCS protein
Glucose results in increased expression of CYCS protein
Glucose results in increased expression of CYCS mRNA; Glucose results in increased expression of CYCS protein
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in increased expression of CYCS protein]]; [Glucose co-treated with Deferoxamine] results in increased expression of CYCS mRNA; diallyl trisulfide inhibits the reaction [Glucose results in increased expression of CYCS protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in increased expression of CYCS protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CYCS mRNA]; MitoTEMPO inhibits the reaction [Glucose results in increased expression of CYCS protein]
naringenin inhibits the reaction [Glucose affects the localization of CYCS protein]; Scopoletin inhibits the reaction [Glucose results in increased expression of CYCS protein] 		CTD PMID:23192364 PMID:31115753 PMID:33962019 PMID:37619648 PMID:39579577 NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816
Ensembl chr18:80,982,668...80,984,816 		JBrowse link
G Cyfip2 cytoplasmic FMR1 interacting protein 2 increases expression ISO Glucose results in increased expression of CYFIP2 mRNA CTD PMID:39922521 NCBI chr10:31,122,653...31,242,440
Ensembl chr10:31,122,653...31,242,440 		JBrowse link
G Cygb cytoglobin decreases expression ISO Glucose results in decreased expression of CYGB mRNA CTD PMID:32942007 NCBI chr10:102,376,506...102,386,272
Ensembl chr10:102,376,507...102,386,272 		JBrowse link
G Cym chymosin multiple interactions
increases expression 		ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CYM mRNA
Glucose results in increased expression of PGA5 mRNA 		CTD PMID:31525975 PMID:37567420 NCBI chr 2:197,516,947...197,527,307
Ensembl chr 2:197,516,950...197,527,837 		JBrowse link
G Cyp11b3 cytochrome P450, family 11, subfamily b, polypeptide 3 decreases expression EXP Glucose results in decreased expression of CYP11B2 mRNA CTD PMID:15017115 NCBI chr 7:108,689,319...108,694,808
Ensembl chr 7:108,689,165...108,694,921 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
increases expression 		ISO Polyphenols promotes the reaction [Glucose results in increased expression of CYP1A1 mRNA]
CYP1A1 protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased secretion of INS1 protein]] 		CTD PMID:21682256 PMID:31776611 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions ISO CYP1A2 protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased secretion of INS1 protein]] CTD PMID:31776611 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 multiple interactions
increases expression 		ISO [Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of CYP1B1 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of CYP1B1 protein
Glucose results in increased expression of CYP1B1 mRNA 		CTD PMID:28400208 PMID:39613055 NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142 		JBrowse link
G Cyp26b1 cytochrome P450, family 26, subfamily b, polypeptide 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CYP26B1 mRNA CTD PMID:37567420 NCBI chr 4:118,599,356...118,616,176
Ensembl chr 4:118,599,356...118,616,176 		JBrowse link
G Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 multiple interactions
increases expression 		ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CYP27B1 mRNA
Glucose results in increased expression of CYP27B1 mRNA 		CTD PMID:37567420 PMID:39922521 NCBI chr 7:64,756,626...64,761,570
Ensembl chr 7:64,756,626...64,761,570 		JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CYP2B10 mRNA CTD PMID:37567420 NCBI chr 1:90,780,468...90,859,852 JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of CYP2E1 mRNA]
Glucose results in increased expression of CYP2E1 protein
Fatty Acids, Nonesterified promotes the reaction [Glucose results in increased expression of CYP2E1 protein]; jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in increased expression of CYP2E1 protein]] 		CTD PMID:33448797 PMID:39059604 NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495 		JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CYP3A13 mRNA CTD PMID:37567420 NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154 		JBrowse link
G Cyp7b1 cytochrome P450 family 7 subfamily B member 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CYP7B1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CYP7B1 mRNA CTD PMID:37567420 NCBI chr 2:102,419,011...102,586,047
Ensembl chr 2:102,419,011...102,451,804 		JBrowse link
G Cysrt1 cysteine rich tail 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CYSRT1 mRNA CTD PMID:37567420 NCBI chr 3:28,452,359...28,456,006
Ensembl chr 3:28,451,219...28,456,118 		JBrowse link
G Dach1 dachshund family transcription factor 1 increases expression ISO Glucose results in increased expression of DACH1 mRNA CTD PMID:39922521 NCBI chr15:80,936,063...81,317,746
Ensembl chr15:80,936,063...81,317,627 		JBrowse link
G Dact1 dishevelled-binding antagonist of beta-catenin 1 increases expression ISO Glucose results in increased expression of DACT1 mRNA CTD PMID:39922521 NCBI chr 6:95,526,645...95,538,625
Ensembl chr 6:95,526,690...95,551,053 		JBrowse link
G Daxx death-domain associated protein affects localization
multiple interactions 		ISO Glucose deficiency affects the localization of DAXX protein
Glucose deficiency promotes the reaction [DAXX protein binds to MAP3K5 protein] 		CTD PMID:14505347 NCBI chr20:4,971,973...4,978,062
Ensembl chr20:4,971,941...4,977,720 		JBrowse link
G Dbi diazepam binding inhibitor increases expression ISO Glucose results in increased expression of DBI mRNA CTD PMID:17178593 NCBI chr13:33,794,231...33,802,632
Ensembl chr13:33,759,845...33,821,450 		JBrowse link
G Dbn1 drebrin 1 decreases expression
multiple interactions 		EXP Glucose results in decreased expression of DBN1 mRNA; Glucose results in decreased expression of DBN1 protein
Curcumin inhibits the reaction [Glucose results in decreased expression of DBN1 mRNA] 		CTD PMID:23333261 NCBI chr17:9,155,729...9,170,121
Ensembl chr17:9,155,787...9,170,122 		JBrowse link
G Dbp D-box binding PAR bZIP transcription factor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of DBP mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DBP mRNA CTD PMID:37567420 NCBI chr 1:105,312,256...105,317,205
Ensembl chr 1:105,312,108...105,317,205 		JBrowse link
G Dclk1 doublecortin-like kinase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DCLK1 mRNA CTD PMID:37567420 NCBI chr 2:141,567,215...141,861,088
Ensembl chr 2:141,571,983...141,861,090 		JBrowse link
G Dcx doublecortin increases expression ISO Glucose results in increased expression of DCX protein CTD PMID:23776576 NCBI chr  X:112,227,455...112,370,291
Ensembl chr  X:112,227,455...112,304,161 		JBrowse link
G Ddias DNA damage-induced apoptosis suppressor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of DDIAS mRNA CTD PMID:37567420 NCBI chr 1:156,318,559...156,342,869
Ensembl chr 1:156,318,563...156,342,869 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 decreases expression
increases expression
multiple interactions 		ISO
EXP 		Glucose results in decreased expression of DDIT3 mRNA
Glucose results in increased expression of DDIT3 mRNA; Glucose results in increased expression of DDIT3 protein
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of DDIT3 protein]; Metformin inhibits the reaction [Glucose results in increased expression of DDIT3 protein]
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in increased expression of DDIT3 protein]]; [Galactose co-treated with Glucose deficiency] promotes the reaction [Leflunomide results in increased expression of DDIT3 protein]; [ginsenoside Rg3 co-treated with Acetylcysteine] inhibits the reaction [Glucose results in increased expression of DDIT3 protein]; [imeglimin co-treated with Glucose] promotes the reaction [Thapsigargin results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [Glucose results in increased expression of DDIT3 protein]; DDIT3 protein inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; DDIT3 protein inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; DDIT3 protein inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of BAX protein]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of DDIT3 mRNA]]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of DDIT3 mRNA]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of DDIT3 protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in increased expression of DDIT3 protein]
2-aminoethoxydiphenyl borate inhibits the reaction [Glucose results in increased expression of DDIT3 protein]; [imeglimin co-treated with Glucose] results in increased expression of DDIT3 mRNA; [imeglimin co-treated with Glucose] results in increased expression of DDIT3 protein; DDIT3 affects the reaction [Glucose results in decreased expression of PPARGC1A mRNA]; Gadolinium inhibits the reaction [Glucose results in increased expression of DDIT3 protein]; Glucose inhibits the reaction [DDIT3 protein binds to PPARGC1A promoter]; TRPM7 protein affects the reaction [Glucose results in increased expression of DDIT3 protein]; waixenicin A inhibits the reaction [Glucose results in increased expression of DDIT3 protein]
Glucose deficiency results in increased expression of DDIT3 mRNA; Glucose results in increased expression of DDIT3 mRNA; Glucose results in increased expression of DDIT3 protein
Glucose deficiency results in increased expression of DDIT3 protein; Glucose results in increased expression of DDIT3 protein 		CTD PMID:17178593 PMID:21337367 PMID:24349266 PMID:27226639 PMID:28482072 More... NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509 		JBrowse link
G Ddx3x DEAD-box helicase 3, X-linked increases degradation ISO Glucose deficiency results in increased degradation of DDX3X protein CTD PMID:30821613 NCBI chr  X:12,152,346...12,165,983
Ensembl chr  X:12,152,346...12,165,983 		JBrowse link
G Ddx4 DEAD-box helicase 4 increases expression ISO Glucose results in increased expression of DDX4 mRNA CTD PMID:39922521 NCBI chr 2:45,961,174...46,016,097
Ensembl chr 2:45,961,174...46,015,951 		JBrowse link
G Defb24 defensin beta 24 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of DEFB19 mRNA CTD PMID:37567420 NCBI chr 3:161,506,850...161,512,983
Ensembl chr 3:161,506,851...161,512,983 		JBrowse link
G Dek DEK proto-oncogene multiple interactions ISO DEK protein affects the chemical synthesis of and affects the uptake of Glucose CTD PMID:28558019 NCBI chr17:17,786,989...17,809,096
Ensembl chr17:17,787,139...17,810,122 		JBrowse link
G Dennd2c DENN domain containing 2C increases expression ISO Glucose results in increased expression of DENND2C mRNA CTD PMID:39613055 NCBI chr 2:193,310,822...193,378,986
Ensembl chr 2:193,335,230...193,378,978 		JBrowse link
G Depp1 DEPP autophagy regulator 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of DEPP1 mRNA CTD PMID:37567420 NCBI chr 4:151,583,105...151,585,455
Ensembl chr 4:151,581,502...151,586,233 		JBrowse link
G Derl3 derlin 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DERL3 mRNA CTD PMID:37567420 NCBI chr20:12,753,926...12,766,478
Ensembl chr20:12,762,981...12,766,477 		JBrowse link
G Deup1 deuterosome assembly protein 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of DEUP1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DEUP1 mRNA CTD PMID:37567420 NCBI chr 8:20,661,687...20,724,083
Ensembl chr 8:20,661,689...20,723,585 		JBrowse link
G Dgkd diacylglycerol kinase, delta multiple interactions
affects localization 		ISO 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine inhibits the reaction [Glucose affects the localization of DGKD protein alternative form]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose affects the localization of DGKD protein alternative form] CTD PMID:22974639 NCBI chr 9:95,964,507...96,055,160
Ensembl chr 9:95,964,148...96,055,160 		JBrowse link
G Dhh desert hedgehog signaling molecule increases expression ISO Glucose results in increased expression of DHH mRNA CTD PMID:31525975 NCBI chr 7:131,929,857...131,935,352
Ensembl chr 7:131,929,857...131,935,352 		JBrowse link
G Dhps deoxyhypusine synthase multiple interactions EXP DHPS protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr19:39,987,328...39,991,418
Ensembl chr19:39,987,324...39,991,432 		JBrowse link
G Dhrs9 dehydrogenase/reductase 9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DHRS9 mRNA CTD PMID:37567420 NCBI chr 3:74,553,357...74,579,535
Ensembl chr 3:74,555,606...74,581,376 		JBrowse link
G Dhtkd1 dehydrogenase E1 and transketolase domain containing 1 increases expression ISO Glucose results in increased expression of DHTKD1 mRNA CTD PMID:39922521 NCBI chr17:77,242,512...77,316,074
Ensembl chr17:77,264,514...77,316,071 		JBrowse link
G Dhx58 DEXH-box helicase 58 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of DHX58 mRNA CTD PMID:37567420 NCBI chr10:86,120,677...86,132,095
Ensembl chr10:86,120,677...86,131,844 		JBrowse link
G Diablo diablo, IAP-binding mitochondrial protein multiple interactions
increases expression 		ISO [Glucose co-treated with Deferoxamine] results in increased expression of DIABLO mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of DIABLO mRNA]
Glucose results in increased expression of DIABLO mRNA 		CTD PMID:33962019 NCBI chr12:38,716,668...38,731,285
Ensembl chr12:38,716,668...38,731,265 		JBrowse link
G Diaph3 diaphanous-related formin 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DIAPH3 mRNA CTD PMID:37567420 NCBI chr15:68,951,992...69,421,623
Ensembl chr15:68,951,989...69,421,552 		JBrowse link
G Diras2 DIRAS family GTPase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of DIRAS2 mRNA CTD PMID:37567420 NCBI chr17:12,882,224...12,913,366
Ensembl chr17:12,880,385...12,914,291 		JBrowse link
G Disc1 DISC1 scaffold protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of DISC1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of DISC1 mRNA CTD PMID:37567420 NCBI chr19:69,911,548...70,120,970
Ensembl chr19:69,911,976...70,120,970 		JBrowse link
G Disp2 dispatched RND transporter family member 2 increases expression
multiple interactions 		ISO Glucose results in increased expression of DISP2 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of DISP2 mRNA] 		CTD PMID:33448797 NCBI chr 3:126,216,194...126,231,724
Ensembl chr 3:126,216,218...126,231,711 		JBrowse link
G Dkk1 dickkopf WNT signaling pathway inhibitor 1 multiple interactions ISO DKK1 protein inhibits the reaction [Glucose results in decreased expression of CDH1 mRNA]; DKK1 protein inhibits the reaction [Glucose results in decreased expression of CDH1 protein]; DKK1 protein inhibits the reaction [Glucose results in increased expression of ACTA2 mRNA]; DKK1 protein inhibits the reaction [Glucose results in increased expression of ACTA2 protein]; DKK1 protein inhibits the reaction [Glucose results in increased expression of COL1A1 mRNA]; DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 mRNA]; DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 protein]; DKK1 protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; DKK1 protein inhibits the reaction [Glucose results in increased expression of LEF1 mRNA] CTD PMID:29163160 NCBI chr 1:237,794,969...237,798,650
Ensembl chr 1:237,794,969...237,798,650 		JBrowse link
G Dlk1 delta like non-canonical Notch ligand 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of DLK1 mRNA CTD PMID:37567420 NCBI chr 6:134,192,491...134,199,779
Ensembl chr 6:134,192,518...134,200,529 		JBrowse link
G Dmtn dematin actin binding protein multiple interactions
increases methylation
decreases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of DMTN mRNA]
Glucose results in increased methylation of DMTN gene 		CTD PMID:33448797 NCBI chr15:52,087,667...52,111,956
Ensembl chr15:52,087,667...52,112,128 		JBrowse link
G Dmxl2 Dmx-like 2 increases expression ISO Glucose results in increased expression of DMXL2 mRNA CTD PMID:39922521 NCBI chr 8:63,637,314...63,803,911
Ensembl chr 8:63,637,314...63,781,116 		JBrowse link
G Dnaaf3 dynein, axonemal, assembly factor 3 increases expression ISO Glucose results in increased expression of DNAAF3 mRNA CTD PMID:39922521 NCBI chr 1:78,333,985...78,342,034
Ensembl chr 1:78,333,971...78,342,685 		JBrowse link
G Dnajb11 DnaJ heat shock protein family (Hsp40) member B11 decreases expression ISO Glucose results in decreased expression of DNAJB11 mRNA CTD PMID:17178593 NCBI chr11:91,656,334...91,672,800
Ensembl chr11:91,656,335...91,672,800 		JBrowse link
G Dnajc3 DnaJ heat shock protein family (Hsp40) member C3 decreases expression ISO Glucose results in decreased expression of DNAJC3 mRNA CTD PMID:17178593 NCBI chr15:102,432,667...102,475,643
Ensembl chr15:102,432,663...102,475,643 		JBrowse link
G Dnase1l3 deoxyribonuclease 1L3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of DNASE1L3 mRNA CTD PMID:37567420 NCBI chr15:19,351,683...19,378,536
Ensembl chr15:19,352,493...19,378,531 		JBrowse link
G Dnd1 DND microRNA-mediated repression inhibitor 1 increases expression ISO Glucose results in increased expression of DND1 mRNA CTD PMID:39922521 NCBI chr18:28,652,712...28,655,336
Ensembl chr18:28,652,712...28,655,336 		JBrowse link
G Dner delta/notch-like EGF repeat containing increases expression ISO Glucose results in increased expression of DNER mRNA CTD PMID:39613055 NCBI chr 9:93,035,108...93,350,568
Ensembl chr 9:93,035,108...93,350,568 		JBrowse link
G Dnm1l dynamin 1-like increases expression
multiple interactions 		EXP
ISO 		Glucose results in increased expression of DNM1L protein
[Glucose co-treated with Deferoxamine] results in increased expression of DNM1L mRNA; diallyl trisulfide inhibits the reaction [Glucose results in increased expression of DNM1L protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of DNM1L mRNA]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of DNM1L protein; cinnamic acid inhibits the reaction [Glucose results in increased expression of DNM1L protein]; Metformin inhibits the reaction [Glucose results in increased expression of DNM1L protein]; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of DNM1L protein] 		CTD PMID:27684054 PMID:30144576 PMID:31115753 PMID:33962019 PMID:36806343 NCBI chr11:98,084,049...98,135,663
Ensembl chr11:98,085,397...98,137,420 		JBrowse link
G Dnmt1 DNA methyltransferase 1 increases expression ISO Glucose results in increased expression of DNMT1 mRNA CTD PMID:29854080 NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119 		JBrowse link
G Dok3 docking protein 3 increases expression ISO Glucose results in increased expression of DOK3 mRNA CTD PMID:39922521 NCBI chr17:9,114,763...9,121,781
Ensembl chr17:9,114,762...9,120,335 		JBrowse link
G Dok7 docking protein 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of DOK7 mRNA CTD PMID:37567420 NCBI chr14:79,890,051...79,924,081
Ensembl chr14:79,891,367...79,932,252 		JBrowse link
G Dpep2 dipeptidase 2 increases expression ISO Glucose results in increased expression of DPEP2 mRNA CTD PMID:31525975 NCBI chr19:50,795,322...50,806,320
Ensembl chr19:50,795,327...50,801,757
Ensembl chr19:50,795,327...50,801,757 		JBrowse link
G Dpp6 dipeptidyl peptidase like 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of DPP6 mRNA CTD PMID:37567420 NCBI chr 4:8,323,220...9,242,694
Ensembl chr 4:8,324,843...9,242,209 		JBrowse link
G Dpysl5 dihydropyrimidinase-like 5 increases expression ISO Glucose results in increased expression of DPYSL5 mRNA CTD PMID:39922521 NCBI chr 6:31,295,035...31,379,348
Ensembl chr 6:31,295,035...31,379,348 		JBrowse link
G Dram1 DNA-damage regulated autophagy modulator 1 increases expression ISO Glucose results in increased expression of DRAM1 mRNA CTD PMID:39613055 NCBI chr 7:24,630,233...24,665,270
Ensembl chr 7:24,630,238...24,664,354 		JBrowse link
G Dscaml1 DS cell adhesion molecule-like 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of DSCAML1 mRNA CTD PMID:37567420 NCBI chr 8:54,637,054...54,954,042
Ensembl chr 8:54,636,932...54,954,040 		JBrowse link
G Duox1 dual oxidase 1 decreases expression ISO Glucose results in decreased expression of DUOX1 mRNA CTD PMID:32942007 NCBI chr 3:129,714,125...129,749,186
Ensembl chr 3:129,714,149...129,749,187 		JBrowse link
G Duox2 dual oxidase 2 decreases expression ISO Glucose results in decreased expression of DUOX2 mRNA CTD PMID:32942007 NCBI chr 3:129,680,543...129,698,886
Ensembl chr 3:129,680,546...129,699,203 		JBrowse link
G Dusp1 dual specificity phosphatase 1 increases expression ISO Glucose results in increased expression of DUSP1 mRNA CTD PMID:17178593 PMID:32942007 NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644 		JBrowse link
G Dusp13b dual specificity phosphatase 13B decreases expression
multiple interactions 		ISO Glucose results in decreased expression of DUSP13B mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of DUSP13B mRNA] 		CTD PMID:31525975 PMID:33448797 NCBI chr15:2,616,761...2,624,434
Ensembl chr15:2,609,049...2,624,887 		JBrowse link
G Dusp2 dual specificity phosphatase 2 increases expression ISO Glucose results in increased expression of DUSP2 mRNA CTD PMID:17178593 PMID:39922521 NCBI chr 3:135,009,636...135,011,821
Ensembl chr 3:135,009,590...135,011,809 		JBrowse link
G Dusp5 dual specificity phosphatase 5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of DUSP5 mRNA CTD PMID:37567420 NCBI chr 1:262,543,774...262,557,201
Ensembl chr 1:262,543,738...262,562,417 		JBrowse link
G Dusp6 dual specificity phosphatase 6 increases expression ISO Glucose results in increased expression of DUSP6 mRNA CTD PMID:17178593 NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:35,977,921...35,983,833 		JBrowse link
G Dzank1 double zinc ribbon and ankyrin repeat domains 1 increases expression ISO Glucose results in increased expression of DZANK1 mRNA CTD PMID:39922521 NCBI chr 3:152,309,228...152,361,548
Ensembl chr 3:152,309,228...152,361,548 		JBrowse link
G Ebln1l1 endogenous Bornavirus like nucleoprotein 1 like 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of IGKV8-24 mRNA CTD PMID:37567420 NCBI chr10:79,435,547...79,437,553 JBrowse link
G Ecm2 extracellular matrix protein 2 increases expression ISO Glucose results in increased expression of ECM2 mRNA CTD PMID:39922521 NCBI chr17:15,326,359...15,358,938
Ensembl chr17:15,326,359...15,358,855 		JBrowse link
G Edaradd EDAR associated via death domain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of EDARADD mRNA CTD PMID:37567420 NCBI chr17:92,850,791...92,894,808
Ensembl chr17:92,831,613...92,894,361 		JBrowse link
G Edem1 ER degradation enhancing alpha-mannosidase like protein 1 decreases expression ISO Glucose results in decreased expression of EDEM1 mRNA CTD PMID:17178593 NCBI chr 4:143,350,989...143,385,693
Ensembl chr 4:143,353,624...143,388,060 		JBrowse link
G Edn1 endothelin 1 multiple interactions
decreases expression
increases expression 		ISO
EXP 		carvedilol inhibits the reaction [Glucose results in increased expression of EDN1 mRNA]; carvedilol inhibits the reaction [Glucose results in increased expression of EDN1 protein]; CAT protein inhibits the reaction [Glucose promotes the reaction [EDN1 protein results in increased chemical synthesis of Inositol 1,4,5-Trisphosphate]]; CEBPA protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]; CEBPA protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]; CEBPB protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]; CEBPB protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]; CEBPD protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]; CEBPD protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]; diphenyleneiodonium inhibits the reaction [Glucose promotes the reaction [EDN1 protein results in increased chemical synthesis of Inositol 1,4,5-Trisphosphate]]; Glucose promotes the reaction [CEBPA protein binds to EDN1 promoter]; Glucose promotes the reaction [CEBPB protein binds to EDN1 promoter]; Glucose promotes the reaction [CEBPD protein binds to EDN1 promoter]; Glucose promotes the reaction [EDN1 protein results in increased chemical synthesis of Inositol 1,4,5-Trisphosphate]; pyrazolanthrone inhibits the reaction [Glucose results in increased expression of EDN1 mRNA]; resveratrol inhibits the reaction [Glucose results in increased expression of EDN1 mRNA]; SB 203580 inhibits the reaction [Glucose results in increased expression of EDN1 mRNA]; U 0126 inhibits the reaction [Glucose results in increased expression of EDN1 mRNA]
Glucose results in decreased expression of EDN1 mRNA
Glucose results in increased expression of EDN1 mRNA; Glucose results in increased expression of EDN1 protein
Glucose affects the reaction [EDN1 protein affects the abundance of and affects the localization of Calcium]; HIF1A protein affects the reaction [Glucose results in increased expression of EDN1 protein]; MIR217 mRNA affects the reaction [Glucose results in increased expression of EDN1 protein]; resveratrol inhibits the reaction [Glucose results in increased expression of EDN1 protein]; SIRT1 protein affects the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of EDN1 protein]] 		CTD PMID:12821678 PMID:16428915 PMID:20691780 PMID:20960276 PMID:24376792 More... NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687 		JBrowse link
G Edn3 endothelin 3 multiple interactions EXP EDN3 protein inhibits the reaction [SLC5A2 protein results in increased uptake of Glucose] CTD PMID:15127950 NCBI chr 3:183,980,458...184,004,958
Ensembl chr 3:183,980,668...184,005,329 		JBrowse link
G Ednra endothelin receptor type A increases expression ISO Glucose results in increased expression of EDNRA mRNA CTD PMID:31655124 NCBI chr19:47,137,360...47,207,961
Ensembl chr19:47,137,771...47,201,284 		JBrowse link
G Eef1a1 eukaryotic translation elongation factor 1 alpha 1 multiple interactions EXP EEF1A1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 8:88,221,839...88,225,688
Ensembl chr 8:88,221,843...88,225,072 		JBrowse link
G Eef2 eukaryotic translation elongation factor 2 decreases phosphorylation
multiple interactions 		ISO Glucose results in decreased phosphorylation of EEF2 protein
resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of EEF2 protein] 		CTD PMID:19765649 NCBI chr 7:9,183,836...9,196,255
Ensembl chr 7:9,183,961...9,189,544 		JBrowse link
G Eef2k eukaryotic elongation factor-2 kinase increases phosphorylation
multiple interactions 		ISO Glucose results in increased phosphorylation of EEF2K protein
resveratrol inhibits the reaction [Glucose results in increased phosphorylation of EEF2K protein] 		CTD PMID:19765649 NCBI chr 1:184,824,420...184,888,048
Ensembl chr 1:184,824,420...184,888,048 		JBrowse link
G Efcab8 EF-hand calcium binding domain 8 increases expression ISO Glucose results in increased expression of EFCAB8 mRNA CTD PMID:39922521 NCBI chr 3:162,717,381...162,783,900
Ensembl chr 3:162,717,494...162,783,899 		JBrowse link
G Efhc1 EF-hand domain containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of EFHC1 mRNA CTD PMID:37567420 NCBI chr 9:30,872,238...30,910,703
Ensembl chr 9:30,871,565...30,910,703 		JBrowse link
G Efna3 ephrin A3 increases expression ISO Glucose results in increased expression of EFNA3 mRNA CTD PMID:39922521 NCBI chr 2:177,026,928...177,035,838
Ensembl chr 2:177,026,933...177,044,843 		JBrowse link
G Egf epidermal growth factor multiple interactions ISO EGF protein inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA]; EGF protein promotes the reaction [Glucose results in increased expression of TGFA mRNA]; Glucose promotes the reaction [EGF protein results in increased expression of TGFA mRNA] CTD PMID:8638660 PMID:19816600 NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297 		JBrowse link
G Egfr epidermal growth factor receptor multiple interactions ISO [Palmitic Acid co-treated with Glucose] results in increased phosphorylation of EGFR protein; albiflorin inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased phosphorylation of EGFR protein]; zhenwu decoction inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased phosphorylation of EGFR protein] CTD PMID:37523837 NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358 		JBrowse link
G Egr1 early growth response 1 multiple interactions
increases expression 		ISO Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA]]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of EGR1 mRNA
Glucose results in increased expression of EGR1 mRNA 		CTD PMID:17178593 PMID:19225232 PMID:37567420 NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843 		JBrowse link
G Egr2 early growth response 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of EGR2 mRNA CTD PMID:37567420 NCBI chr20:21,050,149...21,055,201
Ensembl chr20:21,050,149...21,057,748 		JBrowse link
G Ehd3 EH-domain containing 3 multiple interactions EXP EHD3 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 6:27,392,709...27,417,445
Ensembl chr 6:27,392,709...27,417,445 		JBrowse link
G Ehhadh enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EHHADH mRNA CTD PMID:37567420 NCBI chr11:92,746,409...92,779,647
Ensembl chr11:92,746,420...92,779,662 		JBrowse link
G Eif2a eukaryotic translation initiation factor 2A multiple interactions ISO [imeglimin co-treated with Glucose] inhibits the reaction [Thapsigargin results in increased phosphorylation of EIF2A protein] CTD PMID:34588186 NCBI chr 2:144,911,247...144,944,705
Ensembl chr 2:144,911,153...144,945,201 		JBrowse link
G Eif2ak2 eukaryotic translation initiation factor 2-alpha kinase 2 multiple interactions
increases phosphorylation 		ISO acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Glucose results in increased phosphorylation of EIF2AK2 protein]; Glucose promotes the reaction [EIF2AK2 protein results in increased activity of MAPK14 protein] CTD PMID:18973755 NCBI chr 6:21,941,147...21,977,115
Ensembl chr 6:21,952,631...21,977,116 		JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 multiple interactions
increases phosphorylation 		ISO
EXP 		2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in increased phosphorylation of EIF2AK3 protein]]; 4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased phosphorylation of EIF2AK3 protein]; [Acetylcysteine co-treated with ginsenoside Rg3] inhibits the reaction [Glucose results in increased phosphorylation of EIF2AK3 protein]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased phosphorylation of EIF2AK3 protein]]; ginsenoside Re inhibits the reaction [Glucose results in increased phosphorylation of EIF2AK3 protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in increased phosphorylation of EIF2AK3 protein]
Chlorogenic Acid inhibits the reaction [Glucose results in increased phosphorylation of EIF2AK3 protein]; Metformin inhibits the reaction [Glucose results in increased phosphorylation of EIF2AK3 protein]
Glucose deficiency results in increased phosphorylation of EIF2AK3 protein; Glucose results in increased phosphorylation of EIF2AK3 protein 		CTD PMID:31022492 PMID:34801538 PMID:39579577 PMID:39798073 NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268 		JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2 subunit alpha multiple interactions
increases phosphorylation 		ISO
EXP 		acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Glucose results in increased phosphorylation of EIF2S1 protein]
Chlorogenic Acid inhibits the reaction [Glucose results in increased phosphorylation of EIF2S1 protein]; Metformin inhibits the reaction [Glucose results in increased phosphorylation of EIF2S1 protein]
4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased phosphorylation of EIF2S1 protein]; salubrinal inhibits the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased phosphorylation of EIF2S1 protein]] 		CTD PMID:18973755 PMID:31022492 PMID:34801538 NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649 		JBrowse link
G Eif4a1 eukaryotic translation initiation factor 4A1 increases degradation ISO Glucose deficiency results in increased degradation of EIF4A1 protein CTD PMID:30821613 NCBI chr10:54,883,093...54,888,602
Ensembl chr10:54,883,093...54,888,602 		JBrowse link
G Eif4e eukaryotic translation initiation factor 4E multiple interactions
increases phosphorylation 		ISO Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]; resveratrol inhibits the reaction [Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]]; resveratrol inhibits the reaction [Glucose results in increased phosphorylation of EIF4E protein] CTD PMID:19765649 NCBI chr 2:229,736,309...229,772,628
Ensembl chr 2:229,739,897...229,774,105 		JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 multiple interactions ISO
EXP 		[AKT1 protein mutant form results in increased susceptibility to Glucose deficiency] which results in increased phosphorylation of EIF4EBP1 protein
resveratrol inhibits the reaction [Glucose results in increased phosphorylation of EIF4EBP1 protein] 		CTD PMID:15806154 PMID:20332614 NCBI chr16:71,495,457...71,508,845
Ensembl chr16:71,487,930...71,508,874 		JBrowse link
G Eif4g1 eukaryotic translation initiation factor 4 gamma 1 multiple interactions ISO Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]; resveratrol inhibits the reaction [Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]] CTD PMID:19765649 NCBI chr11:93,726,322...93,746,387
Ensembl chr11:93,726,322...93,746,367 		JBrowse link
G Eif4h eukaryotic translation initiation factor 4H increases degradation ISO Glucose deficiency results in increased degradation of EIF4H protein CTD PMID:30821613 NCBI chr12:27,719,527...27,736,350
Ensembl chr12:27,719,321...27,736,346 		JBrowse link
G Elapor1 endosome-lysosome associated apoptosis and autophagy regulator 1 increases expression
multiple interactions 		ISO Glucose results in increased expression of ELAPOR1 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of ELAPOR1 mRNA] 		CTD PMID:31525975 PMID:33448797 NCBI chr 2:198,777,323...198,856,497
Ensembl chr 2:198,777,323...198,856,497 		JBrowse link
G Elfn2 extracellular leucine-rich repeat and fibronectin type III domain containing 2 decreases expression ISO Glucose results in decreased expression of ELFN2 mRNA CTD PMID:39613055 NCBI chr 7:112,101,998...112,153,280
Ensembl chr 7:112,074,331...112,153,451 		JBrowse link
G Elk3 ETS transcription factor ELK3 increases expression ISO Glucose results in increased expression of ELK3 mRNA CTD PMID:17178593 NCBI chr 7:29,655,676...29,718,163
Ensembl chr 7:29,655,693...29,691,661 		JBrowse link
G Elovl6 ELOVL fatty acid elongase 6 increases expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of ELOVL6 mRNA
(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA] 		CTD PMID:15066988 PMID:16790840 PMID:32613381 NCBI chr 2:220,738,095...220,845,528
Ensembl chr 2:220,738,064...220,845,549 		JBrowse link
G Emc1 ER membrane protein complex subunit 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of EMC1 mRNA CTD PMID:37567420 NCBI chr 5:156,891,773...156,917,092
Ensembl chr 5:156,891,773...156,917,092 		JBrowse link
G Endog endonuclease G multiple interactions
affects localization 		ISO
EXP 		[Glucose deficiency co-treated with Acetylcysteine] affects the localization of ENDOG protein; [Glucose deficiency co-treated with CAT] affects the localization of ENDOG protein; [Glucose deficiency co-treated with Tetradecanoylphorbol Acetate] affects the localization of ENDOG protein
Glucose affects the localization of ENDOG protein 		CTD PMID:17309078 PMID:23192364 NCBI chr 3:33,846,935...33,849,531
Ensembl chr 3:33,846,885...33,849,573 		JBrowse link
G Enkur enkurin, TRPC channel interacting protein multiple interactions
increases expression 		ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ENKUR mRNA
Glucose results in increased expression of ENKUR mRNA 		CTD PMID:37567420 PMID:39922521 NCBI chr17:88,599,057...88,622,668
Ensembl chr17:88,599,057...88,622,668 		JBrowse link
G Eno1 enolase 1 decreases secretion ISO Glucose deficiency results in decreased secretion of ENO1 protein CTD PMID:24802182 NCBI chr 5:166,002,867...166,014,252
Ensembl chr 3:77,946,261...77,986,003
Ensembl chr 5:77,946,261...77,986,003 		JBrowse link
G Eno2 enolase 2 increases secretion ISO Glucose deficiency results in increased secretion of ENO2 protein CTD PMID:24802182 NCBI chr 4:159,258,371...159,267,220
Ensembl chr 4:159,258,371...159,267,220 		JBrowse link
G Enpp1 ectonucleotide pyrophosphatase/phosphodiesterase 1 increases expression ISO Glucose results in increased expression of ENPP1 mRNA CTD PMID:39922521 NCBI chr 1:22,518,051...22,583,044
Ensembl chr 1:22,518,069...22,583,044 		JBrowse link
G Entpd1 ectonucleoside triphosphate diphosphohydrolase 1 increases expression ISO Glucose results in increased expression of ENTPD1 mRNA CTD PMID:31525975 NCBI chr 1:249,374,810...249,502,310
Ensembl chr 1:249,374,836...249,502,317 		JBrowse link
G Entpd4 ectonucleoside triphosphate diphosphohydrolase 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ENTPD4 mRNA CTD PMID:37567420 NCBI chr15:51,040,665...51,068,450
Ensembl chr15:51,040,673...51,068,441 		JBrowse link
G Ep300 E1A binding protein p300 multiple interactions
increases expression 		ISO [cobaltous chloride co-treated with Glucose] promotes the reaction [HIF1A protein binds to EP300 protein]; ERCC1 protein affects the reaction [Glucose results in increased expression of EP300 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of EP300 mRNA]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] promotes the reaction [HIF1A protein binds to EP300 protein]] CTD PMID:22228707 PMID:25192544 PMID:26045780 NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:114,946,982...115,058,574 		JBrowse link
G Epb42 erythrocyte membrane protein band 4.2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EPB42 mRNA CTD PMID:37567420 NCBI chr 3:128,433,460...128,451,683
Ensembl chr 3:128,433,464...128,451,683 		JBrowse link
G Epcam epithelial cell adhesion molecule increases expression ISO Glucose results in increased expression of EPCAM mRNA CTD PMID:39922521 NCBI chr 6:12,633,715...12,649,678
Ensembl chr 6:12,631,611...12,649,702 		JBrowse link
G Epha1 Eph receptor A1 increases expression ISO Glucose results in increased expression of EPHA1 mRNA CTD PMID:39922521 NCBI chr 4:72,213,022...72,227,543
Ensembl chr 4:72,213,037...72,227,474 		JBrowse link
G Ephx4 epoxide hydrolase 4 decreases expression ISO Glucose results in decreased expression of EPHX4 mRNA CTD PMID:31525975 NCBI chr14:2,488,282...2,517,558
Ensembl chr14:2,488,290...2,517,757 		JBrowse link
G Epo erythropoietin multiple interactions ISO [EPO protein co-treated with Glucose] results in increased expression of RUNX2 mRNA; [EPO protein co-treated with Glucose] results in increased expression of RUNX2 protein; [EPO protein co-treated with Glucose] results in increased expression of SP7 mRNA; [EPO protein co-treated with Glucose] results in increased expression of SP7 protein CTD PMID:30894315 NCBI chr12:24,841,285...24,844,725
Ensembl chr12:24,841,285...24,844,725 		JBrowse link
G Epop elongin BC and polycomb repressive complex 2 associated protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EPOP mRNA CTD PMID:37567420 NCBI chr10:83,120,767...83,122,287
Ensembl chr10:83,119,970...83,122,423 		JBrowse link
G Eppk1 epiplakin 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of EPPK1 mRNA CTD PMID:37567420 NCBI chr 7:109,697,607...109,718,468
Ensembl chr 7:109,697,607...109,718,468 		JBrowse link
G Epsti1 epithelial stromal interaction 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of EPSTI1 mRNA CTD PMID:37567420 NCBI chr15:59,692,712...59,791,376
Ensembl chr15:59,693,142...59,791,380 		JBrowse link
G Erbb2 erb-b2 receptor tyrosine kinase 2 multiple interactions ISO [Glucose deficiency co-treated with Quercetin] results in increased ubiquitination of ERBB2 protein; Glucose deficiency inhibits the reaction [Quercetin promotes the reaction [ERBB2 protein binds to HSP90AA1 protein]] CTD PMID:18655187 NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481 		JBrowse link
G Erbb3 erb-b2 receptor tyrosine kinase 3 multiple interactions EXP [NRG1 protein binds to ERBB3 protein] which results in increased transport of Glucose CTD PMID:14711829 NCBI chr 7:1,579,079...1,600,379
Ensembl chr 7:1,579,816...1,601,120 		JBrowse link
G Ercc1 ERCC excision repair 1, endonuclease non-catalytic subunit increases expression
multiple interactions 		ISO Glucose results in increased expression of ERCC1 mRNA; Glucose results in increased expression of ERCC1 protein
3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC1 mRNA]; 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC1 protein]; Curcumin inhibits the reaction [Glucose results in increased expression of ERCC1 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of ERCC1 protein]; ERCC1 protein affects the reaction [Glucose results in increased expression of EP300 mRNA]; ERCC1 protein affects the reaction [Glucose results in increased expression of ERCC4 mRNA]; ERCC1 protein affects the reaction [Glucose results in increased expression of ERCC4 protein]; ERCC1 protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; ERCC1 protein affects the reaction [Glucose results in increased expression of PARP1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of ERCC1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of ERCC1 protein]; trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC1 mRNA]; trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC1 protein] 		CTD PMID:22228707 NCBI chr 1:88,099,308...88,135,966
Ensembl chr 1:88,118,891...88,139,120 		JBrowse link
G Ercc4 ERCC excision repair 4, endonuclease catalytic subunit multiple interactions
increases expression 		ISO 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]; 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC4 protein]; Curcumin inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of ERCC4 protein]; ERCC1 protein affects the reaction [Glucose results in increased expression of ERCC4 mRNA]; ERCC1 protein affects the reaction [Glucose results in increased expression of ERCC4 protein]; ERCC4 protein affects the reaction [Glucose results in increased expression of EP300 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of ERCC1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of ERCC1 protein]; ERCC4 protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of PARP1 mRNA]; trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]; trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC4 protein]
Glucose results in increased expression of ERCC4 mRNA; Glucose results in increased expression of ERCC4 protein 		CTD PMID:22228707 NCBI chr10:2,926,085...2,958,176
Ensembl chr10:2,920,455...2,955,539 		JBrowse link
G Erich5 glutamate-rich 5 increases expression ISO Glucose results in increased expression of ERICH5 mRNA CTD PMID:39922521 NCBI chr 7:67,538,154...67,569,433
Ensembl chr 7:67,536,588...67,563,989 		JBrowse link
G Ern1 endoplasmic reticulum to nucleus signaling 1 increases phosphorylation
multiple interactions 		ISO
EXP 		Glucose deficiency results in increased phosphorylation of ERN1 protein; Glucose results in increased phosphorylation of ERN1 protein
[imeglimin co-treated with Glucose] results in increased expression of ERN1 mRNA
Chlorogenic Acid inhibits the reaction [Glucose results in increased phosphorylation of ERN1 protein]; Metformin inhibits the reaction [Glucose results in increased phosphorylation of ERN1 protein]
4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased phosphorylation of ERN1 protein]; [Glucose co-treated with TGFB1 protein] results in increased phosphorylation of ERN1 protein; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased phosphorylation of ERN1 protein]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased phosphorylation of ERN1 protein]]; ginsenoside Re inhibits the reaction [Glucose results in increased phosphorylation of ERN1 protein] 		CTD PMID:31022492 PMID:34588186 PMID:34801538 PMID:35961541 PMID:39798073 NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,830,428...91,920,791 		JBrowse link
G Ern2 endoplasmic reticulum to nucleus signaling 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ERN2 mRNA CTD PMID:37567420 NCBI chr 1:186,153,115...186,174,521
Ensembl chr 1:186,157,691...186,174,521 		JBrowse link
G Ero1a endoplasmic reticulum oxidoreductase 1 alpha decreases expression
multiple interactions
increases expression 		ISO
EXP 		Glucose results in decreased expression of ERO1A mRNA
[imeglimin co-treated with Glucose] results in increased expression of ERO1A mRNA
Glucose results in increased expression of ERO1A protein
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of ERO1A protein]; Metformin inhibits the reaction [Glucose results in increased expression of ERO1A protein] 		CTD PMID:17178593 PMID:34588186 PMID:34801538 NCBI chr15:20,974,771...21,010,170
Ensembl chr15:20,972,679...21,018,039 		JBrowse link
G Esr1 estrogen receptor 1 decreases expression
multiple interactions
increases abundance
increases phosphorylation
increases expression 		ISO
EXP 		Glucose results in decreased expression of ESR1 mRNA
Endosulfan promotes the reaction [ESR1 protein results in increased abundance of Glucose]
Glucose results in increased phosphorylation of ESR1 protein
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of ESR1 mRNA; ESR1 protein promotes the reaction [[Resveratrol results in increased localization of SLC2A4 protein] which results in increased uptake of Glucose]; tetrahydropalmatine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of ESR1 mRNA]
Glucose results in increased expression of ESR1 mRNA 		CTD PMID:16621514 PMID:18426865 PMID:23690508 PMID:31520823 PMID:37606869 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Esr2 estrogen receptor 2 decreases expression
increases expression 		ISO Glucose results in decreased expression of ESR2 mRNA
Glucose results in increased expression of ESR2 mRNA 		CTD PMID:16621514 NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709 		JBrowse link
G Esrp1 epithelial splicing regulatory protein 1 increases expression
multiple interactions 		ISO Glucose results in increased expression of ESRP1 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of ESRP1 mRNA] 		CTD PMID:33448797 NCBI chr 5:29,224,831...29,279,381
Ensembl chr 5:29,225,360...29,279,278 		JBrowse link
G Esrra estrogen related receptor, alpha decreases expression
multiple interactions 		ISO Glucose results in decreased expression of ESRRA protein
resveratrol inhibits the reaction [Glucose results in decreased expression of ESRRA protein] 		CTD PMID:23090186 NCBI chr 1:213,533,309...213,543,432
Ensembl chr 1:213,533,310...213,543,811 		JBrowse link
G Ezr ezrin decreases expression
multiple interactions 		ISO Glucose results in decreased expression of EZR protein
Eucalyptol inhibits the reaction [Glucose results in decreased expression of EZR protein] 		CTD PMID:31483951 NCBI chr 1:49,373,033...49,416,573
Ensembl chr 1:49,373,035...49,416,573 		JBrowse link
G F13a1 coagulation factor XIII A1 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of F13A1 mRNA CTD PMID:37567420 NCBI chr17:28,021,197...28,197,960
Ensembl chr17:28,020,845...28,197,948 		JBrowse link
G F2r coagulation factor II (thrombin) receptor decreases expression ISO Glucose results in decreased expression of F2R mRNA CTD PMID:31655124 NCBI chr 2:28,604,066...28,620,579
Ensembl chr 2:28,604,066...28,620,579 		JBrowse link
G F3 coagulation factor III, tissue factor increases expression
multiple interactions 		ISO Glucose results in increased expression of F3 mRNA; Glucose results in increased expression of F3 protein
Fluorometholone inhibits the reaction [Glucose results in increased expression of F3 mRNA]; Fluorometholone inhibits the reaction [Glucose results in increased expression of F3 protein] 		CTD PMID:35264022 NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369 		JBrowse link
G F7 coagulation factor VII multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of F7 mRNA CTD PMID:37567420 NCBI chr16:83,191,896...83,202,775
Ensembl chr16:83,191,914...83,202,738 		JBrowse link
G Fabp1 fatty acid binding protein 1 increases expression ISO Glucose results in increased expression of FABP1 mRNA CTD PMID:36156098 NCBI chr 4:104,744,302...104,753,119
Ensembl chr 4:104,744,309...104,753,113 		JBrowse link
G Fabp4 fatty acid binding protein 4 multiple interactions
increases expression 		ISO
EXP 		[Glucose deficiency co-treated with ALB protein] results in decreased expression of FABP4 mRNA; [Glucose deficiency co-treated with Clofibrate co-treated with Oleic Acid] results in increased expression of FABP4 mRNA; [Glucose deficiency co-treated with Clofibrate] results in increased expression of FABP4 mRNA; [Glucose deficiency co-treated with Oleic Acid] results in increased expression of FABP4 mRNA
[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]; dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]
Glucose results in increased expression of FABP4 mRNA 		CTD PMID:3299706 PMID:8536680 PMID:32407875 NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972 		JBrowse link
G Fam151b family with sequence similarity 151, member B increases expression ISO Glucose results in increased expression of FAM151B mRNA CTD PMID:39922521 NCBI chr 2:25,409,382...25,446,225
Ensembl chr 2:25,409,383...25,445,466 		JBrowse link
G Fam163a family with sequence similarity 163, member A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of FAM163A mRNA CTD PMID:37567420 NCBI chr13:70,813,129...70,891,410
Ensembl chr13:70,813,134...70,891,316 		JBrowse link
G Fam163b family with sequence similarity 163, member B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FAM163B mRNA CTD PMID:37567420 NCBI chr 3:30,834,145...30,865,802
Ensembl chr 3:30,834,146...30,864,530 		JBrowse link
G Fam167a family with sequence similarity 167, member A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FAM167A mRNA CTD PMID:37567420 NCBI chr15:41,861,271...41,891,427
Ensembl chr15:41,861,227...41,891,418 		JBrowse link
G Fam178b family with sequence similarity 178, member B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of FAM178B mRNA CTD PMID:37567420 NCBI chr 9:46,301,734...46,409,571
Ensembl chr 9:46,301,734...46,410,686 		JBrowse link
G Fam184b family with sequence similarity 184, member B increases expression ISO Glucose results in increased expression of FAM184B mRNA CTD PMID:39922521 NCBI chr14:69,688,031...69,803,922
Ensembl chr14:69,688,031...69,803,922 		JBrowse link
G Fam217a family with sequence similarity 217, member A increases expression ISO Glucose results in increased expression of FAM217A mRNA CTD PMID:39922521 NCBI chr17:30,180,403...30,186,833
Ensembl chr17:30,172,057...30,186,825 		JBrowse link
G Fam227a family with sequence similarity 227, member A increases expression ISO Glucose results in increased expression of FAM227A mRNA CTD PMID:39922521 NCBI chr 7:113,054,751...113,096,898
Ensembl chr 7:113,054,751...113,096,868 		JBrowse link
G Fam24a family with sequence similarity 24, member A increases expression ISO Glucose results in increased expression of FAM24A mRNA CTD PMID:39922521 NCBI chr 1:195,550,911...195,553,115
Ensembl chr 1:195,546,211...195,554,086 		JBrowse link
G Fam78b family with sequence similarity 78, member B decreases expression
multiple interactions 		ISO Glucose results in decreased expression of FAM78B mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of FAM78B mRNA] 		CTD PMID:33448797 NCBI chr13:81,695,329...81,783,881
Ensembl chr13:81,695,329...81,781,784 		JBrowse link
G Fam83c family with sequence similarity 83, member C multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of FAM83C mRNA] CTD PMID:33448797 NCBI chr 3:164,792,258...164,799,882
Ensembl chr 3:164,793,105...164,799,995 		JBrowse link
G Fam98c family with sequence similarity 98, member C multiple interactions
decreases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of FAM98C mRNA] CTD PMID:33448797 NCBI chr 1:93,580,286...93,583,894
Ensembl chr 1:93,580,287...93,583,831 		JBrowse link
G Fas Fas cell surface death receptor multiple interactions
decreases expression
increases expression 		ISO dorsomorphin inhibits the reaction [platycodin D inhibits the reaction [Glucose results in increased expression of FAS mRNA]]; dorsomorphin inhibits the reaction [platycodin D inhibits the reaction [Glucose results in increased expression of FAS protein]]; platycodin D inhibits the reaction [Glucose results in increased expression of FAS mRNA]; platycodin D inhibits the reaction [Glucose results in increased expression of FAS protein]; STO 609 inhibits the reaction [platycodin D inhibits the reaction [Glucose results in increased expression of FAS mRNA]]
Glucose results in decreased expression of FAS mRNA
Glucose results in increased expression of FAS mRNA; Glucose results in increased expression of FAS protein 		CTD PMID:23319015 PMID:31655124 NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104 		JBrowse link
G Faslg Fas ligand increases expression
multiple interactions 		ISO Glucose results in increased expression of FASLG mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of FASL mRNA 		CTD PMID:31655124 PMID:37567420 NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503 		JBrowse link
G Fasn fatty acid synthase increases expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of FASN mRNA
Allopurinol inhibits the reaction [Glucose results in increased expression of FASN protein]; Glucose promotes the reaction [SREBF1 protein binds to FASN promoter]; Quercetin inhibits the reaction [Glucose results in increased expression of FASN protein]
[Glucose results in increased expression of FASN protein] which results in increased abundance of Triglycerides; [INS protein co-treated with Glucose] results in increased expression of FASN mRNA; [Resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [[Glucose results in increased expression of FASN protein] which results in increased abundance of Triglycerides]; Allopurinol inhibits the reaction [Glucose results in increased expression of FASN protein]; PRKAA2 protein promotes the reaction [SIRT1 protein inhibits the reaction [Glucose results in increased expression of FASN protein]]; Quercetin inhibits the reaction [Glucose results in increased expression of FASN protein]; SIRT1 protein inhibits the reaction [Glucose results in increased expression of FASN protein]; SRT1720 inhibits the reaction [[INS protein co-treated with Glucose] results in increased expression of FASN mRNA] 		CTD PMID:15066988 PMID:18482975 PMID:19724016 PMID:22031849 PMID:23647015 NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583 		JBrowse link
G Fat3 FAT atypical cadherin 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of FAT3 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FAT3 mRNA CTD PMID:37567420 NCBI chr 8:20,972,840...21,555,679
Ensembl chr 8:20,972,840...21,555,240 		JBrowse link
G Faxc failed axon connections homolog, metaxin like GST domain containing multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FAXC mRNA CTD PMID:37567420 NCBI chr 5:40,277,167...40,336,503
Ensembl chr 5:40,277,135...40,344,076 		JBrowse link
G Fbp2 fructose-bisphosphatase 2 multiple interactions
decreases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of FBP2 mRNA] CTD PMID:33448797 NCBI chr17:2,241,767...2,259,371
Ensembl chr17:2,241,975...2,259,366 		JBrowse link
G Fbxl13 F-box and leucine-rich repeat protein 13 increases expression ISO Glucose results in increased expression of FBXL13 mRNA CTD PMID:31525975 NCBI chr 4:14,307,032...14,505,491
Ensembl chr 4:14,307,096...14,499,585 		JBrowse link
G Fbxo10 F-box protein 10 increases expression ISO Glucose results in increased expression of FBXO10 mRNA CTD PMID:39613055 NCBI chr 5:64,092,709...64,139,054
Ensembl chr 5:64,092,709...64,160,923 		JBrowse link
G Fbxo32 F-box protein 32 multiple interactions
increases expression 		ISO FBXO32 protein affects the reaction [Glucose results in decreased expression of KCNN2 protein]
Glucose results in increased expression of FBXO32 protein 		CTD PMID:30635400 NCBI chr 7:91,620,925...91,654,491
Ensembl chr 7:91,620,925...91,654,491 		JBrowse link
G Fbxo43 F-box protein 43 increases expression ISO Glucose results in increased expression of FBXO43 mRNA CTD PMID:39922521 NCBI chr 7:69,218,298...69,231,873
Ensembl chr 7:69,218,299...69,230,310 		JBrowse link
G Fbxo47 F-box protein 47 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FBXO47 mRNA CTD PMID:37567420 NCBI chr10:83,331,750...83,376,669
Ensembl chr10:83,338,060...83,376,781 		JBrowse link
G Fbxo48 F-box protein 48 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of FBXO48 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FBXO48 mRNA CTD PMID:37567420 NCBI chr14:95,582,493...95,583,950
Ensembl chr14:95,581,279...95,587,616 		JBrowse link
G Fbxw12 F-box and WD repeat domain containing 12 increases expression ISO Glucose results in increased expression of FBXW12 CTD PMID:36073553 NCBI chr 8:118,660,777...118,680,565
Ensembl chr 8:118,660,605...118,680,572 		JBrowse link
G Fcer1g Fc epsilon receptor Ig decreases expression ISO Glucose results in decreased expression of FCER1G mRNA CTD PMID:31525975 NCBI chr13:86,181,908...86,186,766
Ensembl chr13:86,181,908...86,186,859 		JBrowse link
G Fcgr3a Fc gamma receptor 3A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of FCGR4 mRNA CTD PMID:37567420 NCBI chr13:85,782,636...85,792,656
Ensembl chr13:85,782,490...85,792,651 		JBrowse link
G Fcho1 FCH and mu domain containing endocytic adaptor 1 multiple interactions
decreases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of FCHO1 mRNA] CTD PMID:33448797 NCBI chr16:18,447,424...18,464,738
Ensembl chr16:18,447,424...18,464,698 		JBrowse link
G Fcrlb Fc receptor-like B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FCRLB mRNA CTD PMID:37567420 NCBI chr13:85,681,403...85,689,880
Ensembl chr13:85,682,472...85,688,707 		JBrowse link
G Fdft1 farnesyl diphosphate farnesyl transferase 1 decreases expression ISO Glucose results in decreased expression of FDFT1 mRNA CTD PMID:39613055 NCBI chr15:41,588,114...41,616,168
Ensembl chr15:41,588,117...41,616,168 		JBrowse link
G Fen1 flap structure-specific endonuclease 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of FEN1 mRNA CTD PMID:37567420 NCBI chr 1:216,270,016...216,274,873
Ensembl chr 1:216,269,163...216,275,016 		JBrowse link
G Fendrr FOXF1 adjacent non-coding developmental regulatory RNA multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of FENDRR mRNA CTD PMID:37567420 NCBI chr19:66,035,910...66,061,466
Ensembl chr19:66,036,856...66,044,268 		JBrowse link
G Ffar1 free fatty acid receptor 1 decreases expression
multiple interactions 		EXP
ISO 		Glucose results in decreased expression of FFAR1 mRNA
[FFAR1 protein affects the susceptibility to Dietary Fats] affects the reaction [Glucose results in increased secretion of INS1 protein]; FFAR1 protein affects the reaction [Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]] 		CTD PMID:24349266 PMID:37217659 NCBI chr 1:95,238,785...95,239,689
Ensembl chr 1:95,238,785...95,239,691 		JBrowse link
G Ffar3 free fatty acid receptor 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of FFAR3 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FFAR3 mRNA CTD PMID:37567420 NCBI chr 1:95,232,804...95,234,144
Ensembl chr 1:95,232,336...95,234,354 		JBrowse link
G Fgf1 fibroblast growth factor 1 increases expression
decreases expression
multiple interactions 		ISO Glucose results in increased expression of FGF1 mRNA
Glucose results in decreased expression of FGF1 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of FGF1 mRNA] 		CTD PMID:31655124 PMID:33448797 NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,939,870...30,961,393 		JBrowse link
G Fgf2 fibroblast growth factor 2 increases expression
decreases expression
multiple interactions 		EXP
ISO 		Glucose results in increased expression of FGF2 mRNA; Glucose results in increased expression of FGF2 protein
Glucose results in decreased expression of FGF2 mRNA
Glucosamine promotes the reaction [Glucose results in increased expression of FGF2 mRNA] 		CTD PMID:1518840 PMID:19759273 PMID:31655124 NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493 		JBrowse link
G Fgf21 fibroblast growth factor 21 affects uptake
increases secretion
multiple interactions
increases expression 		ISO FGF21 protein affects the uptake of Glucose
Glucose results in increased secretion of FGF21 protein
indolo(3,2-b)carbazole inhibits the reaction [Glucose deficiency results in increased expression of FGF21 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Glucose deficiency results in increased expression of FGF21 mRNA]
indolo(3,2-b)carbazole inhibits the reaction [Glucose results in increased expression of FGF21 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased expression of FGF21 mRNA] 		CTD PMID:15902306 PMID:27226639 PMID:28123933 NCBI chr 1:105,219,825...105,221,376
Ensembl chr 1:105,219,825...105,232,056 		JBrowse link
G Fgf7 fibroblast growth factor 7 affects transport ISO FGF7 protein affects the transport of Glucose CTD PMID:12757114 NCBI chr 3:133,734,557...133,786,678
Ensembl chr 3:133,734,673...133,786,328 		JBrowse link
G Fgg fibrinogen gamma chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FGG mRNA CTD PMID:37567420 NCBI chr 2:170,652,929...170,660,372
Ensembl chr 2:170,652,234...170,661,170 		JBrowse link
G Fgl2 fibrinogen-like 2 multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of FGL2 mRNA] CTD PMID:33448797 NCBI chr 4:14,602,762...14,608,405
Ensembl chr 4:14,602,771...14,608,405 		JBrowse link
G Fhad1 forkhead associated phosphopeptide binding domain 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of FHAD1 mRNA CTD PMID:37567420 NCBI chr 5:159,474,111...159,593,455
Ensembl chr 5:159,474,158...159,593,367 		JBrowse link
G Fis1 fission, mitochondrial 1 increases expression
multiple interactions 		EXP
ISO 		Glucose results in increased expression of FIS1 protein
[Glucose co-treated with Deferoxamine] results in increased expression of FIS1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of FIS1 mRNA]
cinnamic acid inhibits the reaction [Glucose results in increased expression of FIS1 protein]; Metformin inhibits the reaction [Glucose results in increased expression of FIS1 protein] 		CTD PMID:27684054 PMID:30144576 PMID:33962019 NCBI chr12:25,345,239...25,360,135
Ensembl chr12:25,345,239...25,349,335 		JBrowse link
G Flg filaggrin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of FLG mRNA CTD PMID:37567420 NCBI chr 2:181,583,801...181,596,464
Ensembl chr 2:181,583,808...181,595,968 		JBrowse link
G Flg2 filaggrin 2 decreases expression
decreases methylation 		ISO Glucose results in decreased expression of FLG2 mRNA
Glucose results in decreased methylation of FLG2 promoter 		CTD PMID:31525975
G Flt1 Fms related receptor tyrosine kinase 1 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of FLT1 mRNA; Glucose results in decreased expression of FLT1 protein
[Glucose co-treated with ICG 001] results in decreased expression of FLT1 protein; Panax notoginseng extract inhibits the reaction [[Glucose co-treated with ICG 001] results in decreased expression of FLT1 protein]; Panax notoginseng extract inhibits the reaction [Glucose results in decreased expression of FLT1 protein] 		CTD PMID:31655124 PMID:35385194 NCBI chr12:12,333,050...12,504,750
Ensembl chr12:12,333,430...12,504,750 		JBrowse link
G Fmo3 flavin containing dimethylaniline monoxygenase 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FMO3 mRNA CTD PMID:37567420 NCBI chr13:77,838,899...77,868,869
Ensembl chr13:77,842,602...77,861,256 		JBrowse link
G Fn1 fibronectin 1 multiple interactions
decreases expression
decreases secretion
increases expression
increases secretion 		ISO
EXP 		3-aminobenzamide inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [Glucose results in increased expression of FN1 protein]; 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Glucose results in increased secretion of FN1 protein]; [Glucose results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased secretion of FN1 protein; acetovanillone inhibits the reaction [Glucose results in increased secretion of FN1 protein]; AKT activator SC79 inhibits the reaction [FOXP1 protein inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]]; alpha-Tocopherol inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]; Bosentan inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; Bosentan inhibits the reaction [Glucose results in increased expression of FN1 protein]; BQ 788 inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; calphostin C inhibits the reaction [Glucose results in increased secretion of FN1 protein]; chelerythrine inhibits the reaction [Glucose results in increased expression of FN1 protein]; Curcumin inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of FN1 protein]; diphenyleneiodonium inhibits the reaction [Glucose results in increased secretion of FN1 protein]; DKK1 protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; ERCC1 protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; gingerol inhibits the reaction [Glucose results in increased secretion of FN1 protein]; Glucose results in increased expression of and results in increased secretion of FN1 protein; Indomethacin inhibits the reaction [Glucose results in increased secretion of FN1 protein]; MAPK14 protein promotes the reaction [Glucose results in increased secretion of FN1 protein]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of FN1 protein]]; MIR142 inhibits the reaction [Glucose results in increased expression of FN1 protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased expression of FN1 protein]; Rotenone inhibits the reaction [Glucose results in increased secretion of FN1 protein]; sitaxsentan inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; SN50 peptide inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; SN50 peptide inhibits the reaction [Glucose results in increased expression of FN1 protein]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased expression of FN1 protein]]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of FN1 protein]; trichostatin A inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; Troglitazone inhibits the reaction [Glucose results in increased expression of FN1 mRNA]
Glucose results in decreased expression of FN1 mRNA
Glucose deficiency results in decreased secretion of FN1 protein
Glucose results in increased expression of FN1 mRNA; Glucose results in increased expression of FN1 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; [[[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1 protein; [Glucose results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1; [JTE 013 binds to and results in decreased activity of S1PR2 protein] inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein]; [sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein; acetovanillone inhibits the reaction [Glucose results in increased expression of FN1 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased expression of FN1 protein]; cinnamaldehyde inhibits the reaction [Glucose results in increased expression of FN1 protein]; CYBA protein promotes the reaction [Glucose results in increased expression of FN1 protein]; diphenyleneiodonium inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; diphenyliodonium inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; farrerol inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; farrerol inhibits the reaction [Glucose results in increased expression of FN1 protein]; HIF1A protein affects the reaction [Glucose results in increased expression of FN1 protein]; LY2109761 inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; manumycin inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; MIR217 mRNA affects the reaction [Glucose results in increased expression of FN1 protein]; N,N-dimethylsphingosine inhibits the reaction [Glucose results in increased expression of FN1 protein]; NCF1 protein promotes the reaction [Glucose results in increased expression of FN1 protein]; Resveratrol inhibits the reaction [[[[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of FN1 protein]; rhodioloside inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; SB 203580 inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of FN1 protein]]; SPHK1 mRNA affects the reaction [Glucose results in increased expression of FN1 protein]; SPHK1 protein inhibits the reaction [Glucose results in increased expression of FN1 protein]; Superoxides affects the reaction [Glucose results in increased expression of FN1 mRNA]; TXNIP protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; TXNIP protein affects the reaction [Glucose results in increased expression of FN1 protein]; Y 27632 inhibits the reaction [Glucose results in increased expression of FN1 protein]
Glucose results in decreased expression of FN1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [Glucose results in increased expression of FN1 protein]]; Enalaprilat inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; NFE2L2 protein affects the reaction [SMARCA4A protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]]; Resveratrol inhibits the reaction [Glucose results in increased expression of FN1 protein]; SMARCA4A protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; SMARCA4A protein inhibits the reaction [Glucose results in increased expression of FN1 protein]; TXNIP promotes the reaction [Glucose results in increased expression of FN1 mRNA] 		CTD PMID:9225831 PMID:12388107 PMID:14520012 PMID:15086456 PMID:16320596 More... NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137 		JBrowse link
G Fn3k fructosamine 3 kinase increases expression ISO Glucose results in increased expression of FN3K mRNA CTD PMID:39922521 NCBI chr10:107,198,566...107,214,176
Ensembl chr10:107,198,892...107,214,175 		JBrowse link
G Folr1 folate receptor alpha decreases expression ISO Glucose results in decreased expression of FOLR1 mRNA CTD PMID:19616087 NCBI chr 1:165,631,462...165,650,430
Ensembl chr 1:165,631,462...165,642,669 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions
increases expression 		ISO
EXP 		[Glucose co-treated with Lipopolysaccharides] results in increased expression of FOS protein; MIR1231 inhibits the reaction [Glucose results in increased expression of FOS protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of FOS protein]
Glucose results in increased expression of FOS mRNA
Dactinomycin inhibits the reaction [Glucose results in increased expression of FOS mRNA]; Glucose affects the reaction [Adenosine Triphosphate results in increased expression of FOS mRNA] 		CTD PMID:10723097 PMID:11123204 PMID:11557636 PMID:17178593 PMID:18180316 More... NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598 		JBrowse link
G Fosl1 FOS like 1, AP-1 transcription factor subunit multiple interactions
increases expression 		ISO Glucose promotes the reaction [AGT protein results in increased expression of FOSL1 mRNA]
Glucose results in increased expression of FOSL1 mRNA 		CTD PMID:17178593 PMID:19225232 NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:212,183,833...212,192,391 		JBrowse link
G Fosl2 FOS like 2, AP-1 transcription factor subunit increases expression ISO Glucose results in increased expression of FOSL2 mRNA CTD PMID:17178593 NCBI chr 6:30,017,952...30,039,269
Ensembl chr 6:30,021,916...30,039,406 		JBrowse link
G Foxa2 forkhead box A2 multiple interactions ISO [Metformin co-treated with Glucose] affects the localization of FOXA2 protein CTD PMID:16489446 NCBI chr 3:155,923,305...155,927,508
Ensembl chr 3:155,923,307...155,928,757 		JBrowse link
G Foxa3 forkhead box A3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of FOXA3 mRNA CTD PMID:37567420 NCBI chr 1:87,790,111...87,800,259
Ensembl chr 1:87,790,012...87,800,953 		JBrowse link
G Foxd2 forkhead box D2 multiple interactions ISO [imeglimin co-treated with Glucose] results in increased expression of FOXD2 mRNA CTD PMID:34588186 NCBI chr 5:133,664,760...133,667,483
Ensembl chr 5:133,664,760...133,667,483 		JBrowse link
G Foxf2 forkhead box F2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FOXF2 mRNA CTD PMID:37567420 NCBI chr17:33,044,446...33,051,259
Ensembl chr17:32,846,603...33,051,259 		JBrowse link
G Foxm1 forkhead box M1 increases expression ISO Glucose results in increased expression of FOXM1 mRNA CTD PMID:32942007 NCBI chr 4:163,325,628...163,338,100
Ensembl chr 4:163,325,614...163,337,172 		JBrowse link
G Foxo1 forkhead box O1 increases abundance
multiple interactions
decreases response to substance 		EXP
ISO 		FOXO1 protein mutant form results in increased abundance of Glucose; FOXO1 protein results in increased abundance of Glucose
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased phosphorylation of and affects the localization of FOXO1 protein]]; Acetylcysteine inhibits the reaction [Glucose affects the localization of FOXO1 protein]; Calcitriol inhibits the reaction [Glucose results in decreased phosphorylation of and affects the localization of FOXO1 protein]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL mRNA]]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP mRNA]]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 mRNA]]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in increased expression of BECN1 protein]]; Glucose results in decreased phosphorylation of and affects the localization of FOXO1 protein
FOXO1 protein results in decreased susceptibility to Glucose
Glucose results in increased acetylation of and results in decreased activity of FOXO1 protein; SIRT3 protein inhibits the reaction [Glucose results in increased acetylation of FOXO1 protein]
FOXO1 protein inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]; FOXO1 protein inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]; FOXO1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]]; FOXO1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]]; Glucose results in increased phosphorylation of and results in decreased activity of FOXO1 protein; INS1 protein inhibits the reaction [FOXO1 protein results in increased abundance of Glucose]; INS1 protein promotes the reaction [FOXO1 protein mutant form results in increased abundance of Glucose]; resveratrol inhibits the reaction [Glucose results in increased phosphorylation of and results in decreased activity of FOXO1 protein]; resveratrol promotes the reaction [FOXO1 protein results in increased abundance of Glucose] 		CTD PMID:15788402 PMID:23494737 PMID:24413998 PMID:33450223 NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419 		JBrowse link
G Foxo3 forkhead box O3 increases phosphorylation
multiple interactions
decreases expression
increases localization 		ISO
EXP 		Glucose results in increased phosphorylation of FOXO3 protein
polyethylene glycol loxenatide inhibits the reaction [Glucose results in decreased expression of FOXO3 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose affects the localization of and results in increased phosphorylation of FOXO3 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and affects the localization of FOXO3 protein]]; 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucose affects the localization of and results in increased phosphorylation of FOXO3 protein]; Acetylcysteine inhibits the reaction [Glucose results in decreased phosphorylation of FOXO3 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased phosphorylation of FOXO3 protein]; Berberine inhibits the reaction [Glucose results in decreased expression of and results in increased acetylation of FOXO3 protein]; Berberine inhibits the reaction [Glucose results in decreased expression of FOXO3 protein]; Glucose results in decreased expression of and results in increased acetylation of FOXO3 protein; Glucose results in decreased phosphorylation of and affects the localization of FOXO3 protein; Glucose results in increased phosphorylation of and affects the localization of FOXO3 protein; Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and affects the localization of FOXO3 protein]
Glucose results in increased localization of FOXO3 protein
[[Resveratrol results in increased activity of SIRT1 protein] which results in increased phosphorylation of and results in decreased activity of FOXO3 protein] which results in decreased susceptibility to Glucose; AKT1 protein promotes the reaction [Glucose affects the phosphorylation of and affects the activity of FOXO3 protein]; FOXO3 protein promotes the reaction [Glucose results in increased cleavage of and results in increased activity of CASP1 protein]; FOXO3 protein promotes the reaction [Glucose results in increased cleavage of and results in increased activity of CASP3 protein]; Glucose affects the phosphorylation of and affects the activity of FOXO3 protein; Resveratrol inhibits the reaction [Glucose results in increased phosphorylation of FOXO3 protein] 		CTD PMID:20370652 PMID:23090186 PMID:23159718 PMID:25471227 PMID:37417536 More... NCBI chr20:47,251,968...47,348,254
Ensembl chr20:47,255,878...47,346,845 		JBrowse link
G Foxp1 forkhead box P1 multiple interactions
decreases expression 		ISO AKT activator SC79 inhibits the reaction [FOXP1 protein inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of CYBB protein]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of NOX4 protein]; FOXP1 protein inhibits the reaction [Glucose results in increased phosphorylation of MTOR protein]
Glucose results in decreased expression of FOXP1 mRNA; Glucose results in decreased expression of FOXP1 protein 		CTD PMID:31494106 NCBI chr 4:133,117,346...133,808,647
Ensembl chr 4:133,122,055...133,500,272 		JBrowse link
G Foxp3 forkhead box P3 increases expression ISO Glucose results in increased expression of FOXP3 mRNA CTD PMID:39922521 NCBI chr  X:17,580,380...17,601,181
Ensembl chr  X:17,580,380...17,595,894 		JBrowse link
G Frat2 FRAT regulator of WNT signaling pathway 2 increases expression ISO Glucose results in increased expression of FRAT2 mRNA CTD PMID:39922521 NCBI chr 1:250,603,450...250,605,779
Ensembl chr 1:250,603,088...250,606,921 		JBrowse link
G Frk fyn-related Src family tyrosine kinase multiple interactions ISO FRK protein inhibits the reaction [Glucose results in increased secretion of INS1 protein] CTD PMID:17179392 NCBI chr20:39,820,441...39,926,065
Ensembl chr20:39,820,295...39,926,362 		JBrowse link
G Frmd3 FERM domain containing 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FRMD3 mRNA CTD PMID:37567420 NCBI chr 5:92,810,989...93,077,326
Ensembl chr 5:92,810,736...93,077,325 		JBrowse link
G Frmpd3 FERM and PDZ domain containing 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FRMPD3 mRNA CTD PMID:37567420 NCBI chr  X:108,752,511...108,902,393
Ensembl chr  X:108,752,716...108,901,496 		JBrowse link
G Fsbp fibrinogen silencer binding protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of FSBP mRNA CTD PMID:37567420 NCBI chr 5:29,855,340...29,861,613
Ensembl chr 5:29,855,304...29,901,964 		JBrowse link
G Fsip1 fibrous sheath interacting protein 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of FSIP1 mRNA CTD PMID:37567420 NCBI chr 3:125,528,538...125,671,135
Ensembl chr 3:125,524,528...125,671,135 		JBrowse link
G Fth1 ferritin heavy chain 1 multiple interactions
increases expression 		ISO
EXP 		FTH1 protein inhibits the reaction [Glucose results in increased abundance of Reactive Oxygen Species]
Glucose results in increased expression of FTH1 protein
[[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Oxygen] results in increased expression of [FTH1 protein binds to FTL protein] 		CTD PMID:16135072 PMID:18931039 PMID:38483099 NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:216,051,998...216,055,214 		JBrowse link
G Ftl1 ferritin light chain 1 multiple interactions
increases expression 		EXP
ISO 		[[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Oxygen] results in increased expression of [FTH1 protein binds to FTL protein]
Glucose results in increased expression of FTL protein
Glucose results in increased expression of FTL1 protein 		CTD PMID:16135072 PMID:38483099 NCBI chr 1:105,072,858...105,074,705
Ensembl chr  X:45,399,355...45,399,915
Ensembl chr 2:45,399,355...45,399,915
Ensembl chr 1:45,399,355...45,399,915 		JBrowse link
G Fut1 fucosyltransferase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FUT1 mRNA CTD PMID:37567420 NCBI chr 1:105,223,399...105,226,817
Ensembl chr 1:105,223,390...105,227,513 		JBrowse link
G Fut2 fucosyltransferase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of FUT2 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FUT2 mRNA CTD PMID:37567420 NCBI chr 1:105,256,013...105,276,828
Ensembl chr 1:105,255,390...105,276,647 		JBrowse link
G Fxyd5 FXYD domain-containing ion transport regulator 5 increases expression ISO Glucose results in increased expression of FXYD5 mRNA CTD PMID:17178593 NCBI chr 1:95,395,327...95,404,722
Ensembl chr 1:95,395,146...95,405,364 		JBrowse link
G Fzd5 frizzled class receptor 5 increases expression ISO Glucose results in increased expression of FZD5 mRNA CTD PMID:39922521 NCBI chr 9:73,606,860...73,614,039
Ensembl chr 9:73,606,860...73,618,612 		JBrowse link
G G3bp1 G3BP stress granule assembly factor 1 multiple interactions
increases uptake 		ISO Deoxyglucose inhibits the reaction [G3BP1 protein results in increased uptake of Glucose]; YWHAZ protein affects the reaction [G3BP1 protein results in increased uptake of Glucose] CTD PMID:35945655 NCBI chr10:40,087,533...40,120,931
Ensembl chr10:40,087,533...40,120,931 		JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 multiple interactions
increases expression
increases activity
decreases expression 		ISO
EXP 		Glucose promotes the reaction [[ARNT protein binds to G6PC1 promoter] which results in increased expression of G6PC1 mRNA]; Glucose results in increased stability of and results in increased expression of G6PC1 mRNA
Glucose results in increased expression of G6PC1 mRNA
[Glucose co-treated with S 4048] results in increased expression of G6PC1 mRNA
Metformin inhibits the reaction [Glucose results in increased expression of G6PC1 mRNA]; tungstate inhibits the reaction [Glucose results in increased activity of G6PC1 protein]; Vanadates inhibits the reaction [Glucose results in increased activity of G6PC1 protein]
Glucose results in decreased expression of G6PC1 mRNA 		CTD PMID:14988444 PMID:15767253 PMID:16920846 PMID:19576170 PMID:31974165 More... NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,757,899...86,818,033 		JBrowse link
G Gabbr2 gamma-aminobutyric acid type B receptor subunit 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GABBR2 mRNA CTD PMID:37567420 NCBI chr 5:65,743,073...66,083,695
Ensembl chr 5:65,743,073...66,083,695 		JBrowse link
G Gabrp gamma-aminobutyric acid type A receptor subunit pi multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of GABRP mRNA CTD PMID:37567420 NCBI chr10:18,647,243...18,673,806
Ensembl chr10:18,647,243...18,673,727 		JBrowse link
G Gabrq gamma-aminobutyric acid type A receptor subunit theta multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GABRQ mRNA CTD PMID:37567420 NCBI chr  X:155,737,838...155,755,225
Ensembl chr  X:155,738,436...155,755,223 		JBrowse link
G Gad1 glutamate decarboxylase 1 multiple interactions EXP GAD1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:25966616 NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:75,777,534...75,818,759 		JBrowse link
G Gad2 glutamate decarboxylase 2 increases expression ISO Glucose results in increased expression of GAD2 mRNA CTD PMID:39922521 NCBI chr17:89,671,718...89,734,246
Ensembl chr17:89,671,716...89,941,089 		JBrowse link
G Gadd45g growth arrest and DNA-damage-inducible, gamma increases expression
multiple interactions 		ISO Glucose results in increased expression of GADD45G mRNA
Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of GADD45G protein]] 		CTD PMID:17178593 PMID:39798073 NCBI chr17:13,528,606...13,530,351
Ensembl chr17:13,528,610...13,530,369 		JBrowse link
G Galnt16 polypeptide N-acetylgalactosaminyltransferase 16 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GALNT16 mRNA CTD PMID:37567420 NCBI chr 6:105,900,987...105,982,039
Ensembl chr 6:105,901,153...105,991,350 		JBrowse link
G Galnt2 polypeptide N-acetylgalactosaminyltransferase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of GALNT2 mRNA CTD PMID:37567420 NCBI chr19:69,110,657...69,222,237
Ensembl chr19:69,110,657...69,222,237 		JBrowse link
G Galnt6 polypeptide N-acetylgalactosaminyltransferase 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GALNT6 mRNA CTD PMID:37567420 NCBI chr 7:133,668,612...133,715,909
Ensembl chr 7:133,668,615...133,698,439 		JBrowse link
G Gapdh glyceraldehyde-3-phosphate dehydrogenase increases expression
increases ADP-ribosylation
multiple interactions 		ISO
EXP 		Glucose results in increased expression of GAPDH mRNA
Glucose results in increased ADP-ribosylation of GAPDH protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of GAPDH mRNA; PARP1 protein affects the reaction [Glucose results in increased ADP-ribosylation of GAPDH protein]
[chloroacetaldehyde results in decreased activity of GAPDH protein] which results in decreased chemical synthesis of Glucose; UCP1 protein inhibits the reaction [[Glucose results in increased chemical synthesis of Superoxides] which results in decreased activity of GAPDH protein]; UCP1 protein inhibits the reaction [Glucose results in decreased activity of and results in increased ADP-ribosylation of GAPDH protein]
SOD2 protein inhibits the reaction [[Glucose results in increased chemical synthesis of Superoxides] which results in decreased activity of GAPDH protein]; SOD2 protein inhibits the reaction [Glucose results in decreased activity of and results in increased ADP-ribosylation of GAPDH protein] 		CTD PMID:7826318 PMID:11050244 PMID:14523042 PMID:19733226 PMID:37567420 NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377 		JBrowse link
G Gapdhs glyceraldehyde-3-phosphate dehydrogenase, spermatogenic increases expression ISO Glucose results in increased expression of GAPDHS mRNA CTD PMID:39922521 NCBI chr 1:95,106,516...95,125,918
Ensembl chr 1:95,106,518...95,121,055 		JBrowse link
G Gask1b golgi associated kinase 1B multiple interactions
decreases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of GASK1B mRNA] CTD PMID:33448797 NCBI chr 2:167,345,738...167,410,606
Ensembl chr 2:167,345,809...167,410,603 		JBrowse link
G Gast gastrin increases secretion EXP Glucose results in increased secretion of GAST protein CTD PMID:19208342 NCBI chr10:85,765,216...85,767,881
Ensembl chr10:85,765,216...85,767,880 		JBrowse link
G Gata4 GATA binding protein 4 increases metabolic processing ISO GATA4 protein results in increased metabolism of Glucose CTD PMID:34087332 NCBI chr15:41,635,572...41,707,252
Ensembl chr15:41,635,572...41,681,609 		JBrowse link
G Gbp2 guanylate binding protein 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GBP2 mRNA CTD PMID:37567420 NCBI chr 2:234,005,727...234,021,812
Ensembl chr 2:234,008,590...234,021,810 		JBrowse link
G Gbp4 guanylate binding protein 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GBP3 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GBP4 mRNA CTD PMID:37567420 NCBI chr 2:233,978,163...233,992,124
Ensembl chr 2:233,978,486...233,992,120 		JBrowse link
G Gbp7 guanylate binding protein 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GBP7 mRNA CTD PMID:37567420 NCBI chr 2:233,948,774...233,970,532
Ensembl chr 2:233,948,677...233,970,526 		JBrowse link
G Gc GC, vitamin D binding protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of GC mRNA CTD PMID:37567420 NCBI chr14:18,916,255...18,951,670
Ensembl chr14:18,916,246...18,951,673 		JBrowse link
G Gcg glucagon multiple interactions
increases expression
increases secretion
decreases secretion
increases abundance 		ISO
EXP 		Glucose inhibits the reaction [[Niacin results in decreased abundance of Fatty Acids, Nonesterified] which results in increased secretion of GCG protein]
Glucose results in increased expression of GCG protein
9-phenanthrol inhibits the reaction [[GCG protein co-treated with Glucose] results in increased secretion of INS1 protein]; [GCG protein co-treated with Glucose] results in increased secretion of INS1 protein; [GCG protein modified form binds to and results in increased activity of GLP1R protein] promotes the reaction [Glucose results in increased secretion of INS1 protein]; Metformin inhibits the reaction [GCG results in increased abundance of Glucose]; Troglitazone inhibits the reaction [Glucose results in decreased secretion of GCG protein]; Zinc inhibits the reaction [Glucose results in increased secretion of GCG protein]
[[imeglimin co-treated with Sitagliptin Phosphate] affects the reaction [A mutant form affects the susceptibility to Glucose]] which affects the expression of GCG protein; [GCG protein modified form binds to and results in increased activity of GLP1R protein] promotes the reaction [Glucose results in increased secretion of INS1 protein]; [imeglimin affects the reaction [A mutant form affects the susceptibility to Glucose]] which affects the expression of GCG protein; GCG protein promotes the reaction [imeglimin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; isosteviol inhibits the reaction [Palmitic Acid promotes the reaction [Glucose results in increased secretion of GCG protein]]; Lithocholic Acid promotes the reaction [Glucose results in increased expression of GCG protein]; Palmitic Acid promotes the reaction [Glucose results in increased secretion of GCG protein] 		CTD PMID:838844 PMID:12914525 PMID:15919803 PMID:18669601 PMID:19002567 More... NCBI chr 3:67,522,489...67,531,533
Ensembl chr 3:67,522,489...67,531,533 		JBrowse link
G Gcgr glucagon receptor multiple interactions ISO [imeglimin co-treated with Glucose] results in increased expression of GCGR mRNA CTD PMID:34588186 NCBI chr10:106,306,803...106,314,970
Ensembl chr10:106,306,559...106,314,969 		JBrowse link
G Gch1 GTP cyclohydrolase 1 increases expression ISO Glucose results in increased expression of GCH1 mRNA CTD PMID:39922521 NCBI chr15:22,884,006...22,917,412
Ensembl chr15:22,884,006...22,917,412 		JBrowse link
G Gck glucokinase multiple interactions
decreases expression
increases expression 		ISO
EXP 		[ebselen co-treated with Glucose] results in increased activity of GCK protein; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of GCK mRNA; Glucose inhibits the reaction [Alloxan results in decreased expression of GCK mRNA]
Glucose results in decreased expression of GCK mRNA
Glucose results in decreased expression of and affects the localization of GCK protein; Metformin inhibits the reaction [Glucose results in decreased expression of GCK mRNA]
Glucose results in increased expression of GCK mRNA 		CTD PMID:12137914 PMID:23795780 PMID:24349266 PMID:31974165 PMID:37567420 NCBI chr14:84,999,019...85,041,098
Ensembl chr14:84,999,020...85,040,949 		JBrowse link
G Gckr glucokinase regulator increases expression ISO Glucose results in increased expression of GCKR mRNA CTD PMID:39922521 NCBI chr 6:30,765,071...30,795,627
Ensembl chr 6:30,765,075...30,795,627 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit multiple interactions ISO
EXP 		[Glucose co-treated with gastrodin] affects the expression of GCLC mRNA CTD PMID:33764184 NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893 		JBrowse link
G Gclm glutamate cysteine ligase, modifier subunit multiple interactions EXP
ISO 		[Glucose co-treated with gastrodin] affects the expression of GCLM mRNA CTD PMID:33764184 NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003 		JBrowse link
G Gcsam germinal center-associated, signaling and motility multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of GCSAM mRNA CTD PMID:37567420 NCBI chr11:68,658,350...68,669,598
Ensembl chr11:68,660,438...68,669,584 		JBrowse link
G Gdap1l1 ganglioside-induced differentiation-associated protein 1-like 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GDAP1L1 mRNA CTD PMID:37567420 NCBI chr 3:172,529,523...172,549,128
Ensembl chr 3:172,509,564...172,549,125 		JBrowse link
G Gdf15 growth differentiation factor 15 increases expression
decreases expression 		ISO Glucose results in increased expression of GDF15 mRNA
Glucose results in decreased expression of GDF15 mRNA 		CTD PMID:39613055 NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022 		JBrowse link
G Gdf7 growth differentiation factor 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GDF7 mRNA CTD PMID:37567420 NCBI chr 6:36,890,799...36,901,783
Ensembl chr 6:36,890,799...36,901,783 		JBrowse link
G Gem GTP binding protein overexpressed in skeletal muscle increases expression ISO Glucose results in increased expression of GEM mRNA CTD PMID:17178593 NCBI chr 5:30,011,641...30,022,554
Ensembl chr 5:30,011,592...30,022,542 		JBrowse link
G Gh1 growth hormone 1 multiple interactions ISO GH1 protein promotes the reaction [Glucose results in increased phosphorylation of TBC1D4 protein]; Glucose inhibits the reaction [[Niacin results in decreased abundance of Fatty Acids, Nonesterified] which results in increased secretion of GH1 protein] CTD PMID:838844 PMID:21559284 NCBI chr10:91,727,883...91,729,860
Ensembl chr10:91,727,884...91,729,859 		JBrowse link
G Ghrhr growth hormone releasing hormone receptor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GHRHR mRNA CTD PMID:37567420 NCBI chr 4:85,830,345...85,863,127
Ensembl chr 4:85,830,486...85,863,127 		JBrowse link
G Ghrl ghrelin and obestatin prepropeptide multiple interactions ISO [homoeriodictyol co-treated with Glucose] results in increased secretion of GHRL protein CTD PMID:28834253 NCBI chr 4:148,421,315...148,431,128
Ensembl chr 4:148,421,315...148,425,969 		JBrowse link
G Gip gastric inhibitory polypeptide multiple interactions ISO [imeglimin affects the reaction [A mutant form affects the susceptibility to Glucose]] which affects the expression of GIP protein; GIP protein promotes the reaction [Glucose results in increased secretion of INS1 protein] CTD PMID:36977210 NCBI chr10:81,465,070...81,473,216
Ensembl chr10:81,465,062...81,473,216 		JBrowse link
G Gja1 gap junction protein, alpha 1 increases expression
multiple interactions
increases degradation
decreases expression 		ISO
EXP 		Glucose results in increased expression of GJA1 mRNA
Glucose results in increased expression of GJA1 protein
Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of GJA1 protein]]; Chloroquine promotes the reaction [Glucose results in increased expression of GJA1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of GJA1 protein]
resveratrol inhibits the reaction [Glucose results in increased degradation of GJA1 protein]
Glucose results in decreased expression of GJA1 protein 		CTD PMID:17178593 PMID:20578705 PMID:28713934 NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689 		JBrowse link
G Gla galactosidase, alpha increases expression ISO Glucose results in increased expression of GLA mRNA CTD PMID:17178593 NCBI chr  X:102,062,497...102,073,915
Ensembl chr  X:102,056,718...102,073,915 		JBrowse link
G Glb1 galactosidase, beta 1 increases expression
increases activity
multiple interactions 		ISO
EXP 		Glucose results in increased expression of GLB1 protein
Glucose results in increased activity of GLB1 protein
NAD inhibits the reaction [Glucose results in increased expression of GLB1 protein]; Niacinamide inhibits the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of GLB1 protein]]; resveratrol inhibits the reaction [Glucose results in increased expression of GLB1 protein]; Sirolimus inhibits the reaction [Glucose results in increased expression of GLB1 protein]; SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of GLB1 protein]]; SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of GLB1 protein]]; SIRT1 protein promotes the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of GLB1 protein]]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased expression of GLB1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Fluorometholone inhibits the reaction [Glucose results in increased activity of GLB1 protein]]; CDKN1A protein affects the reaction [Glucose results in increased expression of GLB1 protein]; CDKN2A protein affects the reaction [Glucose results in increased expression of GLB1 protein]; Fluorometholone inhibits the reaction [Glucose results in increased activity of GLB1 protein]; Melatonin inhibits the reaction [Glucose results in increased expression of GLB1 protein]; Phytic Acid inhibits the reaction [Glucose results in increased expression of GLB1 protein]; SIRT3 protein inhibits the reaction [Glucose results in increased expression of GLB1 protein] 		CTD PMID:17075048 PMID:22561310 PMID:23494737 PMID:35264022 PMID:38000455 More... NCBI chr 8:122,963,718...123,036,326
Ensembl chr 8:122,963,718...123,036,326 		JBrowse link
G Gli1 GLI family zinc finger 1 multiple interactions
increases expression 		ISO [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased localization of GLI1 protein; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA]; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased localization of GLI1 protein]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA]]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased localization of GLI1 protein]]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased localization of GLI1 protein]
Glucose results in increased expression of GLI1 protein 		CTD PMID:27481074 PMID:33992720 NCBI chr 7:65,042,237...65,054,888
Ensembl chr 7:65,042,237...65,054,540 		JBrowse link
G Gli2 GLI family zinc finger 2 affects localization
multiple interactions 		ISO Glucose affects the localization of GLI2 protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GLI2 mRNA 		CTD PMID:33992720 PMID:37567420 NCBI chr13:32,499,678...32,716,418
Ensembl chr13:32,499,678...32,716,418 		JBrowse link
G Glipr1 GLI pathogenesis-related 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GLIPR1 mRNA CTD PMID:37567420 NCBI chr 7:49,373,579...49,399,190
Ensembl chr 7:49,373,581...49,384,640 		JBrowse link
G Glo1 glyoxalase 1 multiple interactions
decreases expression 		ISO
EXP 		GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to HMGB1 promoter]]; GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to S100A12 promoter]]; GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to S100A8 promoter]]; GLO1 inhibits the reaction [Glucose promotes the reaction [RELA protein binds to AGER promoter]]; GLO1 inhibits the reaction [Glucose results in decreased expression of GLO1 protein]; GLO1 inhibits the reaction [Glucose results in increased expression of AGER mRNA]; GLO1 inhibits the reaction [Glucose results in increased expression of AGER protein]; GLO1 inhibits the reaction [Glucose results in increased expression of and results in increased secretion of HMGB1 protein]; GLO1 inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]; GLO1 inhibits the reaction [Glucose results in increased expression of S100A12 mRNA]; GLO1 inhibits the reaction [Glucose results in increased expression of S100A8 mRNA]; GLO1 inhibits the reaction [Glucose results in increased expression of S100A8 protein]; SOD2 inhibits the reaction [Glucose results in decreased expression of GLO1 protein]; UCP1 inhibits the reaction [Glucose results in decreased expression of GLO1 protein]
Glucose results in decreased expression of GLO1 mRNA
morroniside inhibits the reaction [Glucose results in decreased expression of GLO1 mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of GLO1 protein] 		CTD PMID:19833897 PMID:32643284 NCBI chr20:8,665,061...8,683,095
Ensembl chr20:8,665,061...8,683,191 		JBrowse link
G Glp1r glucagon-like peptide 1 receptor multiple interactions
affects response to substance
increases expression 		ISO
EXP 		[GCG protein modified form binds to and results in increased activity of GLP1R protein] promotes the reaction [Glucose results in increased secretion of INS1 protein]; [imeglimin co-treated with Glucose] results in increased expression of GLP1R mRNA; imeglimin affects the reaction [GLP1R protein affects the susceptibility to Glucose]
Glucose results in increased expression of GLP1R mRNA
[GCG protein modified form binds to and results in increased activity of GLP1R protein] promotes the reaction [Glucose results in increased secretion of INS1 protein]; [Glucose co-treated with Oleic Acid] results in decreased expression of GLP1R protein; Exenatide inhibits the reaction [[Glucose co-treated with Oleic Acid] results in decreased expression of GLP1R protein] 		CTD PMID:18669601 PMID:22925809 PMID:34588186 PMID:36977210 PMID:39922521 NCBI chr20:8,973,393...9,011,622
Ensembl chr20:8,973,352...9,011,654 		JBrowse link
G Glrx glutaredoxin multiple interactions ISO GLRX protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] promotes the reaction [Glutathione binds to SIRT1 protein]]; GLRX protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased oxidation of and results in decreased activity of SIRT1 protein] CTD PMID:24451382 NCBI chr 2:7,073,737...7,083,548
Ensembl chr 2:7,073,759...7,083,543 		JBrowse link
G Glt8d2 glycosyltransferase 8 domain containing 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of GLT8D2 mRNA CTD PMID:37567420 NCBI chr 7:22,917,055...22,968,616
Ensembl chr 7:22,917,100...22,968,930 		JBrowse link
G Glud1 glutamate dehydrogenase 1 affects expression EXP Glucose affects the expression of GLUD1 mRNA CTD PMID:24349266 NCBI chr16:9,646,569...9,680,215
Ensembl chr16:9,646,509...9,680,210 		JBrowse link
G Glul glutamate-ammonia ligase multiple interactions
decreases expression 		EXP Glucose results in decreased expression of and results in decreased activity of GLUL protein; Resveratrol inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of GLUL protein]; Resveratrol inhibits the reaction [Glucose results in decreased expression of GLUL mRNA] CTD PMID:26677078 NCBI chr13:68,519,500...68,585,554
Ensembl chr13:68,576,067...68,585,520 		JBrowse link
G Gna11 G protein subunit alpha 11 multiple interactions
increases expression 		EXP acetovanillone inhibits the reaction [Glucose results in increased expression of GNA11 protein]; CAT protein inhibits the reaction [Glucose results in increased expression of GNA11 protein] CTD PMID:20691780 NCBI chr 7:8,814,285...8,828,628
Ensembl chr 7:8,814,327...8,830,558 		JBrowse link
G Gna15 G protein subunit alpha 15 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of GNA15 mRNA CTD PMID:37567420 NCBI chr 7:8,835,396...8,856,269
Ensembl chr 7:8,835,357...8,856,268 		JBrowse link
G Gnai1 G protein subunit alpha i1 decreases expression ISO Glucose results in decreased expression of GNAI1 mRNA CTD PMID:17178593 NCBI chr 4:17,706,061...17,790,176
Ensembl chr 4:17,706,025...17,789,198 		JBrowse link
G Gnai2 G protein subunit alpha i2 multiple interactions
decreases expression 		ISO
EXP 		GNAI2 gene mutant form inhibits the reaction [[Glucose co-treated with Amino Acids] results in increased secretion of INS1 protein]; GNAI2 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]
Glucose results in decreased expression of GNAI2 protein
Acetylcysteine inhibits the reaction [Glucose results in decreased expression of GNAI2 protein]; alpha-Tocopherol inhibits the reaction [Glucose results in decreased expression of GNAI2 protein]; diphenyleneiodonium affects the reaction [Glucose results in decreased expression of GNAI2 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in decreased expression of GNAI2 protein]; Uric Acid inhibits the reaction [Glucose results in decreased expression of GNAI2 protein] 		CTD PMID:18441196 PMID:25205820 NCBI chr 8:117,167,045...117,187,652
Ensembl chr 8:117,167,045...117,187,622 		JBrowse link
G Gnai3 G protein subunit alpha i3 multiple interactions
decreases expression 		EXP Acetylcysteine inhibits the reaction [Glucose results in decreased expression of GNAI3 protein]; alpha-Tocopherol inhibits the reaction [Glucose results in decreased expression of GNAI3 protein]; diphenyleneiodonium affects the reaction [Glucose results in decreased expression of GNAI3 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in decreased expression of GNAI3 protein]; Uric Acid inhibits the reaction [Glucose results in decreased expression of GNAI3 protein] CTD PMID:18441196 NCBI chr 2:198,430,920...198,468,874 JBrowse link
G Gnaq G protein subunit alpha q multiple interactions
increases expression 		EXP
ISO 		acetovanillone inhibits the reaction [Glucose results in increased expression of GNAQ protein]; CAT protein inhibits the reaction [Glucose results in increased expression of GNAQ protein]
GNAQ protein affects the reaction [Glucose results in increased secretion of INS1 protein]; GNAQ protein affects the reaction [Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]] 		CTD PMID:20691780 PMID:37217659 NCBI chr 1:222,852,453...223,098,754
Ensembl chr 1:222,852,097...223,126,742 		JBrowse link
G Gnat2 G protein subunit alpha transducin 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GNAT2 mRNA CTD PMID:37567420 NCBI chr 2:198,414,568...198,431,532
Ensembl chr 2:198,414,920...198,424,022 		JBrowse link
G Gng2 G protein subunit gamma 2 multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of GNG2 mRNA] CTD PMID:33448797 NCBI chr15:4,365,222...4,466,060
Ensembl chr15:4,365,135...4,466,059 		JBrowse link
G Gng3 G protein subunit gamma 3 increases expression ISO Glucose results in increased expression of GNG3 mRNA CTD PMID:39922521 NCBI chr 1:215,160,952...215,162,718
Ensembl chr 1:215,160,952...215,162,718 		JBrowse link
G Gng4 G protein subunit gamma 4 increases expression ISO Glucose results in increased expression of GNG4 mRNA CTD PMID:39922521 NCBI chr17:93,432,791...93,481,709
Ensembl chr17:93,433,195...93,481,709 		JBrowse link
G Gng8 G protein subunit gamma 8 decreases expression ISO Glucose results in decreased expression of GNG8 mRNA CTD PMID:31525975 NCBI chr 1:86,692,609...86,696,463
Ensembl chr 1:86,692,642...86,696,408 		JBrowse link
G Gnrh1 gonadotropin releasing hormone 1 increases expression ISO Glucose results in increased expression of GNRH1 mRNA CTD PMID:39922521 NCBI chr15:46,147,878...46,152,086
Ensembl chr15:46,148,301...46,148,977
Ensembl chr15:46,148,301...46,148,977 		JBrowse link
G Golt1a golgi transport 1A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GOLT1A mRNA CTD PMID:37567420 NCBI chr13:47,312,412...47,325,176
Ensembl chr13:47,322,002...47,325,175 		JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1 increases expression ISO Glucose deficiency results in increased expression of GOT1 mRNA CTD PMID:26811028 NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871 		JBrowse link
G Gp5 glycoprotein V (platelet) multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GP5 mRNA CTD PMID:37567420 NCBI chr11:83,948,507...83,952,362
Ensembl chr11:83,948,507...83,952,367 		JBrowse link
G Gp6 glycoprotein 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of GP6 mRNA CTD PMID:37567420 NCBI chr 1:78,471,900...78,535,374
Ensembl chr 1:78,508,468...78,535,374 		JBrowse link
G Gp9 glycoprotein IX (platelet) multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GP9 mRNA CTD PMID:37567420 NCBI chr 4:121,792,842...121,794,452
Ensembl chr 4:121,792,653...121,794,475 		JBrowse link
G Gpc5 glypican 5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of GPC5 mRNA CTD PMID:37567420 NCBI chr15:98,614,499...100,051,285
Ensembl chr15:98,646,340...100,051,514 		JBrowse link
G Gpd1 glycerol-3-phosphate dehydrogenase 1 increases expression EXP Glucose results in increased expression of GPD1 mRNA CTD PMID:3299706 NCBI chr 7:132,722,982...132,730,373
Ensembl chr 7:132,721,915...132,730,368 		JBrowse link
G Gpd2 glycerol-3-phosphate dehydrogenase 2 multiple interactions ISO [Glucose co-treated with S 4048] results in increased expression of GPD2 mRNA; [GPD2 mutant form co-treated with Aminooxyacetic Acid] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [Potassium Chloride co-treated with Diazoxide] inhibits the reaction [[GPD2 mutant form co-treated with Aminooxyacetic Acid] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; GPD2 protein inhibits the reaction [Glucose results in increased abundance of alpha-glycerophosphoric acid]; GPD2 protein inhibits the reaction [Glucose results in increased abundance of Glucose-6-Phosphate]; GPD2 protein inhibits the reaction [Glucose results in increased expression of TXNIP mRNA] CTD PMID:10199125 PMID:10464266 PMID:31974165 NCBI chr 3:62,209,432...62,346,590
Ensembl chr 3:62,210,814...62,346,593 		JBrowse link
G Gpha2 glycoprotein hormone subunit alpha 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of GPHA2 mRNA CTD PMID:37567420 NCBI chr 1:212,954,579...212,956,536
Ensembl chr 1:212,955,387...212,956,535 		JBrowse link
G Gpm6b glycoprotein m6b decreases expression
multiple interactions 		ISO Glucose results in decreased expression of GPM6B mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of GPM6B mRNA] 		CTD PMID:33448797 NCBI chr  X:31,689,485...31,836,199
Ensembl chr  X:31,690,359...31,733,272 		JBrowse link
G Gpnmb glycoprotein nmb multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of GPNMB mRNA CTD PMID:37567420 NCBI chr 4:79,341,128...79,362,366
Ensembl chr 4:79,341,021...79,380,240 		JBrowse link
G Gpr151 G protein-coupled receptor 151 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GPR151 mRNA CTD PMID:37567420 NCBI chr18:34,819,878...34,821,272
Ensembl chr18:34,819,878...34,821,272 		JBrowse link
G Gpr171 G protein-coupled receptor 171 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of GPR171 mRNA CTD PMID:37567420 NCBI chr 2:145,510,305...145,515,392
Ensembl chr 2:145,505,549...145,515,592 		JBrowse link
G Gpr85 G protein-coupled receptor 85 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GPR85 mRNA CTD PMID:37567420 NCBI chr 4:43,070,194...43,075,662
Ensembl chr 4:43,060,777...43,075,794 		JBrowse link
G Gpr87 G protein-coupled receptor 87 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GPR87 mRNA CTD PMID:37567420 NCBI chr 2:145,589,630...145,608,094
Ensembl chr 2:145,589,569...145,604,442 		JBrowse link
G Gprin1 G protein-regulated inducer of neurite outgrowth 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of GPRIN1 mRNA CTD PMID:37567420 NCBI chr17:9,869,009...9,881,958
Ensembl chr17:9,868,571...9,894,560 		JBrowse link
G Gpt glutamic--pyruvic transaminase multiple interactions
increases expression
increases secretion 		EXP
ISO 		Glucose inhibits the reaction [(5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl)acetic acid results in increased activity of GPT protein]
[Fatty Acids, Nonesterified co-treated with Glucose] results in increased expression of GPT protein; jujuboside A inhibits the reaction [[Fatty Acids, Nonesterified co-treated with Glucose] results in increased expression of GPT protein]
Glucose results in increased expression of GPT protein
Ditiocarb inhibits the reaction [YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in increased expression of GPT protein]]]]; Fatty Acids, Nonesterified promotes the reaction [Glucose results in increased expression of GPT protein]; jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in increased expression of GPT protein]]; solanesol inhibits the reaction [Glucose results in increased secretion of GPT protein]; YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in increased expression of GPT protein]]] 		CTD PMID:29479035 PMID:37586544 PMID:39059604 NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160 		JBrowse link
G Gpx1 glutathione peroxidase 1 decreases expression
multiple interactions 		EXP
ISO 		Glucose results in decreased expression of GPX1 mRNA
ebselen inhibits the reaction [GPX1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; GPX1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]
[Glucose co-treated with Lycopene] results in increased expression of GPX1 mRNA; naringenin inhibits the reaction [Glucose results in decreased expression of GPX1 mRNA] 		CTD PMID:21818840 PMID:23192364 PMID:23795780 PMID:32942007 PMID:38444079 NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581 		JBrowse link
G Gpx2 glutathione peroxidase 2 increases expression
multiple interactions 		EXP
ISO 		Glucose results in increased expression of GPX2 mRNA
Glucose inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of GPX2 protein] 		CTD PMID:28027979 PMID:32942007 NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862 		JBrowse link
G Gpx4 glutathione peroxidase 4 increases expression
decreases expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of GPX4 protein
Glucose results in decreased expression of GPX4 protein
[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of GPX4 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of GPX4 protein; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of GPX4 mRNA]; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of GPX4 protein]
4-Nitroquinoline-1-oxide promotes the reaction [Glucose results in increased expression of GPX4 protein]; Resveratrol inhibits the reaction [Glucose results in decreased expression of GPX4 protein]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of GPX4 protein]] 		CTD PMID:32942007 PMID:36806343 PMID:39719253 NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629 		JBrowse link
G Grap2 GRB2-related adaptor protein 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GRAP2 mRNA CTD PMID:37567420 NCBI chr 7:113,997,356...114,071,073
Ensembl chr 7:113,997,307...114,075,367 		JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 increases expression ISO Glucose results in increased expression of GREB1 mRNA CTD PMID:39922521 NCBI chr 6:45,169,289...45,321,973
Ensembl chr 6:45,169,289...45,291,126 		JBrowse link
G Grem1 gremlin 1, DAN family BMP antagonist increases expression
multiple interactions 		ISO Glucose results in increased expression of GREM1 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of GREM1 mRNA 		CTD PMID:10026205 PMID:10744662 PMID:37567420 NCBI chr 3:120,966,639...120,978,319
Ensembl chr 3:120,966,623...120,979,089 		JBrowse link
G Grem2 gremlin 2, DAN family BMP antagonist multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of GREM2 mRNA CTD PMID:37567420 NCBI chr13:89,310,897...89,403,856
Ensembl chr13:89,310,662...89,404,312 		JBrowse link
G Grhl2 grainyhead-like transcription factor 2 increases expression ISO Glucose results in increased expression of GRHL2 mRNA CTD PMID:39922521 NCBI chr 7:70,280,360...70,415,277
Ensembl chr 7:70,285,310...70,415,274 		JBrowse link
G Gria2 glutamate ionotropic receptor AMPA type subunit 2 multiple interactions EXP [Dithionite co-treated with Glucose deficiency] results in decreased expression of GRIA2 protein; Genistein inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of GRIA2 protein] CTD PMID:27238724 NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:168,247,496...168,367,616 		JBrowse link
G Grin1 glutamate ionotropic receptor NMDA type subunit 1 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of GRIN1 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of GRIN1 mRNA] 		CTD PMID:31525975 PMID:33448797 NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:28,501,836...28,528,754 		JBrowse link
G Grin3a glutamate ionotropic receptor NMDA type subunit 3A increases expression ISO Glucose results in increased expression of GRIN3A mRNA CTD PMID:39922521 NCBI chr 5:68,802,333...69,001,880
Ensembl chr 5:68,804,970...69,001,558 		JBrowse link
G Gsdmd gasdermin D multiple interactions
increases expression
increases cleavage 		ISO Glucose results in increased expression of and results in increased cleavage of GSDMD protein; GSDMD protein affects the reaction [Glucose results in increased secretion of IL18 protein]; GSDMD protein affects the reaction [Glucose results in increased secretion of IL1B protein]; Hirudins inhibits the reaction [Glucose results in increased expression of and results in increased cleavage of GSDMD protein]; IRF2 protein affects the reaction [Glucose results in increased expression of and results in increased cleavage of GSDMD protein]; IRF2 protein affects the reaction [Glucose results in increased expression of GSDMD mRNA]
Glucose results in increased expression of GSDMD mRNA; Glucose results in increased expression of GSDMD protein
[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of GSDMD protein alternative form; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSDMD protein; bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of GSDMD protein alternative form]; bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSDMD protein]; HAGLR protein affects the reaction [Glucose results in increased expression of GSDMD protein]; HAGLR protein promotes the reaction [Glucose results in increased expression of GSDMD protein]; loganin inhibits the reaction [Glucose results in increased expression of GSDMD mRNA]; loganin inhibits the reaction [Glucose results in increased expression of GSDMD protein]; MIR200C mRNA affects the reaction [Glucose results in increased cleavage of GSDMD protein]; PTEN protein affects the reaction [HAGLR protein affects the reaction [Glucose results in increased expression of GSDMD protein]]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased cleavage of GSDMD protein]] 		CTD PMID:34212273 PMID:35607288 PMID:37127800 PMID:37473909 PMID:38088496 NCBI chr 7:109,423,209...109,427,771
Ensembl chr 7:109,422,910...109,430,722 		JBrowse link
G Gsk3b glycogen synthase kinase 3 beta multiple interactions
decreases phosphorylation
increases expression
increases phosphorylation 		EXP
ISO 		[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSK3B mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSK3B protein; gastrodin inhibits the reaction [Glucose results in decreased phosphorylation of GSK3B protein]; Glucose results in decreased phosphorylation of and results in increased activity of GSK3B protein; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of HMOX1 mRNA]]; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]]; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NQO1 mRNA]]; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSK3B mRNA]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSK3B protein]; Simvastatin inhibits the reaction [Glucose results in decreased phosphorylation of and results in increased activity of GSK3B protein]
Glucose results in increased expression of GSK3B protein
Glucose results in increased phosphorylation of GSK3B protein
[Resveratrol results in increased phosphorylation of GSK3B protein] which results in increased uptake of Glucose; dorsomorphin inhibits the reaction [[Resveratrol results in increased phosphorylation of GSK3B protein] which results in increased uptake of Glucose]; Eucalyptol inhibits the reaction [Glucose results in increased expression of GSK3B protein]; gastrodin inhibits the reaction [Glucose results in decreased phosphorylation of GSK3B protein]; RHOA protein inhibits the reaction [Eucalyptol inhibits the reaction [Glucose results in increased expression of GSK3B protein]]; RHOA protein promotes the reaction [Glucose results in increased expression of GSK3B protein]
[[ginsenoside Rg2 results in increased phosphorylation of GSK3B protein] co-treated with [ginsenoside Rg2 results in increased expression of NR0B2 mRNA]] results in decreased chemical synthesis of Glucose; [Glucose co-treated with ICG 001] results in decreased phosphorylation of GSK3B protein; Berberine inhibits the reaction [Glucose results in decreased phosphorylation of GSK3B protein]; Glucose inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; Panax notoginseng extract inhibits the reaction [[Glucose co-treated with ICG 001] results in decreased phosphorylation of GSK3B protein]; Panax notoginseng extract inhibits the reaction [Glucose results in decreased phosphorylation of GSK3B protein]; Panax notoginseng extract inhibits the reaction [Glucose results in increased expression of GSK3B protein] 		CTD PMID:18004065 PMID:21031461 PMID:22062806 PMID:22180358 PMID:23690508 More... NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249 		JBrowse link
G Gsn gelsolin decreases secretion ISO Glucose deficiency results in decreased secretion of GSN protein CTD PMID:24802182 NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:38,982,671...39,035,850 		JBrowse link
G Gsr glutathione-disulfide reductase multiple interactions
decreases activity
decreases expression 		ISO
EXP 		[Ascorbic Acid co-treated with GSR protein] affects the metabolism of Glucose; [Doxorubicin co-treated with GSR protein] affects the metabolism of Glucose; [Nitrofurantoin co-treated with GSR protein] affects the metabolism of Glucose; Furans analog inhibits the reaction [Glucose results in decreased activity of GSR protein]
naringenin inhibits the reaction [Glucose results in decreased expression of GSR mRNA] 		CTD PMID:1901343 PMID:23192364 PMID:28911973 NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 multiple interactions EXP [Glucose co-treated with Lycopene] results in increased expression of GSTP1 mRNA CTD PMID:38444079 NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705 		JBrowse link
G Gtf2i general transcription factor II I increases expression ISO Glucose results in increased expression of GTF2I mRNA CTD PMID:32942007 NCBI chr12:28,037,344...28,112,677
Ensembl chr12:28,037,853...28,112,677 		JBrowse link
G Gucy2e guanylate cyclase 2E multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GUCY2E mRNA CTD PMID:37567420 NCBI chr10:54,453,753...54,478,639
Ensembl chr10:54,457,844...54,472,898 		JBrowse link
G Gypc glycophorin C increases expression
multiple interactions 		ISO Glucose results in increased expression of GYPC mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of GYPC mRNA] 		CTD PMID:33448797 NCBI chr18:24,434,921...24,467,592
Ensembl chr18:24,434,922...24,440,053 		JBrowse link
G Gys1 glycogen synthase 1 multiple interactions
increases phosphorylation 		EXP 3,4-Dihydroxyphenylacetic Acid inhibits the reaction [Glucose results in increased phosphorylation of GYS1 protein]; Catechin inhibits the reaction [Glucose results in increased phosphorylation of GYS1 protein] CTD PMID:29981789 NCBI chr 1:105,051,916...105,071,763
Ensembl chr 1:105,051,961...105,072,419 		JBrowse link
G Gzmb granzyme B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GZMB mRNA CTD PMID:37567420 NCBI chr15:34,459,007...34,462,469
Ensembl chr15:34,459,007...34,462,469 		JBrowse link
G Gzmm granzyme M decreases expression ISO Glucose results in decreased expression of GZMM mRNA CTD PMID:39613055 NCBI chr 7:10,661,683...10,667,448
Ensembl chr 7:10,661,684...10,667,504 		JBrowse link
G H1f2 H1.2 linker histone, cluster member increases expression ISO Glucose results in increased expression of H1F2 mRNA CTD PMID:17178593 NCBI chr17:41,818,962...41,820,453
Ensembl chr17:41,779,051...41,822,317 		JBrowse link
G H2ax H2A.X variant histone increases expression
multiple interactions 		ISO Glucose results in increased expression of H2AX protein
Glucose promotes the reaction [Bupivacaine results in increased expression of H2AX protein] 		CTD PMID:31672611 NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079 		JBrowse link
G H2bc18 H2B clustered histone 18 decreases expression ISO Glucose results in decreased expression of H2BC18 mRNA CTD PMID:31525975 NCBI chr 2:186,527,197...186,531,634 JBrowse link
G H2bc4 H2B clustered histone 4 increases expression ISO Glucose results in increased expression of H2BC4 mRNA CTD PMID:17178593 NCBI chr17:47,388,085...47,392,349
Ensembl chr17:47,404,375...47,419,020 		JBrowse link
G H3f4 H3.4 histone, cluster member multiple interactions EXP Glucose promotes the reaction [H3F4 protein modified form binds to PKLR promoter] CTD PMID:16644726 NCBI chr10:44,240,282...44,240,842 JBrowse link
G H4c8 H4 clustered histone 8 multiple interactions EXP Glucose promotes the reaction [H4C16 protein modified form binds to PKLR promoter] CTD PMID:16644726 NCBI chr17:47,176,246...47,180,690
Ensembl chr17:41,797,152...41,806,539
Ensembl chr17:41,797,152...41,806,539
Ensembl chr17:41,797,152...41,806,539
Ensembl chr 4:41,797,152...41,806,539 		JBrowse link
G Hamp hepcidin antimicrobial peptide multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of HAMP mRNA CTD PMID:37567420 NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:95,298,307...95,300,297 		JBrowse link
G Hapln1 hyaluronan and proteoglycan link protein 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of HAPLN1 mRNA CTD PMID:37567420 NCBI chr 2:22,366,967...22,431,709
Ensembl chr 2:22,366,967...22,429,098 		JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of HAVCR1 mRNA CTD PMID:37567420 NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,619,897...31,653,268 		JBrowse link
G Hba-a2 hemoglobin alpha, adult chain 2 increases glycation ISO Glucose results in increased glycation of HBA1 protein CTD PMID:26163454 NCBI chr10:15,828,291...15,829,138
Ensembl chr10:15,828,377...15,829,141 		JBrowse link
G Hbb hemoglobin subunit beta multiple interactions
affects binding 		ISO
EXP 		Furans analog inhibits the reaction [Glucose binds to HBB protein]
Fructose promotes the reaction [Glucose binds to HBB protein]; geraniol inhibits the reaction [Fructose promotes the reaction [Glucose binds to HBB protein]]; Pioglitazone inhibits the reaction [Fructose promotes the reaction [Glucose binds to HBB protein]] 		CTD PMID:25679220 PMID:28911973 NCBI chr 1:167,662,310...167,663,721
Ensembl chr 1:167,630,245...167,663,873 		JBrowse link
G Hbegf heparin-binding EGF-like growth factor increases expression ISO Glucose results in increased expression of HBEGF mRNA CTD PMID:17178593 NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,380,337...28,390,220 		JBrowse link
G Hcrt hypocretin neuropeptide precursor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of HCRT mRNA CTD PMID:37567420 NCBI chr10:86,190,289...86,191,524
Ensembl chr10:86,189,775...86,191,524 		JBrowse link
G Hdac1 histone deacetylase 1 multiple interactions ISO Glucose promotes the reaction [HDAC1 protein binds to TUG1 promoter] CTD PMID:32467232 NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:147,138,156...147,165,387 		JBrowse link
G Hdc histidine decarboxylase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of HDC mRNA CTD PMID:37567420 NCBI chr 3:134,300,628...134,318,704
Ensembl chr 3:134,300,632...134,318,711 		JBrowse link
G Hepacam hepatic and glial cell adhesion molecule increases expression ISO Glucose results in increased expression of HEPACAM mRNA CTD PMID:39922521 NCBI chr 8:45,276,594...45,294,006
Ensembl chr 8:45,276,683...45,295,548 		JBrowse link
G Herpud1 homocysteine inducible ER protein with ubiquitin like domain 1 decreases expression ISO Glucose results in decreased expression of HERPUD1 mRNA CTD PMID:17178593 NCBI chr19:10,604,360...10,624,168
Ensembl chr19:10,604,362...10,624,081 		JBrowse link
G Hhat hedgehog acyltransferase multiple interactions
decreases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of HHAT mRNA] CTD PMID:33448797 NCBI chr13:106,558,635...106,814,723
Ensembl chr13:106,541,866...106,811,563 		JBrowse link
G Hhipl1 HHIP-like 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of HHIPL1 mRNA CTD PMID:37567420 NCBI chr 6:132,984,028...133,008,248
Ensembl chr 6:132,984,032...133,006,947 		JBrowse link
G Hibch 3-hydroxyisobutyryl-CoA hydrolase decreases secretion ISO Glucose deficiency results in decreased secretion of HIBCH protein CTD PMID:24802182 NCBI chr 9:56,082,082...56,161,796
Ensembl chr 9:56,082,091...56,161,886 		JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha multiple interactions
increases expression
decreases expression 		ISO
EXP 		2-Methoxyestradiol inhibits the reaction [Glucose results in increased expression of HIF1A protein]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Glucose results in increased expression of HIF1A protein]; [3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole results in decreased activity of HIF1A protein] results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]; [Glucose co-treated with Oxygen deficiency] inhibits the reaction [ARNT protein binds to HIF1A protein]; [Glucose co-treated with Oxygen deficiency] promotes the reaction [Pyruvaldehyde binds to and results in decreased activity of HIF1A protein]; [Glucose co-treated with SOD2 gene mutant form] results in decreased expression of HIF1A protein; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HIF1A protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HIF1A mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HIF1A protein; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HIF1A protein]
Glucose results in increased expression of HIF1A mRNA
Glucose results in decreased expression of HIF1A mRNA
Glucose results in increased expression of HIF1A mRNA; Glucose results in increased expression of HIF1A protein
[cobaltous chloride co-treated with Glucose] promotes the reaction [HIF1A protein binds to EP300 protein]; [cobaltous chloride co-treated with Glucose] results in increased expression of and results in decreased ubiquitination of HIF1A protein; [Glucose co-treated with Deferoxamine] results in increased expression of HIF1A mRNA; [Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HIF1A protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HIF1A protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of HIF1A protein]]; Cycloheximide inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of HIF1A protein]; epoxomicin inhibits the reaction [scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of HIF1A protein]]; Glucose affects the reaction [Fusaric Acid affects the expression of HIF1A protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of HIF1A mRNA]; MG 262 inhibits the reaction [scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of HIF1A protein]]; Particulate Matter inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HIF1A protein]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose co-treated with Cycloheximide] results in decreased expression of HIF1A protein]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] promotes the reaction [HIF1A protein binds to EP300 protein]]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of and results in decreased ubiquitination of HIF1A protein]; scutellarin promotes the reaction [Cycloheximide inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of HIF1A protein]]; Vehicle Emissions inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HIF1A protein]
[[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HIF1A protein] which results in increased expression of SLC8A1 mRNA; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HIF1A protein; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HIF1A mRNA; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HIF1A protein; HIF1A protein affects the reaction [Glucose results in increased expression of CCN2 protein]; HIF1A protein affects the reaction [Glucose results in increased expression of EDN1 protein]; HIF1A protein affects the reaction [Glucose results in increased expression of FN1 protein]; HIF1A protein affects the reaction [Glucose results in increased expression of TGFB1 protein]; HIF1A protein affects the reaction [Glucose results in increased expression of VEGFA protein]; MIR217 mRNA affects the reaction [Glucose results in increased expression of HIF1A mRNA]; MIR217 mRNA affects the reaction [Glucose results in increased expression of HIF1A protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HIF1A mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HIF1A protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of HIF1A mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of HIF1A protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of HIF1A protein]] 		CTD PMID:18227068 PMID:19228841 PMID:19429140 PMID:21293012 PMID:21617913 More... NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323 		JBrowse link
G Hipk4 homeodomain interacting protein kinase 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of HIPK4 mRNA CTD PMID:37567420 NCBI chr 1:91,938,308...91,948,680
Ensembl chr 1:91,938,278...91,948,683 		JBrowse link
G Hjurp Holliday junction recognition protein increases expression ISO Glucose results in increased expression of HJURP mRNA CTD PMID:39922521 NCBI chr 9:96,301,183...96,315,587
Ensembl chr 9:96,302,530...96,315,657 		JBrowse link
G Hk1 hexokinase 1 increases expression ISO Glucose results in increased expression of HK1 mRNA CTD PMID:17178593 NCBI chr20:30,773,222...30,874,814
Ensembl chr20:30,773,220...30,874,814 		JBrowse link
G Hk3 hexokinase 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of HK3 mRNA CTD PMID:37567420 NCBI chr17:9,602,119...9,620,038
Ensembl chr17:9,605,016...9,620,037 		JBrowse link
G Hkdc1 hexokinase domain containing 1 increases expression ISO Glucose results in increased expression of HKDC1 mRNA CTD PMID:39613055 NCBI chr20:30,878,037...30,917,044
Ensembl chr20:30,878,319...30,916,704 		JBrowse link
G Hmga2 high mobility group AT-hook 2 increases expression ISO Glucose results in increased expression of HMGA2 mRNA CTD PMID:17178593 NCBI chr 7:57,762,710...57,884,555
Ensembl chr 7:57,765,675...57,880,341 		JBrowse link
G Hmgb1 high mobility group box 1 multiple interactions
increases expression
increases secretion 		ISO GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to HMGB1 promoter]]; GLO1 inhibits the reaction [Glucose results in increased expression of and results in increased secretion of HMGB1 protein]; GLO1 inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]; Glucose promotes the reaction [JUN protein binds to HMGB1 promoter]; Glucose results in increased expression of and results in increased acetylation of HMGB1 protein; Glucose results in increased expression of and results in increased secretion of HMGB1 protein; JUN promotes the reaction [Glucose results in increased expression of HMGB1 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of and results in increased acetylation of HMGB1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of and results in increased acetylation of HMGB1 protein]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]]; SOD2 inhibits the reaction [Glucose results in increased expression of and results in increased secretion of HMGB1 protein]; SOD2 inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]; UCP1 inhibits the reaction [Glucose results in increased expression of and results in increased secretion of HMGB1 protein]; UCP1 inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]
Glucose results in increased expression of HMGB1 mRNA; Glucose results in increased expression of HMGB1 protein
Glucose results in increased secretion of HMGB1 protein
imeglimin inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]; imeglimin inhibits the reaction [Glucose results in increased expression of HMGB1 protein]; NLRP3 protein promotes the reaction [Glucose results in increased secretion of HMGB1 protein] 		CTD PMID:19833897 PMID:27783111 PMID:38334676 PMID:39719253 NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327
Ensembl chr12:39,039,050...39,041,327 		JBrowse link
G Hmgcs1 3-hydroxy-3-methylglutaryl-CoA synthase 1 increases expression ISO Glucose results in increased expression of HMGCS1 mRNA CTD PMID:39613055 NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:53,382,643...53,399,802 		JBrowse link
G Hmmr hyaluronan-mediated motility receptor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of HMMR mRNA CTD PMID:37567420 NCBI chr10:25,635,249...25,665,389
Ensembl chr10:25,635,915...25,665,390 		JBrowse link
G Hmox1 heme oxygenase 1 decreases activity
affects expression
multiple interactions
decreases expression
increases expression 		ISO
EXP 		Glucose results in decreased activity of HMOX1 promoter
Glucose affects the expression of HMOX1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[diallyl trisulfide co-treated with Glucose] results in increased expression of HMOX1 protein]; [cobaltiprotoporphyrin results in increased expression of HMOX1 protein] which results in decreased susceptibility to Glucose; [diallyl trisulfide co-treated with Glucose] results in increased expression of HMOX1 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of HMOX1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein; Acetylcysteine affects the reaction [Glucose affects the expression of HMOX1 mRNA]; Antioxidants inhibits the reaction [Glucose results in increased expression of HMOX1]; cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased activity of HMOX1 protein]; cobaltiprotoporphyrin promotes the reaction [Glucose results in increased expression of HMOX1 protein]; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 mRNA]; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein]; formononetin inhibits the reaction [Glucose results in decreased expression of HMOX1 mRNA]; Glucose results in decreased activity of and results in increased expression of HMOX1 protein; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of HMOX1 mRNA]]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in decreased phosphorylation of STAT3 protein]]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of NPPA mRNA]]; HMOX1 protein promotes the reaction [diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; manganese(III)-tetrakis(4-benzoic acid)porphyrin affects the reaction [Glucose affects the expression of HMOX1 mRNA]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of HMOX1 mRNA]; Propofol inhibits the reaction [Glucose results in decreased activity of HMOX1 protein]; Propofol promotes the reaction [Glucose results in increased expression of HMOX1 protein]; Quercetin inhibits the reaction [Glucose results in decreased expression of HMOX1 mRNA]; Quercetin inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased activity of HMOX1 protein]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin promotes the reaction [Glucose results in increased expression of HMOX1 protein]]; zinc protoporphyrin inhibits the reaction [Propofol inhibits the reaction [Glucose results in decreased activity of HMOX1 protein]]; zinc protoporphyrin inhibits the reaction [Propofol promotes the reaction [Glucose results in increased expression of HMOX1 protein]]
Glucose results in decreased expression of HMOX1 mRNA; Glucose results in decreased expression of HMOX1 protein
Glucose deficiency results in increased expression of HMOX1 mRNA; Glucose results in increased expression of HMOX1 protein
Glucose results in increased expression of HMOX1 mRNA; Glucose results in increased expression of HMOX1 protein
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]]; 4-Nitroquinoline-1-oxide inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]; [4-Nitroquinoline-1-oxide results in increased susceptibility to Glucose] which results in increased expression of HMOX1 protein; [Oxygen co-treated with Glucose] promotes the reaction [Vehicle Emissions promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein]]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein; Acetylcysteine inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]; Acetylcysteine promotes the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]]; Berberine promotes the reaction [Glucose results in increased expression of HMOX1 protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]; Glucose inhibits the reaction [4-Nitroquinoline-1-oxide affects the expression of HMOX1 protein]; Glucose promotes the reaction [cobaltiprotoporphyrin results in increased expression of HMOX1 mRNA]; Glucose promotes the reaction [tin mesoporphyrin results in increased expression of HMOX1 mRNA]; Particulate Matter promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein]; Rosiglitazone inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]; solanesol inhibits the reaction [Glucose results in decreased expression of HMOX1 mRNA]; solanesol inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]; spiraeoside inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]; Vehicle Emissions promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein promotes the reaction [Glucose results in increased expression of HMOX1 protein]]; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of HMOX1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 mRNA; Antioxidants inhibits the reaction [Glucose results in increased expression of HMOX1 mRNA]; Glucose deficiency promotes the reaction [Simvastatin results in increased expression of HMOX1 mRNA]; Glucose deficiency promotes the reaction [Simvastatin results in increased expression of HMOX1 protein]; MIR144 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 mRNA]; NFE2L2 mutant form inhibits the reaction [Glucose deficiency promotes the reaction [Simvastatin results in increased expression of HMOX1 mRNA]]; SMARCA4A protein promotes the reaction [Glucose results in increased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [Glucose deficiency promotes the reaction [Simvastatin results in increased expression of HMOX1 protein]] 		CTD PMID:14766238 PMID:16464909 PMID:17928392 PMID:19489000 PMID:19924377 More... NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818 		JBrowse link
G Hnf1a HNF1 homeobox A affects response to substance ISO HNF1A gene mutant form affects the susceptibility to Glucose CTD PMID:15787664 NCBI chr12:47,299,171...47,333,457
Ensembl chr12:47,306,245...47,332,755 		JBrowse link
G Hnf1b HNF1 homeobox B multiple interactions ISO HNF1B protein inhibits the reaction [bisphenol A inhibits the reaction [INS protein results in increased uptake of Glucose]] CTD PMID:32623698 NCBI chr10:69,233,377...69,287,360
Ensembl chr10:69,233,131...69,287,361 		JBrowse link
G Hnf4a hepatocyte nuclear factor 4, alpha multiple interactions
increases expression
decreases expression 		ISO Cerulenin inhibits the reaction [Glucose results in decreased expression of HNF4A mRNA]; Glucose affects the reaction [HNF4A protein binds to SHBG promoter]
Glucose results in increased expression of HNF4A mRNA 		CTD PMID:17992261 PMID:31525975 NCBI chr 3:172,606,220...172,667,758
Ensembl chr 3:172,606,220...172,667,758 		JBrowse link
G Hnrnpk heterogeneous nuclear ribonucleoprotein K decreases expression EXP Glucose results in decreased expression of HNRNPK mRNA; Glucose results in decreased expression of HNRNPK protein CTD PMID:16837467 NCBI chr17:6,269,302...6,280,429
Ensembl chr17:6,268,385...6,280,565 		JBrowse link
G Hoxa2 homeobox A2 increases expression
multiple interactions 		EXP
ISO 		Glucose results in increased expression of HOXA2 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of HOXA2 mRNA 		CTD PMID:21818840 PMID:37567420 NCBI chr 4:82,593,389...82,597,589
Ensembl chr 4:82,593,389...82,595,692 		JBrowse link
G Hp haptoglobin affects secretion
multiple interactions 		ISO Glucose deficiency affects the secretion of HP protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of HP mRNA 		CTD PMID:24802182 PMID:37567420 NCBI chr19:54,449,151...54,453,701
Ensembl chr19:54,446,217...54,467,518 		JBrowse link
G Hpgds hematopoietic prostaglandin D synthase increases expression ISO Glucose results in increased expression of HPGDS mRNA CTD PMID:31525975 NCBI chr 4:95,698,265...95,727,733
Ensembl chr 4:95,702,392...95,938,501 		JBrowse link
G Hprt1 hypoxanthine phosphoribosyltransferase 1 decreases expression ISO Glucose results in decreased expression of HPRT1 mRNA CTD PMID:31655124 NCBI chr  X:137,655,744...137,687,718
Ensembl chr  X:137,655,680...137,687,712 		JBrowse link
G Hras HRas proto-oncogene, GTPase increases activity
multiple interactions 		EXP Glucose results in increased activity of HRAS protein
manumycin inhibits the reaction [Glucose results in increased activity of HRAS protein] 		CTD PMID:16572112 NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:205,725,975...205,729,590 		JBrowse link
G Hrg histidine-rich glycoprotein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of HRG mRNA CTD PMID:37567420 NCBI chr11:91,559,087...91,573,982
Ensembl chr11:91,559,091...91,573,982 		JBrowse link
G Hrk harakiri, BCL2 interacting protein increases expression ISO Glucose results in increased expression of HRK mRNA CTD PMID:39922521 NCBI chr12:44,048,402...44,070,561
Ensembl chr12:44,048,402...44,070,561 		JBrowse link
G Hs6st2 heparan sulfate 6-O-sulfotransferase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of HS6ST2 mRNA CTD PMID:37567420 NCBI chr  X:135,887,224...136,182,388
Ensembl chr  X:135,888,472...136,182,353 		JBrowse link
G Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 decreases expression EXP Glucose results in decreased expression of HSD11B2 mRNA CTD PMID:15017115 NCBI chr19:50,307,569...50,312,812
Ensembl chr19:50,307,569...50,312,812 		JBrowse link
G Hsd3b1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 increases expression ISO Glucose results in increased expression of HSD3B1 mRNA CTD PMID:31525975 NCBI chr 2:188,858,574...188,864,694 JBrowse link
G Hsf1 heat shock transcription factor 1 decreases activity ISO Glucose results in decreased activity of HSF1 protein CTD PMID:34170685 NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:110,076,710...110,103,665 		JBrowse link
G Hsf2bp heat shock transcription factor 2 binding protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of HSF2BP mRNA CTD PMID:37567420 NCBI chr20:10,035,263...10,121,262
Ensembl chr20:10,035,263...10,121,826 		JBrowse link
G Hsp90aa1 heat shock protein 90 alpha family class A member 1 multiple interactions ISO Glucose deficiency inhibits the reaction [Quercetin promotes the reaction [ERBB2 protein binds to HSP90AA1 protein]] CTD PMID:18655187 NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:135,523,616...135,528,499 		JBrowse link
G Hsp90b1 heat shock protein 90 beta family member 1 decreases expression
increases secretion 		ISO Glucose results in decreased expression of HSP90B1 mRNA
Glucose deficiency results in increased secretion of HSP90B1 protein 		CTD PMID:17178593 PMID:24802182 NCBI chr 7:22,997,962...23,012,293
Ensembl chr 7:22,997,962...23,012,293 		JBrowse link
G Hspa12a heat shock protein family A (Hsp70) member 12A decreases expression
multiple interactions 		EXP Glucose results in decreased expression of HSPA12A protein
KU-32 compound inhibits the reaction [Glucose results in decreased expression of HSPA12A protein] 		CTD PMID:22413817 NCBI chr 1:267,921,780...268,083,171
Ensembl chr 1:267,921,782...268,082,794 		JBrowse link
G Hspa13 heat shock protein family A (Hsp70) member 13 decreases expression ISO Glucose results in decreased expression of HSPA13 mRNA CTD PMID:17178593 NCBI chr11:27,862,717...27,876,898
Ensembl chr11:27,862,593...27,876,898 		JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A multiple interactions ISO [imeglimin co-treated with Glucose] results in increased expression of HSPA1A mRNA CTD PMID:34588186 NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979 		JBrowse link
G Hspa1b heat shock protein family A (Hsp70) member 1B multiple interactions ISO [imeglimin co-treated with Glucose] results in increased expression of HSPA1B mRNA CTD PMID:34588186 NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,855,780...3,877,979 		JBrowse link
G Hspa1l heat shock protein family A (Hsp70) member 1 like multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of HSPA1L mRNA CTD PMID:37567420 NCBI chr20:3,853,496...3,860,223
Ensembl chr20:3,853,331...3,876,877 		JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 increases expression
multiple interactions
decreases expression 		ISO
EXP 		Glucose deficiency results in increased expression of HSPA5 mRNA; Glucose deficiency results in increased expression of HSPA5 protein; Glucose results in increased expression of HSPA5 mRNA; Glucose results in increased expression of HSPA5 protein
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of HSPA5 protein]; Metformin inhibits the reaction [Glucose results in increased expression of HSPA5 protein]
2-aminoethoxydiphenyl borate inhibits the reaction [Glucose results in increased expression of HSPA5 protein]; Gadolinium inhibits the reaction [Glucose results in increased expression of HSPA5 protein]; Glucose affects the reaction [bisphenol A results in decreased expression of HSPA5 protein]; waixenicin A inhibits the reaction [Glucose results in increased expression of HSPA5 protein]
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in increased expression of HSPA5 protein]]; 4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 mRNA]; 4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]; [Acetylcysteine co-treated with ginsenoside Rg3] inhibits the reaction [Glucose results in increased expression of HSPA5 protein]; [Glucose co-treated with TGFB1 protein] results in increased expression of HSPA5 protein; ATF6 protein modified form promotes the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of HSPA5 protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in increased expression of HSPA5 protein]; glucogallin inhibits the reaction [Glucose results in increased expression of HSPA5 protein]; salubrinal inhibits the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]; XBP1 mRNA alternative form promotes the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]
Glucose results in decreased expression of HSPA5 mRNA
Glucose deficiency results in increased expression of HSPA5 protein; Glucose results in increased expression of HSPA5 protein 		CTD PMID:12147617 PMID:16380481 PMID:17178593 PMID:21337367 PMID:21705745 More... NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790 		JBrowse link
G Hspa9 heat shock protein family A (Hsp70) member 9 increases expression
decreases expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of HSPA9 protein
Glucose results in decreased expression of HSPA9 protein
KU-32 compound inhibits the reaction [Glucose results in decreased expression of HSPA9 protein]
resveratrol inhibits the reaction [Glucose results in increased expression of HSPA9 protein] 		CTD PMID:22413817 PMID:24218232 NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,804,774...26,828,398 		JBrowse link
G Hspb1 heat shock protein family B (small) member 1 multiple interactions
increases phosphorylation
increases secretion 		EXP
ISO 		[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HSPB1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HSPB1 protein; resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HSPB1 mRNA]; resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HSPB1 protein]
Glucose results in increased phosphorylation of HSPB1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased phosphorylation of HSPB1 protein]; U 0126 inhibits the reaction [Glucose results in increased phosphorylation of HSPB1 protein]
Glucose deficiency results in increased secretion of HSPB1 protein 		CTD PMID:23421680 PMID:24802182 PMID:25373458 NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301 		JBrowse link
G Hspd1 heat shock protein family D (Hsp60) member 1 decreases expression
multiple interactions 		ISO Glucose deficiency results in decreased expression of HSPD1 protein
[Glucose co-treated with Palmitic Acid] results in decreased expression of HSPD1 mRNA; Nitroprusside inhibits the reaction [Glucose deficiency results in decreased expression of HSPD1 protein] 		CTD PMID:17855661 PMID:39265716 NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037 		JBrowse link
G Htra3 HtrA serine peptidase 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of HTRA3 mRNA CTD PMID:37567420 NCBI chr14:79,293,535...79,321,936
Ensembl chr14:79,293,541...79,321,936 		JBrowse link
G Hunk hormonally upregulated Neu-associated kinase decreases expression
multiple interactions 		ISO Glucose results in decreased expression of HUNK mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of HUNK mRNA] 		CTD PMID:33448797 NCBI chr11:43,127,244...43,244,502
Ensembl chr11:43,127,244...43,244,502 		JBrowse link
G Hyal4 hyaluronidase 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of HYAL4 mRNA CTD PMID:37567420 NCBI chr 4:54,221,728...54,240,364
Ensembl chr 4:54,221,728...54,240,364 		JBrowse link
G Hydin Hydin, axonemal central pair apparatus protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of HYDIN mRNA CTD PMID:37567420 NCBI chr19:55,146,382...55,492,660
Ensembl chr19:55,146,466...55,492,660 		JBrowse link
G Hyou1 hypoxia up-regulated 1 decreases expression ISO Glucose results in decreased expression of HYOU1 mRNA CTD PMID:17178593 NCBI chr 8:53,602,882...53,614,998
Ensembl chr 8:53,602,604...53,614,997 		JBrowse link
G Iapp islet amyloid polypeptide multiple interactions
increases expression 		EXP
ISO 		Diazoxide inhibits the reaction [Glucose results in increased expression of IAPP mRNA]; Mannoheptulose inhibits the reaction [Glucose results in increased expression of IAPP mRNA]; Verapamil inhibits the reaction [Glucose results in increased expression of IAPP mRNA]
IAPP protein inhibits the reaction [Glucose results in increased secretion of INS protein]; rosiglitazone inhibits the reaction [IAPP protein inhibits the reaction [Glucose results in increased secretion of INS protein]] 		CTD PMID:9142872 PMID:16204373 NCBI chr 4:176,968,097...176,975,363
Ensembl chr 4:176,968,097...176,975,363 		JBrowse link
G Ica1l islet cell autoantigen 1-like decreases expression
multiple interactions 		ISO Glucose results in decreased expression of ICA1L mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of ICA1L mRNA] 		CTD PMID:33448797 NCBI chr 9:68,906,148...68,964,078
Ensembl chr 9:68,906,148...68,963,692 		JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions
increases secretion
increases expression 		ISO
EXP 		4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Glucose results in increased expression of ICAM1]; 5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; 5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; aspalathin inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; Hesperidin inhibits the reaction [Glucose results in increased expression of ICAM1]; HTS 466284 inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; isoangustone A inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; manganese chloride inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; Mannitol inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; Mannitol inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased secretion of ICAM1 protein]; naringin inhibits the reaction [Glucose results in increased expression of ICAM1]; nothofagin inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; Polyphenols inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of ICAM1]; Rimonabant inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; sarpogrelate inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of ICAM1 protein]
Curcumin analog inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; Y 27632 inhibits the reaction [Glucose results in increased expression of ICAM1 protein]
Glucose results in increased expression of ICAM1 mRNA; Glucose results in increased expression of ICAM1 protein
Glucose results in increased expression of ICAM1; Glucose results in increased expression of ICAM1 mRNA; Glucose results in increased expression of ICAM1 protein 		CTD PMID:15304054 PMID:16285992 PMID:21367880 PMID:21373835 PMID:21682256 More... NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617 		JBrowse link
G Icam5 intercellular adhesion molecule 5 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of ICAM5 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of ICAM5 mRNA] 		CTD PMID:33448797 NCBI chr 8:27,843,563...27,851,767
Ensembl chr 8:27,844,780...27,857,104 		JBrowse link
G Id1 inhibitor of DNA binding 1 increases expression
affects expression
decreases expression 		ISO Glucose results in increased expression of ID1 mRNA
Glucose affects the expression of ID1 mRNA
Glucose results in decreased expression of ID1 mRNA 		CTD PMID:17178593 PMID:39613055 NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:161,671,538...161,672,685 		JBrowse link
G Id3 inhibitor of DNA binding 3 increases expression
decreases expression 		ISO Glucose results in increased expression of ID3 mRNA
Glucose results in decreased expression of ID3 mRNA 		CTD PMID:17178593 PMID:39613055 NCBI chr 5:153,656,253...153,657,860
Ensembl chr 5:153,630,498...153,657,856 		JBrowse link
G Ide insulin degrading enzyme decreases expression ISO Glucose results in decreased expression of IDE mRNA CTD PMID:17178593 NCBI chr 1:244,415,495...244,516,925
Ensembl chr 1:244,416,343...244,514,526 		JBrowse link
G Idi1 isopentenyl-diphosphate delta isomerase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of IDI1 mRNA CTD PMID:37567420 NCBI chr17:66,539,761...66,547,524
Ensembl chr17:66,539,763...66,547,524 		JBrowse link
G Idi2 isopentenyl-diphosphate delta isomerase 2 increases expression ISO Glucose results in increased expression of IDI2 mRNA CTD PMID:39922521 NCBI chr17:66,022,731...66,026,333 JBrowse link
G Ido1 indoleamine 2,3-dioxygenase 1 multiple interactions ISO IDO1 protein affects the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in increased abundance of Glucose] CTD PMID:39172838 NCBI chr16:74,133,259...74,145,328
Ensembl chr16:74,133,259...74,145,328 		JBrowse link
G Ier5l immediate early response 5-like decreases expression ISO Glucose results in decreased expression of IER5L mRNA CTD PMID:39613055 NCBI chr 3:34,141,866...34,143,457
Ensembl chr 3:34,139,672...34,144,452 		JBrowse link
G Ifi27l2a interferon, alpha-inducible protein 27 like 2A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IFI27L2A mRNA CTD PMID:37567420 NCBI chr 6:128,363,658...128,365,144
Ensembl chr 6:128,363,658...128,365,146 		JBrowse link
G Ifi44 interferon-induced protein 44 increases expression
multiple interactions 		ISO Glucose results in increased expression of IFI44 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of IFI44 mRNA] 		CTD PMID:33448797 NCBI chr 2:243,286,050...243,303,869
Ensembl chr 2:243,286,052...243,306,877 		JBrowse link
G Ifi44l interferon-induced protein 44-like increases expression ISO Glucose results in increased expression of IFI44L mRNA CTD PMID:39613055 NCBI chr 2:243,328,629...243,366,404
Ensembl chr 2:243,328,723...243,366,404 		JBrowse link
G Ifit1 interferon-induced protein with tetratricopeptide repeats 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IFIT1 mRNA CTD PMID:37567420 NCBI chr 1:241,565,197...241,567,262
Ensembl chr 1:241,543,184...241,568,148 		JBrowse link
G Ifit2 interferon-induced protein with tetratricopeptide repeats 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IFIT2 mRNA CTD PMID:37567420 NCBI chr 1:241,515,735...241,521,799
Ensembl chr 1:241,515,709...241,521,798 		JBrowse link
G Ifit3 interferon-induced protein with tetratricopeptide repeats 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IFIT3 mRNA CTD PMID:37567420 NCBI chr 1:241,527,326...241,532,469
Ensembl chr 1:241,526,880...241,532,521 		JBrowse link
G Ifng interferon gamma multiple interactions ISO
EXP 		[IL1B protein co-treated with IFNG protein] promotes the reaction [Glucose results in increased secretion of INS protein]
[TNF protein co-treated with IFNG protein co-treated with IL1B protein] inhibits the reaction [Glucose results in increased secretion of INS protein alternative form]; Quercetin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]
[IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]] 		CTD PMID:10967106 PMID:19071154 PMID:23138875 PMID:31776611 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216 		JBrowse link
G Igf1 insulin-like growth factor 1 increases uptake
multiple interactions
increases expression 		ISO IGF1 protein results in increased uptake of Glucose
MIR1231 inhibits the reaction [Glucose results in increased expression of IGF1 mRNA]; MIR1231 inhibits the reaction [Glucose results in increased expression of IGF1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of IGF1 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of IGF1 protein]
Glucose results in increased expression of IGF1 mRNA; Glucose results in increased expression of IGF1 protein 		CTD PMID:29330302 PMID:38156429 NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764 		JBrowse link
G Igf1r insulin-like growth factor 1 receptor increases expression
multiple interactions
decreases expression 		ISO Glucose results in increased expression of IGF1R mRNA; Glucose results in increased expression of IGF1R protein
[imeglimin co-treated with Glucose] results in increased expression of IGF1R mRNA
Glucose results in decreased expression of IGF1R protein
Berberine inhibits the reaction [Glucose results in decreased expression of IGF1R protein] 		CTD PMID:7826318 PMID:23954465 PMID:34588186 PMID:38069837 NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664 		JBrowse link
G Igf2bp1 insulin-like growth factor 2 mRNA binding protein 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of IGF2BP1 mRNA CTD PMID:37567420 NCBI chr10:81,405,021...81,447,814
Ensembl chr10:81,404,797...81,447,846 		JBrowse link
G Igf2r insulin-like growth factor 2 receptor multiple interactions EXP [Glucose co-treated with IGF2R protein modified form] results in decreased expression of IL6 protein; [Glucose co-treated with IGF2R protein modified form] results in decreased expression of NFKBIA protein; [Glucose co-treated with IGF2R protein modified form] results in decreased expression of NFKBIA protein modified form; [Glucose co-treated with IGF2R protein modified form] results in decreased expression of NOS2 protein; [Glucose co-treated with IGF2R protein modified form] results in increased expression of CASP9 protein; [Glucose co-treated with IGF2R protein modified form] results in increased expression of TNF protein; IGF2R protein modified form inhibits the reaction [Glucose results in increased expression of CASP3 protein modified form]; IGF2R protein modified form inhibits the reaction [Glucose results in increased expression of CASP3 protein] CTD PMID:36462176 NCBI chr 1:50,526,878...50,615,265
Ensembl chr 1:50,526,878...50,615,265 		JBrowse link
G Igfbp4 insulin-like growth factor binding protein 4 decreases expression ISO Glucose results in decreased expression of IGFBP4 mRNA CTD PMID:17178593 NCBI chr10:84,491,471...84,503,487
Ensembl chr10:84,485,775...84,503,473 		JBrowse link
G Igfn1 immunoglobulin-like and fibronectin type III domain containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of IGFN1 mRNA CTD PMID:37567420 NCBI chr13:49,947,330...49,979,203
Ensembl chr13:49,947,330...49,989,601 		JBrowse link
G Igkvl-ps13 immunoglobulin kappa variable like, pseudogene 13 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of IGKV1-133 mRNA CTD PMID:37567420 NCBI chr 4:98,298,232...98,299,135 JBrowse link
G Ikbkb inhibitor of nuclear factor kappa B kinase subunit beta multiple interactions EXP
ISO 		IKBKB affects the reaction [IL1B protein inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]]; IKBKB affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]]
IKBKB protein affects the reaction [Particulate Matter promotes the reaction [Glucose results in increased secretion of INS1 protein]] 		CTD PMID:22558381 PMID:31095431 NCBI chr16:76,021,968...76,075,717
Ensembl chr16:76,022,008...76,081,911 		JBrowse link
G Ikzf4 IKAROS family zinc finger 4 increases expression ISO Glucose results in increased expression of IKZF4 mRNA CTD PMID:39922521 NCBI chr 7:1,643,379...1,687,524
Ensembl chr 7:1,644,799...1,687,094 		JBrowse link
G Il10 interleukin 10 increases expression ISO Glucose results in increased expression of IL10 mRNA CTD PMID:39922521 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580 		JBrowse link
G Il12b interleukin 12B multiple interactions
increases expression 		ISO 2-chloro-4'-methoxychalcone inhibits the reaction [Glucose results in increased expression of IL12B mRNA]; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of IL12B mRNA CTD PMID:21988173 PMID:37567420 NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194 		JBrowse link
G Il12rb2 interleukin 12 receptor subunit beta 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of IL12RB2 mRNA CTD PMID:37567420 NCBI chr 4:97,756,089...97,844,937
Ensembl chr 4:97,756,089...97,844,937 		JBrowse link
G Il17a interleukin 17A multiple interactions
increases expression
increases secretion 		ISO Cycloheximide inhibits the reaction [Glucose results in increased secretion of IL17A protein]; Dactinomycin inhibits the reaction [Glucose results in increased secretion of IL17A protein]; resveratrol inhibits the reaction [Glucose results in increased expression of IL17A mRNA]; resveratrol inhibits the reaction [Glucose results in increased secretion of IL17A protein]
Glucose results in increased expression of IL17A protein 		CTD PMID:18310510 PMID:39613055 NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331 		JBrowse link
G Il17ra interleukin 17 receptor A increases expression ISO Glucose results in increased expression of IL17RA mRNA CTD PMID:18310510 NCBI chr 4:155,339,742...155,362,382
Ensembl chr 4:155,339,400...155,362,382 		JBrowse link
G Il18 interleukin 18 increases secretion
increases expression
multiple interactions 		ISO
EXP 		Glucose results in increased secretion of IL18 protein
Glucose results in increased expression of IL18 mRNA; Glucose results in increased expression of IL18 protein
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL18 protein; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL18 protein]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased secretion of IL18 protein; bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased secretion of IL18 protein]; HAGLR protein affects the reaction [Glucose results in increased expression of IL18 protein]; HAGLR protein promotes the reaction [Glucose results in increased expression of IL18 protein]; Lipopolysaccharides inhibits the reaction [swietenine inhibits the reaction [Glucose results in increased expression of IL18 protein]]; Lipopolysaccharides promotes the reaction [Glucose results in increased expression of IL18 protein]; loganin inhibits the reaction [Glucose results in increased expression of IL18 mRNA]; loganin inhibits the reaction [Glucose results in increased expression of IL18 protein]; MIR200C mRNA affects the reaction [Glucose results in increased secretion of IL18 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Glucose results in increased expression of IL18 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide promotes the reaction [swietenine inhibits the reaction [Glucose results in increased expression of IL18 protein]]; PTEN protein affects the reaction [HAGLR protein affects the reaction [Glucose results in increased expression of IL18 protein]]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased secretion of IL18 protein]]; swietenine inhibits the reaction [Glucose results in increased expression of IL18 protein]
GSDMD protein affects the reaction [Glucose results in increased secretion of IL18 protein]; Hirudins inhibits the reaction [Glucose results in increased secretion of IL18 protein] 		CTD PMID:34212273 PMID:35191607 PMID:35607288 PMID:36066211 PMID:37127800 More... NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286 		JBrowse link
G Il18rap interleukin 18 receptor accessory protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IL18RAP mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of IL18RAP mRNA CTD PMID:37567420 NCBI chr 9:50,263,723...50,296,583
Ensembl chr 9:50,263,733...50,296,583 		JBrowse link
G Il1b interleukin 1 beta multiple interactions
increases secretion
increases expression 		ISO
EXP 		2-chloro-4'-methoxychalcone inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; [cobaltiprotoporphyrin co-treated with IL1B protein] affects the susceptibility to Glucose; [Glucose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased secretion of IL1B protein; [IL1B protein co-treated with IFNG protein] promotes the reaction [Glucose results in increased secretion of INS protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL1B protein; Acetylcysteine inhibits the reaction [Glucose results in increased expression of IL1B protein]; atractylenolide III inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL1B protein]; CDK9 protein affects the reaction [Glucose results in increased expression of IL1B mRNA]; diphenyleneiodonium inhibits the reaction [Glucose promotes the reaction [Particulate Matter results in increased expression of and results in increased cleavage of IL1B protein]]; Edaravone inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL1B protein]; Glucose inhibits the reaction [IL1B protein results in increased expression of MMP1 mRNA]; Glucose inhibits the reaction [IL1B protein results in increased expression of MMP1 protein]; Glucose inhibits the reaction [IL1B protein results in increased phosphorylation of JUN protein]; Glucose inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK1 protein]; Glucose inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK3 protein]; Glucose inhibits the reaction [IL1B protein results in increased phosphorylation of PTK2 protein]; Glucose promotes the reaction [Fatty Acids, Nonesterified results in increased expression of IL1B protein]; Glucose promotes the reaction [Particulate Matter results in increased expression of and results in increased cleavage of IL1B protein]; Glucose promotes the reaction [Particulate Matter results in increased expression of IL1B mRNA]; GSDMD protein affects the reaction [Glucose results in increased secretion of IL1B protein]; Hirudins inhibits the reaction [Glucose results in increased secretion of IL1B protein]; IL1B protein inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]; IL1B protein inhibits the reaction [Glucose results in increased expression of MAFA mRNA]; IL1B protein inhibits the reaction [Glucose results in increased expression of PDX1 mRNA]; imeglimin inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; imeglimin inhibits the reaction [Glucose results in increased secretion of IL1B protein]; jujuboside A inhibits the reaction [Glucose promotes the reaction [Fatty Acids, Nonesterified results in increased expression of IL1B protein]]; Silymarin inhibits the reaction [[Glucose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased secretion of IL1B protein]
Glucose results in increased expression of IL1B mRNA; Glucose results in increased expression of IL1B protein
(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; [Carnosine co-treated with asiatic acid] inhibits the reaction [Glucose results in increased secretion of IL1B protein]; [Fatty Acids, Nonesterified co-treated with Glucose] results in increased expression of IL1B protein; [Glucose co-treated with Lipopolysaccharides] results in decreased expression of IL1B protein; [Glucose co-treated with Pam(3)CSK(4) peptide] results in decreased expression of IL1B protein; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of PPARG mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of PPARA mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL2 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CXCL5 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NFKB1 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of PPARD mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of RELA mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased secretion of IL1B protein; [TNF protein co-treated with IFNG protein co-treated with IL1B protein] inhibits the reaction [Glucose results in increased secretion of INS protein alternative form]; Allopurinol inhibits the reaction [Glucose results in increased expression of IL1B protein]; Anisomycin inhibits the reaction [rutecarpine inhibits the reaction [Glucose results in increased expression of IL1B protein]]; asiatic acid inhibits the reaction [Glucose results in increased secretion of IL1B protein]; bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased secretion of IL1B protein]; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Carnosine inhibits the reaction [Glucose results in increased secretion of IL1B protein]; Catechin inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; Catechin inhibits the reaction [Glucose results in increased expression of IL1B protein]; Ditiocarb inhibits the reaction [YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [[Fatty Acids, Nonesterified co-treated with Glucose] results in increased expression of IL1B protein]]]; epigallocatechin gallate inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; epigallocatechin gallate inhibits the reaction [Glucose results in increased expression of IL1B protein]; Fenofibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Glucose promotes the reaction [Particulate Matter results in increased expression of IL1B mRNA]; HAGLR protein affects the reaction [Glucose results in increased expression of IL1B protein]; HAGLR protein promotes the reaction [Glucose results in increased expression of IL1B protein]; jujuboside A inhibits the reaction [[Fatty Acids, Nonesterified co-treated with Glucose] results in increased expression of IL1B protein]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Lipopolysaccharides inhibits the reaction [swietenine inhibits the reaction [Glucose results in increased expression of IL1B protein]]; Lipopolysaccharides promotes the reaction [Glucose results in increased expression of IL1B protein]; loganin inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; loganin inhibits the reaction [Glucose results in increased expression of IL1B protein]; Luteolin inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; Luteolin inhibits the reaction [Glucose results in increased expression of IL1B protein]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased secretion of IL1B protein]]; MIR142 inhibits the reaction [Glucose results in increased secretion of IL1B protein]; MIR200C mRNA affects the reaction [Glucose results in increased secretion of IL1B protein]; MIR217 mRNA inhibits the reaction [Glucose results in increased secretion of IL1B protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Glucose results in increased expression of IL1B protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide promotes the reaction [swietenine inhibits the reaction [Glucose results in increased expression of IL1B protein]]; Phytic Acid inhibits the reaction [Glucose results in increased expression of IL1B protein]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; PTEN protein affects the reaction [HAGLR protein affects the reaction [Glucose results in increased expression of IL1B protein]]; Quercetin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Quercetin inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of IL1B protein]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; rutecarpine inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; rutecarpine inhibits the reaction [Glucose results in increased expression of IL1B protein]; Rutin inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; Rutin inhibits the reaction [Glucose results in increased expression of IL1B protein]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of IL1B protein]]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased secretion of IL1B protein]]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased secretion of IL1B protein]]; swietenine inhibits the reaction [Glucose results in increased expression of IL1B protein]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased secretion of IL1B protein]; YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [[Fatty Acids, Nonesterified co-treated with Glucose] results in increased expression of IL1B protein]]
[IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL1B protein; [TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Allopurinol inhibits the reaction [Glucose results in increased expression of IL1B protein]; Artesunate inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; Artesunate inhibits the reaction [Glucose results in increased secretion of IL1B protein]; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL1B protein]; Ellagic Acid inhibits the reaction [Glucose results in increased expression of IL1B protein]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Glucose results in increased secretion of IL1B protein]; farrerol inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; farrerol inhibits the reaction [Glucose results in increased secretion of IL1B protein]; Gallic Acid inhibits the reaction [Glucose results in increased secretion of IL1B protein]; IKBKB affects the reaction [IL1B protein inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]]; IL1B protein inhibits the reaction [Glucose results in increased abundance of Proteoglycans]; IL1B protein inhibits the reaction [Glucose results in increased expression of B3GAT3 mRNA]; IL1B protein inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]; morroniside inhibits the reaction [Glucose results in increased secretion of IL1B protein]; prolinedithiocarbamate inhibits the reaction [Glucose results in increased secretion of IL1B protein]; Quercetin inhibits the reaction [Glucose results in increased expression of IL1B protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; S-4-bromobenzylglutathione cyclopentyl diester inhibits the reaction [morroniside inhibits the reaction [Glucose results in increased secretion of IL1B protein]]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL1B protein] 		CTD PMID:10967106 PMID:11801247 PMID:15194409 PMID:19071154 PMID:19557821 More... NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il1rn interleukin 1 receptor antagonist multiple interactions EXP
ISO 		IL1RN protein inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; IL1RN protein inhibits the reaction [Glucose results in increased expression of PTGS2 protein]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of IL1RN mRNA 		CTD PMID:19861503 PMID:37567420 NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732 		JBrowse link
G Il23r interleukin 23 receptor decreases expression
multiple interactions 		ISO Glucose results in decreased expression of IL23R mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of IL23R mRNA] 		CTD PMID:31525975 PMID:33448797 NCBI chr 4:97,910,230...98,003,759
Ensembl chr 4:97,909,972...98,004,110 		JBrowse link
G Il24 interleukin 24 increases expression
multiple interactions
decreases expression 		ISO Glucose results in increased expression of IL24 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of IL24 mRNA] 		CTD PMID:17178593 PMID:33448797 NCBI chr13:44,905,362...44,910,760
Ensembl chr13:44,905,363...44,910,760 		JBrowse link
G Il27 interleukin 27 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IL27 mRNA CTD PMID:37567420 NCBI chr 1:190,603,684...190,609,292
Ensembl chr 1:190,603,522...190,609,258 		JBrowse link
G Il31ra interleukin 31 receptor A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of IL31RA mRNA CTD PMID:37567420 NCBI chr 2:45,851,073...45,922,300
Ensembl chr 2:45,855,868...45,917,009 		JBrowse link
G Il6 interleukin 6 multiple interactions
increases secretion
increases expression 		ISO
EXP 		[Carnosine co-treated with asiatic acid] inhibits the reaction [Glucose results in increased secretion of IL6 protein]; [Fatty Acids, Nonesterified co-treated with Glucose] results in increased expression of IL6 protein; Anisomycin inhibits the reaction [rutecarpine inhibits the reaction [Glucose results in increased expression of IL6 protein]]; asiatic acid inhibits the reaction [Glucose results in increased secretion of IL6 protein]; Captopril inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; Carnosine inhibits the reaction [Glucose results in increased secretion of IL6 protein]; chromic chloride inhibits the reaction [Glucose results in increased secretion of IL6 protein]; chromic chloride promotes the reaction [Estradiol inhibits the reaction [Glucose results in increased secretion of IL6 protein]]; chromium nicotinic acid complex inhibits the reaction [Glucose results in increased secretion of IL6 protein]; Ditiocarb inhibits the reaction [YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [[Fatty Acids, Nonesterified co-treated with Glucose] results in increased expression of IL6 protein]]]; Estradiol inhibits the reaction [Glucose results in increased secretion of IL6 protein]; Fluorometholone inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; Fluorometholone inhibits the reaction [Glucose results in increased secretion of IL6 protein]; Glucose results in increased secretion of and results in increased expression of IL6 protein; huai qi huang inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; jujuboside A inhibits the reaction [[Fatty Acids, Nonesterified co-treated with Glucose] results in increased expression of IL6 protein]; MIR1231 inhibits the reaction [Glucose results in increased expression of IL6 protein]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased secretion of IL6 protein]]; MIR142 inhibits the reaction [Glucose results in increased secretion of IL6 protein]; MIR217 mRNA inhibits the reaction [Glucose results in increased secretion of IL6 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased secretion of IL6 protein]; picolinic acid inhibits the reaction [Glucose results in increased secretion of IL6 protein]; Polyphenols inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; Polyphenols inhibits the reaction [Glucose results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of IL6 protein]; rutecarpine inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; rutecarpine inhibits the reaction [Glucose results in increased expression of IL6 protein]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of IL6 protein]]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased secretion of IL6 protein]]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased secretion of IL6 protein]; YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [[Fatty Acids, Nonesterified co-treated with Glucose] results in increased expression of IL6 protein]]
3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; [Glucose co-treated with IGF2R protein modified form] results in decreased expression of IL6 protein; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of and results in increased secretion of IL6 protein; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of IL6 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL6 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL6 protein; Artesunate inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; Artesunate inhibits the reaction [Glucose results in increased secretion of IL6 protein]; Curcumin analog inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; duanbanhuain A inhibits the reaction [Glucose results in increased secretion of IL6 protein]; duanbanhuain B inhibits the reaction [Glucose results in increased secretion of IL6 protein]; Ellagic Acid inhibits the reaction [Glucose results in increased expression of IL6 protein]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Glucose results in increased secretion of IL6 protein]; farrerol inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; farrerol inhibits the reaction [Glucose results in increased secretion of IL6 protein]; Gallic Acid inhibits the reaction [Glucose results in increased secretion of IL6 protein]; linderalactone inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; morroniside inhibits the reaction [Glucose results in increased secretion of IL6 protein]; Oxygen promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL6 mRNA]; prolinedithiocarbamate inhibits the reaction [Glucose results in increased secretion of IL6 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased secretion of IL6 protein]; S-4-bromobenzylglutathione cyclopentyl diester inhibits the reaction [morroniside inhibits the reaction [Glucose results in increased secretion of IL6 protein]]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL6 protein]
Glucose results in increased expression of IL6 mRNA; Glucose results in increased expression of IL6 protein
2-chloro-4'-methoxychalcone inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased secretion of IL6 protein]; [Glucose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased secretion of IL6 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL6 protein; atractylenolide III inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL6 protein]; CDK9 protein affects the reaction [Glucose results in increased expression of IL6 mRNA]; CDK9 protein affects the reaction [Glucose results in increased secretion of IL6 protein]; Edaravone inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL6 protein]; Fatty Acids, Nonesterified promotes the reaction [Glucose results in increased expression of IL6 protein]; IL6 protein inhibits the reaction [[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] inhibits the reaction [IL6RA protein binds to IL6ST protein]]; IL6 protein inhibits the reaction [[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] results in decreased expression of SOD2 protein]; IL6 protein inhibits the reaction [[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] results in decreased phosphorylation of STAT3 protein]; jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in increased expression of IL6 protein]]; Silymarin inhibits the reaction [[Glucose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased secretion of IL6 protein] 		CTD PMID:11108930 PMID:15304054 PMID:15528032 PMID:17665966 PMID:20578705 More... NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Il6r interleukin 6 receptor multiple interactions ISO [[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] inhibits the reaction [IL6RA protein binds to IL6ST protein]] promotes the reaction [IL6ST protein binds to and results in increased phosphorylation of STAT3 protein]; [[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] inhibits the reaction [IL6RA protein binds to IL6ST protein]; [[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] results in increased oxidation of IL6RA protein; IL6 protein inhibits the reaction [[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] inhibits the reaction [IL6RA protein binds to IL6ST protein]] CTD PMID:21940958 NCBI chr 2:177,582,020...177,646,705
Ensembl chr 2:177,582,164...177,645,221 		JBrowse link
G Il6st interleukin 6 cytokine family signal transducer multiple interactions ISO [[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] inhibits the reaction [IL6RA protein binds to IL6ST protein]] promotes the reaction [IL6ST protein binds to and results in increased phosphorylation of STAT3 protein]; [[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] inhibits the reaction [IL6RA protein binds to IL6ST protein]; [[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] results in increased oxidation of IL6ST protein; IL6 protein inhibits the reaction [[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] inhibits the reaction [IL6RA protein binds to IL6ST protein]] CTD PMID:21940958 NCBI chr 2:45,798,872...45,839,501
Ensembl chr 2:45,799,380...45,843,182 		JBrowse link
G Ins1 insulin 1 affects secretion
increases import
multiple interactions
decreases abundance
increases transport
increases expression
increases uptake
decreases expression
increases secretion
increases metabolic processing
affects expression
decreases chemical synthesis
decreases secretion 		EXP
ISO 		Glucose affects the secretion of INS1 protein
INS1 protein results in increased import of Glucose
[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; [Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein; [Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA; [Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]; bisphenol A inhibits the reaction [INS1 protein results in increased uptake of Glucose]; butylbenzyl phthalate promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; Diethylhexyl Phthalate promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]; dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]; Pioglitazone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; pyrazolanthrone inhibits the reaction [bisphenol A inhibits the reaction [INS1 protein results in increased uptake of Glucose]]; Quercetin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; tributyltin promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]
(+)-JQ1 compound promotes the reaction [Glucose results in increased secretion of INS1 protein]; 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [[Glucose co-treated with INS1 protein] results in increased secretion of LEP protein]; 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the reaction [Dexamethasone inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin promotes the reaction [Glucose results in increased secretion of INS1 protein]; 2,4-Dichlorophenoxyacetic Acid inhibits the reaction [Glucose results in increased secretion of INS1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [apigenin-6-C-(2''-O-rhamnopyranosyl)-fucopyranoside promotes the reaction [Glucose results in increased secretion of INS1 protein]]; 3-(4-((2',6'-dimethylbiphenyl-3-yl)methoxy)-2-fluorophenyl)propanoic acid promotes the reaction [Glucose results in increased secretion of INS1 protein]; 3-(4-((2,6-dichloropyridin-4-yl)ethynyl)phenyl)propanoic acid promotes the reaction [Glucose results in increased secretion of INS1 protein]; 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene inhibits the reaction [Glucose results in increased secretion of INS1 protein]; 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one inhibits the reaction [BL 11282 promotes the reaction [Glucose results in increased secretion of INS1 protein]]; 7-nitroindazole inhibits the reaction [[INS1 protein co-treated with Glucose] results in increased transport of Zinc]; 9-phenanthrol inhibits the reaction [[GCG protein co-treated with Glucose] results in increased secretion of INS1 protein]; 9-phenanthrol inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [4-methylcatechol co-treated with Glucose] results in increased secretion of INS1 protein; [[Glucose co-treated with INS1 protein] results in increased abundance of Adenosine Triphosphate] which results in increased secretion of LEP protein; [[valyl-histidyl-threonyl-aspartamide binds to Zinc] results in increased activity of [INS1 protein binds to INS1 protein binds to INS1 protein binds to INS1 protein binds to INS1 protein binds to INS1 protein]] which results in decreased abundance of Glucose; [Alloxan co-treated with Homocysteine] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [GCG protein co-treated with Glucose] results in increased secretion of INS1 protein; [GCG protein modified form binds to and results in increased activity of GLP1R protein] promotes the reaction [Glucose results in increased secretion of INS1 protein]; [Glucose co-treated with 3,4-dihydroxyphenylethanol] results in increased secretion of INS1 protein; [Glucose co-treated with dihydroxyethyldithiocarbamate] results in decreased expression of INS1; [Glucose co-treated with INS1 protein] results in increased abundance of Adenosine Triphosphate; [Glucose co-treated with INS1 protein] results in increased secretion of LEP protein; [Glucose co-treated with Lipopolysaccharides] results in increased secretion of INS1 protein; [Glucose co-treated with Plant Extracts] results in increased secretion of INS1 protein; [Glucose co-treated with Potassium Chloride] results in increased secretion of INS1 protein; [IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [INS1 protein co-treated with Glucose] results in increased activity of PARP1 protein; [INS1 protein co-treated with Glucose] results in increased transport of Zinc; [sodium arsenite results in increased abundance of Arsenic] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Acetylcysteine inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; ALB protein modified form inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Alloxan inhibits the reaction [Glucose results in increased secretion of INS1 protein]; alpha-methylbenzylaminobenzotriazole inhibits the reaction [BL 11282 promotes the reaction [Glucose results in increased secretion of INS1 protein]]; apigenin-6-C-(2''-O-rhamnopyranosyl)-fucopyranoside promotes the reaction [Glucose results in increased secretion of INS1 protein]; arachidonyltrifluoromethane inhibits the reaction [BL 11282 promotes the reaction [Glucose results in increased secretion of INS1 protein]]; argan oil inhibits the reaction [Glucose results in increased expression of INS1 protein]; Arsenic Trioxide inhibits the reaction [[Glucose co-treated with Lipopolysaccharides] results in increased secretion of INS1 protein]; benazepril inhibits the reaction [Glucose results in increased secretion of INS1 protein]; benazepril promotes the reaction [INS1 protein results in increased metabolism of Glucose]; bisphenol A affects the reaction [Glucose results in increased secretion of INS1 protein]; bisphenol A promotes the reaction [Glucose results in increased secretion of INS1 protein]; BL 11282 analog promotes the reaction [Glucose results in increased secretion of INS1 protein]; BL 11282 promotes the reaction [Glucose results in increased secretion of INS1 protein]; Budesonide inhibits the reaction [Colforsin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Budesonide inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Bumetanide inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Calcium deficiency inhibits the reaction [[Glucose co-treated with INS1 protein] results in increased secretion of LEP protein]; Cannabidiol promotes the reaction [Glucose results in increased secretion of INS1 protein]; Capsaicin promotes the reaction [Glucose results in increased secretion of INS1 protein]; Chlorpyrifos inhibits the reaction [INS1 protein results in increased uptake of Glucose]; Colchicine inhibits the reaction [apigenin-6-C-(2''-O-rhamnopyranosyl)-fucopyranoside promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Colforsin promotes the reaction [Glucose results in increased secretion of INS1 protein]; cordycepin promotes the reaction [Glucose results in increased secretion of INS1 protein]; Corn Oil inhibits the reaction [Glucose results in increased expression of INS1 protein]; Cycloheximide inhibits the reaction [apigenin-6-C-(2''-O-rhamnopyranosyl)-fucopyranoside promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Dexamethasone inhibits the reaction [Colforsin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Dexamethasone inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Diazoxide inhibits the reaction [[Glucose co-treated with INS1 protein] results in increased secretion of LEP protein]; Dietary Fats affects the reaction [INS1 protein results in increased uptake of Glucose]; Dietary Fats inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Diethylhexyl Phthalate inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Diethylhexyl Phthalate inhibits the reaction [INS1 protein results in increased metabolism of Glucose]; Dithiothreitol inhibits the reaction [INS1 protein results in increased uptake of Glucose]; dorsomorphin inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Exenatide inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Exenatide inhibits the reaction [Hydrogen Peroxide inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Exenatide inhibits the reaction [Palmitic Acid inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Fluticasone inhibits the reaction [Colforsin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Fluticasone inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Fulvestrant inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; ginsenoside Rh4 inhibits the reaction [Alloxan inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Glucosamine inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Glucose inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Glucose inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]; Homocysteine inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Hydrocortisone inhibits the reaction [Colforsin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Hydrogen Peroxide inhibits the reaction [Glucose results in increased secretion of INS1 protein]; imeglimin promotes the reaction [Glucose results in increased secretion of INS1 protein]; INS1 protein inhibits the reaction [Dichlorvos results in increased abundance of Glucose]; INS1 protein inhibits the reaction [FOXO1 protein results in increased abundance of Glucose]; INS1 protein promotes the reaction [FOXO1 protein mutant form results in increased abundance of Glucose]; INS1 protein promotes the reaction [Glucose results in increased expression of LEP mRNA]; INS1 protein promotes the reaction [Glucose results in increased secretion of LEP protein]; INS1 protein results in increased transport of and results in increased oxidation of Glucose; KMUP 1 inhibits the reaction [Glucose results in decreased secretion of INS1 protein]; Lenalidomide inhibits the reaction [Arsenic Trioxide inhibits the reaction [[Glucose co-treated with Lipopolysaccharides] results in increased secretion of INS1 protein]]; LEP promotes the reaction [Glucose results in increased secretion of INS1 protein]; Manganese deficiency inhibits the reaction [INS1 protein results in increased oxidation of Glucose]; manganese(III)-tetrakis(4-benzoic acid)porphyrin affects the reaction [Glucose affects the expression of INS1 mRNA]; manganese(III)-tetrakis(4-benzoic acid)porphyrin affects the reaction [Glucose affects the secretion of INS1 protein]; Melatonin inhibits the reaction [Triiodothyronine, Reverse inhibits the reaction [INS1 protein results in increased uptake of Glucose]]; Metformin inhibits the reaction [Glucose results in increased secretion of INS1 protein]; MK615 extract inhibits the reaction [ALB protein modified form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; N-(-4-(N-(biphenyl-2-ylmethyl)-N-2-methylpropylamino)- 1-(2-(2,4-difluorobenzoyl)benzoyl)pyrrolidin- 2-yl)methyl-3-(4-(2,4-dioxothiazolidin-5-ylidenemethyl) phenyl)acrylamide inhibits the reaction [BL 11282 promotes the reaction [Glucose results in increased secretion of INS1 protein]]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Arsenic Trioxide inhibits the reaction [[Glucose co-treated with Lipopolysaccharides] results in increased secretion of INS1 protein]]; NFE2L2 protein affects the reaction [Exenatide inhibits the reaction [Hydrogen Peroxide inhibits the reaction [Glucose results in increased secretion of INS1 protein]]]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan inhibits the reaction [Glucose results in increased secretion of INS1 protein]]]; Niacinamide inhibits the reaction [Glucose results in increased expression of INS1 protein]; nickel chloride inhibits the reaction [[Glucose co-treated with INS1 protein] results in increased secretion of LEP protein]; nymphayol promotes the reaction [INS1 protein results in increased uptake of Glucose]; Oleic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]; oxophenylarsine inhibits the reaction [INS1 protein results in increased transport of Glucose]; oxophenylarsine inhibits the reaction [INS1 protein results in increased uptake of Glucose]; Palmitic Acid inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]; pimobendan promotes the reaction [Glucose results in increased secretion of INS1 protein]; PPARA protein promotes the reaction [Glucose results in increased secretion of INS1 protein]; PPARG protein inhibits the reaction [Glucose results in increased secretion of INS1 protein]; PRKAA1 protein affects the reaction [Glucose results in increased secretion of INS1 protein]; Quercetin inhibits the reaction [INS1 protein results in increased transport of and results in increased oxidation of Glucose]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Resveratrol inhibits the reaction [Dietary Fats inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Resveratrol inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Ro 31-8220 inhibits the reaction [apigenin-6-C-(2''-O-rhamnopyranosyl)-fucopyranoside promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Ro 32-0432 inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Sirolimus inhibits the reaction [Glucose results in increased secretion of INS1 protein]; SIRT1 protein promotes the reaction [[Glucose results in increased abundance of Adenosine Triphosphate] which results in increased expression of INS1 protein]; SIRT1 protein promotes the reaction [Glucose results in increased expression of INS1 protein]; SLC30A8 protein affects the reaction [Glucose results in increased secretion of INS1 protein]; SOD1 protein inhibits the reaction [[INS1 protein co-treated with Glucose] results in increased activity of PARP1 protein]; sodium arsenite inhibits the reaction [Glucose results in increased secretion of INS1 protein]; sodium arsenite promotes the reaction [Glucose results in increased secretion of INS1 protein]; Sorbitol promotes the reaction [Glucose results in increased secretion of INS1 protein]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Taurine inhibits the reaction [Arsenic Trioxide inhibits the reaction [[Glucose co-treated with Lipopolysaccharides] results in increased secretion of INS1 protein]]; Tetradecanoylphorbol Acetate inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Tetradecanoylphorbol Acetate promotes the reaction [Glucose results in increased secretion of INS1 protein]; TRIB3 protein affects the reaction [INS1 protein results in increased uptake of Glucose]; tributyltin promotes the reaction [Glucose results in increased secretion of INS1 protein]; trichostatin A inhibits the reaction [Dexamethasone inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Triiodothyronine, Reverse inhibits the reaction [INS1 protein results in increased uptake of Glucose]; tubacin inhibits the reaction [Dexamethasone inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; tubacin promotes the reaction [Glucose results in increased secretion of INS1 protein]; UCP2 protein inhibits the reaction [SIRT1 protein promotes the reaction [Glucose results in increased expression of INS1 protein]]; Vitamin E inhibits the reaction [Triiodothyronine, Reverse inhibits the reaction [INS1 protein results in increased uptake of Glucose]]; Wortmannin inhibits the reaction [apigenin-6-C-(2''-O-rhamnopyranosyl)-fucopyranoside promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Zinc inhibits the reaction [Glucose results in increased secretion of INS1 protein]
INS1 protein results in decreased abundance of Glucose
INS1 protein results in increased uptake of Glucose; INS1 results in increased uptake of Glucose
Glucose results in decreased expression of INS1 mRNA
1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [[4-(3-3,4-p-menthadien-(1,8)-yl)olivetol co-treated with Glucose] results in increased secretion of INS1 protein]; 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [[O-1602 compound co-treated with Glucose] results in increased secretion of INS1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [BLX 1002 promotes the reaction [Glucose results in increased secretion of INS1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [INS1 protein results in increased uptake of Glucose]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [mono-(2-ethylhexyl)phthalate promotes the reaction [INS1 protein results in increased uptake of Glucose]]; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester inhibits the reaction [arsenite inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester inhibits the reaction [dimethylarsinous acid inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester inhibits the reaction [methylarsonite inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester promotes the reaction [Glucose results in increased secretion of INS1 protein]; 7-Ala-angiotensin (1-7) promotes the reaction [Glucose results in increased secretion of INS1 protein]; 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [Acrolein inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [Arsenic Trioxide inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; 8-bromo-cyclic-ADP-ribose inhibits the reaction [imeglimin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; [4-(3-3,4-p-menthadien-(1,8)-yl)olivetol co-treated with Glucose] results in increased secretion of INS1 protein; [[imeglimin co-treated with Sitagliptin Phosphate] affects the reaction [A mutant form affects the susceptibility to Glucose]] which affects the expression of INS1 protein; [arachidonyl-2-chloroethylamide co-treated with Glucose] results in increased secretion of INS1 protein; [Cadmium Chloride results in increased abundance of Cadmium] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [Carbachol co-treated with Glucose] results in increased secretion of INS1 protein; [Chromium co-treated with Vanadates] promotes the reaction [INS1 protein results in increased uptake of Glucose]; [Chromium Compounds co-treated with Vanadates] promotes the reaction [INS1 protein results in increased uptake of Glucose]; [Dietary Fats affects the susceptibility to INS1 protein] which affects the oxidation of Glucose; [Dietary Fats affects the susceptibility to INS1 protein] which affects the uptake of Glucose; [FFAR1 protein affects the susceptibility to Dietary Fats] affects the reaction [Glucose results in increased secretion of INS1 protein]; [GCG protein modified form binds to and results in increased activity of GLP1R protein] promotes the reaction [Glucose results in increased secretion of INS1 protein]; [Glucose co-treated with Amino Acids] results in increased secretion of INS1 protein; [Glucose co-treated with Dichlorodiphenyl Dichloroethylene] results in increased secretion of INS1 protein; [Glucose co-treated with INS1 protein] affects the expression of KAT6B mRNA; [Glucose co-treated with INS1 protein] affects the expression of KDM1B mRNA; [Glucose co-treated with INS1 protein] affects the expression of KDM4B mRNA; [Glucose co-treated with INS1 protein] affects the localization of PDX1 protein; [GPD2 mutant form co-treated with Aminooxyacetic Acid] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [imeglimin affects the reaction [A mutant form affects the susceptibility to Glucose]] which affects the expression of INS1 protein; [LDLR gene mutant form results in increased susceptibility to Pravastatin] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [lead nitrate results in increased abundance of Lead] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [Mercuric Chloride results in increased abundance of Mercury] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [MME protein results in increased cleavage of angiotensin I (1-7)] affects the reaction [Glucose results in increased secretion of INS1 protein]; [molybdenum trioxide results in increased abundance of Molybdenum] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [O-1602 compound co-treated with Glucose] results in increased secretion of INS1 protein; [Pertussis Toxin co-treated with FR900359] promotes the reaction [Glucose results in increased secretion of INS1 protein]; [Pertussis Toxin co-treated with Glucose] results in increased secretion of INS1 protein; [Potassium Chloride co-treated with Diazoxide] inhibits the reaction [[GPD2 mutant form co-treated with Aminooxyacetic Acid] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; [Tetradecanoylphorbol Acetate co-treated with Glucose] results in increased secretion of INS1 protein; [Tolbutamide co-treated with FR900359] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Acetylcysteine inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Acrolein inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Adenosine Triphosphate inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Akt-I-1,2 compound inhibits the reaction [INS1 protein results in increased uptake of Glucose]; Akt-I-1,2 compound inhibits the reaction [mono-(2-ethylhexyl)phthalate promotes the reaction [INS1 protein results in increased uptake of Glucose]]; AKT1 protein modified form inhibits the reaction [arsenite inhibits the reaction [INS1 protein results in increased uptake of Glucose]]; AKT1 protein modified form inhibits the reaction [monomethylarsonous acid inhibits the reaction [INS1 protein results in increased uptake of Glucose]]; angiotensin I (1-7) promotes the reaction [Glucose results in increased secretion of INS1 protein]; Arecoline inhibits the reaction [INS1 protein results in increased uptake of Glucose]; Arsenic Trioxide inhibits the reaction [Estradiol promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Arsenic Trioxide inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Arsenic Trioxide promotes the reaction [Estrogens deficiency inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; arsenite inhibits the reaction [3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester promotes the reaction [Glucose results in increased secretion of INS1 protein]]; arsenite inhibits the reaction [Glucose results in increased secretion of INS1 protein]; arsenite inhibits the reaction [INS1 protein results in increased uptake of Glucose]; Benzamides promotes the reaction [INS1 protein results in increased uptake of Glucose]; bisphenol A inhibits the reaction [Glucose results in increased secretion of INS1 protein]; bisphenol A inhibits the reaction [INS1 protein results in increased metabolism of Glucose]; bisphenol A promotes the reaction [Glucose results in increased secretion of INS1 protein]; bisphenol S inhibits the reaction [Glucose results in increased secretion of INS1 protein]; BL 11282 promotes the reaction [Glucose results in increased secretion of INS1 protein]; BLX 1002 promotes the reaction [Glucose results in increased secretion of INS1 protein]; Bumetanide inhibits the reaction [SLC12A2 gene mutant form promotes the reaction [Glucose results in increased secretion of INS1 protein]]; celastrol affects the reaction [[Dietary Fats affects the susceptibility to INS1 protein] which affects the oxidation of Glucose]; celastrol affects the reaction [[Dietary Fats affects the susceptibility to INS1 protein] which affects the uptake of Glucose]; Chromium Compounds promotes the reaction [INS1 protein results in increased uptake of Glucose]; Chromium promotes the reaction [INS1 protein results in increased uptake of Glucose]; cis-9, trans-11-conjugated linoleic acid promotes the reaction [INS1 protein affects the transport of Glucose]; cobaltiprotoporphyrin inhibits the reaction [Methylprednisolone inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Colforsin promotes the reaction [Glucose results in increased secretion of INS1 protein]; copper bis(3,5-diisopropylsalicylate) inhibits the reaction [SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; CYP1A1 protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; CYP1A2 protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Cytochalasin B inhibits the reaction [INS1 protein results in increased uptake of Glucose]; Cytochalasin B inhibits the reaction [mono-(2-ethylhexyl)phthalate promotes the reaction [INS1 protein results in increased uptake of Glucose]]; Dexamethasone inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Diethylhexyl Phthalate inhibits the reaction [Glucose results in increased secretion of INS1 protein]; dimethylarsine analog inhibits the reaction [INS1 protein results in increased uptake of Glucose]; dimethylarsinous acid inhibits the reaction [3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester promotes the reaction [Glucose results in increased secretion of INS1 protein]]; dimethylarsinous acid inhibits the reaction [Glucose results in increased secretion of INS1 protein]; DX600 peptide inhibits the reaction [angiotensin I (1-7) promotes the reaction [Glucose results in increased secretion of INS1 protein]]; DX600 peptide promotes the reaction [Glucose results in increased secretion of INS1 protein]; ebselen inhibits the reaction [GPX1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; ebselen inhibits the reaction [SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; ebselen promotes the reaction [Glucose results in increased secretion of INS1 protein]; Estradiol inhibits the reaction [Arsenic Trioxide promotes the reaction [Estrogens deficiency inhibits the reaction [Glucose results in increased secretion of INS1 protein]]]; Estradiol inhibits the reaction [Estrogens deficiency inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Estradiol inhibits the reaction [INS1 protein results in increased transport of Glucose]; Estradiol promotes the reaction [Glucose results in increased secretion of INS1 protein]; Estrogens deficiency inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Exenatide inhibits the reaction [FR900359 inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Exenatide promotes the reaction [Glucose results in increased secretion of INS1 protein]; ferrostatin-1 inhibits the reaction [Acrolein inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; FFAR1 protein affects the reaction [Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]]; FR900359 inhibits the reaction [Exenatide promotes the reaction [Glucose results in increased secretion of INS1 protein]]; FR900359 inhibits the reaction [Glucose results in increased secretion of INS1 protein]; FR900359 inhibits the reaction [Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]]; FR900359 inhibits the reaction [TUG-469 promotes the reaction [Glucose results in increased secretion of INS1 protein]]; FRK protein inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Fulvestrant inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; GCG protein promotes the reaction [imeglimin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; GIP protein promotes the reaction [Glucose results in increased secretion of INS1 protein]; Glyburide inhibits the reaction [Nanotubes, Carbon inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; GNAI2 gene mutant form inhibits the reaction [[Glucose co-treated with Amino Acids] results in increased secretion of INS1 protein]; GNAI2 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]; GNAQ protein affects the reaction [Glucose results in increased secretion of INS1 protein]; GNAQ protein affects the reaction [Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]]; GPX1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]; IKBKB protein affects the reaction [Particulate Matter promotes the reaction [Glucose results in increased secretion of INS1 protein]]; imeglimin promotes the reaction [Glucose results in increased secretion of INS1 protein]; isosteviol inhibits the reaction [Palmitic Acid inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; kaempferol promotes the reaction [INS1 protein results in increased uptake of Glucose]; mercaptosteroid 4 inhibits the reaction [Glucose results in increased secretion of INS1 protein]; mercaptosteroid 6 inhibits the reaction [Glucose results in increased secretion of INS1 protein]; methylarsine oxide inhibits the reaction [INS1 protein results in increased uptake of Glucose]; methylarsonite inhibits the reaction [3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester promotes the reaction [Glucose results in increased secretion of INS1 protein]]; methylarsonite inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Methylprednisolone inhibits the reaction [Glucose results in increased secretion of INS1 protein]; MME protein affects the reaction [angiotensin I (1-7) promotes the reaction [Glucose results in increased secretion of INS1 protein]]; mono-(2-ethylhexyl)phthalate promotes the reaction [INS1 protein results in increased uptake of Glucose]; monomethylarsonic acid inhibits the reaction [INS1 protein results in increased uptake of Glucose]; Nanotubes, Carbon inhibits the reaction [Glucose results in increased secretion of INS1 protein]; naringin inhibits the reaction [Nanotubes, Carbon inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; naringin promotes the reaction [Glucose results in increased secretion of INS1 protein]; nuciferine promotes the reaction [INS1 protein results in increased metabolism of Glucose]; Ozone promotes the reaction [INS1 protein results in decreased abundance of Glucose]; Palmitic Acid inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]; Particulate Matter promotes the reaction [Glucose results in increased secretion of INS1 protein]; perfluorooctane sulfonic acid inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Pioglitazone promotes the reaction [INS1 protein results in increased uptake of Glucose]; platyconic acid promotes the reaction [INS1 protein results in increased uptake of Glucose]; POMC inhibits the reaction [INS1 results in increased uptake of Glucose]; Potassium Chloride inhibits the reaction [FR900359 inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Potassium Chloride promotes the reaction [Glucose results in increased secretion of INS1 protein]; Progesterone inhibits the reaction [INS1 protein results in increased transport of Glucose]; pronuciferine promotes the reaction [INS1 protein results in increased metabolism of Glucose]; Quercetin promotes the reaction [INS1 protein results in increased uptake of Glucose]; Resveratrol inhibits the reaction [Acrolein inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Ro 32-0432 inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Rosiglitazone inhibits the reaction [Acrolein inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Rosiglitazone promotes the reaction [INS1 protein results in increased metabolism of Glucose]; rutamarin promotes the reaction [INS1 protein results in increased uptake of Glucose]; Sildenafil Citrate promotes the reaction [INS1 protein results in increased import of Glucose]; SIRT3 protein inhibits the reaction [sodium arsenite inhibits the reaction [INS1 protein results in increased uptake of Glucose]]; SLC12A2 gene mutant form promotes the reaction [Glucose results in increased secretion of INS1 protein]; SLC30A3 results in increased susceptibility to [Glucose co-treated with INS1 protein]; SLC30A8 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]; SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]; SOD2 protein inhibits the reaction [sodium arsenite inhibits the reaction [INS1 protein results in increased uptake of Glucose]]; sodium arsenite inhibits the reaction [Glucose results in increased secretion of INS1 protein]; sodium arsenite inhibits the reaction [INS1 protein results in increased uptake of Glucose]; sodium arsenite promotes the reaction [INS1 protein results in decreased chemical synthesis of Glucose]; Sodium Selenite inhibits the reaction [SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Streptozocin inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Testosterone inhibits the reaction [INS1 protein results in increased transport of Glucose]; Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Tolbutamide inhibits the reaction [arsenite inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Tolbutamide inhibits the reaction [dimethylarsinous acid inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Tolbutamide inhibits the reaction [methylarsonite inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Tolbutamide promotes the reaction [Glucose results in increased secretion of INS1 protein]; tributyltin promotes the reaction [Glucose results in increased secretion of INS1 protein]; TRPM2 protein affects the reaction [imeglimin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; TUG-469 promotes the reaction [Glucose results in increased secretion of INS1 protein]; UGT1A6A protein affects the reaction [Glucose results in increased secretion of INS1 protein]; Vanadates promotes the reaction [INS1 protein results in increased uptake of Glucose]; Wortmannin inhibits the reaction [BLX 1002 promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Wortmannin inhibits the reaction [INS1 protein results in increased uptake of Glucose]; Wortmannin inhibits the reaction [mono-(2-ethylhexyl)phthalate promotes the reaction [INS1 protein results in increased uptake of Glucose]]; YM-254890 inhibits the reaction [Glucose results in increased secretion of INS1 protein]; YM-254890 inhibits the reaction [Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Zinc promotes the reaction [INS1 protein results in increased uptake of Glucose] 		CTD PMID:222008 PMID:1324726 PMID:2185640 PMID:2204694 PMID:2262933 More... NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682 		JBrowse link
G Ins2 insulin 2 multiple interactions
increases secretion
affects response to substance
increases uptake
increases expression
decreases expression
decreases chemical synthesis
decreases secretion
increases activity 		ISO
EXP 		(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; 1-Methyl-3-isobutylxanthine promotes the reaction [Glucose results in increased secretion of INS protein]; 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [Fatty Acids, Nonesterified inhibits the reaction [INS protein results in increased secretion of Glucose]]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; 3,4-dihydro-5-methyl-1(2H)-isoquinolinone inhibits the reaction [Glucose inhibits the reaction [MAFA protein binds to INS promoter]]; 3,4-dihydro-5-methyl-1(2H)-isoquinolinone inhibits the reaction [Glucose results in increased expression of INS mRNA]; 3,4-dihydro-5-methyl-1(2H)-isoquinolinone inhibits the reaction [Glucose results in increased expression of INS protein]; 3-aminobenzamide inhibits the reaction [Glucose inhibits the reaction [MAFA protein binds to INS promoter]]; 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of INS mRNA]; 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of INS protein]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [SIRT1 protein inhibits the reaction [Resveratrol promotes the reaction [Glucose results in increased secretion of INS protein]]]; [6alpha-ethyl-23(S)-methylcholic acid co-treated with Glucose] results in increased secretion of INS protein; [Cadmium Chloride results in increased abundance of Cadmium] inhibits the reaction [Glucose results in increased secretion of INS protein]; [chromic chloride results in increased activity of INS protein modified form] which results in increased import of Glucose; [Glucose affects the susceptibility to INS protein] which affects the phosphorylation of AKT1 protein; [Glucose affects the susceptibility to INS protein] which affects the uptake of Glucose; [Glucose co-treated with INS protein] affects the localization of PDX1 protein; [Glucose co-treated with sodium arsenite] results in increased secretion of INS protein; [Glyburide co-treated with Glucose] results in increased expression of INS protein; [INS protein co-treated with Glucose] results in decreased chemical synthesis of Nitric Oxide; [INS protein co-treated with Glucose] results in decreased expression of SLC2A3 protein; [INS protein co-treated with Glucose] results in increased expression of ACACA mRNA; [INS protein co-treated with Glucose] results in increased expression of FASN mRNA; [INS protein co-treated with Glucose] results in increased expression of SREBF1 mRNA; [Lithocholic Acid co-treated with Glucose] results in increased secretion of INS protein; [manganese chloride results in increased abundance of Manganese] inhibits the reaction [Glucose results in increased secretion of INS protein]; [Oleanolic Acid co-treated with Glucose] results in increased secretion of INS protein; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of PPARG mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of PPARA mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL2 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CXCL5 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NFKB1 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of PPARD mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of RELA mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein; [SB 203580 co-treated with INS protein] inhibits the reaction [Glucose affects the localization of PDX1 protein]; [sodium arsenite results in increased abundance of arsenite] inhibits the reaction [Glucose results in increased secretion of INS protein]; [TNF protein co-treated with IFNG protein co-treated with IL1B protein] inhibits the reaction [Glucose results in increased secretion of INS protein alternative form]; [Wortmannin co-treated with INS protein] inhibits the reaction [Glucose affects the localization of PDX1 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased expression of INS protein]; Acetylcysteine inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS protein]]; alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol promotes the reaction [Glucose results in increased secretion of INS protein]; Arachidonic Acid promotes the reaction [Glucose results in increased secretion of INS protein]; arachidonyltrifluoromethane inhibits the reaction [Glucose results in increased secretion of INS protein]; baicalein promotes the reaction [Glucose results in increased secretion of INS protein]; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; bisphenol A inhibits the reaction [INS protein results in increased uptake of Glucose]; bisphenol A promotes the reaction [Glucose results in increased secretion of INS protein]; Cadmium Chloride promotes the reaction [Glucose results in increased secretion of INS protein]; Chlorpropamide inhibits the reaction [Glucose results in decreased secretion of INS protein]; Dexamethasone inhibits the reaction [Glucose results in increased secretion of INS protein]; Dexamethasone inhibits the reaction [INS protein results in increased uptake of Glucose]; Diazoxide inhibits the reaction [Glucose results in increased secretion of INS protein]; Dichlorodiphenyl Dichloroethylene promotes the reaction [Glucose results in increased secretion of INS protein]; Diethylhexyl Phthalate affects the reaction [Glucose results in increased secretion of INS protein]; Enalaprilat inhibits the reaction [Glucose results in decreased secretion of INS protein]; Exenatide inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased secretion of INS protein alternative form]]; Fatty Acids, Nonesterified inhibits the reaction [INS protein results in increased secretion of Glucose]; Fenofibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Fulvestrant inhibits the reaction [bisphenol A inhibits the reaction [INS protein results in increased uptake of Glucose]]; Fulvestrant inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS protein]]; fumosorinone promotes the reaction [INS protein results in increased uptake of Glucose]; Glucose inhibits the reaction [INS protein results in increased chemical synthesis of Glycogen]; Glucose inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]; Glucose inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]; Glucose inhibits the reaction [INS protein results in increased phosphorylation of INSR protein]; Glucose inhibits the reaction [INS protein results in increased secretion of Nitric Oxide]; Glyburide inhibits the reaction [Glucose results in decreased secretion of INS protein]; GW8510 promotes the reaction [Glucose results in increased secretion of INS protein]; HNF1B protein inhibits the reaction [bisphenol A inhibits the reaction [INS protein results in increased uptake of Glucose]]; IAPP protein inhibits the reaction [Glucose results in increased secretion of INS protein]; INS protein inhibits the reaction [[Arsenic Trioxide co-treated with Glucose] results in increased expression of AQP7 mRNA]; INS protein inhibits the reaction [[Arsenic Trioxide co-treated with Glucose] results in increased expression of AQP7 protein]; INS protein inhibits the reaction [Glucose results in decreased expression of ATP1A1 protein]; INS protein mutant form results in decreased uptake of and results in decreased oxidation of Glucose; IRS1 protein polymorphism inhibits the reaction [Glucose results in increased secretion of INS protein]; Kynurenic Acid inhibits the reaction [[INS protein co-treated with Glucose] results in decreased chemical synthesis of Nitric Oxide]; Kynurenic Acid inhibits the reaction [[INS protein co-treated with Glucose] results in decreased expression of SLC2A3 protein]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; mercaptosteroid 6 inhibits the reaction [Glucose results in increased secretion of INS protein]; Metformin inhibits the reaction [[Glucose affects the susceptibility to INS protein] which affects the uptake of Glucose]; Metformin promotes the reaction [Glucose results in increased secretion of INS protein]; methylarsine oxide inhibits the reaction [Glucose results in increased secretion of INS protein]; Methylcholanthrene promotes the reaction [Glucose results in increased secretion of INS protein alternative form]; MIR133A1 affects the reaction [Glucose results in decreased chemical synthesis of INS protein]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [Glucose results in increased secretion of INS protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased phosphorylation of INSR protein]]; Niacinamide inhibits the reaction [Glucose inhibits the reaction [MAFA protein binds to INS promoter]]; Niacinamide inhibits the reaction [Glucose results in increased expression of INS mRNA]; Niacinamide inhibits the reaction [Glucose results in increased expression of INS protein]; NKX6-1 protein promotes the reaction [Glucose results in increased secretion of INS protein]; palmitoyl trifluoromethyl ketone inhibits the reaction [Glucose results in increased secretion of INS protein]; PARP1 protein affects the reaction [Glucose inhibits the reaction [INS protein results in increased phosphorylation of INSR protein]]; perfluorooctane sulfonic acid promotes the reaction [Glucose results in increased secretion of INS protein]; perfluorooctanoic acid inhibits the reaction [Glucose results in increased secretion of INS protein]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Plant Extracts inhibits the reaction [[Glucose affects the susceptibility to INS protein] which affects the uptake of Glucose]; PPARG protein affects the reaction [Fulvestrant inhibits the reaction [bisphenol A inhibits the reaction [INS protein results in increased uptake of Glucose]]]; Quercetin inhibits the reaction [Glucose results in increased expression of INS protein]; Resveratrol inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased secretion of Nitric Oxide]]; Resveratrol promotes the reaction [Glucose results in increased secretion of INS protein]; Ro 32-0432 inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS protein]]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Rosiglitazone inhibits the reaction [Fatty Acids, Nonesterified inhibits the reaction [INS protein results in increased secretion of Glucose]]; Rosiglitazone inhibits the reaction [IAPP protein inhibits the reaction [Glucose results in increased secretion of INS protein]]; Rosiglitazone promotes the reaction [INS protein results in increased uptake of Glucose]; Saquinavir inhibits the reaction [INS protein results in increased import of Glucose]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased secretion of Nitric Oxide]]]; SIRT1 protein inhibits the reaction [Resveratrol promotes the reaction [Glucose results in increased secretion of INS protein]]; SLC30A8 protein promotes the reaction [Glucose results in increased secretion of INS protein]; sodium arsenite inhibits the reaction [Glucose results in increased secretion of INS protein]; sodium arsenite inhibits the reaction [INS protein results in increased uptake of Glucose]; SRT1720 inhibits the reaction [[INS protein co-treated with Glucose] results in increased expression of ACACA mRNA]; SRT1720 inhibits the reaction [[INS protein co-treated with Glucose] results in increased expression of FASN mRNA]; SRT1720 inhibits the reaction [[INS protein co-treated with Glucose] results in increased expression of SREBF1 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased secretion of INS protein alternative form]; Thapsigargin inhibits the reaction [Glucose results in increased secretion of INS protein alternative form]; Thioctic Acid inhibits the reaction [Glucose results in increased expression of INS protein]; TNF protein inhibits the reaction [INS protein results in increased uptake of Glucose]; TPH1 protein affects the reaction [Glucose results in increased secretion of INS protein]; TPH1 protein affects the reaction [sodium arsenite inhibits the reaction [Glucose results in increased secretion of INS protein]]; TPH1 protein affects the reaction [UGT1A6A protein affects the reaction [sodium arsenite inhibits the reaction [Glucose results in increased secretion of INS protein]]]; tributyltin promotes the reaction [Glucose results in increased secretion of INS protein]; triphenyl phosphate promotes the reaction [Glucose results in increased secretion of INS protein]; Troglitazone inhibits the reaction [TNF protein inhibits the reaction [INS protein results in increased uptake of Glucose]]; UCP3 protein promotes the reaction [Glucose results in increased secretion of INS protein]; UGT1A6A protein affects the reaction [sodium arsenite inhibits the reaction [Glucose results in increased secretion of INS protein]]
Acetylcysteine inhibits the reaction [Dexamethasone inhibits the reaction [Glucose results in increased secretion of INS protein]]; Dexamethasone inhibits the reaction [Glucose results in increased secretion of INS protein]; Diethylhexyl Phthalate inhibits the reaction [Glucose results in increased secretion of INS protein]; IKBKB affects the reaction [IL1B protein inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]]; IKBKB affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]]; IL1B protein inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]; lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]; Palmitic Acid inhibits the reaction [INS protein results in increased uptake of Glucose]; Quercetin inhibits the reaction [INS protein results in increased uptake of Glucose]; sodium bisulfide inhibits the reaction [INS protein results in increased uptake of Glucose]
Glucose results in increased expression of INS mRNA; Glucose results in increased expression of INS2 mRNA alternative form
Glucose results in increased secretion of INS protein; Glucose results in increased secretion of INS2 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [triphenyl phosphate promotes the reaction [INS protein results in increased import of Glucose]]; 3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [INS protein results in increased uptake of Glucose]; [IL1B protein co-treated with IFNG protein] promotes the reaction [Glucose results in increased secretion of INS protein]; bisphenol A promotes the reaction [Glucose results in increased secretion of INS protein]; Estradiol promotes the reaction [Glucose results in increased secretion of INS2 protein]; IL1B protein inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]; lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]; MIR338 mRNA affects the reaction [Glucose results in increased secretion of INS protein]; Palmitic Acid inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]; PDX1 protein affects the reaction [bisphenol A promotes the reaction [Glucose results in increased secretion of INS protein]]; perfluorooctane sulfonic acid promotes the reaction [INS protein results in increased uptake of Glucose]; resveratrol inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [INS protein results in increased uptake of Glucose]]; TLR4 affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]]; triphenyl phosphate promotes the reaction [INS protein results in increased import of Glucose]
Glucose results in decreased expression of INS2 mRNA
Glucose results in increased secretion of INS protein; Glucose results in increased secretion of INS protein alternative form; INS protein results in increased secretion of Glucose
Glucose results in increased activity of INS promoter 		CTD PMID:838844 PMID:3511099 PMID:7956951 PMID:8725009 PMID:9032110 More... NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805 		JBrowse link
G Insl6 insulin-like 6 multiple interactions ISO [imeglimin co-treated with Glucose] results in increased expression of INSL6 mRNA CTD PMID:34588186 NCBI chr 1:236,483,530...236,487,065
Ensembl chr 1:236,483,530...236,487,065 		JBrowse link
G Insr insulin receptor decreases degradation
multiple interactions
decreases expression
increases phosphorylation
increases expression 		ISO
EXP 		Glucose results in decreased degradation of INSR mRNA
3,4-Dihydroxyphenylacetic Acid inhibits the reaction [Glucose results in decreased expression of and results in decreased phosphorylation of INSR protein]; Catechin inhibits the reaction [Glucose results in decreased expression of and results in decreased phosphorylation of INSR protein]; Glucose results in decreased expression of and results in decreased phosphorylation of INSR protein
Glucose results in decreased expression of INSR protein; Glucose results in decreased expression of INSR protein modified form
Catechin inhibits the reaction [Glucose results in decreased expression of INSR protein modified form]; Catechin inhibits the reaction [Glucose results in decreased expression of INSR protein]; Glucose inhibits the reaction [INS protein results in increased phosphorylation of INSR protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased phosphorylation of INSR protein]]; PARP1 protein affects the reaction [Glucose inhibits the reaction [INS protein results in increased phosphorylation of INSR protein]]; Plant Extracts inhibits the reaction [Glucose results in decreased expression of INSR protein modified form]; Plant Extracts inhibits the reaction [Glucose results in decreased expression of INSR protein]
Glucose results in increased phosphorylation of INSR protein
Glucose results in increased expression of INSR mRNA 		CTD PMID:7826318 PMID:21031461 PMID:24262486 PMID:29981789 NCBI chr12:5,991,135...6,129,275
Ensembl chr12:5,981,835...6,128,803 		JBrowse link
G Insyn2a inhibitory synaptic factor 2A increases expression ISO Glucose results in increased expression of INSYN2A mRNA CTD PMID:31525975 NCBI chr 1:199,127,735...199,183,077
Ensembl chr 1:198,962,151...199,182,799 		JBrowse link
G Ip6k3 inositol hexakisphosphate kinase 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of IP6K3 mRNA CTD PMID:37567420 NCBI chr20:5,225,706...5,247,293
Ensembl chr20:5,226,134...5,273,392 		JBrowse link
G Ipcef1 interaction protein for cytohesin exchange factors 1 decreases expression ISO Glucose results in decreased expression of IPCEF1 mRNA CTD PMID:32942007 NCBI chr 1:45,654,252...45,857,045
Ensembl chr 1:45,662,818...45,856,993 		JBrowse link
G Irag1 inositol 1,4,5-triphosphate receptor associated 1 multiple interactions
decreases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of IRAG1 mRNA] CTD PMID:33448797 NCBI chr 1:174,416,383...174,528,913
Ensembl chr 1:174,416,385...174,528,851 		JBrowse link
G Ireb2 iron responsive element binding protein 2 multiple interactions
increases expression 		EXP
ISO 		[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of IREB2 protein; Deferoxamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of IREB2 protein]
Glucose results in increased expression of IREB2 protein 		CTD PMID:16135072 PMID:38483099 NCBI chr 8:64,124,152...64,207,702
Ensembl chr 8:64,154,945...64,205,520 		JBrowse link
G Irf1 interferon regulatory factor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IRF1 mRNA CTD PMID:37567420 NCBI chr10:38,417,935...38,424,946
Ensembl chr10:38,417,148...38,424,947 		JBrowse link
G Irf2 interferon regulatory factor 2 multiple interactions
increases expression 		ISO Hirudins inhibits the reaction [Glucose results in increased expression of IRF2 mRNA]; IRF2 protein affects the reaction [Glucose results in increased expression of and results in increased cleavage of GSDMD protein]; IRF2 protein affects the reaction [Glucose results in increased expression of GSDMD mRNA] CTD PMID:34212273 NCBI chr16:52,171,855...52,283,620
Ensembl chr16:52,164,442...52,282,627 		JBrowse link
G Irf7 interferon regulatory factor 7 multiple interactions
increases expression 		ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IRF7 mRNA; fucoxanthin inhibits the reaction [Glucose results in increased expression of IRF7 mRNA] CTD PMID:33448797 PMID:37567420 NCBI chr 1:205,796,956...205,800,543
Ensembl chr 1:205,796,959...205,800,023 		JBrowse link
G Irgm immunity-related GTPase M multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IRGM1 mRNA CTD PMID:37567420 NCBI chr10:33,734,640...33,742,720
Ensembl chr10:33,732,961...33,743,228 		JBrowse link
G Irs1 insulin receptor substrate 1 multiple interactions
decreases phosphorylation
decreases expression
increases phosphorylation 		ISO ACACB protein affects the reaction [Glucose results in decreased phosphorylation of IRS1 protein]; Catechin inhibits the reaction [Glucose results in decreased expression of IRS1 protein modified form]; Catechin inhibits the reaction [Glucose results in decreased expression of IRS1 protein]; Glucose promotes the reaction [PIK3R1 protein binds to IRS1 protein]; IRS1 protein polymorphism inhibits the reaction [Glucose results in increased secretion of INS protein]; Plant Extracts inhibits the reaction [Glucose results in decreased expression of IRS1 protein modified form]; Plant Extracts inhibits the reaction [Glucose results in decreased expression of IRS1 protein]
Glucose results in decreased expression of IRS1 protein; Glucose results in decreased expression of IRS1 protein modified form
Glucose results in increased phosphorylation of IRS1 protein 		CTD PMID:10430617 PMID:24262486 PMID:33957017 NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:90,993,519...91,054,538 		JBrowse link
G Irs2 insulin receptor substrate 2 increases phosphorylation
decreases expression
multiple interactions
increases abundance 		ISO Glucose results in increased phosphorylation of IRS2 protein
Glucose results in decreased expression of IRS2 protein; Glucose results in decreased expression of IRS2 protein modified form
[Glucose co-treated with Cadmium] results in decreased phosphorylation of IRS2 protein; Catechin inhibits the reaction [Glucose results in decreased expression of IRS2 protein modified form]; Catechin inhibits the reaction [Glucose results in decreased expression of IRS2 protein]; Plant Extracts inhibits the reaction [Glucose results in decreased expression of IRS2 protein modified form]; Plant Extracts inhibits the reaction [Glucose results in decreased expression of IRS2 protein]
IRS2 gene mutant form results in increased abundance of Glucose 		CTD PMID:10430617 PMID:20028942 PMID:24262486 PMID:39191366 NCBI chr16:85,190,310...85,214,543
Ensembl chr16:85,190,111...85,214,543 		JBrowse link
G Islr2 immunoglobulin superfamily containing leucine-rich repeat 2 increases expression
multiple interactions 		ISO Glucose results in increased expression of ISLR2 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ISLR2 mRNA 		CTD PMID:31525975 PMID:37567420 NCBI chr 8:67,504,042...67,512,125
Ensembl chr 8:67,504,037...67,513,708 		JBrowse link
G Ism2 isthmin 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of ISM2 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ISM2 mRNA CTD PMID:37567420 NCBI chr 6:112,652,772...112,675,098
Ensembl chr 6:112,657,122...112,675,295 		JBrowse link
G Itga2b integrin subunit alpha 2b multiple interactions ISO Glucose inhibits the reaction [Aspirin inhibits the reaction [Arachidonic Acid results in increased expression of ITGA2B protein]] CTD PMID:18413191 NCBI chr10:87,908,697...87,926,225
Ensembl chr10:87,908,697...87,925,833 		JBrowse link
G Itga3 integrin subunit alpha 3 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of ITGA3 mRNA; Glucose results in decreased expression of ITGA3 protein
notoginsenoside R1 inhibits the reaction [Glucose results in decreased expression of ITGA3 mRNA]; notoginsenoside R1 inhibits the reaction [Glucose results in decreased expression of ITGA3 protein] 		CTD PMID:25503068 NCBI chr10:80,486,998...80,522,548
Ensembl chr10:80,486,999...80,518,901 		JBrowse link
G Itga5 integrin subunit alpha 5 decreases expression ISO Glucose results in decreased expression of ITGA5 mRNA CTD PMID:31655124 NCBI chr 7:136,358,097...136,381,305
Ensembl chr 7:136,358,097...136,381,305 		JBrowse link
G Itgav integrin subunit alpha V decreases expression ISO Glucose results in decreased expression of ITGAV mRNA CTD PMID:31655124 NCBI chr 3:89,245,382...89,333,512
Ensembl chr 3:89,245,095...89,333,511 		JBrowse link
G Itgb1 integrin subunit beta 1 increases expression
decreases expression
multiple interactions 		EXP
ISO 		Glucose results in increased expression of ITGB1 mRNA; Glucose results in increased expression of ITGB1 protein
Glucose results in decreased expression of ITGB1 mRNA
notoginsenoside R1 inhibits the reaction [Glucose results in decreased expression of ITGB1 mRNA]; notoginsenoside R1 inhibits the reaction [Glucose results in decreased expression of ITGB1 protein]
Glucose results in decreased expression of ITGB1 mRNA; Glucose results in decreased expression of ITGB1 protein
rosiglitazone inhibits the reaction [Glucose results in increased expression of ITGB1 mRNA]; rosiglitazone inhibits the reaction [Glucose results in increased expression of ITGB1 protein] 		CTD PMID:17441352 PMID:25503068 PMID:31655124 NCBI chr19:73,602,277...73,650,271
Ensembl chr19:73,602,126...73,650,269 		JBrowse link
G Itgb1bp2 integrin subunit beta 1 binding protein 2 increases expression ISO Glucose results in increased expression of ITGB1BP2 mRNA CTD PMID:39922521 NCBI chr  X:70,612,118...70,617,158
Ensembl chr  X:70,612,521...70,617,158 		JBrowse link
G Itgb3 integrin subunit beta 3 multiple interactions
decreases expression 		ISO Glucose inhibits the reaction [Aspirin inhibits the reaction [Arachidonic Acid results in increased expression of ITGB3 protein]]
Glucose results in decreased expression of ITGB3 mRNA 		CTD PMID:18413191 PMID:31655124 NCBI chr10:90,009,927...90,067,787
Ensembl chr10:90,009,900...90,067,800 		JBrowse link
G Itgb4 integrin subunit beta 4 increases expression ISO Glucose results in increased expression of ITGB4 mRNA CTD PMID:39922521 NCBI chr10:101,705,592...101,741,933
Ensembl chr10:101,705,587...101,741,932 		JBrowse link
G Itih2 inter-alpha-trypsin inhibitor heavy chain 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ITIH2 mRNA CTD PMID:37567420 NCBI chr17:73,285,281...73,321,555
Ensembl chr17:73,285,270...73,321,547 		JBrowse link
G Itpka inositol-trisphosphate 3-kinase A increases expression ISO Glucose results in increased expression of ITPKA mRNA CTD PMID:39922521 NCBI chr 3:127,179,841...127,188,405
Ensembl chr 3:127,179,808...127,188,414 		JBrowse link
G Izumo1 izumo sperm-oocyte fusion 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of IZUMO1 mRNA CTD PMID:37567420 NCBI chr 1:105,227,603...105,233,357 JBrowse link
G Jak2 Janus kinase 2 multiple interactions
increases phosphorylation 		ISO
EXP 		(3,4-dihydroxyphenylamino)-2-imidazoline inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]; 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]; acetovanillone inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]; Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]; Rotenone inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]
Glucose results in increased phosphorylation of JAK2 protein
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Glucose results in increased phosphorylation of JAK2 protein] 		CTD PMID:15677497 PMID:20060012 NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762 		JBrowse link
G Jph1 junctophilin 1 increases expression ISO Glucose results in increased expression of JPH1 mRNA CTD PMID:39922521 NCBI chr 5:6,813,553...6,920,488
Ensembl chr 5:6,813,602...6,906,241 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions
affects localization
increases phosphorylation
increases expression 		ISO
EXP 		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased phosphorylation of JUN protein]; [Glucose co-treated with Lipopolysaccharides] results in increased expression of JUN protein; Aspirin inhibits the reaction [Glucose results in increased expression of JUN protein]; Clofibrate inhibits the reaction [Glucose results in increased expression of JUN protein]; Fenofibrate inhibits the reaction [Glucose results in increased expression of JUN protein]; GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to HMGB1 promoter]]; GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to S100A12 promoter]]; GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to S100A8 promoter]]; Glucose promotes the reaction [JUN protein binds to HMGB1 promoter]; Glucose promotes the reaction [JUN protein binds to MMP9 promoter]; Glucose promotes the reaction [JUN protein binds to S100A12 promoter]; Glucose promotes the reaction [JUN protein binds to S100A8 promoter]; JUN promotes the reaction [Glucose results in increased expression of HMGB1 mRNA]; JUN promotes the reaction [Glucose results in increased expression of S100A12 mRNA]; JUN promotes the reaction [Glucose results in increased expression of S100A8 mRNA]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose promotes the reaction [JUN protein binds to MMP9 promoter]]; PARP1 protein affects the reaction [Glucose promotes the reaction [JUN protein binds to MMP9 promoter]]; SB 203580 inhibits the reaction [Glucose results in increased phosphorylation of JUN protein]
Dichloroacetic Acid inhibits the reaction [Glucose results in increased expression of JUN mRNA]; Glucose inhibits the reaction [IL1B protein results in increased phosphorylation of JUN protein]; Oxamic Acid inhibits the reaction [Glucose results in increased expression of JUN mRNA]
Dactinomycin inhibits the reaction [Glucose results in increased expression of JUN mRNA]; diphenyliodonium inhibits the reaction [Glucose results in increased phosphorylation of JUN protein]; Quercetin inhibits the reaction [Glucose affects the localization of JUN protein]; Superoxides affects the reaction [Glucose results in increased phosphorylation of JUN protein] 		CTD PMID:11123204 PMID:11557636 PMID:16572112 PMID:16600694 PMID:17178593 More... NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285 		JBrowse link
G Junb JunB proto-oncogene, AP-1 transcription factor subunit increases expression ISO Glucose results in increased expression of JUNB mRNA CTD PMID:17178593 PMID:39922521 NCBI chr19:40,081,126...40,082,910
Ensembl chr19:40,073,541...40,085,218 		JBrowse link
G Kap kidney androgen regulated protein multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of KAP mRNA] CTD PMID:33448797 NCBI chr 4:168,405,981...168,409,032
Ensembl chr 4:168,405,988...168,409,032 		JBrowse link
G Kat6b lysine acetyltransferase 6B multiple interactions ISO [Glucose co-treated with INS1 protein] affects the expression of KAT6B mRNA CTD PMID:22951486 NCBI chr15:2,688,535...2,861,443
Ensembl chr15:2,688,811...2,844,343 		JBrowse link
G Kbtbd12 kelch repeat and BTB domain containing 12 increases expression ISO Glucose results in increased expression of KBTBD12 mRNA CTD PMID:39922521 NCBI chr 4:122,571,903...122,645,895
Ensembl chr 4:122,573,526...122,645,810 		JBrowse link
G Kcnd2 potassium voltage-gated channel subfamily D member 2 multiple interactions
increases import 		ISO [[FAM66C mRNA binds to and results in decreased expression of MIR23 mRNA] which results in increased expression of KCND2 protein] which results in increased import of Glucose; [[MIR23B mRNA binds to KCND2 3' UTR] which results in decreased expression of KCND2 protein] which results in decreased import of Glucose
KCND2 protein results in increased import of Glucose 		CTD PMID:34418280 NCBI chr 4:50,741,595...51,243,540
Ensembl chr 4:50,742,839...51,243,522 		JBrowse link
G Kcng1 potassium voltage-gated channel modifier subfamily G member 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of KCNG1 mRNA CTD PMID:37567420 NCBI chr 3:177,379,593...177,412,986
Ensembl chr 3:177,392,031...177,411,507 		JBrowse link
G Kcng3 potassium voltage-gated channel modifier subfamily G member 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of KCNG3 mRNA CTD PMID:37567420 NCBI chr 6:16,803,842...16,851,791
Ensembl chr 6:16,803,665...16,851,791 		JBrowse link
G Kcnh1 potassium voltage-gated channel subfamily H member 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of KCNH1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of KCNH1 mRNA CTD PMID:37567420 NCBI chr13:106,253,101...106,555,712
Ensembl chr13:106,253,213...106,555,710 		JBrowse link
G Kcnh2 potassium voltage-gated channel subfamily H member 2 multiple interactions
decreases expression
decreases activity 		ISO
EXP 		[Deoxyglucose co-treated with Glucose deficiency] results in decreased activity of KCNH2 protein; alpha-Tocopherol inhibits the reaction [Glucose results in decreased activity of KCNH2 protein]; Deoxyglucose inhibits the reaction [Glucose results in decreased activity of KCNH2 protein]; Deoxyglucose promotes the reaction [Glucose deficiency results in decreased activity of KCNH2 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in decreased activity of KCNH2 protein]; Pyruvic Acid inhibits the reaction [[Deoxyglucose co-treated with Glucose deficiency] results in decreased activity of KCNH2 protein]; Sodium Cyanide inhibits the reaction [Glucose results in decreased activity of KCNH2 protein]
Glucose results in decreased expression of KCNH2 protein
Glucose deficiency results in decreased activity of KCNH2 protein; Glucose results in decreased activity of KCNH2 protein 		CTD PMID:12531891 PMID:31729781 NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:11,692,980...11,751,421 		JBrowse link
G Kcnh4 potassium voltage-gated channel subfamily H member 4 increases expression ISO Glucose results in increased expression of KCNH4 mRNA CTD PMID:39922521 NCBI chr10:86,168,644...86,188,476
Ensembl chr10:86,168,644...86,188,476 		JBrowse link
G Kcnh6 potassium voltage-gated channel subfamily H member 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of KCNH6 mRNA CTD PMID:37567420 NCBI chr10:91,449,025...91,471,012
Ensembl chr10:91,449,651...91,470,506 		JBrowse link
G Kcnip2 potassium voltage-gated channel interacting protein 2 increases methylation
multiple interactions
decreases expression 		ISO Glucose results in increased methylation of KCNIP2 gene; Glucose results in increased methylation of KCNIP2 promoter
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of KCNIP2 mRNA; fucoxanthin inhibits the reaction [Glucose results in decreased expression of KCNIP2 mRNA]; fucoxanthin inhibits the reaction [Glucose results in increased methylation of KCNIP2 gene] 		CTD PMID:31525975 PMID:33448797 PMID:37567420 NCBI chr 1:254,590,172...254,614,437
Ensembl chr 1:254,590,175...254,613,898 		JBrowse link
G Kcnj10 potassium inwardly-rectifying channel, subfamily J, member 10 increases expression ISO Glucose results in increased expression of KCNJ10 mRNA CTD PMID:39922521 NCBI chr13:87,334,510...87,367,747
Ensembl chr13:87,334,216...87,368,678 		JBrowse link
G Kcnj15 potassium inwardly-rectifying channel, subfamily J, member 15 increases expression ISO Glucose results in increased expression of KCNJ15 mRNA CTD PMID:31525975 NCBI chr11:48,046,953...48,091,285
Ensembl chr11:48,035,655...48,092,457 		JBrowse link
G Kcnma1 potassium calcium-activated channel subfamily M alpha 1 multiple interactions ISO Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]; Glucose results in decreased activity of [KCNMA1 protein binds to KCNMB1 protein]; NS 1619 inhibits the reaction [Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]]; NS 1619 inhibits the reaction [Glucose results in decreased activity of [KCNMA1 protein binds to KCNMB1 protein]]; Tamoxifen inhibits the reaction [Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]]; Tamoxifen inhibits the reaction [Glucose results in decreased activity of [KCNMA1 protein binds to KCNMB1 protein]]; Tetraethylammonium promotes the reaction [Glucose results in decreased activity of [KCNMA1 protein binds to KCNMB1 protein]]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of KCNMA1 mRNA 		CTD PMID:21413024 PMID:37567420 NCBI chr15:351,065...1,057,117
Ensembl chr15:351,659...1,057,117 		JBrowse link
G Kcnmb1 potassium calcium-activated channel subfamily M regulatory beta subunit 1 multiple interactions ISO Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]; Glucose results in decreased activity of [KCNMA1 protein binds to KCNMB1 protein]; NS 1619 inhibits the reaction [Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]]; NS 1619 inhibits the reaction [Glucose results in decreased activity of [KCNMA1 protein binds to KCNMB1 protein]]; Tamoxifen inhibits the reaction [Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]]; Tamoxifen inhibits the reaction [Glucose results in decreased activity of [KCNMA1 protein binds to KCNMB1 protein]]; Tetraethylammonium promotes the reaction [Glucose results in decreased activity of [KCNMA1 protein binds to KCNMB1 protein]] CTD PMID:21413024 NCBI chr10:19,062,014...19,119,005
Ensembl chr10:19,062,291...19,073,204 		JBrowse link
G Kcnmb3 potassium calcium-activated channel subfamily M regulatory beta subunit 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of KCNMB3 mRNA CTD PMID:37567420 NCBI chr 2:117,184,165...117,198,519
Ensembl chr 2:117,182,431...117,200,919 		JBrowse link
G Kcnn2 potassium calcium-activated channel subfamily N member 2 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of KCNN2 protein
FBXO32 protein affects the reaction [Glucose results in decreased expression of KCNN2 protein] 		CTD PMID:30635400 NCBI chr18:40,004,693...40,445,043
Ensembl chr18:40,155,939...40,445,045 		JBrowse link
G Kcnq4 potassium voltage-gated channel subfamily Q member 4 increases expression ISO Glucose results in increased expression of KCNQ4 mRNA CTD PMID:39922521 NCBI chr 5:139,560,366...139,612,212
Ensembl chr 5:139,560,366...139,612,102 		JBrowse link
G Kctd8 potassium channel tetramerization domain containing 8 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of KCTD8 mRNA CTD PMID:37567420 NCBI chr14:39,127,210...39,372,118
Ensembl chr14:39,127,379...39,372,078 		JBrowse link
G Kdm1a lysine demethylase 1A multiple interactions EXP KDM1A protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 5:154,066,436...154,121,913
Ensembl chr 5:154,065,543...154,121,775 		JBrowse link
G Kdm1b lysine demethylase 1B multiple interactions ISO [Glucose co-treated with INS1 protein] affects the expression of KDM1B mRNA CTD PMID:22951486 NCBI chr17:17,809,232...17,850,141
Ensembl chr17:17,809,232...17,850,068 		JBrowse link
G Kdm4b lysine demethylase 4B multiple interactions ISO [Glucose co-treated with INS1 protein] affects the expression of KDM4B mRNA CTD PMID:22951486 NCBI chr 9:1,245,885...1,324,384
Ensembl chr 9:1,245,899...1,324,384 		JBrowse link
G Kdr kinase insert domain receptor multiple interactions
increases expression
decreases expression 		ISO [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of KDR protein
Glucose results in increased expression of KDR mRNA
[Glucose co-treated with Deferoxamine] results in increased expression of KDR mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of KDR mRNA]
Glucose results in decreased expression of KDR mRNA 		CTD PMID:19228841 PMID:31655124 PMID:33962019 NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,572,049...32,615,192 		JBrowse link
G Keap1 Kelch-like ECH-associated protein 1 multiple interactions
increases expression 		ISO
EXP 		[NFE2L2 protein co-treated with KEAP1 protein] affects the abundance of Glucose
Glucose results in increased expression of KEAP1 mRNA; Glucose results in increased expression of KEAP1 protein
solanesol inhibits the reaction [Glucose results in increased expression of KEAP1 mRNA]; solanesol inhibits the reaction [Glucose results in increased expression of KEAP1 protein]
[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of KEAP1 protein; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of KEAP1 protein]; KEAP1 protein inhibits the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; KEAP1 protein inhibits the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PARP1 protein modified form]]; KEAP1 protein inhibits the reaction [diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of KEAP1 protein]]; KEAP1 protein inhibits the reaction [diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and affects the localization of NFE2L2 protein]]; NFE2L2 protein promotes the reaction [diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of KEAP1 protein]] 		CTD PMID:23017736 PMID:35191607 PMID:37586544 NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042 		JBrowse link
G Kif19b kinesin family member 19B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of KIF19B mRNA CTD PMID:37567420 NCBI chr12:19,258,078...19,310,167
Ensembl chr12:19,258,108...19,307,553 		JBrowse link
G Kif1a kinesin family member 1A increases expression EXP Glucose results in increased expression of KIF1A protein CTD PMID:23776493 NCBI chr 9:101,010,447...101,094,891
Ensembl chr 9:101,010,447...101,094,777 		JBrowse link
G Kif20b kinesin family member 20B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of KIF20B mRNA CTD PMID:37567420 NCBI chr 1:241,840,898...241,896,451
Ensembl chr 1:241,840,987...241,896,451 		JBrowse link
G Kif27 kinesin family member 27 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of KIF27 mRNA CTD PMID:37567420 NCBI chr17:6,304,960...6,383,745
Ensembl chr17:6,304,989...6,375,182 		JBrowse link
G Kif4a kinesin family member 4A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of KIF4 mRNA CTD PMID:37567420 NCBI chr  X:69,761,803...69,864,335
Ensembl chr  X:69,761,883...69,864,335 		JBrowse link
G Kif5b kinesin family member 5B decreases expression EXP Glucose results in decreased expression of KIF5B protein CTD PMID:23776493 NCBI chr17:56,185,386...56,222,990
Ensembl chr17:56,185,380...56,223,008 		JBrowse link
G Kif9 kinesin family member 9 increases expression ISO Glucose results in increased expression of KIF9 mRNA CTD PMID:39922521 NCBI chr 8:119,338,014...119,406,632
Ensembl chr 8:119,338,088...119,383,137 		JBrowse link
G Kit KIT proto-oncogene receptor tyrosine kinase decreases expression
increases expression 		ISO Glucose results in decreased expression of KIT mRNA
Glucose results in increased expression of KIT mRNA 		CTD PMID:31655124 PMID:39922521 NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,903,033...32,978,812 		JBrowse link
G Klf10 KLF transcription factor 10 multiple interactions
increases expression 		ISO Glucose promotes the reaction [AGT protein results in increased expression of KLF10 mRNA]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of KLF10 mRNA]]
Glucose results in increased expression of KLF10 mRNA 		CTD PMID:17178593 PMID:19225232 NCBI chr 7:71,352,612...71,358,680
Ensembl chr 7:71,350,573...71,358,948 		JBrowse link
G Klf13 KLF transcription factor 13 multiple interactions EXP [[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Carvedilol] which results in decreased expression of KLF13 mRNA CTD PMID:29122578 NCBI chr 1:126,917,671...126,948,436
Ensembl chr 1:126,916,781...126,961,056 		JBrowse link
G Klf2 KLF transcription factor 2 increases expression
decreases expression 		ISO Glucose results in increased expression of KLF2 mRNA
Glucose results in decreased expression of KLF2 mRNA 		CTD PMID:39613055 PMID:39922521 NCBI chr16:17,555,136...17,557,768
Ensembl chr16:17,555,136...17,557,768 		JBrowse link
G Klf6 KLF transcription factor 6 increases expression ISO Glucose results in increased expression of KLF6 mRNA CTD PMID:17178593 NCBI chr17:69,449,483...69,458,478
Ensembl chr17:69,441,493...69,498,601 		JBrowse link
G Klf9 KLF transcription factor 9 increases expression ISO Glucose results in increased expression of KLF9 mRNA CTD PMID:17178593 NCBI chr 1:230,126,646...230,151,641
Ensembl chr 1:230,126,646...230,151,641 		JBrowse link
G Klkb1 kallikrein B1 increases expression ISO Glucose results in increased expression of KLKB1 mRNA CTD PMID:31525975 NCBI chr16:53,690,180...53,714,570
Ensembl chr16:53,691,220...53,716,339 		JBrowse link
G Klrd1 killer cell lectin like receptor D1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of KLRD1 mRNA CTD PMID:37567420 NCBI chr 4:164,730,833...164,742,539
Ensembl chr 4:164,730,856...164,742,538 		JBrowse link
G Klrg1 killer cell lectin like receptor G1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of KLRG1 mRNA CTD PMID:37567420 NCBI chr 4:157,127,571...157,139,372
Ensembl chr 4:157,127,571...157,139,372 		JBrowse link
G Knl1 kinetochore scaffold 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of KNL1 mRNA CTD PMID:37567420 NCBI chr 3:126,483,498...126,545,774
Ensembl chr 3:126,483,544...126,545,774 		JBrowse link
G Krt17 keratin 17 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of KRT17 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of KRT17 mRNA CTD PMID:37567420 NCBI chr10:85,679,068...85,683,792
Ensembl chr10:85,679,070...85,683,787 		JBrowse link
G Krt20 keratin 20 multiple interactions
increases expression
decreases expression 		ISO [Glucose co-treated with TGFB1 protein] results in decreased expression of KRT20 protein; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in decreased expression of KRT20 protein]; MAPK14 protein promotes the reaction [Glucose results in decreased expression of KRT20 mRNA]; MAPK14 protein promotes the reaction [Glucose results in decreased expression of KRT20 protein]
Glucose results in increased expression of KRT20 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of KRT20 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of KRT20 mRNA
Glucose results in decreased expression of KRT20 mRNA; Glucose results in decreased expression of KRT20 protein 		CTD PMID:21829520 PMID:37567420 PMID:39922521 NCBI chr10:84,880,952...84,890,285
Ensembl chr10:84,880,952...84,890,285 		JBrowse link
G Krt5 keratin 5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of KRT5 mRNA CTD PMID:37567420 NCBI chr 7:134,724,840...134,730,569
Ensembl chr 7:134,724,840...134,730,569 		JBrowse link
G Kynu kynureninase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of KYNU mRNA CTD PMID:37567420 NCBI chr 3:48,188,286...48,338,996
Ensembl chr 3:48,188,182...48,339,014 		JBrowse link
G Lacc1 laccase domain containing 1 increases expression ISO Glucose results in increased expression of LACC1 mRNA CTD PMID:39613055 NCBI chr15:58,799,477...58,816,840
Ensembl chr15:58,786,637...58,816,840 		JBrowse link
G Lag3 lymphocyte activating 3 increases expression ISO Glucose results in increased expression of LAG3 mRNA CTD PMID:39922521 NCBI chr 4:159,398,930...159,407,001
Ensembl chr 4:159,398,932...159,406,669 		JBrowse link
G Lamb1 laminin subunit beta 1 multiple interactions ISO TXNIP promotes the reaction [Glucose results in increased expression of LAMB1 mRNA] CTD PMID:17178593 NCBI chr 6:53,562,849...53,630,118
Ensembl chr 6:53,563,073...53,630,760 		JBrowse link
G Lamb2 laminin subunit beta 2 multiple interactions ISO TXNIP promotes the reaction [Glucose results in increased expression of LAMB2 mRNA] CTD PMID:17178593 NCBI chr 8:118,056,899...118,069,090
Ensembl chr 8:118,056,935...118,069,090 		JBrowse link
G Lamb3 laminin subunit beta 3 multiple interactions ISO TXNIP promotes the reaction [Glucose results in increased expression of LAMB3 mRNA] CTD PMID:17178593 NCBI chr13:107,362,514...107,404,081
Ensembl chr13:107,322,526...107,404,081 		JBrowse link
G Lamc1 laminin subunit gamma 1 multiple interactions ISO TXNIP promotes the reaction [Glucose results in increased expression of LAMC1 mRNA] CTD PMID:17178593 NCBI chr13:67,924,872...68,051,986
Ensembl chr13:67,924,872...68,051,986 		JBrowse link
G Lamp1 lysosomal-associated membrane protein 1 increases expression EXP Glucose results in increased expression of LAMP1 protein CTD PMID:22253932 NCBI chr16:83,058,131...83,082,843
Ensembl chr16:83,058,385...83,075,159 		JBrowse link
G Lamp2 lysosomal-associated membrane protein 2 multiple interactions ISO [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of LAMP2 protein CTD PMID:21392095 NCBI chr  X:122,038,734...122,087,745
Ensembl chr  X:121,922,187...122,087,675 		JBrowse link
G Lax1 lymphocyte transmembrane adaptor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of LAX1 mRNA CTD PMID:37567420 NCBI chr13:47,686,840...47,697,396
Ensembl chr13:47,686,849...47,697,460 		JBrowse link
G Lca5l lebercilin LCA5 like multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of LCA5L mRNA CTD PMID:37567420 NCBI chr11:48,930,127...48,964,613
Ensembl chr11:48,930,127...48,964,551 		JBrowse link
G Lcat lecithin cholesterol acyltransferase increases expression ISO Glucose results in increased expression of LCAT mRNA CTD PMID:39922521 NCBI chr19:50,744,598...50,748,064
Ensembl chr19:50,744,601...50,748,081 		JBrowse link
G Lcn2 lipocalin 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LCN2 mRNA CTD PMID:37567420 NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842 		JBrowse link
G Lcp1 lymphocyte cytosolic protein 1 increases expression ISO Glucose results in increased expression of LCP1 mRNA CTD PMID:39613055 NCBI chr15:56,846,375...56,954,090
Ensembl chr15:56,847,433...56,954,092 		JBrowse link
G Lct lactase multiple interactions
increases hydrolysis 		EXP [Aspirin results in decreased activity of LCT protein] which results in decreased transport of Glucose; [nimesulide results in decreased activity of LCT protein] which results in decreased transport of Glucose
LCT protein results in increased hydrolysis of Glucose 		CTD PMID:14701853 PMID:16382204 NCBI chr13:42,334,347...42,376,872
Ensembl chr13:42,334,347...42,376,872 		JBrowse link
G Ldha lactate dehydrogenase A multiple interactions
increases activity
increases expression 		EXP
ISO 		LDHA protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
Glucose results in increased activity of LDHA protein
Glucose affects the reaction [Fusaric Acid results in increased expression of LDHA mRNA]; Panax notoginseng extract inhibits the reaction [Glucose results in increased activity of LDHA protein]
Glucose results in increased expression of LDHA protein 		CTD PMID:21124846 PMID:27566995 PMID:31654802 PMID:35385194 NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:106,502,182...106,517,521 		JBrowse link
G Ldhb lactate dehydrogenase B affects metabolic processing ISO LDHB protein affects the metabolism of Glucose CTD PMID:23437403 NCBI chr 4:177,159,389...177,177,408
Ensembl chr 4:177,159,392...177,177,408 		JBrowse link
G Ldhd lactate dehydrogenase D increases expression ISO Glucose results in increased expression of LDHD mRNA CTD PMID:31525975 NCBI chr19:56,492,827...56,497,695
Ensembl chr19:56,482,924...56,509,197 		JBrowse link
G Ldlr low density lipoprotein receptor multiple interactions ISO [LDLR gene mutant form results in increased susceptibility to Pravastatin] inhibits the reaction [Glucose results in increased secretion of INS1 protein] CTD PMID:26875785 NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675 		JBrowse link
G Lef1 lymphoid enhancer binding factor 1 multiple interactions
increases expression 		ISO DKK1 protein inhibits the reaction [Glucose results in increased expression of LEF1 mRNA] CTD PMID:29163160 NCBI chr 2:222,340,541...222,453,931
Ensembl chr 2:222,340,704...222,453,929 		JBrowse link
G Leng9 leukocyte receptor cluster member 9 decreases expression ISO Glucose results in decreased expression of LENG9 mRNA CTD PMID:39613055 NCBI chr 1:79,112,064...79,113,881
Ensembl chr 1:79,108,050...79,196,305 		JBrowse link
G Lep leptin multiple interactions
increases expression
increases secretion
increases response to substance 		EXP
ISO 		1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [[Glucose co-treated with INS1 protein] results in increased secretion of LEP protein]; [[Glucose co-treated with INS1 protein] results in increased abundance of Adenosine Triphosphate] which results in increased secretion of LEP protein; [Glucose co-treated with INS1 protein] results in increased secretion of LEP protein; argan oil inhibits the reaction [Glucose results in increased expression of LEP protein]; Calcium deficiency inhibits the reaction [[Glucose co-treated with INS1 protein] results in increased secretion of LEP protein]; Corn Oil inhibits the reaction [Glucose results in increased expression of LEP protein]; Diazoxide inhibits the reaction [[Glucose co-treated with INS1 protein] results in increased secretion of LEP protein]; INS1 protein promotes the reaction [Glucose results in increased expression of LEP mRNA]; INS1 protein promotes the reaction [Glucose results in increased secretion of LEP protein]; LEP promotes the reaction [Glucose results in increased secretion of INS1 protein]; naringin inhibits the reaction [Glucose results in increased expression of LEP protein]; nickel chloride inhibits the reaction [[Glucose co-treated with INS1 protein] results in increased secretion of LEP protein]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LEP mRNA; [LEP gene mutant form results in increased susceptibility to [Methionine co-treated with Choline]] which results in decreased abundance of Glucose
Glucose results in increased expression of LEP mRNA; Glucose results in increased expression of LEP protein
Glucose results in increased susceptibility to LEP protein
Glucose promotes the reaction [LEP protein results in increased chemical synthesis of Reactive Oxygen Species]; LEP protein promotes the reaction [Glucose results in increased chemical synthesis of Reactive Oxygen Species] 		CTD PMID:9751766 PMID:10780946 PMID:11342529 PMID:18627777 PMID:24399619 More... NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661 		JBrowse link
G Lepr leptin receptor decreases response to substance
increases expression
multiple interactions
affects abundance 		ISO
EXP 		LEPR results in decreased susceptibility to Glucose
Glucose results in increased expression of LEPR protein
naringin inhibits the reaction [Glucose results in increased expression of LEPR protein]
Hesperidin affects the reaction [LEPR protein affects the abundance of Glucose]; naringin affects the reaction [LEPR protein affects the abundance of Glucose]
LEPR affects the abundance of Glucose; LEPR protein affects the abundance of Glucose 		CTD PMID:16427799 PMID:20567778 PMID:24399619 NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:121,474,099...121,591,215 		JBrowse link
G Lgals3bp galectin 3 binding protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of LGALS3BP mRNA CTD PMID:37567420 NCBI chr10:104,118,510...104,127,848
Ensembl chr10:104,118,510...104,127,848 		JBrowse link
G Lgr5 leucine rich repeat containing G protein coupled receptor 5 increases expression ISO Glucose results in increased expression of LGR5 mRNA CTD PMID:39613055 NCBI chr 7:52,973,151...53,107,964
Ensembl chr 7:52,974,332...53,108,163 		JBrowse link
G Lhx9 LIM homeobox 9 increases expression ISO Glucose results in increased expression of LHX9 mRNA CTD PMID:39922521 NCBI chr13:52,941,207...52,961,436
Ensembl chr13:52,941,210...52,962,266 		JBrowse link
G Lif LIF, interleukin 6 family cytokine multiple interactions
increases expression 		ISO [Valsartan co-treated with Simvastatin] inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of LIF mRNA]]; Glucose promotes the reaction [AGT protein results in increased expression of LIF mRNA]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of LIF mRNA]]
Glucose results in increased expression of LIF mRNA 		CTD PMID:17178593 PMID:19225232 NCBI chr14:83,354,602...83,364,053
Ensembl chr14:83,358,164...83,364,053 		JBrowse link
G Lims2 LIM zinc finger domain containing 2 increases expression ISO Glucose results in increased expression of LIMS2 mRNA CTD PMID:39922521 NCBI chr18:23,828,164...23,866,363
Ensembl chr18:23,837,686...23,867,086 		JBrowse link
G Lin7b lin-7 homolog B, crumbs cell polarity complex component multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of LIN7B mRNA CTD PMID:37567420 NCBI chr 1:104,983,368...104,986,795
Ensembl chr 1:104,982,771...104,986,078 		JBrowse link
G Lipg lipase G, endothelial type decreases expression
increases expression 		ISO Glucose results in decreased expression of LIPG mRNA
Glucose results in increased expression of LIPG mRNA 		CTD PMID:17178593 PMID:39922521 NCBI chr18:70,790,077...70,811,259
Ensembl chr18:70,790,077...70,812,260 		JBrowse link
G Lipn lipase, family member N increases expression ISO Glucose results in increased expression of LIPN mRNA CTD PMID:31525975 NCBI chr 1:240,998,154...241,016,658
Ensembl chr 1:240,998,154...241,016,658 		JBrowse link
G Llcfc1 LLLL and CFNLAS motif containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of LLCFC1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LLCFC1 mRNA CTD PMID:37567420 NCBI chr 4:71,532,854...71,534,229
Ensembl chr 4:71,532,901...71,534,225 		JBrowse link
G Lmod1 leiomodin 1 increases expression ISO Glucose results in increased expression of LMOD1 mRNA CTD PMID:39922521 NCBI chr13:49,305,693...49,347,970
Ensembl chr13:49,305,830...49,348,116 		JBrowse link
G Lmod3 leiomodin 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of LMOD3 mRNA CTD PMID:37567420 NCBI chr 4:131,400,643...131,415,411
Ensembl chr 4:131,400,423...131,415,342 		JBrowse link
G Lonp1 lon peptidase 1, mitochondrial decreases expression
multiple interactions 		EXP Glucose results in decreased expression of LONP1 protein
LONP1 protein affects the reaction [SRT1720 inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of ACO2 protein]]; LONP1 protein affects the reaction [SRT1720 inhibits the reaction [Glucose results in decreased expression of LONP1 protein]]; SRT1720 inhibits the reaction [Glucose results in decreased expression of LONP1 protein] 		CTD PMID:31639451 NCBI chr 9:1,534,581...1,546,908
Ensembl chr 9:1,534,584...1,547,427 		JBrowse link
G Loxl1 lysyl oxidase-like 1 decreases expression ISO Glucose results in decreased expression of LOXL1 mRNA CTD PMID:39613055 NCBI chr 8:67,587,636...67,612,224
Ensembl chr 8:67,587,636...67,612,224 		JBrowse link
G Lpcat1 lysophosphatidylcholine acyltransferase 1 multiple interactions
decreases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of LPCAT1 mRNA] CTD PMID:33448797 NCBI chr 1:31,594,621...31,644,946
Ensembl chr 1:31,594,622...31,644,946 		JBrowse link
G Lpl lipoprotein lipase multiple interactions
decreases activity 		ISO LPL protein promotes the reaction [Fatty Acids results in increased uptake of Glucose]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of LPL mRNA
Glucose analog results in decreased activity of LPL protein 		CTD PMID:9414485 PMID:20628023 PMID:37567420 NCBI chr16:25,596,205...25,621,928
Ensembl chr16:25,596,211...25,622,107 		JBrowse link
G Lrch4 leucine rich repeats and calponin homology domain containing 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of LRCH4 mRNA CTD PMID:37567420 NCBI chr12:24,694,364...24,709,354
Ensembl chr12:24,694,370...24,706,412 		JBrowse link
G Lrp8 LDL receptor related protein 8 increases expression ISO Glucose results in increased expression of LRP8 mRNA CTD PMID:39922521 NCBI chr 5:127,792,236...127,864,207
Ensembl chr 5:127,792,299...127,864,207 		JBrowse link
G Lrrc26 leucine rich repeat containing 26 multiple interactions
decreases expression 		ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LRRC26 mRNA
Glucose results in decreased expression of LRRC26 mRNA 		CTD PMID:37567420 PMID:39613055 NCBI chr 3:28,500,517...28,501,843
Ensembl chr 3:28,500,517...28,501,843 		JBrowse link
G Lrrc34 leucine rich repeat containing 34 increases expression ISO Glucose results in increased expression of LRRC34 mRNA CTD PMID:39922521 NCBI chr 2:114,680,787...114,702,961
Ensembl chr 2:114,680,094...114,702,961 		JBrowse link
G Lrrc3b leucine rich repeat containing 3B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LRRC3B mRNA CTD PMID:37567420 NCBI chr15:12,404,309...12,481,618
Ensembl chr15:12,336,369...12,481,866 		JBrowse link
G Lrrc61 leucine rich repeat containing 61 multiple interactions
decreases methylation
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of LRRC61 mRNA]
Glucose results in decreased methylation of LRRC61 gene 		CTD PMID:33448797 NCBI chr 4:78,834,783...78,854,810
Ensembl chr 4:78,833,857...78,868,931 		JBrowse link
G Lrrc69 leucine rich repeat containing 69 increases expression ISO Glucose results in increased expression of LRRC69 mRNA CTD PMID:39922521 NCBI chr 5:32,820,840...32,979,176
Ensembl chr 5:32,820,840...32,979,375 		JBrowse link
G Lrrn1 leucine rich repeat neuronal 1 increases expression ISO Glucose results in increased expression of LRRN1 mRNA CTD PMID:39613055 NCBI chr 4:142,032,805...142,072,320
Ensembl chr 4:142,032,041...142,074,760 		JBrowse link
G Lrrn2 leucine rich repeat neuronal 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LRRN2 mRNA CTD PMID:37567420 NCBI chr13:46,874,048...46,934,544
Ensembl chr13:46,873,755...46,935,492 		JBrowse link
G Lrrtm1 leucine rich repeat transmembrane neuronal 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of LRRTM1 mRNA CTD PMID:37567420 NCBI chr 4:111,246,213...111,295,638
Ensembl chr 4:111,235,054...111,276,818 		JBrowse link
G Lsm11 LSM11, U7 small nuclear RNA associated increases expression ISO Glucose results in increased expression of LSM11 mRNA CTD PMID:39922521 NCBI chr10:30,869,168...30,887,275
Ensembl chr10:30,872,054...30,887,269 		JBrowse link
G Lst1 leukocyte specific transcript 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of LST1 mRNA CTD PMID:37567420 NCBI chr20:3,639,353...3,644,399
Ensembl chr20:3,639,341...3,642,669 		JBrowse link
G Ltc4s leukotriene C4 synthase multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of LTC4S mRNA] CTD PMID:33448797 NCBI chr10:35,060,002...35,066,466
Ensembl chr10:35,061,437...35,063,768 		JBrowse link
G Ly6a lymphocyte antigen 6 family member A increases expression ISO Glucose results in increased expression of LY6A mRNA CTD PMID:17178593 NCBI chr 7:109,064,222...109,067,757 JBrowse link
G Ly96 lymphocyte antigen 96 multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of LY96 mRNA] CTD PMID:33448797 NCBI chr 5:7,365,536...7,397,864
Ensembl chr 5:7,365,557...7,395,816 		JBrowse link
G Mafa MAF bZIP transcription factor A multiple interactions
affects expression
increases expression 		ISO
EXP 		3,4-dihydro-5-methyl-1(2H)-isoquinolinone inhibits the reaction [Glucose inhibits the reaction [MAFA protein binds to INS promoter]]; 3-aminobenzamide inhibits the reaction [Glucose inhibits the reaction [MAFA protein binds to INS promoter]]; Niacinamide inhibits the reaction [Glucose inhibits the reaction [MAFA protein binds to INS promoter]]
Glucose affects the expression of MAFA mRNA
Glucose results in increased expression of MAFA mRNA
IL1B protein inhibits the reaction [Glucose results in increased expression of MAFA mRNA]; lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of MAFA mRNA]; Palmitic Acid inhibits the reaction [Glucose results in increased expression of MAFA mRNA]; TLR4 affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of MAFA mRNA]]
3,4-dihydro-5-methyl-1(2H)-isoquinolinone inhibits the reaction [Glucose results in decreased expression of MAFA mRNA]; 3,4-dihydro-5-methyl-1(2H)-isoquinolinone inhibits the reaction [Glucose results in decreased expression of MAFA protein]; 3-aminobenzamide inhibits the reaction [Glucose results in decreased expression of MAFA mRNA]; 3-aminobenzamide inhibits the reaction [Glucose results in decreased expression of MAFA protein]; lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of MAFA mRNA] 		CTD PMID:16505238 PMID:22558381 PMID:24349266 NCBI chr 7:109,313,021...109,315,813
Ensembl chr 7:109,313,121...109,315,760 		JBrowse link
G Maff MAF bZIP transcription factor F increases expression ISO Glucose results in increased expression of MAFF mRNA CTD PMID:17178593 NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:112,791,416...112,804,147 		JBrowse link
G Magt1 magnesium transporter 1 decreases expression ISO Glucose results in decreased expression of MAGT1 mRNA CTD PMID:17178593 NCBI chr  X:75,104,040...75,145,247
Ensembl chr  X:75,106,172...75,145,365 		JBrowse link
G Mak male germ cell-associated kinase decreases expression
multiple interactions 		ISO Glucose results in decreased expression of MAK mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of MAK mRNA] 		CTD PMID:33448797 NCBI chr17:23,889,417...23,936,857
Ensembl chr17:23,889,516...23,936,855 		JBrowse link
G Mall mal, T-cell differentiation protein-like multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MALL mRNA CTD PMID:37567420 NCBI chr 3:135,381,180...135,404,136
Ensembl chr 3:135,377,410...135,404,066 		JBrowse link
G Mamdc2 MAM domain containing 2 decreases expression
multiple interactions
increases methylation 		ISO Glucose results in decreased expression of MAMDC2 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of MAMDC2 mRNA]
Glucose results in increased methylation of MAMDC2 gene 		CTD PMID:31525975 PMID:33448797 NCBI chr 1:230,290,482...230,443,014
Ensembl chr 1:230,290,499...230,442,711 		JBrowse link
G Maob monoamine oxidase B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of MAOB mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MAOB mRNA CTD PMID:37567420 NCBI chr  X:8,490,405...8,594,065
Ensembl chr  X:8,490,344...8,594,375 		JBrowse link
G Map1lc3a microtubule-associated protein 1 light chain 3 alpha increases expression EXP Glucose results in increased expression of MAP1LC3A mRNA CTD PMID:38444079 NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:164,243,093...164,244,850 		JBrowse link
G Map1lc3b microtubule-associated protein 1 light chain 3 beta multiple interactions
increases expression
decreases lipidation
decreases expression 		EXP
ISO 		3-methyladenine inhibits the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of MAP1LC3B protein]]; [Glucose co-treated with Lycopene] results in increased expression of MAP1LC3B mRNA; Berberine inhibits the reaction [Glucose results in decreased expression of MAP1LC3B protein]; Inositol inhibits the reaction [Glucose results in decreased lipidation of MAP1LC3B protein]; N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of MAP1LC3B protein]; Sirolimus promotes the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of MAP1LC3B protein]]; SRT1720 inhibits the reaction [Glucose results in decreased expression of MAP1LC3B protein]; ULK1 protein affects the reaction [Glucose results in decreased expression of MAP1LC3B protein]; ULK1 protein affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of MAP1LC3B protein]]
Glucose results in increased expression of MAP1LC3B mRNA
U 0126 inhibits the reaction [Glucose deficiency results in increased expression of MAP1LC3B protein modified form]
Glucose deficiency results in increased expression of MAP1LC3B protein; Glucose deficiency results in increased expression of MAP1LC3B protein modified form 		CTD PMID:29128638 PMID:34580807 PMID:35243728 PMID:38444079 PMID:39127087 NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358
Ensembl chr16:66,574,407...66,584,358 		JBrowse link
G Map2k6 mitogen-activated protein kinase kinase 6 multiple interactions ISO [MAP2K6 gene mutant form results in increased activity of MAP2K6 protein] which results in increased susceptibility to Glucose CTD PMID:27278863 NCBI chr10:95,872,747...95,987,747
Ensembl chr10:95,872,546...95,987,721 		JBrowse link
G Map3k1 mitogen-activated protein kinase kinase kinase 1 increases expression
multiple interactions 		ISO Glucose results in increased expression of MAP3K1 mRNA
[MAP3K1 gene mutant form results in increased activity of MAP3K1 protein] which results in increased susceptibility to Glucose
resveratrol inhibits the reaction [Glucose results in increased expression of MAP3K1 mRNA] 		CTD PMID:24659233 PMID:27278863 NCBI chr 2:45,081,889...45,150,555
Ensembl chr 2:45,081,889...45,149,897 		JBrowse link
G Map3k13 mitogen-activated protein kinase kinase kinase 13 increases methylation
multiple interactions
decreases expression 		ISO Glucose results in increased methylation of MAP3K13 gene
fucoxanthin inhibits the reaction [Glucose results in decreased expression of MAP3K13 mRNA] 		CTD PMID:33448797 NCBI chr11:92,596,436...92,741,717
Ensembl chr11:92,601,738...92,739,663 		JBrowse link
G Map3k4 mitogen activated protein kinase kinase kinase 4 increases expression
multiple interactions 		ISO Glucose results in increased expression of MAP3K4 mRNA
resveratrol inhibits the reaction [Glucose results in increased expression of MAP3K4 mRNA] 		CTD PMID:24659233 NCBI chr 1:50,977,870...51,067,117
Ensembl chr 1:50,979,586...51,067,117 		JBrowse link
G Map3k5 mitogen-activated protein kinase kinase kinase 5 increases expression
multiple interactions 		ISO Glucose results in increased expression of MAP3K5 protein
[[[[Glucose results in decreased expression of MIR17 mRNA] which results in increased expression of TXNIP mRNA] which results in increased expression of TXNIP protein] promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein; [Glucose promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein; Glucose results in increased phosphorylation of and results in increased activity of MAP3K5 protein
Glucose deficiency promotes the reaction [DAXX protein binds to MAP3K5 protein]; Glucose results in increased phosphorylation of and results in increased activity of MAP3K5 protein 		CTD PMID:14505347 PMID:16731828 PMID:26660634 NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:16,505,596...16,723,898 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
increases phosphorylation
increases expression
affects phosphorylation
increases activity
decreases phosphorylation 		ISO
EXP 		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]]; 4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; CAT inhibits the reaction [Glucose deficiency results in increased activity of MAPK1 protein]; Catechin inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; epigallocatechin gallate inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; EUK-134 inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; Fulvestrant inhibits the reaction [4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]]; Glucose deficiency results in increased expression of and results in increased phosphorylation of MAPK1 protein; Glucose promotes the reaction [Bupivacaine results in increased phosphorylation of MAPK1 protein]; Glucose results in increased phosphorylation of and results in increased activity of MAPK1 protein; Heparin analog inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; Luteolin inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; MIR1231 inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; Phytic Acid inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; Quercetin inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; Resveratrol inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; Rutin inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; Tetradecanoylphorbol Acetate inhibits the reaction [Glucose deficiency results in increased activity of MAPK1 protein]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of MAPK1 protein modified form]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; [sphingosine 1-phosphate co-treated with Glucose] results in increased expression of MAPK1 protein modified form; cinnamaldehyde inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; diphenyleneiodonium inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; diphenyliodonium inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; farrerol inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; Glucose results in increased phosphorylation of and results in increased activity of MAPK1 protein; Hydrogen Peroxide promotes the reaction [Glucose results in increased expression of MAPK1 protein modified form]; linderalactone inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; MAPK1 protein promotes the reaction [NRG1 protein results in increased transport of Glucose]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Quercetin promotes the reaction [Glucose results in increased expression of MAPK1 protein modified form]]; PRKCB protein affects the reaction [Glucose results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Quercetin promotes the reaction [Glucose results in increased expression of MAPK1 protein modified form]; Resveratrol inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; ruboxistaurin inhibits the reaction [Glucose results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Superoxides affects the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [Glucose results in increased expression of MAPK1 protein modified form]; U 0126 inhibits the reaction [Quercetin promotes the reaction [Glucose results in increased expression of MAPK1 protein modified form]]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased phosphorylation of and results in increased activity of MAPK1 protein]; 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of MAPK1 protein; CDK9 protein affects the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; Glucose inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK1 protein]; Glucose promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK1 protein]; Glucose results in increased phosphorylation of and results in increased activity of MAPK1 protein; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of MAPK1 protein]; Silymarin promotes the reaction [Glucose promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK1 protein]]; SOD1 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of MAPK1 protein]
Glucose affects the phosphorylation of MAPK1 protein
Glucose results in decreased phosphorylation of MAPK1 protein 		CTD PMID:14711829 PMID:16572112 PMID:17309078 PMID:18057711 PMID:18310510 More... NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825 		JBrowse link
G Mapk14 mitogen activated protein kinase 14 multiple interactions
decreases phosphorylation
increases activity 		ISO CAT inhibits the reaction [Glucose deficiency results in increased activity of MAPK14 protein]; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in decreased expression of CDH1 protein]; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in decreased expression of KRT20 protein]; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of ACTA2 protein]; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of VIM protein]; MAPK14 protein promotes the reaction [Glucose results in decreased expression of CDH1 protein]; MAPK14 protein promotes the reaction [Glucose results in decreased expression of KRT20 mRNA]; MAPK14 protein promotes the reaction [Glucose results in decreased expression of KRT20 protein]; MAPK14 protein promotes the reaction [Glucose results in increased expression of ACTA2 protein]; MAPK14 protein promotes the reaction [Glucose results in increased expression of SNAI1 mRNA]; MAPK14 protein promotes the reaction [Glucose results in increased expression of VIM mRNA]; MAPK14 protein promotes the reaction [Glucose results in increased secretion of FN1 protein]; Tetradecanoylphorbol Acetate inhibits the reaction [Glucose deficiency results in increased activity of MAPK14 protein]
[resveratrol co-treated with Glucose] results in decreased expression of MAPK14 mRNA; Glucose promotes the reaction [EIF2AK2 protein results in increased activity of MAPK14 protein]
Glucose results in decreased phosphorylation of MAPK14 protein 		CTD PMID:17309078 PMID:18973755 PMID:20200188 PMID:21829520 PMID:24659233 NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions
increases phosphorylation
increases expression
affects phosphorylation
decreases phosphorylation
increases activity 		ISO
EXP 		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]]; 4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; CAT inhibits the reaction [Glucose deficiency results in increased activity of MAPK3 protein]; Catechin inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; epigallocatechin gallate inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; EUK-134 inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; Fulvestrant inhibits the reaction [4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]]; Glucose deficiency results in increased expression of and results in increased phosphorylation of MAPK3 protein; Glucose promotes the reaction [Bupivacaine results in increased phosphorylation of MAPK3 protein]; Glucose results in increased phosphorylation of and results in increased activity of MAPK3 protein; Heparin analog inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; Luteolin inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; MIR1231 inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; Phytic Acid inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; Quercetin inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; Resveratrol inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; Rutin inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; Tetradecanoylphorbol Acetate inhibits the reaction [Glucose deficiency results in increased activity of MAPK3 protein]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of MAPK3 protein modified form]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; [sphingosine 1-phosphate co-treated with Glucose] results in increased expression of MAPK3 protein modified form; cinnamaldehyde inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; diphenyleneiodonium inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; diphenyliodonium inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; farrerol inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; Glucose results in increased phosphorylation of and results in increased activity of MAPK3 protein; Hydrogen Peroxide promotes the reaction [Glucose results in increased expression of MAPK3 protein modified form]; linderalactone inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; MAPK3 protein promotes the reaction [NRG1 protein results in increased transport of Glucose]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Quercetin promotes the reaction [Glucose results in increased expression of MAPK3 protein modified form]]; PRKCB protein affects the reaction [Glucose results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Quercetin promotes the reaction [Glucose results in increased expression of MAPK3 protein modified form]; Resveratrol inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; ruboxistaurin inhibits the reaction [Glucose results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Superoxides affects the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [Glucose results in increased expression of MAPK3 protein modified form]; U 0126 inhibits the reaction [Quercetin promotes the reaction [Glucose results in increased expression of MAPK3 protein modified form]]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased phosphorylation of and results in increased activity of MAPK3 protein]; 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of MAPK3 protein; CDK9 protein affects the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; Glucose inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK3 protein]; Glucose promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK3 protein]; Glucose results in increased phosphorylation of and results in increased activity of MAPK3 protein; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of MAPK3 protein]; Silymarin promotes the reaction [Glucose promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK3 protein]]; SOD1 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of MAPK3 protein]
Glucose affects the phosphorylation of MAPK3 protein
Glucose results in decreased phosphorylation of MAPK3 protein 		CTD PMID:14711829 PMID:16572112 PMID:17309078 PMID:18057711 PMID:18310510 More... NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411 		JBrowse link
G Mapk8 mitogen-activated protein kinase 8 increases phosphorylation
multiple interactions 		EXP
ISO 		Glucose results in increased phosphorylation of MAPK8 protein
[[Paraquat results in increased phosphorylation of MAPK8 protein] which results in decreased abundance of Insulin] which results in increased abundance of Glucose; Chlorogenic Acid inhibits the reaction [Glucose results in increased phosphorylation of MAPK8 protein]; linderalactone inhibits the reaction [Glucose results in increased phosphorylation of MAPK8 protein]; Metformin inhibits the reaction [Glucose results in increased phosphorylation of MAPK8 protein]; Scopoletin inhibits the reaction [Glucose results in increased phosphorylation of MAPK8 protein]
Anisomycin inhibits the reaction [rutecarpine inhibits the reaction [Glucose results in increased phosphorylation of MAPK8 protein]]; Glucose deficiency results in increased activity of and results in increased phosphorylation of MAPK8 protein; rutecarpine inhibits the reaction [Glucose results in increased phosphorylation of MAPK8 protein] 		CTD PMID:14505347 PMID:19861503 PMID:34801538 PMID:36394833 PMID:36928891 More... NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427 		JBrowse link
G Mapk9 mitogen-activated protein kinase 9 increases phosphorylation EXP Glucose results in increased phosphorylation of MAPK9 protein CTD PMID:19861503 NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228 		JBrowse link
G Mapt microtubule-associated protein tau multiple interactions
increases abundance 		ISO [amyloid beta-protein (1-42) binds to MAPT protein] which results in increased abundance of Glucose; PF-06840003 inhibits the reaction [[amyloid beta-protein (1-42) binds to MAPT protein] which results in increased abundance of Glucose]
PF-06840003 inhibits the reaction [MAPT protein mutant form results in increased abundance of Glucose] 		CTD PMID:39172838 NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108 		JBrowse link
G Mas1 MAS1 proto-oncogene, G protein-coupled receptor multiple interactions
decreases expression 		EXP
ISO 		NFE2L2 protein affects the reaction [Glucose results in decreased expression of MAS1 mRNA]; oltipraz inhibits the reaction [trigonelline inhibits the reaction [Glucose results in decreased expression of MAS1 mRNA]]; trigonelline inhibits the reaction [Glucose results in decreased expression of MAS1 mRNA]
CEBPB protein inhibits the reaction [Glucose results in decreased expression of MAS1 protein] 		CTD PMID:29211853 PMID:29266779 NCBI chr 1:50,428,064...50,459,537
Ensembl chr 1:50,425,257...50,500,561 		JBrowse link
G Mast1 microtubule associated serine/threonine kinase 1 increases expression ISO Glucose results in increased expression of MAST1 mRNA CTD PMID:39922521 NCBI chr19:40,121,271...40,149,073
Ensembl chr19:40,112,831...40,149,073 		JBrowse link
G Matk megakaryocyte-associated tyrosine kinase increases expression ISO Glucose results in increased expression of MATK mRNA CTD PMID:39922521 NCBI chr 7:9,107,711...9,116,864
Ensembl chr 7:9,107,722...9,112,746 		JBrowse link
G Mcub mitochondrial calcium uniporter dominant negative subunit beta multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MCUB mRNA CTD PMID:37567420 NCBI chr 2:221,153,525...221,223,814
Ensembl chr 2:221,153,525...221,223,814 		JBrowse link
G Mdh1 malate dehydrogenase 1 increases expression EXP
ISO 		Glucose results in increased expression of MDH1 mRNA
Glucose deficiency results in increased expression of MDH1 mRNA 		CTD PMID:24349266 PMID:26811028 NCBI chr14:99,831,934...99,847,227
Ensembl chr14:99,831,615...99,847,232 		JBrowse link
G Mdk midkine increases expression ISO Glucose results in increased expression of MDK protein CTD PMID:17607302 NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:98,356,789...98,358,743 		JBrowse link
G Me2 malic enzyme 2 multiple interactions ISO [imeglimin co-treated with Glucose] results in increased expression of ME2 mRNA CTD PMID:34588186 NCBI chr18:69,626,073...69,676,218
Ensembl chr18:69,626,087...69,676,218 		JBrowse link
G Mef2b myocyte enhancer factor 2B increases expression ISO Glucose results in increased expression of MEF2B mRNA CTD PMID:39922521 NCBI chr16:19,286,951...19,305,547
Ensembl chr16:19,286,953...19,302,910 		JBrowse link
G Meig1 meiosis/spermiogenesis associated 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MEIG1 mRNA CTD PMID:37567420 NCBI chr17:79,718,630...79,737,604
Ensembl chr17:79,723,811...79,737,533 		JBrowse link
G Meiob meiosis specific with OB-fold multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MEIOB mRNA CTD PMID:37567420 NCBI chr10:14,336,869...14,369,566
Ensembl chr10:14,338,288...14,369,565 		JBrowse link
G Mesp2 mesoderm posterior bHLH transcription factor 2 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of MESP2 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MESP2 mRNA 		CTD PMID:31525975 PMID:37567420 NCBI chr 1:143,165,914...143,168,520
Ensembl chr 1:143,165,849...143,168,511 		JBrowse link
G Mfap3 microfibril associated protein 3 multiple interactions EXP MFAP3 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr10:42,197,292...42,213,011
Ensembl chr10:42,197,275...42,210,988 		JBrowse link
G Mfap4 microfibril associated protein 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MFAP4 mRNA CTD PMID:37567420 NCBI chr10:46,666,552...46,669,613
Ensembl chr10:46,655,722...46,669,740 		JBrowse link
G Mfap5 microfibril associated protein 5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MFAP5 mRNA CTD PMID:37567420 NCBI chr 4:157,399,919...157,422,448
Ensembl chr 4:157,395,597...157,422,448 		JBrowse link
G Mff mitochondrial fission factor increases expression
multiple interactions 		ISO Glucose results in increased expression of MFF mRNA
[Glucose co-treated with Deferoxamine] results in increased expression of MFF mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of MFF mRNA] 		CTD PMID:33962019 NCBI chr 9:91,455,931...91,484,171
Ensembl chr 9:91,455,871...91,484,171 		JBrowse link
G Mfn1 mitofusin 1 decreases expression EXP
ISO 		Glucose results in decreased expression of MFN1 protein
Glucose results in decreased expression of MFN1 mRNA 		CTD PMID:27684054 PMID:33962019 NCBI chr 2:117,240,525...117,288,017
Ensembl chr 2:117,241,759...117,290,190 		JBrowse link
G Mfn2 mitofusin 2 multiple interactions
decreases expression
increases expression 		EXP
ISO 		[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of MFN2 protein; cinnamic acid inhibits the reaction [Glucose results in decreased expression of MFN2 protein]; Metformin inhibits the reaction [Glucose results in decreased expression of MFN2 protein]; Oxygen deficiency inhibits the reaction [Glucose results in increased expression of MFN2 protein]; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of MFN2 protein]; Sevoflurane inhibits the reaction [Oxygen deficiency inhibits the reaction [Glucose results in increased expression of MFN2 protein]]
[Glucose co-treated with Deferoxamine] results in decreased expression of MFN2 mRNA; Melatonin affects the reaction [[Glucose co-treated with Deferoxamine] results in decreased expression of MFN2 mRNA] 		CTD PMID:27684054 PMID:30144576 PMID:33962019 PMID:36806343 NCBI chr 5:163,587,463...163,617,363
Ensembl chr 5:163,587,463...163,618,495 		JBrowse link
G Mfrp membrane frizzled-related protein increases expression ISO Glucose results in increased expression of MFRP mRNA CTD PMID:39922521 NCBI chr 8:53,342,483...53,347,696
Ensembl chr 8:53,342,534...53,347,861 		JBrowse link
G Mfsd13b major facilitator superfamily domain containing 13B increases expression ISO Glucose results in increased expression of MFSD13B mRNA CTD PMID:39922521 NCBI chr 1:184,959,572...184,991,433
Ensembl chr 1:184,959,134...184,991,429 		JBrowse link
G Mfsd2a MFSD2 lysolipid transporter A, lysophospholipid multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of MFSD2A mRNA CTD PMID:37567420 NCBI chr 5:140,510,933...140,525,828
Ensembl chr 5:140,510,953...140,525,916 		JBrowse link
G Mfsd3 major facilitator superfamily domain containing 3 increases expression
multiple interactions 		ISO Glucose results in increased expression of MFSD3 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of MFSD3 mRNA] 		CTD PMID:33448797 NCBI chr 7:110,300,254...110,304,108
Ensembl chr 7:110,302,018...110,304,112 		JBrowse link
G Mgam maltase-glucoamylase multiple interactions ISO [MGAM protein results in increased metabolism of maltodextrin] which results in increased abundance of Glucose; [MGAM protein results in increased metabolism of Maltose] which results in increased abundance of Glucose CTD PMID:17585022 NCBI chr 4:70,408,263...70,568,752
Ensembl chr 4:70,408,263...70,568,752 		JBrowse link
G Miat myocardial infarction associated transcript multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of MIAT mRNA CTD PMID:37567420 NCBI chr12:50,075,026...50,090,259 JBrowse link
G Mief2 mitochondrial elongation factor 2 multiple interactions ISO [Glucose co-treated with Deferoxamine] results in increased expression of MIEF2 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of MIEF2 mRNA] CTD PMID:33962019 NCBI chr10:45,907,576...45,913,658
Ensembl chr10:45,908,706...45,913,658 		JBrowse link
G Mir106b microRNA 106b multiple interactions ISO HAGLR protein inhibits the reaction [MIR106B inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; HAGLR protein inhibits the reaction [MIR106B inhibits the reaction [Glucose results in increased expression of PTEN protein]]; MIR106B inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; MIR106B inhibits the reaction [Glucose results in increased expression of PTEN protein] CTD PMID:38088496 NCBI chr12:22,157,053...22,157,134 JBrowse link
G Mir122 microRNA 122 multiple interactions
increases expression 		ISO Resveratrol inhibits the reaction [Glucose results in increased expression of MIR122 mRNA] CTD PMID:38156429 NCBI chr18:61,028,817...61,028,901 JBrowse link
G Mir133a1 microRNA 133a-1 multiple interactions
increases expression 		ISO MIR133A1 affects the reaction [Glucose results in decreased chemical synthesis of INS protein]
Glucose results in increased expression of MIR133A1 mRNA 		CTD PMID:20520763 NCBI chr18:2,157,872...2,157,958 JBrowse link
G Mir135a2 microRNA 135a-2 multiple interactions EXP [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of MIR135A2 mRNA; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of HMOX1 mRNA]]; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]]; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NQO1 mRNA]]; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of HMOX1 mRNA]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NQO1 mRNA]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSK3B mRNA]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSK3B protein] CTD PMID:29719095 NCBI chr 7:28,499,166...28,499,265 JBrowse link
G Mir141 microRNA 141 increases expression ISO Glucose results in increased expression of MIR141 mRNA CTD PMID:26548909 NCBI chr 4:159,209,525...159,209,618 JBrowse link
G Mir142 microRNA 142 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of MIR142 mRNA
MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in decreased expression of BCL2 protein]]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased cleavage of CASP3 protein]]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of BAX protein]]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of COL1A1 protein]]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of COL4A1 protein]]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of FN1 protein]]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased secretion of IL1B protein]]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased secretion of IL6 protein]]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased secretion of TNF protein]]; MIR142 inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; MIR142 inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; MIR142 inhibits the reaction [Glucose results in increased expression of BAX protein]; MIR142 inhibits the reaction [Glucose results in increased expression of COL1A1 protein]; MIR142 inhibits the reaction [Glucose results in increased expression of COL4A1 protein]; MIR142 inhibits the reaction [Glucose results in increased expression of FN1 protein]; MIR142 inhibits the reaction [Glucose results in increased expression of SOX6 protein]; MIR142 inhibits the reaction [Glucose results in increased secretion of IL1B protein]; MIR142 inhibits the reaction [Glucose results in increased secretion of IL6 protein]; MIR142 inhibits the reaction [Glucose results in increased secretion of TNF protein]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased expression of BAX protein]]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased expression of COL1A1 protein]]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased expression of COL4A1 protein]]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased expression of FN1 protein]]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased secretion of IL1B protein]]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased secretion of IL6 protein]]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased secretion of TNF protein]]; TAOK1 mRNA alternative form affects the reaction [Glucose results in decreased expression of MIR142 mRNA] 		CTD PMID:38124441 NCBI chr10:73,055,104...73,055,190
Ensembl chr10:73,055,097...73,055,207 		JBrowse link
G Mir144 microRNA 144 multiple interactions ISO [MIR144 mRNA results in decreased expression of SMARCA4 protein] affects the susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of MIR144 mRNA; MIR144 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 mRNA]; MIR144 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NQO1 mRNA]; MIR144 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMARCA4 mRNA]; MIR144 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMARCA4 protein]; MIR144 mRNA promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein] CTD PMID:29457851 NCBI chr10:63,459,397...63,459,479
Ensembl chr10:63,459,397...63,459,479 		JBrowse link
G Mir145 microRNA 145 increases expression ISO Glucose results in increased expression of MIR145 mRNA CTD PMID:24223694 NCBI chr18:57,369,983...57,370,070 JBrowse link
G Mir146a microRNA 146a increases expression
decreases expression
multiple interactions 		ISO Glucose results in increased expression of MIR146A mRNA
Glucose results in decreased expression of MIR146 mRNA
Polyphenols inhibits the reaction [Glucose results in increased expression of MIR146A mRNA] 		CTD PMID:20520763 PMID:21682256 NCBI chr10:28,349,996...28,350,090 JBrowse link
G Mir148a microRNA 148a decreases expression ISO Glucose results in decreased expression of MIR148A mRNA CTD PMID:21682256 NCBI chr 4:81,664,431...81,664,527 JBrowse link
G Mir17 microRNA 17 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of MIR17 mRNA
[[[[Glucose results in decreased expression of MIR17 mRNA] which results in increased expression of TXNIP mRNA] which results in increased expression of TXNIP protein] promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein; [Glucose results in decreased expression of MIR17 mRNA] which results in increased expression of TXNIP mRNA; [Glucose results in decreased expression of MIR17 mRNA] which results in increased stability of TXNIP protein 		CTD PMID:26660634 NCBI chr15:98,587,848...98,587,931
Ensembl chr15:98,587,848...98,587,931 		JBrowse link
G Mir184 microRNA 184 increases expression EXP Glucose results in increased expression of MIR184 mRNA CTD PMID:31729781 NCBI chr 8:99,222,982...99,223,058 JBrowse link
G Mir186 microRNA 186 multiple interactions ISO [Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of MIR186 mRNA; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]]; MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HIF1A protein] CTD PMID:33759271 NCBI chr 2:249,241,650...249,241,735
Ensembl chr 2:249,241,650...249,241,735 		JBrowse link
G Mir195 microRNA 195 increases expression EXP Glucose results in increased expression of MIR195 mRNA CTD PMID:31729781 NCBI chr10:55,450,495...55,450,581
Ensembl chr10:55,450,495...55,450,581 		JBrowse link
G Mir200a microRNA 200a decreases expression ISO Glucose results in decreased expression of MIR200A mRNA CTD PMID:23776576 NCBI chr 5:171,930,717...171,930,805 JBrowse link
G Mir200b microRNA 200b decreases expression ISO Glucose results in decreased expression of MIR200B mRNA CTD PMID:23776576 NCBI chr 5:171,931,495...171,931,589 JBrowse link
G Mir200c microRNA 200c increases expression
multiple interactions 		ISO Glucose results in increased expression of MIR200C mRNA
MIR200C mRNA affects the reaction [Glucose results in increased cleavage of CASP1 protein]; MIR200C mRNA affects the reaction [Glucose results in increased cleavage of GSDMD protein]; MIR200C mRNA affects the reaction [Glucose results in increased secretion of IL18 protein]; MIR200C mRNA affects the reaction [Glucose results in increased secretion of IL1B protein]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased cleavage of CASP1 protein]]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased cleavage of GSDMD protein]]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased secretion of IL18 protein]]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased secretion of IL1B protein]] 		CTD PMID:35607288 NCBI chr 4:159,209,965...159,210,033 JBrowse link
G Mir210 microRNA 210 multiple interactions
increases expression 		ISO
EXP 		MIR210 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 mRNA]; MIR210 mRNA results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
Glucose results in increased expression of MIR210 mRNA 		CTD PMID:23108914 PMID:31729781 NCBI chr 1:205,755,923...205,756,032
Ensembl chr 1:205,755,917...205,756,034 		JBrowse link
G Mir217 microRNA 217 multiple interactions
decreases expression
increases expression 		EXP
ISO 		MIR217 mRNA affects the reaction [Glucose results in decreased expression of SIRT1 mRNA]; MIR217 mRNA affects the reaction [Glucose results in decreased expression of SIRT1 protein]; MIR217 mRNA affects the reaction [Glucose results in increased expression of CCN2 protein]; MIR217 mRNA affects the reaction [Glucose results in increased expression of EDN1 protein]; MIR217 mRNA affects the reaction [Glucose results in increased expression of FN1 protein]; MIR217 mRNA affects the reaction [Glucose results in increased expression of HIF1A mRNA]; MIR217 mRNA affects the reaction [Glucose results in increased expression of HIF1A protein]; MIR217 mRNA affects the reaction [Glucose results in increased expression of TGFB1 protein]; MIR217 mRNA affects the reaction [Glucose results in increased expression of VEGFA protein]
Glucose results in decreased expression of MIR217 mRNA
MIR217 mRNA inhibits the reaction [Glucose results in increased secretion of IL1B protein]; MIR217 mRNA inhibits the reaction [Glucose results in increased secretion of IL6 protein]; MIR217 mRNA inhibits the reaction [Glucose results in increased secretion of TNF protein]
Glucose results in increased expression of MIR217 mRNA 		CTD PMID:26891083 PMID:33283391 NCBI chr14:106,732,485...106,732,589
Ensembl chr14:106,732,485...106,732,589 		JBrowse link
G Mir23b microRNA 23b multiple interactions
decreases import 		ISO [[MIR23B mRNA binds to KCND2 3' UTR] which results in decreased expression of KCND2 protein] which results in decreased import of Glucose
MIR23B mRNA results in decreased import of Glucose 		CTD PMID:34418280 NCBI chr17:1,819,386...1,819,482 JBrowse link
G Mir27b microRNA 27b multiple interactions ISO MIR27B mRNA affects the reaction [Glucose results in increased expression of CCL2 protein]; MIR27B mRNA affects the reaction [Glucose results in increased expression of TNF protein]; SNHG1 affects the reaction [MIR27B mRNA affects the reaction [Glucose results in increased expression of CCL2 protein]]; SNHG1 affects the reaction [MIR27B mRNA affects the reaction [Glucose results in increased expression of TNF protein]] CTD PMID:36243327 NCBI chr17:1,819,147...1,819,243 JBrowse link
G Mir29a microRNA 29a multiple interactions EXP MIR29A mRNA inhibits the reaction [Glucose results in increased expression of CNR1 mRNA]; MIR29A mRNA inhibits the reaction [Glucose results in increased expression of CNR1 protein] CTD PMID:30642005 NCBI chr 4:60,617,955...60,618,042 JBrowse link
G Mir32 microRNA 32 decreases expression
increases expression 		EXP
ISO 		Glucose results in decreased expression of MIR32 mRNA
Glucose results in increased expression of MIR32 mRNA 		CTD PMID:31729781 PMID:32959695 NCBI chr 5:76,391,285...76,391,354 JBrowse link
G Mir322 microRNA 322 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of MIR322
MIR322 affects the reaction [Glucose results in increased cleavage of CASP3 protein]; tempol inhibits the reaction [Glucose results in decreased expression of MIR322] 		CTD PMID:25516495 NCBI chr  X:137,726,147...137,726,241 JBrowse link
G Mir331 microRNA 331 increases expression EXP Glucose results in increased expression of MIR331 mRNA CTD PMID:31729781 NCBI chr 7:30,414,386...30,414,481 JBrowse link
G Mir3588 microRNA 3588 decreases expression EXP Glucose results in decreased expression of MIR3588 mRNA CTD PMID:31729781 NCBI chr11:29,732,563...29,732,668 JBrowse link
G Mir466b-1 microRNA mir-466b-1 decreases expression EXP Glucose results in decreased expression of MIR466B-1 mRNA CTD PMID:31729781 NCBI chr17:72,945,493...72,945,578 JBrowse link
G Mir466d microRNA 466d decreases expression EXP Glucose results in decreased expression of MIR466D mRNA CTD PMID:31729781 NCBI chr17:72,913,004...72,913,096 JBrowse link
G Mir484 microRNA 484 increases expression EXP Glucose results in increased expression of MIR484 mRNA CTD PMID:31729781 NCBI chr10:1,394,905...1,394,981 JBrowse link
G Mir503 microRNA 503 increases expression EXP Glucose results in increased expression of MIR503 mRNA CTD PMID:31729781 NCBI chr  X:137,725,856...137,725,926 JBrowse link
G Mir6216 microRNA 6216 increases expression EXP Glucose results in increased expression of MIR6216 mRNA CTD PMID:31729781 NCBI chr 3:65,165,553...65,165,630 JBrowse link
G Mir99a microRNA 99a multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MIR99A mRNA CTD PMID:37567420 NCBI chr11:29,687,392...29,687,472
Ensembl chr11:29,687,392...29,687,472 		JBrowse link
G Mki67 marker of proliferation Ki-67 multiple interactions
increases expression
decreases expression
affects expression 		ISO [cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA; [cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 protein; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 protein]
Glucose results in increased expression of MKI67 protein
Glucose results in decreased expression of MKI67 mRNA
Glucose affects the expression of MKI67 protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MKI67 mRNA; alanosine inhibits the reaction [imeglimin promotes the reaction [Glucose results in increased expression of MKI67 protein]]; imeglimin promotes the reaction [Glucose results in increased expression of MKI67 protein] 		CTD PMID:25192544 PMID:37567420 PMID:39613055 PMID:40638403 NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593 		JBrowse link
G Mkrn2os MKRN2 opposite strand increases expression ISO Glucose results in increased expression of MKRN2OS mRNA CTD PMID:39922521 NCBI chr 4:150,317,116...150,327,559
Ensembl chr 4:150,316,991...150,325,689 		JBrowse link
G Mlx MAX dimerization protein MLX multiple interactions ISO Glucose promotes the reaction [MLX protein binds to TUG1 promoter] CTD PMID:32467232 NCBI chr10:86,519,517...86,524,607
Ensembl chr10:86,519,864...86,524,772 		JBrowse link
G Mlxip MLX interacting protein multiple interactions
affects localization 		ISO Glucose promotes the reaction [MLXIP protein binds to TUG1 promoter]
pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose affects the localization of MLXIP protein]; RELA protein affects the reaction [Glucose affects the localization of MLXIP protein]; SRI protein inhibits the reaction [Glucose affects the localization of MLXIP protein] 		CTD PMID:32467232 PMID:33930463 NCBI chr12:38,789,404...38,853,059
Ensembl chr12:38,789,404...38,853,059 		JBrowse link
G Mlxipl MLX interacting protein-like increases expression
multiple interactions 		EXP
ISO 		Glucose results in increased expression of MLXIPL protein
Glucose results in increased expression of MLXIPL mRNA alternative form
[Glucose co-treated with S 4048] results in increased expression of MLXIPL mRNA; Glucose promotes the reaction [MLXIPL protein binds to TUG1 promoter] 		CTD PMID:16644726 PMID:16790840 PMID:31974165 PMID:32467232 NCBI chr12:27,178,158...27,213,675
Ensembl chr12:27,178,158...27,213,660 		JBrowse link
G Mme membrane metallo-endopeptidase decreases expression
multiple interactions 		ISO Glucose results in decreased expression of MME mRNA
[MME protein results in increased cleavage of angiotensin I (1-7)] affects the reaction [Glucose results in increased secretion of INS1 protein]; MME protein affects the reaction [angiotensin I (1-7) promotes the reaction [Glucose results in increased secretion of INS1 protein]] 		CTD PMID:17178593 PMID:28559246 NCBI chr 2:149,806,826...149,957,381
Ensembl chr 2:149,872,291...149,953,463 		JBrowse link
G Mmp1 matrix metallopeptidase 1 multiple interactions
increases expression
decreases expression 		ISO CD14 protein affects the reaction [Glucose promotes the reaction [Lipopolysaccharides results in increased secretion of MMP1 protein]]
Glucose results in increased expression of MMP1 mRNA
Glucose inhibits the reaction [IL1B protein results in increased expression of MMP1 mRNA]; Glucose inhibits the reaction [IL1B protein results in increased expression of MMP1 protein]
Glucose results in decreased expression of MMP1 mRNA 		CTD PMID:18180316 PMID:30098273 PMID:31655124 PMID:39613055 NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:12,943,453...12,963,964 		JBrowse link
G Mmp12 matrix metallopeptidase 12 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MMP12 mRNA CTD PMID:37567420 NCBI chr 8:12,866,652...12,876,554
Ensembl chr 8:12,866,641...12,884,478 		JBrowse link
G Mmp14 matrix metallopeptidase 14 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of MMP14 protein
isoangustone A inhibits the reaction [Glucose results in decreased expression of MMP14 protein] 		CTD PMID:21367880 NCBI chr15:31,857,824...31,867,049
Ensembl chr15:31,857,546...31,869,893 		JBrowse link
G Mmp17 matrix metallopeptidase 17 increases expression ISO Glucose results in increased expression of MMP17 mRNA CTD PMID:39922521 NCBI chr12:32,710,504...32,735,418
Ensembl chr12:32,710,504...32,735,414 		JBrowse link
G Mmp19 matrix metallopeptidase 19 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MMP19 mRNA CTD PMID:37567420 NCBI chr 7:1,805,732...1,814,054
Ensembl chr 7:1,805,860...1,814,863 		JBrowse link
G Mmp2 matrix metallopeptidase 2 increases expression
decreases expression
multiple interactions
increases activity 		EXP
ISO 		Glucose results in increased expression of MMP2 mRNA; Glucose results in increased expression of MMP2 protein
Glucose results in decreased expression of MMP2 mRNA; Glucose results in decreased expression of MMP2 protein
Glucose promotes the reaction [Air Pollutants results in increased activity of MMP2 protein]; Glucose promotes the reaction [Air Pollutants results in increased expression of MMP2 mRNA]; Glucose promotes the reaction [Particulate Matter results in increased activity of MMP2 protein]; Glucose promotes the reaction [Particulate Matter results in increased expression of MMP2 mRNA]; SB 203580 inhibits the reaction [Glucose promotes the reaction [Air Pollutants results in increased activity of MMP2 protein]]; SB 203580 inhibits the reaction [Glucose promotes the reaction [Particulate Matter results in increased activity of MMP2 protein]]
Glucose results in increased activity of MMP2 protein
CEBPB protein inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of MMP2 protein]; Glucose results in decreased expression of and results in decreased activity of MMP2 protein; Resveratrol inhibits the reaction [Glucose results in increased activity of MMP2 protein]; Valsartan inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of MMP2 protein]
farrerol inhibits the reaction [Glucose results in decreased expression of MMP2 mRNA]; farrerol inhibits the reaction [Glucose results in decreased expression of MMP2 protein]; Rosiglitazone inhibits the reaction [Glucose results in increased expression of MMP2 mRNA]; Rosiglitazone inhibits the reaction [Glucose results in increased expression of MMP2 protein] 		CTD PMID:18665442 PMID:24659233 PMID:26179980 PMID:29266779 PMID:31838053 NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856 		JBrowse link
G Mmp21 matrix metallopeptidase 21 increases expression ISO Glucose results in increased expression of MMP21 mRNA CTD PMID:39922521 NCBI chr 1:197,910,178...197,915,847
Ensembl chr 1:197,910,178...197,915,847 		JBrowse link
G Mmp25 matrix metallopeptidase 25 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MMP25 mRNA CTD PMID:37567420 NCBI chr10:13,164,974...13,180,503
Ensembl chr10:13,164,977...13,180,503 		JBrowse link
G Mmp7 matrix metallopeptidase 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MMP7 mRNA CTD PMID:37567420 NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:13,133,043...13,140,755 		JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions
affects expression
decreases activity
decreases expression
increases expression 		ISO
EXP 		[Glucose co-treated with Particulate Matter] results in increased expression of and results in increased secretion of MMP9 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 protein; [Resveratrol co-treated with Glucose] results in decreased activity of MMP9 protein; Glucose promotes the reaction [Particulate Matter results in increased expression of MMP9 mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 protein]; U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 mRNA]; U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 protein]
Glucose affects the expression of MMP9 protein
Glucose deficiency results in decreased activity of MMP9 protein
Glucose results in decreased expression of MMP9 protein
Glucose results in increased expression of MMP9 mRNA
[Glucose co-treated with Resveratrol] results in decreased expression of MMP9 mRNA; Glucose promotes the reaction [Air Pollutants results in increased activity of MMP9 protein]; Glucose promotes the reaction [Air Pollutants results in increased expression of MMP9 mRNA]; Glucose promotes the reaction [JUN protein binds to MMP9 promoter]; Glucose promotes the reaction [PARP1 protein binds to MMP9 promoter]; Glucose promotes the reaction [Particulate Matter results in increased activity of MMP9 protein]; Glucose promotes the reaction [Particulate Matter results in increased expression of MMP9 mRNA]; Glucose promotes the reaction [RELA protein binds to MMP9 promoter]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose promotes the reaction [JUN protein binds to MMP9 promoter]]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose promotes the reaction [RELA protein binds to MMP9 promoter]]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased expression of MMP9 mRNA]; PARP1 protein affects the reaction [Glucose promotes the reaction [JUN protein binds to MMP9 promoter]]; PARP1 protein affects the reaction [Glucose promotes the reaction [RELA protein binds to MMP9 promoter]]; PARP1 protein affects the reaction [Glucose results in increased expression of MMP9 mRNA]; SB 203580 inhibits the reaction [Glucose promotes the reaction [Air Pollutants results in increased activity of MMP9 protein]]; SB 203580 inhibits the reaction [Glucose promotes the reaction [Particulate Matter results in increased activity of MMP9 protein]]; SIRT1 protein inhibits the reaction [Glucose promotes the reaction [PARP1 protein binds to MMP9 promoter]]
[Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of MMP9 protein]; farrerol inhibits the reaction [Glucose results in decreased expression of MMP9 mRNA]; farrerol inhibits the reaction [Glucose results in decreased expression of MMP9 protein]; Glucose affects the reaction [Azoxymethane affects the expression of MMP9 protein] 		CTD PMID:22467055 PMID:24064760 PMID:24659233 PMID:24682241 PMID:26179980 More... NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442 		JBrowse link
G Mnda myeloid cell nuclear differentiation antigen multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IFI204 mRNA CTD PMID:37567420 NCBI chr13:88,550,224...88,567,892
Ensembl chr13:88,550,228...88,566,537 		JBrowse link
G Mogat2 monoacylglycerol O-acyltransferase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MOGAT2 mRNA CTD PMID:37567420 NCBI chr 1:162,933,964...162,957,896
Ensembl chr 1:162,933,966...162,957,896 		JBrowse link
G Morc2 MORC family CW-type zinc finger 2 decreases expression ISO Glucose results in decreased expression of MORC2A mRNA CTD PMID:32467232 NCBI chr14:82,752,444...82,794,980
Ensembl chr14:82,752,018...82,794,979 		JBrowse link
G Morf4l2 mortality factor 4 like 2 multiple interactions EXP MORF4L2 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr  X:104,874,850...104,885,946
Ensembl chr  X:104,852,693...104,892,855 		JBrowse link
G Morn4 MORN repeat containing 4 multiple interactions EXP MORN4 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 1:250,837,639...250,847,943
Ensembl chr 1:250,837,643...250,848,026 		JBrowse link
G Mpo myeloperoxidase multiple interactions
increases expression 		EXP
ISO 		[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of MPO protein; Quercetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of MPO protein]
Glucose results in increased expression of MPO mRNA 		CTD PMID:23758074 PMID:32942007 NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056 		JBrowse link
G Mpst mercaptopyruvate sulfurtransferase decreases expression EXP Glucose deficiency results in decreased expression of MPST mRNA CTD PMID:35577173 NCBI chr 7:111,836,079...111,843,651
Ensembl chr 7:111,835,587...111,843,650 		JBrowse link
G Mpv17 mitochondrial inner membrane protein MPV17 increases expression ISO Glucose results in increased expression of MPV17 mRNA CTD PMID:32942007 NCBI chr 6:30,941,693...30,956,389
Ensembl chr 6:30,943,356...30,956,386 		JBrowse link
G Mpv17l MPV17 mitochondrial inner membrane protein like multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of MPV17L mRNA CTD PMID:37567420 NCBI chr10:2,495,605...2,532,448
Ensembl chr10:2,495,607...2,532,448 		JBrowse link
G Mrap melanocortin 2 receptor accessory protein multiple interactions
increases expression 		ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MRAP mRNA
Glucose results in increased expression of MRAP mRNA 		CTD PMID:37567420 PMID:39922521 NCBI chr11:43,477,382...43,489,118
Ensembl chr11:43,478,001...43,489,118 		JBrowse link
G Mras muscle RAS oncogene homolog increases activity
multiple interactions 		EXP Glucose results in increased activity of MRAS protein
manumycin inhibits the reaction [Glucose results in increased activity of MRAS protein]; Simvastatin inhibits the reaction [Glucose results in increased activity of MRAS protein] 		CTD PMID:18569938 NCBI chr 8:108,823,374...108,886,104
Ensembl chr 8:108,823,374...108,875,911 		JBrowse link
G Mro maestro multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of MRO mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of MRO mRNA CTD PMID:37567420 NCBI chr18:69,723,764...69,742,815
Ensembl chr18:69,725,798...69,743,031 		JBrowse link
G Mroh2a maestro heat-like repeat family member 2A increases expression ISO Glucose results in increased expression of MROH2A mRNA CTD PMID:39922521 NCBI chr 9:96,262,307...96,309,036
Ensembl chr 9:96,262,271...96,301,635 		JBrowse link
G Ms4a1 membrane spanning 4-domains A1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of MS4A1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MS4A1 mRNA CTD PMID:37567420 NCBI chr 1:217,331,274...217,351,934
Ensembl chr 1:217,331,274...217,343,447 		JBrowse link
G Ms4a6a membrane spanning 4-domains A6A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MS4A6C mRNA CTD PMID:37567420 NCBI chr 1:217,826,261...217,839,606
Ensembl chr 1:217,826,261...217,850,013 		JBrowse link
G Msantd1 Myb/SANT DNA binding domain containing 1 increases expression ISO Glucose results in increased expression of MSANTD1 mRNA CTD PMID:39922521 NCBI chr14:80,059,985...80,070,336
Ensembl chr14:80,059,288...80,069,002 		JBrowse link
G Msh4 mutS homolog 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of MSH4 mRNA CTD PMID:37567420 NCBI chr 2:245,445,118...245,504,493
Ensembl chr 2:245,452,240...245,503,358 		JBrowse link
G Msi1 musashi RNA-binding protein 1 increases expression ISO Glucose results in increased expression of MSI1 mRNA CTD PMID:39922521 NCBI chr12:46,815,225...46,911,852
Ensembl chr12:46,819,039...46,845,425 		JBrowse link
G Mslnl mesothelin-like increases expression ISO Glucose results in increased expression of MSLNL mRNA CTD PMID:39922521 NCBI chr10:15,260,084...15,276,190
Ensembl chr10:15,263,955...15,276,490 		JBrowse link
G Msr1 macrophage scavenger receptor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MSR1 mRNA CTD PMID:37567420 NCBI chr16:59,421,250...59,507,070
Ensembl chr16:59,421,057...59,507,070 		JBrowse link
G Mss51 MSS51 mitochondrial translational activator increases expression ISO Glucose results in increased expression of MSS51 mRNA CTD PMID:39922521 NCBI chr15:3,855,094...3,868,614
Ensembl chr15:3,855,478...3,868,611 		JBrowse link
G Mt-atp6 mitochondrially encoded ATP synthase membrane subunit 6 affects response to substance EXP ATP6 protein affects the susceptibility to Glucose CTD PMID:18273840 NCBI chr MT:7,919...8,599
Ensembl chr MT:7,904...8,584 		JBrowse link
G Mt-co1 mitochondrially encoded cytochrome c oxidase I multiple interactions EXP [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of COX1 protein CTD PMID:25997894 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,309...6,853 		JBrowse link
G Mt-co2 mitochondrially encoded cytochrome c oxidase II increases expression ISO Glucose deficiency results in increased expression of COX2 mRNA CTD PMID:26811028 NCBI chr MT:7,006...7,689
Ensembl chr MT:6,991...7,674 		JBrowse link
G Mt-cyb mitochondrially encoded cytochrome b multiple interactions
decreases expression 		ISO N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in decreased expression of CYTB mRNA]; PARP1 protein affects the reaction [Glucose results in decreased expression of CYTB mRNA] CTD PMID:28478229 NCBI chr MT:14,136...15,278
Ensembl chr MT:14,124...15,266 		JBrowse link
G Mt1a metallothionein 1A increases expression
multiple interactions
affects expression 		EXP
ISO 		Glucose results in increased expression of MT1A mRNA
Glucose inhibits the reaction [Cadmium results in increased expression of MT1A mRNA]
Glucose affects the expression of MT1A mRNA
manganese(III)-tetrakis(4-benzoic acid)porphyrin affects the reaction [Glucose affects the expression of MT1A mRNA]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Glucose results in increased expression of MT1A mRNA]; zinc chloride promotes the reaction [Glucose results in increased expression of MT1A mRNA] 		CTD PMID:22643931 PMID:23056475 PMID:39191366 NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200
Ensembl chr  X:79,695,809...79,696,200
Ensembl chr19:79,695,809...79,696,200 		JBrowse link
G Mt2 metallothionein 2 multiple interactions
increases expression 		EXP
ISO 		N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Glucose results in increased expression of MT2A mRNA]; zinc chloride promotes the reaction [Glucose results in increased expression of MT2A mRNA]
Glucose inhibits the reaction [Cadmium results in increased expression of MT2A mRNA] 		CTD PMID:23056475 PMID:39191366 NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709 		JBrowse link
G Mt3 metallothionein 3 decreases expression ISO Glucose results in decreased expression of MT3 mRNA CTD PMID:32942007 NCBI chr19:10,854,676...10,856,080
Ensembl chr19:10,854,677...10,856,080 		JBrowse link
G Mthfd2 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of MTHFD2 mRNA CTD PMID:37567420 NCBI chr 4:117,368,833...117,380,350
Ensembl chr 4:117,368,835...117,380,350 		JBrowse link
G Mtm1 myotubularin 1 decreases expression ISO Glucose results in decreased expression of MTM1 mRNA CTD PMID:17178593 NCBI chr 6:6,234,917...6,252,874
Ensembl chr 6:6,234,922...6,252,961 		JBrowse link
G Mtor mechanistic target of rapamycin kinase increases activity
decreases phosphorylation
increases phosphorylation
multiple interactions
decreases uptake
increases expression 		ISO
EXP 		Glucose results in increased activity of MTOR protein
Glucose results in decreased phosphorylation of MTOR protein
Glucose results in increased phosphorylation of MTOR protein
gastrodin inhibits the reaction [Glucose results in decreased phosphorylation of MTOR protein]; Resveratrol inhibits the reaction [Glucose results in increased phosphorylation of MTOR protein]
[Glucose promotes the reaction [MTOR protein binds to YY1 protein]] which results in increased expression of YY1 protein; FOXP1 protein inhibits the reaction [Glucose results in increased phosphorylation of MTOR protein]
MTOR gene mutant form results in decreased uptake of Glucose
Glucose results in increased expression of MTOR protein; Glucose results in increased expression of MTOR protein modified form
gastrodin inhibits the reaction [Glucose results in decreased phosphorylation of MTOR protein]; HU 308 inhibits the reaction [Glucose results in increased phosphorylation of MTOR protein]; Resveratrol inhibits the reaction [Glucose results in increased activity of MTOR protein] 		CTD PMID:19765649 PMID:22561310 PMID:28713934 PMID:29384525 PMID:30459625 More... NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435 		JBrowse link
G Mtx1 Metaxin 1 increases expression ISO Glucose results in increased expression of MTX1 mRNA CTD PMID:17178593 NCBI chr 2:176,913,225...176,919,148
Ensembl chr 2:176,913,225...176,918,824 		JBrowse link
G Muc16 mucin 16, cell surface associated multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of MUC16 mRNA CTD PMID:37567420 NCBI chr 8:24,440,840...24,644,494 JBrowse link
G Muc19 mucin 19, oligomeric multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of MUC19 mRNA CTD PMID:37567420 NCBI chr 7:124,897,424...125,018,582
Ensembl chr 7:124,897,424...125,018,582 		JBrowse link
G Muc5ac mucin 5AC, oligomeric mucus/gel-forming decreases expression ISO Glucose results in decreased expression of MUC5AC mRNA CTD PMID:39613055 NCBI chr 1:206,293,717...206,326,006
Ensembl chr 1:206,293,869...206,326,006 		JBrowse link
G Mx1 MX dynamin like GTPase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MX1 mRNA CTD PMID:37567420 NCBI chr11:50,269,056...50,294,699
Ensembl chr11:50,269,057...50,292,904 		JBrowse link
G Mxd1 max dimerization protein 1 multiple interactions
increases expression 		ISO Glucose promotes the reaction [MXD1 protein binds to TUG1 promoter]
Glucose results in increased expression of MXD1 mRNA 		CTD PMID:32467232 PMID:39922521 NCBI chr 4:120,654,731...120,678,972
Ensembl chr 4:120,654,731...120,675,129 		JBrowse link
G Mybl2 MYB proto-oncogene like 2 decreases expression ISO Glucose results in decreased expression of MYBL2 mRNA CTD PMID:39613055 NCBI chr 3:172,124,765...172,153,221
Ensembl chr 3:172,116,550...172,153,221 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions
increases expression
affects expression 		ISO
EXP 		Glucose affects the reaction [Dexamethasone results in increased expression of MYC mRNA]; Glucose affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of MYC mRNA]
Glucose results in increased expression of MYC protein
manganese(III)-tetrakis(4-benzoic acid)porphyrin affects the reaction [Glucose affects the expression of MYC mRNA]
MYC protein affects the reaction [Tetrachlorodibenzodioxin results in decreased uptake of Glucose] 		CTD PMID:2558650 PMID:11990355 PMID:22643931 PMID:33992720 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028 		JBrowse link
G Myd88 MYD88, innate immune signal transduction adaptor multiple interactions
increases expression 		EXP artesunate inhibits the reaction [Glucose results in increased expression of MYD88 protein] CTD PMID:30031708 NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:127,952,161...127,956,230 		JBrowse link
G Myh1 myosin heavy chain 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of MYH1 mRNA CTD PMID:37567420 NCBI chr10:52,384,810...52,408,698
Ensembl chr10:52,384,908...52,409,047 		JBrowse link
G Myh15 myosin, heavy chain 15 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MYH15 mRNA CTD PMID:37567420 NCBI chr11:65,084,666...65,226,010
Ensembl chr11:65,084,467...65,245,716 		JBrowse link
G Myh2 myosin heavy chain 2 multiple interactions ISO MYH2 protein affects the reaction [SLC2A4 protein results in increased uptake of Glucose] CTD PMID:18773891 NCBI chr10:52,355,739...52,382,235
Ensembl chr10:52,355,739...52,382,235 		JBrowse link
G Mylk myosin light chain kinase multiple interactions
increases expression
increases uptake 		ISO ML 7 inhibits the reaction [MYLK protein results in increased uptake of Glucose]; ML 9 inhibits the reaction [MYLK protein results in increased uptake of Glucose]
Glucose results in increased expression of MYLK mRNA; Glucose results in increased expression of MYLK protein
MYLK protein inhibits the reaction [Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN mRNA]]; Telmisartan inhibits the reaction [Glucose results in increased expression of MYLK mRNA]; Telmisartan inhibits the reaction [Glucose results in increased expression of MYLK protein] 		CTD PMID:18773891 PMID:34464088 NCBI chr11:79,288,243...79,535,450
Ensembl chr11:79,288,243...79,535,659 		JBrowse link
G Myo1a myosin IA increases expression ISO Glucose results in increased expression of MYO1A mRNA CTD PMID:39922521 NCBI chr 7:65,424,206...65,443,227
Ensembl chr 7:65,428,258...65,443,213 		JBrowse link
G Myo1f myosin IF decreases expression ISO Glucose results in decreased expression of MYO1F mRNA CTD PMID:39613055 NCBI chr 7:15,065,530...15,116,087
Ensembl chr 7:15,065,530...15,116,087 		JBrowse link
G Myo5a myosin VA multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of MYO5A mRNA CTD PMID:37567420 NCBI chr 8:84,692,524...84,860,564
Ensembl chr 8:84,692,910...84,856,265 		JBrowse link
G Myo7b myosin VIIb decreases expression
multiple interactions 		ISO Glucose results in decreased expression of MYO7B mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of MYO7B mRNA] 		CTD PMID:31525975 PMID:33448797 NCBI chr18:23,862,533...23,944,081
Ensembl chr18:23,862,533...23,944,049 		JBrowse link
G Myoc myocilin increases expression ISO Glucose results in increased expression of MYOC mRNA CTD PMID:39922521 NCBI chr13:77,509,963...77,520,361
Ensembl chr13:77,509,963...77,520,361 		JBrowse link
G Myom3 myomesin 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of MYOM3 mRNA CTD PMID:37567420 NCBI chr 5:153,276,306...153,326,847
Ensembl chr 5:153,276,261...153,326,839 		JBrowse link
G Mzb1 marginal zone B and B1 cell-specific protein increases expression ISO Glucose results in increased expression of MZB1 mRNA CTD PMID:39922521 NCBI chr18:27,513,087...27,515,148
Ensembl chr18:27,513,089...27,515,182 		JBrowse link
G Nalcn sodium leak channel, non-selective multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of NALCN mRNA CTD PMID:37567420 NCBI chr15:106,805,209...107,148,837
Ensembl chr15:106,805,209...107,147,858 		JBrowse link
G Nampt nicotinamide phosphoribosyltransferase decreases expression
increases expression
multiple interactions
increases secretion 		ISO
EXP 		Glucose results in decreased expression of NAMPT mRNA
Glucose results in increased expression of NAMPT mRNA
imeglimin promotes the reaction [Glucose results in increased expression of NAMPT mRNA]
Diazoxide inhibits the reaction [Glucose results in increased secretion of NAMPT protein]; Nifedipine inhibits the reaction [Glucose results in increased secretion of NAMPT protein] 		CTD PMID:20068143 PMID:23536823 PMID:33606677 NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:55,151,926...55,189,544 		JBrowse link
G Nanp N-acetylneuraminic acid phosphatase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of NANP mRNA CTD PMID:37567420 NCBI chr 3:160,289,269...160,302,001
Ensembl chr 3:160,288,830...160,302,002 		JBrowse link
G Napa NSF attachment protein alpha decreases expression ISO Glucose deficiency results in decreased expression of NAPA protein CTD PMID:22314686 NCBI chr 1:85,915,088...85,934,054
Ensembl chr 1:85,915,119...85,934,053 		JBrowse link
G Nat2 N-acetyltransferase 2 increases expression
multiple interactions
increases activity 		ISO Glucose results in increased expression of NAT2 mRNA; Glucose results in increased expression of NAT2 protein
[2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine affects the activity of NAT2 polymorphism] which affects the chemical synthesis of Glucose; [2-amino-3,4-dimethylimidazo(4,5-f)quinoline affects the activity of NAT2 polymorphism] which affects the chemical synthesis of Glucose; [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline affects the activity of NAT2 polymorphism] which affects the chemical synthesis of Glucose
Glucose results in increased activity of NAT2 protein 		CTD PMID:36156098 PMID:37423373 NCBI chr16:26,974,874...27,005,191
Ensembl chr16:26,974,601...26,976,304 		JBrowse link
G Nat8l N-acetyltransferase 8-like increases expression ISO Glucose results in increased expression of NAT8L mRNA CTD PMID:39922521 NCBI chr14:80,980,629...80,987,264
Ensembl chr14:80,980,629...80,987,463 		JBrowse link
G Nbea neurobeachin decreases expression ISO Glucose results in decreased expression of NBEA mRNA CTD PMID:17178593 NCBI chr 2:141,930,147...142,489,172
Ensembl chr 2:141,930,147...142,489,172 		JBrowse link
G Ncapg non-SMC condensin I complex, subunit G multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of NCAPG mRNA CTD PMID:37567420 NCBI chr14:69,616,473...69,645,445
Ensembl chr14:69,616,473...69,645,445 		JBrowse link
G Ncf1 neutrophil cytosolic factor 1 multiple interactions
increases phosphorylation
increases expression
affects localization 		ISO
EXP 		acetovanillone inhibits the reaction [Glucose results in increased expression of and results in increased activity of NCF1 protein]; bisindolylmaleimide I inhibits the reaction [Glucose affects the localization of NCF1 protein]; Glucose results in increased expression of and results in increased activity of NCF1 protein; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of NCF1 protein]; PRKAA1 protein affects the reaction [Rosiglitazone inhibits the reaction [Glucose affects the localization of NCF1 protein]]; Rosiglitazone inhibits the reaction [Glucose affects the localization of NCF1 protein]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of NCF1 mRNA
Glucose results in increased phosphorylation of NCF1 protein
Glucose results in increased expression of NCF1 mRNA; Glucose results in increased expression of NCF1 protein
[[[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1 protein; [[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of and results in increased phosphorylation of NCF1 protein]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of NCF1 protein]]; Glucose results in increased expression of and results in increased phosphorylation of NCF1 protein; Glucose results in increased phosphorylation of and affects the localization of NCF1 protein; NCF1 protein promotes the reaction [Glucose results in increased chemical synthesis of Reactive Oxygen Species]; NCF1 protein promotes the reaction [Glucose results in increased expression of FN1 protein]; PRKCB protein affects the reaction [Glucose results in increased phosphorylation of and affects the localization of NCF1 protein]; puerarin inhibits the reaction [Glucose results in increased phosphorylation of and affects the localization of NCF1 protein]; pyrazolanthrone inhibits the reaction [Glucose results in increased expression of NCF1 protein]; Resveratrol inhibits the reaction [[[[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of NCF1 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of NCF1 protein]; Resveratrol inhibits the reaction [Glucose results in increased phosphorylation of NCF1 protein] 		CTD PMID:12821678 PMID:17320767 PMID:17916771 PMID:18088078 PMID:19854265 More... NCBI chr12:28,121,816...28,131,080
Ensembl chr12:28,121,366...28,131,079 		JBrowse link
G Ncf2 neutrophil cytosolic factor 2 multiple interactions
increases expression 		EXP dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of NCF2 protein]]; Glucose results in increased phosphorylation of and affects the localization of NCF2 protein; PRKCB protein affects the reaction [Glucose results in increased phosphorylation of and affects the localization of NCF2 protein]; puerarin inhibits the reaction [Glucose results in increased phosphorylation of and affects the localization of NCF2 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of NCF2 protein] CTD PMID:19854265 PMID:26054749 NCBI chr13:67,505,492...67,536,015
Ensembl chr13:67,505,375...67,536,149 		JBrowse link
G Ncf4 neutrophil cytosolic factor 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of NCF4 mRNA CTD PMID:37567420 NCBI chr 7:111,705,926...111,723,893
Ensembl chr 7:111,706,520...111,723,898 		JBrowse link
G Nckap5 NCK-associated protein 5 increases expression ISO Glucose results in increased expression of NCKAP5 mRNA CTD PMID:31525975 NCBI chr13:39,922,576...40,835,849
Ensembl chr13:39,922,737...40,835,521 		JBrowse link
G Ncor1 nuclear receptor co-repressor 1 multiple interactions ISO Glucose promotes the reaction [NCOR1 protein binds to SRI promoter]; NCOR1 protein affects the reaction [Glucose results in decreased expression of SRI protein] CTD PMID:33930463 NCBI chr10:47,498,852...47,641,612
Ensembl chr10:47,498,852...47,640,350 		JBrowse link
G Ncr1 natural cytotoxicity triggering receptor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of NCR1 mRNA CTD PMID:37567420 NCBI chr 1:78,657,409...78,665,255
Ensembl chr 1:78,659,262...78,703,273 		JBrowse link
G Ndel1 nudE neurodevelopment protein 1-like 1 increases expression ISO Glucose results in increased expression of NDEL1 mRNA CTD PMID:17178593 NCBI chr10:54,001,435...54,080,909
Ensembl chr10:54,016,149...54,062,375 		JBrowse link
G Ndrg2 NDRG family member 2 multiple interactions EXP
ISO 		[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of NDRG2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NDRG2 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NDRG2 protein; NDRG2 protein affects the susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]; TP53 protein affects the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NDRG2]
NDRG2 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein] 		CTD PMID:23451161 NCBI chr15:27,074,481...27,087,376
Ensembl chr15:27,074,481...27,083,125 		JBrowse link
G Ndufb8 NADH:ubiquinone oxidoreductase subunit B8 multiple interactions EXP [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of NDUFB8 protein CTD PMID:25997894 NCBI chr 1:253,357,878...253,362,936
Ensembl chr 1:253,357,841...253,362,936 		JBrowse link
G Nedd4l NEDD4 like E3 ubiquitin protein ligase decreases phosphorylation EXP Glucose results in decreased phosphorylation of NEDD4L protein CTD PMID:31729781 NCBI chr18:60,663,918...60,996,824
Ensembl chr18:60,663,970...60,996,824 		JBrowse link
G Nek2 NIMA-related kinase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of NEK2 mRNA CTD PMID:37567420 NCBI chr13:105,936,809...105,950,054
Ensembl chr13:105,936,788...105,950,056 		JBrowse link
G Neurl1b neuralized E3 ubiquitin protein ligase 1B decreases expression ISO Glucose results in decreased expression of NEURL1B mRNA CTD PMID:39613055 NCBI chr10:17,258,317...17,289,362
Ensembl chr10:17,258,328...17,289,362 		JBrowse link
G Neurog2 neurogenin 2 increases expression ISO Glucose results in increased expression of NEUROG2 mRNA CTD PMID:39922521 NCBI chr 2:218,767,205...218,769,772
Ensembl chr 2:218,765,949...218,769,784 		JBrowse link
G Nfe2 nuclear factor, erythroid 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of NFE2 mRNA CTD PMID:37567420 NCBI chr 7:136,261,234...136,273,850
Ensembl chr 7:136,261,236...136,268,585 		JBrowse link
G Nfe2l1 NFE2 like bZIP transcription factor 1 multiple interactions
increases expression 		ISO benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Glucose results in increased expression of NFE2L1 protein]; Glucose promotes the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of NFE2L1 protein]
Glucose results in increased expression of NFE2L1 mRNA; Glucose results in increased expression of NFE2L1 protein 		CTD PMID:33838154 NCBI chr10:82,296,824...82,309,472
Ensembl chr10:82,292,508...82,309,375 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 increases expression
affects localization
multiple interactions
decreases expression
affects response to substance
increases localization 		ISO
EXP 		Glucose deficiency results in increased expression of NFE2L2 mRNA; Glucose deficiency results in increased expression of NFE2L2 protein; Glucose results in increased expression of NFE2L2; Glucose results in increased expression of NFE2L2 mRNA; Glucose results in increased expression of NFE2L2 protein
Glucose affects the localization of NFE2L2 protein
4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits the reaction [[Glucose co-treated with gastrodin] affects the localization of NFE2L2 protein]; [Glucose co-treated with gastrodin] affects the localization of NFE2L2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and affects the localization of NFE2L2 protein; diallyl trisulfide promotes the reaction [Glucose results in increased expression of and affects the localization of NFE2L2 protein]; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and affects the localization of NFE2L2 protein]; Glucose results in increased expression of and affects the localization of NFE2L2 protein; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]]; Inositol inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]; KEAP1 protein inhibits the reaction [diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and affects the localization of NFE2L2 protein]]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]; NFE2L2 mutant form inhibits the reaction [diallyl trisulfide inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; NFE2L2 protein affects the reaction [Exenatide inhibits the reaction [Hydrogen Peroxide inhibits the reaction [Glucose results in increased secretion of INS1 protein]]]; NFE2L2 protein affects the reaction [gastrodin inhibits the reaction [Glucose results in decreased activity of CAT protein]]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan inhibits the reaction [Glucose results in increased secretion of INS1 protein]]]; NFE2L2 protein affects the reaction [Glucose results in decreased expression of ACE2 mRNA]; NFE2L2 protein affects the reaction [Glucose results in decreased expression of MAS1 mRNA]; NFE2L2 protein affects the reaction [Glucose results in increased expression of ACE mRNA]; NFE2L2 protein affects the reaction [Glucose results in increased expression of AGT mRNA]; NFE2L2 protein affects the reaction [Glucose results in increased expression of NQO1 mRNA]; NFE2L2 protein mutant form affects the reaction [plumbagin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; NFE2L2 protein promotes the reaction [diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; NFE2L2 protein promotes the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; NFE2L2 protein promotes the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PARP1 protein modified form]]; NFE2L2 protein promotes the reaction [diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of KEAP1 protein]]; NFE2L2 protein promotes the reaction [diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and affects the localization of NFE2L2 protein]]; oltipraz inhibits the reaction [trigonelline inhibits the reaction [Glucose results in increased expression of NFE2L2 protein]]; Quercetin inhibits the reaction [Glucose results in decreased expression of NFE2L2 mRNA]; Quercetin inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]; SRT1720 inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]; trigonelline inhibits the reaction [Glucose results in increased expression of NFE2L2 protein]
Glucose results in decreased expression of NFE2L2 mRNA; Glucose results in decreased expression of NFE2L2 protein
NFE2L2 protein affects the susceptibility to Glucose
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]]; [imeglimin co-treated with Glucose] promotes the reaction [Thapsigargin results in increased expression of NFE2L2 mRNA]; [Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Glucose results in increased expression of NFE2L2 protein]; NFE2L2 mutant form inhibits the reaction [Berberine inhibits the reaction [Glucose results in increased abundance of Reactive Oxygen Species]]; Particulate Matter inhibits the reaction [[Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]]; Phytic Acid inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]; Rosiglitazone inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]; solanesol inhibits the reaction [Glucose results in decreased expression of NFE2L2 mRNA]; solanesol inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]; spiraeoside inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]; Vehicle Emissions inhibits the reaction [[Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]]
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NFE2L2 mRNA]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NFE2L2 protein]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NFE2L2 mRNA]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NFE2L2 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [SMARCA4A protein affects the reaction [Glucose affects the localization of NFE2L2 protein]]; 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits the reaction [[Glucose co-treated with gastrodin] affects the localization of NFE2L2 protein]; [Glucose co-treated with gastrodin] affects the localization of NFE2L2 protein; [Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NFE2L2 mRNA; [Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NFE2L2 protein; [NFE2L2 protein binds to TXNIP promoter] inhibits the reaction [Glucose results in increased expression of TXNIP mRNA]; [NFE2L2 protein co-treated with KEAP1 protein] affects the abundance of Glucose; [NFE2L2 protein mutant form co-treated with Streptozocin] results in increased abundance of Glucose; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NFE2L2 mRNA]]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NFE2L2 protein]]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NFE2L2 mRNA]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NFE2L2 protein]; NFE2L2 mutant form inhibits the reaction [Glucose deficiency promotes the reaction [Simvastatin results in increased expression of HMOX1 mRNA]]; NFE2L2 protein affects the reaction [gastrodin inhibits the reaction [Glucose results in decreased activity of CAT protein]]; NFE2L2 protein affects the reaction [SMARCA4A protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]]; NFE2L2 protein inhibits the reaction [Glucose results in increased expression of TXNIP mRNA]; SMARCA4A protein affects the reaction [Glucose affects the localization of NFE2L2 protein]
Glucose deficiency results in increased localization of NFE2L2 protein 		CTD PMID:17928392 PMID:20028456 PMID:20086057 PMID:20103708 PMID:21333731 More... NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090 		JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 increases expression
multiple interactions 		ISO Glucose results in increased expression of NFKB1 mRNA; Glucose results in increased expression of NFKB1 protein
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NFKB1 protein; Glucose results in increased activity of and affects the localization of NFKB1 protein; INO 1001 inhibits the reaction [Glucose results in increased activity of and affects the localization of NFKB1 protein]; NFKB1 protein inhibits the reaction [SOD1 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTGS2 protein]]; SOD1 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and results in increased activity of NFKB1 protein]
[Glucose results in increased susceptibility to sodium arsenite] which results in increased expression of NFKB1 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NFKB1 mRNA; Polyphenols inhibits the reaction [Glucose results in increased expression of NFKB1 mRNA] 		CTD PMID:16395278 PMID:17065336 PMID:18180316 PMID:21682256 PMID:28264687 More... NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088 		JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions
increases phosphorylation
increases expression
decreases expression 		ISO
EXP 		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased phosphorylation of NFKBIA protein]; Catechin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of NFKBIA protein]; epigallocatechin gallate inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of NFKBIA protein]; Glucose results in increased degradation of and results in decreased expression of NFKBIA protein; Luteolin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of NFKBIA protein]; Quercetin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of NFKBIA protein]; Rutin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of NFKBIA protein]; SB 203580 inhibits the reaction [Glucose results in increased phosphorylation of NFKBIA protein]
Glucose results in increased expression of NFKBIA protein; Glucose results in increased expression of NFKBIA protein modified form
Glucose results in decreased expression of NFKBIA protein
3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Glucose results in decreased expression of NFKBIA protein]; [Glucose co-treated with IGF2R protein modified form] results in decreased expression of NFKBIA protein; [Glucose co-treated with IGF2R protein modified form] results in decreased expression of NFKBIA protein modified form; Glucose results in increased phosphorylation of and results in increased degradation of NFKBIA protein; prolinedithiocarbamate inhibits the reaction [Glucose results in decreased expression of NFKBIA protein]; pyrazolanthrone inhibits the reaction [Glucose results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; Quercetin inhibits the reaction [Glucose results in increased expression of NFKBIA protein modified form]; Quercetin inhibits the reaction [Glucose results in increased expression of NFKBIA protein]; Resveratrol inhibits the reaction [Glucose results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; Resveratrol inhibits the reaction [Glucose results in increased phosphorylation of NFKBIA protein]; Sulfasalazine inhibits the reaction [Glucose results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; Y 27632 inhibits the reaction [Glucose results in decreased expression of NFKBIA protein]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased degradation of NFKBIA protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of and results in increased degradation of NFKBIA protein; [Ribose co-treated with Glucose] results in increased phosphorylation of NFKBIA protein; acetovanillone inhibits the reaction [Glucose results in increased phosphorylation of NFKBIA protein]; INO 1001 inhibits the reaction [Glucose results in increased phosphorylation of NFKBIA protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased phosphorylation of NFKBIA protein]; Prodigiosin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased degradation of NFKBIA protein]; prolinedithiocarbamate inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased degradation of NFKBIA protein]
Glucose results in increased expression of NFKBIA mRNA 		CTD PMID:16395278 PMID:17065336 PMID:17178593 PMID:19132243 PMID:19557821 More... NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072 		JBrowse link
G Nfkbid NFKB inhibitor delta multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of NFKBID mRNA CTD PMID:37567420 NCBI chr 1:94,808,459...94,824,726
Ensembl chr 1:94,808,453...94,817,861 		JBrowse link
G Ngb neuroglobin increases expression ISO Glucose results in increased expression of NGB mRNA CTD PMID:39922521 NCBI chr 6:112,475,332...112,480,786
Ensembl chr 6:112,475,332...112,480,786 		JBrowse link
G Ngf nerve growth factor decreases activity
multiple interactions
decreases expression 		EXP
ISO 		Glucose results in decreased activity of NGF protein
formononetin inhibits the reaction [Glucose results in decreased expression of NGF mRNA]; formononetin inhibits the reaction [Glucose results in decreased secretion of and results in decreased expression of NGF protein]; Glucose results in decreased secretion of and results in decreased expression of NGF protein
Glucose results in decreased expression of NGF protein
Berberine inhibits the reaction [Glucose results in decreased expression of NGF protein] 		CTD PMID:19501110 PMID:23954465 PMID:37944786 NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834 		JBrowse link
G Nicol1 NELL2 interacting cell ontogeny regulator 1 decreases expression ISO Glucose results in decreased expression of NICOL1 mRNA CTD PMID:39613055 NCBI chr14:80,992,697...80,994,213
Ensembl chr14:80,992,697...80,994,213 		JBrowse link
G Nkd2 NKD inhibitor of WNT signaling pathway 2 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of NKD2 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of NKD2 mRNA] 		CTD PMID:33448797 NCBI chr 1:31,268,856...31,299,390
Ensembl chr 1:31,272,519...31,299,387 		JBrowse link
G Nkg7 natural killer cell granule protein 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of NKG7 mRNA CTD PMID:37567420 NCBI chr 1:102,981,497...102,982,564
Ensembl chr 1:102,981,450...102,982,562 		JBrowse link
G Nkpd1 NTPase, KAP family P-loop domain containing 1 multiple interactions
increases expression 		ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of NKPD1 mRNA
Glucose results in increased expression of NKPD1 mRNA 		CTD PMID:37567420 PMID:39922521 NCBI chr 1:88,293,626...88,303,117
Ensembl chr 1:88,295,091...88,302,224 		JBrowse link
G Nkx6-1 NK6 homeobox 1 multiple interactions ISO NKX6-1 protein promotes the reaction [Glucose results in increased secretion of INS protein] CTD PMID:18347054 NCBI chr14:8,274,238...8,281,171
Ensembl chr14:8,274,238...8,281,163 		JBrowse link
G Nlgn3 neuroligin 3 increases expression ISO Glucose results in increased expression of NLGN3 mRNA CTD PMID:39922521 NCBI chr  X:70,469,251...70,497,380
Ensembl chr  X:70,469,457...70,497,379 		JBrowse link
G Nlrc5 NLR family, CARD domain containing 5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of NLRC5 mRNA CTD PMID:37567420 NCBI chr19:10,483,601...10,587,223
Ensembl chr19:10,483,755...10,555,786 		JBrowse link
G Nlrp3 NLR family, pyrin domain containing 3 multiple interactions
increases expression
increases response to substance 		ISO
EXP 		[Glucose co-treated with TGFB1 protein] results in increased expression of NLRP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NLRP3 protein; Allopurinol inhibits the reaction [Glucose results in increased expression of NLRP3 protein]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of NLRP3 protein]; bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NLRP3 protein]; HAGLR protein affects the reaction [Glucose results in increased expression of NLRP3 protein]; Lipopolysaccharides inhibits the reaction [swietenine inhibits the reaction [Glucose results in increased expression of NLRP3 protein]]; Lipopolysaccharides promotes the reaction [Glucose results in increased expression of NLRP3 protein]; loganin inhibits the reaction [Glucose results in increased expression of NLRP3 mRNA]; loganin inhibits the reaction [Glucose results in increased expression of NLRP3 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Glucose results in increased expression of NLRP3 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide promotes the reaction [swietenine inhibits the reaction [Glucose results in increased expression of NLRP3 protein]]; PTEN protein affects the reaction [HAGLR protein affects the reaction [Glucose results in increased expression of NLRP3 protein]]; pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased expression of NLRP3 protein]; pyrrolidine dithiocarbamic acid promotes the reaction [swietenine inhibits the reaction [Glucose results in increased expression of NLRP3 protein]]; Quercetin inhibits the reaction [Glucose results in increased expression of NLRP3 protein]; swietenine inhibits the reaction [Glucose results in increased expression of NLRP3 protein]
NLRP3 protein results in increased susceptibility to Glucose
diphenyleneiodonium inhibits the reaction [Glucose promotes the reaction [Particulate Matter results in increased expression of NLRP3 protein]]; Glucose promotes the reaction [Particulate Matter results in increased expression of NLRP3 mRNA]; Glucose promotes the reaction [Particulate Matter results in increased expression of NLRP3 protein]; imeglimin inhibits the reaction [Glucose results in increased expression of NLRP3 protein]; NLRP3 protein promotes the reaction [Glucose results in decreased expression of TJP1 protein]; NLRP3 protein promotes the reaction [Glucose results in decreased expression of TJP2 protein]; NLRP3 protein promotes the reaction [Glucose results in increased secretion of HMGB1 protein]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NLRP3 protein; Allopurinol inhibits the reaction [Glucose results in increased expression of NLRP3 protein]; Artesunate inhibits the reaction [Glucose results in increased expression of NLRP3 protein]; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NLRP3 protein]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Glucose results in increased expression of NLRP3 protein]; prolinedithiocarbamate inhibits the reaction [Glucose results in increased expression of NLRP3 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of NLRP3 protein]; rhodioloside inhibits the reaction [Glucose results in increased expression of NLRP3 protein]
Glucose results in increased expression of NLRP3 mRNA; Glucose results in increased expression of NLRP3 protein 		CTD PMID:23647015 PMID:27783111 PMID:29031534 PMID:30031708 PMID:35191607 More... NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,828,014...44,853,394 		JBrowse link
G Nmu neuromedin U decreases methylation
increases expression 		ISO Glucose results in decreased methylation of NMU promoter
Glucose results in increased expression of NMU mRNA 		CTD PMID:31525975 NCBI chr14:32,198,789...32,226,397
Ensembl chr14:32,198,943...32,226,632 		JBrowse link
G Nnt nicotinamide nucleotide transhydrogenase affects response to substance
decreases metabolic processing 		ISO NNT protein affects the susceptibility to Glucose
NNT protein results in decreased metabolism of Glucose 		CTD PMID:23504317 NCBI chr 2:53,144,157...53,237,857
Ensembl chr 2:53,144,160...53,237,310 		JBrowse link
G Nobox NOBOX oogenesis homeobox multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of NOBOX mRNA CTD PMID:37567420 NCBI chr 4:73,128,926...73,134,431
Ensembl chr 4:73,127,925...73,134,630 		JBrowse link
G Nog noggin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of NOG mRNA CTD PMID:37567420 NCBI chr10:74,625,874...74,627,501
Ensembl chr10:74,625,875...74,628,103 		JBrowse link
G Nol6 nucleolar protein 6 multiple interactions EXP NOL6 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 5:61,055,863...61,083,249
Ensembl chr 5:61,055,863...61,083,264 		JBrowse link
G Nono non-POU domain containing, octamer-binding affects metabolic processing ISO NONO gene mutant form affects the metabolism of Glucose CTD PMID:29358041 NCBI chr  X:70,594,116...70,611,976
Ensembl chr  X:70,593,888...70,611,979 		JBrowse link
G Nos1 nitric oxide synthase 1 decreases expression
multiple interactions 		ISO Glucose deficiency results in decreased expression of NOS1 protein
Nitroprusside inhibits the reaction [Glucose deficiency results in decreased expression of NOS1 protein] 		CTD PMID:17855661 NCBI chr12:44,276,011...44,456,371
Ensembl chr12:44,287,614...44,371,837 		JBrowse link
G Nos2 nitric oxide synthase 2 increases expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of NOS2 mRNA; Glucose results in increased expression of NOS2 protein
[Glucose co-treated with IGF2R protein modified form] results in decreased expression of NOS2 protein; [Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of NOS2 protein]; [Oxygen co-treated with Glucose] promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOS2 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOS2 protein; PRKCB protein affects the reaction [Glucose results in increased expression of NOS2 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of NOS2 mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of NOS2 protein]; ruboxistaurin inhibits the reaction [Glucose results in increased expression of NOS2 protein]
SOD1 protein inhibits the reaction [Glucose results in increased expression of NOS2 mRNA]; SOD1 protein inhibits the reaction [Glucose results in increased expression of NOS2 protein]
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased expression of NOS2 mRNA]; [Glucose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOS2 protein; CDK9 protein affects the reaction [Glucose results in increased expression of NOS2 mRNA]; Prodigiosin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOS2 protein]; prolinedithiocarbamate inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOS2 protein]; Silymarin inhibits the reaction [[Glucose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein] 		CTD PMID:19587355 PMID:21925195 PMID:22363694 PMID:22425406 PMID:22467055 More... NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880 		JBrowse link
G Nos3 nitric oxide synthase 3 multiple interactions
increases O-linked glycosylation
decreases phosphorylation
increases expression
decreases expression 		ISO
EXP 		2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Rosiglitazone inhibits the reaction [[Glucose results in decreased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased phosphorylation of NOS3 protein]]; [Glucose results in decreased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide; [salvianolic acid co-treated with Glucose] inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in decreased phosphorylation of NOS3 protein]; acetovanillone inhibits the reaction [Glucose results in decreased expression of NOS3 protein]; cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of NOS3 protein]; Glucose inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in decreased phosphorylation of NOS3 protein]; Glucose results in increased expression of and results in increased activity of NOS3 protein; Nitroprusside inhibits the reaction [Glucose deficiency results in decreased expression of NOS3 protein]; Resveratrol inhibits the reaction [Glucose results in decreased expression of NOS3 mRNA]; Rosiglitazone inhibits the reaction [[Glucose results in decreased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide]; Rosiglitazone inhibits the reaction [Glucose results in decreased phosphorylation of NOS3 protein]; salvianolic acid inhibits the reaction [Glucose results in decreased phosphorylation of NOS3 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of NOS3 mRNA]]; TRPM7 affects the reaction [Glucose results in decreased expression of NOS3 protein]; U 0126 inhibits the reaction [TRPM7 affects the reaction [Glucose results in decreased expression of NOS3 protein]]; Wortmannin inhibits the reaction [Rosiglitazone inhibits the reaction [[Glucose results in decreased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide]]; Wortmannin inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased phosphorylation of NOS3 protein]]
Glucose results in increased O-linked glycosylation of NOS3 protein
Glucose results in increased expression of NOS3 mRNA; Glucose results in increased expression of NOS3 protein
Glucose results in decreased expression of and results in decreased phosphorylation of NOS3 protein; pimagedine inhibits the reaction [Glucose results in decreased expression of and results in decreased phosphorylation of NOS3 protein]
Glucose deficiency results in decreased expression of NOS3 protein; Glucose results in decreased expression of NOS3 mRNA; Glucose results in decreased expression of NOS3 protein 		CTD PMID:10502298 PMID:11696579 PMID:15490108 PMID:17075048 PMID:17090780 More... NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664 		JBrowse link
G Nox1 NADPH oxidase 1 multiple interactions
increases expression 		ISO Glucose results in increased expression of and results in increased activity of NOX1 protein; resveratrol inhibits the reaction [Glucose results in increased expression of and results in increased activity of NOX1 protein]; resveratrol inhibits the reaction [Glucose results in increased expression of NOX1 mRNA] CTD PMID:23731528 NCBI chr  X:101,572,338...101,625,571
Ensembl chr  X:101,572,340...101,595,520 		JBrowse link
G Nox4 NADPH oxidase 4 multiple interactions
increases expression 		EXP
ISO 		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of NOX4 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOX4 mRNA; Antigen-Antibody Complex inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOX4 mRNA]; diphenyliodonium inhibits the reaction [Glucose results in increased expression of NOX4 protein]; farrerol inhibits the reaction [Glucose results in increased expression of NOX4 mRNA]; farrerol inhibits the reaction [Glucose results in increased expression of NOX4 protein]
Glucose results in increased expression of NOX4 mRNA; Glucose results in increased expression of NOX4 protein
[Glucose co-treated with TGFB1 protein] results in increased expression of NOX4 protein; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of NOX4 protein]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of NOX4 protein] 		CTD PMID:29702141 PMID:31494106 PMID:31838053 PMID:35961541 NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:150,313,728...150,491,483 		JBrowse link
G Noxred1 NADP-dependent oxidoreductase domain containing 1 increases expression ISO Glucose results in increased expression of NOXRED1 mRNA CTD PMID:39922521 NCBI chr 6:112,593,296...112,619,113
Ensembl chr 6:112,592,353...112,619,081 		JBrowse link
G Npas3 neuronal PAS domain protein 3 decreases expression ISO Glucose results in decreased expression of NPAS3 mRNA CTD PMID:31525975 NCBI chr 6:76,438,064...77,263,185
Ensembl chr 6:76,438,260...77,263,185 		JBrowse link
G Npc1l1 NPC1 like intracellular cholesterol transporter 1 increases expression ISO Glucose results in increased expression of NPC1L1 mRNA CTD PMID:39922521 NCBI chr14:85,285,387...85,305,050
Ensembl chr14:85,285,390...85,305,050 		JBrowse link
G Nphs1 NPHS1 adhesion molecule, nephrin decreases expression
multiple interactions 		ISO Glucose results in decreased expression of NPHS1 protein
Oxamic Acid inhibits the reaction [Glucose results in decreased expression of NPHS1 protein]; Rotenone promotes the reaction [Glucose results in decreased expression of NPHS1 protein] 		CTD PMID:39922521 NCBI chr 1:94,848,261...94,876,522
Ensembl chr 1:94,848,261...94,876,521 		JBrowse link
G Nppa natriuretic peptide A multiple interactions
increases expression 		EXP cinnamic acid inhibits the reaction [Glucose results in increased expression of NPPA protein]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of NPPA mRNA]]; linderalactone inhibits the reaction [Glucose results in increased expression of NPPA mRNA]; Metformin inhibits the reaction [Glucose results in increased expression of NPPA protein]; NPPA protein inhibits the reaction [SLC5A2 protein results in increased uptake of Glucose]; Propofol inhibits the reaction [Glucose results in increased expression of NPPA mRNA]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of NPPA mRNA]]
Glucose results in increased expression of NPPA mRNA; Glucose results in increased expression of NPPA protein 		CTD PMID:15127950 PMID:24810525 PMID:30144576 PMID:37757635 NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:163,712,184...163,713,493 		JBrowse link
G Nppb natriuretic peptide B multiple interactions
increases expression 		EXP linderalactone inhibits the reaction [Glucose results in increased expression of NPPB mRNA] CTD PMID:37757635 NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:163,699,839...163,701,310 		JBrowse link
G Npr1 natriuretic peptide receptor 1 increases expression ISO Glucose results in increased expression of NPR1 mRNA CTD PMID:31655124 NCBI chr 2:178,231,766...178,247,591
Ensembl chr 2:178,231,766...178,247,088 		JBrowse link
G Npy neuropeptide Y decreases expression
multiple interactions
increases expression 		EXP
ISO 		Glucose results in decreased expression of NPY mRNA; Glucose results in decreased expression of NPY protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of NPY mRNA
17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the reaction [Dexamethasone inhibits the reaction [Glucose results in increased expression of NPY protein]]; Dexamethasone inhibits the reaction [Glucose results in increased expression of NPY protein]
Glucose deficiency results in increased expression of NPY mRNA; Glucose results in increased expression of NPY protein 		CTD PMID:11177238 PMID:16210367 PMID:18627777 PMID:31778773 PMID:37567420 NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:80,212,111...80,219,310 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases expression
decreases expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of NQO1 mRNA; Glucose results in increased expression of NQO1 protein
Glucose results in decreased expression of NQO1 mRNA; Glucose results in decreased expression of NQO1 protein
solanesol inhibits the reaction [Glucose results in decreased expression of NQO1 mRNA]; solanesol inhibits the reaction [Glucose results in decreased expression of NQO1 protein]
Glucose deficiency results in increased expression of NQO1 protein
[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NQO1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NQO1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NQO1 protein; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NQO1 mRNA]; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NQO1 protein]; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NQO1 mRNA]]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NQO1 mRNA]; NFE2L2 protein affects the reaction [Glucose results in increased expression of NQO1 mRNA]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein promotes the reaction [Glucose results in increased expression of NQO1 protein]]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NQO1 mRNA; MIR144 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NQO1 mRNA]; NQO1 gene mutant form promotes the reaction [Glucose results in increased chemical synthesis of Hydrogen Peroxide]; SMARCA4A protein promotes the reaction [Glucose results in increased expression of NQO1 protein] 		CTD PMID:17178593 PMID:27558805 PMID:29211853 PMID:29457851 PMID:29649567 More... NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260 		JBrowse link
G Nr0b2 nuclear receptor subfamily 0, group B, member 2 multiple interactions ISO [[ginsenoside Rg2 results in increased phosphorylation of GSK3B protein] co-treated with [ginsenoside Rg2 results in increased expression of NR0B2 mRNA]] results in decreased chemical synthesis of Glucose CTD PMID:22062806 NCBI chr 5:151,063,160...151,066,475
Ensembl chr 5:151,063,160...151,066,475 		JBrowse link
G Nr1d2 nuclear receptor subfamily 1, group D, member 2 decreases expression ISO Glucose results in decreased expression of NR1D2 mRNA CTD PMID:17178593 NCBI chr15:9,955,034...9,981,329
Ensembl chr15:9,954,906...9,981,330 		JBrowse link
G Nr1h2 nuclear receptor subfamily 1, group H, member 2 multiple interactions
decreases expression 		ISO morroniside inhibits the reaction [Glucose results in decreased expression of NR1H2 mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of NR1H2 protein]
Glucose results in decreased expression of NR1H2 mRNA; Glucose results in decreased expression of NR1H2 protein 		CTD PMID:34485530 NCBI chr 1:104,178,483...104,183,863
Ensembl chr 1:104,178,234...104,183,863 		JBrowse link
G Nr1h3 nuclear receptor subfamily 1, group H, member 3 multiple interactions
increases expression 		ISO
EXP 		Allopurinol inhibits the reaction [Glucose results in increased expression of NR1H3 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of NR1H3 protein] CTD PMID:23647015 NCBI chr 3:97,614,616...97,632,053
Ensembl chr 3:97,614,616...97,624,532 		JBrowse link
G Nr1h4 nuclear receptor subfamily 1, group H, member 4 affects expression ISO Glucose affects the expression of NR1H4 mRNA CTD PMID:36156098 NCBI chr 7:25,733,471...25,829,440
Ensembl chr 7:25,733,471...25,829,389 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 decreases activity
increases expression
decreases expression
multiple interactions 		ISO Glucose results in decreased activity of NR1I2 protein
Glucose results in increased expression of NR1I2 mRNA
Glucose results in decreased expression of NR1I2 mRNA
[Simvastatin co-treated with NR1I2 protein] results in increased secretion of Glucose; Ketoconazole inhibits the reaction [NR1I2 protein results in decreased uptake of and results in decreased metabolism of Glucose]; NR1I2 protein results in decreased uptake of and results in decreased metabolism of Glucose; Polyphenols inhibits the reaction [Glucose results in decreased activity of NR1I2 protein]; resveratrol inhibits the reaction [NR1I2 protein results in decreased uptake of and results in decreased metabolism of Glucose]; SGK2 mutant form inhibits the reaction [[Simvastatin co-treated with NR1I2 protein] results in increased secretion of Glucose] 		CTD PMID:21682256 PMID:22363694 PMID:24204015 PMID:26616219 PMID:36156098 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380 		JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 decreases metabolic processing ISO NR1I3 mRNA results in decreased metabolism of Glucose CTD PMID:32428594 NCBI chr13:86,165,327...86,170,362
Ensembl chr13:86,165,349...86,170,370 		JBrowse link
G Nr2f1 nuclear receptor subfamily 2, group F, member 1 multiple interactions ISO Glucose affects the reaction [NR2F1 protein binds to SHBG promoter] CTD PMID:17992261 NCBI chr 2:9,776,179...9,785,924
Ensembl chr 2:9,776,179...9,785,924 		JBrowse link
G Nr2f6 nuclear receptor subfamily 2, group F, member 6 decreases expression ISO Glucose results in decreased expression of NR2F6 mRNA CTD PMID:39613055 NCBI chr16:18,080,003...18,087,449
Ensembl chr16:18,080,003...18,087,449 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 multiple interactions ISO NR3C1 protein affects the metabolism of and affects the abundance of Glucose CTD PMID:15919808 NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843 		JBrowse link
G Nr4a2 nuclear receptor subfamily 4, group A, member 2 multiple interactions ISO [imeglimin co-treated with Glucose] results in increased expression of NR4A2 mRNA CTD PMID:34588186 NCBI chr 3:62,098,739...62,115,926
Ensembl chr 3:62,098,743...62,106,769 		JBrowse link
G Nrbp2 nuclear receptor binding protein 2 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of NRBP2 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of NRBP2 mRNA] 		CTD PMID:33448797 NCBI chr 7:109,679,330...109,685,656
Ensembl chr 7:109,679,330...109,685,588 		JBrowse link
G Nrf1 nuclear respiratory factor 1 multiple interactions EXP [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NRF1 protein; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NRF1 protein] CTD PMID:36806343 NCBI chr 4:59,632,366...59,738,166
Ensembl chr 4:59,632,372...59,738,353 		JBrowse link
G Nrg1 neuregulin 1 multiple interactions
increases transport 		EXP
ISO 		[NRG1 protein binds to ERBB3 protein] which results in increased transport of Glucose; MAPK1 protein promotes the reaction [NRG1 protein results in increased transport of Glucose]; MAPK3 protein promotes the reaction [NRG1 protein results in increased transport of Glucose]; PDK1 protein promotes the reaction [NRG1 protein results in increased transport of Glucose]; PRKCZ protein promotes the reaction [NRG1 protein results in increased transport of Glucose]; Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [NRG1 protein results in increased transport of Glucose]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of NRG1 mRNA 		CTD PMID:14711829 PMID:37567420 NCBI chr16:65,954,084...67,007,484
Ensembl chr16:65,953,865...66,999,849 		JBrowse link
G Nrip2 nuclear receptor interacting protein 2 decreases expression ISO Glucose results in decreased expression of NRIP2 mRNA CTD PMID:17178593 NCBI chr 4:163,359,592...163,370,144
Ensembl chr 4:163,360,665...163,370,141 		JBrowse link
G Nrip3 nuclear receptor interacting protein 3 increases expression ISO Glucose results in increased expression of NRIP3 mRNA CTD PMID:39922521 NCBI chr 1:173,224,532...173,249,829
Ensembl chr 1:173,224,532...173,251,769 		JBrowse link
G Nt5c1a 5'-nucleotidase, cytosolic IA multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of NT5C1A mRNA CTD PMID:37567420 NCBI chr 5:140,758,219...140,782,706
Ensembl chr 5:140,757,729...140,778,968 		JBrowse link
G Nt5dc2 5'-nucleotidase domain containing 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of NT5DC2 mRNA CTD PMID:37567420 NCBI chr16:6,328,925...6,336,978
Ensembl chr16:6,328,523...6,336,980 		JBrowse link
G Ntm neurotrimin increases expression
multiple interactions 		ISO Glucose results in increased expression of NTM mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of NTM mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of NTM mRNA; fucoxanthin inhibits the reaction [Glucose results in increased expression of NTM mRNA] 		CTD PMID:33448797 PMID:37567420 NCBI chr 8:35,634,929...36,625,081
Ensembl chr 8:35,635,640...36,624,807 		JBrowse link
G Nts neurotensin increases transport EXP NTS protein results in increased transport of Glucose CTD PMID:11208724 NCBI chr 7:39,451,484...39,460,888
Ensembl chr 7:39,451,073...39,460,961 		JBrowse link
G Nucb2 nucleobindin 2 decreases expression ISO Glucose results in decreased expression of NUCB2 mRNA CTD PMID:17178593 NCBI chr 1:180,185,121...180,221,644
Ensembl chr 1:180,199,551...180,230,116 		JBrowse link
G Nudt8 nudix hydrolase 8 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of NUDT8 mRNA CTD PMID:37567420 NCBI chr 1:210,723,209...210,724,717
Ensembl chr 1:210,723,209...210,725,638 		JBrowse link
G Nuf2 NUF2 component of NDC80 kinetochore complex multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of NUF2 mRNA CTD PMID:37567420 NCBI chr13:84,226,448...84,290,957
Ensembl chr13:84,226,509...84,255,598 		JBrowse link
G Nup210l nucleoporin 210-like increases expression ISO Glucose results in increased expression of NUP210L mRNA CTD PMID:39922521 NCBI chr 2:177,843,647...177,962,975
Ensembl chr 2:177,845,633...177,962,969 		JBrowse link
G Nupr1 nuclear protein 1, transcriptional regulator decreases abundance ISO NUPR1 results in decreased abundance of Glucose CTD PMID:16822955 NCBI chr 1:190,643,866...190,645,901
Ensembl chr 1:190,643,867...190,645,901 		JBrowse link
G Nutm1 NUT midline carcinoma, family member 1 decreases expression ISO Glucose results in decreased expression of NUTM1 mRNA CTD PMID:31525975 NCBI chr 3:119,507,908...119,518,709
Ensembl chr 3:119,507,908...119,526,185 		JBrowse link
G Nwd1 NACHT and WD repeat domain containing 1 increases expression ISO Glucose results in increased expression of NWD1 mRNA CTD PMID:39922521 NCBI chr16:17,204,731...17,278,184
Ensembl chr16:17,157,352...17,270,664 		JBrowse link
G Nxnl1 nucleoredoxin-like 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of NXNL1 mRNA CTD PMID:37567420 NCBI chr16:18,303,454...18,311,510
Ensembl chr16:18,304,991...18,312,957 		JBrowse link
G Nxpe3 neurexophilin and PC-esterase domain family, member 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of NXPE3 mRNA CTD PMID:37567420 NCBI chr11:58,195,951...58,246,739
Ensembl chr11:58,195,976...58,248,644 		JBrowse link
G Nxpe4 neurexophilin and PC-esterase domain family member 4 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of NXPE4 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of NXPE4 mRNA] 		CTD PMID:33448797 NCBI chr 8:57,399,199...57,640,629
Ensembl chr 8:57,631,895...57,644,186 		JBrowse link
G Nxph3 neurexophilin 3 increases expression ISO Glucose results in increased expression of NXPH3 mRNA CTD PMID:39922521 NCBI chr10:80,953,080...80,956,746
Ensembl chr10:80,952,227...80,956,668 		JBrowse link
G Nxph4 neurexophilin 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of NXPH4 mRNA CTD PMID:37567420 NCBI chr 7:65,253,043...65,261,864
Ensembl chr 7:65,252,904...65,261,864 		JBrowse link
G Oas1a 2'-5' oligoadenylate synthetase 1A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of OAS1G mRNA CTD PMID:37567420 NCBI chr12:41,330,423...41,341,130
Ensembl chr12:41,285,211...41,341,128 		JBrowse link
G Oas2 2'-5' oligoadenylate synthetase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of OAS2 mRNA CTD PMID:37567420 NCBI chr12:41,464,568...41,492,036
Ensembl chr12:41,467,315...41,495,881 		JBrowse link
G Oas3 2'-5'-oligoadenylate synthetase 3 multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of OAS3 mRNA] CTD PMID:33448797 NCBI chr12:41,439,645...41,463,392
Ensembl chr12:41,439,643...41,464,420 		JBrowse link
G Oasl 2'-5'-oligoadenylate synthetase-like multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of OASL1 mRNA CTD PMID:37567420 NCBI chr12:47,343,551...47,356,509
Ensembl chr12:47,343,551...47,356,483 		JBrowse link
G Oat ornithine aminotransferase multiple interactions EXP Glucose inhibits the reaction [Cyclic AMP results in increased activity of OAT protein] CTD PMID:2827574 NCBI chr 1:196,777,973...196,797,754
Ensembl chr 1:196,777,975...196,797,754 		JBrowse link
G Obscn obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF increases expression
multiple interactions 		ISO Glucose results in increased expression of OBSCN mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of OBSCN mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of OBSCN mRNA 		CTD PMID:31525975 PMID:37567420 NCBI chr10:44,273,686...44,419,275
Ensembl chr10:44,288,866...44,419,297 		JBrowse link
G Ocln occludin decreases expression
multiple interactions 		ISO Glucose results in decreased expression of OCLN mRNA; Glucose results in decreased expression of OCLN protein
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in decreased expression of OCLN protein]]; [ginsenoside Rg3 co-treated with Acetylcysteine] inhibits the reaction [Glucose results in decreased expression of OCLN protein]; Acetylcysteine inhibits the reaction [Glucose results in decreased expression of OCLN protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in decreased expression of OCLN protein]; MYLK protein inhibits the reaction [Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN mRNA]]; Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN mRNA]; Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN protein] 		CTD PMID:21617913 PMID:31655124 PMID:34464088 PMID:39579577 NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:33,391,303...33,430,411 		JBrowse link
G Oga O-GlcNAcase increases expression ISO Glucose results in increased expression of OGA mRNA CTD PMID:39613055 NCBI chr 1:254,547,311...254,589,596
Ensembl chr 1:254,547,311...254,582,855 		JBrowse link
G Ogt O-linked N-acetylglucosamine (GlcNAc) transferase decreases expression ISO Glucose results in decreased expression of OGT mRNA CTD PMID:17178593 NCBI chr  X:70,811,317...70,856,123
Ensembl chr  X:70,811,319...70,856,123 		JBrowse link
G Olfml1 olfactomedin-like 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of OLFML1 mRNA CTD PMID:37567420 NCBI chr 1:170,889,912...170,914,300
Ensembl chr 1:170,889,980...170,915,762 		JBrowse link
G Olr1 oxidized low density lipoprotein receptor 1 multiple interactions
increases expression 		ISO acetovanillone inhibits the reaction [Glucose results in increased expression of OLR1 mRNA] CTD PMID:19878672 NCBI chr 4:164,612,460...164,635,082
Ensembl chr 4:164,612,463...164,634,598 		JBrowse link
G Opa1 OPA1, mitochondrial dynamin like GTPase decreases expression
multiple interactions
increases expression 		EXP
ISO 		Glucose results in decreased expression of OPA1 protein
[Glucose co-treated with Deferoxamine] results in increased expression of OPA1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of OPA1 mRNA]
Glucose results in increased expression of OPA1 mRNA
[Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of OPA1 protein; Berberine inhibits the reaction [Glucose results in decreased expression of and results in decreased ubiquitination of OPA1 protein]; cinnamic acid inhibits the reaction [Glucose results in decreased expression of OPA1 protein]; Glucose results in decreased expression of and results in decreased ubiquitination of OPA1 protein; Metformin inhibits the reaction [Glucose results in decreased expression of OPA1 protein]; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of OPA1 protein] 		CTD PMID:27684054 PMID:30144576 PMID:33962019 PMID:36806343 PMID:39127087 NCBI chr11:84,612,943...84,690,025
Ensembl chr11:84,615,340...84,689,955 		JBrowse link
G Orc4 origin recognition complex, subunit 4 decreases expression ISO Glucose results in decreased expression of ORC4 mRNA CTD PMID:17178593 NCBI chr 3:53,700,046...53,743,293
Ensembl chr 3:53,703,615...53,742,264 		JBrowse link
G Otop1 otopetrin 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of OTOP1 mRNA CTD PMID:37567420 NCBI chr14:76,717,330...76,744,785
Ensembl chr14:76,716,329...76,744,785 		JBrowse link
G Ovol3 ovo-like zinc finger 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of OVOL3 mRNA CTD PMID:37567420 NCBI chr 1:94,612,417...94,616,053
Ensembl chr 1:94,612,417...94,616,053 		JBrowse link
G Oxr1 oxidation resistance 1 decreases expression ISO Glucose results in decreased expression of OXR1 mRNA CTD PMID:17178593 NCBI chr 7:74,413,609...74,850,487
Ensembl chr 7:74,413,590...74,850,487 		JBrowse link
G P2rx2 purinergic receptor P2X 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of P2RX2 mRNA CTD PMID:37567420 NCBI chr12:51,999,107...52,002,627
Ensembl chr12:51,999,372...52,002,627 		JBrowse link
G P2rx7 purinergic receptor P2X 7 increases expression
decreases expression 		EXP
ISO 		Glucose results in increased expression of P2RX7 mRNA
Glucose results in decreased expression of P2RX7 mRNA; Glucose results in decreased expression of P2RX7 protein 		CTD PMID:21832250 PMID:31702818 NCBI chr12:39,550,531...39,594,984
Ensembl chr12:39,540,567...39,595,193 		JBrowse link
G P2ry10 P2Y receptor family member 10 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of P2RY10 mRNA CTD PMID:37567420 NCBI chr  X:76,184,064...76,279,996
Ensembl chr  X:76,184,001...76,280,953 		JBrowse link
G P4ha1 prolyl 4-hydroxylase subunit alpha 1 increases expression ISO Glucose deficiency results in increased expression of P4HA1 protein CTD PMID:22314686 NCBI chr20:27,784,696...27,895,785
Ensembl chr20:27,845,141...27,895,404 		JBrowse link
G P4hb prolyl 4-hydroxylase subunit beta increases expression
multiple interactions 		EXP Glucose results in increased expression of P4HB protein
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of P4HB protein]; Metformin inhibits the reaction [Glucose results in increased expression of P4HB protein] 		CTD PMID:34801538 NCBI chr10:106,335,300...106,346,911
Ensembl chr10:106,335,300...106,346,911 		JBrowse link
G Pabpc1l poly(A) binding protein, cytoplasmic 1-like multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of PABPC1L mRNA CTD PMID:37567420 NCBI chr 3:173,111,856...173,145,389
Ensembl chr 3:173,112,904...173,146,038 		JBrowse link
G Pacsin1 protein kinase C and casein kinase substrate in neurons 1 increases expression
multiple interactions 		ISO Glucose results in increased expression of PACSIN1 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of PACSIN1 mRNA] 		CTD PMID:33448797 NCBI chr20:5,719,929...5,769,492
Ensembl chr20:5,721,311...5,767,109 		JBrowse link
G Pafah1b1 platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 increases expression ISO Glucose results in increased expression of PAFAH1B1 protein CTD PMID:23776576 NCBI chr10:60,031,441...60,090,259
Ensembl chr10:60,032,514...60,090,196 		JBrowse link
G Pagr1 Paxip1-associated glutamate-rich protein 1 increases expression ISO Glucose results in increased expression of PAGR1A mRNA CTD PMID:39922521 NCBI chr 1:191,053,228...191,055,554 JBrowse link
G Paip2 poly(A) binding protein interacting protein 2 multiple interactions ISO Glucose promotes the reaction [PAIP2 protein binds to SLC2A5 3' UTR] CTD PMID:12820898 NCBI chr18:27,475,278...27,492,452
Ensembl chr 1:188,508,623...188,508,997
Ensembl chr18:188,508,623...188,508,997 		JBrowse link
G Pak3 p21 (RAC1) activated kinase 3 decreases expression ISO Glucose results in decreased expression of PAK3 mRNA CTD PMID:17178593 NCBI chr  X:111,912,967...112,171,037
Ensembl chr  X:111,913,059...112,165,035 		JBrowse link
G Pappa2 pappalysin 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PAPPA2 mRNA CTD PMID:37567420 NCBI chr13:73,407,385...73,683,699
Ensembl chr13:73,407,385...73,681,568 		JBrowse link
G Paqr9 progestin and adipoQ receptor family member 9 increases expression ISO Glucose results in increased expression of PAQR9 mRNA CTD PMID:39922521 NCBI chr 8:104,993,884...104,996,180
Ensembl chr 8:104,993,827...104,998,285 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 multiple interactions
increases expression
increases activity
increases acetylation
affects localization
increases cleavage
decreases expression 		ISO
EXP 		[Glucose co-treated with Oxygen deficiency] results in increased activity of PARP1 protein; [Glucose deficiency co-treated with Acetylcysteine] results in increased cleavage of PARP1 protein; [Glucose deficiency co-treated with CAT] results in increased cleavage of PARP1 protein; [Glucose deficiency co-treated with Tetradecanoylphorbol Acetate] results in increased cleavage of PARP1 protein; Acetylcysteine inhibits the reaction [Glucose results in increased activity of PARP1 protein]; ERCC1 protein affects the reaction [Glucose results in increased expression of PARP1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of PARP1 mRNA]; Glucose promotes the reaction [PARP1 protein binds to MMP9 promoter]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased activity of PARP1 protein]; PARP1 protein affects the reaction [Glucose inhibits the reaction [INS protein results in increased phosphorylation of INSR protein]]; PARP1 protein affects the reaction [Glucose promotes the reaction [JUN protein binds to MMP9 promoter]]; PARP1 protein affects the reaction [Glucose promotes the reaction [RELA protein binds to MMP9 promoter]]; PARP1 protein affects the reaction [Glucose results in decreased expression of CYTB mRNA]; PARP1 protein affects the reaction [Glucose results in decreased expression of SIRT1 protein]; PARP1 protein affects the reaction [Glucose results in increased expression of MMP9 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of PARP1 protein modified form]; SIRT1 protein inhibits the reaction [Glucose promotes the reaction [PARP1 protein binds to MMP9 promoter]]; SIRT1 protein inhibits the reaction [Glucose results in increased acetylation of PARP1 protein]; SOD2 protein inhibits the reaction [Glucose results in increased activity of PARP1 protein]
Glucose affects the localization of PARP1 protein
Glucose deficiency inhibits the reaction [Arsenic Trioxide results in increased expression of PARP1 protein modified form]; imeglimin inhibits the reaction [Glucose results in increased expression of PARP1 protein]; PARP1 protein affects the reaction [Glucose results in increased ADP-ribosylation of GAPDH protein]
Glucose results in increased cleavage of PARP1 protein
Glucose results in increased expression of PARP1 mRNA; Glucose results in increased expression of PARP1 protein modified form
[INS1 protein co-treated with Glucose] results in increased activity of PARP1 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of PARP1 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PARP1 protein modified form; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PARP1 protein modified form]; KEAP1 protein inhibits the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PARP1 protein modified form]]; NFE2L2 protein promotes the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PARP1 protein modified form]]; protosappanin A inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of PARP1 protein]; Quercetin inhibits the reaction [Glucose results in increased cleavage of PARP1 protein]; Scopoletin inhibits the reaction [Glucose results in decreased expression of PARP1 protein]; sesamin inhibits the reaction [Glucose results in increased cleavage of PARP1 protein]; Simvastatin inhibits the reaction [Glucose results in increased activity of PARP1 protein]; SOD1 protein inhibits the reaction [[INS1 protein co-treated with Glucose] results in increased activity of PARP1 protein]
Glucose results in decreased expression of PARP1 mRNA; Glucose results in decreased expression of PARP1 protein 		CTD PMID:14523042 PMID:17309078 PMID:18004065 PMID:18545258 PMID:21031461 More... NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567 		JBrowse link
G Parp14 poly (ADP-ribose) polymerase family, member 14 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of PARP14 mRNA CTD PMID:37567420 NCBI chr11:78,408,134...78,440,201
Ensembl chr11:78,408,058...78,440,195 		JBrowse link
G Parvg parvin, gamma increases expression ISO Glucose results in increased expression of PARVG mRNA CTD PMID:39922521 NCBI chr 7:117,336,160...117,366,341
Ensembl chr 7:117,336,187...117,362,155 		JBrowse link
G Pax3 paired box 3 multiple interactions
decreases expression 		ISO
EXP 		alpha-Tocopherol inhibits the reaction [Glucose results in decreased expression of PAX3 mRNA]; S-ethyl glutathione inhibits the reaction [Glucose results in decreased expression of PAX3 mRNA] CTD PMID:12739027 PMID:21818840 NCBI chr 9:87,015,960...87,112,531
Ensembl chr 9:87,016,999...87,124,141 		JBrowse link
G Pax5 paired box 5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PAX5 mRNA CTD PMID:37567420 NCBI chr 5:63,554,784...63,741,380
Ensembl chr 5:63,560,722...63,739,987 		JBrowse link
G Pax6 paired box 6 decreases expression
multiple interactions 		EXP
ISO 		Glucose results in decreased expression of PAX6 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of PAX6 mRNA 		CTD PMID:21818840 PMID:37567420 NCBI chr 3:112,590,034...112,611,771
Ensembl chr 3:112,590,391...112,611,763 		JBrowse link
G Pbk PDZ binding kinase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of PBK mRNA CTD PMID:37567420 NCBI chr15:44,198,506...44,209,572
Ensembl chr15:44,198,544...44,209,570 		JBrowse link
G Pbld1 phenazine biosynthesis-like protein domain containing 1 increases expression ISO Glucose results in increased expression of PBLD1 mRNA CTD PMID:31525975 NCBI chr20:25,549,974...25,565,390
Ensembl chr20:25,549,974...25,565,226 		JBrowse link
G Pbx4 PBX homeobox 4 multiple interactions
increases expression 		ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PBX4 mRNA
Glucose results in increased expression of PBX4 mRNA 		CTD PMID:37567420 PMID:39922521 NCBI chr16:19,588,998...19,624,016
Ensembl chr16:19,588,999...19,623,921 		JBrowse link
G Pc pyruvate carboxylase increases oxidation
affects expression 		ISO
EXP 		PC protein results in increased oxidation of Glucose
Glucose affects the expression of PC mRNA 		CTD PMID:23504317 PMID:24349266 NCBI chr 1:211,228,708...211,327,792
Ensembl chr 1:211,228,731...211,329,940 		JBrowse link
G Pcdh10 protocadherin 10 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of PCDH10 mRNA CTD PMID:37567420 NCBI chr 2:130,553,432...130,619,591
Ensembl chr 2:130,553,425...130,613,407 		JBrowse link
G Pcdh17 protocadherin 17 increases expression
multiple interactions 		ISO Glucose results in increased expression of PCDH17 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of PCDH17 mRNA] 		CTD PMID:33448797 NCBI chr15:66,631,549...66,725,007
Ensembl chr15:66,633,142...66,722,105 		JBrowse link
G Pcdhga1 protocadherin gamma subfamily A, 1 increases expression ISO Glucose results in increased expression of PCDHGA1 mRNA CTD PMID:39613055 NCBI chr18:29,738,639...29,919,095 JBrowse link
G Pcdhga8 protocadherin gamma subfamily A, 8 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of PCDHGA8 mRNA CTD PMID:37567420 NCBI chr18:29,805,113...29,919,095 JBrowse link
G Pcf11 PCF11 cleavage and polyadenylation factor subunit increases expression ISO Glucose results in increased expression of PCF11 mRNA CTD PMID:39922521 NCBI chr 1:156,109,724...156,136,950
Ensembl chr 1:156,109,724...156,136,435 		JBrowse link
G Pck1 phosphoenolpyruvate carboxykinase 1 multiple interactions
increases expression 		ISO [Glucose deficiency co-treated with ALB protein] results in decreased expression of PCK1 mRNA; [Glucose deficiency co-treated with alpha-Linolenic Acid] results in increased expression of PCK1 mRNA; [Glucose deficiency co-treated with Clofibrate co-treated with Oleic Acid] results in increased expression of PCK1 mRNA; [Glucose deficiency co-treated with Clofibrate] results in increased expression of PCK1 mRNA; [Glucose deficiency co-treated with Docosahexaenoic Acids] results in increased expression of PCK1 mRNA; [Glucose deficiency co-treated with Linoleic Acid] results in increased expression of PCK1 mRNA; [Glucose deficiency co-treated with Oleic Acid] results in increased expression of PCK1 mRNA; [Glucose deficiency co-treated with palmitoleic acid] results in increased expression of PCK1 mRNA
Glucose results in increased expression of PCK1 mRNA 		CTD PMID:8536680 PMID:36156098 NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:182,348,572...182,354,561 		JBrowse link
G Pck2 phosphoenolpyruvate carboxykinase 2 (mitochondrial) multiple interactions
increases expression 		ISO Catechin inhibits the reaction [Glucose results in increased expression of PCK2 protein]; Plant Extracts inhibits the reaction [Glucose results in increased expression of PCK2 protein] CTD PMID:24262486 NCBI chr15:32,997,853...33,006,691
Ensembl chr15:32,997,834...33,016,864 		JBrowse link
G Pcmtd1 protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 decreases expression ISO Glucose results in decreased expression of PCMTD1 mRNA CTD PMID:17178593 NCBI chr 5:17,071,629...17,143,803
Ensembl chr 5:17,071,629...17,142,010 		JBrowse link
G Pcna proliferating cell nuclear antigen multiple interactions
affects expression
increases expression 		EXP
ISO 		resveratrol inhibits the reaction [Glucose results in increased expression of PCNA protein]; rosiglitazone inhibits the reaction [Glucose results in increased expression of PCNA protein]
Glucose affects the expression of PCNA protein
[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] promotes the reaction [[lard co-treated with Cholesterol co-treated with Glucose co-treated with Sucrose co-treated with Fructose] results in decreased expression of PCNA protein]; [2,4-Dichlorophenoxyacetic Acid co-treated with lard co-treated with Cholesterol co-treated with Glucose co-treated with Sucrose co-treated with Fructose] results in decreased expression of PCNA protein; [Glyphosate co-treated with lard co-treated with Cholesterol co-treated with Glucose co-treated with Sucrose co-treated with Fructose] results in decreased expression of PCNA protein; [lard co-treated with Cholesterol co-treated with Glucose co-treated with Sucrose co-treated with Fructose] results in decreased expression of PCNA protein
[cobaltous chloride co-treated with Glucose] results in increased expression of PCNA mRNA; [cobaltous chloride co-treated with Glucose] results in increased expression of PCNA protein; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of PCNA mRNA]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of PCNA protein] 		CTD PMID:18665442 PMID:24971582 PMID:25192544 PMID:37615203 PMID:39613055 NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901 		JBrowse link
G Pcsk2 proprotein convertase subtilisin/kexin type 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of PCSK2 mRNA CTD PMID:37567420 NCBI chr 3:151,333,938...151,636,628
Ensembl chr 3:151,333,234...151,638,849 		JBrowse link
G Pcsk9 proprotein convertase subtilisin/kexin type 9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of PCSK9 mRNA CTD PMID:37567420 NCBI chr 5:126,440,102...126,462,507
Ensembl chr 5:126,440,102...126,462,507 		JBrowse link
G Pde11a phosphodiesterase 11A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of PDE11A mRNA CTD PMID:37567420 NCBI chr 3:81,320,822...81,704,397
Ensembl chr 3:81,320,822...81,680,612 		JBrowse link
G Pdha1 pyruvate dehydrogenase E1 subunit alpha 1 multiple interactions ISO Glucose inhibits the reaction [Dichloroacetic Acid results in decreased phosphorylation of PDHA1 protein] CTD PMID:31654802 NCBI chr  X:38,509,158...38,522,986
Ensembl chr  X:38,509,084...38,522,536 		JBrowse link
G Pdhb pyruvate dehydrogenase E1 subunit beta affects expression EXP Glucose affects the expression of PDHB mRNA CTD PMID:24349266 NCBI chr15:19,182,789...19,188,731
Ensembl chr15:19,181,208...19,188,976 		JBrowse link
G Pdia3 protein disulfide isomerase family A, member 3 decreases expression ISO Glucose results in decreased expression of PDIA3 mRNA CTD PMID:17178593 NCBI chr 3:128,841,781...128,865,733
Ensembl chr 3:128,841,917...128,867,327 		JBrowse link
G Pdia4 protein disulfide isomerase family A, member 4 decreases expression ISO Glucose results in decreased expression of PDIA4 mRNA CTD PMID:17178593 NCBI chr 4:78,134,144...78,153,191
Ensembl chr 4:78,134,144...78,153,191 		JBrowse link
G Pdia6 protein disulfide isomerase family A, member 6 decreases expression ISO Glucose results in decreased expression of PDIA6 mRNA CTD PMID:17178593 NCBI chr 6:45,791,704...45,808,947
Ensembl chr 6:45,791,678...45,810,091 		JBrowse link
G Pdk1 pyruvate dehydrogenase kinase 1 multiple interactions
affects expression 		EXP
ISO 		PDK1 protein promotes the reaction [NRG1 protein results in increased transport of Glucose]
Glucose affects the reaction [Fusaric Acid results in increased expression of PDK1 mRNA]; Glucose affects the reaction [Fusaric Acid results in increased expression of PDK1 protein]
Glucose affects the expression of PDK1 mRNA 		CTD PMID:14711829 PMID:24349266 PMID:31654802 NCBI chr 3:77,113,464...77,144,145
Ensembl chr 3:77,113,473...77,144,145 		JBrowse link
G Pdk2 pyruvate dehydrogenase kinase 2 affects expression EXP Glucose affects the expression of PDK2 mRNA CTD PMID:24349266 NCBI chr10:80,469,388...80,483,988
Ensembl chr10:80,469,389...80,484,355 		JBrowse link
G Pdk4 pyruvate dehydrogenase kinase 4 increases expression
multiple interactions 		ISO Glucose results in increased expression of PDK4 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of PDK4 mRNA 		CTD PMID:17178593 PMID:37567420 NCBI chr 4:34,558,327...34,568,329
Ensembl chr 4:34,556,330...34,568,381 		JBrowse link
G Pdp1 pyruvate dehydrogenase phosphatase catalytic subunit 1 multiple interactions EXP [Dexamethasone results in decreased oxidation of Glucose] which results in increased phosphorylation of and results in decreased activity of PDP1 protein CTD PMID:20181797 NCBI chr 5:30,245,699...30,252,494
Ensembl chr 5:30,242,704...30,253,960 		JBrowse link
G Pdx1 pancreatic and duodenal homeobox 1 multiple interactions
affects localization
decreases expression
affects expression
increases expression
increases activity 		ISO
EXP 		2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose affects the localization of PDX1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased phosphorylation of and results in increased activity of PDX1 protein]; [Glucose co-treated with INS protein] affects the localization of PDX1 protein; [Glucose co-treated with sodium arsenite] affects the localization of PDX1 protein; [SB 203580 co-treated with INS protein] inhibits the reaction [Glucose affects the localization of PDX1 protein]; [wortmannin co-treated with INS protein] inhibits the reaction [Glucose affects the localization of PDX1 protein]; calyculin A inhibits the reaction [Glucose affects the localization of PDX1 protein]; Glucose results in increased phosphorylation of and results in increased activity of PDX1 protein; Okadaic Acid inhibits the reaction [Glucose affects the localization of PDX1 protein]; Palmitic Acid inhibits the reaction [Glucose affects the localization of PDX1 protein]; SB 203580 inhibits the reaction [[Glucose co-treated with sodium arsenite] affects the localization of PDX1 protein]; SB 203580 inhibits the reaction [Glucose affects the localization of PDX1 protein]; SB 203580 inhibits the reaction [Glucose results in increased phosphorylation of and results in increased activity of PDX1 protein]; wortmannin inhibits the reaction [Glucose affects the localization of PDX1 protein]; wortmannin inhibits the reaction [Glucose results in increased phosphorylation of and results in increased activity of PDX1 protein]
Glucose results in decreased expression of PDX1 protein
Glucose affects the expression of PDX1 mRNA
lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of PDX1 mRNA]
Glucose results in increased activity of PDX1 promoter
[copper bis(3,5-diisopropylsalicylate) co-treated with Glucose] results in increased expression of PDX1 protein; [ebselen co-treated with Glucose] results in increased expression of PDX1 protein; [Glucose co-treated with INS1 protein] affects the localization of PDX1 protein; [Glucose co-treated with sodium arsenite] affects the localization of PDX1 protein; [imeglimin co-treated with Glucose] results in increased expression of PDX1 mRNA; [Metformin co-treated with Glucose] affects the localization of PDX1 protein; calyculin A inhibits the reaction [Glucose affects the localization of PDX1 protein]; Glucose results in increased phosphorylation of and results in increased activity of PDX1 protein; IL1B protein inhibits the reaction [Glucose results in increased expression of PDX1 mRNA]; lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of PDX1 mRNA]; Okadaic Acid inhibits the reaction [Glucose affects the localization of PDX1 protein]; Palmitic Acid inhibits the reaction [Glucose results in increased expression of PDX1 mRNA]; PDX1 protein affects the reaction [bisphenol A promotes the reaction [Glucose results in increased secretion of INS protein]]; Rosiglitazone promotes the reaction [Glucose results in increased activity of PDX1 promoter]; SB 203580 inhibits the reaction [[Glucose co-treated with sodium arsenite] affects the localization of PDX1 protein]; SB 203580 inhibits the reaction [Glucose affects the localization of PDX1 protein]; TLR4 affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of PDX1 mRNA]]; Wortmannin inhibits the reaction [Glucose affects the localization of PDX1 protein] 		CTD PMID:9873045 PMID:11574405 PMID:16489446 PMID:22558381 PMID:23795780 More... NCBI chr12:12,793,957...12,799,156
Ensembl chr12:12,793,957...12,799,156 		JBrowse link
G Pebp1 phosphatidylethanolamine binding protein 1 increases expression
increases secretion 		ISO Glucose deficiency results in increased expression of PEBP1 protein
Glucose deficiency results in increased secretion of PEBP1 protein 		CTD PMID:22314686 PMID:24802182 NCBI chr12:44,946,307...44,967,890
Ensembl chr12:44,963,675...44,971,780 		JBrowse link
G Pecam1 platelet and endothelial cell adhesion molecule 1 decreases expression ISO Glucose results in decreased expression of PECAM1 mRNA CTD PMID:31655124 NCBI chr10:92,090,263...92,152,002
Ensembl chr10:92,090,235...92,151,839 		JBrowse link
G Peg10 paternally expressed 10 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PEG10 mRNA CTD PMID:37567420 NCBI chr 4:33,809,026...33,822,224
Ensembl chr 4:33,817,190...33,819,166
Ensembl chr 4:33,817,190...33,819,166 		JBrowse link
G Penk proenkephalin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of PENK mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of PENK mRNA CTD PMID:37567420 NCBI chr 5:21,981,381...21,987,074
Ensembl chr 5:21,981,382...21,986,705 		JBrowse link
G Per3 period circadian regulator 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of PER3 mRNA CTD PMID:37567420 NCBI chr 5:166,740,914...166,778,243
Ensembl chr 5:166,743,050...166,777,999 		JBrowse link
G Pf4 platelet factor 4 increases expression ISO Glucose results in increased expression of PF4 mRNA CTD PMID:31655124 NCBI chr14:17,582,477...17,583,392
Ensembl chr14:17,582,477...17,583,392 		JBrowse link
G Pgam2 phosphoglycerate mutase 2 increases expression ISO Glucose results in increased expression of PGAM2 mRNA CTD PMID:39922521 NCBI chr14:84,895,763...84,897,874
Ensembl chr14:84,895,744...84,897,894 		JBrowse link
G Phb2 prohibitin 2 decreases expression
multiple interactions 		EXP Glucose results in decreased expression of PHB2 protein
Inositol inhibits the reaction [Glucose results in decreased expression of PHB2 protein] 		CTD PMID:35243728 NCBI chr 4:159,203,948...159,208,561
Ensembl chr 4:159,203,926...159,209,231 		JBrowse link
G Phf11 PHD finger protein 11 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of PHF11 mRNA CTD PMID:37567420 NCBI chr15:37,568,090...37,592,490
Ensembl chr15:37,568,090...37,591,016 		JBrowse link
G Phf19 PHD finger protein 19 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of PHF19 mRNA CTD PMID:37567420 NCBI chr 3:38,572,766...38,604,950
Ensembl chr 3:38,572,766...38,593,854 		JBrowse link
G Phf21b PHD finger protein 21B increases expression ISO Glucose results in increased expression of PHF21B mRNA CTD PMID:39922521 NCBI chr 7:117,793,643...117,864,141
Ensembl chr 7:117,794,046...117,864,141 		JBrowse link
G Phgdh phosphoglycerate dehydrogenase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of PHGDH mRNA CTD PMID:37567420 NCBI chr 2:188,595,700...188,624,789
Ensembl chr 2:188,595,700...188,624,789 		JBrowse link
G Phlda1 pleckstrin homology-like domain, family A, member 1 increases expression ISO Glucose results in increased expression of PHLDA1 mRNA CTD PMID:17178593 NCBI chr 7:48,853,690...48,855,894
Ensembl chr 7:48,853,260...48,857,542 		JBrowse link
G Pi16 peptidase inhibitor 16 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PI16 mRNA CTD PMID:37567420 NCBI chr20:7,377,739...7,387,003
Ensembl chr20:7,377,729...7,387,691 		JBrowse link
G Pianp PILR alpha associated neural protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PIANP mRNA CTD PMID:37567420 NCBI chr 4:159,482,678...159,491,085
Ensembl chr 4:159,482,648...159,491,083 		JBrowse link
G Piga phosphatidylinositol glycan anchor biosynthesis, class A decreases expression ISO Glucose results in decreased expression of PIGA mRNA CTD PMID:17178593 NCBI chr  X:33,672,832...33,687,747
Ensembl chr  X:33,674,923...33,687,636 		JBrowse link
G Pik3r1 phosphoinositide-3-kinase regulatory subunit 1 multiple interactions ISO [Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of PIK3R1 protein; Glucose promotes the reaction [PIK3R1 protein binds to IRS1 protein]; nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of PIK3R1 protein]; Wortmannin inhibits the reaction [nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of PIK3R1 protein]] CTD PMID:10430617 PMID:38528077 NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:34,612,946...34,626,347 		JBrowse link
G Pik3r2 phosphoinositide-3-kinase regulatory subunit 2 multiple interactions ISO [Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of PIK3R2 protein; nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of PIK3R2 protein]; Wortmannin inhibits the reaction [nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of PIK3R2 protein]] CTD PMID:38528077 NCBI chr16:18,699,389...18,708,045
Ensembl chr16:18,699,448...18,709,665 		JBrowse link
G Pik3r3 phosphoinositide-3-kinase regulatory subunit 3 multiple interactions ISO [Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of PIK3R3 protein; nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of PIK3R3 protein]; Wortmannin inhibits the reaction [nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of PIK3R3 protein]] CTD PMID:38528077 NCBI chr 5:134,936,790...135,009,303
Ensembl chr 5:134,934,857...135,007,762 		JBrowse link
G Pik3r5 phosphoinositide-3-kinase, regulatory subunit 5 increases expression ISO Glucose results in increased expression of PIK3R5 mRNA CTD PMID:39922521 NCBI chr10:53,631,469...53,699,550
Ensembl chr10:53,631,476...53,699,539 		JBrowse link
G Pilral1 paired immunoglobin-like type 2 receptor alpha like 1 increases expression ISO Glucose results in increased expression of ZNF37A mRNA CTD PMID:39613055 NCBI chr12:23,409,774...23,421,574 JBrowse link
G Pim1 Pim-1 proto-oncogene, serine/threonine kinase multiple interactions
decreases expression 		ISO 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of PIM1 mRNA]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of PIM1 protein]]; resveratrol inhibits the reaction [Glucose results in decreased expression of PIM1 mRNA]; resveratrol inhibits the reaction [Glucose results in decreased expression of PIM1 protein]
Glucose results in decreased expression of PIM1 mRNA; Glucose results in decreased expression of PIM1 protein 		CTD PMID:27049278 NCBI chr20:7,556,496...7,560,747
Ensembl chr20:7,556,113...7,561,764 		JBrowse link
G Pimreg PICALM interacting mitotic regulator multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of PIMREG mRNA CTD PMID:37567420 NCBI chr10:57,168,136...57,173,713
Ensembl chr10:57,167,797...57,173,063 		JBrowse link
G Pink1 PTEN induced kinase 1 increases expression
multiple interactions
decreases expression 		ISO
EXP 		Glucose results in increased expression of PINK1 mRNA
Glucose results in increased expression of PINK1 protein
imeglimin inhibits the reaction [Glucose results in increased expression of PINK1 protein]
Inositol inhibits the reaction [Glucose results in decreased expression of PINK1 protein]
[Glucose co-treated with Deferoxamine] results in increased expression of PINK1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of PINK1 mRNA] 		CTD PMID:33962019 PMID:35243728 PMID:38334676 NCBI chr 5:155,813,838...155,825,950
Ensembl chr 5:155,813,838...155,825,950 		JBrowse link
G Pip5k1b phosphatidylinositol-4-phosphate 5-kinase type 1 beta decreases methylation
multiple interactions
increases expression 		ISO Glucose results in decreased methylation of PIP5K1B gene
fucoxanthin inhibits the reaction [Glucose results in decreased methylation of PIP5K1B gene]; fucoxanthin inhibits the reaction [Glucose results in increased expression of PIP5K1B mRNA] 		CTD PMID:33448797 NCBI chr 1:231,331,836...231,610,092
Ensembl chr 1:231,340,606...231,496,812 		JBrowse link
G Pitpnm3 PITPNM family member 3 multiple interactions
decreases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of PITPNM3 mRNA] CTD PMID:33448797 NCBI chr10:57,173,230...57,265,186
Ensembl chr10:57,175,721...57,265,291 		JBrowse link
G Pjvk pejvakin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of PJVK mRNA CTD PMID:37567420 NCBI chr 3:82,002,106...82,012,273
Ensembl chr 3:82,002,368...82,012,451 		JBrowse link
G Pklr pyruvate kinase L/R increases expression
increases activity
multiple interactions 		ISO
EXP 		Glucose results in increased expression of PKLR mRNA
Glucose results in increased activity of PKLR protein
4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2,3-b)pyridine-5-carbonitrile inhibits the reaction [Glucose results in increased expression of PKLR mRNA]; Fatty Acids affects the reaction [Glucose results in increased activity of PKLR protein]; Fatty Acids, Unsaturated inhibits the reaction [Glucose results in increased expression of PKLR mRNA]; Glucose promotes the reaction [H3F4 protein modified form binds to PKLR promoter]; Glucose promotes the reaction [H4C16 protein modified form binds to PKLR promoter]; Metformin inhibits the reaction [Glucose results in increased expression of PKLR mRNA]; pirinixic acid inhibits the reaction [Glucose results in increased activity of PKLR protein]; pirinixic acid inhibits the reaction [Glucose results in increased expression of PKLR mRNA] 		CTD PMID:2824512 PMID:8144600 PMID:16644726 PMID:16790840 PMID:17786952 More... NCBI chr 2:176,840,779...176,849,637
Ensembl chr 2:176,840,764...176,849,644 		JBrowse link
G Pkm pyruvate kinase M1/2 increases uptake
multiple interactions 		ISO PKM protein results in increased uptake of Glucose
Fulvestrant inhibits the reaction [Glucose promotes the reaction [Estradiol results in increased phosphorylation of PKM protein]]; Glucose affects the reaction [Fusaric Acid results in increased expression of PKM mRNA]; Glucose affects the reaction [Fusaric Acid results in increased expression of PKM protein]; Glucose deficiency promotes the reaction [SAICAR binds to and results in increased activity of PKM protein]; Glucose promotes the reaction [Estradiol results in increased phosphorylation of PKM protein] 		CTD PMID:22574221 PMID:23086999 PMID:31654802 PMID:32078667 NCBI chr 8:68,949,731...68,975,394
Ensembl chr 8:68,948,815...68,975,396 		JBrowse link
G Pla2g12b phospholipase A2, group XIIB multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PLA2G12B mRNA CTD PMID:37567420 NCBI chr20:27,910,620...27,931,734
Ensembl chr20:27,913,259...27,932,148 		JBrowse link
G Pla2g2d phospholipase A2, group IID increases expression ISO Glucose results in increased expression of PLA2G2D mRNA CTD PMID:39922521 NCBI chr 5:156,299,374...156,305,816
Ensembl chr 5:156,297,777...156,305,812 		JBrowse link
G Pla2g4d phospholipase A2 group IVD increases expression ISO Glucose results in increased expression of PLA2G4B mRNA CTD PMID:39922521 NCBI chr 3:127,674,743...127,695,991
Ensembl chr 3:127,674,814...127,695,998 		JBrowse link
G Plagl1 PLAG1 like zinc finger 1 decreases expression ISO Glucose results in decreased expression of PLAGL1 mRNA CTD PMID:17178593 NCBI chr 1:9,297,066...9,337,394
Ensembl chr 1:9,330,204...9,337,394 		JBrowse link
G Plat plasminogen activator, tissue type increases expression ISO Glucose results in increased expression of PLAT mRNA CTD PMID:17178593 NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696 		JBrowse link
G Plau plasminogen activator, urokinase decreases expression ISO Glucose results in decreased expression of PLAU mRNA CTD PMID:31655124 NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030 		JBrowse link
G Plcb1 phospholipase C beta 1 multiple interactions
increases expression 		EXP acetovanillone inhibits the reaction [Glucose results in increased expression of PLCB1 protein]; CAT protein inhibits the reaction [Glucose results in increased expression of PLCB1 protein] CTD PMID:20691780 NCBI chr 3:142,512,765...143,224,042
Ensembl chr 3:142,513,033...143,225,646 		JBrowse link
G Plcb2 phospholipase C, beta 2 multiple interactions
increases expression 		EXP acetovanillone inhibits the reaction [Glucose results in increased expression of PLCB2 protein]; CAT protein inhibits the reaction [Glucose results in increased expression of PLCB2 protein] CTD PMID:20691780 NCBI chr 3:126,134,925...126,158,303
Ensembl chr 3:126,138,736...126,158,221 		JBrowse link
G Plekha7 pleckstrin homology domain containing A7 increases expression ISO Glucose results in increased expression of PLEKHA7 mRNA CTD PMID:39922521 NCBI chr 1:179,798,856...179,982,155
Ensembl chr 1:179,799,040...179,982,281 		JBrowse link
G Plekhg4 pleckstrin homology and RhoGEF domain containing G4 increases expression ISO Glucose results in increased expression of PLEKHG4 mRNA CTD PMID:39922521 NCBI chr19:50,161,722...50,176,491
Ensembl chr19:50,159,754...50,182,133 		JBrowse link
G Plg plasminogen multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of PLG mRNA CTD PMID:37567420 NCBI chr 1:50,872,927...50,915,406
Ensembl chr 1:50,872,926...50,917,320 		JBrowse link
G Plin1 perilipin 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PLIN1 mRNA CTD PMID:37567420 NCBI chr 1:143,073,612...143,086,199
Ensembl chr 1:143,074,214...143,086,206 		JBrowse link
G Plk1 polo-like kinase 1 increases expression
multiple interactions 		ISO Glucose results in increased expression of PLK1 mRNA
[imeglimin co-treated with Glucose] results in increased expression of PLK1 mRNA 		CTD PMID:17178593 PMID:34588186 NCBI chr 1:186,147,658...186,157,637
Ensembl chr 1:186,147,658...186,157,637 		JBrowse link
G Plod2 procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 increases expression ISO Glucose results in increased expression of PLOD2 mRNA CTD PMID:17178593 NCBI chr 8:101,964,318...102,047,022
Ensembl chr 8:101,964,318...102,047,022 		JBrowse link
G Pls3 plastin 3 increases expression ISO Glucose results in increased expression of PLS3 mRNA CTD PMID:10026205 NCBI chr  X:116,401,247...116,495,898
Ensembl chr  X:116,401,293...116,495,893 		JBrowse link
G Plxdc1 plexin domain containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of PLXDC1 mRNA CTD PMID:37567420 NCBI chr10:83,418,837...83,478,451
Ensembl chr10:83,418,837...83,478,755 		JBrowse link
G Pmaip1 phorbol-12-myristate-13-acetate-induced protein 1 multiple interactions ISO [Glucose co-treated with Deferoxamine] results in increased expression of PMAIP1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of PMAIP1 mRNA] CTD PMID:33962019 NCBI chr18:62,255,970...62,262,384
Ensembl chr18:62,255,598...62,262,382 		JBrowse link
G Pms2 PMS1 homolog 2, mismatch repair system component increases expression ISO Glucose results in increased expression of RSPH10B mRNA CTD PMID:39922521 NCBI chr12:15,790,478...15,814,790
Ensembl chr12:15,790,478...15,815,248 		JBrowse link
G Pnkp polynucleotide kinase 3'-phosphatase decreases expression ISO Glucose results in decreased expression of PNKP mRNA CTD PMID:32942007 NCBI chr 1:104,476,801...104,483,409
Ensembl chr 1:104,478,088...104,483,408 		JBrowse link
G Pnpla2 patatin-like phospholipase domain containing 2 decreases expression ISO Glucose deficiency results in decreased expression of PNPLA2 protein CTD PMID:24802182 NCBI chr 1:205,982,279...205,987,361
Ensembl chr 1:205,982,258...205,987,359 		JBrowse link
G Pnpla3 patatin-like phospholipase domain containing 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of PNPLA3 mRNA CTD PMID:37567420 NCBI chr 7:117,173,485...117,194,065
Ensembl chr 7:117,173,516...117,194,594 		JBrowse link
G Polh DNA polymerase eta increases expression ISO Glucose results in increased expression of POLH mRNA CTD PMID:39922521 NCBI chr 9:22,275,929...22,310,576
Ensembl chr 9:22,275,946...22,310,577 		JBrowse link
G Poln DNA polymerase nu increases expression ISO Glucose results in increased expression of POLN mRNA CTD PMID:39922521
G Pomc proopiomelanocortin decreases expression
increases response to substance
multiple interactions 		EXP
ISO 		Glucose results in decreased expression of POMC mRNA
Glucose results in increased susceptibility to POMC protein
POMC inhibits the reaction [INS1 results in increased uptake of Glucose] 		CTD PMID:18310442 PMID:18627777 PMID:19489000 NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:32,659,346...32,665,173 		JBrowse link
G Pon2 paraoxonase 2 affects abundance ISO PON2 gene polymorphism affects the abundance of Glucose CTD PMID:16185677 NCBI chr 4:34,356,270...34,391,684
Ensembl chr 4:34,356,274...34,391,996 		JBrowse link
G Popdc3 popeye domain cAMP effector 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of POPDC3 mRNA CTD PMID:37567420 NCBI chr20:50,354,775...50,383,050
Ensembl chr20:50,354,767...50,385,674 		JBrowse link
G Pou4f1 POU class 4 homeobox 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of POU4F1 mRNA CTD PMID:37567420 NCBI chr15:87,668,328...87,674,643
Ensembl chr15:87,668,328...87,674,643 		JBrowse link
G Pou5f1 POU class 5 homeobox 1 affects localization ISO Glucose affects the localization of POU5F1 protein CTD PMID:33992720 NCBI chr20:3,227,836...3,232,598
Ensembl chr20:3,227,837...3,232,598 		JBrowse link
G Ppara peroxisome proliferator activated receptor alpha multiple interactions
decreases expression
affects expression
affects metabolic processing
affects abundance 		ISO
EXP 		[Acetylglucosamine co-treated with Glucose] binds to PPARA protein; [Atropine co-treated with Glucose] binds to PPARA protein; [Budesonide co-treated with Glucose] binds to PPARA protein; [Enalapril co-treated with Glucose] binds to PPARA protein; [gamma-Aminobutyric Acid co-treated with Glucose] binds to PPARA protein; [gedunin co-treated with Glucose] binds to PPARA protein; [GW 7647 binds to and results in increased activity of PPARA protein] affects the reaction [Glucose affects the abundance of Calcium]; [Oleylethanolamide binds to and results in increased activity of PPARA protein] affects the reaction [Glucose affects the abundance of Calcium]; [pirinixic acid binds to and results in increased activity of PPARA protein] affects the reaction [Glucose affects the abundance of Calcium]; [Pyrazinamide co-treated with Glucose] binds to PPARA protein; [Saccharin co-treated with Glucose] binds to PPARA protein; [salicylamide co-treated with Glucose] binds to PPARA protein; [Tolazoline co-treated with Glucose] binds to PPARA protein; [Tolmetin co-treated with Glucose] binds to PPARA protein; Acetylglucosamine inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; Atorvastatin promotes the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; Atropine inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; Budesonide inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; Enalapril inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; Fenofibrate promotes the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; gamma-Aminobutyric Acid inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; gedunin inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]; PPARA protein promotes the reaction [pirinixic acid results in decreased abundance of Glucose]; Pravastatin promotes the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; Pyrazinamide inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; Resveratrol inhibits the reaction [Glucose results in decreased expression of PPARA protein]; Saccharin inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; salicylamide inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; Tolazoline inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; Tolmetin inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]
[pirinixic acid binds to and results in increased activity of PPARA protein] which affects the metabolism of Glucose; [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased susceptibility to Glucose; Allopurinol inhibits the reaction [Glucose results in decreased expression of PPARA protein]; HET0016 inhibits the reaction [naringenin inhibits the reaction [Glucose results in decreased expression of PPARA protein]]; naringenin inhibits the reaction [Glucose results in decreased expression of PPARA protein]; PPARA protein promotes the reaction [Glucose results in increased secretion of INS1 protein]; Quercetin inhibits the reaction [Glucose results in decreased expression of PPARA protein]; TXNIP mRNA promotes the reaction [Glucose results in decreased expression of PPARA protein]
Glucose results in decreased expression of PPARA mRNA; Glucose results in decreased expression of PPARA protein
[Bezafibrate binds to and results in increased activity of PPARA protein] which results in decreased abundance of Glucose; [Glucose co-treated with Fatty Acids, Nonesterified] results in decreased expression of PPARA protein; [Glucose co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of PPARA mRNA; acadesine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA]; Allopurinol inhibits the reaction [Glucose results in decreased expression of PPARA protein]; Ditiocarb inhibits the reaction [YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [[Glucose co-treated with Fatty Acids, Nonesterified] results in decreased expression of PPARA protein]]]; dorsomorphin promotes the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA]; jujuboside A inhibits the reaction [[Glucose co-treated with Fatty Acids, Nonesterified] results in decreased expression of PPARA protein]; PPARGC1A protein affects the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA]; Quercetin inhibits the reaction [Glucose results in decreased expression of PPARA protein]; TERT protein inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA]; TXNIP mRNA promotes the reaction [Glucose results in decreased expression of PPARA protein]; YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [[Glucose co-treated with Fatty Acids, Nonesterified] results in decreased expression of PPARA protein]]
Glucose affects the expression of PPARA mRNA
PPARA protein affects the metabolism of Glucose
PPARA protein affects the abundance of Glucose 		CTD PMID:15878969 PMID:16600694 PMID:16777972 PMID:18469201 PMID:18812576 More... NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714 		JBrowse link
G Ppard peroxisome proliferator-activated receptor delta affects expression
multiple interactions
decreases expression 		EXP
ISO 		Glucose affects the expression of PPARD mRNA
[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of PPARD mRNA
Glucose results in decreased expression of PPARB protein
HET0016 inhibits the reaction [naringenin inhibits the reaction [Glucose results in decreased expression of PPARB protein]]; naringenin inhibits the reaction [Glucose results in decreased expression of PPARB protein] 		CTD PMID:24349266 PMID:31063766 PMID:32613381 NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,352,183...6,365,707 		JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions
decreases expression 		EXP
ISO 		[ciglitazone binds to and results in increased activity of PPARG protein] which results in increased transport of Glucose; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PPARG mRNA; HET0016 inhibits the reaction [naringenin inhibits the reaction [Glucose results in decreased expression of PPARG protein]]; naringenin inhibits the reaction [Glucose results in decreased expression of PPARG protein]; PPARG protein inhibits the reaction [Glucose results in increased secretion of INS1 protein]; tetrahydropalmatine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PPARG mRNA]
2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]]; [Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA; [Glucose co-treated with Palmitic Acid] results in decreased expression of PPARG mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of PPARG mRNA; acadesine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARG mRNA]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]; dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]; dorsomorphin promotes the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARG mRNA]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]; PPARG protein affects the reaction [Fulvestrant inhibits the reaction [bisphenol A inhibits the reaction [INS protein results in increased uptake of Glucose]]]; PPARGC1A protein affects the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARG mRNA]; Rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]; TERT protein inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARG mRNA]
Glucose results in decreased expression of PPARG mRNA; Glucose results in decreased expression of PPARG protein 		CTD PMID:15878969 PMID:18063688 PMID:19609456 PMID:21333731 PMID:31063766 More... NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104 		JBrowse link
G Ppargc1a PPARG coactivator 1 alpha decreases expression
multiple interactions
increases expression
affects expression
increases acetylation 		ISO
EXP 		Glucose deficiency results in decreased expression of PPARGC1A mRNA; Glucose results in decreased expression of PPARGC1A mRNA; Glucose results in decreased expression of PPARGC1A protein
[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of PPARGC1A protein; formononetin inhibits the reaction [Glucose results in decreased expression of PPARGC1A mRNA]; formononetin inhibits the reaction [Glucose results in decreased expression of PPARGC1A protein]; Inositol inhibits the reaction [Glucose results in decreased expression of PPARGC1A protein]; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of PPARGC1A protein]; SRT1720 inhibits the reaction [Glucose results in decreased expression of PPARGC1A protein]
Glucose deficiency results in increased expression of PPARGC1A mRNA; Glucose results in increased expression of PPARGC1A mRNA
Glucose affects the expression of PPARGC1A mRNA
Glucose results in increased acetylation of PPARGC1A protein
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [ACACB protein affects the reaction [Glucose results in decreased expression of PPARGC1A protein]]; [Glucose co-treated with Palmitic Acid] results in decreased expression of PPARGC1A mRNA; [Glucose co-treated with Palmitic Acid] results in decreased expression of PPARGC1A protein; [Pyruvic Acid co-treated with Glucose] results in decreased acetylation of PPARGC1A protein; ACACB protein affects the reaction [Glucose results in decreased expression of PPARGC1A protein]; acadesine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARGC1A mRNA]; acadesine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARGC1A protein]; dorsomorphin promotes the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARGC1A mRNA]; dorsomorphin promotes the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARGC1A protein]; Glucose promotes the reaction [YY1 protein binds to PPARGC1A promoter]; Nitroprusside inhibits the reaction [Glucose deficiency results in decreased expression of PPARGC1A mRNA]; PPARGC1A protein affects the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA]; PPARGC1A protein affects the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARG mRNA]; PPARGC1A protein affects the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TERT mRNA]; PPARGC1A protein affects the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TERT protein]; PPARGC1A protein affects the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TFAM mRNA]; TERT protein inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARGC1A protein]; YY1 promotes the reaction [Glucose results in decreased expression of PPARGC1A protein]
4-phenylbutyric acid inhibits the reaction [Glucose results in decreased expression of PPARGC1A mRNA]; [SIRT1 protein co-treated with Resveratrol] affects the reaction [Glucose affects the expression of PPARGC1A protein]; AICA ribonucleotide inhibits the reaction [Glucose results in decreased expression of PPARGC1A protein]; CEBPB protein inhibits the reaction [Glucose results in decreased expression of PPARGC1A protein]; DDIT3 affects the reaction [Glucose results in decreased expression of PPARGC1A mRNA]; Glucose inhibits the reaction [DDIT3 protein binds to PPARGC1A promoter]; Metformin inhibits the reaction [Glucose results in decreased expression of PPARGC1A protein]; morroniside inhibits the reaction [Glucose results in decreased expression of PPARGC1A mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of PPARGC1A protein] 		CTD PMID:17855661 PMID:19071085 PMID:23090186 PMID:24349266 PMID:26811028 More... NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213 		JBrowse link
G Ppp1r12a protein phosphatase 1, regulatory subunit 12A multiple interactions EXP 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid inhibits the reaction [notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased phosphorylation of PPP1R12A protein]]; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased phosphorylation of PPP1R12A protein; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased phosphorylation of PPP1R12A protein]; Y 27632 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased phosphorylation of PPP1R12A protein] CTD PMID:25305180 NCBI chr 7:45,368,922...45,480,158
Ensembl chr 7:45,369,315...45,480,157 		JBrowse link
G Ppp1r13l protein phosphatase 1, regulatory subunit 13 like increases expression ISO Glucose results in increased expression of PPP1R13L mRNA CTD PMID:39922521 NCBI chr 1:88,139,000...88,158,714
Ensembl chr 1:88,140,532...88,158,714 		JBrowse link
G Ppp1r15a protein phosphatase 1, regulatory subunit 15A multiple interactions ISO [imeglimin co-treated with Glucose] promotes the reaction [Thapsigargin results in increased expression of PPP1R15A mRNA]
[imeglimin co-treated with Glucose] results in increased expression of PPP1R15A mRNA 		CTD PMID:34588186 NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:105,136,525...105,139,774 		JBrowse link
G Ppp1r16b protein phosphatase 1, regulatory subunit 16B multiple interactions ISO [imeglimin co-treated with Glucose] results in increased expression of PPP1R16B mRNA CTD PMID:34588186 NCBI chr 3:167,743,518...167,839,511
Ensembl chr 3:167,743,952...167,839,242 		JBrowse link
G Prdm1 PR/SET domain 1 increases expression ISO Glucose results in increased expression of PRDM1 mRNA CTD PMID:39922521 NCBI chr20:49,542,465...49,564,088
Ensembl chr20:49,542,465...49,564,088 		JBrowse link
G Prdm10 PR/SET domain 10 increases expression ISO Glucose results in increased expression of PRDM10 mRNA CTD PMID:39922521 NCBI chr 8:37,982,210...38,085,907
Ensembl chr 8:37,982,403...38,085,907 		JBrowse link
G Prdx1 peroxiredoxin 1 increases expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of PRDX1 mRNA
[PRDX1 protein affects the susceptibility to sodium arsenite] which affects the uptake of Glucose
[Glucose co-treated with gastrodin] affects the expression of PRDX1 mRNA 		CTD PMID:32942007 PMID:33764184 PMID:38067110 NCBI chr 5:135,383,906...135,399,504
Ensembl chr 5:135,383,906...135,399,504 		JBrowse link
G Prex1 phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 decreases expression ISO Glucose results in decreased expression of PREX1 mRNA CTD PMID:32942007 NCBI chr 3:175,724,939...175,875,764
Ensembl chr 3:175,726,012...175,875,764 		JBrowse link
G Prkaa1 protein kinase AMP-activated catalytic subunit alpha 1 multiple interactions ISO
EXP 		6,8-diallyl 5,7-dihydroxy 2-(2-allyl 3-hydroxy 4-methoxyphenyl)1-H benzo(b)pyran-4-one inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein]; [Resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein]; Apigenin inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein]; Glucose inhibits the reaction [SGA 360 results in increased phosphorylation of PRKAA1 protein]; Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein; Metformin inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein]; PRKAA1 protein affects the reaction [Metformin inhibits the reaction [Glucose deficiency results in increased chemical synthesis of Reactive Oxygen Species]]; PRKAA1 protein affects the reaction [Ribonucleosides inhibits the reaction [Glucose deficiency results in increased chemical synthesis of Reactive Oxygen Species]]; PRKAA1 protein affects the reaction [Rosiglitazone inhibits the reaction [Glucose affects the localization of NCF1 protein]]; PRKAA1 protein affects the reaction [Rosiglitazone inhibits the reaction [Glucose affects the localization of RAC1 protein]]; PRKAA1 protein affects the reaction [Rosiglitazone inhibits the reaction [Glucose results in increased abundance of Reactive Oxygen Species]]; Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein]
PRKAA1 protein affects the reaction [Glucose results in increased secretion of INS1 protein]
[[PRKAA1 gene mutant form co-treated with PRKAA2 gene mutant form] affects the susceptibility to [Glucose co-treated with S 4048]] which results in decreased abundance of Adenosine Triphosphate; [[PRKAA1 gene mutant form co-treated with PRKAA2 gene mutant form] affects the susceptibility to [Glucose co-treated with S 4048]] which results in increased abundance of Glucose-6-Phosphate; [PRKAA1 gene mutant form co-treated with PRKAA2 gene mutant form] affects the susceptibility to [Glucose co-treated with S 4048]; Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein; PRKAA1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]] 		CTD PMID:16380484 PMID:16873680 PMID:17916771 PMID:18482975 PMID:19052259 More... NCBI chr 2:55,967,766...56,003,450
Ensembl chr 2:55,967,351...56,003,450 		JBrowse link
G Prkaa2 protein kinase AMP-activated catalytic subunit alpha 2 multiple interactions
decreases expression
affects response to substance 		ISO
EXP 		[[PRKAA1 gene mutant form co-treated with PRKAA2 gene mutant form] affects the susceptibility to [Glucose co-treated with S 4048]] which results in decreased abundance of Adenosine Triphosphate; [[PRKAA1 gene mutant form co-treated with PRKAA2 gene mutant form] affects the susceptibility to [Glucose co-treated with S 4048]] which results in increased abundance of Glucose-6-Phosphate; [PRKAA1 gene mutant form co-treated with PRKAA2 gene mutant form] affects the susceptibility to [Glucose co-treated with S 4048]; Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein; PRKAA2 protein affects the reaction [AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form affects the susceptibility to Glucose deficiency]]; PRKAA2 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]]
Glucose results in decreased expression of PRKAA2 mRNA; Glucose results in decreased expression of PRKAA2 protein
[resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]] which results in decreased abundance of Triglycerides; [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]; Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein; PRKAA2 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in increased abundance of Triglycerides]]; PRKAA2 protein promotes the reaction [SIRT1 protein inhibits the reaction [Glucose results in decreased phosphorylation of ACACA protein]]; PRKAA2 protein promotes the reaction [SIRT1 protein inhibits the reaction [Glucose results in increased abundance of Triglycerides]]; PRKAA2 protein promotes the reaction [SIRT1 protein inhibits the reaction [Glucose results in increased expression of FASN protein]]; resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]; SIRT1 protein promotes the reaction [[resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]] which results in decreased abundance of Triglycerides]
PRKAA2 protein mutant form affects the susceptibility to Glucose deficiency 		CTD PMID:15806154 PMID:18482975 PMID:19052259 PMID:23090186 PMID:24349266 More... NCBI chr 5:125,036,945...125,109,010
Ensembl chr 5:125,042,179...125,108,324 		JBrowse link
G Prkar2b protein kinase cAMP-dependent type II regulatory subunit beta increases expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of PRKAR2B mRNA
2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside inhibits the reaction [[Oxygen co-treated with Glucose deficiency] results in decreased expression of PRKAR2B protein]; [Oxygen co-treated with Glucose deficiency] results in decreased expression of PRKAR2B protein; rhodioloside inhibits the reaction [[Oxygen co-treated with Glucose deficiency] results in decreased expression of PRKAR2B protein] 		CTD PMID:17178593 PMID:24726522 NCBI chr 6:54,291,143...54,381,639
Ensembl chr 6:54,291,151...54,381,411 		JBrowse link
G Prkca protein kinase C, alpha multiple interactions
increases phosphorylation 		EXP
ISO 		Glucose promotes the reaction [zinc chloride affects the localization of and results in increased activity of PRKCA protein]
[Glucose co-treated with Silymarin] results in increased phosphorylation of PRKCA protein; Glucose promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of PRKCA protein]
Glucose results in increased phosphorylation of PRKCA protein 		CTD PMID:20800666 PMID:22162761 PMID:29753610 NCBI chr10:93,388,991...93,787,617
Ensembl chr10:93,388,991...93,787,572 		JBrowse link
G Prkcb protein kinase C, beta multiple interactions
increases expression
increases activity
increases phosphorylation 		EXP
ISO 		Glucose results in increased phosphorylation of and affects the localization of PRKCB protein; Glucose results in increased phosphorylation of and results in increased activity of PRKCB protein; PRKCB protein affects the reaction [Glucose results in increased activity of RELA protein]; PRKCB protein affects the reaction [Glucose results in increased expression of NOS2 protein]; PRKCB protein affects the reaction [Glucose results in increased phosphorylation of and affects the localization of NCF1 protein]; PRKCB protein affects the reaction [Glucose results in increased phosphorylation of and affects the localization of NCF2 protein]; PRKCB protein affects the reaction [Glucose results in increased phosphorylation of and affects the localization of RAC1 protein]; PRKCB protein affects the reaction [Glucose results in increased phosphorylation of and results in increased activity of MAPK1 protein]; PRKCB protein affects the reaction [Glucose results in increased phosphorylation of and results in increased activity of MAPK3 protein]; puerarin inhibits the reaction [Glucose results in increased phosphorylation of and affects the localization of PRKCB protein]; ruboxistaurin inhibits the reaction [Glucose results in increased phosphorylation of and results in increased activity of PRKCB protein]
Glucose results in increased expression of PRKCB protein; Glucose results in increased expression of PRKCB protein alternative form
5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate inhibits the reaction [Glucose results in increased expression of PRKCB protein alternative form]; 5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate inhibits the reaction [Glucose results in increased expression of PRKCB protein]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of PRKCB protein alternative form]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of PRKCB protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of PRKCB protein alternative form]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of PRKCB protein]; Mannitol inhibits the reaction [Glucose results in increased expression of PRKCB protein alternative form]; Mannitol inhibits the reaction [Glucose results in increased expression of PRKCB protein]; resveratrol inhibits the reaction [Glucose results in increased activity of PRKCB protein]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of PRKCB protein alternative form]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of PRKCB protein]
Glucose results in increased phosphorylation of PRKCB protein 		CTD PMID:16285992 PMID:19587355 PMID:19854265 PMID:20578705 PMID:22162761 NCBI chr 1:186,263,397...186,594,743
Ensembl chr 1:186,263,447...186,594,740 		JBrowse link
G Prkcd protein kinase C, delta multiple interactions
increases expression 		EXP
ISO 		diphenyleneiodonium inhibits the reaction [Glucose results in increased expression of PRKCD protein]
5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate inhibits the reaction [Glucose results in increased expression of PRKCD protein]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of PRKCD protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of PRKCD protein]; Mannitol inhibits the reaction [Glucose results in increased expression of PRKCD protein]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of PRKCD protein] 		CTD PMID:12821678 PMID:16285992 NCBI chr16:5,775,681...5,806,122
Ensembl chr16:5,775,681...5,805,839 		JBrowse link
G Prkch protein kinase C, eta decreases expression ISO Glucose results in decreased expression of PRKCH mRNA CTD PMID:17178593 NCBI chr 6:98,027,830...98,226,486
Ensembl chr 6:98,027,646...98,226,477 		JBrowse link
G Prkcz protein kinase C, zeta multiple interactions EXP PRKCZ protein promotes the reaction [NRG1 protein results in increased transport of Glucose] CTD PMID:14711829 NCBI chr 5:171,101,774...171,212,694
Ensembl chr 5:171,101,774...171,212,674 		JBrowse link
G Prkg1 protein kinase cGMP-dependent 1 multiple interactions
decreases expression 		EXP acetovanillone inhibits the reaction [Glucose results in decreased expression of PRKG1 protein]; diphenyleneiodonium inhibits the reaction [Glucose results in decreased expression of PRKG1 protein]; Glucose results in decreased expression of and results in decreased activity of PRKG1 protein; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in decreased expression of PRKG1 protein]; Reactive Oxygen Species promotes the reaction [Glucose results in decreased expression of PRKG1 protein]; tempol inhibits the reaction [Glucose results in decreased expression of PRKG1 protein]
Glucose results in decreased expression of PRKG1 mRNA 		CTD PMID:17320767 NCBI chr 1:237,818,950...239,052,184
Ensembl chr 1:237,823,053...239,103,005 		JBrowse link
G Prkg2 protein kinase cGMP-dependent 2 increases expression ISO Glucose results in increased expression of PRKG2 mRNA CTD PMID:17178593 NCBI chr14:10,864,020...10,972,617
Ensembl chr14:10,864,186...10,972,614 		JBrowse link
G Prkn parkin RBR E3 ubiquitin protein ligase multiple interactions
decreases expression 		EXP Inositol inhibits the reaction [Glucose results in decreased expression of PRKN protein] CTD PMID:35243728 NCBI chr 1:51,236,410...52,430,242
Ensembl chr 1:51,210,330...52,430,304 		JBrowse link
G Prlr prolactin receptor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of PRLR mRNA CTD PMID:37567420 NCBI chr 2:60,861,391...61,051,883
Ensembl chr 2:60,861,658...61,051,882 		JBrowse link
G Prnp prion protein multiple interactions ISO [PRNP protein results in increased expression of SLC2A1 protein] which results in increased uptake of Glucose CTD PMID:21265952 NCBI chr 3:139,639,076...139,654,420
Ensembl chr 3:139,630,144...139,658,436 		JBrowse link
G Prok1 prokineticin 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of PROK1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of PROK1 mRNA CTD PMID:37567420 NCBI chr 2:197,538,747...197,547,550
Ensembl chr 2:197,537,068...197,547,550 		JBrowse link
G Prpf40a pre-mRNA processing factor 40 homolog A decreases expression ISO Glucose results in decreased expression of PRPF40A mRNA CTD PMID:17178593 NCBI chr 3:58,036,779...58,098,996
Ensembl chr 3:58,038,042...58,099,363 		JBrowse link
G Prr11 proline rich 11 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PRR11 mRNA CTD PMID:37567420 NCBI chr10:72,396,127...72,440,643
Ensembl chr10:72,398,667...72,418,275 		JBrowse link
G Prr15l proline rich 15-like increases expression ISO Glucose results in increased expression of PRR15L mRNA CTD PMID:39922521 NCBI chr10:82,412,934...82,418,897
Ensembl chr10:82,402,733...82,419,558 		JBrowse link
G Prr18 proline rich 18 increases expression ISO Glucose results in increased expression of PRR18 mRNA CTD PMID:39922521 NCBI chr 1:54,947,775...54,951,558
Ensembl chr 1:54,947,351...54,959,997 		JBrowse link
G Prr32 proline rich 32 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PRR32 mRNA CTD PMID:37567420 NCBI chr  X:128,856,085...128,858,003
Ensembl chr  X:128,856,069...128,857,999 		JBrowse link
G Prr33 proline rich 33 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of PRR33 mRNA CTD PMID:37567420 NCBI chr 1:207,074,382...207,080,233
Ensembl chr 1:207,045,684...207,078,423 		JBrowse link
G Prrg4 proline rich and Gla domain 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of PRRG4 mRNA CTD PMID:37567420 NCBI chr 3:111,669,508...111,698,205
Ensembl chr 3:111,673,582...111,698,205 		JBrowse link
G Prrt3 proline-rich transmembrane protein 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of PRRT3 mRNA CTD PMID:37567420 NCBI chr 4:148,196,800...148,206,086
Ensembl chr 4:148,196,800...148,205,944 		JBrowse link
G Prss53 serine protease 53 increases expression ISO Glucose results in increased expression of PRSS53 mRNA CTD PMID:39922521 NCBI chr 1:191,923,398...191,931,292
Ensembl chr 1:191,925,434...191,955,449 		JBrowse link
G Prtn3 proteinase 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of PRTN3 mRNA CTD PMID:37567420 NCBI chr 7:10,472,750...10,482,037
Ensembl chr 7:10,472,755...10,482,474 		JBrowse link
G Psd2 pleckstrin and Sec7 domain containing 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PSD2 mRNA CTD PMID:37567420 NCBI chr18:27,838,943...27,890,712
Ensembl chr18:27,839,627...27,890,709 		JBrowse link
G Psen1 presenilin 1 multiple interactions ISO [APP protein mutant form co-treated with PSEN1 protein mutant form co-treated with PF-06840003] results in decreased abundance of Glucose; [APP protein mutant form co-treated with PSEN1 protein mutant form] results in increased abundance of Glucose; IDO1 protein affects the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in increased abundance of Glucose] CTD PMID:39172838 NCBI chr 6:109,054,160...109,106,191
Ensembl chr 6:109,060,352...109,106,189 		JBrowse link
G Psen2 presenilin 2 multiple interactions
decreases expression
increases methylation 		ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of PSEN2 mRNA]
Glucose results in increased methylation of PSEN2 gene 		CTD PMID:33448797 NCBI chr13:94,499,451...94,528,419
Ensembl chr13:94,499,928...94,525,116 		JBrowse link
G Psma1 proteasome 20S subunit alpha 1 decreases expression ISO Glucose deficiency results in decreased expression of PSMA1 protein CTD PMID:22314686 NCBI chr 1:177,876,838...177,887,857
Ensembl chr 1:177,875,353...177,887,949 		JBrowse link
G Psmb10 proteasome 20S subunit beta 10 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of PSMB10 mRNA CTD PMID:37567420 NCBI chr19:50,740,808...50,743,292
Ensembl chr19:50,740,811...50,743,210 		JBrowse link
G Psmb5 proteasome 20S subunit beta 5 increases secretion ISO Glucose deficiency results in increased secretion of PSMB5 protein CTD PMID:24802182 NCBI chr15:32,042,784...32,047,379
Ensembl chr15:32,042,787...32,047,379 		JBrowse link
G Psmb8 proteasome 20S subunit beta 8 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of PSMB8 mRNA CTD PMID:37567420 NCBI chr20:4,654,068...4,657,049
Ensembl chr20:4,654,068...4,657,031 		JBrowse link
G Psors1c2 psoriasis susceptibility 1 candidate 2 multiple interactions
increases expression 		ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of PSORS1C2 mRNA
Glucose results in increased expression of PSORS1C2 mRNA 		CTD PMID:37567420 PMID:39922521 NCBI chr20:3,206,886...3,208,307
Ensembl chr20:3,206,886...3,208,307 		JBrowse link
G Ptafr platelet-activating factor receptor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of PTAFR mRNA CTD PMID:37567420 NCBI chr 5:150,049,322...150,079,060
Ensembl chr 5:150,049,460...150,079,408 		JBrowse link
G Ptch1 patched 1 multiple interactions ISO [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTCH1 protein; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTCH1 protein]; SHH protein affects the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTCH1 protein] CTD PMID:27481074 NCBI chr17:1,548,449...1,613,461
Ensembl chr17:1,548,449...1,613,461 		JBrowse link
G Pten phosphatase and tensin homolog multiple interactions
increases expression 		ISO HAGLR protein affects the reaction [Glucose results in increased expression of PTEN protein]; HAGLR protein inhibits the reaction [MIR106B inhibits the reaction [Glucose results in increased expression of PTEN protein]]; MIR106B inhibits the reaction [Glucose results in increased expression of PTEN protein]; PTEN protein affects the reaction [HAGLR protein affects the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; PTEN protein affects the reaction [HAGLR protein affects the reaction [Glucose results in increased expression of and results in increased cleavage of CASP1 protein]]; PTEN protein affects the reaction [HAGLR protein affects the reaction [Glucose results in increased expression of GSDMD protein]]; PTEN protein affects the reaction [HAGLR protein affects the reaction [Glucose results in increased expression of IL18 protein]]; PTEN protein affects the reaction [HAGLR protein affects the reaction [Glucose results in increased expression of IL1B protein]]; PTEN protein affects the reaction [HAGLR protein affects the reaction [Glucose results in increased expression of NLRP3 protein]] CTD PMID:38088496 NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330 		JBrowse link
G Ptgds prostaglandin D2 synthase decreases secretion ISO Glucose deficiency results in decreased secretion of PTGDS protein CTD PMID:24802182 NCBI chr 3:28,680,044...28,682,978
Ensembl chr 3:28,680,044...28,682,978 		JBrowse link
G Ptger1 prostaglandin E receptor 1 increases expression EXP Glucose results in increased expression of PTGER1 mRNA CTD PMID:12888618 NCBI chr19:41,374,983...41,379,593
Ensembl chr19:41,374,471...41,378,284 		JBrowse link
G Ptger4 prostaglandin E receptor 4 increases expression EXP Glucose results in increased expression of PTGER4 mRNA; Glucose results in increased expression of PTGER4 protein CTD PMID:12888618 NCBI chr 2:56,061,699...56,074,594
Ensembl chr 2:56,062,890...56,074,135 		JBrowse link
G Ptges prostaglandin E synthase decreases expression ISO Glucose results in decreased expression of PTGES mRNA CTD PMID:39613055 NCBI chr 3:34,575,643...34,586,987
Ensembl chr 3:34,575,639...34,586,995 		JBrowse link
G Ptgis prostaglandin I2 synthase decreases activity ISO Glucose decreases activity of PTGIS protein in aortic endothelial cells RGD PMID:11756341 RGD:401960102 NCBI chr 3:176,347,589...176,383,251
Ensembl chr 3:176,335,437...176,407,650 		JBrowse link
G Ptgs1 prostaglandin-endoperoxide synthase 1 increases expression EXP
ISO 		Glucose results in increased expression of PTGS1 protein
Glucose results in increased expression of PTGS1 mRNA 		CTD PMID:12888618 PMID:32942007 NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:39,981,415...40,002,990 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases expression
decreases expression 		ISO
EXP 		2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased expression of PTGS2 protein]]; [Oxygen deficiency co-treated with Glucose deficiency] inhibits the reaction [Vehicle Emissions results in increased expression of PTGS2 protein]; Captopril inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; Carbonyl Cyanide m-Chlorophenyl Hydrazone inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; Carbonyl Cyanide m-Chlorophenyl Hydrazone inhibits the reaction [Glucose results in increased expression of PTGS2 protein]; Catechin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; Catechin inhibits the reaction [Glucose results in increased expression of PTGS2 protein]; epigallocatechin gallate inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; epigallocatechin gallate inhibits the reaction [Glucose results in increased expression of PTGS2 protein]; huai qi huang inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; Luteolin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; Luteolin inhibits the reaction [Glucose results in increased expression of PTGS2 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of PTGS2 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of PTGS2 protein]; Rosiglitazone inhibits the reaction [Glucose results in decreased expression of PTGS2 protein]; Rutin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; Rutin inhibits the reaction [Glucose results in increased expression of PTGS2 protein]; Simvastatin promotes the reaction [Glucose promotes the reaction [AGT protein results in increased expression of PTGS2 mRNA]]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of PTGS2 protein]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTGS2 mRNA; IL1RN protein inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; IL1RN protein inhibits the reaction [Glucose results in increased expression of PTGS2 protein]; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTGS2 mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of PTGS2 protein]
Glucose results in increased expression of PTGS2 mRNA; Glucose results in increased expression of PTGS2 protein
Glucose results in decreased expression of PTGS2 mRNA; Glucose results in decreased expression of PTGS2 protein
[Glucose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTGS2 protein; NFKB1 protein inhibits the reaction [SOD1 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTGS2 protein]]; SOD1 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTGS2 protein] 		CTD PMID:12888618 PMID:14514642 PMID:16395278 PMID:17178593 PMID:19225232 More... NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320 		JBrowse link
G Ptgs2os prostaglandin-endoperoxide synthase 2, opposite strand multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of PTGS2OS mRNA] CTD PMID:33448797 NCBI chr13:64,710,129...64,713,837 JBrowse link
G Ptk2 protein tyrosine kinase 2 multiple interactions
decreases expression 		ISO
EXP 		Eucalyptol inhibits the reaction [Glucose results in decreased expression of PTK2 protein]; Glucose inhibits the reaction [IL1B protein results in increased phosphorylation of PTK2 protein]
[Oxygen deficiency co-treated with Glucose deficiency] results in decreased phosphorylation of PTK2 protein; Isoflurane affects the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased phosphorylation of PTK2 protein]; Thiopental affects the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased phosphorylation of PTK2 protein]
Glucose results in decreased expression of PTK2 mRNA 		CTD PMID:15194624 PMID:30098273 PMID:31483951 PMID:31655124 NCBI chr 7:107,015,730...107,220,865
Ensembl chr 7:107,015,733...107,172,091 		JBrowse link
G Ptpn1 protein tyrosine phosphatase, non-receptor type 1 increases expression ISO Glucose increases expression of Ptpn1 protein in photoreceptor cells RGD PMID:28050125 RGD:401976377 NCBI chr 3:177,056,588...177,106,424
Ensembl chr 3:177,057,659...177,106,416 		JBrowse link
G Ptpn7 protein tyrosine phosphatase, non-receptor type 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of PTPN7 mRNA CTD PMID:37567420 NCBI chr13:49,122,679...49,136,096
Ensembl chr13:49,122,609...49,136,094 		JBrowse link
G Ptprh protein tyrosine phosphatase, receptor type, H multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of PTPRH mRNA CTD PMID:37567420 NCBI chr 1:78,272,414...78,318,977
Ensembl chr 1:78,271,276...78,318,977 		JBrowse link
G Pvr PVR cell adhesion molecule increases expression ISO Glucose results in increased expression of PVR mRNA CTD PMID:17178593 NCBI chr 1:88,689,235...88,704,641
Ensembl chr 1:88,688,981...88,704,630 		JBrowse link
G Pxmp2 peroxisomal membrane protein 2 increases expression ISO Glucose results in increased expression of PXMP2 mRNA CTD PMID:39922521 NCBI chr12:52,053,951...52,064,283
Ensembl chr12:52,053,788...52,064,283 		JBrowse link
G Pxn paxillin multiple interactions
increases expression
decreases expression 		ISO Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]; Eucalyptol inhibits the reaction [Glucose results in increased expression of PXN protein modified form]; RHOA protein inhibits the reaction [Glucose results in decreased expression of PXN protein]; RHOA protein promotes the reaction [Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]] CTD PMID:31483951 NCBI chr12:46,721,546...46,768,706
Ensembl chr12:46,721,546...46,768,697 		JBrowse link
G Pycard PYD and CARD domain containing multiple interactions
increases expression 		ISO
EXP 		[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PYCARD protein; Allopurinol inhibits the reaction [Glucose results in increased expression of PYCARD protein]; bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PYCARD protein]; Quercetin inhibits the reaction [Glucose results in increased expression of PYCARD protein]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PYCARD protein; Allopurinol inhibits the reaction [Glucose results in increased expression of PYCARD protein]; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PYCARD protein]; Quercetin inhibits the reaction [Glucose results in increased expression of PYCARD protein]; rhodioloside inhibits the reaction [Glucose results in increased expression of PYCARD protein] 		CTD PMID:23647015 PMID:29031534 PMID:35191607 PMID:37127800 NCBI chr 1:192,032,124...192,033,419
Ensembl chr 1:192,032,124...192,033,419 		JBrowse link
G Pygl glycogen phosphorylase L multiple interactions EXP Glucose inhibits the reaction [[Phenylephrine co-treated with Calcium] results in increased activity of PYGL protein] CTD PMID:747652 NCBI chr 6:94,433,558...94,476,219
Ensembl chr 6:94,426,346...94,476,269 		JBrowse link
G Pyy peptide YY affects expression EXP Glucose affects the expression of PYY protein CTD PMID:18627777 NCBI chr10:87,561,347...87,562,470
Ensembl chr10:87,561,353...87,562,206 		JBrowse link
G Pzp2 PZP alpha-2-macroglobulin like 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of PZP mRNA CTD PMID:37567420 NCBI chr 4:163,445,265...163,491,358
Ensembl chr 4:163,445,271...163,491,363 		JBrowse link
G Qpct glutaminyl-peptide cyclotransferase multiple interactions ISO [imeglimin co-treated with Glucose] results in increased expression of QPCT mRNA CTD PMID:34588186 NCBI chr 6:21,716,824...21,748,895
Ensembl chr 6:21,716,824...21,748,895 		JBrowse link
G R3hdml R3H domain containing-like multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of R3HDML mRNA CTD PMID:37567420 NCBI chr 3:172,590,815...172,601,584
Ensembl chr 3:172,590,815...172,602,009 		JBrowse link
G Rab11fip4 RAB11 family interacting protein 4 increases expression ISO Glucose results in increased expression of RAB11FIP4 mRNA CTD PMID:39922521 NCBI chr10:65,048,070...65,156,086
Ensembl chr10:65,048,140...65,152,722 		JBrowse link
G Rab3b RAB3B, member RAS oncogene family increases expression ISO Glucose results in increased expression of RAB3B mRNA CTD PMID:39613055 NCBI chr 5:128,859,034...128,926,087
Ensembl chr 5:128,841,716...128,926,086 		JBrowse link
G Rab40b Rab40b, member RAS oncogene family decreases expression
multiple interactions 		ISO Glucose results in decreased expression of RAB40B mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of RAB40B mRNA] 		CTD PMID:33448797 NCBI chr10:107,129,801...107,157,375
Ensembl chr10:107,129,801...107,157,457 		JBrowse link
G Rab42 RAB42, member RAS oncogene family multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of RAB42 mRNA CTD PMID:37567420 NCBI chr 5:149,781,181...149,782,851
Ensembl chr 5:149,781,181...149,782,851 		JBrowse link
G Rac1 Rac family small GTPase 1 multiple interactions
increases expression
increases activity
increases localization
affects localization 		ISO
EXP 		Atorvastatin inhibits the reaction [Glucose results in increased localization of RAC1 protein]; bisindolylmaleimide I inhibits the reaction [Glucose affects the localization of RAC1 protein]; geranylgeranyl pyrophosphate inhibits the reaction [Atorvastatin inhibits the reaction [Glucose results in increased localization of RAC1 protein]]; PRKAA1 protein affects the reaction [Rosiglitazone inhibits the reaction [Glucose affects the localization of RAC1 protein]]; Rosiglitazone inhibits the reaction [Glucose affects the localization of RAC1 protein]
Glucose results in increased expression of RAC1 protein
Glucose results in increased activity of RAC1 protein
dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased activity of RAC1 protein]]; Glucose results in increased phosphorylation of and affects the localization of RAC1 protein; PRKCB protein affects the reaction [Glucose results in increased phosphorylation of and affects the localization of RAC1 protein]; puerarin inhibits the reaction [Glucose results in increased phosphorylation of and affects the localization of RAC1 protein]; Resveratrol inhibits the reaction [Glucose results in increased activity of RAC1 protein]
[Resveratrol co-treated with Glucose] results in decreased expression of RAC1 mRNA; Eucalyptol inhibits the reaction [Glucose results in increased expression of RAC1 protein] 		CTD PMID:17279352 PMID:17916771 PMID:19854265 PMID:24659233 PMID:26054749 More... NCBI chr12:16,150,411...16,170,864
Ensembl chr12:16,128,649...16,172,109 		JBrowse link
G Rad51b RAD51 paralog B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of RAD51B mRNA CTD PMID:37567420 NCBI chr 6:103,829,390...104,373,923
Ensembl chr 6:103,829,554...104,374,509 		JBrowse link
G Raet1e retinoic acid early transcript 1E increases expression ISO Glucose results in increased expression of RAET1E mRNA CTD PMID:39613055 NCBI chr 1:3,474,487...3,476,431 JBrowse link
G Raf1 Raf-1 proto-oncogene, serine/threonine kinase multiple interactions
increases phosphorylation 		ISO MIR1231 inhibits the reaction [Glucose results in increased phosphorylation of RAF1 protein]; Resveratrol inhibits the reaction [Glucose results in increased phosphorylation of RAF1 protein] CTD PMID:38156429 NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:150,352,160...150,412,813 		JBrowse link
G Ramp2 receptor activity modifying protein 2 increases expression ISO Glucose results in increased expression of RAMP2 mRNA CTD PMID:17178593 NCBI chr10:86,689,148...86,690,956
Ensembl chr10:86,688,703...86,691,231 		JBrowse link
G Ramp3 receptor activity modifying protein 3 increases expression ISO Glucose results in increased expression of RAMP3 mRNA CTD PMID:17178593 NCBI chr14:85,741,314...85,758,813
Ensembl chr14:85,755,211...85,758,818 		JBrowse link
G Ranbp17 RAN binding protein 17 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of RANBP17 mRNA CTD PMID:37567420 NCBI chr10:18,304,634...18,607,162
Ensembl chr10:18,305,227...18,607,047 		JBrowse link
G Rarres2 retinoic acid receptor responder 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RARRES2 mRNA CTD PMID:37567420 NCBI chr 4:78,853,450...78,856,652
Ensembl chr 4:78,853,453...78,856,457 		JBrowse link
G Rasl12 RAS-like, family 12 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of RASL12 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RASL12 mRNA CTD PMID:37567420 NCBI chr 8:74,813,000...74,827,041
Ensembl chr 8:74,813,000...74,827,897 		JBrowse link
G Rassf4 Ras association domain family member 4 increases expression ISO Glucose results in increased expression of RASSF4 mRNA CTD PMID:39922521 NCBI chr 4:151,569,984...151,605,203
Ensembl chr 4:151,569,984...151,604,883 		JBrowse link
G Rb1 RB transcriptional corepressor 1 multiple interactions
increases expression 		ISO Fluorometholone inhibits the reaction [Glucose results in increased expression of RB1 protein] CTD PMID:35264022 NCBI chr15:54,780,858...54,911,989
Ensembl chr15:54,780,858...54,911,857 		JBrowse link
G Rbm11 RNA binding motif protein 11 increases expression ISO Glucose results in increased expression of RBM11 mRNA CTD PMID:39922521 NCBI chr11:27,721,870...27,731,125
Ensembl chr11:27,721,866...27,731,120 		JBrowse link
G Rbm3 RNA binding motif protein 3 increases expression ISO Glucose results in increased expression of RBM3 mRNA CTD PMID:10026205 NCBI chr  X:17,020,863...17,024,341
Ensembl chr  X:17,020,864...17,024,841 		JBrowse link
G Rbp4 retinol binding protein 4 increases abundance ISO RBP4 protein results in increased abundance of Glucose CTD PMID:31228551 NCBI chr 1:245,306,349...245,313,551
Ensembl chr 1:245,306,349...245,313,898 		JBrowse link
G Rbpjl recombination signal binding protein for immunoglobulin kappa J region-like multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of RBPJL mRNA CTD PMID:37567420 NCBI chr 3:173,553,389...173,565,869
Ensembl chr 3:173,553,498...173,565,869 		JBrowse link
G Rd3 RD3 regulator of GUCY2D multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of RD3 mRNA CTD PMID:37567420 NCBI chr13:106,060,657...106,097,063
Ensembl chr13:106,084,171...106,093,540 		JBrowse link
G Rdh10 retinol dehydrogenase 10 decreases expression ISO Glucose results in decreased expression of RDH10 mRNA CTD PMID:25627686 NCBI chr 5:7,969,931...7,998,834
Ensembl chr 5:7,971,705...7,999,019 		JBrowse link
G Rec114 REC114 meiotic recombination protein increases expression ISO Glucose results in increased expression of REC114 mRNA CTD PMID:39922521 NCBI chr 8:67,959,181...68,117,296
Ensembl chr 8:67,958,421...68,119,234 		JBrowse link
G Recql4 RecQ like helicase 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of RECQL4 mRNA CTD PMID:37567420 NCBI chr 7:110,304,092...110,311,426
Ensembl chr 7:110,304,094...110,311,258 		JBrowse link
G Reep1 receptor accessory protein 1 increases expression ISO Glucose results in increased expression of REEP1 mRNA CTD PMID:39922521 NCBI chr 4:105,303,974...105,420,611
Ensembl chr 4:105,303,969...105,420,602 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions
increases expression
affects localization
increases phosphorylation
increases activity
decreases phosphorylation 		ISO
EXP 		[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of RELA mRNA; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of CCL2 protein]; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of TNF mRNA]; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of TNF protein]; [Resveratrol affects the localization of RELA protein] which results in decreased susceptibility to Glucose; aspalathin inhibits the reaction [Glucose affects the localization of RELA protein]; Aspirin inhibits the reaction [Glucose results in increased expression of RELA protein]; Bosentan inhibits the reaction [Glucose results in increased activity of RELA protein]; Captopril inhibits the reaction [Glucose results in increased phosphorylation of and results in increased localization of RELA protein]; Catechin inhibits the reaction [Glucose affects the localization of RELA protein]; chelerythrine inhibits the reaction [Glucose results in increased activity of RELA protein]; Clofibrate inhibits the reaction [Glucose results in increased expression of RELA protein]; Curcumin inhibits the reaction [Glucose results in increased activity of RELA protein]; epigallocatechin gallate inhibits the reaction [Glucose affects the localization of RELA protein]; Fenofibrate inhibits the reaction [Glucose results in increased expression of RELA protein]; GLO1 inhibits the reaction [Glucose promotes the reaction [RELA protein binds to AGER promoter]]; Glucose promotes the reaction [RELA protein binds to AGER promoter]; Glucose promotes the reaction [RELA protein binds to MMP9 promoter]; Glucose promotes the reaction [RELA protein binds to SRI promoter]; Glucose results in increased phosphorylation of and results in increased localization of RELA protein; huai qi huang inhibits the reaction [Glucose results in increased phosphorylation of and results in increased localization of RELA protein]; isoangustone A inhibits the reaction [Glucose affects the localization of RELA protein]; Lipopolysaccharides inhibits the reaction [swietenine inhibits the reaction [Glucose results in increased expression of RELA protein]]; Lipopolysaccharides promotes the reaction [Glucose results in increased expression of RELA protein]; Luteolin inhibits the reaction [Glucose affects the localization of RELA protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose promotes the reaction [RELA protein binds to MMP9 promoter]]; nothofagin inhibits the reaction [Glucose affects the localization of RELA protein]; PARP1 protein affects the reaction [Glucose promotes the reaction [RELA protein binds to MMP9 promoter]]; Phytic Acid inhibits the reaction [Glucose results in increased phosphorylation of RELA protein]; Polyphenols inhibits the reaction [Glucose results in increased phosphorylation of RELA protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose affects the localization of RELA protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased activity of RELA protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased expression of RELA protein]; pyrrolidine dithiocarbamic acid promotes the reaction [swietenine inhibits the reaction [Glucose results in increased expression of RELA protein]]; Quercetin inhibits the reaction [Glucose affects the localization of RELA protein]; RELA promotes the reaction [Glucose results in increased expression of AGER mRNA]; RELA protein affects the reaction [Glucose affects the localization of MLXIP protein]; RELA protein affects the reaction [Glucose results in decreased expression of SRI protein]; Rutin inhibits the reaction [Glucose affects the localization of RELA protein]; sitaxsentan inhibits the reaction [Glucose results in increased activity of RELA protein]; SN50 peptide inhibits the reaction [Glucose results in increased activity of RELA protein]; swietenine inhibits the reaction [Glucose results in increased expression of RELA protein]
Glucose results in increased expression of RELA mRNA; Glucose results in increased expression of RELA protein; Glucose results in increased expression of RELA protein modified form
3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Glucose results in increased expression of and affects the localization of RELA protein]; ALB protein modified form inhibits the reaction [Glucose results in increased phosphorylation of RELA protein]; Artesunate inhibits the reaction [Glucose results in increased phosphorylation of RELA protein]; Ellagic Acid inhibits the reaction [Glucose results in increased expression of RELA protein]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Glucose results in increased phosphorylation of RELA protein]; Gallic Acid inhibits the reaction [Glucose results in increased expression of RELA protein]; Glucose results in increased expression of and affects the localization of RELA protein; MK615 extract inhibits the reaction [ALB protein modified form inhibits the reaction [Glucose results in increased phosphorylation of RELA protein]]; PRKCB protein affects the reaction [Glucose results in increased activity of RELA protein]; prolinedithiocarbamate inhibits the reaction [Glucose affects the localization of RELA protein]; Quercetin inhibits the reaction [Glucose affects the localization of RELA protein]; Quercetin inhibits the reaction [Glucose results in increased expression of RELA mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of RELA protein]; ruboxistaurin inhibits the reaction [Glucose results in increased activity of RELA protein]; Y 27632 inhibits the reaction [Glucose affects the localization of RELA protein]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of and affects the localization of RELA protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of RELA protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of RELA protein; [Ribose co-treated with Glucose] affects the localization of RELA protein; AGER protein affects the reaction [Ribose promotes the reaction [Glucose results in increased phosphorylation of RELA protein]]; diphenyleneiodonium inhibits the reaction [Glucose promotes the reaction [Particulate Matter affects the localization of RELA protein]]; Glucose promotes the reaction [Particulate Matter affects the localization of RELA protein]; Glucose results in increased phosphorylation of and affects the localization of RELA protein; Prodigiosin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of RELA protein]; prolinedithiocarbamate inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of RELA protein]; RELA protein modified form promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of SLC11A2 mRNA alternative form]; RELA protein promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of SLC11A2 mRNA alternative form]; Ribose promotes the reaction [Glucose results in increased phosphorylation of RELA protein]
Glucose results in decreased phosphorylation of RELA protein 		CTD PMID:12388107 PMID:16395278 PMID:16600694 PMID:19557821 PMID:19587355 More... NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817 		JBrowse link
G Ren renin increases expression EXP Glucose results in increased expression of REN mRNA; Glucose results in increased expression of REN protein CTD PMID:19861503 NCBI chr13:47,348,312...47,359,539
Ensembl chr13:47,348,143...47,359,543 		JBrowse link
G Ret ret proto-oncogene increases expression EXP Glucose results in increased expression of RET mRNA CTD PMID:21818840 NCBI chr 4:152,998,344...153,040,556
Ensembl chr 4:152,998,812...153,040,556 		JBrowse link
G Retn resistin decreases uptake
multiple interactions 		ISO RETN protein results in decreased uptake of Glucose
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of RETN mRNA 		CTD PMID:14671216 PMID:37567420 NCBI chr12:6,508,653...6,511,115
Ensembl chr12:6,508,801...6,511,116 		JBrowse link
G Retreg1 reticulophagy regulator 1 decreases expression
multiple interactions 		EXP Glucose results in decreased expression of RETREG1 protein
Chlorogenic Acid inhibits the reaction [Glucose results in decreased expression of RETREG1 protein] 		CTD PMID:34801538 NCBI chr 2:78,045,435...78,205,316
Ensembl chr 2:78,066,031...78,225,356 		JBrowse link
G Rgcc regulator of cell cycle increases expression ISO Glucose results in increased expression of RGCC mRNA CTD PMID:39922521 NCBI chr15:61,071,574...61,084,408
Ensembl chr15:61,071,574...61,084,408 		JBrowse link
G Rhd Rh blood group, D antigen multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of RHD mRNA CTD PMID:37567420 NCBI chr 5:152,371,160...152,405,396
Ensembl chr 5:152,371,200...152,405,395 		JBrowse link
G Rhoa ras homolog family member A increases activity
multiple interactions
increases expression 		EXP
ISO 		Glucose results in increased activity of RHOA protein
Eucalyptol inhibits the reaction [Glucose results in increased expression of RHOA protein]; RHOA protein inhibits the reaction [Eucalyptol inhibits the reaction [Glucose results in increased expression of GSK3B protein]]; RHOA protein inhibits the reaction [Glucose results in decreased expression of PXN protein]; RHOA protein inhibits the reaction [Glucose results in decreased expression of VCL protein]; RHOA protein promotes the reaction [Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]]; RHOA protein promotes the reaction [Eucalyptol inhibits the reaction [Glucose results in decreased expression of VCL protein]]; RHOA protein promotes the reaction [Glucose results in increased expression of GSK3B protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased activity of RHOA protein] 		CTD PMID:22031849 PMID:23376009 PMID:31483951 NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:117,870,270...117,904,302 		JBrowse link
G Rhob ras homolog family member B increases expression ISO Glucose results in increased expression of RHOB mRNA CTD PMID:17178593 PMID:39922521 NCBI chr 6:37,083,030...37,085,204
Ensembl chr 6:37,075,015...37,112,772 		JBrowse link
G Rhoxf2b Rhox homeobox family member 2B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of RHOX6 mRNA CTD PMID:37567420 NCBI chr  X:121,373,153...121,379,870
Ensembl chr  X:121,373,165...121,379,545 		JBrowse link
G Rhpn1 rhophilin, Rho GTPase binding protein 1 increases expression ISO Glucose results in increased expression of RHPN1 mRNA CTD PMID:39922521 NCBI chr 7:109,272,676...109,283,444
Ensembl chr 7:109,272,715...109,283,444 		JBrowse link
G Ribc2 RIB43A domain with coiled-coils 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of RIBC2 mRNA CTD PMID:37567420 NCBI chr 7:118,122,722...118,137,772
Ensembl chr 7:118,122,408...118,137,767 		JBrowse link
G Rimbp3 RIMS binding protein 3 increases expression
multiple interactions 		ISO Glucose results in increased expression of RIMBP3 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of RIMBP3 mRNA] 		CTD PMID:33448797 NCBI chr11:97,288,041...97,293,616
Ensembl chr11:97,273,234...97,303,170 		JBrowse link
G Ripk1 receptor interacting serine/threonine kinase 1 multiple interactions
increases expression 		EXP [Glucose co-treated with Lycopene] results in increased expression of RIPK1 mRNA
Glucose results in increased expression of RIPK1 mRNA 		CTD PMID:38444079 NCBI chr17:31,044,983...31,077,167
Ensembl chr17:31,044,994...31,077,167 		JBrowse link
G Ripk3 receptor-interacting serine-threonine kinase 3 multiple interactions
increases expression 		EXP [Glucose co-treated with Lycopene] results in increased expression of RIPK3 mRNA
Glucose results in increased expression of RIPK3 mRNA 		CTD PMID:38444079 NCBI chr15:33,253,071...33,262,025
Ensembl chr15:33,253,071...33,262,025 		JBrowse link
G Rmi2 RecQ mediated genome instability 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of RMI2 mRNA CTD PMID:37567420 NCBI chr10:5,336,269...5,344,202
Ensembl chr10:5,338,060...5,344,235 		JBrowse link
G Rnasel ribonuclease L multiple interactions ISO [2',5'-oligoadenylate binds to and results in increased activity of RNASEL protein] which results in increased uptake of Glucose CTD PMID:24651439 NCBI chr13:68,446,641...68,460,804
Ensembl chr13:68,446,882...68,459,557 		JBrowse link
G Rnd3 Rho family GTPase 3 increases expression ISO Glucose results in increased expression of RND3 mRNA CTD PMID:39613055 NCBI chr 3:55,981,142...55,998,494
Ensembl chr 3:55,980,355...55,998,536 		JBrowse link
G Rnf149 ring finger protein 149 increases expression ISO Glucose results in increased expression of RNF149 mRNA CTD PMID:39922521 NCBI chr 9:49,322,524...49,350,361
Ensembl chr 9:49,323,857...49,350,042 		JBrowse link
G Rnf180 ring finger protein 180 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of RNF180 mRNA CTD PMID:37567420 NCBI chr 2:38,064,026...38,244,854
Ensembl chr 2:38,064,031...38,265,358 		JBrowse link
G Rnf24 ring finger protein 24 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of RNF24 mRNA CTD PMID:37567420 NCBI chr 3:138,973,492...138,987,354
Ensembl chr 3:138,973,492...139,028,177 		JBrowse link
G Rnf43 ring finger protein 43 increases expression ISO Glucose results in increased expression of RNF43 mRNA CTD PMID:39922521 NCBI chr10:72,958,744...73,034,540
Ensembl chr10:72,961,641...73,034,551 		JBrowse link
G Rock1 Rho-associated coiled-coil containing protein kinase 1 multiple interactions
increases expression 		EXP
ISO 		[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased expression of ROCK1 protein; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased expression of ROCK1 protein]
Glucose results in increased expression of ROCK1 protein
Eucalyptol inhibits the reaction [Glucose results in increased expression of ROCK1 protein] 		CTD PMID:25305180 PMID:31483951 NCBI chr18:1,387,360...1,509,218
Ensembl chr18:1,387,360...1,509,147 		JBrowse link
G Rpgrip1 RPGR interacting protein 1 increases expression ISO Glucose results in increased expression of RPGRIP1 mRNA CTD PMID:39922521 NCBI chr15:27,282,997...27,341,021
Ensembl chr15:27,282,998...27,341,021 		JBrowse link
G Rpl13a ribosomal protein L13A multiple interactions EXP RPL13A protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 1:104,746,223...104,748,975
Ensembl chr 1:104,746,223...104,748,914 		JBrowse link
G Rpl18a ribosomal protein L18A increases expression ISO Glucose results in increased expression of RPL18A mRNA CTD PMID:39613055 NCBI chr16:18,576,467...18,578,653
Ensembl chr 1:70,166,729...70,167,654
Ensembl chr16:70,166,729...70,167,654 		JBrowse link
G Rpl23 ribosomal protein L23 increases expression ISO Glucose results in increased expression of RPL23 mRNA CTD PMID:39613055 NCBI chr10:83,268,223...83,272,184
Ensembl chr10:83,262,592...83,272,214 		JBrowse link
G Rpl35 ribosomal protein L35 increases expression ISO Glucose results in increased expression of RPL35 mRNA CTD PMID:39613055 NCBI chr 3:43,162,960...43,166,485
Ensembl chr 3:43,162,764...43,165,947 		JBrowse link
G Rpl9 ribosomal protein L9 increases expression ISO Glucose results in increased expression of RPL9 mRNA CTD PMID:39613055 NCBI chr14:43,247,536...43,250,784
Ensembl chr14:43,247,588...43,250,782
Ensembl chr 1:43,247,588...43,250,782 		JBrowse link
G Rps12 ribosomal protein S12 decreases expression ISO Glucose deficiency results in decreased expression of RPS12 protein CTD PMID:22314686 NCBI chr 1:23,499,943...23,502,234
Ensembl chr 1:23,500,073...23,502,235 		JBrowse link
G Rps15a ribosomal protein S15a increases expression ISO Glucose results in increased expression of RPS15A mRNA CTD PMID:39613055 NCBI chr 1:181,854,396...181,861,330
Ensembl chr 1:181,854,396...181,861,201 		JBrowse link
G Rps2 ribosomal protein S2 increases expression ISO Glucose results in increased expression of RPS2 mRNA CTD PMID:39613055 NCBI chr10:14,251,841...14,253,697
Ensembl chr10:14,251,380...14,253,695 		JBrowse link
G Rps3a ribosomal protein S3a increases expression ISO Glucose results in increased expression of RPS3A mRNA CTD PMID:39613055 NCBI chr 2:173,822,673...173,827,042
Ensembl chr 2:173,822,488...173,827,043 		JBrowse link
G Rps5 ribosomal protein S5 increases expression ISO Glucose results in increased expression of RPS5 mRNA CTD PMID:39613055 NCBI chr 1:82,610,965...82,615,262
Ensembl chr 1:82,610,965...82,615,262 		JBrowse link
G Rps6 ribosomal protein S6 multiple interactions EXP resveratrol inhibits the reaction [Glucose results in increased phosphorylation of RPS6 protein] CTD PMID:20332614 NCBI chr 5:106,417,680...106,420,540
Ensembl chr 5:106,417,680...106,420,566 		JBrowse link
G Rps6kb1 ribosomal protein S6 kinase B1 increases phosphorylation
multiple interactions
decreases phosphorylation 		ISO
EXP 		Glucose results in increased phosphorylation of RPS6KB1 protein
gastrodin inhibits the reaction [Glucose results in decreased phosphorylation of RPS6KB1 protein]
gastrodin inhibits the reaction [Glucose results in decreased phosphorylation of RPS6KB1 protein]; HU 308 inhibits the reaction [Glucose results in increased phosphorylation of RPS6KB1 protein]; Sirolimus inhibits the reaction [Glucose results in increased phosphorylation of RPS6KB1 protein] 		CTD PMID:30459625 PMID:33764184 PMID:35445903 NCBI chr10:71,817,794...71,865,211
Ensembl chr10:71,815,614...71,865,238 		JBrowse link
G Rps9 ribosomal protein S9 decreases expression ISO Glucose results in decreased expression of RPS9 mRNA CTD PMID:39613055 NCBI chr 1:74,427,084...74,430,513
Ensembl chr 1:74,427,087...74,430,105 		JBrowse link
G Rpsa ribosomal protein SA decreases expression
multiple interactions 		ISO
EXP 		Glucose deficiency results in decreased expression of RPSA protein
RPSA protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] 		CTD PMID:21124846 PMID:22314686 NCBI chr 8:128,728,761...128,732,736
Ensembl chr 8:128,728,862...128,732,737 		JBrowse link
G Rptn repetin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of RPTN mRNA CTD PMID:37567420 NCBI chr 2:181,743,463...181,750,101
Ensembl chr 2:181,745,307...181,749,364 		JBrowse link
G RT1-Bb RT1 class II, locus Bb multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of H2-AB1 mRNA CTD PMID:37567420 NCBI chr20:4,598,475...4,604,118
Ensembl chr20:4,598,475...4,604,118 		JBrowse link
G RT1-DMa RT1 class II, locus DMa multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of H2-DMA mRNA CTD PMID:37567420 NCBI chr20:4,708,932...4,712,335
Ensembl chr20:4,708,933...4,712,335 		JBrowse link
G RT1-DMb RT1 class II, locus DMb multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of H2-DMB1 mRNA CTD PMID:37567420 NCBI chr20:4,695,009...4,702,560
Ensembl chr20:4,695,010...4,702,246 		JBrowse link
G RT1-M3-1 RT1 class Ib, locus M3, gene 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of H2-M3 mRNA CTD PMID:37567420 NCBI chr20:1,329,227...1,333,394
Ensembl chr20:1,329,225...1,333,366 		JBrowse link
G Rtn3 reticulon 3 multiple interactions
increases expression 		EXP Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of RTN3 protein]; Metformin inhibits the reaction [Glucose results in increased expression of RTN3 protein] CTD PMID:34801538 NCBI chr 1:214,041,838...214,098,644
Ensembl chr 1:214,041,838...214,109,638 		JBrowse link
G Rtn4rl2 reticulon 4 receptor-like 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RTN4RL2 mRNA CTD PMID:37567420 NCBI chr 3:90,361,234...90,377,775
Ensembl chr 3:90,361,839...90,377,974 		JBrowse link
G Rtp4 receptor (chemosensory) transporter protein 4 multiple interactions
increases expression 		ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of RTP4 mRNA; fucoxanthin inhibits the reaction [Glucose results in increased expression of RTP4 mRNA] CTD PMID:33448797 PMID:37567420 NCBI chr11:90,741,992...90,840,061
Ensembl chr11:90,741,992...90,753,851 		JBrowse link
G Rubcnl rubicon like autophagy enhancer multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RUBCNL mRNA CTD PMID:37567420 NCBI chr15:56,741,897...56,807,086
Ensembl chr15:56,741,869...56,779,649 		JBrowse link
G Rufy4 RUN and FYVE domain containing 4 increases expression ISO Glucose results in increased expression of RUFY4 mRNA CTD PMID:39922521 NCBI chr 9:83,152,139...83,172,683
Ensembl chr 9:83,154,445...83,172,897 		JBrowse link
G Rundc3b RUN domain containing 3B increases expression ISO Glucose results in increased expression of RUNDC3B mRNA CTD PMID:39922521 NCBI chr 4:26,417,501...26,554,404
Ensembl chr 4:26,417,437...26,554,403 		JBrowse link
G Runx2 RUNX family transcription factor 2 increases expression
decreases expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of RUNX2 mRNA
Glucose results in decreased expression of RUNX2 mRNA; Glucose results in decreased expression of RUNX2 protein
morroniside inhibits the reaction [Glucose results in decreased expression of RUNX2 mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]]; Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 mRNA]; Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 mRNA]]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]]; Sirolimus inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 mRNA]]; Sirolimus inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in decreased expression of RUNX2 mRNA]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]]; [EPO protein co-treated with Glucose] results in increased expression of RUNX2 mRNA; [EPO protein co-treated with Glucose] results in increased expression of RUNX2 protein; Melatonin inhibits the reaction [Glucose results in decreased expression of RUNX2 mRNA]; Melatonin inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]; Phytic Acid inhibits the reaction [Glucose results in decreased expression of RUNX2 mRNA]; Phytic Acid inhibits the reaction [Glucose results in decreased expression of RUNX2 protein] 		CTD PMID:17178593 PMID:30894315 PMID:32643284 PMID:33450223 PMID:38000455 NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:23,664,952...23,990,027 		JBrowse link
G Runx3 RUNX family transcription factor 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of RUNX3 mRNA CTD PMID:37567420 NCBI chr 5:152,644,270...152,702,835
Ensembl chr 5:152,644,270...152,702,835 		JBrowse link
G S100a14 S100 calcium binding protein A14 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of S100A14 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of S100A14 mRNA CTD PMID:37567420 NCBI chr 2:178,305,976...178,308,004
Ensembl chr 2:178,306,025...178,307,999 		JBrowse link
G S100a8 S100 calcium binding protein A8 multiple interactions
increases expression 		ISO GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to S100A8 promoter]]; GLO1 inhibits the reaction [Glucose results in increased expression of S100A8 mRNA]; GLO1 inhibits the reaction [Glucose results in increased expression of S100A8 protein]; Glucose promotes the reaction [JUN protein binds to S100A8 promoter]; JUN promotes the reaction [Glucose results in increased expression of S100A8 mRNA]; SOD2 inhibits the reaction [Glucose results in increased expression of S100A8 mRNA]; SOD2 inhibits the reaction [Glucose results in increased expression of S100A8 protein]; UCP1 inhibits the reaction [Glucose results in increased expression of S100A8 mRNA]; UCP1 inhibits the reaction [Glucose results in increased expression of S100A8 protein]
Glucose results in increased expression of S100A8 mRNA; Glucose results in increased expression of S100A8 protein 		CTD PMID:19833897 NCBI chr 2:178,464,095...178,465,223
Ensembl chr 2:178,464,702...178,465,221 		JBrowse link
G S100a9 S100 calcium binding protein A9 increases secretion ISO Glucose deficiency results in increased secretion of S100A9 protein CTD PMID:24802182 NCBI chr 2:178,487,941...178,490,622
Ensembl chr 2:178,487,941...178,490,870 		JBrowse link
G S100b S100 calcium binding protein B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of S100B mRNA CTD PMID:37567420 NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,348...12,381,081 		JBrowse link
G S1pr1 sphingosine-1-phosphate receptor 1 decreases expression EXP Glucose results in decreased expression of S1PR1 mRNA CTD PMID:22406263 NCBI chr 2:206,309,715...206,314,070
Ensembl chr 2:205,900,836...206,328,689 		JBrowse link
G S1pr2 sphingosine-1-phosphate receptor 2 multiple interactions
increases expression 		EXP [JTE 013 binds to and results in decreased activity of S1PR2 protein] inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein]; [JTE 013 binds to and results in decreased activity of S1PR2 protein] results in decreased susceptibility to [sphingosine 1-phosphate co-treated with Glucose]
Glucose results in increased expression of S1PR2 mRNA 		CTD PMID:22406263 NCBI chr 8:27,779,452...27,790,344
Ensembl chr 8:27,774,566...27,790,577 		JBrowse link
G S1pr3 sphingosine-1-phosphate receptor 3 decreases expression EXP Glucose results in decreased expression of S1PR3 mRNA CTD PMID:22406263 NCBI chr17:13,932,773...13,946,213
Ensembl chr17:13,928,444...13,947,197 		JBrowse link
G S1pr4 sphingosine-1-phosphate receptor 4 decreases expression EXP Glucose results in decreased expression of S1PR4 mRNA CTD PMID:22406263 NCBI chr 7:8,858,528...8,860,804
Ensembl chr 7:8,858,904...8,860,800 		JBrowse link
G S1pr5 sphingosine-1-phosphate receptor 5 increases expression EXP Glucose results in increased expression of S1PR5 mRNA CTD PMID:22406263 NCBI chr 8:28,062,841...28,068,013
Ensembl chr 8:28,061,752...28,068,389 		JBrowse link
G Saa4 serum amyloid A4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SAA4 mRNA CTD PMID:37567420 NCBI chr 1:106,383,856...106,388,158
Ensembl chr 1:106,383,856...106,387,354 		JBrowse link
G Samd15 sterile alpha motif domain containing 15 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SAMD15 mRNA CTD PMID:37567420 NCBI chr 6:112,572,352...112,587,142
Ensembl chr 6:112,572,501...112,576,796 		JBrowse link
G Samd9l sterile alpha motif domain containing 9 like increases expression ISO Glucose results in increased expression of SAMD9L mRNA CTD PMID:39613055 NCBI chr 4:32,316,748...32,331,112
Ensembl chr 4:32,222,623...32,331,067 		JBrowse link
G Sash3 SAM and SH3 domain containing 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of SASH3 mRNA CTD PMID:37567420 NCBI chr  X:132,204,717...132,219,421
Ensembl chr  X:132,204,543...132,219,419 		JBrowse link
G Sbsn suprabasin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of SBSN mRNA CTD PMID:37567420 NCBI chr 1:95,106,390...95,133,448
Ensembl chr 1:95,120,927...95,134,220 		JBrowse link
G Scamp4 secretory carrier membrane protein 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of SCAMP4 mRNA CTD PMID:37567420 NCBI chr 7:9,752,193...9,764,614
Ensembl chr 7:9,752,193...9,778,736 		JBrowse link
G Scarna17 small Cajal body-specific RNA 17 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of SCARNA17 mRNA CTD PMID:37567420 NCBI chr18:70,619,801...70,619,941 JBrowse link
G Scd stearoyl-CoA desaturase increases expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of SCD1 mRNA
(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]
Glucose results in increased expression of SCD mRNA; Glucose results in increased expression of SCD1 mRNA 		CTD PMID:15066988 PMID:16790840 PMID:22413010 PMID:32613381 NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785 		JBrowse link
G Scg5 secretogranin V increases expression ISO Glucose results in increased expression of SCG5 mRNA CTD PMID:39922521 NCBI chr 3:120,998,420...121,042,881
Ensembl chr 3:120,998,420...121,042,795 		JBrowse link
G Scn1a sodium voltage-gated channel alpha subunit 1 increases expression ISO Glucose results in increased expression of SCN1A mRNA CTD PMID:31525975 NCBI chr 3:71,360,840...71,479,870
Ensembl chr 3:71,360,841...71,479,791 		JBrowse link
G Scn4a sodium voltage-gated channel alpha subunit 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SCN4A mRNA CTD PMID:37567420 NCBI chr10:91,745,459...91,796,452
Ensembl chr10:91,746,715...91,796,324 		JBrowse link
G Scnn1a sodium channel epithelial 1 subunit alpha decreases expression ISO Glucose results in decreased expression of SCNN1A mRNA CTD PMID:39613055 NCBI chr 4:159,809,187...159,832,409
Ensembl chr 4:159,809,170...159,832,405 		JBrowse link
G Sdf2l1 stromal cell-derived factor 2-like 1 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of SDF2L1 mRNA
[imeglimin co-treated with Glucose] results in increased expression of SDF2L1 mRNA 		CTD PMID:34588186 PMID:39613055 NCBI chr11:97,376,878...97,379,120
Ensembl chr11:97,376,878...97,379,120 		JBrowse link
G Sec11c SEC11 homolog C, signal peptidase complex subunit decreases expression ISO Glucose results in decreased expression of SEC11C mRNA CTD PMID:17178593 NCBI chr18:61,590,905...61,607,247
Ensembl chr18:61,590,885...61,607,348 		JBrowse link
G Sec13 SEC13 homolog, nuclear pore and COPII coat complex component decreases expression ISO Glucose deficiency results in decreased expression of SEC13 protein CTD PMID:22314686 NCBI chr 4:148,433,344...148,446,735
Ensembl chr 4:148,433,349...148,446,755 		JBrowse link
G Sec14l3 SEC14-like lipid binding 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SEC14L3 mRNA CTD PMID:37567420 NCBI chr14:83,168,154...83,181,240
Ensembl chr14:83,168,208...83,179,654 		JBrowse link
G Sec14l4 SEC14-like lipid binding 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SEC14L4 mRNA CTD PMID:37567420 NCBI chr14:83,136,335...83,152,382
Ensembl chr14:83,136,339...83,153,215 		JBrowse link
G Sec31b SEC31 homolog B, COPII coat complex component increases expression ISO Glucose results in increased expression of SEC31B mRNA CTD PMID:39922521 NCBI chr 1:253,324,081...253,353,779
Ensembl chr 1:253,327,232...253,353,779 		JBrowse link
G Sec62 SEC62 homolog, preprotein translocation factor multiple interactions
increases expression 		EXP Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of SEC62 protein]; Metformin inhibits the reaction [Glucose results in increased expression of SEC62 protein] CTD PMID:34801538 NCBI chr 2:114,499,317...114,526,705
Ensembl chr 2:114,499,317...114,530,321 		JBrowse link
G Sele selectin E multiple interactions
increases secretion
increases expression 		ISO 5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate inhibits the reaction [Glucose results in increased expression of SELE mRNA]; 5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate inhibits the reaction [Glucose results in increased expression of SELE protein]; aspalathin inhibits the reaction [Glucose results in increased expression of SELE protein]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of SELE mRNA]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of SELE protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of SELE mRNA]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of SELE protein]; Mannitol inhibits the reaction [Glucose results in increased expression of SELE mRNA]; Mannitol inhibits the reaction [Glucose results in increased expression of SELE protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased expression of SELE mRNA]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased secretion of SELE protein]; nothofagin inhibits the reaction [Glucose results in increased expression of SELE protein]; Polyphenols inhibits the reaction [Glucose results in increased expression of SELE mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of SELE mRNA]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of SELE mRNA]]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of SELE mRNA]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of SELE protein]
Glucose results in increased expression of SELE; Glucose results in increased expression of SELE mRNA; Glucose results in increased expression of SELE protein 		CTD PMID:15304054 PMID:16285992 PMID:20960276 PMID:21682256 PMID:22074828 More... NCBI chr13:78,935,997...78,945,905
Ensembl chr13:78,936,036...78,945,903 		JBrowse link
G Selenop selenoprotein P increases expression
multiple interactions
increases secretion 		EXP Glucose results in increased expression of SELENOP mRNA
Metformin inhibits the reaction [Glucose results in increased expression of SELENOP mRNA]; Metformin inhibits the reaction [Glucose results in increased secretion of SELENOP protein] 		CTD PMID:19576170 NCBI chr 2:54,225,736...54,236,022
Ensembl chr 2:54,225,152...54,236,019 		JBrowse link
G Selenos selenoprotein S affects expression ISO Glucose affects the expression of SELENOS mRNA CTD PMID:18498015 NCBI chr 1:129,070,240...129,080,007
Ensembl chr 1:129,070,230...129,077,991 		JBrowse link
G Selp selectin P multiple interactions ISO [Glucose results in increased susceptibility to sodium arsenite] which results in increased expression of SELP protein; Glucose inhibits the reaction [Aspirin inhibits the reaction [Arachidonic Acid results in increased expression of SELP protein]] CTD PMID:18413191 PMID:28264687 NCBI chr13:79,009,379...79,044,994
Ensembl chr13:79,009,475...79,044,987 		JBrowse link
G Sema3a semaphorin 3A decreases expression ISO Glucose results in decreased expression of SEMA3A mRNA CTD PMID:17178593 NCBI chr 4:22,239,418...22,709,907
Ensembl chr 4:22,245,322...22,535,774 		JBrowse link
G Sema6a semaphorin 6A multiple interactions ISO [imeglimin co-treated with Glucose] results in increased expression of SEMA6A mRNA CTD PMID:34588186 NCBI chr18:42,237,227...42,358,540
Ensembl chr18:42,237,228...42,358,540 		JBrowse link
G Serpina3n serpin family A member 3N multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SERPINA3N mRNA CTD PMID:37567420 NCBI chr 6:129,088,392...129,095,950
Ensembl chr 6:129,088,398...129,097,415 		JBrowse link
G Serpinc1 serpin family C member 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of SERPINC1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SERPINC1 mRNA CTD PMID:37567420 NCBI chr13:75,790,558...75,804,826
Ensembl chr13:75,790,546...75,817,643 		JBrowse link
G Serpine1 serpin family E member 1 increases secretion
decreases expression
increases expression
multiple interactions 		ISO
EXP 		Glucose results in increased secretion of SERPINE1 protein
Glucose results in decreased expression of SERPINE1 mRNA
Glucose results in increased expression of SERPINE1 mRNA
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of SERPINE1 mRNA]; [Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 mRNA; [Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 protein; [Eplerenone co-treated with Enalapril] inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 mRNA]; [Eplerenone co-treated with Enalapril] inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 protein]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of SERPINE1 mRNA]; Enalapril inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 mRNA]; Enalapril inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 protein]; Eplerenone inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 mRNA]; Eplerenone inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 protein]; UCP1 protein inhibits the reaction [Glucose results in increased expression of SERPINE1 mRNA]
Indomethacin inhibits the reaction [Glucose results in increased secretion of SERPINE1 protein]; SOD2 protein inhibits the reaction [Glucose results in increased expression of SERPINE1 mRNA] 		CTD PMID:11050244 PMID:12409145 PMID:16320596 PMID:18682491 PMID:31655124 NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357 		JBrowse link
G Serpinf1 serpin family F member 1 decreases secretion
multiple interactions 		ISO Glucose deficiency results in decreased secretion of SERPINF1 protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SERPINF1 mRNA 		CTD PMID:24802182 PMID:37567420 NCBI chr10:60,748,504...60,760,898
Ensembl chr10:60,748,506...60,760,898 		JBrowse link
G Sesn2 sestrin 2 decreases expression ISO Glucose results in decreased expression of SESN2 mRNA CTD PMID:39613055 NCBI chr 5:149,986,304...150,005,255
Ensembl chr 5:149,986,317...150,005,255 		JBrowse link
G Setd7 SET domain containing 7, histone lysine methyltransferase multiple interactions EXP Glucose promotes the reaction [SETD7 protein binds to CDKN1A promoter]; TGFB1 protein promotes the reaction [Glucose promotes the reaction [SETD7 protein binds to CDKN1A promoter]] CTD PMID:27652271 NCBI chr 2:137,713,545...137,756,319
Ensembl chr 2:137,713,545...137,756,319 		JBrowse link
G Sfrp2 secreted frizzled-related protein 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SFRP2 mRNA CTD PMID:37567420 NCBI chr 2:171,387,536...171,395,081
Ensembl chr 2:171,387,385...171,395,079 		JBrowse link
G Sftpb surfactant protein B increases expression ISO Glucose results in increased expression of SFTPB mRNA CTD PMID:39922521 NCBI chr 4:105,917,495...105,926,631
Ensembl chr 4:105,917,578...105,927,646 		JBrowse link
G Sftpd surfactant protein D decreases expression ISO Glucose results in decreased expression of SFTPD mRNA CTD PMID:32942007 NCBI chr16:17,080,575...17,093,047
Ensembl chr16:17,080,567...17,094,036 		JBrowse link
G Sgk1 serum/glucocorticoid regulated kinase 1 increases expression
decreases expression 		ISO
EXP 		Glucose results in increased expression of SGK1 mRNA
Glucose results in decreased expression of SGK1 mRNA; Glucose results in decreased expression of SGK1 protein 		CTD PMID:17178593 PMID:31729781 NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:24,799,396...24,807,231 		JBrowse link
G Sgk2 serum/glucocorticoid regulated kinase 2 multiple interactions ISO SGK2 mutant form inhibits the reaction [[Simvastatin co-treated with NR1I2 protein] results in increased secretion of Glucose] CTD PMID:24204015 NCBI chr 3:172,063,625...172,089,000
Ensembl chr 3:172,063,776...172,089,011 		JBrowse link
G Sh2d5 SH2 domain containing 5 increases expression ISO Glucose results in increased expression of SH2D5 mRNA CTD PMID:39922521 NCBI chr 5:155,753,087...155,763,936
Ensembl chr 5:155,750,803...155,763,936 		JBrowse link
G Sh3bgr SH3 domain binding glutamate-rich protein decreases expression ISO Glucose results in decreased expression of SH3BGR mRNA CTD PMID:31525975 NCBI chr11:48,973,033...48,997,328
Ensembl chr11:48,973,097...48,997,326 		JBrowse link
G Sh3bp2 SH3-domain binding protein 2 increases expression ISO Glucose results in increased expression of SH3BP2 mRNA CTD PMID:17178593 NCBI chr14:80,400,685...80,437,887
Ensembl chr14:80,400,685...80,437,906 		JBrowse link
G Sh3gl3 SH3 domain containing GRB2 like 3, endophilin A3 increases expression ISO Glucose results in increased expression of SH3GL3 mRNA CTD PMID:39922521 NCBI chr 1:145,533,728...145,664,881
Ensembl chr 1:145,533,728...145,664,881 		JBrowse link
G Shbg sex hormone binding globulin multiple interactions
decreases expression 		ISO Cerulenin inhibits the reaction [Glucose results in decreased expression of SHBG protein]; Glucose affects the reaction [HNF4A protein binds to SHBG promoter]; Glucose affects the reaction [NR2F1 protein binds to SHBG promoter] CTD PMID:17992261 NCBI chr10:54,831,716...54,849,162
Ensembl chr10:54,831,718...54,838,760 		JBrowse link
G Shc1 SHC adaptor protein 1 increases expression
multiple interactions 		ISO Glucose results in increased expression of SHC1; Glucose results in increased expression of SHC1 mRNA; Glucose results in increased expression of SHC1 protein
SIRT1 inhibits the reaction [Glucose results in increased expression of SHC1]; SIRT1 mutant form promotes the reaction [Glucose results in increased expression of SHC1 mRNA]; SIRT1 mutant form promotes the reaction [Glucose results in increased expression of SHC1 protein]; SIRT1 protein inhibits the reaction [Glucose results in increased expression of SHC1 mRNA]; SIRT1 protein inhibits the reaction [Glucose results in increased expression of SHC1 protein] 		CTD PMID:21778425 PMID:23993977 NCBI chr 2:177,135,649...177,147,257
Ensembl chr 2:177,135,659...177,147,914 		JBrowse link
G Shc2 SHC adaptor protein 2 decreases expression ISO Glucose results in decreased expression of SHC2 mRNA CTD PMID:39613055 NCBI chr 7:10,717,320...10,739,539
Ensembl chr 7:10,717,320...10,739,539 		JBrowse link
G Shc3 SHC adaptor protein 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of SHC3 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SHC3 mRNA CTD PMID:37567420 NCBI chr17:13,803,980...13,924,433
Ensembl chr17:13,803,781...13,924,433 		JBrowse link
G Shc4 SHC adaptor protein 4 increases expression
multiple interactions 		ISO Glucose results in increased expression of SHC4 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of SHC4 mRNA] 		CTD PMID:33448797 NCBI chr 3:133,334,026...133,428,404
Ensembl chr 3:133,334,034...133,427,826 		JBrowse link
G Shcbp1l SHC binding and spindle associated 1 like multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SHCBP1L mRNA CTD PMID:37567420 NCBI chr13:68,118,861...68,149,646
Ensembl chr13:68,119,328...68,149,645 		JBrowse link
G Shfl shiftless antiviral inhibitor of ribosomal frameshifting decreases expression ISO Glucose results in decreased expression of SHFL mRNA CTD PMID:31525975 NCBI chr 8:27,683,560...27,690,269
Ensembl chr 8:27,684,510...27,690,679 		JBrowse link
G Shh sonic hedgehog signaling molecule multiple interactions ISO cyclopamine inhibits the reaction [SHH protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]]; SHH protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and results in increased secretion of SHH protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SHH mRNA; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and results in increased secretion of SHH protein]; SHH protein affects the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTCH1 protein]; SHH protein affects the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMO protein] 		CTD PMID:27481074 NCBI chr 4:7,687,872...7,697,025
Ensembl chr 4:7,687,846...7,697,901 		JBrowse link
G Shisal1 shisa like 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SHISAL1 mRNA CTD PMID:37567420 NCBI chr 7:117,388,210...117,491,539 JBrowse link
G Si sucrase-isomaltase increases expression ISO Glucose results in increased expression of SI mRNA CTD PMID:17786952 NCBI chr 2:159,804,568...159,884,902
Ensembl chr 2:159,804,568...159,883,934 		JBrowse link
G Siglec1 sialic acid binding Ig like lectin 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SIGLEC1 mRNA CTD PMID:37567420 NCBI chr 3:138,740,171...138,759,966
Ensembl chr 3:138,741,019...138,759,881 		JBrowse link
G Sik1 salt-inducible kinase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of SIK1 mRNA CTD PMID:37567420 NCBI chr20:9,947,104...9,958,729
Ensembl chr20:9,947,105...9,958,698 		JBrowse link
G Sim2 SIM bHLH transcription factor 2 multiple interactions
increases response to substance
increases expression 		EXP Curcumin inhibits the reaction [Glucose results in increased expression of SIM2 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of SIM2 protein]
SIM2 protein results in increased susceptibility to Glucose
Glucose results in increased expression of SIM2 mRNA; Glucose results in increased expression of SIM2 protein 		CTD PMID:23333261 NCBI chr11:46,883,859...46,923,305
Ensembl chr11:46,883,859...46,923,305 		JBrowse link
G Sirt1 sirtuin 1 multiple interactions
increases phosphorylation
decreases expression
increases expression
affects expression
decreases response to substance
affects abundance
increases response to substance 		ISO
EXP 		6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [[Glucose co-treated with Resveratrol] results in increased expression of SIRT1 protein]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [ACACB protein affects the reaction [Glucose results in decreased expression of SIRT1 protein]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [SIRT1 protein inhibits the reaction [Resveratrol promotes the reaction [Glucose results in increased secretion of INS protein]]]; [Glucose co-treated with Resveratrol] results in increased expression of SIRT1 protein; [Glucose deficiency co-treated with Galactose co-treated with Amino Acids co-treated with Pyruvic Acid] inhibits the reaction [Resveratrol results in increased expression of SIRT1 protein]; [Palmitic Acid co-treated with Glucose] promotes the reaction [Glutathione binds to SIRT1 protein]; [Palmitic Acid co-treated with Glucose] results in increased oxidation of and results in decreased activity of SIRT1 protein; [Pyruvic Acid co-treated with Glucose] results in increased expression of and results in increased activity of SIRT1 protein; [Resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [[Glucose results in increased expression of FASN protein] which results in increased abundance of Triglycerides]; [Resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein]; [Resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]; ACACB protein affects the reaction [Glucose results in decreased expression of SIRT1 protein]; Acetylcysteine inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; GLRX protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] promotes the reaction [Glutathione binds to SIRT1 protein]]; GLRX protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased oxidation of and results in decreased activity of SIRT1 protein]; Glucose results in decreased expression of and results in decreased activity of SIRT1 protein; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of SIRT1 protein]; PARP1 protein affects the reaction [Glucose results in decreased expression of SIRT1 protein]; PRKAA2 protein promotes the reaction [SIRT1 protein inhibits the reaction [Glucose results in decreased phosphorylation of ACACA protein]]; PRKAA2 protein promotes the reaction [SIRT1 protein inhibits the reaction [Glucose results in increased abundance of Triglycerides]]; PRKAA2 protein promotes the reaction [SIRT1 protein inhibits the reaction [Glucose results in increased expression of FASN protein]]; Resveratrol inhibits the reaction [Glucose results in decreased expression of SIRT1 mRNA]; Resveratrol inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; salvianolic acid inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; SIRT1 inhibits the reaction [Glucose results in increased expression of SHC1]; SIRT1 mutant form promotes the reaction [Glucose results in increased expression of SHC1 mRNA]; SIRT1 mutant form promotes the reaction [Glucose results in increased expression of SHC1 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased secretion of Nitric Oxide]]]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of NOS3 mRNA]]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of SELE mRNA]]; SIRT1 protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased acetylation of TP53 protein]; SIRT1 protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased cleavage of CASP3 protein]; SIRT1 protein inhibits the reaction [Glucose promotes the reaction [PARP1 protein binds to MMP9 promoter]]; SIRT1 protein inhibits the reaction [Glucose results in decreased phosphorylation of ACACA protein]; SIRT1 protein inhibits the reaction [Glucose results in increased abundance of Triglycerides]; SIRT1 protein inhibits the reaction [Glucose results in increased acetylation of PARP1 protein]; SIRT1 protein inhibits the reaction [Glucose results in increased expression of FASN protein]; SIRT1 protein inhibits the reaction [Glucose results in increased expression of SHC1 mRNA]; SIRT1 protein inhibits the reaction [Glucose results in increased expression of SHC1 protein]; SIRT1 protein inhibits the reaction [Resveratrol promotes the reaction [Glucose results in increased secretion of INS protein]]; SIRT1 protein mutant form inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased expression of BBC3 mRNA]; SIRT1 protein mutant form inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased expression of CDKN1A mRNA]; SIRT1 protein promotes the reaction [[Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]] which results in decreased abundance of Triglycerides]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of GPX4 protein]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of SLC7A11 protein]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased acetylation of TP53 protein]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of and results in increased acetylation of HMGB1 protein]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of IL1B protein]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of IL6 protein]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of TNF protein]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of VEGFA protein]]
Glucose deficiency results in increased phosphorylation of SIRT1 protein
Glucose results in decreased expression of SIRT1 mRNA; Glucose results in decreased expression of SIRT1 protein
Glucose deficiency results in increased expression of SIRT1 mRNA; Glucose deficiency results in increased expression of SIRT1 protein
Glucose affects the expression of SIRT1 protein
SIRT1 protein results in decreased susceptibility to Glucose
SIRT1 protein affects the abundance of Glucose
SIRT1 protein results in increased susceptibility to Glucose
[6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in decreased activity of SIRT1 protein] inhibits the reaction [Fructose results in increased abundance of Glucose]; [Niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [Fructose results in increased abundance of Glucose]; [SIRT1 protein results in decreased expression of UCP2 mRNA] promotes the reaction [Glucose results in increased abundance of Adenosine Triphosphate]; [SRT1720 results in increased activity of SIRT1 protein] which results in increased abundance of Glucose; Berberine inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; formononetin inhibits the reaction [Glucose results in decreased expression of SIRT1 mRNA]; formononetin inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; Glycyrrhizic Acid inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; Inositol inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; MIR217 mRNA affects the reaction [Glucose results in decreased expression of SIRT1 mRNA]; MIR217 mRNA affects the reaction [Glucose results in decreased expression of SIRT1 protein]; NAD inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; Resveratrol inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; Sirolimus inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CCN2 protein]]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of EDN1 protein]]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of FN1 protein]]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of HIF1A protein]]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of TGFB1 protein]]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of VEGFA protein]]; SIRT1 protein promotes the reaction [[Glucose results in increased abundance of Adenosine Triphosphate] which results in increased expression of INS1 protein]; SIRT1 protein promotes the reaction [Glucose results in increased abundance of Adenosine Triphosphate]; SIRT1 protein promotes the reaction [Glucose results in increased expression of INS1 protein]; SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein]]; SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of GLB1 protein]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1B protein]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of GLB1 protein]]; SIRT1 protein promotes the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; SIRT1 protein promotes the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein]]; SIRT1 protein promotes the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of GLB1 protein]]; SRT1720 inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; UCP2 protein inhibits the reaction [SIRT1 protein promotes the reaction [Glucose results in increased expression of INS1 protein]]
[6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in decreased activity of SIRT1 protein] which results in increased susceptibility to Glucose; [[Resveratrol results in increased activity of SIRT1 protein] which results in increased phosphorylation of and results in decreased activity of FOXO3 protein] which results in decreased susceptibility to Glucose; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT1 protein; [Resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of BAD protein]; [Resveratrol results in increased localization of and results in increased activity of SIRT1 protein] which results in decreased susceptibility to Glucose; [SIRT1 protein co-treated with Resveratrol] affects the reaction [Glucose affects the expression of PPARGC1A protein]; [sirtinol results in decreased activity of SIRT1 protein] which results in decreased susceptibility to Glucose; AICA ribonucleotide inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; icariin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT1 mRNA]; icariin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT1 protein]; Metformin inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; PRKAA1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]]; PRKAA2 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]]; Resveratrol inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; SB 203580 inhibits the reaction [icariin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT1 mRNA]]; SB 203580 inhibits the reaction [icariin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT1 protein]] 		CTD PMID:16366736 PMID:18482975 PMID:18849969 PMID:19071085 PMID:19303870 More... NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000 		JBrowse link
G Sirt3 sirtuin 3 increases expression
decreases expression
multiple interactions 		ISO
EXP 		Glucose deficiency results in increased expression of SIRT3 protein
Glucose results in decreased expression of SIRT3 mRNA; Glucose results in decreased expression of SIRT3 protein
formononetin inhibits the reaction [Glucose results in decreased expression of SIRT3 mRNA]; formononetin inhibits the reaction [Glucose results in decreased expression of SIRT3 protein]
SIRT3 protein inhibits the reaction [sodium arsenite inhibits the reaction [INS1 protein results in increased uptake of Glucose]]
polyethylene glycol loxenatide inhibits the reaction [Glucose results in decreased expression of SIRT3 protein]; SIRT3 protein inhibits the reaction [Glucose results in increased acetylation of FOXO1 protein]; SIRT3 protein inhibits the reaction [Glucose results in increased expression of CAT protein]; SIRT3 protein inhibits the reaction [Glucose results in increased expression of CDKN2A protein alternative form]; SIRT3 protein inhibits the reaction [Glucose results in increased expression of GLB1 protein]; SIRT3 protein inhibits the reaction [Glucose results in increased expression of SOD2 protein] 		CTD PMID:23494737 PMID:25979314 PMID:37417536 PMID:37944786 NCBI chr 1:205,371,703...205,394,145
Ensembl chr 1:205,371,710...205,394,076 		JBrowse link
G Sirt4 sirtuin 4 affects expression
decreases expression 		EXP Glucose affects the expression of SIRT4 protein
Glucose results in decreased expression of SIRT4 mRNA 		CTD PMID:24349266 NCBI chr12:46,785,852...46,800,179
Ensembl chr12:46,791,898...46,800,173 		JBrowse link
G Sirt7 sirtuin 7 multiple interactions ISO [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT7 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT7 protein; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BBC3 protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TRP53 protein modified form]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TRP53 protein] CTD PMID:28675767 NCBI chr10:106,394,802...106,401,627
Ensembl chr10:106,394,802...106,401,498 		JBrowse link
G Sit1 signaling threshold regulating transmembrane adaptor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SIT1 mRNA CTD PMID:37567420 NCBI chr 5:62,536,003...62,538,230
Ensembl chr 5:62,536,009...62,537,911 		JBrowse link
G Skil SKI-like proto-oncogene increases expression ISO Glucose results in increased expression of SKIL mRNA CTD PMID:17178593 NCBI chr 2:114,175,534...114,203,663
Ensembl chr 2:114,175,534...114,201,974 		JBrowse link
G Slamf1 signaling lymphocytic activation molecule family member 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLAMF1 mRNA CTD PMID:37567420 NCBI chr13:86,802,708...86,837,890
Ensembl chr13:86,802,708...86,837,890 		JBrowse link
G Slamf8 SLAM family member 8 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of SLAMF8 mRNA CTD PMID:37567420 NCBI chr13:87,580,081...87,589,941
Ensembl chr13:87,580,182...87,589,560 		JBrowse link
G Slc11a2 solute carrier family 11 member 2 multiple interactions
increases expression 		ISO [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of SLC11A2 mRNA alternative form; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of SLC11A2 protein alternative form
Glucose results in increased expression of SLC11A2 protein
RELA protein modified form promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of SLC11A2 mRNA alternative form]; RELA protein promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of SLC11A2 mRNA alternative form] 		CTD PMID:22666436 PMID:38483099 NCBI chr 7:133,381,878...133,429,921
Ensembl chr 7:133,381,878...133,418,941 		JBrowse link
G Slc12a1 solute carrier family 12 member 1 increases activity
multiple interactions 		EXP Glucose results in increased activity of SLC12A1 protein
[Glucose results in increased activity of SLC12A1 protein] which results in increased import of Water 		CTD PMID:12433675 NCBI chr 3:132,859,581...132,936,354
Ensembl chr 3:132,859,590...132,936,340 		JBrowse link
G Slc12a2 solute carrier family 12 member 2 multiple interactions ISO Bumetanide inhibits the reaction [SLC12A2 gene mutant form promotes the reaction [Glucose results in increased secretion of INS1 protein]]; SLC12A2 gene mutant form promotes the reaction [Glucose results in increased secretion of INS1 protein] CTD PMID:22872759 NCBI chr18:53,546,263...53,614,478
Ensembl chr18:53,546,333...53,614,470 		JBrowse link
G Slc16a14 solute carrier family 16, member 14 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC16A14 mRNA CTD PMID:37567420 NCBI chr 9:93,558,144...93,585,396
Ensembl chr 9:93,558,144...93,585,396 		JBrowse link
G Slc16a5 solute carrier family 16 member 5 increases methylation
multiple interactions
decreases expression 		ISO Glucose results in increased methylation of SLC16A5 gene
fucoxanthin inhibits the reaction [Glucose results in decreased expression of SLC16A5 mRNA] 		CTD PMID:33448797 NCBI chr10:101,206,371...101,220,300
Ensembl chr10:101,206,398...101,220,300 		JBrowse link
G Slc16a7 solute carrier family 16 member 7 increases expression ISO Glucose results in increased expression of SLC16A7 protein CTD PMID:39922521 NCBI chr 7:62,929,067...63,096,995
Ensembl chr 7:62,936,567...63,040,386 		JBrowse link
G Slc17a2 solute carrier family 17, member 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLC17A2 mRNA CTD PMID:37567420 NCBI chr17:41,748,195...41,767,601
Ensembl chr17:41,748,195...41,764,180 		JBrowse link
G Slc17a8 solute carrier family 17 member 8 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of SLC17A8 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLC17A8 mRNA CTD PMID:37567420 NCBI chr 7:25,881,557...25,936,837
Ensembl chr 7:25,881,557...25,935,410 		JBrowse link
G Slc18a2 solute carrier family 18 member A2 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of SLC18A2 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of SLC18A2 mRNA] 		CTD PMID:33448797 NCBI chr 1:268,399,815...268,435,229
Ensembl chr 1:268,400,016...268,435,231 		JBrowse link
G Slc1a3 solute carrier family 1 member 3 decreases expression
multiple interactions 		EXP Glucose results in decreased expression of SLC1A3 mRNA; Glucose results in decreased expression of SLC1A3 protein
resveratrol inhibits the reaction [Glucose results in decreased expression of SLC1A3 mRNA]; resveratrol inhibits the reaction [Glucose results in decreased expression of SLC1A3 protein] 		CTD PMID:26677078 NCBI chr 2:59,482,707...59,557,808
Ensembl chr 2:59,482,709...59,557,808 		JBrowse link
G Slc22a19 solute carrier family 22, member 19 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLC22A19 mRNA CTD PMID:37567420 NCBI chr 1:214,339,594...214,394,681
Ensembl chr 1:214,339,599...214,394,681 		JBrowse link
G Slc22a3 solute carrier family 22 member 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of SLC22A3 mRNA CTD PMID:37567420 NCBI chr 1:50,783,218...50,872,358
Ensembl chr 1:50,783,218...50,872,353 		JBrowse link
G Slc22a7 solute carrier family 22 member 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLC22A7 mRNA CTD PMID:37567420 NCBI chr 9:22,044,672...22,052,051
Ensembl chr 9:22,045,435...22,051,681 		JBrowse link
G Slc25a1 solute carrier family 25 member 1 increases expression EXP Glucose results in increased expression of SLC25A1 protein CTD PMID:24349266 NCBI chr11:96,560,054...96,563,071
Ensembl chr11:96,560,041...96,565,052 		JBrowse link
G Slc25a10 solute carrier family 25 member 10 increases expression EXP Glucose results in increased expression of SLC25A10 mRNA; Glucose results in increased expression of SLC25A10 protein CTD PMID:24349266 NCBI chr10:106,264,396...106,271,895
Ensembl chr10:106,264,344...106,273,498 		JBrowse link
G Slc25a12 solute carrier family 25 member 12 decreases expression EXP Glucose results in decreased expression of SLC25A12 mRNA CTD PMID:24349266 NCBI chr 3:76,504,868...76,599,536
Ensembl chr 3:76,504,868...76,599,536 		JBrowse link
G Slc25a14 solute carrier family 25 member 14 increases expression EXP Glucose results in increased expression of SLC25A14 mRNA CTD PMID:24349266 NCBI chr  X:132,685,518...132,723,705
Ensembl chr  X:132,676,818...132,723,703 		JBrowse link
G Slc25a22 solute carrier family 25 member 22 affects expression EXP Glucose affects the expression of SLC25A22 protein CTD PMID:24349266 NCBI chr 1:205,954,713...205,966,188
Ensembl chr 1:205,958,032...205,965,877 		JBrowse link
G Slc25a27 solute carrier family 25, member 27 increases expression EXP Glucose results in increased expression of SLC25A27 mRNA CTD PMID:24349266 NCBI chr 9:24,804,183...24,831,219
Ensembl chr 9:24,804,185...24,831,217 		JBrowse link
G Slc26a3 solute carrier family 26 member 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of SLC26A3 mRNA CTD PMID:37567420 NCBI chr 6:53,751,415...53,792,300
Ensembl chr 6:53,751,415...53,792,294 		JBrowse link
G Slc26a6 solute carrier family 26 member 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC26A6 mRNA CTD PMID:37567420 NCBI chr 8:118,438,110...118,448,271
Ensembl chr 8:118,438,180...118,448,270 		JBrowse link
G Slc27a2 solute carrier family 27 member 2 multiple interactions ISO [Glucose co-treated with Palmitic Acid] results in decreased expression of SLC27A2 mRNA CTD PMID:39265716 NCBI chr 3:134,258,101...134,295,581
Ensembl chr 3:134,258,101...134,295,581 		JBrowse link
G Slc27a3 solute carrier family 27 member 3 increases expression ISO Glucose results in increased expression of SLC27A3 mRNA CTD PMID:39922521 NCBI chr 2:178,150,835...178,155,503
Ensembl chr 2:178,150,835...178,155,503 		JBrowse link
G Slc2a1 solute carrier family 2 member 1 multiple interactions
increases uptake
increases expression
increases activity
decreases expression
increases transport
increases stability 		ISO
EXP 		7-hydroxyflavone inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; [bisphenol A results in increased activity of and affects the localization of SLC2A1 protein] which results in increased uptake of Glucose; [Deoxyglucose results in increased abundance of Glucose] which affects the localization of SLC2A1 protein; [PRNP protein results in increased expression of SLC2A1 protein] which results in increased uptake of Glucose; [sodium arsenite results in increased abundance of Arsenic] inhibits the reaction [[Deoxyglucose results in increased abundance of Glucose] which affects the localization of SLC2A1 protein]; Barbiturates inhibits the reaction [SLC2A1 protein results in increased transport of Glucose]; Chloral Hydrate inhibits the reaction [SLC2A1 protein results in increased transport of Glucose]; Cyclofenil inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; Cytochalasin B inhibits the reaction [SLC2A1 protein results in increased transport of Glucose]; daidzein inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; Diazepam inhibits the reaction [SLC2A1 protein results in increased transport of Glucose]; Diethylstilbestrol inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; Genistein inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; isoliquiritigenin inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; kaempferol inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; myricetin inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; naringenin inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; Phloretin inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; Quercetin inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; Resveratrol inhibits the reaction [SLC2A1 protein results in increased uptake of Glucose]; Tamoxifen inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; Valproic Acid inhibits the reaction [SLC2A1 protein results in increased transport of Glucose]
[troglitazone results in increased expression of SLC2A1 mRNA] which results in increased uptake of Glucose
Glucose results in increased expression of SLC2A1 mRNA
Glucose deficiency results in increased activity of SLC2A1 protein
Glucose results in decreased expression of SLC2A1 mRNA
[2-butenal co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein; [3-phenylpropanol-1 co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein; [benzaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein; [bromopyruvate results in decreased expression of SLC2A1 protein] which results in decreased uptake of Glucose; [cinnamaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein; [cinnamyl alcohol co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein; [Progesterone results in increased expression of SLC2A1 protein] which results in increased uptake of Glucose; [propionaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein; [Troglitazone results in increased expression of SLC2A1 mRNA] which results in increased uptake of Glucose; [Troglitazone results in increased expression of SLC2A1 protein] which results in increased uptake of Glucose; Cysteine inhibits the reaction [[cinnamaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein]; Mercaptoethanol inhibits the reaction [[cinnamaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein]; oxophenylarsine inhibits the reaction [Glucose deficiency results in increased activity of SLC2A1 protein]
Glucose results in increased stability of SLC2A1 protein 		CTD PMID:1727734 PMID:8457197 PMID:8895337 PMID:10726906 PMID:11420438 More... NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:138,002,522...138,030,742 		JBrowse link
G Slc2a2 solute carrier family 2 member 2 multiple interactions
increases expression
decreases expression
increases transport 		ISO
EXP 		Catechin inhibits the reaction [Glucose results in decreased expression of SLC2A2 protein]; Glucose inhibits the reaction [SLC2A2 protein results in increased transport of Deoxyglucose]; Glucose inhibits the reaction [SLC2A2 protein results in increased transport of Fructose]; Plant Extracts inhibits the reaction [Glucose results in decreased expression of SLC2A2 protein]
Glucose results in increased expression of SLC2A2 mRNA
[copper bis(3,5-diisopropylsalicylate) co-treated with Glucose] results in increased expression of SLC2A2 protein; [ebselen co-treated with Glucose] results in increased expression of SLC2A2 protein; [Sodium Selenite co-treated with Glucose] results in increased expression of SLC2A2 protein; Glucose inhibits the reaction [Alloxan results in decreased expression of SLC2A2 mRNA]; Glucose results in increased expression of and affects the localization of SLC2A2 protein
Dactinomycin inhibits the reaction [Glucose results in increased expression of SLC2A2 mRNA]; ML 7 inhibits the reaction [SLC2A2 protein results in increased uptake of Glucose]; Phloretin inhibits the reaction [SLC2A2 protein results in increased uptake of Glucose]
SLC2A2 protein results in increased transport of Glucose 		CTD PMID:1727734 PMID:8457197 PMID:12137914 PMID:12787936 PMID:12937289 More... NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:113,537,972...113,568,467 		JBrowse link
G Slc2a3 solute carrier family 2 member 3 multiple interactions EXP
ISO 		[Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased expression of SLC2A3 protein; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased expression of SLC2A3 protein]
[INS protein co-treated with Glucose] results in decreased expression of SLC2A3 protein; Glucose inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose]; Glucose inhibits the reaction [SLC2A3 protein results in increased transport of Galactose]; Kynurenic Acid inhibits the reaction [[INS protein co-treated with Glucose] results in decreased expression of SLC2A3 protein] 		CTD PMID:8457197 PMID:24726522 PMID:28951307 NCBI chr 4:157,632,887...157,698,034
Ensembl chr 4:157,632,887...157,646,186 		JBrowse link
G Slc2a4 solute carrier family 2 member 4 decreases expression
multiple interactions
increases uptake
increases expression 		EXP
ISO 		Glucose results in decreased expression of SLC2A4 mRNA
ACACB protein affects the reaction [Glucose results in decreased expression of SLC2A4 protein]
[3,3',4,5'-tetrahydroxystilbene results in increased localization of SLC2A4 protein] which results in increased uptake of Glucose; [Glucose co-treated with picolinic acid] affects the localization of SLC2A4 protein; Glucosamine inhibits the reaction [SLC2A4 protein results in increased uptake of Glucose]; Glucose inhibits the reaction [SLC2A4 protein results in increased uptake of Glucosamine]; mangiferin promotes the reaction [SLC2A4 protein results in increased uptake of Glucose]; MYH2 protein affects the reaction [SLC2A4 protein results in increased uptake of Glucose]; Plant Extracts promotes the reaction [SLC2A4 protein results in increased uptake of Glucose]
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [[Chloroquine affects the localization of SLC2A4 protein] which results in increased uptake of Glucose]; [[Chloroquine results in increased abundance of Calcium] which affects the localization of SLC2A4 protein] which results in increased uptake of Glucose; [Chloroquine affects the localization of SLC2A4 protein] which results in increased uptake of Glucose; [Resveratrol results in increased localization of SLC2A4 protein] which results in increased uptake of Glucose; ESR1 protein promotes the reaction [[Resveratrol results in increased localization of SLC2A4 protein] which results in increased uptake of Glucose]; Fulvestrant inhibits the reaction [[Resveratrol results in increased localization of SLC2A4 protein] which results in increased uptake of Glucose]
Glucose results in increased expression of SLC2A4 mRNA 		CTD PMID:1727734 PMID:15111496 PMID:16870493 PMID:18426865 PMID:18773891 More... NCBI chr10:55,164,721...55,170,289
Ensembl chr10:55,164,721...55,170,270 		JBrowse link
G Slc2a5 solute carrier family 2 member 5 multiple interactions
increases expression
increases transport 		ISO
EXP 		Colforsin promotes the reaction [Glucose results in increased expression of SLC2A5 mRNA]; Glucose promotes the reaction [PAIP2 protein binds to SLC2A5 3' UTR]
Glucose results in increased expression of SLC2A5 mRNA; Glucose results in increased expression of SLC2A5 protein
SLC2A5 protein results in increased transport of Glucose 		CTD PMID:8048533 PMID:8554516 PMID:12820898 PMID:12937289 PMID:17710649 NCBI chr 5:165,857,412...165,892,928
Ensembl chr 5:165,866,172...165,894,038 		JBrowse link
G Slc2a6 solute carrier family 2 member 6 decreases expression ISO Glucose results in decreased expression of SLC2A6 mRNA CTD PMID:17178593 NCBI chr 3:30,746,472...30,753,287
Ensembl chr 3:30,745,995...30,753,287 		JBrowse link
G Slc2a7 solute carrier family 2 member 7 increases transport ISO SLC2A7 protein results in increased transport of Glucose CTD PMID:15033637 PMID:17710649 NCBI chr 5:165,907,721...165,927,277
Ensembl chr 5:165,907,721...165,926,891 		JBrowse link
G Slc2a9 solute carrier family 2 member 9 multiple interactions
increases transport 		ISO Glucose promotes the reaction [SLC2A9 protein alternative form results in increased transport of Uric Acid]
SLC2A9 protein results in increased transport of Glucose 		CTD PMID:17710649 PMID:18842065 NCBI chr14:76,540,649...76,674,277
Ensembl chr14:76,540,571...76,674,277 		JBrowse link
G Slc30a1 solute carrier family 30 member 1 increases expression
multiple interactions 		EXP Glucose results in increased expression of SLC30A1 mRNA
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Glucose results in increased expression of SLC30A1 mRNA]; zinc chloride promotes the reaction [Glucose results in increased expression of SLC30A1 mRNA] 		CTD PMID:23056475 NCBI chr13:106,022,019...106,025,892
Ensembl chr13:106,022,019...106,025,892 		JBrowse link
G Slc30a3 solute carrier family 30 member 3 increases expression
multiple interactions
affects expression 		ISO
EXP 		Glucose results in increased expression of SLC30A3; Glucose results in increased expression of SLC30A3 mRNA
SLC30A3 results in increased susceptibility to [Glucose co-treated with INS1 protein]
[Glucose co-treated with dihydroxyethyldithiocarbamate] results in increased expression of SLC30A3 mRNA
Glucose affects the expression of SLC30A3 		CTD PMID:18545258 PMID:19492079 PMID:39922521 NCBI chr 6:30,984,241...31,004,689
Ensembl chr 6:30,984,276...31,005,120 		JBrowse link
G Slc30a5 solute carrier family 30 member 5 affects expression EXP Glucose affects the expression of SLC30A5 CTD PMID:19492079 NCBI chr 2:33,679,800...33,710,025
Ensembl chr 2:33,679,800...33,712,596 		JBrowse link
G Slc30a7 solute carrier family 30 member 7 multiple interactions ISO SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased cleavage of CASP1 protein]]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased cleavage of GSDMD protein]]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased secretion of IL18 protein]]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased secretion of IL1B protein]] CTD PMID:35607288 NCBI chr 2:206,544,800...206,607,087
Ensembl chr 2:206,544,800...206,607,043 		JBrowse link
G Slc30a8 solute carrier family 30 member 8 multiple interactions
decreases expression 		ISO
EXP 		SLC30A8 protein promotes the reaction [Glucose results in increased secretion of INS protein]
[Glucose co-treated with dihydroxyethyldithiocarbamate] results in decreased expression of SLC30A8; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Glucose results in decreased expression of SLC30A8 mRNA]; SLC30A8 protein affects the reaction [Glucose results in increased secretion of INS1 protein]
SLC30A8 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]
Glucose results in decreased expression of SLC30A8; Glucose results in decreased expression of SLC30A8 mRNA 		CTD PMID:16984975 PMID:19450229 PMID:19479076 PMID:19492079 PMID:23056475 NCBI chr 7:85,481,864...85,517,255
Ensembl chr 7:85,481,864...85,517,177 		JBrowse link
G Slc38a11 solute carrier family 38, member 11 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of SLC38A11 mRNA CTD PMID:37567420 NCBI chr 3:70,374,550...70,442,313
Ensembl chr 3:70,395,233...70,441,712 		JBrowse link
G Slc38a4 solute carrier family 38, member 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLC38A4 mRNA CTD PMID:37567420 NCBI chr 7:130,022,039...130,082,169
Ensembl chr 7:130,023,980...130,082,097 		JBrowse link
G Slc39a8 solute carrier family 39 member 8 increases expression ISO Glucose results in increased expression of SLC39A8 mRNA CTD PMID:39922521 NCBI chr 2:226,845,686...226,992,668
Ensembl chr 2:226,929,644...226,992,667 		JBrowse link
G Slc40a1 solute carrier family 40 member 1 increases expression ISO
EXP 		Glucose results in increased expression of SLC40A1 protein CTD PMID:38483099 NCBI chr 9:55,525,457...55,633,463
Ensembl chr 9:55,525,532...55,543,460 		JBrowse link
G Slc47a2 solute carrier family 47 member 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLC47A2 mRNA CTD PMID:37567420 NCBI chr10:46,490,262...46,532,954
Ensembl chr10:46,489,831...46,533,425 		JBrowse link
G Slc4a1 solute carrier family 4 member 1 (Diego blood group) increases expression
multiple interactions 		ISO Glucose results in increased expression of SLC4A1 protein
Furans analog inhibits the reaction [Glucose results in increased expression of SLC4A1 protein] 		CTD PMID:28911973 NCBI chr10:87,807,010...87,823,274
Ensembl chr10:87,807,013...87,823,258 		JBrowse link
G Slc4a5 solute carrier family 4 member 5 decreases expression ISO Glucose results in decreased expression of SLC4A5 mRNA CTD PMID:31525975 NCBI chr 4:117,267,803...117,368,024
Ensembl chr 4:117,267,822...117,368,024 		JBrowse link
G Slc5a1 solute carrier family 5 member 1 affects transport
affects uptake
multiple interactions
increases expression 		ISO
EXP 		SLC5A1 protein affects the transport of Glucose
SLC5A1 protein affects the uptake of Glucose
[Cisplatin results in decreased expression of SLC5A1 mRNA] which affects the transport of Glucose; [Gentamicins results in decreased expression of SLC5A1 mRNA] which affects the transport of Glucose
Glucose results in increased expression of SLC5A1 protein
Glucose inhibits the reaction [[Sodium co-treated with SLC5A1 protein] results in increased uptake of methylglucoside]
[gentamicin C results in decreased expression of SLC5A1 protein] which results in decreased uptake of Glucose; [Phlorhizin results in decreased activity of SLC5A1 protein] which results in decreased uptake of Glucose
Glucose results in increased expression of SLC5A1 mRNA 		CTD PMID:8048533 PMID:12927799 PMID:12937289 PMID:16300400 PMID:17288452 More... NCBI chr14:81,778,495...81,843,084
Ensembl chr14:81,778,348...81,846,624 		JBrowse link
G Slc5a10 solute carrier family 5 member 10 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC5A10 mRNA CTD PMID:37567420 NCBI chr10:46,851,527...46,898,460
Ensembl chr10:46,851,527...46,899,277 		JBrowse link
G Slc5a2 solute carrier family 5 member 2 multiple interactions EXP [Cisplatin results in decreased expression of SLC5A2 mRNA] which affects the transport of Glucose; [Gentamicins results in decreased expression of SLC5A2 mRNA] which affects the transport of Glucose; EDN3 protein inhibits the reaction [SLC5A2 protein results in increased uptake of Glucose]; NPPA protein inhibits the reaction [SLC5A2 protein results in increased uptake of Glucose] CTD PMID:15127950 PMID:18656965 NCBI chr 1:192,277,621...192,283,742
Ensembl chr 1:192,277,621...192,283,742 		JBrowse link
G Slc5a4 solute carrier family 5 member 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLC5A4A mRNA CTD PMID:37567420 NCBI chr20:12,475,096...12,518,186
Ensembl chr20:12,475,096...12,527,506 		JBrowse link
G Slc5a7 solute carrier family 5 member 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC5A7 mRNA CTD PMID:37567420 NCBI chr 9:7,922,693...7,953,509
Ensembl chr 9:7,922,697...7,953,509 		JBrowse link
G Slc6a18 solute carrier family 6 member 18 increases expression
multiple interactions 		ISO Glucose results in increased expression of SLC6A18 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of SLC6A18 mRNA] 		CTD PMID:33448797 NCBI chr 1:31,436,577...31,450,478
Ensembl chr 1:31,436,630...31,450,478 		JBrowse link
G Slc6a7 solute carrier family 6 member 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC6A7 mRNA CTD PMID:37567420 NCBI chr18:56,718,849...56,737,702
Ensembl chr18:56,718,849...56,737,702 		JBrowse link
G Slc7a10 solute carrier family 7 member 10 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC7A10 mRNA CTD PMID:37567420 NCBI chr 1:96,966,030...96,982,020
Ensembl chr 1:96,966,076...96,982,018 		JBrowse link
G Slc7a11 solute carrier family 7 member 11 multiple interactions
decreases expression 		EXP
ISO 		[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of SLC7A11 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of SLC7A11 protein; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of SLC7A11 mRNA]; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of SLC7A11 protein]
Resveratrol inhibits the reaction [Glucose results in decreased expression of SLC7A11 protein]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of SLC7A11 protein]] 		CTD PMID:36806343 PMID:39719253 NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695 		JBrowse link
G Slc7a12 solute carrier family 7 (cationic amino acid transporter, y+ system), member 12 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC7A12 mRNA CTD PMID:37567420 NCBI chr 2:88,800,954...88,868,117
Ensembl chr 2:88,800,979...88,868,103 		JBrowse link
G Slc8a1 solute carrier family 8 member A1 multiple interactions EXP [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HIF1A protein] which results in increased expression of SLC8A1 mRNA; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of SLC8A1 mRNA; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of SLC8A1 protein CTD PMID:21293012 NCBI chr 6:18,975,498...19,299,704
Ensembl chr 6:18,946,798...19,287,964 		JBrowse link
G Slc8a2 solute carrier family 8 member A2 increases expression ISO Glucose results in increased expression of SLC8A2 mRNA CTD PMID:39922521 NCBI chr 1:85,944,752...85,982,900
Ensembl chr 1:85,947,204...85,981,889 		JBrowse link
G Slfn9 schlafen family member 9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of SLFN9 mRNA CTD PMID:37567420 NCBI chr10:68,406,641...68,420,062
Ensembl chr10:68,406,642...68,421,134 		JBrowse link
G Slfnl1 schlafen-like 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLFNL1 mRNA CTD PMID:37567420 NCBI chr 5:139,402,861...139,407,332
Ensembl chr 5:139,403,672...139,407,332 		JBrowse link
G Slitrk6 SLIT and NTRK-like family, member 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLITRK6 mRNA CTD PMID:37567420 NCBI chr15:93,977,812...93,984,431
Ensembl chr15:93,969,038...93,984,526 		JBrowse link
G Smad2 SMAD family member 2 multiple interactions
increases phosphorylation 		ISO
EXP 		Glucose results in increased phosphorylation of and affects the localization of SMAD2 protein; isoangustone A inhibits the reaction [Glucose results in increased phosphorylation of SMAD2 protein]; protocatechualdehyde inhibits the reaction [Glucose results in increased phosphorylation of and affects the localization of SMAD2 protein]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased phosphorylation of SMAD2 protein]; diphenyleneiodonium inhibits the reaction [Glucose results in increased phosphorylation of SMAD2 protein]; farrerol inhibits the reaction [Glucose results in increased phosphorylation of SMAD2 protein]; LY2109761 inhibits the reaction [Glucose results in increased phosphorylation of SMAD2 protein] 		CTD PMID:17597607 PMID:21367880 PMID:31838053 NCBI chr18:72,124,792...72,193,345
Ensembl chr18:72,124,863...72,187,388 		JBrowse link
G Smad3 SMAD family member 3 multiple interactions
increases phosphorylation 		ISO 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [Glucose results in increased phosphorylation of SMAD3 protein]; Glucose results in increased phosphorylation of and affects the localization of SMAD3 protein; protocatechualdehyde inhibits the reaction [Glucose results in increased phosphorylation of and affects the localization of SMAD3 protein] CTD PMID:17597607 PMID:26045780 NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:73,024,760...73,132,324 		JBrowse link
G Smad4 SMAD family member 4 increases expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of SMAD4 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of SMAD4 protein]; diphenyleneiodonium inhibits the reaction [Glucose results in increased expression of SMAD4 protein]; farrerol inhibits the reaction [Glucose results in increased expression of SMAD4 protein]; LY2109761 inhibits the reaction [Glucose results in increased expression of SMAD4 protein]
isoangustone A inhibits the reaction [Glucose results in increased expression of SMAD4 protein] 		CTD PMID:21367880 PMID:31838053 NCBI chr18:69,518,988...69,549,684
Ensembl chr18:69,518,988...69,549,684 		JBrowse link
G Smarca4 SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4 multiple interactions ISO [MIR144 mRNA results in decreased expression of SMARCA4 protein] affects the susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMARCA4 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMARCA4 protein; MIR144 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMARCA4 mRNA]; MIR144 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMARCA4 protein] CTD PMID:29457851 NCBI chr 8:28,438,370...28,535,071
Ensembl chr 8:28,443,810...28,535,070 		JBrowse link
G Smc4 structural maintenance of chromosomes 4 increases expression ISO Glucose results in increased expression of SMC4 mRNA CTD PMID:17178593 NCBI chr 2:155,550,262...155,578,695
Ensembl chr 2:155,550,262...155,581,937 		JBrowse link
G Smim38 small integral membrane protein 38 increases expression ISO Glucose results in increased expression of SMIM38 mRNA CTD PMID:39922521 NCBI chr 1:209,795,854...209,801,269
Ensembl chr 1:209,795,854...209,801,269 		JBrowse link
G Smo smoothened, frizzled class receptor multiple interactions ISO [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMO protein; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMO protein]; SHH protein affects the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMO protein] CTD PMID:27481074 NCBI chr 4:59,311,084...59,341,280
Ensembl chr 4:59,311,041...59,341,281 		JBrowse link
G Smox spermine oxidase increases expression ISO Glucose results in increased expression of SMOX mRNA CTD PMID:17178593 NCBI chr 3:139,184,793...139,220,174
Ensembl chr 3:139,184,798...139,220,170
Ensembl chr  X:139,184,798...139,220,170 		JBrowse link
G Smpd1 sphingomyelin phosphodiesterase 1 increases expression ISO Glucose results in increased expression of SMPD1 mRNA CTD PMID:32481596 NCBI chr 1:169,304,772...169,308,615
Ensembl chr 1:169,304,708...169,308,614 		JBrowse link
G Smyd1 SET and MYND domain containing 1 decreases expression ISO Glucose results in decreased expression of SMYD1 mRNA CTD PMID:31525975 NCBI chr 4:104,757,281...104,811,307
Ensembl chr 4:104,760,475...104,870,081 		JBrowse link
G Snai1 snail family transcriptional repressor 1 multiple interactions
increases expression 		ISO [Glucose co-treated with TGFB1 protein] results in increased expression of SNAI1 protein; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of SNAI1 protein]; gingerol inhibits the reaction [Glucose results in increased expression of SNAI1 mRNA]; MAPK14 protein promotes the reaction [Glucose results in increased expression of SNAI1 mRNA]
Glucose results in increased expression of SNAI1 mRNA; Glucose results in increased expression of SNAI1 protein 		CTD PMID:21829520 PMID:35445903 PMID:35961541 NCBI chr 3:176,667,476...176,671,965 JBrowse link
G Snai3 snail family transcriptional repressor 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SNAI3 mRNA CTD PMID:37567420 NCBI chr19:67,425,311...67,437,830
Ensembl chr19:67,425,157...67,434,268 		JBrowse link
G Snap25 synaptosome associated protein 25 decreases expression EXP Glucose results in decreased expression of SNAP25 protein CTD PMID:23776493 NCBI chr 3:144,494,579...144,576,449
Ensembl chr 3:144,494,595...144,576,448 		JBrowse link
G Snora31 small nucleolar RNA, H/ACA box 31 increases expression ISO Glucose results in increased expression of SNORA31 mRNA CTD PMID:39922521 NCBI chr15:57,568,564...57,568,693
Ensembl chr15:57,568,564...57,568,693 		JBrowse link
G Snora5c small nucleolar RNA, H/ACA box 5C increases expression ISO Glucose results in increased expression of SNORA5C mRNA CTD PMID:31525975 NCBI chr14:85,701,133...85,701,269
Ensembl chr14:85,701,133...85,701,269 		JBrowse link
G Snord49a small nucleolar RNA, C/D box 49A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of SNORD49A mRNA CTD PMID:37567420 NCBI chr10:47,796,770...47,796,841
Ensembl chr10:47,796,770...47,796,841 		JBrowse link
G Socs2 suppressor of cytokine signaling 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SOCS2 mRNA CTD PMID:37567420 NCBI chr 7:31,890,564...31,932,092
Ensembl chr 7:31,874,463...31,930,423 		JBrowse link
G Socs3 suppressor of cytokine signaling 3 increases expression ISO Glucose results in increased expression of SOCS3 mRNA CTD PMID:17178593 NCBI chr10:103,692,579...103,695,975
Ensembl chr10:103,690,976...103,704,825 		JBrowse link
G Sod1 superoxide dismutase 1 multiple interactions
decreases metabolic processing
decreases expression
increases expression
affects binding 		ISO
EXP 		[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of SOD1 protein; Acetylcysteine inhibits the reaction [Glucose deficiency results in increased degradation of SOD1 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Glucose deficiency results in increased degradation of SOD1 protein]; CAT inhibits the reaction [Glucose deficiency results in increased degradation of SOD1 protein]; Glucose deficiency results in decreased expression of and results in increased degradation of SOD1 protein; Glucose promotes the reaction [SOD1 protein mutant form results in increased chemical synthesis of Hydrogen Peroxide]; lactacystin inhibits the reaction [Glucose deficiency results in increased degradation of SOD1 protein]; SOD1 protein inhibits the reaction [Glucose results in increased expression of NOS2 mRNA]; SOD1 protein inhibits the reaction [Glucose results in increased expression of NOS2 protein]; Tetradecanoylphorbol Acetate promotes the reaction [Glucose deficiency results in decreased expression of and results in increased degradation of SOD1 protein]; U 0126 inhibits the reaction [Glucose deficiency results in increased degradation of SOD1 protein]
SOD1 protein mutant form results in decreased metabolism of Glucose
Glucose results in decreased expression of SOD1 mRNA
Glucose results in increased expression of SOD1 mRNA
[Glucose co-treated with Lycopene] results in increased expression of SOD1 mRNA; [Glucose co-treated with Palmitic Acid] results in decreased expression of SOD1 protein; [Oxygen co-treated with Glucose] promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SOD1 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SOD1 protein; formononetin inhibits the reaction [Glucose results in decreased expression of SOD1 mRNA]; formononetin inhibits the reaction [Glucose results in decreased expression of SOD1 protein]; naringenin inhibits the reaction [Glucose results in increased expression of SOD1 mRNA]; SOD1 protein inhibits the reaction [[INS1 protein co-treated with Glucose] results in increased activity of PARP1 protein]; Thioctic Acid inhibits the reaction [Glucose results in decreased expression of SOD1 protein]
Glucose results in increased expression of SOD1 protein
copper bis(3,5-diisopropylsalicylate) inhibits the reaction [SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; ebselen inhibits the reaction [SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; NFKB1 protein inhibits the reaction [SOD1 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTGS2 protein]]; resveratrol inhibits the reaction [Glucose results in decreased expression of SOD1 protein]; SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]; SOD1 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and results in increased activity of NFKB1 protein]; SOD1 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of MAPK1 protein]; SOD1 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of MAPK3 protein]; SOD1 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTGS2 protein]; Sodium Selenite inhibits the reaction [SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]
Glucose results in decreased expression of SOD1 mRNA; Glucose results in decreased expression of SOD1 protein
Glucose binds to SOD1 protein mutant form 		CTD PMID:12626432 PMID:16395278 PMID:17309078 PMID:18545258 PMID:19228841 More... NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399 		JBrowse link
G Sod2 superoxide dismutase 2 multiple interactions
affects expression
decreases secretion
decreases expression
decreases activity
increases expression
decreases response to substance
affects folding 		ISO
EXP 		2,3-bis(4-hydroxyphenyl)-propionitrile inhibits the reaction [4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [Glucose results in decreased expression of SOD2 protein]]; 4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of SOD2 protein]; Acetylcysteine inhibits the reaction [Glucose deficiency affects the folding of SOD2 protein]; CAT inhibits the reaction [Glucose deficiency affects the folding of SOD2 protein]; Fulvestrant inhibits the reaction [4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of SOD2 protein]]; Glucose results in decreased expression of and results in decreased activity of SOD2 protein; manganese chloride inhibits the reaction [Glucose results in decreased activity of SOD2 protein]; SIRT3 protein inhibits the reaction [Glucose results in increased expression of SOD2 protein]; SOD2 inhibits the reaction [Glucose results in decreased expression of GLO1 protein]; SOD2 inhibits the reaction [Glucose results in increased expression of AGER mRNA]; SOD2 inhibits the reaction [Glucose results in increased expression of AGER protein]; SOD2 inhibits the reaction [Glucose results in increased expression of and results in increased secretion of HMGB1 protein]; SOD2 inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]; SOD2 inhibits the reaction [Glucose results in increased expression of S100A12 mRNA]; SOD2 inhibits the reaction [Glucose results in increased expression of S100A8 mRNA]; SOD2 inhibits the reaction [Glucose results in increased expression of S100A8 protein]; SOD2 protein inhibits the reaction [[Glucose results in increased chemical synthesis of Superoxides] which results in decreased activity of GAPDH protein]; SOD2 protein inhibits the reaction [Glucose results in decreased activity of and results in increased ADP-ribosylation of GAPDH protein]; SOD2 protein inhibits the reaction [Glucose results in decreased phosphorylation of SP1 protein]; SOD2 protein inhibits the reaction [Glucose results in increased activity of PARP1 protein]; SOD2 protein inhibits the reaction [Glucose results in increased chemical synthesis of Dinoprostone]; SOD2 protein inhibits the reaction [Glucose results in increased chemical synthesis of Reactive Oxygen Species]; SOD2 protein inhibits the reaction [Glucose results in increased expression of SERPINE1 mRNA]; SOD2 protein inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; SOD2 protein inhibits the reaction [Glucose results in increased O-linked glycosylation of SP1 protein]
Glucose affects the expression of SOD2 mRNA
Glucose deficiency results in decreased secretion of SOD2 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in decreased expression of SOD2 mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in decreased expression of SOD2 protein]; 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucose results in decreased expression of SOD2 mRNA]; 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucose results in decreased expression of SOD2 protein]; [Glucose co-treated with Lycopene] results in increased expression of SOD2 mRNA; Acetylcysteine inhibits the reaction [Glucose results in decreased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [Glucose results in decreased expression of SOD2 protein]; formononetin inhibits the reaction [Glucose results in decreased expression of SOD2 mRNA]; formononetin inhibits the reaction [Glucose results in decreased expression of SOD2 protein]; Glycyrrhizic Acid inhibits the reaction [Glucose results in decreased expression of SOD2 protein]; KU-32 compound inhibits the reaction [Glucose results in decreased expression of SOD2 protein]; naringenin inhibits the reaction [Glucose results in decreased expression of SOD2 mRNA]; SRT1720 inhibits the reaction [Glucose results in decreased expression of SOD2 protein]
Glucose results in decreased expression of SOD2 mRNA; Glucose results in decreased expression of SOD2 protein
Glucose deficiency results in increased expression of SOD2 protein; Glucose results in increased expression of SOD2 protein
Glucose results in increased expression of SOD2 mRNA
SOD2 protein results in decreased susceptibility to Glucose
Glucose deficiency results in decreased expression of SOD2 protein
[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] results in decreased expression of SOD2 protein; [Glucose co-treated with SOD2 gene mutant form] results in decreased expression of HIF1A protein; IL6 protein inhibits the reaction [[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] results in decreased expression of SOD2 protein]; pimagedine inhibits the reaction [Glucose results in decreased expression of SOD2 protein]; resveratrol inhibits the reaction [Glucose results in decreased expression of SOD2 protein]; SOD2 protein inhibits the reaction [sodium arsenite inhibits the reaction [INS1 protein results in increased uptake of Glucose]] 		CTD PMID:11050244 PMID:14514642 PMID:14523042 PMID:17309078 PMID:18483403 More... NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168 		JBrowse link
G Sod3 superoxide dismutase 3 decreases expression EXP Glucose results in decreased expression of SOD3 mRNA CTD PMID:21818840 NCBI chr14:62,822,865...62,828,602
Ensembl chr14:62,811,177...62,829,125 		JBrowse link
G Sorcs1 sortilin-related VPS10 domain containing receptor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of SORCS1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SORCS1 mRNA CTD PMID:37567420 NCBI chr 1:259,022,007...259,535,731
Ensembl chr 1:259,021,631...259,535,685 		JBrowse link
G Sord sorbitol dehydrogenase increases expression ISO Glucose results in increased expression of SORD mRNA CTD PMID:16805838 NCBI chr 3:129,638,282...129,669,727
Ensembl chr 3:129,638,302...129,686,100 		JBrowse link
G Sox2 SRY-box transcription factor 2 decreases expression ISO Glucose results in decreased expression of SOX2 protein CTD PMID:33992720 NCBI chr 2:119,465,131...119,467,542
Ensembl chr 2:119,454,541...119,496,350 		JBrowse link
G Sox6 SRY-box transcription factor 6 increases expression
multiple interactions 		ISO Glucose results in increased expression of SOX6 mRNA; Glucose results in increased expression of SOX6 protein
MIR142 inhibits the reaction [Glucose results in increased expression of SOX6 protein]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased expression of BAX protein]]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased expression of COL1A1 protein]]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased expression of COL4A1 protein]]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased expression of FN1 protein]]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased secretion of IL1B protein]]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased secretion of IL6 protein]]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased secretion of TNF protein]] 		CTD PMID:36073553 PMID:38124441 NCBI chr 1:179,157,678...179,769,243
Ensembl chr 1:179,163,566...179,711,727 		JBrowse link
G Sox9 SRY-box transcription factor 9 multiple interactions
increases expression 		ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SOX9 mRNA
Glucose results in increased expression of SOX9 mRNA 		CTD PMID:37567420 PMID:39922521 NCBI chr10:98,305,744...98,311,250
Ensembl chr10:98,305,744...98,311,250 		JBrowse link
G Sp1 Sp1 transcription factor multiple interactions EXP
ISO 		UCP1 protein inhibits the reaction [Glucose results in decreased phosphorylation of SP1 protein]; UCP1 protein inhibits the reaction [Glucose results in increased O-linked glycosylation of SP1 protein]
SOD2 protein inhibits the reaction [Glucose results in decreased phosphorylation of SP1 protein]; SOD2 protein inhibits the reaction [Glucose results in increased O-linked glycosylation of SP1 protein] 		CTD PMID:11050244 NCBI chr 7:135,419,864...135,450,513
Ensembl chr 7:135,420,050...135,450,513 		JBrowse link
G Sp7 Sp7 transcription factor multiple interactions ISO [EPO protein co-treated with Glucose] results in increased expression of SP7 mRNA; [EPO protein co-treated with Glucose] results in increased expression of SP7 protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of SP7 mRNA 		CTD PMID:30894315 PMID:37567420 NCBI chr 7:135,363,193...135,373,376
Ensembl chr 7:135,363,199...135,373,559 		JBrowse link
G Spaca9 sperm acrosome associated 9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of SPACA9 mRNA CTD PMID:37567420 NCBI chr 3:32,417,350...32,426,776
Ensembl chr 3:32,417,350...32,426,934 		JBrowse link
G Sparc secreted protein acidic and cysteine rich decreases expression
multiple interactions 		ISO Glucose results in decreased expression of SPARC mRNA
cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of SPARC mRNA] 		CTD PMID:19924377 NCBI chr10:40,017,065...40,038,816
Ensembl chr10:40,017,075...40,039,268 		JBrowse link
G Spata20 spermatogenesis associated 20 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of SPATA20 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SPATA20 mRNA CTD PMID:37567420 NCBI chr10:79,924,407...79,932,351
Ensembl chr10:79,924,330...79,931,250 		JBrowse link
G Sphk1 sphingosine kinase 1 multiple interactions
increases expression 		EXP Acetylcysteine inhibits the reaction [Glucose results in increased expression of and results in increased activity of SPHK1 protein]; Glucose results in increased expression of and results in increased activity of SPHK1 protein; N,N-dimethylsphingosine inhibits the reaction [Glucose results in increased activity of SPHK1 protein]; Pyridoxamine inhibits the reaction [Glucose results in increased expression of and results in increased activity of SPHK1 protein]; SPHK1 mRNA affects the reaction [Glucose results in increased expression of FN1 protein]; SPHK1 protein inhibits the reaction [Glucose results in increased expression of FN1 protein]
Glucose results in increased expression of SPHK1 mRNA 		CTD PMID:21998146 NCBI chr10:102,257,413...102,263,086
Ensembl chr10:102,258,975...102,263,082 		JBrowse link
G Spib Spi-B transcription factor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SPIB mRNA CTD PMID:37567420 NCBI chr 1:104,155,456...104,161,311
Ensembl chr 1:104,155,464...104,161,517 		JBrowse link
G Spmip7 sperm microtubule inner protein 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of SPMIP7 mRNA CTD PMID:37567420 NCBI chr14:90,244,087...90,299,294
Ensembl chr14:90,244,289...90,299,293 		JBrowse link
G Spp1 secreted phosphoprotein 1 increases expression
multiple interactions
decreases expression
increases secretion 		ISO
EXP 		Glucose results in increased expression of SPP1 mRNA
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in decreased expression of SPP1 mRNA]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in decreased expression of SPP1 protein]]; Melatonin inhibits the reaction [Glucose results in decreased expression of SPP1 mRNA]; Melatonin inhibits the reaction [Glucose results in decreased expression of SPP1 protein]; Phytic Acid inhibits the reaction [Glucose results in decreased expression of SPP1 mRNA]; Phytic Acid inhibits the reaction [Glucose results in decreased expression of SPP1 protein]
Glucose results in decreased expression of SPP1 mRNA; Glucose results in decreased expression of SPP1 protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of SPP1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SPP1 mRNA
Glucose results in increased secretion of SPP1 protein
Glucose results in increased expression of SPP1; Glucose results in increased expression of SPP1 mRNA
1-Methyl-3-isobutylxanthine inhibits the reaction [Glucose results in increased secretion of SPP1 protein]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Glucose results in increased secretion of SPP1 protein]; 8-bromocyclic GMP inhibits the reaction [Glucose results in increased secretion of SPP1 protein]; Dinitrochlorobenzene inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Glucose results in increased secretion of SPP1 protein]]; Dinitrochlorobenzene inhibits the reaction [8-bromocyclic GMP inhibits the reaction [Glucose results in increased secretion of SPP1 protein]]; Dinitrochlorobenzene inhibits the reaction [Dipyridamole inhibits the reaction [Glucose results in increased secretion of SPP1 protein]]; Dipyridamole inhibits the reaction [Glucose results in increased expression of SPP1 mRNA]; Dipyridamole inhibits the reaction [Glucose results in increased secretion of SPP1 protein]; KT 5823 inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Glucose results in increased secretion of SPP1 protein]]; KT 5823 inhibits the reaction [8-bromocyclic GMP inhibits the reaction [Glucose results in increased secretion of SPP1 protein]]; KT 5823 inhibits the reaction [Dipyridamole inhibits the reaction [Glucose results in increased secretion of SPP1 protein]]; morroniside inhibits the reaction [Glucose results in decreased expression of SPP1 mRNA]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Glucose results in increased secretion of SPP1 protein]]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [8-bromocyclic GMP inhibits the reaction [Glucose results in increased secretion of SPP1 protein]]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Dipyridamole inhibits the reaction [Glucose results in increased secretion of SPP1 protein]] 		CTD PMID:12505755 PMID:17178593 PMID:20453393 PMID:32643284 PMID:37567420 More... NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820 		JBrowse link
G Spry2 sprouty RTK signaling antagonist 2 increases expression ISO Glucose results in increased expression of SPRY2 mRNA CTD PMID:17178593 NCBI chr15:89,106,809...89,111,926
Ensembl chr15:89,103,731...89,115,074 		JBrowse link
G Spsb1 splA/ryanodine receptor domain and SOCS box containing 1 increases expression ISO Glucose results in increased expression of SPSB1 mRNA CTD PMID:17178593 NCBI chr 5:165,641,255...165,701,482
Ensembl chr 5:165,642,851...165,654,225 		JBrowse link
G Spta1 spectrin, alpha, erythrocytic 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of SPTA1 mRNA CTD PMID:37567420 NCBI chr13:88,735,833...88,811,697
Ensembl chr13:88,735,833...88,811,697 		JBrowse link
G Sptbn4 spectrin, beta, non-erythrocytic 4 increases expression ISO Glucose results in increased expression of SPTBN4 mRNA CTD PMID:39922521 NCBI chr 1:91,778,379...91,865,970
Ensembl chr 1:91,778,380...91,865,049 		JBrowse link
G Sptbn5 spectrin, beta, non-erythrocytic 5 increases expression ISO Glucose results in increased expression of SPTBN5 mRNA CTD PMID:39922521 NCBI chr 3:127,467,137...127,511,814
Ensembl chr 3:127,466,932...127,508,860 		JBrowse link
G Sptlc3 serine palmitoyltransferase, long chain base subunit 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of SPTLC3 mRNA CTD PMID:37567420 NCBI chr 3:147,301,570...147,431,696
Ensembl chr 3:147,301,801...147,434,044 		JBrowse link
G Sqle squalene epoxidase increases expression ISO Glucose results in increased expression of SQLE mRNA CTD PMID:39613055 NCBI chr 7:92,758,175...92,773,049
Ensembl chr 7:92,757,409...92,773,050 		JBrowse link
G Sqstm1 sequestosome 1 increases expression
multiple interactions
decreases expression 		EXP
ISO 		Glucose results in increased expression of SQSTM1 mRNA; Glucose results in increased expression of SQSTM1 protein
Glucose deficiency results in increased expression of SQSTM1 protein
HU 308 inhibits the reaction [Glucose results in increased expression of SQSTM1 protein]
Glucose deficiency results in decreased expression of SQSTM1 protein
3-methyladenine inhibits the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in increased expression of SQSTM1 protein]]; [Glucose co-treated with Lycopene] results in increased expression of SQSTM1 mRNA; Berberine inhibits the reaction [Glucose results in increased expression of SQSTM1 protein]; Chloroquine promotes the reaction [Glucose results in increased expression of SQSTM1 protein]; Chloroquine promotes the reaction [Resveratrol promotes the reaction [Glucose results in increased expression of SQSTM1 protein]]; Inositol inhibits the reaction [Glucose results in increased expression of SQSTM1 protein]; N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in increased expression of SQSTM1 protein]; Resveratrol promotes the reaction [Glucose results in increased expression of SQSTM1 protein]; Sirolimus promotes the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in increased expression of SQSTM1 protein]]; ULK1 protein affects the reaction [Glucose results in increased expression of SQSTM1 protein]; ULK1 protein affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in increased expression of SQSTM1 protein]] 		CTD PMID:28713934 PMID:29128638 PMID:29649567 PMID:30459625 PMID:34580807 More... NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750 		JBrowse link
G Src SRC proto-oncogene, non-receptor tyrosine kinase multiple interactions
decreases expression 		ISO
EXP 		[Resveratrol co-treated with Glucose] results in decreased expression of SRC mRNA; [Resveratrol co-treated with Glucose] results in decreased expression of SRC protein; [Resveratrol co-treated with Glucose] results in decreased expression of SRC protein modified form; Eucalyptol inhibits the reaction [Glucose results in decreased expression of SRC protein]; SRC protein promotes the reaction [Tetrachlorodibenzodioxin results in decreased uptake of Glucose]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of SRC protein; Antigen-Antibody Complex inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of SRC protein]; Chlorpromazine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of SRC protein] 		CTD PMID:11990355 PMID:24659233 PMID:29702141 PMID:31483951 NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462 		JBrowse link
G Srebf1 sterol regulatory element binding transcription factor 1 increases expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of SREBF1 mRNA; Glucose results in increased expression of SREBF1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased cleavage of SREBF1 protein]; 4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [Glucose results in increased cleavage of SREBF1 protein]; Allopurinol inhibits the reaction [Glucose results in increased expression of SREBF1 protein]; exoenzyme C3, Clostridium botulinum inhibits the reaction [Glucose results in increased cleavage of SREBF1 protein]; fatostatin inhibits the reaction [Glucose promotes the reaction [SREBF1 protein binds to TGFB1 promoter]]; fatostatin inhibits the reaction [Glucose results in increased activity of and results in increased cleavage of SREBF1 protein]; Glucose promotes the reaction [SREBF1 protein binds to FASN promoter]; Glucose promotes the reaction [SREBF1 protein binds to TGFB1 promoter]; Glucose results in increased activity of and results in increased cleavage of SREBF1 protein; L 709049 analog inhibits the reaction [Glucose results in increased expression of SREBF1 protein]; PD168393 inhibits the reaction [Glucose results in increased activity of and results in increased cleavage of SREBF1 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of SREBF1 protein]; RTKI cpd inhibits the reaction [Glucose results in increased activity of and results in increased cleavage of SREBF1 protein]; SREBF1 protein affects the reaction [Glucose results in increased expression of TGFB1 mRNA]; Wortmannin inhibits the reaction [Glucose results in increased cleavage of SREBF1 protein]; Y 27632 inhibits the reaction [Glucose results in increased cleavage of SREBF1 protein]
[INS protein co-treated with Glucose] results in increased expression of SREBF1 mRNA; Allopurinol inhibits the reaction [Glucose results in increased expression of SREBF1 protein]; dorsomorphin inhibits the reaction [platycodin D inhibits the reaction [Glucose results in increased expression of SREBF1 mRNA]]; dorsomorphin inhibits the reaction [platycodin D inhibits the reaction [Glucose results in increased expression of SREBF1 protein]]; L 709049 analog inhibits the reaction [Glucose results in increased expression of SREBF1 protein]; Niacinamide inhibits the reaction [platycodin D inhibits the reaction [Glucose results in increased expression of SREBF1 protein]]; platycodin D inhibits the reaction [Glucose results in increased expression of SREBF1 mRNA]; platycodin D inhibits the reaction [Glucose results in increased expression of SREBF1 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of SREBF1 protein]; SRT1720 inhibits the reaction [[INS protein co-treated with Glucose] results in increased expression of SREBF1 mRNA]; STO 609 inhibits the reaction [platycodin D inhibits the reaction [Glucose results in increased expression of SREBF1 mRNA]]
resveratrol inhibits the reaction [Glucose results in increased expression of SREBF1 protein] 		CTD PMID:10913129 PMID:15066988 PMID:19724016 PMID:22031849 PMID:23090186 More... NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164 		JBrowse link
G Srebf2 sterol regulatory element binding transcription factor 2 multiple interactions
increases expression 		ISO
EXP 		Allopurinol inhibits the reaction [Glucose results in increased expression of SREBF2 protein]; L 709049 analog inhibits the reaction [Glucose results in increased expression of SREBF2 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of SREBF2 protein] CTD PMID:23647015 NCBI chr 7:115,542,774...115,600,945
Ensembl chr 7:115,543,290...115,600,943 		JBrowse link
G Sri sorcin multiple interactions
decreases expression 		ISO Glucose promotes the reaction [NCOR1 protein binds to SRI promoter]; Glucose promotes the reaction [RELA protein binds to SRI promoter]; NCOR1 protein affects the reaction [Glucose results in decreased expression of SRI protein]; RELA protein affects the reaction [Glucose results in decreased expression of SRI protein]; SRI protein inhibits the reaction [Glucose affects the localization of MLXIP protein] CTD PMID:33930463 NCBI chr 4:26,928,338...26,952,980
Ensembl chr 4:26,923,662...26,961,361 		JBrowse link
G Sstr3 somatostatin receptor 3 multiple interactions
increases expression 		EXP 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the reaction [Dexamethasone inhibits the reaction [Glucose results in increased expression of SSTR3 protein]]; Dexamethasone inhibits the reaction [Glucose results in increased expression of SSTR3 protein] CTD PMID:31778773 NCBI chr 7:111,973,049...111,980,250
Ensembl chr 7:111,972,811...111,997,368 		JBrowse link
G St18 ST18 C2H2C-type zinc finger transcription factor increases expression ISO Glucose results in increased expression of ST18 mRNA CTD PMID:23236509 NCBI chr 5:17,369,383...17,701,094
Ensembl chr 5:17,371,000...17,458,676 		JBrowse link
G St8sia4 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 increases expression ISO Glucose results in increased expression of ST8SIA4 mRNA CTD PMID:39613055 NCBI chr 9:103,437,479...103,532,008
Ensembl chr 9:103,437,479...103,532,008 		JBrowse link
G Stac2 SH3 and cysteine rich domain 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of STAC2 mRNA CTD PMID:37567420 NCBI chr10:83,528,741...83,544,583
Ensembl chr10:83,528,741...83,544,583 		JBrowse link
G Stag2 STAG2 cohesin complex component decreases expression ISO Glucose results in decreased expression of STAG2 mRNA CTD PMID:17178593 NCBI chr  X:125,839,660...125,971,209
Ensembl chr  X:125,840,401...125,971,209 		JBrowse link
G Stat1 signal transducer and activator of transcription 1 multiple interactions
increases phosphorylation 		EXP
ISO 		alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Glucose results in increased phosphorylation of STAT1 protein]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of STAT1 mRNA 		CTD PMID:20060012 PMID:37567420 NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:56,911,523...57,077,346 		JBrowse link
G Stat3 signal transducer and activator of transcription 3 multiple interactions
decreases phosphorylation
increases expression 		EXP
ISO 		[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of STAT3 mRNA; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of STAT3 protein; cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased phosphorylation of STAT3 protein]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in decreased phosphorylation of STAT3 protein]]; Propofol inhibits the reaction [Glucose results in decreased phosphorylation of STAT3 protein]; resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of STAT3 mRNA]; resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of STAT3 protein]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of NPPA mRNA]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased phosphorylation of STAT3 protein]]; zinc protoporphyrin inhibits the reaction [Propofol inhibits the reaction [Glucose results in decreased phosphorylation of STAT3 protein]]
[[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] inhibits the reaction [IL6RA protein binds to IL6ST protein]] promotes the reaction [IL6ST protein binds to and results in increased phosphorylation of STAT3 protein]; [[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] results in decreased phosphorylation of STAT3 protein; IL6 protein inhibits the reaction [[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] results in decreased phosphorylation of STAT3 protein]; STAT3 gene mutant form inhibits the reaction [IL22 protein results in decreased abundance of Glucose]
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of STAT3 protein modified form]]; resveratrol inhibits the reaction [Glucose results in increased expression of STAT3 protein modified form]
Glucose results in increased expression of STAT3 protein; Glucose results in increased expression of STAT3 protein modified form 		CTD PMID:21940958 PMID:23421680 PMID:24064760 PMID:24810525 PMID:26064446 NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359 		JBrowse link
G Stbd1 starch binding domain 1 multiple interactions ISO [imeglimin co-treated with Glucose] results in increased expression of STBD1 mRNA CTD PMID:34588186 NCBI chr14:15,754,769...15,758,174
Ensembl chr14:15,754,644...15,761,659 		JBrowse link
G Stc2 stanniocalcin 2 multiple interactions ISO [imeglimin co-treated with Glucose] results in increased expression of STC2 mRNA CTD PMID:34588186 NCBI chr10:16,755,508...16,765,275
Ensembl chr10:16,755,267...16,767,447 		JBrowse link
G Stim1 stromal interaction molecule 1 increases expression
multiple interactions 		EXP Glucose results in increased expression of STIM1 mRNA; Glucose results in increased expression of STIM1 protein
STIM1 protein affects the reaction [Glucose results in decreased expression of BCL2 protein]; STIM1 protein affects the reaction [Glucose results in increased cleavage of CASP3 protein]; STIM1 protein affects the reaction [Glucose results in increased expression of BAX protein] 		CTD PMID:27234048 NCBI chr 1:166,067,450...166,230,733
Ensembl chr 1:166,067,962...166,233,108 		JBrowse link
G Stk11 serine/threonine kinase 11 multiple interactions ISO Glucose results in increased acetylation of and results in decreased activity of STK11 protein; resveratrol inhibits the reaction [Glucose results in increased acetylation of and results in decreased activity of STK11 protein] CTD PMID:19765649 NCBI chr 7:10,225,204...10,241,965
Ensembl chr 7:10,225,204...10,241,965 		JBrowse link
G Stmn3 stathmin 3 decreases expression ISO Glucose results in decreased expression of STMN3 mRNA CTD PMID:39613055 NCBI chr 3:188,794,358...188,802,494
Ensembl chr 3:188,794,358...188,802,873 		JBrowse link
G Stmnd1 stathmin domain containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of STMND1 mRNA CTD PMID:37567420 NCBI chr17:18,600,537...18,626,807
Ensembl chr17:18,599,971...18,643,590 		JBrowse link
G Stra6 signaling receptor and transporter of retinol STRA6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of STRA6 mRNA CTD PMID:37567420 NCBI chr 8:67,444,757...67,464,719
Ensembl chr 8:67,444,742...67,464,720 		JBrowse link
G Strbp spermatid perinuclear RNA binding protein decreases expression ISO Glucose results in decreased expression of STRBP mRNA CTD PMID:17178593 NCBI chr 3:41,738,096...41,879,054
Ensembl chr 3:41,712,311...41,824,707 		JBrowse link
G Strip2 striatin interacting protein 2 increases expression
multiple interactions 		ISO Glucose results in increased expression of STRIP2 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of STRIP2 mRNA] 		CTD PMID:33448797 PMID:39922521 NCBI chr 4:59,503,478...59,545,745
Ensembl chr 4:59,503,481...59,545,739 		JBrowse link
G Stum stum, mechanosensory transduction mediator homolog multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of STUM mRNA CTD PMID:37567420 NCBI chr13:94,704,074...94,759,097 JBrowse link
G Stx19 syntaxin 19 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of STX19 mRNA CTD PMID:37567420 NCBI chr11:13,619,436...13,624,634
Ensembl chr11:13,593,134...13,629,410 		JBrowse link
G Sult4a1 sulfotransferase family 4A, member 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SULT4A1 mRNA CTD PMID:37567420 NCBI chr 7:117,096,064...117,120,714
Ensembl chr 7:117,096,064...117,120,083 		JBrowse link
G Syn1 synapsin I multiple interactions
decreases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of SYN1 mRNA] CTD PMID:33448797 NCBI chr  X:3,725,745...3,780,940
Ensembl chr  X:3,725,714...3,780,938 		JBrowse link
G Syndig1 synapse differentiation inducing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of SYNDIG1 mRNA CTD PMID:37567420 NCBI chr 3:158,491,474...158,695,174
Ensembl chr 3:158,491,996...158,658,652 		JBrowse link
G Syngr3 synaptogyrin 3 increases expression ISO Glucose results in increased expression of SYNGR3 mRNA CTD PMID:39922521 NCBI chr10:14,215,088...14,219,844
Ensembl chr10:14,215,088...14,220,179 		JBrowse link
G Synpo2l synaptopodin 2-like multiple interactions
decreases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of SYNPO2L mRNA] CTD PMID:33448797 NCBI chr15:3,681,224...3,690,673
Ensembl chr15:3,681,104...3,690,673 		JBrowse link
G Syp synaptophysin decreases expression EXP Glucose results in decreased expression of SYP protein CTD PMID:23776493 NCBI chr  X:17,521,348...17,536,449
Ensembl chr  X:17,521,348...17,536,984 		JBrowse link
G Syt1 synaptotagmin 1 increases expression EXP Glucose results in increased expression of SYT1 protein CTD PMID:23776493 NCBI chr 7:45,699,649...46,244,460
Ensembl chr 7:45,702,228...46,244,213 		JBrowse link
G Syt15 synaptotagmin 15 increases expression ISO Glucose results in increased expression of SYT15 mRNA CTD PMID:39613055 NCBI chr16:9,538,740...9,549,548
Ensembl chr16:9,538,748...9,549,558 		JBrowse link
G Syvn1 synoviolin 1 decreases expression ISO Glucose results in decreased expression of SYVN1 mRNA CTD PMID:17178593 NCBI chr 1:212,766,736...212,775,426
Ensembl chr 1:212,768,907...212,776,457 		JBrowse link
G Tac1 tachykinin, precursor 1 multiple interactions ISO [imeglimin co-treated with Glucose] results in increased expression of TAC1 mRNA CTD PMID:34588186 NCBI chr 4:36,645,344...36,653,548
Ensembl chr 4:36,645,571...36,653,546 		JBrowse link
G Tagln transgelin increases secretion ISO Glucose deficiency results in increased secretion of TAGLN protein CTD PMID:24802182 NCBI chr 8:55,121,647...55,127,121
Ensembl chr 8:55,121,301...55,127,563 		JBrowse link
G Taok1 TAO kinase 1 multiple interactions
increases expression 		ISO MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in decreased expression of BCL2 protein]]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased cleavage of CASP3 protein]]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of BAX protein]]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of COL1A1 protein]]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of COL4A1 protein]]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of FN1 protein]]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased secretion of IL1B protein]]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased secretion of IL6 protein]]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased secretion of TNF protein]]; TAOK1 mRNA alternative form affects the reaction [Glucose results in decreased expression of BCL2 protein]; TAOK1 mRNA alternative form affects the reaction [Glucose results in decreased expression of MIR142 mRNA]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased cleavage of CASP3 protein]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of BAX protein]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of COL1A1 protein]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of COL4A1 protein]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of FN1 protein]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased secretion of IL1B protein]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased secretion of IL6 protein]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased secretion of TNF protein]
Glucose results in increased expression of TAOK1 mRNA alternative form 		CTD PMID:38124441 NCBI chr10:62,871,198...62,989,049
Ensembl chr10:62,871,198...62,957,595 		JBrowse link
G Tap1 transporter 1, ATP binding cassette subfamily B member multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of TAP1 mRNA CTD PMID:37567420 NCBI chr20:4,658,171...4,668,543
Ensembl chr20:4,658,172...4,668,810 		JBrowse link
G Tas1r1 taste 1 receptor member 1 multiple interactions ISO Glucose promotes the reaction [TAS1R3 protein binds to TAS1R1 protein]; TAS1R1 protein affects the reaction [Glucose results in decreased expression of CDKN1A protein] CTD PMID:33992720 NCBI chr 5:167,816,566...167,829,136
Ensembl chr 5:167,816,569...167,828,489 		JBrowse link
G Tas1r2 taste 1 receptor member 2 multiple interactions ISO Glucose promotes the reaction [TAS1R3 protein binds to TAS1R2 protein] CTD PMID:33992720 NCBI chr 5:157,192,799...157,208,937
Ensembl chr 5:157,192,799...157,208,937 		JBrowse link
G Tas1r3 taste 1 receptor member 3 multiple interactions ISO Glucose promotes the reaction [TAS1R3 protein binds to TAS1R1 protein]; Glucose promotes the reaction [TAS1R3 protein binds to TAS1R2 protein] CTD PMID:33992720 NCBI chr 5:171,750,937...171,754,993
Ensembl chr 5:171,750,937...171,754,993 		JBrowse link
G Tbc1d4 TBC1 domain family, member 4 multiple interactions
increases phosphorylation 		ISO GH1 protein promotes the reaction [Glucose results in increased phosphorylation of TBC1D4 protein] CTD PMID:21559284 NCBI chr15:84,670,756...84,848,876
Ensembl chr15:84,670,756...84,848,693 		JBrowse link
G Tbc1d9 TBC1 domain family member 9 increases expression
multiple interactions 		ISO Glucose results in increased expression of TBC1D9 mRNA
Dichloroacetic Acid inhibits the reaction [Glucose results in increased expression of TBC1D9 mRNA]; Oxamic Acid inhibits the reaction [Glucose results in increased expression of TBC1D9 mRNA] 		CTD PMID:39922521 NCBI chr19:41,746,732...41,855,924
Ensembl chr19:41,746,732...41,856,092 		JBrowse link
G Tbx15 T-box transcription factor 15 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of TBX15 mRNA CTD PMID:37567420 NCBI chr 2:189,265,373...189,376,466
Ensembl chr 2:189,265,373...189,376,466 		JBrowse link
G Tbx2 T-box transcription factor 2 increases expression EXP Glucose results in increased expression of TBX2 mRNA CTD PMID:21818840 NCBI chr10:71,177,082...71,186,275
Ensembl chr10:71,177,082...71,186,275 		JBrowse link
G Tbx4 T-box transcription factor 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of TBX4 mRNA CTD PMID:37567420 NCBI chr10:71,228,145...71,258,222
Ensembl chr10:71,197,727...71,258,218 		JBrowse link
G Tc2n tandem C2 domains, nuclear multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of TC2N mRNA CTD PMID:37567420 NCBI chr 6:126,526,006...126,622,163
Ensembl chr 6:126,526,009...126,614,215 		JBrowse link
G Tcf19 transcription factor 19 affects activity
affects response to substance
multiple interactions 		ISO Glucose affects the activity of TCF19 protein
TCF19 protein affects the susceptibility to Glucose
Glucose promotes the reaction [TCF19 protein binds to CHD2 protein] 		CTD PMID:29042441 NCBI chr20:3,223,464...3,227,569
Ensembl chr20:3,223,324...3,230,060 		JBrowse link
G Tdrd9 tudor domain containing 9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of TDRD9 mRNA CTD PMID:37567420 NCBI chr 6:136,850,797...136,966,225
Ensembl chr 6:136,850,812...136,966,225 		JBrowse link
G Tek TEK receptor tyrosine kinase decreases expression ISO Glucose results in decreased expression of TEK mRNA CTD PMID:31655124 NCBI chr 5:114,722,815...114,849,535
Ensembl chr 5:114,723,006...114,849,991 		JBrowse link
G Tektip1 tektin bundle interacting protein 1 increases expression ISO Glucose results in increased expression of TEKTIP1 mRNA CTD PMID:39922521 NCBI chr 7:8,996,403...8,998,165
Ensembl chr 7:8,996,386...8,998,165 		JBrowse link
G Tert telomerase reverse transcriptase multiple interactions
decreases activity 		ISO [Glucose co-treated with Palmitic Acid] results in decreased expression of TERT mRNA; [Glucose co-treated with Palmitic Acid] results in decreased expression of TERT protein; acadesine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TERT mRNA]; acadesine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TERT protein]; dorsomorphin promotes the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TERT mRNA]; dorsomorphin promotes the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TERT protein]; Fluorometholone inhibits the reaction [Glucose results in decreased activity of TERT protein]; PPARGC1A protein affects the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TERT mRNA]; PPARGC1A protein affects the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TERT protein]; TERT protein inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA]; TERT protein inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARG mRNA]; TERT protein inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of PPARGC1A protein]; TERT protein inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TFAM mRNA] CTD PMID:35264022 PMID:39265716 NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:31,466,056...31,488,111 		JBrowse link
G Tex51 testis expressed 51 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of TEX51 mRNA CTD PMID:37567420 NCBI chr18:24,367,088...24,371,538
Ensembl chr18:24,367,302...24,371,588 		JBrowse link
G Tfam transcription factor A, mitochondrial multiple interactions
decreases expression
increases expression 		EXP
ISO 		[Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of TFAM protein; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of TFAM protein; formononetin inhibits the reaction [Glucose results in decreased expression of TFAM mRNA]; Inositol inhibits the reaction [Glucose results in decreased expression of TFAM protein]; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of TFAM protein]
[Glucose co-treated with Palmitic Acid] results in decreased expression of TFAM mRNA; acadesine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TFAM mRNA]; dorsomorphin promotes the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TFAM mRNA]; PPARGC1A protein affects the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TFAM mRNA]; TERT protein inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in decreased expression of TFAM mRNA]
Glucose results in decreased expression of TFAM mRNA; Glucose results in decreased expression of TFAM protein
Glucose deficiency results in increased expression of TFAM mRNA 		CTD PMID:25997894 PMID:26811028 PMID:35243728 PMID:36806343 PMID:37944786 More... NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,355,363...17,369,877 		JBrowse link
G Tfb2m transcription factor B2, mitochondrial decreases expression
multiple interactions 		EXP Glucose results in decreased expression of TFB2M mRNA
formononetin inhibits the reaction [Glucose results in decreased expression of TFB2M mRNA] 		CTD PMID:37944786 NCBI chr13:93,810,859...93,828,678
Ensembl chr13:93,810,731...93,828,594 		JBrowse link
G Tfpi tissue factor pathway inhibitor decreases expression ISO Glucose results in decreased expression of TFPI mRNA CTD PMID:31655124 NCBI chr 3:89,939,862...89,989,253
Ensembl chr 3:89,939,868...89,980,742 		JBrowse link
G Tfrc transferrin receptor increases expression ISO
EXP 		Glucose results in increased expression of TFRC protein CTD PMID:38483099 NCBI chr11:81,668,478...81,690,318
Ensembl chr11:81,668,478...81,690,318 		JBrowse link
G Tgfa transforming growth factor alpha multiple interactions
increases expression 		ISO
EXP 		Diazooxonorleucine inhibits the reaction [Glucose results in increased expression of TGFA mRNA]; EGF protein promotes the reaction [Glucose results in increased expression of TGFA mRNA]; Glucose promotes the reaction [EGF protein results in increased expression of TGFA mRNA]
[Glucose co-treated with Glucosamine] results in increased expression of TGFA protein; Glucosamine promotes the reaction [Glucose results in increased expression of TGFA mRNA] 		CTD PMID:1518840 PMID:8638660 NCBI chr 4:120,175,549...120,258,342
Ensembl chr 4:120,175,593...120,258,339 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions
increases expression
increases acetylation
increases secretion 		ISO
EXP 		4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; [Glucose co-treated with TGFB1 protein] results in decreased expression of CDH1 protein; [Glucose co-treated with TGFB1 protein] results in decreased expression of KRT20 protein; [Glucose co-treated with TGFB1 protein] results in increased cleavage of CASP1 protein; [Glucose co-treated with TGFB1 protein] results in increased expression of ACTA2 protein; [Glucose co-treated with TGFB1 protein] results in increased expression of HSPA5 protein; [Glucose co-treated with TGFB1 protein] results in increased expression of NLRP3 protein; [Glucose co-treated with TGFB1 protein] results in increased expression of NOX4 protein; [Glucose co-treated with TGFB1 protein] results in increased expression of SNAI1 protein; [Glucose co-treated with TGFB1 protein] results in increased expression of TXNIP protein; [Glucose co-treated with TGFB1 protein] results in increased expression of VIM protein; [Glucose co-treated with TGFB1 protein] results in increased phosphorylation of ERN1 protein; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in decreased expression of CDH1 protein]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased cleavage of CASP1 protein]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of ACTA2 protein]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of HSPA5 protein]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of NLRP3 protein]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of NOX4 protein]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of SNAI1 protein]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of TXNIP protein]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased phosphorylation of ERN1 protein]; isoangustone A inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in decreased expression of CDH1 protein]; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in decreased expression of KRT20 protein]; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of ACTA2 protein]; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of VIM protein]; protocatechualdehyde inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; protocatechualdehyde inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; SOD2 protein inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; Troglitazone inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; Troglitazone inhibits the reaction [Glucose results in increased secretion of TGFB1 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]]; 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of TGFB1 mRNA]; CEBPB protein inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; SMARCA4A protein inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; Valsartan inhibits the reaction [Glucose results in increased expression of TGFB1 protein]
Glucose results in increased expression of TGFB1 mRNA; Glucose results in increased expression of TGFB1 protein
Glucose results in increased acetylation of TGFB1 promoter
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; 4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; [Aldosterone co-treated with Glucose] results in increased secretion of TGFB1 protein; [Eplerenone co-treated with Enalapril] inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased secretion of TGFB1 protein]; [Eplerenone co-treated with Enalapril] inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of TGFB1 mRNA]]; [Lipopolysaccharides co-treated with Glucose] results in increased secretion of TGFB1 protein; Acetylcysteine inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; Acetylcysteine inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; Aldosterone promotes the reaction [Glucose results in increased expression of TGFB1 mRNA]; Calcitriol inhibits the reaction [[Lipopolysaccharides co-treated with Glucose] results in increased secretion of TGFB1 protein]; Curcumin analog inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; Dinoprostone inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; diphenyleneiodonium inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; diphenyliodonium inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; Enalapril inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased secretion of TGFB1 protein]; Enalapril inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of TGFB1 mRNA]]; Eplerenone inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased secretion of TGFB1 protein]; Eplerenone inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of TGFB1 mRNA]]; farrerol inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; fatostatin inhibits the reaction [Glucose promotes the reaction [SREBF1 protein binds to TGFB1 promoter]]; fatostatin inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; Glucose promotes the reaction [SREBF1 protein binds to TGFB1 promoter]; Glycyrrhizic Acid inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; HIF1A protein affects the reaction [Glucose results in increased expression of TGFB1 protein]; linderalactone inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; LY2109761 inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; manumycin inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; MIR217 mRNA affects the reaction [Glucose results in increased expression of TGFB1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of TGFB1 protein]]; SREBF1 protein affects the reaction [Glucose results in increased expression of TGFB1 mRNA]; Superoxides affects the reaction [Glucose results in increased expression of TGFB1 mRNA]; TGFB1 protein promotes the reaction [Glucose promotes the reaction [SETD7 protein binds to CDKN1A promoter]]; TGFB1 protein promotes the reaction [Glucose results in increased expression of CDKN1A mRNA]; UCP1 protein inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; Y 27632 inhibits the reaction [Glucose results in increased expression of TGFB1 protein] 		CTD PMID:8877289 PMID:11050244 PMID:16572112 PMID:17199790 PMID:17597607 More... NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899 		JBrowse link
G Tgfb1i1 transforming growth factor beta 1 induced transcript 1 decreases expression
multiple interactions
increases methylation 		ISO Glucose results in decreased expression of TGFB1I1 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of TGFB1I1 mRNA]
Glucose results in increased methylation of TGFB1I1 gene 		CTD PMID:33448797 NCBI chr 1:192,258,992...192,265,903
Ensembl chr 1:192,258,598...192,265,903 		JBrowse link
G Tgfbr1 transforming growth factor, beta receptor 1 increases expression
multiple interactions 		ISO Glucose results in increased expression of TGFBR1 protein
isoangustone A inhibits the reaction [Glucose results in increased expression of TGFBR1 protein] 		CTD PMID:21367880 NCBI chr 5:66,449,348...66,506,371
Ensembl chr 5:66,449,293...66,527,260 		JBrowse link
G Tgfbr2 transforming growth factor, beta receptor 2 multiple interactions
increases expression 		ISO isoangustone A inhibits the reaction [Glucose results in increased expression of TGFBR2 protein] CTD PMID:21367880 NCBI chr 8:124,672,677...124,761,741
Ensembl chr 8:124,674,986...124,761,469 		JBrowse link
G Tgif2 TGFB-induced factor homeobox 2 increases expression ISO Glucose results in increased expression of TGIF2 mRNA CTD PMID:39922521 NCBI chr 3:165,791,101...165,808,669
Ensembl chr 3:165,793,480...165,808,666 		JBrowse link
G Tgm4 transglutaminase 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of TGM4 mRNA CTD PMID:37567420 NCBI chr 8:131,566,887...131,603,920
Ensembl chr 8:131,566,887...131,603,920 		JBrowse link
G Tgm5 transglutaminase 5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of TGM5 mRNA CTD PMID:37567420 NCBI chr 3:128,461,836...128,497,761
Ensembl chr 3:128,461,836...128,497,761 		JBrowse link
G Thbd thrombomodulin decreases expression ISO Glucose results in decreased expression of THBD mRNA CTD PMID:31655124 NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:156,306,632...156,320,582 		JBrowse link
G Thbs1 thrombospondin 1 multiple interactions
decreases expression 		EXP
ISO 		Glucose inhibits the reaction [Dietary Fats results in increased expression of THBS1 protein]
Glucose results in decreased expression of THBS1 mRNA 		CTD PMID:21394550 PMID:31655124 NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:125,510,250...125,525,402 		JBrowse link
G Thbs2 thrombospondin 2 increases expression ISO Glucose results in increased expression of THBS2 protein CTD PMID:23723366 NCBI chr 1:64,343,523...64,372,918
Ensembl chr 1:64,343,523...64,372,918 		JBrowse link
G Them5 thioesterase superfamily member 5 increases expression ISO Glucose results in increased expression of THEM5 mRNA CTD PMID:31525975 NCBI chr 2:184,665,335...184,675,041
Ensembl chr 2:184,669,822...184,675,744 		JBrowse link
G Themis thymocyte selection associated multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of THEMIS mRNA CTD PMID:37567420 NCBI chr 1:18,251,136...18,483,851
Ensembl chr 1:18,272,056...18,483,502 		JBrowse link
G Themis2 thymocyte selection associated family member 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of THEMIS2 mRNA CTD PMID:37567420 NCBI chr 5:150,275,094...150,290,343
Ensembl chr 5:150,275,094...150,290,343 		JBrowse link
G Thg1l tRNA-histidine guanylyltransferase 1-like increases expression ISO Glucose results in increased expression of THG1L mRNA CTD PMID:10026205 NCBI chr10:30,889,259...30,897,903
Ensembl chr10:30,890,520...30,898,061 		JBrowse link
G Thsd7a thrombospondin type 1 domain containing 7A increases expression
multiple interactions 		ISO Glucose results in increased expression of THSD7A mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of THSD7A mRNA] 		CTD PMID:33448797 NCBI chr 4:41,427,276...41,865,524
Ensembl chr 4:41,426,275...41,865,723 		JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 increases secretion
multiple interactions 		ISO Glucose deficiency results in increased secretion of TIMP1 protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TIMP1 mRNA 		CTD PMID:24802182 PMID:37567420 NCBI chr  X:3,766,509...3,772,578
Ensembl chr  X:3,766,510...3,771,135 		JBrowse link
G Timp2 TIMP metallopeptidase inhibitor 2 increases expression
multiple interactions 		ISO Glucose results in increased expression of TIMP2 protein
[Glucose co-treated with Air Pollutants] results in decreased expression of TIMP2 mRNA; [Glucose co-treated with Particulate Matter] results in decreased expression of TIMP2 mRNA; isoangustone A inhibits the reaction [Glucose results in increased expression of TIMP2 protein] 		CTD PMID:21367880 PMID:26179980 NCBI chr10:104,041,604...104,089,214
Ensembl chr10:104,041,604...104,089,214 		JBrowse link
G Tjp1 tight junction protein 1 multiple interactions
decreases expression 		ISO 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in decreased expression of TJP1 protein]]; 2-Methoxyestradiol inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; [Acetylcysteine co-treated with ginsenoside Rg3] inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; Acetylcysteine inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in decreased expression of TJP1 protein]
Acetylcysteine inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; Dichloroacetic Acid inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; Glycyrrhizic Acid inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; NLRP3 protein promotes the reaction [Glucose results in decreased expression of TJP1 protein]; Oxamic Acid inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; Rotenone promotes the reaction [Glucose results in decreased expression of TJP1 protein] 		CTD PMID:21617913 PMID:27783111 PMID:35445903 PMID:39579577 PMID:39922521 NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:128,260,330...128,505,158 		JBrowse link
G Tjp2 tight junction protein 2 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of TJP2 protein
Acetylcysteine inhibits the reaction [Glucose results in decreased expression of TJP2 protein]; Glycyrrhizic Acid inhibits the reaction [Glucose results in decreased expression of TJP2 protein]; NLRP3 protein promotes the reaction [Glucose results in decreased expression of TJP2 protein] 		CTD PMID:27783111 NCBI chr 1:231,136,218...231,264,750
Ensembl chr 1:231,136,243...231,264,750 		JBrowse link
G Tlcd2 TLC domain containing 2 multiple interactions
increases expression 		ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of TLCD2 mRNA
Glucose results in increased expression of TLCD2 mRNA 		CTD PMID:37567420 PMID:39922521 NCBI chr10:60,809,391...60,812,617
Ensembl chr10:60,809,391...60,811,599 		JBrowse link
G Tlk1 tousled-like kinase 1 decreases expression ISO Glucose results in decreased expression of TLK1 mRNA CTD PMID:17178593 NCBI chr 3:75,928,303...76,035,246
Ensembl chr 3:75,928,303...76,035,059 		JBrowse link
G Tln1 talin 1 multiple interactions
decreases expression 		ISO Eucalyptol inhibits the reaction [Glucose results in decreased expression of TLN1 protein] CTD PMID:31483951 NCBI chr 5:62,583,730...62,613,687
Ensembl chr 5:62,583,731...62,613,687 		JBrowse link
G Tlr2 toll-like receptor 2 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of TLR2 protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TLR2 mRNA 		CTD PMID:20200188 PMID:37567420 NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194 		JBrowse link
G Tlr4 toll-like receptor 4 decreases expression
increases expression
multiple interactions 		ISO
EXP 		Glucose results in decreased expression of TLR4 protein
Glucose results in increased expression of TLR4 protein
Phytic Acid inhibits the reaction [Glucose results in increased expression of TLR4 protein]
artesunate inhibits the reaction [Glucose results in increased expression of TLR4 protein]
TLR4 affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]]; TLR4 affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of MAFA mRNA]]; TLR4 affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of PDX1 mRNA]] 		CTD PMID:20200188 PMID:22558381 PMID:30031708 PMID:38000455 NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007 		JBrowse link
G Tlr8 toll-like receptor 8 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TLR8 mRNA CTD PMID:37567420 NCBI chr  X:30,708,714...30,733,104
Ensembl chr  X:30,708,033...30,737,079 		JBrowse link
G Tlr9 toll-like receptor 9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of TLR9 mRNA CTD PMID:37567420 NCBI chr 8:115,743,407...115,747,523
Ensembl chr 8:115,742,889...115,750,148 		JBrowse link
G Tm6sf2 transmembrane 6 superfamily member 2 increases expression ISO Glucose results in increased expression of TM6SF2 mRNA CTD PMID:39922521 NCBI chr16:19,378,148...19,385,360
Ensembl chr16:19,378,152...19,385,467 		JBrowse link
G Tmc7 transmembrane channel-like 7 increases expression ISO Glucose results in increased expression of TMC7 mRNA CTD PMID:39922521 NCBI chr 1:182,287,742...182,340,000
Ensembl chr 1:182,287,742...182,339,947 		JBrowse link
G Tmed3 transmembrane p24 trafficking protein 3 decreases expression ISO Glucose results in decreased expression of TMED3 mRNA CTD PMID:17178593 NCBI chr 8:99,121,361...99,129,653
Ensembl chr 8:99,121,361...99,129,215 		JBrowse link
G Tmeff1 transmembrane protein with EGF-like and two follistatin-like domains 1 increases methylation
decreases expression
multiple interactions 		ISO Glucose results in increased methylation of TMEFF1 gene
Glucose results in decreased expression of TMEFF1 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of TMEFF1 mRNA]; fucoxanthin inhibits the reaction [Glucose results in increased methylation of TMEFF1 gene] 		CTD PMID:33448797 NCBI chr 5:67,706,269...67,792,022
Ensembl chr 5:67,706,269...67,792,021 		JBrowse link
G Tmem108 transmembrane protein 108 increases expression ISO Glucose results in increased expression of TMEM108 mRNA CTD PMID:39922521 NCBI chr 8:112,944,925...113,238,996
Ensembl chr 8:112,944,928...112,984,211 		JBrowse link
G Tmem123 transmembrane protein 123 multiple interactions EXP [Oxygen deficiency co-treated with Glucose deficiency] affects the expression of TMEM123 mRNA CTD PMID:23637816 NCBI chr 8:13,206,907...13,237,069
Ensembl chr 8:13,206,403...13,257,427 		JBrowse link
G Tmem145 transmembrane protein 145 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TMEM145 mRNA CTD PMID:37567420 NCBI chr 1:90,019,727...90,029,432
Ensembl chr 1:90,019,745...90,029,427 		JBrowse link
G Tmem198 transmembrane protein 198 increases expression ISO Glucose results in increased expression of TMEM198 mRNA CTD PMID:39922521 NCBI chr 9:84,416,741...84,422,759
Ensembl chr 9:84,416,752...84,422,758 		JBrowse link
G Tmem202 transmembrane protein 202 increases expression ISO Glucose results in increased expression of TMEM202 mRNA CTD PMID:39922521 NCBI chr 8:68,806,629...68,832,638
Ensembl chr 8:68,806,632...68,812,417 		JBrowse link
G Tmem229b transmembrane protein 229B decreases expression
multiple interactions 		ISO Glucose results in decreased expression of TMEM229B mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of TMEM229B mRNA] 		CTD PMID:33448797 NCBI chr 6:103,509,457...103,552,600
Ensembl chr 6:103,508,342...103,552,647 		JBrowse link
G Tmem232 transmembrane protein 232 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of TMEM232 mRNA CTD PMID:37567420 NCBI chr 9:112,334,569...112,562,627
Ensembl chr 9:112,334,569...112,580,069 		JBrowse link
G Tmem238 transmembrane protein 238 decreases expression ISO Glucose results in decreased expression of TMEM238 mRNA CTD PMID:39613055 NCBI chr 1:78,085,880...78,091,272
Ensembl chr 1:78,085,670...78,093,983 		JBrowse link
G Tmem265 transmembrane protein 265 increases expression ISO Glucose results in increased expression of TMEM265 mRNA CTD PMID:39922521 NCBI chr 1:191,603,200...191,607,096 JBrowse link
G Tmem45a2 transmembrane protein 45A2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of TMEM45A2 mRNA CTD PMID:37567420 NCBI chr11:56,952,176...56,996,145
Ensembl chr11:56,952,622...56,996,037 		JBrowse link
G Tmem52 transmembrane protein 52 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of TMEM52 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TMEM52 mRNA CTD PMID:37567420 NCBI chr 5:171,330,948...171,332,704
Ensembl chr 5:171,330,966...171,332,704 		JBrowse link
G Tmem63c transmembrane protein 63c increases expression ISO Glucose results in increased expression of TMEM63C mRNA CTD PMID:39922521 NCBI chr 6:112,398,308...112,469,732
Ensembl chr 6:112,399,118...112,469,729 		JBrowse link
G Tmod1 tropomodulin 1 increases expression ISO Glucose results in increased expression of TMOD1 mRNA CTD PMID:39922521 NCBI chr 5:65,112,062...65,189,563
Ensembl chr 5:65,134,132...65,189,561 		JBrowse link
G Tmsb4x thymosin beta 4, X-linked increases expression ISO Glucose results in increased expression of TMSB4X mRNA CTD PMID:17178593 NCBI chr  X:30,761,611...30,763,612
Ensembl chr  X:30,761,612...30,763,613 		JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases secretion
decreases uptake
increases expression
increases oxidation 		ISO
EXP 		(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; [Fatty Acids, Nonesterified co-treated with Glucose] results in increased expression of TNF protein; [Glucose co-treated with Lipopolysaccharides] results in decreased expression of TNF protein; [Glucose co-treated with Pam(3)CSK(4) peptide] results in decreased expression of TNF protein; [Glucose co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of PPARG mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of PPARA mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL2 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CXCL5 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NFKB1 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of PPARD mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of RELA mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of TNF mRNA]; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of TNF protein]; [TNF protein co-treated with IFNG protein co-treated with IL1B protein] inhibits the reaction [Glucose results in increased secretion of INS protein alternative form]; Anisomycin inhibits the reaction [rutecarpine inhibits the reaction [Glucose results in increased expression of TNF protein]]; asiatic acid inhibits the reaction [Glucose results in increased secretion of TNF protein]; asiatic acid promotes the reaction [Carnosine inhibits the reaction [Glucose results in increased secretion of TNF protein]]; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Captopril inhibits the reaction [Glucose results in increased expression of TNF mRNA]; Carnosine inhibits the reaction [Glucose results in increased secretion of TNF protein]; Carnosine promotes the reaction [asiatic acid inhibits the reaction [Glucose results in increased secretion of TNF protein]]; Catechin inhibits the reaction [Glucose results in increased expression of TNF mRNA]; Catechin inhibits the reaction [Glucose results in increased expression of TNF protein]; chromic acid inhibits the reaction [[Glucose co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein]; epigallocatechin gallate inhibits the reaction [Glucose results in increased expression of TNF mRNA]; epigallocatechin gallate inhibits the reaction [Glucose results in increased expression of TNF protein]; Fenofibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Fluorometholone inhibits the reaction [Glucose results in increased expression of TNF mRNA]; Fluorometholone inhibits the reaction [Glucose results in increased secretion of TNF protein]; huai qi huang inhibits the reaction [Glucose results in increased expression of TNF mRNA]; jujuboside A inhibits the reaction [[Fatty Acids, Nonesterified co-treated with Glucose] results in increased expression of TNF protein]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Luteolin inhibits the reaction [Glucose results in increased expression of TNF mRNA]; Luteolin inhibits the reaction [Glucose results in increased expression of TNF protein]; MIR1231 inhibits the reaction [Glucose results in increased expression of TNF protein]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased secretion of TNF protein]]; MIR142 inhibits the reaction [Glucose results in increased secretion of TNF protein]; MIR217 mRNA inhibits the reaction [Glucose results in increased secretion of TNF protein]; Phytic Acid inhibits the reaction [Glucose results in increased expression of TNF protein]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Quercetin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Quercetin inhibits the reaction [Glucose results in increased expression of TNF mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of TNF protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of TNF mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of TNF protein]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; rutecarpine inhibits the reaction [Glucose results in increased expression of TNF mRNA]; rutecarpine inhibits the reaction [Glucose results in increased expression of TNF protein]; Rutin inhibits the reaction [Glucose results in increased expression of TNF mRNA]; Rutin inhibits the reaction [Glucose results in increased expression of TNF protein]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of TNF protein]]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased secretion of TNF protein]]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased secretion of TNF protein]; TNF protein inhibits the reaction [INS protein results in increased uptake of Glucose]; Troglitazone inhibits the reaction [TNF protein inhibits the reaction [INS protein results in increased uptake of Glucose]]; YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [[Fatty Acids, Nonesterified co-treated with Glucose] results in increased expression of TNF protein]]
TNF protein results in decreased uptake of Glucose
Glucose results in increased expression of TNF mRNA; Glucose results in increased expression of TNF protein
TNF protein results in increased oxidation of Glucose
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TNF protein]]; 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Glucose results in increased expression of TNF mRNA]; [Glucose co-treated with IGF2R protein modified form] results in increased expression of TNF protein; [Lipopolysaccharides co-treated with Glucose] results in increased secretion of TNF protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TNF protein; [TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Artesunate inhibits the reaction [Glucose results in increased expression of TNF mRNA]; Artesunate inhibits the reaction [Glucose results in increased secretion of TNF protein]; Atorvastatin inhibits the reaction [TNF protein results in increased oxidation of Glucose]; Calcitriol inhibits the reaction [[Lipopolysaccharides co-treated with Glucose] results in increased secretion of TNF protein]; Curcumin analog inhibits the reaction [Glucose results in increased expression of TNF mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of TNF mRNA]; Ellagic Acid inhibits the reaction [Glucose results in increased expression of TNF protein]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Glucose results in increased secretion of TNF protein]; farrerol inhibits the reaction [Glucose results in increased expression of TNF mRNA]; farrerol inhibits the reaction [Glucose results in increased secretion of TNF protein]; Gallic Acid inhibits the reaction [Glucose results in increased secretion of TNF protein]; linderalactone inhibits the reaction [Glucose results in increased expression of TNF mRNA]; morroniside inhibits the reaction [Glucose results in increased secretion of TNF protein]; prolinedithiocarbamate inhibits the reaction [Glucose results in increased secretion of TNF protein]; Quercetin inhibits the reaction [Glucose results in increased expression of TNF mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of TNF protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; S-4-bromobenzylglutathione cyclopentyl diester inhibits the reaction [morroniside inhibits the reaction [Glucose results in increased secretion of TNF protein]]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TNF protein]
2-chloro-4'-methoxychalcone inhibits the reaction [Glucose results in increased expression of TNF mRNA]; 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased expression of TNF mRNA]; 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased secretion of TNF protein]; [Glucose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased secretion of TNF protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TNF protein; atractylenolide III inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TNF protein]; CDK9 protein affects the reaction [Glucose results in increased expression of TNF mRNA]; CDK9 protein affects the reaction [Glucose results in increased secretion of TNF protein]; Edaravone inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TNF protein]; Fatty Acids, Nonesterified promotes the reaction [Glucose results in increased expression of TNF protein]; imeglimin inhibits the reaction [Glucose results in increased expression of TNF mRNA]; imeglimin inhibits the reaction [Glucose results in increased secretion of TNF protein]; jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in increased expression of TNF protein]]; MIR27B mRNA affects the reaction [Glucose results in increased expression of TNF protein]; Plant Extracts inhibits the reaction [TNF protein results in decreased uptake of Glucose]; Silymarin inhibits the reaction [[Glucose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased secretion of TNF protein]; SNHG1 affects the reaction [Glucose results in increased expression of TNF mRNA]; SNHG1 affects the reaction [Glucose results in increased expression of TNF protein]; SNHG1 affects the reaction [MIR27B mRNA affects the reaction [Glucose results in increased expression of TNF protein]] 		CTD PMID:7956951 PMID:11726202 PMID:19557821 PMID:20200188 PMID:21788014 More... NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Tnfaip6 TNF alpha induced protein 6 increases expression ISO Glucose results in increased expression of TNFAIP6 mRNA CTD PMID:17178593 NCBI chr 3:56,911,398...56,930,797
Ensembl chr 3:56,911,252...56,930,796 		JBrowse link
G Tnfaip8l3 TNF alpha induced protein 8 like 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of TNFAIP8L3 mRNA CTD PMID:37567420 NCBI chr 8:63,309,683...63,351,687
Ensembl chr 8:63,310,107...63,318,501 		JBrowse link
G Tnfrsf11b TNF receptor superfamily member 11B multiple interactions
decreases secretion 		ISO cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased secretion of TNFRSF11B protein] CTD PMID:19924377 NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:87,456,319...87,485,075 		JBrowse link
G Tnfrsf13c TNF receptor superfamily member 13C increases expression ISO Glucose results in increased expression of TNFRSF13C mRNA CTD PMID:39922521 NCBI chr 7:115,616,139...115,618,647
Ensembl chr 7:115,616,303...115,618,620 		JBrowse link
G Tnfrsf25 TNF receptor superfamily member 25 decreases expression ISO Glucose results in decreased expression of TNFRSF25 mRNA CTD PMID:31525975 NCBI chr 5:167,904,377...167,909,052
Ensembl chr 5:167,904,786...167,909,052 		JBrowse link
G Tnfrsf9 TNF receptor superfamily member 9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TNFRSF9 mRNA CTD PMID:37567420 NCBI chr 5:166,664,494...166,690,834
Ensembl chr 5:166,664,494...166,690,831 		JBrowse link
G Tnfsf10 TNF superfamily member 10 decreases expression ISO Glucose results in decreased expression of TNFSF10 mRNA CTD PMID:31655124 NCBI chr 2:112,136,550...112,155,903 JBrowse link
G Tnfsf13 TNF superfamily member 13 multiple interactions
decreases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of TNFSF13 mRNA] CTD PMID:33448797 NCBI chr10:54,898,805...54,901,815
Ensembl chr10:54,898,805...54,901,815 		JBrowse link
G Tnfsf14 TNF superfamily member 14 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of TNFSF14 mRNA CTD PMID:37567420 NCBI chr 9:2,155,270...2,160,100
Ensembl chr 9:2,155,270...2,160,191 		JBrowse link
G Tnfsf8 TNF superfamily member 8 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TNFSF8 mRNA CTD PMID:37567420 NCBI chr 5:82,266,436...82,292,858
Ensembl chr 5:82,266,436...82,292,858 		JBrowse link
G Tnni3 troponin I3, cardiac type increases expression ISO Glucose results in increased expression of TNNI3 mRNA CTD PMID:39922521 NCBI chr 1:78,342,571...78,346,255
Ensembl chr 1:78,342,592...78,346,253 		JBrowse link
G Tnnt2 troponin T2, cardiac type increases expression ISO Glucose results in increased expression of TNNT2 mRNA CTD PMID:17178593 NCBI chr13:49,819,123...49,837,125
Ensembl chr13:49,822,304...49,837,125 		JBrowse link
G Tomm20l translocase of outer mitochondrial membrane 20 like multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of TOMM20L mRNA CTD PMID:37567420 NCBI chr 6:95,335,681...95,346,116
Ensembl chr 6:95,335,840...95,347,299 		JBrowse link
G Top2a DNA topoisomerase II alpha multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of TOP2A mRNA CTD PMID:37567420 NCBI chr10:84,441,954...84,473,093
Ensembl chr10:84,441,954...84,473,366 		JBrowse link
G Tp53 tumor protein p53 multiple interactions
increases expression
affects localization
increases acetylation 		ISO
EXP 		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased expression of TP53 mRNA]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased expression of TP53 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Fluorometholone inhibits the reaction [Glucose results in increased expression of TP53 protein]]; [Glucose co-treated with Deferoxamine] results in increased expression of TP53 mRNA; [Palmitic Acid co-treated with Glucose] results in increased acetylation of TP53 protein; [Resveratrol co-treated with AICA ribonucleotide] inhibits the reaction [Glucose results in increased expression of TP53 protein]; [Tretinoin results in increased uptake of Glucose] inhibits the reaction [bis((2-oxindol-3-ylimino)-2-(2-aminoethyl)pyridine-N,N')copper(II) results in increased expression of TP53 protein]; Fluorometholone inhibits the reaction [Glucose results in increased expression of TP53 protein]; Glucose inhibits the reaction [bis((2-oxindol-3-ylimino)-2-(2-aminoethyl)pyridine-N,N')copper(II) results in increased expression of TP53 protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of TP53 mRNA]; Melatonin inhibits the reaction [Glucose results in increased expression of TP53 protein]; Phytic Acid inhibits the reaction [Glucose results in increased expression of TP53 mRNA]; Phytic Acid inhibits the reaction [Glucose results in increased expression of TP53 protein]; Resveratrol inhibits the reaction [Glucose affects the localization of TP53 protein]; Resveratrol inhibits the reaction [Glucose results in increased acetylation of TP53 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of TP53 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of TP53 protein]; SIRT1 protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased acetylation of TP53 protein]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased acetylation of TP53 protein]]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TRP53 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TRP53 protein modified form; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TRP53 protein modified form]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TRP53 protein]
Glucose results in increased expression of TP53 mRNA; Glucose results in increased expression of TP53 protein
[Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased expression of TP53 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TP53 protein; TP53 protein affects the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NDRG2]; TP53 protein affects the susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] 		CTD PMID:20068143 PMID:21548882 PMID:23451161 PMID:24218232 PMID:24451382 More... NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
G Tp63 tumor protein p63 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of TRP63 mRNA CTD PMID:37567420 NCBI chr11:88,343,647...88,554,543
Ensembl chr11:88,343,651...88,554,177 		JBrowse link
G Tp73 tumor protein p73 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of TRP73 mRNA CTD PMID:37567420 NCBI chr 5:169,903,801...169,988,075
Ensembl chr 5:169,903,801...169,963,552 		JBrowse link
G Tph1 tryptophan hydroxylase 1 multiple interactions ISO TPH1 protein affects the reaction [Glucose results in increased secretion of INS protein]; TPH1 protein affects the reaction [sodium arsenite inhibits the reaction [Glucose results in increased secretion of INS protein]]; TPH1 protein affects the reaction [UGT1A6A protein affects the reaction [sodium arsenite inhibits the reaction [Glucose results in increased secretion of INS protein]]] CTD PMID:30562058 NCBI chr 1:106,293,695...106,314,628
Ensembl chr 1:106,085,953...106,312,484 		JBrowse link
G Tph2 tryptophan hydroxylase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TPH2 mRNA CTD PMID:37567420 NCBI chr 7:52,571,909...52,676,305
Ensembl chr 7:52,571,911...52,675,639 		JBrowse link
G Tpsb2 tryptase beta 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of TPSB2 mRNA CTD PMID:37567420 NCBI chr10:14,886,310...14,888,102
Ensembl chr10:14,886,360...14,888,100 		JBrowse link
G Traf2 Tnf receptor-associated factor 2 increases expression
multiple interactions 		EXP Glucose results in increased expression of TRAF2 protein
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of TRAF2 protein] 		CTD PMID:34801538 NCBI chr 3:28,740,098...28,764,752
Ensembl chr 3:28,740,098...28,764,691 		JBrowse link
G Traf3 Tnf receptor-associated factor 3 multiple interactions
increases expression 		ISO tempol inhibits the reaction [Glucose results in increased expression of TRAF3 protein]; TRAF3 affects the reaction [Glucose results in increased cleavage of CASP3 protein] CTD PMID:25516495 NCBI chr 6:136,025,097...136,128,363
Ensembl chr 6:136,027,157...136,128,363 		JBrowse link
G Trem2 triggering receptor expressed on myeloid cells 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TREM2 mRNA CTD PMID:37567420 NCBI chr 9:20,145,215...20,151,797
Ensembl chr 9:20,144,334...20,151,779 		JBrowse link
G Trib3 tribbles pseudokinase 3 multiple interactions
decreases expression 		EXP
ISO 		TRIB3 protein affects the reaction [INS1 protein results in increased uptake of Glucose]
Glucose results in decreased expression of TRIB3 mRNA 		CTD PMID:21190014 PMID:39613055 NCBI chr 3:161,269,939...161,275,533
Ensembl chr 3:161,269,955...161,274,802 		JBrowse link
G Trim63 tripartite motif containing 63 increases expression ISO Glucose results in increased expression of TRIM63 mRNA CTD PMID:39922521 NCBI chr 5:151,817,209...151,831,026
Ensembl chr 5:151,817,225...151,831,058 		JBrowse link
G Trim66 tripartite motif-containing 66 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of TRIM66 mRNA CTD PMID:37567420 NCBI chr 1:172,903,771...172,974,475
Ensembl chr 1:172,799,348...172,974,801 		JBrowse link
G Trim69 tripartite motif-containing 69 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TRIM69 mRNA CTD PMID:37567420 NCBI chr 3:129,565,060...129,585,629
Ensembl chr 3:129,564,934...129,585,629 		JBrowse link
G Trim71 tripartite motif containing 71 increases expression ISO Glucose results in increased expression of TRIM71 mRNA CTD PMID:39922521 NCBI chr 8:123,076,499...123,129,016 JBrowse link
G Trpm2 transient receptor potential cation channel, subfamily M, member 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of TRPM2 mRNA; TRPM2 protein affects the reaction [imeglimin promotes the reaction [Glucose results in increased secretion of INS1 protein]] CTD PMID:34523242 PMID:37567420 NCBI chr20:10,703,190...10,752,795
Ensembl chr20:10,704,482...10,752,802 		JBrowse link
G Trpm7 transient receptor potential cation channel, subfamily M, member 7 multiple interactions
increases expression 		ISO Glucose results in increased expression of and results in increased activity of TRPM7 protein; TRPM7 affects the reaction [Glucose results in decreased expression of NOS3 protein]; U 0126 inhibits the reaction [TRPM7 affects the reaction [Glucose results in decreased expression of NOS3 protein]]
Glucose results in increased expression of TRPM7 mRNA
Glucose results in increased expression of and results in increased activity of TRPM7 protein; TRPM7 protein affects the reaction [Glucose results in increased cleavage of CASP12 protein]; TRPM7 protein affects the reaction [Glucose results in increased cleavage of CASP3 protein]; TRPM7 protein affects the reaction [Glucose results in increased expression of DDIT3 protein] 		CTD PMID:24223965 PMID:30076216 NCBI chr 3:134,499,617...134,588,113
Ensembl chr 3:134,499,617...134,588,113 		JBrowse link
G Tsbp1 testis expressed basic protein 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of TSBP1 mRNA CTD PMID:37567420 NCBI chr20:4,411,926...4,469,214
Ensembl chr20:4,411,928...4,457,068 		JBrowse link
G Tsc22d1 TSC22 domain family, member 1 increases expression ISO Glucose results in increased expression of TSC22D1 mRNA CTD PMID:17178593 NCBI chr15:58,159,612...58,260,244
Ensembl chr15:58,159,952...58,183,322 		JBrowse link
G Tshb thyroid stimulating hormone subunit beta multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of TSHB mRNA CTD PMID:37567420 NCBI chr 2:192,913,171...192,918,054
Ensembl chr 2:192,913,171...192,942,984 		JBrowse link
G Tshr thyroid stimulating hormone receptor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TSHR mRNA CTD PMID:37567420 NCBI chr 6:116,072,321...116,206,009
Ensembl chr 6:116,072,281...116,206,010 		JBrowse link
G Tsku tsukushi, small leucine rich proteoglycan multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of TSKU mRNA CTD PMID:37567420 NCBI chr 1:162,071,459...162,082,972
Ensembl chr 1:162,064,126...162,089,272 		JBrowse link
G Tspan7 tetraspanin 7 multiple interactions EXP TSPAN7 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr  X:14,881,327...14,978,627
Ensembl chr  X:14,881,334...14,978,655 		JBrowse link
G Tssk2 testis-specific serine kinase 2 decreases expression ISO Glucose results in decreased expression of TSSK2 mRNA CTD PMID:31525975 NCBI chr11:96,590,864...96,592,219 JBrowse link
G Ttc16 tetratricopeptide repeat domain 16 increases expression ISO Glucose results in increased expression of TTC16 mRNA CTD PMID:39922521 NCBI chr 3:36,450,271...36,462,590
Ensembl chr 3:36,446,272...36,462,368 		JBrowse link
G Ttc21a tetratricopeptide repeat domain 21A decreases expression
increases methylation
multiple interactions 		ISO Glucose results in decreased expression of TTC21A mRNA
Glucose results in increased methylation of TTC21A gene
fucoxanthin inhibits the reaction [Glucose results in decreased expression of TTC21A mRNA] 		CTD PMID:33448797 NCBI chr 8:128,544,684...128,580,464
Ensembl chr 8:128,544,734...128,580,086 		JBrowse link
G Ttc6 tetratricopeptide repeat domain 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of TTC6 mRNA CTD PMID:37567420 NCBI chr 6:80,872,055...81,103,170
Ensembl chr 6:80,889,487...81,103,163 		JBrowse link
G Ttk Ttk protein kinase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TTK mRNA CTD PMID:37567420 NCBI chr 8:93,632,678...93,672,664
Ensembl chr 8:93,634,319...93,672,664 		JBrowse link
G Ttll13 tubulin tyrosine ligase like 13 increases expression ISO Glucose results in increased expression of TTLL13 mRNA CTD PMID:39922521 NCBI chr 1:143,601,777...143,622,344
Ensembl chr 1:143,606,883...143,622,341 		JBrowse link
G Tuba1a tubulin, alpha 1A multiple interactions
increases expression 		EXP
ISO 		TUBA1A protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
Glucose results in increased expression of TUBA1A mRNA 		CTD PMID:21124846 PMID:39613055 NCBI chr 7:131,992,151...131,996,850
Ensembl chr 7:131,968,770...131,996,035 		JBrowse link
G Tubb2a tubulin, beta 2A class IIa increases expression ISO Glucose results in increased expression of TUBB2A mRNA CTD PMID:17178593 NCBI chr17:31,002,186...31,006,057
Ensembl chr17:30,983,387...31,006,838 		JBrowse link
G Tubb4a tubulin, beta 4A class IVa increases expression ISO Glucose results in increased expression of TUBB4A mRNA CTD PMID:39922521 NCBI chr 9:2,004,836...2,012,281
Ensembl chr 9:2,004,840...2,012,286 		JBrowse link
G Tubb6 tubulin, beta 6 class V increases expression ISO Glucose results in increased expression of TUBB6 mRNA CTD PMID:17178593 NCBI chr18:63,213,287...63,222,926
Ensembl chr18:63,213,279...63,224,303 		JBrowse link
G Tug1 taurine up-regulated 1 multiple interactions
decreases expression 		ISO Glucose promotes the reaction [HDAC1 protein binds to TUG1 promoter]; Glucose promotes the reaction [MLX protein binds to TUG1 promoter]; Glucose promotes the reaction [MLXIP protein binds to TUG1 promoter]; Glucose promotes the reaction [MLXIPL protein binds to TUG1 promoter]; Glucose promotes the reaction [MXD1 protein binds to TUG1 promoter]
Glucose results in decreased expression of TUG1 mRNA 		CTD PMID:32467232 NCBI chr14:82,743,501...82,750,534
Ensembl chr14:82,746,113...82,750,534 		JBrowse link
G Tvp23a trans-golgi network vesicle protein 23 homolog A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of TVP23A mRNA CTD PMID:37567420 NCBI chr10:5,734,100...5,770,002
Ensembl chr10:5,734,100...5,769,998 		JBrowse link
G Twist1 twist family bHLH transcription factor 1 decreases expression
increases expression 		ISO Glucose deficiency results in decreased expression of TWIST1 mRNA
Glucose results in increased expression of TWIST1 protein 		CTD PMID:35427737 PMID:35445903 NCBI chr 6:56,402,309...56,404,303
Ensembl chr 6:56,398,061...56,404,965 		JBrowse link
G Txk TXK tyrosine kinase increases expression ISO Glucose results in increased expression of TXK mRNA CTD PMID:39922521 NCBI chr14:35,817,270...35,873,454
Ensembl chr14:35,817,893...35,873,460 		JBrowse link
G Txn1 thioredoxin 1 decreases expression
increases secretion
multiple interactions 		ISO
EXP 		Glucose results in decreased expression of TXN1 protein
Glucose deficiency results in increased secretion of TXN protein
[[[[Glucose results in decreased expression of MIR17 mRNA] which results in increased expression of TXNIP mRNA] which results in increased expression of TXNIP protein] promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein; [Glucose promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein; Glucose promotes the reaction [TXNIP protein binds to TXN1 protein]
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Glucose results in decreased expression of TXN1 protein]; 8-bromocyclic GMP inhibits the reaction [Glucose results in decreased expression of TXN1 protein]; Dipyridamole inhibits the reaction [Glucose results in decreased expression of TXN1 protein]; KT 5823 inhibits the reaction [Dipyridamole inhibits the reaction [Glucose results in decreased expression of TXN1 protein]]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Dipyridamole inhibits the reaction [Glucose results in decreased expression of TXN1 protein]] 		CTD PMID:17178593 PMID:20453393 PMID:24802182 PMID:26660634 NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:77,507,321...77,520,307 		JBrowse link
G Txnip thioredoxin interacting protein increases activity
increases response to substance
increases expression
multiple interactions
decreases expression 		EXP
ISO 		Glucose results in increased activity of TXNIP mRNA
TXNIP mRNA results in increased susceptibility to Glucose
Glucose results in increased expression of TXNIP protein
Allopurinol inhibits the reaction [Glucose results in increased expression of TXNIP protein]; Quercetin inhibits the reaction [Glucose results in increased expression of TXNIP protein]; rhodioloside inhibits the reaction [Glucose results in increased expression of TXNIP protein]; TXNIP mRNA promotes the reaction [Glucose results in decreased expression of PPARA protein]; TXNIP mRNA promotes the reaction [Glucose results in increased expression of CASP1 protein]; TXNIP mRNA promotes the reaction [Glucose results in increased expression of TXNIP protein]; TXNIP protein affects the reaction [Glucose results in increased expression of CERT1 mRNA]; TXNIP protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; TXNIP protein affects the reaction [Glucose results in increased expression of FN1 protein]
Glucose results in increased expression of TXNIP mRNA; Glucose results in increased expression of TXNIP protein
[Glucose co-treated with TGFB1 protein] results in increased expression of TXNIP protein; Allopurinol inhibits the reaction [Glucose results in increased expression of TXNIP protein]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of TXNIP protein]; Quercetin inhibits the reaction [Glucose results in increased expression of TXNIP protein]; TXNIP mRNA promotes the reaction [Glucose results in decreased expression of PPARA protein]; TXNIP mRNA promotes the reaction [Glucose results in increased expression of CASP1 protein]; TXNIP mRNA promotes the reaction [Glucose results in increased expression of TXNIP protein]
[[[[Glucose results in decreased expression of MIR17 mRNA] which results in increased expression of TXNIP mRNA] which results in increased expression of TXNIP protein] promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein; [Glucose promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein; [Glucose results in decreased expression of MIR17 mRNA] which results in increased expression of TXNIP mRNA; [Glucose results in decreased expression of MIR17 mRNA] which results in increased stability of TXNIP protein; [imeglimin co-treated with Glucose] inhibits the reaction [Thapsigargin results in increased expression of TXNIP mRNA]; [NFE2L2 protein binds to TXNIP promoter] inhibits the reaction [Glucose results in increased expression of TXNIP mRNA]; Glucose promotes the reaction [TXNIP protein binds to TXN1 protein]; Glucose promotes the reaction [TXNIP results in increased abundance of Reactive Oxygen Species]; GPD2 protein inhibits the reaction [Glucose results in increased expression of TXNIP mRNA]; imeglimin inhibits the reaction [Glucose results in increased expression of TXNIP protein]; Metformin inhibits the reaction [Glucose results in increased expression of TXNIP mRNA]; NFE2L2 protein inhibits the reaction [Glucose results in increased expression of TXNIP mRNA]; TXNIP promotes the reaction [Glucose results in increased expression of FN1 mRNA]; TXNIP promotes the reaction [Glucose results in increased expression of LAMB1 mRNA]; TXNIP promotes the reaction [Glucose results in increased expression of LAMB2 mRNA]; TXNIP promotes the reaction [Glucose results in increased expression of LAMB3 mRNA]; TXNIP promotes the reaction [Glucose results in increased expression of LAMC1 mRNA]
Glucose deficiency results in decreased expression of TXNIP mRNA; Glucose deficiency results in decreased expression of TXNIP protein 		CTD PMID:17178593 PMID:20195491 PMID:21832250 PMID:22869588 PMID:23647015 More... NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:186,781,163...186,785,731 		JBrowse link
G Txnrd1 thioredoxin reductase 1 increases expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of TXNRD1 mRNA
[Glucose co-treated with gastrodin] affects the expression of TXNRD1 mRNA 		CTD PMID:32942007 PMID:33764184 NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:22,719,317...22,739,817 		JBrowse link
G Ubd ubiquitin D multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of UBD mRNA CTD PMID:37567420 NCBI chr20:1,390,734...1,392,685
Ensembl chr20:1,390,600...1,413,965 		JBrowse link
G Ube2c ubiquitin-conjugating enzyme E2C multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of UBE2C mRNA CTD PMID:37567420 NCBI chr 3:173,925,975...173,928,375
Ensembl chr 3:173,925,934...173,932,678 		JBrowse link
G Ube2l6 ubiquitin-conjugating enzyme E2L 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of UBE2L6 mRNA CTD PMID:37567420 NCBI chr 3:90,279,705...90,294,721
Ensembl chr 3:90,279,668...90,294,717 		JBrowse link
G Ube2ql1 ubiquitin conjugating enzyme E2 QL1 increases expression ISO Glucose results in increased expression of UBE2QL1 mRNA CTD PMID:39922521 NCBI chr 1:35,377,264...35,417,624 JBrowse link
G Uchl1 ubiquitin C-terminal hydrolase L1 increases expression ISO Glucose results in increased expression of UCHL1 mRNA CTD PMID:39922521 NCBI chr14:41,838,859...41,849,743
Ensembl chr14:41,838,861...41,849,417 		JBrowse link
G Uchl3 ubiquitin C-terminal hydrolase L3 increases secretion ISO Glucose deficiency results in increased secretion of UCHL3 protein CTD PMID:24802182 NCBI chr15:84,888,847...84,942,095
Ensembl chr15:84,899,806...84,942,095
Ensembl chr 3:84,899,806...84,942,095 		JBrowse link
G Ucp1 uncoupling protein 1 multiple interactions
decreases response to substance 		EXP
ISO 		UCP1 protein inhibits the reaction [[Glucose results in increased chemical synthesis of Superoxides] which results in decreased activity of GAPDH protein]; UCP1 protein inhibits the reaction [Glucose results in decreased activity of and results in increased ADP-ribosylation of GAPDH protein]; UCP1 protein inhibits the reaction [Glucose results in decreased phosphorylation of SP1 protein]; UCP1 protein inhibits the reaction [Glucose results in increased chemical synthesis of Dinoprostone]; UCP1 protein inhibits the reaction [Glucose results in increased chemical synthesis of Reactive Oxygen Species]; UCP1 protein inhibits the reaction [Glucose results in increased expression of SERPINE1 mRNA]; UCP1 protein inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; UCP1 protein inhibits the reaction [Glucose results in increased O-linked glycosylation of SP1 protein]
UCP1 inhibits the reaction [Glucose results in decreased expression of GLO1 protein]; UCP1 inhibits the reaction [Glucose results in increased expression of AGER mRNA]; UCP1 inhibits the reaction [Glucose results in increased expression of AGER protein]; UCP1 inhibits the reaction [Glucose results in increased expression of and results in increased secretion of HMGB1 protein]; UCP1 inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]; UCP1 inhibits the reaction [Glucose results in increased expression of S100A12 mRNA]; UCP1 inhibits the reaction [Glucose results in increased expression of S100A8 mRNA]; UCP1 inhibits the reaction [Glucose results in increased expression of S100A8 protein]
UCP1 protein results in decreased susceptibility to Glucose 		CTD PMID:11050244 PMID:14514642 PMID:14523042 PMID:19833897 NCBI chr19:41,713,350...41,721,421
Ensembl chr19:41,713,351...41,721,420 		JBrowse link
G Ucp2 uncoupling protein 2 multiple interactions
increases expression 		EXP
ISO 		[SIRT1 protein results in decreased expression of UCP2 mRNA] promotes the reaction [Glucose results in increased abundance of Adenosine Triphosphate]; UCP2 protein inhibits the reaction [SIRT1 protein promotes the reaction [Glucose results in increased expression of INS1 protein]]
Glucose results in increased expression of UCP2 mRNA
[copper bis(3,5-diisopropylsalicylate) co-treated with Glucose] results in increased expression of UCP2 protein; [ebselen co-treated with Glucose] results in decreased expression of UCP2 protein; [Sodium Selenite co-treated with Glucose] results in decreased expression of UCP2 protein
Glucose results in increased expression of UCP2 protein 		CTD PMID:16366736 PMID:18167556 PMID:23795780 PMID:28027979 NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:164,251,373...164,257,743 		JBrowse link
G Ucp3 uncoupling protein 3 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of UCP3 protein
UCP3 protein promotes the reaction [Glucose results in increased secretion of INS protein] 		CTD PMID:18167556 NCBI chr 1:164,227,910...164,240,893
Ensembl chr 1:164,227,882...164,241,210 		JBrowse link
G Ugt1a1 UDP glucuronosyltransferase family 1 member A1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of UGT1A1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of UGT1A1 mRNA CTD PMID:37567420 NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:96,144,786...96,256,264 		JBrowse link
G Ugt1a2 UDP glucuronosyltransferase 1 family, polypeptide A2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of UGT1A2 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of UGT1A2 mRNA CTD PMID:37567420 NCBI chr 9:96,239,019...96,256,264
Ensembl chr 9:96,144,786...96,256,264 		JBrowse link
G Ugt1a6a UDP glucuronosyltransferase family 1 member A6a multiple interactions ISO TPH1 protein affects the reaction [UGT1A6A protein affects the reaction [sodium arsenite inhibits the reaction [Glucose results in increased secretion of INS protein]]]; UGT1A6A protein affects the reaction [sodium arsenite inhibits the reaction [Glucose results in increased secretion of INS protein]]
UGT1A6A protein affects the reaction [Glucose results in increased secretion of INS1 protein] 		CTD PMID:30562058 NCBI chr 9:96,195,018...96,256,264
Ensembl chr 9:96,144,786...96,256,264 		JBrowse link
G Ugt1a9 UDP glucuronosyltransferase family 1 member A9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of UGT1A9 mRNA CTD PMID:37567420 NCBI chr 9:96,144,786...96,256,264
Ensembl chr 9:96,144,786...96,256,264 		JBrowse link
G Uhrf1 ubiquitin-like with PHD and ring finger domains 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of UHRF1 mRNA CTD PMID:37567420 NCBI chr 9:1,220,162...1,241,792
Ensembl chr 9:1,222,063...1,241,792 		JBrowse link
G Ulk1 unc-51 like autophagy activating kinase 1 multiple interactions
decreases phosphorylation
affects phosphorylation 		EXP
ISO 		3-methyladenine affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide affects the reaction [Glucose affects the phosphorylation of ULK1 protein]]; bafilomycin A1 affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide affects the reaction [Glucose affects the phosphorylation of ULK1 protein]]; N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide affects the reaction [Glucose affects the phosphorylation of ULK1 protein]; Sirolimus affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide affects the reaction [Glucose affects the phosphorylation of ULK1 protein]]; ULK1 protein affects the reaction [Glucose affects the phosphorylation of ULK1 protein]; ULK1 protein affects the reaction [Glucose results in decreased expression of ATG5 protein]; ULK1 protein affects the reaction [Glucose results in decreased expression of MAP1LC3B protein]; ULK1 protein affects the reaction [Glucose results in increased expression of SQSTM1 protein]; ULK1 protein affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide affects the reaction [Glucose affects the phosphorylation of ULK1 protein]]; ULK1 protein affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of ATG5 protein]]; ULK1 protein affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of MAP1LC3B protein]]; ULK1 protein affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in increased expression of SQSTM1 protein]]
Glucose results in decreased phosphorylation of ULK1 protein
imeglimin inhibits the reaction [Glucose results in decreased phosphorylation of ULK1 protein] 		CTD PMID:29128638 PMID:38334676 NCBI chr12:51,511,492...51,537,746
Ensembl chr12:51,511,492...51,537,746 		JBrowse link
G Unc13c unc-13 homolog C multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of UNC13C mRNA CTD PMID:37567420 NCBI chr 8:83,127,650...83,553,822
Ensembl chr 8:83,128,523...83,553,822 		JBrowse link
G Unc5a unc-5 netrin receptor A increases expression ISO Glucose results in increased expression of UNC5A mRNA CTD PMID:39922521 NCBI chr17:9,620,005...9,675,794
Ensembl chr17:9,620,005...9,676,140 		JBrowse link
G Unc79 unc-79 homolog, NALCN channel complex subunit multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of UNC79 mRNA CTD PMID:37567420 NCBI chr 6:127,841,671...128,092,380
Ensembl chr 6:127,848,074...128,092,995 		JBrowse link
G Unc80 unc-80 homolog, NALCN channel complex subunit multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of UNC80 mRNA CTD PMID:37567420 NCBI chr 9:75,461,618...75,639,849
Ensembl chr 9:75,461,599...75,639,842 		JBrowse link
G Upk1a uroplakin 1A increases expression ISO Glucose results in increased expression of UPK1A mRNA CTD PMID:39922521 NCBI chr 1:94,987,110...94,998,083
Ensembl chr 1:94,987,108...94,997,787 		JBrowse link
G Upp2 uridine phosphorylase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of UPP2 mRNA CTD PMID:37567420 NCBI chr 3:63,681,671...63,726,194
Ensembl chr 3:63,681,826...63,726,191 		JBrowse link
G Usf2 upstream transcription factor 2, c-fos interacting increases activity ISO Glucose results in increased activity of USF2 protein CTD PMID:15767253 NCBI chr 1:95,302,109...95,321,334
Ensembl chr 1:95,302,105...95,313,119 		JBrowse link
G Usp44 ubiquitin specific peptidase 44 increases expression ISO Glucose results in increased expression of USP44 mRNA CTD PMID:39922521 NCBI chr 7:30,251,142...30,301,185
Ensembl chr 7:30,251,205...30,297,906 		JBrowse link
G Vash2 vasohibin 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of VASH2 mRNA CTD PMID:37567420 NCBI chr13:105,060,857...105,092,325
Ensembl chr13:105,060,857...105,092,275 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions
increases secretion
increases expression 		ISO
EXP 		5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate inhibits the reaction [Glucose results in increased expression of VCAM1 mRNA]; 5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate inhibits the reaction [Glucose results in increased expression of VCAM1 protein]; [Glucose co-treated with Serotonin] results in increased expression of VCAM1 protein; aspalathin inhibits the reaction [Glucose results in increased expression of VCAM1 protein]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of VCAM1 mRNA]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of VCAM1 protein]; Captopril inhibits the reaction [Glucose results in increased expression of VCAM1 mRNA]; huai qi huang inhibits the reaction [Glucose results in increased expression of VCAM1 mRNA]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of VCAM1 mRNA]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of VCAM1 protein]; Mannitol inhibits the reaction [Glucose results in increased expression of VCAM1 mRNA]; Mannitol inhibits the reaction [Glucose results in increased expression of VCAM1 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased expression of VCAM1 mRNA]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased secretion of VCAM1 protein]; nothofagin inhibits the reaction [Glucose results in increased expression of VCAM1 protein]; Polyphenols inhibits the reaction [Glucose results in increased expression of VCAM1 mRNA]; Rimonabant inhibits the reaction [Glucose results in increased expression of VCAM1 protein]; sarpogrelate inhibits the reaction [[Glucose co-treated with Serotonin] results in increased expression of VCAM1 protein]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of VCAM1 mRNA]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of VCAM1 protein]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of VCAM1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of VCAM1 mRNA
Curcumin analog inhibits the reaction [Glucose results in increased expression of VCAM1 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of VCAM1 mRNA]
Glucose results in increased expression of VCAM1 mRNA; Glucose results in increased expression of VCAM1 protein 		CTD PMID:15304054 PMID:16285992 PMID:21373835 PMID:21682256 PMID:22785018 More... NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801 		JBrowse link
G Vcl vinculin increases expression
decreases expression
multiple interactions 		ISO Glucose results in increased expression of VCL protein modified form
Glucose results in decreased expression of VCL protein
Eucalyptol inhibits the reaction [Glucose results in decreased expression of VCL protein]; Eucalyptol inhibits the reaction [Glucose results in increased expression of VCL protein modified form]; RHOA protein inhibits the reaction [Glucose results in decreased expression of VCL protein]; RHOA protein promotes the reaction [Eucalyptol inhibits the reaction [Glucose results in decreased expression of VCL protein]] 		CTD PMID:31483951 NCBI chr15:3,315,069...3,404,891
Ensembl chr15:3,315,069...3,405,163 		JBrowse link
G Vdac1 voltage-dependent anion channel 1 multiple interactions ISO [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of VDAC1 protein; resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of VDAC1 protein]; VDAC1 protein inhibits the reaction [resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; VDAC1 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; VDAC1 protein results in increased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
[Glucose co-treated with Palmitic Acid] results in decreased expression of VDAC1 mRNA 		CTD PMID:25488258 PMID:39265716 NCBI chr10:37,029,377...37,060,542
Ensembl chr10:37,023,145...37,060,541 		JBrowse link
G Vdr vitamin D receptor multiple interactions
increases expression 		EXP
ISO 		[Lipopolysaccharides co-treated with Glucose] results in decreased expression of VDR mRNA; [Lipopolysaccharides co-treated with Glucose] results in decreased expression of VDR protein; Calcitriol inhibits the reaction [[Lipopolysaccharides co-treated with Glucose] results in decreased expression of VDR mRNA]; Calcitriol inhibits the reaction [[Lipopolysaccharides co-treated with Glucose] results in decreased expression of VDR protein]
Glucose results in increased expression of VDR mRNA 		CTD PMID:21788014 PMID:39922521 NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:130,866,745...130,916,757 		JBrowse link
G Vegfa vascular endothelial growth factor A decreases expression
multiple interactions
increases expression
increases secretion 		EXP
ISO 		Glucose results in decreased expression of VEGFA mRNA
[Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of VEGFA protein]; HIF1A protein affects the reaction [Glucose results in increased expression of VEGFA protein]; manumycin inhibits the reaction [Glucose results in increased expression of VEGFA mRNA]; MIR217 mRNA affects the reaction [Glucose results in increased expression of VEGFA protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of VEGFA protein]; Rosiglitazone inhibits the reaction [Glucose results in decreased expression of VEGFA mRNA]; Simvastatin inhibits the reaction [Glucose results in increased expression of VEGFA mRNA]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of VEGFA protein]]
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in increased expression of VEGFA protein]]; [cobaltous chloride co-treated with Glucose] results in increased expression of VEGFA mRNA; [cobaltous chloride co-treated with Glucose] results in increased expression of VEGFA protein; [Glucose co-treated with Deferoxamine] results in increased expression of VEGFA mRNA; [Glucose co-treated with Resveratrol] results in decreased expression of VEGFA mRNA; Acetylcysteine inhibits the reaction [Glucose results in increased expression of VEGFA protein]; Acetylcysteine promotes the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in increased expression of VEGFA protein]]; Fluorometholone inhibits the reaction [Glucose results in increased expression of VEGFA mRNA]; Fluorometholone inhibits the reaction [Glucose results in increased expression of VEGFA protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in increased expression of VEGFA protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of VEGFA mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of VEGFA protein]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of VEGFA mRNA]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of VEGFA protein]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of VEGFA protein]]
2-methoxyestradiol inhibits the reaction [Glucose results in increased expression of VEGFA protein]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Glucose results in increased expression of VEGFA protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of VEGFA protein
Glucose deficiency results in increased secretion of VEGFA protein
Glucose deficiency results in increased expression of VEGFA mRNA; Glucose results in increased expression of VEGFA mRNA; Glucose results in increased expression of VEGFA protein 		CTD PMID:12147617 PMID:18569938 PMID:19228841 PMID:19609456 PMID:19759273 More... NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194 		JBrowse link
G Vegfd vascular endothelial growth factor D increases expression ISO Glucose results in increased expression of VEGFD mRNA CTD PMID:17178593 NCBI chr  X:33,704,582...33,740,305
Ensembl chr  X:33,706,055...33,740,167 		JBrowse link
G Vim vimentin multiple interactions
increases secretion
increases expression 		ISO [Glucose co-treated with TGFB1 protein] results in increased expression of VIM protein; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of VIM protein]; MAPK14 protein promotes the reaction [Glucose results in increased expression of VIM mRNA]
Glucose deficiency results in increased secretion of VIM protein
Glucose results in increased expression of VIM mRNA; Glucose results in increased expression of VIM protein 		CTD PMID:21829520 PMID:24802182 PMID:33992720 PMID:35445903 NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746 		JBrowse link
G Vpreb3 V-set pre-B cell surrogate light chain 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of VPREB3 mRNA CTD PMID:37567420 NCBI chr20:12,716,862...12,720,108 JBrowse link
G Vwa1 von Willebrand factor A domain containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of VWA1 mRNA CTD PMID:37567420 NCBI chr 5:171,659,694...171,664,880
Ensembl chr 5:171,659,698...171,664,880 		JBrowse link
G Vwf von Willebrand factor decreases expression ISO Glucose results in decreased expression of VWF mRNA CTD PMID:31655124 NCBI chr 4:160,042,900...160,177,757
Ensembl chr 4:160,047,982...160,177,757 		JBrowse link
G Wdr17 WD repeat domain 17 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of WDR17 mRNA CTD PMID:37567420 NCBI chr16:43,792,989...43,924,187
Ensembl chr16:43,792,973...43,924,184 		JBrowse link
G Wdr35 WD repeat domain 35 increases expression
multiple interactions 		EXP Glucose results in increased expression of WDR35 mRNA
WDR35 protein affects the reaction [Glucose results in increased activity of CASP3 protein] 		CTD PMID:20224876 NCBI chr 6:37,490,557...37,550,391
Ensembl chr 6:37,490,545...37,550,664 		JBrowse link
G Wfikkn2 WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of WFIKKN2 mRNA CTD PMID:37567420 NCBI chr10:79,682,459...79,688,553
Ensembl chr10:79,682,459...79,688,553 		JBrowse link
G Wipi1 WD repeat domain, phosphoinositide interacting 1 increases expression ISO Glucose results in increased expression of WIPI1 mRNA CTD PMID:39613055 NCBI chr10:95,042,451...95,079,679
Ensembl chr10:95,042,441...95,079,293 		JBrowse link
G Wnk2 WNK lysine deficient protein kinase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of WNK2 mRNA CTD PMID:37567420 NCBI chr17:15,709,648...15,818,874
Ensembl chr17:15,710,657...15,818,869 		JBrowse link
G Wnk4 WNK lysine deficient protein kinase 4 increases expression ISO Glucose results in increased expression of WNK4 mRNA CTD PMID:39922521 NCBI chr10:86,702,828...86,719,917
Ensembl chr10:86,702,865...86,720,198 		JBrowse link
G Wnt1 Wnt family member 1 increases expression ISO Glucose results in increased expression of WNT1 mRNA CTD PMID:29163160 NCBI chr 7:131,817,558...131,821,605
Ensembl chr 7:131,817,558...131,821,605 		JBrowse link
G Wnt3a Wnt family member 3A decreases expression EXP Glucose results in decreased expression of WNT3A mRNA CTD PMID:21818840 NCBI chr10:44,533,734...44,577,919
Ensembl chr10:44,533,734...44,577,919 		JBrowse link
G Wnt4 Wnt family member 4 decreases expression
multiple interactions 		EXP Glucose results in decreased expression of WNT4 mRNA
Simvastatin inhibits the reaction [Glucose results in decreased expression of WNT4 mRNA] 		CTD PMID:18004065 NCBI chr 5:154,797,245...154,818,565
Ensembl chr 5:154,797,311...154,817,128 		JBrowse link
G Wnt5a Wnt family member 5A decreases expression
increases expression
multiple interactions 		EXP
ISO 		Glucose results in decreased expression of WNT5A mRNA
Glucose results in increased expression of WNT5A mRNA
Simvastatin inhibits the reaction [Glucose results in decreased expression of WNT5A mRNA] 		CTD PMID:18004065 PMID:29163160 NCBI chr16:3,702,300...3,724,860
Ensembl chr16:3,703,665...3,724,860 		JBrowse link
G Wnt7a Wnt family member 7A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of WNT7A mRNA CTD PMID:37567420 NCBI chr 4:125,420,276...125,466,149
Ensembl chr 4:125,420,276...125,466,149 		JBrowse link
G Wnt7b Wnt family member 7B decreases expression
increases expression
multiple interactions 		ISO Glucose results in decreased expression of WNT7B mRNA
Glucose results in increased expression of WNT7B mRNA
Dichloroacetic Acid inhibits the reaction [Glucose results in increased expression of WNT7B mRNA]; fucoxanthin inhibits the reaction [Glucose results in decreased expression of WNT7B mRNA]; Oxamic Acid inhibits the reaction [Glucose results in increased expression of WNT7B mRNA] 		CTD PMID:33448797 PMID:39922521 NCBI chr 7:118,514,684...118,559,316
Ensembl chr 7:118,514,684...118,559,316 		JBrowse link
G Wwp1 WW domain containing E3 ubiquitin protein ligase 1 decreases expression ISO Glucose results in decreased expression of WWP1 mRNA CTD PMID:17178593 NCBI chr 5:37,889,280...37,982,743
Ensembl chr 5:37,895,398...37,982,959 		JBrowse link
G Xaf1 XIAP associated factor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of XAF1 mRNA CTD PMID:37567420 NCBI chr10:57,415,935...57,428,348
Ensembl chr10:57,415,658...57,428,349 		JBrowse link
G Xbp1 X-box binding protein 1 decreases expression
multiple interactions
increases splicing
increases expression 		ISO
EXP 		Glucose results in decreased expression of XBP1 mRNA
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of XBP1 mRNA]; Metformin inhibits the reaction [Glucose results in increased expression of XBP1 mRNA]
Glucose deficiency results in increased splicing of XBP1 mRNA
4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased splicing of XBP1 mRNA]; XBP1 mRNA alternative form promotes the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]
Glucose deficiency results in increased expression of XBP1 protein; Glucose results in increased expression of XBP1 mRNA 		CTD PMID:17178593 PMID:21337367 PMID:24349266 PMID:31022492 PMID:34801538 NCBI chr14:84,604,623...84,609,707
Ensembl chr14:84,604,107...84,609,706 		JBrowse link
G Xcr1 X-C motif chemokine receptor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of XCR1 mRNA CTD PMID:37567420 NCBI chr 8:132,357,020...132,393,596
Ensembl chr 8:132,357,020...132,385,862 		JBrowse link
G Xdh xanthine dehydrogenase multiple interactions EXP [XDH protein co-treated with Hypoxanthine] inhibits the reaction [Glucose results in increased abundance of Proteoglycans]; [XDH protein co-treated with Hypoxanthine] inhibits the reaction [Glucose results in increased expression of B3GAT3 mRNA] CTD PMID:11801247 NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350 		JBrowse link
G Xkr5 XK related 5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of XKR5 mRNA CTD PMID:37567420 NCBI chr16:77,577,387...77,595,377
Ensembl chr16:77,577,481...77,595,376 		JBrowse link
G Xpnpep2 X-prolyl aminopeptidase 2 increases expression ISO Glucose results in increased expression of XPNPEP2 mRNA CTD PMID:39922521 NCBI chr  X:132,165,696...132,194,937
Ensembl chr  X:132,165,701...132,195,126 		JBrowse link
G Xrcc5 X-ray repair cross complementing 5 multiple interactions ISO [2-hydroxyethyl disulfide co-treated with Glucose deficiency] results in decreased activity of [XRCC5 protein binds to XRCC6 protein] CTD PMID:22926048 NCBI chr 9:81,404,507...81,493,293
Ensembl chr 9:81,375,863...81,493,293 		JBrowse link
G Xrcc6 X-ray repair cross complementing 6 multiple interactions ISO [2-hydroxyethyl disulfide co-treated with Glucose deficiency] results in decreased activity of [XRCC5 protein binds to XRCC6 protein]
8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one inhibits the reaction [[Glucose co-treated with Bupivacaine] results in increased expression of XRCC6 protein]; [Glucose co-treated with Bupivacaine] results in increased expression of XRCC6 protein; Glucose inhibits the reaction [Bupivacaine results in increased expression of XRCC6 protein] 		CTD PMID:22926048 PMID:31672611 NCBI chr 7:115,423,026...115,443,884
Ensembl chr 7:115,422,662...115,443,884 		JBrowse link
G Ybx2 Y box binding protein 2 increases expression ISO Glucose results in increased expression of YBX2 mRNA CTD PMID:39922521 NCBI chr10:55,158,420...55,164,077
Ensembl chr10:55,158,420...55,164,077 		JBrowse link
G Ypel2 yippee-like 2 increases expression ISO Glucose results in increased expression of YPEL2 mRNA CTD PMID:39922521 NCBI chr10:72,243,591...72,301,124
Ensembl chr10:72,243,591...72,301,124 		JBrowse link
G Ywhaz tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta multiple interactions ISO YWHAZ protein affects the reaction [G3BP1 protein results in increased uptake of Glucose] CTD PMID:35945655 NCBI chr 7:69,826,404...69,848,702
Ensembl chr 7:69,826,404...69,849,007 		JBrowse link
G Yy1 YY1 transcription factor multiple interactions ISO [Glucose co-treated with Fatty Acids, Nonesterified] results in increased expression of YY1 protein; [Glucose promotes the reaction [MTOR protein binds to YY1 protein]] which results in increased expression of YY1 protein; Ditiocarb inhibits the reaction [YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [[Fatty Acids, Nonesterified co-treated with Glucose] results in increased expression of IL1B protein]]]; Ditiocarb inhibits the reaction [YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [[Fatty Acids, Nonesterified co-treated with Glucose] results in increased expression of IL6 protein]]]; Ditiocarb inhibits the reaction [YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [[Glucose co-treated with Fatty Acids, Nonesterified] results in decreased expression of PPARA protein]]]; Ditiocarb inhibits the reaction [YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of ACOX1 protein]]]]; Ditiocarb inhibits the reaction [YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of CPT1A protein]]]]; Ditiocarb inhibits the reaction [YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in increased expression of GPT protein]]]]; Glucose promotes the reaction [YY1 protein binds to PPARGC1A promoter]; Glucose results in increased expression of and affects the localization of YY1 protein; jujuboside A inhibits the reaction [[Glucose co-treated with Fatty Acids, Nonesterified] results in increased expression of YY1 protein]; YY1 promotes the reaction [Glucose results in decreased expression of PPARGC1A protein]; YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [[Fatty Acids, Nonesterified co-treated with Glucose] results in increased expression of IL1B protein]]; YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [[Fatty Acids, Nonesterified co-treated with Glucose] results in increased expression of IL6 protein]]; YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [[Fatty Acids, Nonesterified co-treated with Glucose] results in increased expression of TNF protein]]; YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [[Glucose co-treated with Fatty Acids, Nonesterified] results in decreased expression of PPARA protein]]; YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of ACOX1 protein]]]; YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of CPT1A protein]]]; YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in increased expression of GPT protein]]]
Sirolimus inhibits the reaction [Glucose results in increased phosphorylation of YY1 protein] 		CTD PMID:35445903 PMID:39059604 NCBI chr 6:133,471,615...133,500,875
Ensembl chr 6:133,471,562...133,497,257 		JBrowse link
G Zap70 zeta chain of T cell receptor associated protein kinase 70 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ZAP70 mRNA CTD PMID:37567420 NCBI chr 9:46,485,605...46,507,552
Ensembl chr 9:46,485,598...46,509,062 		JBrowse link
G Zbtb16 zinc finger and BTB domain containing 16 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ZBTB16 mRNA CTD PMID:37567420 NCBI chr 8:57,885,886...58,073,507
Ensembl chr 8:57,891,081...58,073,507 		JBrowse link
G Zc3h6 zinc finger CCCH type containing 6 increases expression ISO Glucose results in increased expression of ZC3H6 mRNA CTD PMID:39922521 NCBI chr 3:136,656,116...136,717,560
Ensembl chr 3:136,657,414...136,706,504 		JBrowse link
G Zdhhc19 zinc finger DHHC-type palmitoyltransferase 19 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of ZDHHC19 mRNA CTD PMID:37567420 NCBI chr11:81,782,899...81,794,105
Ensembl chr11:81,782,903...81,794,008 		JBrowse link
G Zfand4 zinc finger AN1-type containing 4 multiple interactions
increases expression 		ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ZFAND4 mRNA
Glucose results in increased expression of ZFAND4 mRNA 		CTD PMID:37567420 PMID:39922521 NCBI chr 4:150,999,821...151,071,942
Ensembl chr 4:150,999,836...151,072,055 		JBrowse link
G Zfp36 zinc finger protein 36 increases expression ISO Glucose results in increased expression of ZFP36 mRNA CTD PMID:39922521 NCBI chr 1:92,796,628...92,799,108
Ensembl chr 1:92,796,628...92,799,108 		JBrowse link
G Zfp386 zinc finger protein 386 (Kruppel-like) decreases expression ISO Glucose results in decreased expression of ZFP386 mRNA CTD PMID:17178593 NCBI chr 6:143,109,563...143,124,266
Ensembl chr 6:143,109,610...143,127,027 		JBrowse link
G Zfp521 zinc finger protein 521 increases expression
multiple interactions
decreases expression 		ISO Glucose results in increased expression of ZFP521 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of ZFP521 mRNA] 		CTD PMID:16805838 PMID:33448797 NCBI chr18:5,050,297...5,343,188
Ensembl chr18:5,056,236...5,343,054 		JBrowse link
G Zfp566 zinc finger protein 566 increases expression
multiple interactions 		ISO Glucose results in increased expression of ZFP566 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of ZFP566 mRNA] 		CTD PMID:33448797 NCBI chr 1:94,445,850...94,461,215
Ensembl chr 1:94,446,515...94,460,665 		JBrowse link
G Zfp647 zinc finger protein 647 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of ZFP647 mRNA CTD PMID:37567420 NCBI chr 7:110,512,866...110,527,680
Ensembl chr 7:110,512,866...110,527,778 		JBrowse link
G Zfp68 zinc finger protein 68 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ZFP300 mRNA CTD PMID:37567420 NCBI chr12:21,139,838...21,154,775
Ensembl chr12:21,139,868...21,154,769 		JBrowse link
G Zfp683 zinc finger protein 683 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of ZFP683 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ZFP683 mRNA CTD PMID:37567420 NCBI chr 5:151,558,880...151,569,937
Ensembl chr 5:151,561,480...151,569,764 		JBrowse link
G Zic2 Zic family member 2 decreases expression ISO Glucose results in decreased expression of ZIC2 mRNA CTD PMID:31525975 NCBI chr15:105,982,711...105,988,167
Ensembl chr15:105,983,342...105,988,167 		JBrowse link
G Zkscan2 zinc finger with KRAB and SCAN domains 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of ZKSCAN2 mRNA CTD PMID:37567420 NCBI chr 1:187,437,095...187,459,300
Ensembl chr 1:187,440,330...187,458,985 		JBrowse link
G Zscan2 zinc finger and SCAN domain containing 2 increases expression ISO Glucose results in increased expression of ZSCAN2 mRNA CTD PMID:39922521 NCBI chr 1:144,243,082...144,258,192
Ensembl chr 1:144,242,595...144,258,188 		JBrowse link
G Zwint ZW10 interacting kinetochore protein multiple interactions EXP ZWINT protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr20:15,502,559...15,953,701
Ensembl chr20:15,937,396...15,953,203 		JBrowse link
G Zxdc ZXD family zinc finger C decreases expression
multiple interactions 		ISO Glucose results in decreased expression of ZXDA mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of ZXDA mRNA] 		CTD PMID:33448797 NCBI chr 4:124,439,560...124,471,694
Ensembl chr 4:124,439,573...124,471,683 		JBrowse link
aldehydo-D-glucose term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A2m alpha-2-macroglobulin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of A2M mRNA CTD PMID:37567420 NCBI chr 4:156,570,163...156,619,870
Ensembl chr 4:156,569,860...156,619,868 		JBrowse link
G Abca1 ATP binding cassette subfamily A member 1 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of ABCA1 mRNA; Glucose results in decreased expression of ABCA1 protein
morroniside inhibits the reaction [Glucose results in decreased expression of ABCA1 mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of ABCA1 protein] 		CTD PMID:34485530 NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473 		JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A decreases expression ISO Glucose results in decreased expression of ABCB1 protein CTD PMID:22363694 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135 		JBrowse link
G Abcb4 ATP binding cassette subfamily B member 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of ABCB4 mRNA CTD PMID:37567420 NCBI chr 4:26,106,895...26,164,440 JBrowse link
G Abcb7 ATP binding cassette subfamily B member 7 decreases expression ISO Glucose results in decreased expression of ABCB7 mRNA CTD PMID:17178593 NCBI chr  X:73,361,296...73,502,464
Ensembl chr  X:73,361,310...73,502,547 		JBrowse link
G Abcc1 ATP binding cassette subfamily C member 1 multiple interactions ISO Glucose inhibits the reaction [Sodium Azide inhibits the reaction [ABCC1 protein results in decreased uptake of Daunorubicin]]; Glucose inhibits the reaction [Sodium Azide inhibits the reaction [ABCC1 protein results in decreased uptake of Etoposide]] CTD PMID:10856430 NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 multiple interactions EXP [Benzbromarone results in decreased activity of ABCC2 protein] inhibits the reaction [Glucose results in increased secretion of S-(2,4-dinitrophenyl)glutathione]; [Furosemide results in increased activity of ABCC2 protein] promotes the reaction [Glucose results in increased secretion of S-(2,4-dinitrophenyl)glutathione]; [sulfanitran results in increased activity of ABCC2 protein] promotes the reaction [Glucose results in increased secretion of S-(2,4-dinitrophenyl)glutathione] CTD PMID:19782883 NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471 		JBrowse link
G Abcd2 ATP binding cassette subfamily D member 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ABCD2 mRNA CTD PMID:37567420 NCBI chr 7:124,142,597...124,191,202
Ensembl chr 7:124,142,595...124,191,202 		JBrowse link
G Abcg1 ATP binding cassette subfamily G member 1 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of ABCG1 mRNA; Glucose results in decreased expression of ABCG1 protein
morroniside inhibits the reaction [Glucose results in decreased expression of ABCG1 mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of ABCG1 protein] 		CTD PMID:34485530 NCBI chr20:9,128,056...9,184,312
Ensembl chr20:9,127,803...9,186,563 		JBrowse link
G Abcg4 ATP binding cassette subfamily G member 4 increases expression ISO Glucose results in increased expression of ABCG4 mRNA CTD PMID:39922521 NCBI chr 8:53,508,005...53,525,314
Ensembl chr 8:53,508,005...53,523,571 		JBrowse link
G Acaca acetyl-CoA carboxylase alpha multiple interactions
decreases expression
increases expression
decreases phosphorylation 		ISO
EXP 		[INS protein co-treated with Glucose] results in increased expression of ACACA mRNA; [Pyruvic Acid co-treated with Glucose] results in increased phosphorylation of ACACA protein; PRKAA2 protein promotes the reaction [SIRT1 protein inhibits the reaction [Glucose results in decreased phosphorylation of ACACA protein]]; SIRT1 protein inhibits the reaction [Glucose results in decreased phosphorylation of ACACA protein]; SRT1720 inhibits the reaction [[INS protein co-treated with Glucose] results in increased expression of ACACA mRNA]
Glucose results in decreased expression of ACACA protein modified form
Glucose results in increased expression of ACACA mRNA 		CTD PMID:15066988 PMID:18482975 PMID:19071085 PMID:19724016 PMID:24349266 More... NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888 		JBrowse link
G Acacb acetyl-CoA carboxylase beta multiple interactions
decreases phosphorylation 		ISO 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [ACACB protein affects the reaction [Glucose results in decreased expression of PPARGC1A protein]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [ACACB protein affects the reaction [Glucose results in decreased expression of SIRT1 protein]]; ACACB protein affects the reaction [Glucose results in decreased expression of NPHS1 protein]; ACACB protein affects the reaction [Glucose results in decreased expression of PPARGC1A protein]; ACACB protein affects the reaction [Glucose results in decreased expression of SIRT1 protein]; ACACB protein affects the reaction [Glucose results in decreased expression of SLC2A4 protein]; ACACB protein affects the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; ACACB protein affects the reaction [Glucose results in decreased phosphorylation of IRS1 protein]
Glucose results in decreased phosphorylation of ACACB protein 		CTD PMID:33957017 NCBI chr12:48,026,394...48,138,214
Ensembl chr12:48,026,394...48,138,214 		JBrowse link
G Acadl acyl-CoA dehydrogenase, long chain multiple interactions ISO [Glucose co-treated with Palmitic Acid] results in decreased expression of ACADL mRNA CTD PMID:39265716 NCBI chr 9:75,783,689...75,822,077
Ensembl chr 9:75,783,689...75,822,164 		JBrowse link
G Acadsb acyl-CoA dehydrogenase, short/branched chain multiple interactions ISO 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA] CTD PMID:32613381 NCBI chr 1:195,619,088...195,660,564
Ensembl chr 1:195,619,038...195,660,561 		JBrowse link
G Acat2 acetyl-CoA acetyltransferase 2 decreases expression ISO Glucose results in decreased expression of ACAT2 mRNA CTD PMID:39613055 NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:50,100,817...50,135,095 		JBrowse link
G Ace angiotensin I converting enzyme increases expression
multiple interactions
decreases expression 		ISO
EXP 		Glucose results in increased expression of ACE protein
NFE2L2 protein affects the reaction [Glucose results in increased expression of ACE mRNA]; oltipraz inhibits the reaction [trigonelline inhibits the reaction [Glucose results in increased expression of ACE mRNA]]; trigonelline inhibits the reaction [Glucose results in increased expression of ACE mRNA]
CEBPB protein inhibits the reaction [Glucose results in increased expression of ACE protein]
Glucose results in decreased expression of ACE mRNA
Enalaprilat inhibits the reaction [Glucose results in increased expression of ACE protein] 		CTD PMID:16452552 PMID:29211853 PMID:29266779 PMID:31655124 NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942 		JBrowse link
G Ace2 angiotensin converting enzyme 2 multiple interactions
decreases expression 		EXP
ISO 		NFE2L2 protein affects the reaction [Glucose results in decreased expression of ACE2 mRNA]; oltipraz inhibits the reaction [trigonelline inhibits the reaction [Glucose results in decreased expression of ACE2 mRNA]]; trigonelline inhibits the reaction [Glucose results in decreased expression of ACE2 mRNA]
CEBPB protein inhibits the reaction [Glucose results in decreased expression of ACE2 protein]; Glucose inhibits the reaction [CEBPB protein binds to ACE2 promoter]; Valsartan inhibits the reaction [Glucose results in decreased expression of ACE2 protein] 		CTD PMID:29211853 PMID:29266779 NCBI chr  X:33,925,458...33,972,851
Ensembl chr  X:33,925,458...33,971,596 		JBrowse link
G Ache acetylcholinesterase multiple interactions
increases expression
decreases activity 		ISO Ascorbic Acid inhibits the reaction [Glucose results in decreased activity of ACHE protein]
Glucose results in increased expression of ACHE mRNA 		CTD PMID:26163454 PMID:39922521 NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410 		JBrowse link
G Acly ATP citrate lyase increases expression EXP
ISO 		Glucose results in increased expression of ACLY mRNA
Glucose deficiency results in increased expression of ACLY mRNA; Glucose deficiency results in increased expression of ACLY protein 		CTD PMID:24349266 PMID:26811028 NCBI chr10:85,912,402...85,964,605
Ensembl chr10:85,912,402...85,963,631 		JBrowse link
G Aco1 aconitase 1 multiple interactions
increases expression 		EXP
ISO 		[Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein; Oxygen inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein]
Glucose results in increased expression of ACO1 protein 		CTD PMID:16135072 PMID:38483099 NCBI chr 5:60,055,895...60,111,920
Ensembl chr 5:60,055,866...60,112,600 		JBrowse link
G Aco2 aconitase 2 multiple interactions EXP [Glucose co-treated with Oxygen] affects the activity of ACO2 protein; Glucose results in decreased expression of and results in decreased activity of ACO2 protein; LONP1 protein affects the reaction [SRT1720 inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of ACO2 protein]]; manganese tetrakis-(N-ethyl-2 pyridyl) porphyrin inhibits the reaction [[Glucose co-treated with Oxygen] affects the activity of ACO2 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[Glucose co-treated with Oxygen] affects the activity of ACO2 protein]; SRT1720 inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of ACO2 protein] CTD PMID:11520895 PMID:31639451 NCBI chr 7:115,265,816...115,308,931
Ensembl chr 7:115,265,791...115,308,892 		JBrowse link
G Acot1 acyl-CoA thioesterase 1 increases expression
multiple interactions 		ISO Glucose results in increased expression of ACOT1 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of ACOT1 mRNA 		CTD PMID:17178593 PMID:37567420 NCBI chr 6:109,367,274...109,375,268
Ensembl chr 6:109,367,268...109,380,749 		JBrowse link
G Acox1 acyl-CoA oxidase 1 increases expression
decreases expression
multiple interactions 		ISO Glucose results in increased expression of ACOX1 mRNA
Glucose results in decreased expression of ACOX1 protein
[Glucose co-treated with Palmitic Acid] results in decreased expression of ACOX1 mRNA; Ditiocarb inhibits the reaction [YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of ACOX1 protein]]]]; Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of ACOX1 protein]; jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of ACOX1 protein]]; YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of ACOX1 protein]]] 		CTD PMID:36156098 PMID:39059604 PMID:39265716 NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,905,083...101,930,136 		JBrowse link
G Acox2 acyl-CoA oxidase 2 decreases expression ISO Glucose results in decreased expression of ACOX2 mRNA CTD PMID:17178593 NCBI chr15:19,090,820...19,122,392
Ensembl chr15:19,090,926...19,122,392 		JBrowse link
G Acp5 acid phosphatase 5, tartrate resistant increases expression ISO Glucose results in increased expression of ACP5 mRNA CTD PMID:39922521 NCBI chr 8:28,939,984...28,946,639
Ensembl chr 8:28,939,985...28,943,929 		JBrowse link
G Acrbp acrosin binding protein increases expression ISO Glucose results in increased expression of ACRBP mRNA CTD PMID:39922521 NCBI chr 4:159,537,395...159,550,454
Ensembl chr 4:159,537,391...159,550,454 		JBrowse link
G Acsbg1 acyl-CoA synthetase bubblegum family member 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of ACSBG1 mRNA CTD PMID:37567420 NCBI chr 8:63,887,433...63,943,486
Ensembl chr 8:63,887,435...63,984,178 		JBrowse link
G Acsbg3 acyl-CoA synthetase bubblegum family member 3 increases expression ISO Glucose results in increased expression of ACSBG3 mRNA CTD PMID:39922521 NCBI chr 9:1,802,729...1,814,761
Ensembl chr 9:1,802,744...1,814,761 		JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 multiple interactions ISO [Glucose co-treated with Palmitic Acid] results in decreased expression of ACSL1 mRNA CTD PMID:39265716 NCBI chr16:52,487,870...52,554,110
Ensembl chr16:52,487,870...52,554,023 		JBrowse link
G Acsl4 acyl-CoA synthetase long-chain family member 4 multiple interactions EXP [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of ACSL4 protein; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of ACSL4 protein] CTD PMID:36806343 NCBI chr  X:110,739,633...110,803,416
Ensembl chr  X:110,739,648...110,803,261 		JBrowse link
G Acsm2 acyl-CoA synthetase medium-chain family member 2 increases expression ISO Glucose results in increased expression of ACSM2 mRNA CTD PMID:31525975 NCBI chr 1:183,347,705...183,386,453
Ensembl chr 1:183,347,705...183,386,453 		JBrowse link
G Acsm3 acyl-CoA synthetase medium-chain family member 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ACSM3 mRNA CTD PMID:37567420 NCBI chr 1:183,564,652...183,591,328
Ensembl chr 1:183,564,635...183,591,437 		JBrowse link
G Acss1 acyl-CoA synthetase short-chain family member 1 increases expression ISO Glucose results in increased expression of ACSS1 mRNA CTD PMID:36156098 NCBI chr 3:159,910,809...159,960,748
Ensembl chr 3:159,910,809...159,960,748 		JBrowse link
G Acss2 acyl-CoA synthetase short-chain family member 2 increases expression ISO Glucose results in increased expression of ACSS2 mRNA CTD PMID:36156098 PMID:39613055 NCBI chr 3:164,464,124...164,507,607
Ensembl chr 3:164,464,055...164,519,830 		JBrowse link
G Acta1 actin, alpha 1, skeletal muscle increases expression
decreases expression
multiple interactions 		EXP
ISO 		Glucose results in increased expression of ACTA1 mRNA
Glucose results in decreased expression of ACTA1 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ACTA1 mRNA; fucoxanthin inhibits the reaction [Glucose results in decreased expression of ACTA1 mRNA]
HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]]; Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]] 		CTD PMID:24810525 PMID:33448797 PMID:37567420 NCBI chr19:68,781,168...68,784,194
Ensembl chr19:68,781,168...68,786,178 		JBrowse link
G Acta2 actin alpha 2, smooth muscle multiple interactions
increases expression 		ISO
EXP 		4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [Glucose results in increased expression of ACTA2 protein]; [Glucose co-treated with TGFB1 protein] results in increased expression of ACTA2 protein; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of ACTA2 protein]; DKK1 protein inhibits the reaction [Glucose results in increased expression of ACTA2 mRNA]; DKK1 protein inhibits the reaction [Glucose results in increased expression of ACTA2 protein]; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of ACTA2 protein]; MAPK14 protein promotes the reaction [Glucose results in increased expression of ACTA2 protein]
Dichloroacetic Acid inhibits the reaction [Glucose results in increased expression of ACTA2 protein]; Oxamic Acid inhibits the reaction [Glucose results in increased expression of ACTA2 protein]
Glucose results in increased expression of ACTA2 mRNA; Glucose results in increased expression of ACTA2 protein
cinnamaldehyde inhibits the reaction [Glucose results in increased expression of ACTA2 protein] 		CTD PMID:20060012 PMID:21829520 PMID:26045780 PMID:29163160 PMID:35961541 More... NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503 		JBrowse link
G Actb actin, beta decreases expression ISO Glucose deficiency results in decreased expression of ACTB protein CTD PMID:22314686 NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242 		JBrowse link
G Actg1 actin, gamma 1 multiple interactions EXP ACTG1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr10:106,118,106...106,120,951
Ensembl chr10:106,118,108...106,120,951 		JBrowse link
G Actr2 actin related protein 2 multiple interactions
decreases expression 		ISO Eucalyptol inhibits the reaction [Glucose results in decreased expression of ACTR2 protein] CTD PMID:31483951 NCBI chr14:98,500,119...98,535,092
Ensembl chr14:98,500,138...98,541,998 		JBrowse link
G Acvr2b activin A receptor type 2B increases expression ISO Glucose results in increased expression of ACVR2B mRNA CTD PMID:39922521 NCBI chr 8:128,016,589...128,056,193
Ensembl chr 8:128,016,526...128,048,171 		JBrowse link
G Adam17 ADAM metallopeptidase domain 17 decreases expression ISO Glucose results in decreased expression of ADAM17 mRNA CTD PMID:31655124 NCBI chr 6:46,601,583...46,663,690
Ensembl chr 6:46,601,583...46,649,344 		JBrowse link
G Adam19 ADAM metallopeptidase domain 19 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of ADAM19 mRNA CTD PMID:37567420 NCBI chr10:30,992,713...31,084,455
Ensembl chr10:30,992,754...31,084,455 		JBrowse link
G Adam32 ADAM metallopeptidase domain 32 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of ADAM32 mRNA CTD PMID:37567420 NCBI chr16:73,805,023...73,914,787
Ensembl chr16:73,805,052...73,914,785 		JBrowse link
G Adam7 ADAM metallopeptidase domain 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of ADAM7 mRNA CTD PMID:37567420 NCBI chr15:47,009,176...47,057,581
Ensembl chr15:47,009,176...47,057,581 		JBrowse link
G Adam8 ADAM metallopeptidase domain 8 increases expression
multiple interactions 		ISO Glucose results in increased expression of ADAM8 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADAM8 mRNA 		CTD PMID:17178593 PMID:37567420 NCBI chr 1:204,206,206...204,218,988
Ensembl chr 1:204,206,199...204,218,485 		JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 increases expression ISO Glucose results in increased expression of ADAMTS1 mRNA CTD PMID:17178593 NCBI chr11:38,418,565...38,427,384
Ensembl chr11:38,418,101...38,427,390 		JBrowse link
G Adamts3 ADAM metallopeptidase with thrombospondin type 1, motif 3 increases expression ISO Glucose results in increased expression of ADAMTS3 mRNA CTD PMID:39922521 NCBI chr14:18,515,249...18,721,887
Ensembl chr14:18,515,249...18,721,887 		JBrowse link
G Adamtsl2 ADAMTS-like 2 increases expression ISO Glucose results in increased expression of ADAMTSL2 mRNA CTD PMID:39922521 NCBI chr 3:30,795,882...30,832,635
Ensembl chr 3:30,802,700...30,832,635 		JBrowse link
G Adcy7 adenylate cyclase 7 decreases methylation
multiple interactions
increases expression 		ISO Glucose results in decreased methylation of ADCY7 gene
fucoxanthin inhibits the reaction [Glucose results in decreased methylation of ADCY7 gene]; fucoxanthin inhibits the reaction [Glucose results in increased expression of ADCY7 mRNA] 		CTD PMID:33448797 NCBI chr19:34,913,154...34,972,366
Ensembl chr19:34,914,322...34,936,743 		JBrowse link
G Adgra1 adhesion G protein-coupled receptor A1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADGRA1 mRNA CTD PMID:37567420 NCBI chr 1:204,059,218...204,102,869
Ensembl chr 1:204,059,367...204,102,869 		JBrowse link
G Adgrb1 adhesion G protein-coupled receptor B1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADGRB1 mRNA CTD PMID:37567420 NCBI chr 7:108,293,681...108,365,892
Ensembl chr 7:108,293,818...108,365,870 		JBrowse link
G Adgre4 adhesion G protein-coupled receptor E4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADGRE4 mRNA CTD PMID:37567420 NCBI chr 9:10,085,258...10,240,346
Ensembl chr 9:10,085,352...10,240,229 		JBrowse link
G Adgrf4 adhesion G protein-coupled receptor F4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ADGRF4 mRNA CTD PMID:37567420 NCBI chr 9:25,769,265...25,800,438
Ensembl chr 9:25,769,265...25,800,438 		JBrowse link
G Adgrg4 adhesion G protein-coupled receptor G4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of ADGRG4 mRNA CTD PMID:37567420 NCBI chr  X:139,771,962...139,901,771 JBrowse link
G Adgrg5 adhesion G protein-coupled receptor G5 increases expression ISO Glucose results in increased expression of ADGRG5 mRNA CTD PMID:39922521 NCBI chr19:10,080,800...10,104,659
Ensembl chr19:10,085,388...10,103,220 		JBrowse link
G Adhfe1 alcohol dehydrogenase, iron containing, 1 decreases expression ISO Glucose results in decreased expression of ADHFE1 mRNA CTD PMID:17178593 NCBI chr 5:14,488,784...14,515,405
Ensembl chr 5:14,488,788...14,515,835 		JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing decreases expression
increases expression
multiple interactions
increases secretion 		EXP
ISO 		Glucose results in decreased expression of ADIPOQ protein
Glucose results in increased expression of ADIPOQ protein
[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; [Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; butylbenzyl phthalate promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; Diethylhexyl Phthalate promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; Pioglitazone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; tributyltin promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]
Glucose deficiency results in increased secretion of ADIPOQ protein
ADIPOQ protein inhibits the reaction [Glucose results in decreased expression of ADIPOR2 protein]; argan oil promotes the reaction [Glucose results in increased expression of ADIPOQ protein]; Corn Oil promotes the reaction [Glucose results in increased expression of ADIPOQ protein] 		CTD PMID:21912612 PMID:24802182 PMID:29165388 PMID:32407875 NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169 		JBrowse link
G Adipor1 adiponectin receptor 1 multiple interactions
decreases expression 		EXP FOXO1 protein inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]; FOXO1 protein inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]; FOXO1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]]; FOXO1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]]; Resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]; Resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]
Glucose results in decreased expression of ADIPOR1 mRNA; Glucose results in decreased expression of ADIPOR1 protein 		CTD PMID:24413998 NCBI chr13:48,411,438...48,431,251
Ensembl chr13:48,411,826...48,431,255 		JBrowse link
G Adipor2 adiponectin receptor 2 multiple interactions
decreases expression 		EXP ADIPOQ protein inhibits the reaction [Glucose results in decreased expression of ADIPOR2 protein] CTD PMID:21912612 NCBI chr 4:154,195,440...154,261,141
Ensembl chr 4:154,172,567...154,231,666 		JBrowse link
G Adra1a adrenoceptor alpha 1A multiple interactions EXP 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose]; 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose]; 2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose]; [cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose; [Phenylephrine results in increased activity of ADRA1A protein] which results in increased transport of Glucose; Prazosin inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose] CTD PMID:15550506 NCBI chr15:45,005,648...45,111,416
Ensembl chr15:45,005,799...45,102,534 		JBrowse link
G Adrb2 adrenoceptor beta 2 multiple interactions ISO [BRL 37344 binds to and results in increased activity of ADRB2 protein] which results in increased uptake of Glucose; [Clenbuterol binds to and results in increased activity of ADRB2 protein] which results in decreased uptake of Glucose; ICI 118551 inhibits the reaction [[BRL 37344 binds to and results in increased activity of ADRB2 protein] which results in increased uptake of Glucose]; ICI 118551 inhibits the reaction [[Clenbuterol binds to and results in increased activity of ADRB2 protein] which results in decreased uptake of Glucose] CTD PMID:18552870 NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803 		JBrowse link
G Adrb3 adrenoceptor beta 3 multiple interactions ISO [BRL 37344 binds to and results in increased activity of ADRB3 protein] which results in decreased abundance of Glucose; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADRB3 mRNA CTD PMID:20930473 PMID:37567420 NCBI chr16:71,544,603...71,547,410
Ensembl chr16:71,542,567...71,547,420 		JBrowse link
G Afg2b AFG2 AAA ATPase homolog B increases expression ISO Glucose results in increased expression of AFG2B mRNA CTD PMID:39922521 NCBI chr 3:130,148,061...130,162,458
Ensembl chr 3:130,148,301...130,162,112 		JBrowse link
G Afp alpha-fetoprotein increases expression ISO Glucose results in increased expression of AFP mRNA CTD PMID:17178593 NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,857,584...17,875,649 		JBrowse link
G Agbl4 AGBL carboxypeptidase 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of AGBL4 mRNA CTD PMID:37567420 NCBI chr 5:130,483,551...131,762,906 JBrowse link
G Ager advanced glycosylation end product-specific receptor multiple interactions
increases expression 		ISO
EXP 		GLO1 inhibits the reaction [Glucose promotes the reaction [RELA protein binds to AGER promoter]]; GLO1 inhibits the reaction [Glucose results in increased expression of AGER mRNA]; GLO1 inhibits the reaction [Glucose results in increased expression of AGER protein]; Glucose promotes the reaction [RELA protein binds to AGER promoter]; Luteolin inhibits the reaction [Glucose results in increased expression of AGER mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of AGER mRNA]; RELA promotes the reaction [Glucose results in increased expression of AGER mRNA]; Rutin inhibits the reaction [Glucose results in increased expression of AGER mRNA]; SOD2 inhibits the reaction [Glucose results in increased expression of AGER mRNA]; SOD2 inhibits the reaction [Glucose results in increased expression of AGER protein]; UCP1 inhibits the reaction [Glucose results in increased expression of AGER mRNA]; UCP1 inhibits the reaction [Glucose results in increased expression of AGER protein]
[Ribose co-treated with Glucose] results in increased expression of AGER protein; AGER protein affects the reaction [Ribose promotes the reaction [Glucose results in increased phosphorylation of RELA protein]]
Glucose results in increased expression of AGER mRNA; Glucose results in increased expression of AGER protein
AGER protein results in increased susceptibility to [Azoxymethane co-treated with Glucose co-treated with Linoleic Acid]; Glucose promotes the reaction [Azoxymethane results in increased expression of AGER protein]; Glucose promotes the reaction [Linoleic Acid promotes the reaction [Azoxymethane results in increased expression of AGER protein]]; Linoleic Acid promotes the reaction [Glucose promotes the reaction [Azoxymethane results in increased expression of AGER protein]]; Losartan inhibits the reaction [Glucose promotes the reaction [Linoleic Acid promotes the reaction [Azoxymethane results in increased expression of AGER protein]]]; Losartan inhibits the reaction [Linoleic Acid promotes the reaction [Glucose promotes the reaction [Azoxymethane results in increased expression of AGER protein]]]; Metformin inhibits the reaction [Glucose promotes the reaction [Linoleic Acid promotes the reaction [Azoxymethane results in increased expression of AGER protein]]]; Metformin inhibits the reaction [Linoleic Acid promotes the reaction [Glucose promotes the reaction [Azoxymethane results in increased expression of AGER protein]]] 		CTD PMID:19557821 PMID:19759273 PMID:19833897 PMID:22467055 PMID:30101366 More... NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685 		JBrowse link
G Agl amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase increases uptake ISO AGL protein results in increased uptake of Glucose CTD PMID:24700805 NCBI chr 2:207,389,949...207,445,959
Ensembl chr 2:207,389,949...207,445,724 		JBrowse link
G Agt angiotensinogen multiple interactions
increases expression
affects metabolic processing 		ISO
EXP 		(3,4-dihydroxyphenylamino)-2-imidazoline inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]; 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]; [Valsartan co-treated with Simvastatin] inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]]; [Valsartan co-treated with Simvastatin] inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of LIF mRNA]]; acetovanillone inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]; Enalaprilat inhibits the reaction [Glucose results in increased expression of AGT protein]; Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]; Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA]; Glucose promotes the reaction [AGT protein results in increased expression of FOSL1 mRNA]; Glucose promotes the reaction [AGT protein results in increased expression of KLF10 mRNA]; Glucose promotes the reaction [AGT protein results in increased expression of LIF mRNA]; Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]; Rotenone inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]; Simvastatin promotes the reaction [Glucose promotes the reaction [AGT protein results in increased expression of PTGS2 mRNA]]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA]]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of KLF10 mRNA]]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of LIF mRNA]]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Glucose results in increased expression of AGT mRNA]; 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Glucose results in increased expression of AGT protein]; alpha-cyano-4-hydroxycinnamate inhibits the reaction [Glucose results in increased expression of AGT mRNA]; alpha-cyano-4-hydroxycinnamate inhibits the reaction [Glucose results in increased expression of AGT protein]; Carbonyl Cyanide m-Chlorophenyl Hydrazone inhibits the reaction [Glucose results in increased expression of AGT mRNA]; Carbonyl Cyanide m-Chlorophenyl Hydrazone inhibits the reaction [Glucose results in increased expression of AGT protein]; CAT protein inhibits the reaction [Glucose results in increased expression of AGT mRNA]; CAT protein inhibits the reaction [Glucose results in increased expression of AGT protein]; Hydrogen Peroxide promotes the reaction [Glucose results in increased expression of AGT mRNA]; Hydrogen Peroxide promotes the reaction [Glucose results in increased expression of AGT protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of AGT mRNA]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of AGT protein]; NFE2L2 protein affects the reaction [Glucose results in increased expression of AGT mRNA]; oltipraz inhibits the reaction [trigonelline inhibits the reaction [Glucose results in increased expression of AGT mRNA]]; Rotenone inhibits the reaction [Glucose results in increased expression of AGT mRNA]; Rotenone inhibits the reaction [Glucose results in increased expression of AGT protein]; SB 203580 inhibits the reaction [Glucose results in increased expression of AGT mRNA]; SB 203580 inhibits the reaction [Glucose results in increased expression of AGT protein]; Taurine inhibits the reaction [Glucose results in increased expression of AGT mRNA]; Taurine inhibits the reaction [Glucose results in increased expression of AGT protein]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of AGT mRNA]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of AGT protein]; trigonelline inhibits the reaction [Glucose results in increased expression of AGT mRNA]; Valsartan promotes the reaction [Glucose results in increased expression of AGT protein]
AGT protein affects the metabolism of Glucose
Glucose results in increased expression of AGT mRNA; Glucose results in increased expression of AGT protein 		CTD PMID:11115780 PMID:12130563 PMID:15677497 PMID:16452552 PMID:19225232 More... NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944 		JBrowse link
G Agtr1a angiotensin II receptor, type 1a increases expression
multiple interactions 		ISO Glucose results in increased expression of AGTR1 mRNA; Glucose results in increased expression of AGTR1 protein
Enalaprilat inhibits the reaction [Glucose results in increased expression of AGTR1 protein]
CEBPB protein inhibits the reaction [Glucose results in increased expression of AGTR1 protein] 		CTD PMID:16452552 PMID:29266779 PMID:31655124 PMID:34464088 NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660 		JBrowse link
G Agtr2 angiotensin II receptor, type 2 multiple interactions
increases expression 		ISO CEBPB protein inhibits the reaction [Glucose results in increased expression of AGTR2 protein] CTD PMID:29266779 NCBI chr  X:116,914,320...116,918,504
Ensembl chr  X:116,913,656...116,918,745 		JBrowse link
G Ahr aryl hydrocarbon receptor multiple interactions
increases response to substance 		ISO 4,7-phenanthroline inhibits the reaction [AHR promotes the reaction [Tetrachlorodibenzodioxin results in decreased uptake of Glucose]]; AHR promotes the reaction [Tetrachlorodibenzodioxin results in decreased uptake of Glucose]; alpha-naphthoflavone inhibits the reaction [AHR promotes the reaction [Tetrachlorodibenzodioxin results in decreased uptake of Glucose]]
AHR protein promotes the reaction [Tetrachlorodibenzodioxin affects the susceptibility to Glucose]
AHR results in increased susceptibility to Glucose 		CTD PMID:8738555 PMID:19623578 PMID:21849270 NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901 		JBrowse link
G Aif1 allograft inflammatory factor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of AIF1 mRNA CTD PMID:37567420 NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,652,243...3,657,339 		JBrowse link
G Aifm1 apoptosis inducing factor, mitochondria associated 1 affects localization
multiple interactions 		EXP Glucose affects the localization of AIFM1 protein
[Oxygen co-treated with Glucose] results in decreased expression of AIFM1 protein; protosappanin A inhibits the reaction [[Oxygen co-treated with Glucose] results in decreased expression of AIFM1 protein]; Quercetin affects the reaction [Glucose affects the localization of AIFM1 protein]; sesamin affects the reaction [Glucose affects the localization of AIFM1 protein] 		CTD PMID:19146853 PMID:22524206 PMID:33225685 NCBI chr  X:132,528,107...132,567,237
Ensembl chr  X:132,528,107...132,567,237 		JBrowse link
G Aim2 absent in melanoma 2 increases expression ISO Glucose results in increased expression of AIM2 mRNA CTD PMID:39613055 NCBI chr13:88,397,516...88,439,325
Ensembl chr13:88,404,048...88,439,318 		JBrowse link
G Ak7 adenylate kinase 7 increases expression ISO Glucose results in increased expression of AK7 mRNA CTD PMID:39922521 NCBI chr 6:130,376,499...130,444,674
Ensembl chr 6:130,376,550...130,444,677 		JBrowse link
G Ak8 adenylate kinase 8 increases expression
multiple interactions 		ISO Glucose results in increased expression of AK8 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of AK8 mRNA] 		CTD PMID:33448797 NCBI chr 3:32,426,892...32,542,432
Ensembl chr 3:32,426,421...32,542,431 		JBrowse link
G Akap5 A-kinase anchoring protein 5 increases expression ISO Glucose results in increased expression of AKAP5 mRNA CTD PMID:31525975 NCBI chr 6:100,787,169...100,796,712
Ensembl chr 6:100,790,148...100,796,620 		JBrowse link
G Akr1a1 aldo-keto reductase family 1 member A1 multiple interactions
decreases expression 		ISO fidarestat inhibits the reaction [Glucose results in decreased expression of AKR1A1 mRNA] CTD PMID:16805838 NCBI chr 5:135,329,605...135,367,037
Ensembl chr 5:135,329,606...135,367,035 		JBrowse link
G Akr1b1 aldo-keto reductase family 1 member B1 multiple interactions
increases expression 		ISO AKR1B1 protein promotes the reaction [Glucose results in increased abundance of Sorbitol]
Glucose results in increased expression of AKR1B1 mRNA; Glucose results in increased expression of AKR1B1 protein 		CTD PMID:16805838 PMID:25451566 NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:63,899,222...63,913,315 		JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of AKR1C6 mRNA CTD PMID:37567420 NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247 		JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of AKR1C18 mRNA CTD PMID:37567420 NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 increases phosphorylation
increases expression
decreases phosphorylation
multiple interactions
decreases expression
increases response to substance 		ISO
EXP 		Glucose results in increased phosphorylation of AKT1 protein
Glucose results in increased expression of AKT1 mRNA
Glucose results in decreased phosphorylation of AKT1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [deuterohemin-alanyl-histidyl-threonyl-valyl-glutamyl-lysine inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [diallyl trisulfide inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein]; 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; [3,4-Dihydroxyphenylacetic Acid co-treated with Glucose] results in increased phosphorylation of AKT1 protein; [Catechin co-treated with Glucose] results in increased phosphorylation of AKT1 protein; [Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein; Acetylcysteine inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; deuterohemin-alanyl-histidyl-threonyl-valyl-glutamyl-lysine inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; diallyl trisulfide inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; Simvastatin inhibits the reaction [Glucose results in decreased expression of AKT1 protein modified form]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Glucose co-treated with Calcitriol] results in increased phosphorylation of AKT1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; [AKT1 protein mutant form results in increased susceptibility to Glucose deficiency] which results in increased phosphorylation of EIF4EBP1 protein; [Glucose co-treated with Calcitriol] results in increased phosphorylation of AKT1 protein; AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form results in increased susceptibility to Glucose deficiency]; AKT1 protein modified form inhibits the reaction [arsenite inhibits the reaction [INS1 protein results in increased uptake of Glucose]]; AKT1 protein modified form inhibits the reaction [monomethylarsonous acid inhibits the reaction [INS1 protein results in increased uptake of Glucose]]; AKT1 protein promotes the reaction [Glucose affects the phosphorylation of and affects the activity of FOXO3 protein]; Bezafibrate inhibits the reaction [AKT1 protein mutant form results in increased susceptibility to Glucose deficiency]; Glucose affects the phosphorylation of and affects the activity of AKT1 protein; methyl pyruvate inhibits the reaction [AKT1 protein mutant form results in increased susceptibility to Glucose deficiency]; PRKAA2 protein affects the reaction [AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form affects the susceptibility to Glucose deficiency]]; SMARCA4A protein inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; [Glucose affects the susceptibility to INS protein] which affects the phosphorylation of AKT1 protein; [Glucose co-treated with Cadmium] results in increased phosphorylation of AKT1 protein; [Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT1 protein; [Palmitic Acid co-treated with Glucose] results in increased phosphorylation of AKT1 protein; ACACB protein affects the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; albiflorin inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased phosphorylation of AKT1 protein]; Berberine inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Captopril inhibits the reaction [Glucose results in increased expression of AKT1 mRNA]; Fluorometholone inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; Glucose inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]; HAGLR protein affects the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; HAGLR protein inhibits the reaction [MIR106B inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; huai qi huang inhibits the reaction [Glucose results in increased expression of AKT1 mRNA]; Metformin inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; MIR106B inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]]; nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT1 protein]; PTEN protein affects the reaction [HAGLR protein affects the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Rosiglitazone inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; spiraeoside inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Wortmannin inhibits the reaction [nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT1 protein]]; zhenwu decoction inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased phosphorylation of AKT1 protein] 		CTD PMID:15806154 PMID:16385087 PMID:17520061 PMID:18004065 PMID:20370652 More... NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610 		JBrowse link
G Akt2 AKT serine/threonine kinase 2 affects response to substance
multiple interactions 		ISO AKT2 protein affects the susceptibility to Glucose
[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT2 protein; nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT2 protein]; Wortmannin inhibits the reaction [nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT2 protein]] 		CTD PMID:21964073 PMID:38528077 NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:92,014,859...92,061,420 		JBrowse link
G Akt3 AKT serine/threonine kinase 3 multiple interactions ISO [Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT3 protein; nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT3 protein]; Wortmannin inhibits the reaction [nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT3 protein]] CTD PMID:38528077 NCBI chr13:91,475,839...91,758,060
Ensembl chr13:91,475,839...91,748,020 		JBrowse link
G Alb albumin multiple interactions
decreases uptake
increases metabolic processing 		ISO
EXP 		[Fructose co-treated with Glucose] results in increased glycation of ALB protein; [Peroxynitrous Acid co-treated with Glucose] results in increased glycation of ALB protein; Phlorhizin inhibits the reaction [Glucose results in decreased uptake of ALB protein]; pimagedine inhibits the reaction [[Fructose co-treated with Glucose] results in increased glycation of ALB protein]; pimagedine inhibits the reaction [[Peroxynitrous Acid co-treated with Glucose] results in increased glycation of ALB protein]; ursonic acid inhibits the reaction [[Fructose co-treated with Glucose] results in increased glycation of ALB protein]
ALB protein modified form inhibits the reaction [Glucose results in increased phosphorylation of RELA protein]; ALB protein modified form inhibits the reaction [Glucose results in increased secretion of INS1 protein]; MK615 extract inhibits the reaction [ALB protein modified form inhibits the reaction [Glucose results in increased phosphorylation of RELA protein]]; MK615 extract inhibits the reaction [ALB protein modified form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]
[Glucose deficiency co-treated with ALB protein] results in decreased expression of FABP4 mRNA; [Glucose deficiency co-treated with ALB protein] results in decreased expression of PCK1 mRNA
Glucose results in increased metabolism of ALB protein 		CTD PMID:8536680 PMID:12196478 PMID:12434198 PMID:16313995 PMID:27415824 More... NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865 		JBrowse link
G Alcam activated leukocyte cell adhesion molecule multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of ALCAM mRNA] CTD PMID:33448797 NCBI chr11:61,804,932...62,005,250
Ensembl chr11:61,805,049...62,006,876 		JBrowse link
G Aldh1b1 aldehyde dehydrogenase 1 family, member B1 increases expression ISO Glucose deficiency results in increased expression of ALDH1B1 protein CTD PMID:22314686 NCBI chr 5:64,859,000...64,864,008
Ensembl chr 5:64,858,934...64,864,365 		JBrowse link
G Aldh1l2 aldehyde dehydrogenase 1 family, member L2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of ALDH1L2 mRNA CTD PMID:37567420 NCBI chr 7:22,141,872...22,193,403
Ensembl chr 7:22,141,842...22,193,398 		JBrowse link
G Aldh2 aldehyde dehydrogenase 2 family member decreases expression
multiple interactions 		EXP Glucose results in decreased expression of ALDH2 protein
N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of ALDH2 protein] 		CTD PMID:29128638 NCBI chr12:40,610,244...40,643,220
Ensembl chr12:40,610,224...40,643,219 		JBrowse link
G Aldh3a1 aldehyde dehydrogenase 3 family, member A1 decreases expression ISO Glucose results in decreased expression of ALDH3A1 mRNA CTD PMID:39613055 NCBI chr10:46,392,464...46,402,151
Ensembl chr10:46,392,411...46,402,151 		JBrowse link
G Aldh3b3 aldehyde dehydrogenase 3 family, member B3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ALDH3B3 mRNA CTD PMID:37567420 NCBI chr 1:210,617,090...210,629,886
Ensembl chr 1:210,622,639...210,629,879 		JBrowse link
G Aldh6a1 aldehyde dehydrogenase 6 family, member A1 decreases expression ISO Glucose results in decreased expression of ALDH6A1 mRNA CTD PMID:17178593 NCBI chr 6:109,809,092...109,829,725
Ensembl chr 6:109,809,122...109,829,743 		JBrowse link
G Alg12 ALG12, alpha-1,6-mannosyltransferase decreases expression ISO Glucose results in decreased expression of ALG12 mRNA CTD PMID:17178593 NCBI chr 7:121,774,796...121,789,175
Ensembl chr 7:121,768,234...121,788,983 		JBrowse link
G Alk ALK receptor tyrosine kinase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ALK mRNA CTD PMID:37567420 NCBI chr 6:28,631,431...29,351,321
Ensembl chr 6:28,632,197...29,349,721 		JBrowse link
G Alox12 arachidonate 12-lipoxygenase, 12S type increases expression ISO Glucose results in increased expression of ALOX12 mRNA CTD PMID:32942007 NCBI chr10:55,456,923...55,469,239
Ensembl chr10:55,456,928...55,469,199 		JBrowse link
G Alox12b arachidonate 12-lipoxygenase, 12R type increases expression ISO Glucose results in increased expression of ALOX12B mRNA CTD PMID:39922521 NCBI chr10:54,361,898...54,373,776
Ensembl chr10:54,361,898...54,373,776 		JBrowse link
G Alox5 arachidonate 5-lipoxygenase multiple interactions
increases expression 		EXP
ISO 		[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein; caffeic acid inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein]; Edaravone inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein]; SB 203580 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein]
Glucose results in increased expression of ALOX5 mRNA 		CTD PMID:18951527 PMID:31655124 NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:151,203,949...151,251,126 		JBrowse link
G Aloxe3 arachidonate epidermal lipoxygenase 3 increases expression ISO Glucose results in increased expression of ALOXE3 mRNA CTD PMID:39922521 NCBI chr10:54,329,224...54,353,167
Ensembl chr10:54,329,043...54,353,166 		JBrowse link
G Alpk3 alpha-kinase 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ALPK3 mRNA CTD PMID:37567420 NCBI chr 1:144,423,690...144,471,534
Ensembl chr 1:144,423,726...144,490,309 		JBrowse link
G Alpl alkaline phosphatase, biomineralization associated decreases expression
multiple interactions 		ISO
EXP 		Glucose results in decreased expression of ALPL mRNA
morroniside inhibits the reaction [Glucose results in decreased expression of ALPL mRNA]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL protein]]; Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL mRNA]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL mRNA]]; Sirolimus inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL mRNA]] 		CTD PMID:32643284 PMID:33450223 NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167 		JBrowse link
G Amer2 APC membrane recruitment protein 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of AMER2 mRNA CTD PMID:37567420 NCBI chr15:38,701,509...38,711,817
Ensembl chr15:38,701,657...38,705,633 		JBrowse link
G Amot angiomotin decreases expression ISO Glucose results in decreased expression of AMOT mRNA CTD PMID:17178593 NCBI chr  X:113,778,990...113,837,846
Ensembl chr  X:113,781,526...113,837,482 		JBrowse link
G Angptl4 angiopoietin-like 4 increases expression ISO Glucose results in increased expression of ANGPTL4 mRNA CTD PMID:16805838 NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681 		JBrowse link
G Ankrd53 ankyrin repeat domain 53 increases expression ISO Glucose results in increased expression of ANKRD53 mRNA CTD PMID:39922521 NCBI chr 4:117,804,702...117,810,650
Ensembl chr 4:117,804,548...117,810,645 		JBrowse link
G Ankrd61 ankyrin repeat domain 61 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of ANKRD61 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of ANKRD61 mRNA] 		CTD PMID:31525975 PMID:33448797 NCBI chr12:15,832,567...15,836,925
Ensembl chr12:15,832,108...15,836,923 		JBrowse link
G Anks1b ankyrin repeat and sterile alpha motif domain containing 1B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ANKS1B mRNA CTD PMID:37567420 NCBI chr 7:26,200,649...27,366,552
Ensembl chr 7:26,201,240...27,364,943 		JBrowse link
G Anp32e acidic nuclear phosphoprotein 32 family member E increases expression ISO Glucose results in increased expression of ANP32E mRNA CTD PMID:39922521 NCBI chr 2:186,161,520...186,177,984
Ensembl chr 2:186,161,532...186,177,986 		JBrowse link
G Anxa5 annexin A5 decreases expression ISO Glucose results in decreased expression of ANXA5 mRNA CTD PMID:31655124 NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:121,242,136...121,281,400 		JBrowse link
G Aoc1 amine oxidase, copper containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of AOC1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of AOC1 mRNA CTD PMID:37567420 NCBI chr 4:79,143,126...79,162,705
Ensembl chr 4:79,143,126...79,162,704 		JBrowse link
G Aoc2-ps1 amine oxidase, copper containing 2, pseudogene 1 increases expression ISO Glucose results in increased expression of AOC2 mRNA CTD PMID:39922521 NCBI chr10:86,767,268...86,768,734 JBrowse link
G Apaf1 apoptotic peptidase activating factor 1 multiple interactions ISO [Glucose co-treated with Deferoxamine] results in increased expression of APAF1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of APAF1 mRNA] CTD PMID:33962019 NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772 		JBrowse link
G Apba1 amyloid beta precursor protein binding family A member 1 increases expression ISO Glucose results in increased expression of APBA1 mRNA CTD PMID:39922521 NCBI chr 1:230,790,297...230,995,986
Ensembl chr 1:230,790,297...230,995,986 		JBrowse link
G Apc APC regulator of WNT signaling pathway decreases expression EXP Glucose results in decreased expression of APC mRNA CTD PMID:21818840 NCBI chr18:26,138,382...26,196,021
Ensembl chr18:26,102,679...26,197,022 		JBrowse link
G Apcs amyloid P component, serum multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of APCS mRNA CTD PMID:37567420 NCBI chr13:87,905,532...87,906,508
Ensembl chr13:87,905,532...87,928,824 		JBrowse link
G Apoa1 apolipoprotein A1 increases expression
decreases expression 		EXP Glucose results in increased expression of APOA1 mRNA; Glucose results in increased expression of APOA1 protein
Glucose results in decreased expression of APOA1 mRNA 		CTD PMID:9322794 PMID:9668074 NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:55,423,825...55,425,729 		JBrowse link
G Apob apolipoprotein B multiple interactions ISO Glucose promotes the reaction [Copper Sulfate results in increased cleavage of APOB protein] CTD PMID:19489629 NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:36,563,704...36,611,814 		JBrowse link
G Apobec2 apolipoprotein B mRNA editing enzyme catalytic subunit 2 increases expression ISO Glucose results in increased expression of APOBEC2 mRNA CTD PMID:39922521 NCBI chr 9:20,062,561...20,076,074
Ensembl chr 9:20,062,526...20,076,071 		JBrowse link
G Apoe apolipoprotein E affects secretion
decreases expression
multiple interactions 		ISO Glucose deficiency affects the secretion of APOE protein
Glucose results in decreased expression of APOE mRNA; Glucose results in decreased expression of APOE protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of APOE mRNA; morroniside inhibits the reaction [Glucose results in decreased expression of APOE mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of APOE protein] 		CTD PMID:24802182 PMID:34485530 PMID:37567420 NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855 		JBrowse link
G Apol9a apolipoprotein L9a multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of APOL9A mRNA CTD PMID:37567420 NCBI chr 7:111,021,452...111,030,380
Ensembl chr 7:111,021,453...111,028,213 		JBrowse link
G Apold1 apolipoprotein L domain containing 1 increases expression ISO Glucose results in increased expression of APOLD1 mRNA CTD PMID:39922521 NCBI chr 4:169,499,728...169,557,075
Ensembl chr 4:169,549,679...169,559,176 		JBrowse link
G App amyloid beta precursor protein multiple interactions
increases abundance 		ISO [APP protein mutant form co-treated with PSEN1 protein mutant form co-treated with PF-06840003] results in decreased abundance of Glucose; [APP protein mutant form co-treated with PSEN1 protein mutant form] results in increased abundance of Glucose; IDO1 protein affects the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in increased abundance of Glucose]
PF-06840003 inhibits the reaction [APP protein mutant form results in increased abundance of Glucose] 		CTD PMID:39172838 NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971 		JBrowse link
G Aqp1 aquaporin 1 increases expression
multiple interactions 		EXP Glucose results in increased expression of AQP1 mRNA
benazepril inhibits the reaction [Glucose results in increased expression of AQP1 mRNA]; valsartan inhibits the reaction [Glucose results in increased expression of AQP1 mRNA] 		CTD PMID:11510275 NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504 		JBrowse link
G Aqp3 aquaporin 3 (Gill blood group) multiple interactions
increases expression 		ISO Glucose promotes the reaction [AQP3 protein results in increased transport of Glycerol]
Glucose results in increased expression of AQP3 mRNA; Glucose results in increased expression of AQP3 protein 		CTD PMID:12234316 NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:61,035,166...61,040,685 		JBrowse link
G Aqp4 aquaporin 4 multiple interactions
increases expression 		EXP benazepril inhibits the reaction [Glucose results in increased expression of AQP4 mRNA]; valsartan inhibits the reaction [Glucose results in increased expression of AQP4 mRNA] CTD PMID:11510275 NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,782,389...6,799,098 		JBrowse link
G Aqp5 aquaporin 5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of AQP5 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of AQP5 mRNA CTD PMID:37567420 NCBI chr 7:132,601,528...132,605,060
Ensembl chr 7:132,601,059...132,605,062 		JBrowse link
G Aqp7 aquaporin 7 multiple interactions ISO [Arsenic Trioxide co-treated with Glucose] results in increased expression of AQP7 mRNA; [Arsenic Trioxide co-treated with Glucose] results in increased expression of AQP7 protein; INS protein inhibits the reaction [[Arsenic Trioxide co-treated with Glucose] results in increased expression of AQP7 mRNA]; INS protein inhibits the reaction [[Arsenic Trioxide co-treated with Glucose] results in increased expression of AQP7 protein] CTD PMID:37146668 NCBI chr 5:60,968,495...60,982,618
Ensembl chr 5:60,967,558...60,982,618 		JBrowse link
G Aqp8 aquaporin 8 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of AQP8 mRNA CTD PMID:37567420 NCBI chr 1:187,424,314...187,430,243
Ensembl chr 1:187,424,417...187,430,242 		JBrowse link
G Ar androgen receptor multiple interactions EXP
ISO 		[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of AR mRNA; tetrahydropalmatine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of AR mRNA]
[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate co-treated with lard co-treated with Cholesterol co-treated with Glucose co-treated with Sucrose co-treated with Fructose] results in decreased expression of AR protein 		CTD PMID:37606869 PMID:37615203 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Areg amphiregulin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of AREG mRNA CTD PMID:37567420 NCBI chr14:17,256,384...17,265,641
Ensembl chr14:17,256,384...17,265,641 		JBrowse link
G Arg2 arginase 2 increases expression
decreases expression 		ISO Glucose results in increased expression of ARG2 mRNA
Glucose results in decreased expression of ARG2 mRNA 		CTD PMID:17178593 PMID:39613055 NCBI chr 6:103,669,001...103,694,375
Ensembl chr 6:103,668,988...103,694,375 		JBrowse link
G Arhgap6 Rho GTPase activating protein 6 increases expression ISO Glucose results in increased expression of ARHGAP6 mRNA CTD PMID:31525975 NCBI chr  X:28,525,912...29,062,344
Ensembl chr  X:28,525,917...29,061,244 		JBrowse link
G Arhgdib Rho GDP dissociation inhibitor beta decreases expression
multiple interactions 		ISO Glucose results in decreased expression of ARHGDIB mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of ARHGDIB mRNA] 		CTD PMID:33448797 NCBI chr 4:171,554,139...171,573,057
Ensembl chr 4:171,554,140...171,573,068 		JBrowse link
G Arl4d ARF like GTPase 4D multiple interactions EXP [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of ARL4D mRNA; ARL4D protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr10:87,092,276...87,103,079
Ensembl chr10:87,077,523...87,106,199 		JBrowse link
G Arl5b ARF like GTPase 5B increases expression ISO Glucose results in increased expression of ARL5B mRNA CTD PMID:17178593 NCBI chr17:82,864,315...82,888,458
Ensembl chr17:82,864,287...82,890,646 		JBrowse link
G Arl5c ARF like GTPase 5C multiple interactions
increases expression 		ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of ARL5C mRNA
Glucose results in increased expression of ARL5C mRNA 		CTD PMID:37567420 PMID:39922521 NCBI chr10:83,481,540...83,492,915
Ensembl chr10:83,481,540...83,488,406 		JBrowse link
G Arl9 ARF like GTPase 9 increases expression ISO Glucose results in increased expression of ARL9 mRNA CTD PMID:39922521 NCBI chr14:31,511,845...31,521,038
Ensembl chr14:31,511,330...31,520,988 		JBrowse link
G Armcx6 armadillo repeat containing, X-linked 6 multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of ARMCX6 mRNA] CTD PMID:33448797 NCBI chr  X:102,222,288...102,229,871
Ensembl chr  X:102,222,220...102,240,052 		JBrowse link
G Armt1 acidic residue methyltransferase 1 increases expression ISO Glucose results in increased expression of ARMT1 mRNA CTD PMID:39922521 NCBI chr 1:43,299,916...43,323,675
Ensembl chr 1:43,299,826...43,323,670 		JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator multiple interactions
increases activity 		ISO [Glucose co-treated with Deferoxamine] results in increased expression of ARNT mRNA; Glucose promotes the reaction [[ARNT protein binds to G6PC1 promoter] which results in increased expression of G6PC1 mRNA]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of ARNT mRNA]
[Glucose co-treated with Oxygen deficiency] inhibits the reaction [ARNT protein binds to HIF1A protein]
Glucose results in increased activity of ARNT protein 		CTD PMID:15767253 PMID:18227068 PMID:33962019 NCBI chr 2:185,686,703...185,745,546
Ensembl chr 2:185,680,683...185,745,546 		JBrowse link
G Arsj arylsulfatase family, member J multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of ARSJ mRNA CTD PMID:37567420 NCBI chr 2:217,449,147...217,529,142
Ensembl chr 2:217,449,147...217,529,142 		JBrowse link
G Ascl1 achaete-scute family bHLH transcription factor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ASCL1 mRNA CTD PMID:37567420 NCBI chr 7:23,790,642...23,793,509
Ensembl chr 7:23,790,360...23,798,231 		JBrowse link
G Asic3 acid sensing ion channel subunit 3 increases expression ISO Glucose results in increased expression of ASIC3 mRNA CTD PMID:39922521 NCBI chr 4:11,652,946...11,657,415
Ensembl chr 4:11,652,946...11,657,367 		JBrowse link
G Asip agouti signaling protein multiple interactions
affects response to substance 		ISO [[imeglimin co-treated with Sitagliptin Phosphate] affects the reaction [A mutant form affects the susceptibility to Glucose]] which affects the expression of GCG protein; [[imeglimin co-treated with Sitagliptin Phosphate] affects the reaction [A mutant form affects the susceptibility to Glucose]] which affects the expression of INS1 protein; [imeglimin affects the reaction [A mutant form affects the susceptibility to Glucose]] which affects the expression of GCG protein; [imeglimin affects the reaction [A mutant form affects the susceptibility to Glucose]] which affects the expression of GIP protein; [imeglimin affects the reaction [A mutant form affects the susceptibility to Glucose]] which affects the expression of INS1 protein; [Sitagliptin Phosphate co-treated with imeglimin] affects the reaction [A mutant form affects the susceptibility to Glucose]; imeglimin affects the reaction [A mutant form affects the susceptibility to Glucose] CTD PMID:36977210 NCBI chr 3:163,933,768...164,021,377
Ensembl chr 3:164,015,903...164,021,378 		JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) affects expression ISO Glucose affects the expression of ASNS mRNA CTD PMID:17409444 NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050 		JBrowse link
G Aspg asparaginase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ASPG mRNA CTD PMID:37567420 NCBI chr 6:136,997,832...137,017,417
Ensembl chr 6:136,998,023...137,017,417 		JBrowse link
G Aspn asporin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of ASPN mRNA CTD PMID:37567420 NCBI chr17:15,286,338...15,310,567
Ensembl chr17:15,287,065...15,310,632 		JBrowse link
G Atad1 ATPase family, AAA domain containing 1 multiple interactions EXP ATAD1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 1:239,957,329...240,023,792
Ensembl chr 1:239,957,882...240,009,822 		JBrowse link
G Atf3 activating transcription factor 3 multiple interactions
increases expression 		ISO [imeglimin co-treated with Glucose] results in increased expression of ATF3 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ATF3 mRNA
Glucose results in increased expression of ATF3 mRNA
[imeglimin co-treated with Glucose] promotes the reaction [Thapsigargin results in increased expression of ATF3 mRNA] 		CTD PMID:34588186 PMID:37567420 PMID:39613055 NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750 		JBrowse link
G Atf4 activating transcription factor 4 increases expression
increases response to substance
multiple interactions 		ISO
EXP 		Glucose deficiency results in increased expression of ATF4 mRNA
ATF4 protein results in increased susceptibility to Glucose
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of ATF4 protein]
Glucose deficiency results in increased expression of ATF4 protein; Glucose results in increased expression of ATF4 protein
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in increased expression of ATF4 protein]]; 4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of ATF4 protein]; [Galactose co-treated with Glucose deficiency] promotes the reaction [Leflunomide results in increased expression of ATF4 protein]; [imeglimin co-treated with Glucose] promotes the reaction [Thapsigargin results in increased expression of ATF4 mRNA]; Acetylcysteine inhibits the reaction [Glucose results in increased expression of ATF4 protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in increased expression of ATF4 protein]; ginsenoside Rg3 promotes the reaction [Acetylcysteine inhibits the reaction [Glucose results in increased expression of ATF4 protein]]; salubrinal inhibits the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of ATF4 protein]] 		CTD PMID:27226639 PMID:27278863 PMID:29427785 PMID:31022492 PMID:34588186 More... NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739 		JBrowse link
G Atf6 activating transcription factor 6 increases expression
multiple interactions 		ISO
EXP 		Glucose deficiency results in increased expression of ATF6 protein; Glucose results in increased expression of ATF6 mRNA; Glucose results in increased expression of ATF6 protein
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of ATF6 protein]; Glucose results in increased expression of and affects the localization of ATF6 protein; Metformin inhibits the reaction [Glucose results in increased expression of and affects the localization of ATF6 protein]
4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of ATF6 protein]; ATF6 protein modified form promotes the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 mRNA]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 protein]]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 mRNA]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 protein] 		CTD PMID:31022492 PMID:34801538 PMID:39798073 NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033 		JBrowse link
G Atg10 autophagy related 10 increases expression
multiple interactions 		ISO Glucose results in increased expression of ATG10 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of ATG10 mRNA] 		CTD PMID:33448797 NCBI chr 2:23,843,695...24,133,459
Ensembl chr 2:23,844,482...24,133,368 		JBrowse link
G Atg3 autophagy related 3 increases expression
multiple interactions
decreases expression 		EXP Glucose results in increased expression of ATG3 mRNA
Berberine inhibits the reaction [Glucose results in decreased expression of ATG3 protein] 		CTD PMID:38444079 PMID:39127087 NCBI chr11:69,130,948...69,159,280
Ensembl chr11:69,121,952...69,159,280 		JBrowse link
G Atg5 autophagy related 5 multiple interactions
increases expression
decreases expression 		EXP 3-methyladenine inhibits the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of ATG5 protein]]; [Glucose co-treated with Lycopene] results in increased expression of ATG5 mRNA; Berberine inhibits the reaction [Glucose results in decreased expression of ATG5 protein]; N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of ATG5 protein]; Sirolimus promotes the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of ATG5 protein]]; SRT1720 inhibits the reaction [Glucose results in decreased expression of ATG5 protein]; ULK1 protein affects the reaction [Glucose results in decreased expression of ATG5 protein]; ULK1 protein affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of ATG5 protein]]
Glucose results in increased expression of ATG5 mRNA 		CTD PMID:29128638 PMID:38444079 PMID:39127087 NCBI chr20:49,380,835...49,471,826
Ensembl chr20:49,380,813...49,471,821 		JBrowse link
G Atg7 autophagy related 7 multiple interactions
decreases expression 		EXP Berberine inhibits the reaction [Glucose results in decreased expression of ATG7 protein]; Inositol inhibits the reaction [Glucose results in decreased expression of ATG7 protein]; SRT1720 inhibits the reaction [Glucose results in decreased expression of ATG7 protein] CTD PMID:35243728 PMID:39127087 NCBI chr 4:149,390,000...149,597,534
Ensembl chr 4:149,391,390...149,598,319 		JBrowse link
G Atl1 atlastin GTPase 1 multiple interactions EXP ATL1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 6:94,113,149...94,210,955
Ensembl chr 6:94,112,877...94,211,219 		JBrowse link
G Atoh8 atonal bHLH transcription factor 8 decreases expression ISO Glucose results in decreased expression of ATOH8 mRNA CTD PMID:39613055 NCBI chr 4:105,818,203...105,850,379
Ensembl chr 4:105,818,203...105,850,379 		JBrowse link
G Atox1 antioxidant 1 copper chaperone increases expression ISO Glucose results in increased expression of ATOX1 mRNA CTD PMID:32942007 NCBI chr10:40,065,525...40,080,627
Ensembl chr10:40,065,527...40,080,585 		JBrowse link
G Atp1a1 ATPase Na+/K+ transporting subunit alpha 1 multiple interactions ISO
EXP 		Glucose results in decreased expression of and results in decreased activity of ATP1A1 protein; INS protein inhibits the reaction [Glucose results in decreased expression of ATP1A1 protein]
[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of and affects the localization of ATP1A1 protein; Antigen-Antibody Complex inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of and affects the localization of ATP1A1 protein] 		CTD PMID:22162761 PMID:29702141 NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:191,709,311...191,737,425 		JBrowse link
G Atp2a1 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of ATP2A1 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of ATP2A1 mRNA] 		CTD PMID:31525975 PMID:33448797 NCBI chr 1:190,457,198...190,475,410
Ensembl chr 1:190,457,198...190,475,423 		JBrowse link
G Atp5f1a ATP synthase F1 subunit alpha multiple interactions EXP [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of ATP5F1A protein CTD PMID:25997894 NCBI chr18:73,567,537...73,575,473
Ensembl chr18:73,567,526...73,575,922 		JBrowse link
G Atp5f1d ATP synthase F1 subunit delta multiple interactions EXP 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid inhibits the reaction [notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of ATP5F1D protein]]; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of ATP5F1D protein; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of ATP5F1D protein]; Y 27632 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of ATP5F1D protein] CTD PMID:25305180 NCBI chr 7:10,211,260...10,218,989
Ensembl chr 7:10,211,262...10,216,583 		JBrowse link
G Atp6ap2 ATPase H+ transporting accessory protein 2 increases expression
multiple interactions 		EXP Glucose results in increased expression of ATP6AP2 mRNA; Glucose results in increased expression of ATP6AP2 protein
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Glucose results in increased expression of ATP6AP2 mRNA]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Glucose results in increased expression of ATP6AP2 protein] 		CTD PMID:19861503 NCBI chr  X:12,856,708...12,883,670
Ensembl chr  X:12,855,859...12,905,875 		JBrowse link
G Atp7b ATPase copper transporting beta increases expression ISO Glucose results in increased expression of ATP7B mRNA CTD PMID:39922521 NCBI chr16:76,654,725...76,726,092
Ensembl chr16:76,653,660...76,728,801 		JBrowse link
G Aurka aurora kinase A increases expression ISO Glucose results in increased expression of AURKA mRNA CTD PMID:17178593 NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:181,546,742...181,562,771 		JBrowse link
G Azgp1 alpha-2-glycoprotein 1, zinc-binding affects secretion ISO Glucose deficiency affects the secretion of AZGP1 protein CTD PMID:24802182 NCBI chr12:22,044,685...22,051,248
Ensembl chr12:22,044,751...22,053,020 		JBrowse link
G B2m beta-2 microglobulin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of B2M mRNA CTD PMID:37567420 NCBI chr 3:129,549,236...129,555,354
Ensembl chr 3:129,549,318...129,555,356 		JBrowse link
G B3gat3 beta-1,3-glucuronyltransferase 3 increases expression
multiple interactions 		EXP Glucose results in increased expression of B3GAT3 mRNA
[XDH protein co-treated with Hypoxanthine] inhibits the reaction [Glucose results in increased expression of B3GAT3 mRNA]; IL1B protein inhibits the reaction [Glucose results in increased expression of B3GAT3 mRNA] 		CTD PMID:11801247 NCBI chr 1:215,246,453...215,253,033
Ensembl chr 1:215,246,482...215,266,876 		JBrowse link
G B3gnt6 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 multiple interactions
increases expression 		ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of B3GNT6 mRNA
Glucose results in increased expression of B3GNT6 mRNA 		CTD PMID:37567420 PMID:39922521 NCBI chr 1:161,897,504...161,915,046
Ensembl chr 1:161,898,323...161,903,354 		JBrowse link
G B4galnt4 beta-1,4-N-acetyl-galactosaminyl transferase 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of B4GALNT4 mRNA CTD PMID:37567420 NCBI chr 1:205,600,989...205,611,889
Ensembl chr 1:205,600,989...205,611,889 		JBrowse link
G Baat bile acid CoA:amino acid N-acyltransferase increases expression ISO Glucose results in increased expression of BAAT mRNA CTD PMID:39922521 NCBI chr 5:68,647,166...68,656,137
Ensembl chr 5:68,646,203...68,656,181 		JBrowse link
G Bad BCL2-associated agonist of cell death multiple interactions
increases expression 		ISO
EXP 		[resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of BAD protein]; Glucose results in decreased phosphorylation of and results in decreased activity of BAD protein
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAD protein
Glucose results in increased expression of BAD mRNA 		CTD PMID:17293559 PMID:20370652 PMID:38444079 NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034 		JBrowse link
G Bak1 BCL2-antagonist/killer 1 multiple interactions
increases expression 		EXP
ISO 		[[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Carvedilol] which results in decreased expression of BAK1 mRNA
Glucose results in increased expression of BAK1 mRNA
[Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA] 		CTD PMID:29122578 PMID:33962019 PMID:38444079 NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,102,335...5,110,974 		JBrowse link
G Bambi BMP and activin membrane-bound inhibitor multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of BAMBI mRNA] CTD PMID:33448797 NCBI chr17:58,816,438...58,821,003
Ensembl chr17:58,816,442...58,821,247 		JBrowse link
G Barx2 BARX homeobox 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of BARX2 mRNA CTD PMID:37567420 NCBI chr 8:38,509,277...38,576,978
Ensembl chr 8:38,509,277...38,576,978 		JBrowse link
G Batf2 basic leucine zipper ATF-like transcription factor 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of BATF2 mRNA CTD PMID:37567420 NCBI chr 1:212,897,076...212,905,740
Ensembl chr 1:212,875,148...212,905,831 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression
affects expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of BAX mRNA; Glucose results in increased expression of BAX protein
Glucose affects the expression of BAX protein
3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Glucose results in increased expression of BAX protein]; [Dithionite co-treated with Glucose deficiency] results in increased expression of BAX protein; [morroniside co-treated with Diosgenin] inhibits the reaction [Glucose results in increased expression of BAX protein]; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased expression of BAX protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein; Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of BAX protein]]; cinnamic acid inhibits the reaction [Glucose results in increased expression of BAX protein]; Diosgenin inhibits the reaction [Glucose results in increased expression of BAX protein]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of BAX protein]]; gastrodin inhibits the reaction [Glucose results in increased expression of BAX protein]; Metformin inhibits the reaction [Glucose results in increased expression of BAX protein]; morroniside inhibits the reaction [Glucose results in increased expression of BAX protein]; naringenin inhibits the reaction [Glucose results in increased expression of BAX mRNA]; naringenin inhibits the reaction [Glucose results in increased expression of BAX protein]; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased expression of BAX protein]; protosappanin A inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; Quercetin affects the reaction [Glucose affects the expression of BAX protein]; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in increased expression of BAX protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of BAX protein]; Scopoletin inhibits the reaction [Glucose results in increased expression of BAX protein]; sesamin affects the reaction [Glucose affects the expression of BAX protein]; STIM1 protein affects the reaction [Glucose results in increased expression of BAX protein]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX mRNA]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX mRNA]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; 8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one promotes the reaction [[Glucose co-treated with Bupivacaine] results in increased expression of BAX protein]; [Glucose co-treated with Bupivacaine] results in increased expression of BAX protein; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX mRNA; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein modified form; atractylenolide III inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of BAX protein]; Edaravone inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; gastrodin inhibits the reaction [Glucose results in increased expression of BAX protein]; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX mRNA]]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX mRNA]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; Valsartan inhibits the reaction [Glucose results in increased expression of BAX protein]
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in increased expression of BAX protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in increased expression of BAX protein]]; [Carnosine co-treated with asiatic acid] inhibits the reaction [Glucose results in increased expression of BAX mRNA]; [Glucose co-treated with Deferoxamine] results in increased expression of BAX mRNA; [Glucose co-treated with Deferoxamine] results in increased expression of BAX protein; asiatic acid inhibits the reaction [Glucose results in increased expression of BAX mRNA]; Carnosine inhibits the reaction [Glucose results in increased expression of BAX mRNA]; DDIT3 protein inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of BAX protein]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of BAX protein]]; diallyl trisulfide inhibits the reaction [Glucose results in increased expression of BAX protein]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of BAX protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in increased expression of BAX protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BAX mRNA]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BAX protein]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of BAX protein]]; MIR142 inhibits the reaction [Glucose results in increased expression of BAX protein]; MitoTEMPO inhibits the reaction [Glucose results in increased expression of BAX protein]; NDRG2 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; polyethylene glycol loxenatide inhibits the reaction [Glucose results in increased expression of BAX protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of BAX protein]; salvianolic acid inhibits the reaction [Glucose results in increased expression of BAX protein]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased expression of BAX protein]]; spiraeoside inhibits the reaction [Glucose results in increased expression of BAX protein]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of BAX protein] 		CTD PMID:21803128 PMID:22524206 PMID:23192364 PMID:23451161 PMID:24218232 More... NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Bbc3 Bcl-2 binding component 3 multiple interactions ISO [Glucose co-treated with Deferoxamine] results in increased expression of BBC3 mRNA; [Palmitic Acid co-treated with Glucose] results in increased expression of BBC3 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BBC3 mRNA]; SIRT1 protein mutant form inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased expression of BBC3 mRNA]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BBC3 protein modified form; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BBC3 protein] 		CTD PMID:24451382 PMID:28675767 PMID:33962019 NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:86,141,603...86,150,666 		JBrowse link
G Bcan brevican increases expression ISO Glucose results in increased expression of BCAN mRNA CTD PMID:39922521 NCBI chr 2:175,752,333...175,765,766
Ensembl chr 2:175,752,336...175,765,314 		JBrowse link
G Bche butyrylcholinesterase multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of BCHE mRNA] CTD PMID:33448797 NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760 		JBrowse link
G Bcl11a BCL11 transcription factor A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of BCL11A mRNA CTD PMID:37567420 NCBI chr14:102,230,147...102,325,289
Ensembl chr14:102,231,113...102,325,623 		JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression
multiple interactions
affects expression 		ISO
EXP 		Glucose results in decreased expression of BCL2 mRNA; Glucose results in decreased expression of BCL2 protein
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 mRNA]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 mRNA]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; 8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one promotes the reaction [[Glucose co-treated with Bupivacaine] results in decreased expression of BCL2 protein]; [Glucose co-treated with Bupivacaine] results in decreased expression of BCL2 protein; [Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 mRNA; [Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA; atractylenolide III inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]]; gastrodin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 mRNA]]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 mRNA]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; linderalactone inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; MIR210 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 mRNA]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]; U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; [Glucose co-treated with Deferoxamine] results in decreased expression of BCL2 mRNA; [Glucose co-treated with Deferoxamine] results in decreased expression of BCL2 protein; [Resveratrol co-treated with Glucose] results in increased expression of BCL2 protein; asiatic acid inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]; asiatic acid promotes the reaction [Carnosine inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]]; Berberine inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Carnosine inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]; Carnosine promotes the reaction [asiatic acid inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]]; Catechin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]; DDIT3 protein inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; diallyl trisulfide inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; epigallocatechin gallate inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]; ginsenoside Re inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Gliclazide inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]; Glucose results in increased degradation of and results in decreased expression of BCL2 protein; Luteolin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in decreased expression of BCL2 mRNA]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in decreased expression of BCL2 protein]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in decreased expression of BCL2 protein]]; MIR142 inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; MitoTEMPO inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; NS 1619 inhibits the reaction [Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]]; polyethylene glycol loxenatide inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Quercetin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]; Rutin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]; salvianolic acid inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; spiraeoside inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Tamoxifen inhibits the reaction [Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]]; TAOK1 mRNA alternative form affects the reaction [Glucose results in decreased expression of BCL2 protein]
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid inhibits the reaction [notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of BCL2 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]; 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; [Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein; [Glucose co-treated with Lycopene] results in increased expression of BCL2 mRNA; [Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of BCL2 protein]; [morroniside co-treated with Diosgenin] inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of BCL2 protein; [Oxygen deficiency co-treated with Glucose deficiency] affects the expression of BCL2 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein; Chlorogenic Acid inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; cinnamic acid inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Diosgenin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; gastrodin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Metformin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; morroniside inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; naringenin inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]; naringenin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of BCL2 protein]; Quercetin affects the reaction [Glucose affects the expression of BCL2 protein]; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Scopoletin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; sesamin affects the reaction [Glucose affects the expression of BCL2 protein]; STIM1 protein affects the reaction [Glucose results in decreased expression of BCL2 protein]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]
Glucose affects the expression of BCL2 mRNA; Glucose affects the expression of BCL2 protein 		CTD PMID:18088078 PMID:19557821 PMID:21413024 PMID:21803128 PMID:21818840 More... NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Bcl2l1 Bcl2-like 1 multiple interactions EXP BCL2L1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907
Ensembl chr 1:161,745,540...161,764,907 		JBrowse link
G Bcl2l11 Bcl2-like 11 multiple interactions
increases expression 		EXP 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein]]; resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein] CTD PMID:25471227 NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:135,817,562...135,960,695 		JBrowse link
G Bcl2l15 Bcl2-like 15 multiple interactions ISO [Glucose co-treated with Deferoxamine] results in increased expression of BCL2L15 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BCL2L15 mRNA] CTD PMID:33962019 NCBI chr 2:194,019,158...194,032,516
Ensembl chr 2:194,027,397...194,032,516 		JBrowse link
G Bcl3 BCL3, transcription coactivator decreases expression ISO Glucose results in decreased expression of BCL3 mRNA CTD PMID:39613055 NCBI chr 1:88,599,321...88,613,555
Ensembl chr 1:88,599,321...88,614,368 		JBrowse link
G Bco1 beta-carotene oxygenase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of BCO1 mRNA CTD PMID:37567420 NCBI chr19:62,058,061...62,094,923
Ensembl chr19:62,058,089...62,094,917 		JBrowse link
G Bdkrb1 bradykinin receptor B1 increases expression
multiple interactions 		EXP Glucose results in increased expression of BDKRB1 protein
argan oil inhibits the reaction [Glucose results in increased expression of BDKRB1 protein]; Corn Oil inhibits the reaction [Glucose results in increased expression of BDKRB1 protein] 		CTD PMID:29165388 NCBI chr 6:130,275,631...130,284,968
Ensembl chr 6:130,275,478...130,280,973 		JBrowse link
G Becn1 beclin 1 multiple interactions
increases expression
decreases expression 		EXP
ISO 		[Glucose co-treated with Lycopene] results in increased expression of BECN1 mRNA; [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in decreased expression of BECN1 protein]; [Resveratrol co-treated with Glucose] results in increased expression of BECN1 protein; Inositol inhibits the reaction [Glucose results in decreased expression of BECN1 protein]; SRT1720 inhibits the reaction [Glucose results in decreased expression of BECN1 protein]
Glucose results in increased expression of BECN1 mRNA
Glucose results in increased expression of BECN1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in increased expression of BECN1 protein]]; Calcitriol inhibits the reaction [Glucose results in increased expression of BECN1 protein]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in increased expression of BECN1 protein]]; HU 308 inhibits the reaction [Glucose results in decreased expression of BECN1 protein] 		CTD PMID:25997894 PMID:28713934 PMID:30459625 PMID:33450223 PMID:35243728 More... NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002 		JBrowse link
G Begain brain-enriched guanylate kinase-associated multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of BEGAIN mRNA CTD PMID:37567420 NCBI chr 6:133,708,010...133,744,264
Ensembl chr 6:133,708,007...133,744,526 		JBrowse link
G Bglap bone gamma-carboxyglutamate protein multiple interactions
decreases expression 		ISO
EXP 		2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP protein]]; Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP mRNA]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP mRNA]]; Sirolimus inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP mRNA]]
Glucose results in decreased expression of BGLAP mRNA; Glucose results in decreased expression of BGLAP protein
morroniside inhibits the reaction [Glucose results in decreased expression of BGLAP mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of BGLAP protein] 		CTD PMID:32643284 PMID:33450223 NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:176,136,341...176,137,318 		JBrowse link
G Bhlha15 basic helix-loop-helix family, member a15 affects expression ISO Glucose affects the expression of BHLHA15 mRNA CTD PMID:39613055 NCBI chr12:15,534,123...15,538,299
Ensembl chr12:15,534,123...15,538,515 		JBrowse link
G Bhmt betaine-homocysteine S-methyltransferase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of BHMT mRNA CTD PMID:37567420 NCBI chr 2:26,594,852...26,614,429
Ensembl chr 2:26,594,854...26,614,715 		JBrowse link
G Bid BH3 interacting domain death agonist multiple interactions ISO [Glucose co-treated with Deferoxamine] results in increased expression of BID mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BID mRNA] CTD PMID:33962019 NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275 		JBrowse link
G Bmp2 bone morphogenetic protein 2 decreases expression
multiple interactions 		ISO
EXP 		Glucose results in decreased expression of BMP2 mRNA
cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of BMP2 mRNA]; tin mesoporphyrin promotes the reaction [Glucose results in decreased expression of BMP2 mRNA]
morroniside inhibits the reaction [Glucose results in decreased expression of BMP2 mRNA] 		CTD PMID:19924377 PMID:32643284 NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:141,264,646...141,274,760 		JBrowse link
G Bmper BMP-binding endothelial regulator multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of BMPER mRNA CTD PMID:37567420 NCBI chr 8:30,008,049...30,253,201
Ensembl chr 8:30,008,148...30,434,359 		JBrowse link
G Bnip3 BCL2 interacting protein 3 multiple interactions
decreases expression 		ISO
EXP 		[Glucose co-treated with Deferoxamine] results in increased expression of BNIP3 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BNIP3 mRNA]
Berberine inhibits the reaction [Glucose results in decreased expression of BNIP3 protein]; SRT1720 inhibits the reaction [Glucose results in decreased expression of BNIP3 protein] 		CTD PMID:33962019 PMID:39127087 NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962 		JBrowse link
G Bnip3l BCL2 interacting protein 3 like multiple interactions
decreases expression 		ISO
EXP 		[Glucose co-treated with Deferoxamine] results in increased expression of BNIP3L mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BNIP3L mRNA]
Glucose results in decreased expression of BNIP3L protein
Inositol inhibits the reaction [Glucose results in decreased expression of BNIP3L protein] 		CTD PMID:33962019 PMID:35243728 NCBI chr15:45,350,081...45,373,213
Ensembl chr15:45,334,537...45,373,282 		JBrowse link
G Bop1 BOP1 ribosomal biogenesis factor increases expression ISO Glucose results in increased expression of BOP1 mRNA CTD PMID:39613055 NCBI chr 7:110,052,716...110,076,529
Ensembl chr 7:110,052,720...110,076,529 		JBrowse link
G Bspry B-box and SPRY domain containing increases expression ISO Glucose results in increased expression of BSPRY mRNA CTD PMID:39922521 NCBI chr 5:80,942,974...80,965,157
Ensembl chr 5:80,942,979...80,988,154 		JBrowse link
G Bst2 bone marrow stromal cell antigen 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of BST2 mRNA CTD PMID:37567420 NCBI chr16:18,250,593...18,254,967
Ensembl chr16:18,251,847...18,254,967 		JBrowse link
G Btbd17 BTB domain containing 17 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of BTBD17 mRNA CTD PMID:37567420 NCBI chr10:100,325,177...100,331,669
Ensembl chr10:100,325,177...100,331,771 		JBrowse link
G Btn1a1 butyrophilin, subfamily 1, member A1 increases expression ISO Glucose results in increased expression of BTN1A1 mRNA CTD PMID:39922521 NCBI chr17:42,080,217...42,092,286
Ensembl chr17:42,081,527...42,092,276 		JBrowse link
G C1qtnf3 C1q and TNF related 3 decreases expression ISO Glucose results in decreased expression of C1QTNF3 mRNA CTD PMID:31525975 NCBI chr 2:61,644,225...61,666,640
Ensembl chr 2:61,644,276...61,666,559 		JBrowse link
G C1r complement C1r decreases secretion ISO Glucose deficiency results in decreased secretion of C1R protein CTD PMID:24802182 NCBI chr 4:159,099,013...159,109,770
Ensembl chr 4:159,098,918...159,109,714 		JBrowse link
G C1s complement C1s affects secretion ISO Glucose deficiency affects the secretion of C1S protein CTD PMID:24802182 NCBI chr 4:159,116,549...159,128,736
Ensembl chr 4:159,116,549...159,128,736 		JBrowse link
G C3 complement C3 increases expression
multiple interactions 		ISO Glucose results in increased expression of C3 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of C3 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of C3 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of C3 mRNA 		CTD PMID:17178593 PMID:23199288 PMID:37567420 NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339 		JBrowse link
G C4b complement C4B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of C4B mRNA CTD PMID:37567420 NCBI chr20:4,201,979...4,216,292
Ensembl chr20:4,201,961...4,216,289 		JBrowse link
G C5 complement C5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of HC mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of HC mRNA CTD PMID:37567420 NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:38,668,174...38,759,468 		JBrowse link
G C5ar1 complement C5a receptor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of C5AR1 mRNA CTD PMID:37567420 NCBI chr 1:86,077,309...86,088,001 JBrowse link
G Ca14 carbonic anhydrase 14 increases expression ISO Glucose results in increased expression of CAR14 mRNA CTD PMID:39922521 NCBI chr 2:186,131,196...186,138,164
Ensembl chr 2:186,129,341...186,138,863 		JBrowse link
G Ca3 carbonic anhydrase 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CAR3 mRNA CTD PMID:37567420 NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:88,491,670...88,500,524 		JBrowse link
G Cabp4 calcium binding protein 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of CABP4 mRNA CTD PMID:37567420 NCBI chr 1:210,857,223...210,872,431
Ensembl chr 1:210,858,133...210,862,632 		JBrowse link
G Cacna1s calcium voltage-gated channel subunit alpha1 S multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CACNA1S mRNA CTD PMID:37567420 NCBI chr13:50,045,668...50,115,903
Ensembl chr13:50,045,668...50,115,903 		JBrowse link
G Calca calcitonin-related polypeptide alpha increases expression
multiple interactions 		ISO Glucose results in increased expression of CALCA mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CALCA mRNA 		CTD PMID:31655124 PMID:37567420 NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529 		JBrowse link
G Calm2 calmodulin 2 multiple interactions EXP CALM2 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 6:12,845,170...12,857,830
Ensembl chr15:64,519,554...64,520,657
Ensembl chr 6:64,519,554...64,520,657 		JBrowse link
G Calr calreticulin decreases expression ISO Glucose results in decreased expression of CALR mRNA CTD PMID:17178593 NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236 		JBrowse link
G Calu calumenin decreases secretion ISO Glucose deficiency results in decreased secretion of CALU protein CTD PMID:24802182 NCBI chr 4:58,914,456...58,941,957
Ensembl chr 4:58,914,421...58,941,956 		JBrowse link
G Caly calcyon neuron-specific vesicular protein multiple interactions EXP CALY protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 1:204,292,317...204,303,506
Ensembl chr 1:204,292,318...204,303,196 		JBrowse link
G Canx calnexin decreases expression
multiple interactions
increases expression 		ISO
EXP 		Glucose results in decreased expression of CANX mRNA
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of CANX protein] 		CTD PMID:17178593 PMID:34801538 NCBI chr10:35,124,941...35,157,954
Ensembl chr10:35,124,941...35,157,857 		JBrowse link
G Capn1 calpain 1 multiple interactions
increases expression 		EXP
ISO 		2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside inhibits the reaction [[Oxygen co-treated with Glucose deficiency] results in increased expression of CAPN1 protein]; [Oxygen co-treated with Glucose deficiency] results in increased expression of CAPN1 protein
Furans analog inhibits the reaction [Glucose results in increased expression of CAPN1 protein] 		CTD PMID:24726522 PMID:28911973 NCBI chr 1:212,705,219...212,736,134
Ensembl chr 1:212,705,222...212,729,445 		JBrowse link
G Card14 caspase recruitment domain family, member 14 increases expression ISO Glucose results in increased expression of CARD14 mRNA CTD PMID:39922521 NCBI chr10:105,064,941...105,100,132
Ensembl chr10:105,064,941...105,100,132 		JBrowse link
G Casp1 caspase 1 multiple interactions
increases cleavage
increases expression
increases activity 		ISO
EXP 		Acetylcysteine inhibits the reaction [Glucose results in increased cleavage of CASP1 protein]; FOXO3 protein promotes the reaction [Glucose results in increased cleavage of and results in increased activity of CASP1 protein]; Glucose results in increased cleavage of and results in increased activity of CASP1 protein; Glucose results in increased expression of and results in increased cleavage of CASP1 protein
Glucose results in increased expression of CASP1 mRNA
Glucose results in increased expression of CASP1 protein
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP1 protein modified form; Allopurinol inhibits the reaction [Glucose results in increased expression of CASP1 protein]; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP1 protein modified form]; L 709049 analog inhibits the reaction [Glucose results in increased expression of CASP1 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of CASP1 protein]; rhodioloside inhibits the reaction [Glucose results in increased expression of CASP1 protein]; Suramin inhibits the reaction [Glucose results in increased activity of CASP1 protein]; TXNIP mRNA promotes the reaction [Glucose results in increased expression of CASP1 protein]
[Glucose co-treated with TGFB1 protein] results in increased cleavage of CASP1 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP1 protein; Allopurinol inhibits the reaction [Glucose results in increased expression of CASP1 protein]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased cleavage of CASP1 protein]; bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP1 protein]; Glucose results in increased expression of and results in increased cleavage of CASP1 protein; HAGLR protein affects the reaction [Glucose results in increased expression of and results in increased cleavage of CASP1 protein]; HAGLR protein promotes the reaction [Glucose results in increased expression of and results in increased cleavage of CASP1 protein]; L 709049 analog inhibits the reaction [Glucose results in increased expression of CASP1 protein]; Lipopolysaccharides inhibits the reaction [swietenine inhibits the reaction [Glucose results in increased expression of CASP1 protein]]; Lipopolysaccharides promotes the reaction [Glucose results in increased expression of CASP1 protein]; loganin inhibits the reaction [Glucose results in increased expression of CASP1 mRNA]; loganin inhibits the reaction [Glucose results in increased expression of CASP1 protein]; MIR200C mRNA affects the reaction [Glucose results in increased cleavage of CASP1 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Glucose results in increased expression of CASP1 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide promotes the reaction [swietenine inhibits the reaction [Glucose results in increased expression of CASP1 protein]]; PTEN protein affects the reaction [HAGLR protein affects the reaction [Glucose results in increased expression of and results in increased cleavage of CASP1 protein]]; Quercetin inhibits the reaction [Glucose results in increased expression of CASP1 protein]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased cleavage of CASP1 protein]]; swietenine inhibits the reaction [Glucose results in increased expression of CASP1 protein]; TXNIP mRNA promotes the reaction [Glucose results in increased expression of CASP1 protein]
Glucose results in increased expression of CASP1 mRNA; Glucose results in increased expression of CASP1 protein
Glucose results in increased activity of CASP1 mRNA; Glucose results in increased activity of CASP1 protein 		CTD PMID:20370652 PMID:21832250 PMID:23647015 PMID:27783111 PMID:29031534 More... NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275 		JBrowse link
G Casp12 caspase 12 multiple interactions
increases cleavage
increases expression 		ISO
EXP 		TRPM7 protein affects the reaction [Glucose results in increased cleavage of CASP12 protein]; waixenicin A inhibits the reaction [Glucose results in increased cleavage of CASP12 protein]
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in increased cleavage of CASP12 protein]]; Acetylcysteine inhibits the reaction [Glucose results in increased cleavage of CASP12 protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in increased cleavage of CASP12 protein]; ginsenoside Rg3 promotes the reaction [Acetylcysteine inhibits the reaction [Glucose results in increased cleavage of CASP12 protein]]
Glucose results in increased expression of CASP12 protein
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of CASP12 protein] 		CTD PMID:30076216 PMID:34801538 PMID:39579577 NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:10,926,994...10,954,442 		JBrowse link
G Casp3 caspase 3 multiple interactions
decreases expression
increases cleavage
increases expression
increases activity 		ISO
EXP 		2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; [Carnosine co-treated with asiatic acid] inhibits the reaction [Glucose results in increased activity of CASP3 protein]; [Glucose co-treated with Deferoxamine] results in increased expression of CASP3 mRNA; [Glucose co-treated with Deferoxamine] results in increased expression of CASP3 protein; [Glucose co-treated with Deferoxamine] results in increased expression of CASP3 protein modified form; [Glucose deficiency co-treated with Acetylcysteine] results in increased activity of CASP3 protein; [Glucose deficiency co-treated with CAT] results in increased activity of CASP3 protein; [Glucose deficiency co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP3 protein; [Palmitic Acid co-treated with Glucose] results in increased cleavage of CASP3 protein; asiatic acid inhibits the reaction [Glucose results in increased activity of CASP3 protein]; Captopril inhibits the reaction [Glucose results in increased expression of CASP3 mRNA]; Carnosine inhibits the reaction [Glucose results in increased activity of CASP3 protein]; DDIT3 protein inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; diallyl trisulfide inhibits the reaction [Glucose results in increased activity of CASP3 protein]; Fluorometholone inhibits the reaction [Glucose results in increased activity of CASP3 protein]; ginsenoside Re inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Gliclazide inhibits the reaction [Glucose results in increased expression of CASP3 protein]; huai qi huang inhibits the reaction [Glucose results in increased expression of CASP3 mRNA]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of CASP3 protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CASP3 mRNA]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CASP3 protein modified form]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CASP3 protein]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased cleavage of CASP3 protein]]; MIR142 inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; MitoTEMPO inhibits the reaction [Glucose results in increased activity of CASP3 protein]; polyethylene glycol loxenatide inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Rosiglitazone inhibits the reaction [Glucose results in increased activity of CASP3 protein]; rutecarpine inhibits the reaction [Glucose results in increased activity of CASP3 protein]; salvianolic acid inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; SIRT1 protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased cleavage of CASP3 protein]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased cleavage of CASP3 protein]
Glucose results in decreased expression of CASP3 mRNA
Glucose results in increased expression of CASP3 mRNA; Glucose results in increased expression of CASP3 protein; Glucose results in increased expression of CASP3 protein modified form
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid inhibits the reaction [notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased cleavage of CASP3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [2-chloro-N(6)cyclopentyladenosine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [LY 379268 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; 2-chloro-N(6)cyclopentyladenosine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; [Dithionite co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein; [Glucose co-treated with Lycopene] results in increased expression of CASP3 mRNA; [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]; [morroniside co-treated with Diosgenin] inhibits the reaction [Glucose results in increased expression of and results in increased activity of CASP3 protein]; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased activity of CASP3 protein; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased cleavage of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] affects the expression of and affects the activity of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of and results in increased cleavage of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form; Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP3]; Antigen-Antibody Complex inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; Chlorogenic Acid inhibits the reaction [Glucose results in increased activity of CASP3 protein]; cinnamic acid inhibits the reaction [Glucose results in increased activity of CASP3 protein]; cobaltiprotoporphyrin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]; diallyl trisulfide inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Diosgenin inhibits the reaction [Glucose results in increased expression of and results in increased activity of CASP3 protein]; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]; gastrodin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Glucose results in increased expression of and results in increased activity of CASP3 protein; Glucose results in increased expression of and results in increased cleavage of CASP3 protein; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; HMOX1 protein promotes the reaction [diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; IGF2R protein modified form inhibits the reaction [Glucose results in increased expression of CASP3 protein modified form]; IGF2R protein modified form inhibits the reaction [Glucose results in increased expression of CASP3 protein]; KEAP1 protein inhibits the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; LY 379268 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; Metformin inhibits the reaction [Glucose results in increased activity of CASP3 protein]; Metformin inhibits the reaction [Glucose results in increased expression of and results in increased activity of CASP3 protein]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; morroniside inhibits the reaction [Glucose results in increased expression of and results in increased activity of CASP3 protein]; naringenin inhibits the reaction [Glucose results in increased activity of CASP3 protein]; naringenin inhibits the reaction [Glucose results in increased expression of and results in increased cleavage of CASP3 protein]; naringenin inhibits the reaction [Glucose results in increased expression of CASP3 mRNA]; NFE2L2 mutant form inhibits the reaction [diallyl trisulfide inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; NFE2L2 protein mutant form affects the reaction [plumbagin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; NFE2L2 protein promotes the reaction [diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; NFE2L2 protein promotes the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased activity of CASP3 protein]; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased cleavage of CASP3 protein]; plumbagin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; protosappanin A inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of and results in increased cleavage of CASP3 protein]; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in increased expression of CASP3 protein]; Quercetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein]; Quercetin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of CASP3 mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of CASP3 protein modified form]; Scopoletin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; sesamin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Simvastatin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; STIM1 protein affects the reaction [Glucose results in increased cleavage of CASP3 protein]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; U 0126 inhibits the reaction [2-chloro-N(6)cyclopentyladenosine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; U 0126 inhibits the reaction [LY 379268 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; WDR35 protein affects the reaction [Glucose results in increased activity of CASP3 protein]; Y 27632 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased cleavage of CASP3 protein]
Glucose results in increased activity of CASP3; Glucose results in increased activity of CASP3 protein
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CASP3 mRNA]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CASP3 mRNA]; [Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CASP3 mRNA; [Glucose deficiency co-treated with Simvastatin] results in increased cleavage of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein; atractylenolide III inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein]; Edaravone inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein]; FOXO3 protein promotes the reaction [Glucose results in increased cleavage of and results in increased activity of CASP3 protein]; gastrodin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Glucose deficiency inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein modified form]; Glucose results in increased cleavage of and results in increased activity of CASP3 protein; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]]; imeglimin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; INO 1001 inhibits the reaction [Glucose results in increased activity of CASP3 protein]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CASP3 mRNA]]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CASP3 mRNA]; linderalactone inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; MIR144 mRNA promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; MIR322 affects the reaction [Glucose results in increased cleavage of CASP3 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; TRAF3 affects the reaction [Glucose results in increased cleavage of CASP3 protein]; TRPM7 protein affects the reaction [Glucose results in increased cleavage of CASP3 protein]; U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein]; VDAC1 protein inhibits the reaction [Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; VDAC1 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; waixenicin A inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; zinc protoporphyrin inhibits the reaction [[Glucose deficiency co-treated with Simvastatin] results in increased cleavage of CASP3 protein] 		CTD PMID:15322300 PMID:16135072 PMID:17065336 PMID:17293559 PMID:17309078 More... NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Casp8 caspase 8 increases activity
increases expression
multiple interactions 		ISO
EXP 		Glucose results in increased activity of CASP8 protein
Glucose results in increased expression of CASP8 mRNA
[Glucose co-treated with Deferoxamine] results in increased expression of CASP8 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CASP8 mRNA]
[Glucose co-treated with Lycopene] results in increased expression of CASP8 mRNA; Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP8] 		CTD PMID:18791325 PMID:18973755 PMID:33962019 PMID:38444079 NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699 		JBrowse link
G Casp9 caspase 9 multiple interactions
increases cleavage
increases expression
increases activity 		ISO
EXP 		2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in increased cleavage of CASP9 protein]]; [Glucose deficiency co-treated with Acetylcysteine] results in increased activity of CASP9 protein; [Glucose deficiency co-treated with CAT] results in increased activity of CASP9 protein; [Glucose deficiency co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP9 protein; ginsenoside Rg3 inhibits the reaction [Glucose results in increased cleavage of CASP9 protein]; salvianolic acid inhibits the reaction [Glucose results in increased cleavage of CASP9 protein]
Glucose results in increased expression of CASP9 mRNA; Glucose results in increased expression of CASP9 protein
[Glucose co-treated with IGF2R protein modified form] results in increased expression of CASP9 protein; [Glucose co-treated with Lycopene] results in increased expression of CASP9 mRNA; [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of and results in increased cleavage of CASP9 protein; Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP9]; Glucose results in increased expression of and results in increased cleavage of CASP9 protein; naringenin inhibits the reaction [Glucose results in increased expression of and results in increased cleavage of CASP9 protein]; naringenin inhibits the reaction [Glucose results in increased expression of CASP9 mRNA]; protosappanin A inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of and results in increased cleavage of CASP9 protein]; Scopoletin inhibits the reaction [Glucose results in increased expression of CASP9 protein] 		CTD PMID:17309078 PMID:18791325 PMID:23192364 PMID:25997894 PMID:30431688 More... Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Casz1 castor zinc finger 1 increases expression
multiple interactions 		ISO Glucose results in increased expression of CASZ1 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of CASZ1 mRNA] 		CTD PMID:33448797 NCBI chr 5:164,527,083...164,677,037
Ensembl chr 5:164,527,112...164,677,014 		JBrowse link
G Cat catalase multiple interactions
decreases expression
decreases activity
increases activity
increases expression 		ISO
EXP 		2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in increased activity of CAT protein]]; [Glucose deficiency co-treated with CAT] affects the localization of ENDOG protein; [Glucose deficiency co-treated with CAT] results in increased activity of CASP3 protein; [Glucose deficiency co-treated with CAT] results in increased activity of CASP9 protein; [Glucose deficiency co-treated with CAT] results in increased cleavage of PARP1 protein; CAT inhibits the reaction [Glucose deficiency affects the folding of SOD2 protein]; CAT inhibits the reaction [Glucose deficiency results in increased activity of MAPK1 protein]; CAT inhibits the reaction [Glucose deficiency results in increased activity of MAPK14 protein]; CAT inhibits the reaction [Glucose deficiency results in increased activity of MAPK3 protein]; CAT inhibits the reaction [Glucose deficiency results in increased degradation of SOD1 protein]; CAT protein inhibits the reaction [Glucose promotes the reaction [EDN1 protein results in increased chemical synthesis of Inositol 1,4,5-Trisphosphate]]; cyclopamine inhibits the reaction [SHH protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]]; Furans analog inhibits the reaction [Glucose results in decreased activity of CAT protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in decreased expression of CAT protein]; SHH protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]; SIRT3 protein inhibits the reaction [Glucose results in increased expression of CAT protein]; solanesol inhibits the reaction [Glucose results in decreased activity of CAT protein]; spiraeoside inhibits the reaction [Glucose results in increased activity of CAT protein]
4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits the reaction [gastrodin inhibits the reaction [Glucose results in decreased activity of CAT protein]]; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein; cyclopamine inhibits the reaction [polydatin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]]; cyclopamine promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]; gastrodin inhibits the reaction [Glucose results in decreased activity of CAT protein]; NFE2L2 protein affects the reaction [gastrodin inhibits the reaction [Glucose results in decreased activity of CAT protein]]; polydatin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]
Glucose deficiency results in increased expression of CAT protein; Glucose results in increased expression of CAT protein
4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits the reaction [gastrodin inhibits the reaction [Glucose results in decreased activity of CAT protein]]; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in decreased activity of CAT protein; CAT protein inhibits the reaction [Glucose results in increased expression of AGT mRNA]; CAT protein inhibits the reaction [Glucose results in increased expression of AGT protein]; CAT protein inhibits the reaction [Glucose results in increased expression of GNA11 protein]; CAT protein inhibits the reaction [Glucose results in increased expression of GNAQ protein]; CAT protein inhibits the reaction [Glucose results in increased expression of PLCB1 protein]; CAT protein inhibits the reaction [Glucose results in increased expression of PLCB2 protein]; gastrodin inhibits the reaction [Glucose results in decreased activity of CAT protein]; naringenin inhibits the reaction [Glucose results in decreased activity of CAT protein]; NFE2L2 protein affects the reaction [gastrodin inhibits the reaction [Glucose results in decreased activity of CAT protein]]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [Glucose results in decreased activity of CAT protein]
Glucose results in decreased expression of CAT mRNA 		CTD PMID:12130563 PMID:17309078 PMID:20691780 PMID:21818840 PMID:23192364 More... NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Cav1 caveolin 1 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of CAV1 mRNA; Glucose results in decreased expression of CAV1 protein
EGF protein inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA]; Simvastatin inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA] 		CTD PMID:19816600 PMID:31655124 NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740 		JBrowse link
G Cbr3 carbonyl reductase 3 increases expression ISO Glucose results in increased expression of CBR3 mRNA CTD PMID:17178593 NCBI chr11:46,478,295...46,486,555
Ensembl chr11:46,478,274...46,486,558 		JBrowse link
G Cbs cystathionine beta synthase increases expression
decreases expression 		ISO
EXP 		Glucose results in increased expression of CBS mRNA
Glucose deficiency results in decreased expression of CBS mRNA 		CTD PMID:17178593 PMID:35577173 NCBI chr20:9,709,394...9,733,925
Ensembl chr20:9,709,395...9,734,066 		JBrowse link
G Ccdc116 coiled-coil domain containing 116 multiple interactions
decreases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of CCDC116 mRNA] CTD PMID:33448797 NCBI chr11:97,346,927...97,354,827
Ensembl chr11:97,346,675...97,354,824 		JBrowse link
G Ccdc146 coiled-coil domain containing 146 increases expression ISO Glucose results in increased expression of CCDC146 mRNA CTD PMID:39922521 NCBI chr 4:14,554,966...14,703,801
Ensembl chr 4:14,554,966...14,703,799 		JBrowse link
G Ccdc169 coiled-coil domain containing 169 multiple interactions
increases expression 		ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CCDC169 mRNA
Glucose results in increased expression of CCDC169 mRNA 		CTD PMID:37567420 PMID:39922521 NCBI chr 2:141,471,762...141,501,325
Ensembl chr 2:141,471,810...141,501,325 		JBrowse link
G Ccdc190 coiled-coil domain containing 190 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of CCDC190 mRNA CTD PMID:37567420 NCBI chr13:84,679,959...84,687,661
Ensembl chr13:84,679,986...84,687,658 		JBrowse link
G Ccdc73 coiled-coil domain containing 73 increases expression ISO Glucose results in increased expression of CCDC73 mRNA CTD PMID:39922521 NCBI chr 3:111,737,771...111,879,588
Ensembl chr 3:111,737,730...111,880,105 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 increases expression
multiple interactions
increases secretion 		ISO
EXP 		Glucose results in increased expression of CCL2 mRNA; Glucose results in increased expression of CCL2 protein
(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CCL2 protein]; [Glucose co-treated with fatostatin] results in increased expression of CCL2 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL2 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of CCL2 protein]; [Valsartan co-treated with Simvastatin] inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]]; aspalathin inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; aspalathin inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Aspirin inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Aspirin inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Aspirin inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; CCL2 mRNA affects the reaction [Glucose results in increased expression of CCN2 protein]; chromic chloride inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; chromium nicotinic acid complex inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Clofibrate inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Clofibrate inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Clofibrate inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; diphenyleneiodonium inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; diphenyleneiodonium inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Fenofibrate inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Fenofibrate inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Fenofibrate inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Glucose inhibits the reaction [Fructose results in increased secretion of CCL2 protein]; Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]; HTS 466284 inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; isoangustone A inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; manganese chloride inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; nothofagin inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; nothofagin inhibits the reaction [Glucose results in increased expression of CCL2 protein]; picolinic acid inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; psicose inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; psicose inhibits the reaction [Glucose results in increased expression of CCL2 protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of MCP1 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; SB 203580 inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; SB 203580 inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Selenium inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]]
Glucose results in increased expression of CCL2 mRNA; Glucose results in increased expression of CCL2 protein; Glucose results in increased expression of MCP1 mRNA
duanbanhuain A inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; duanbanhuain B inhibits the reaction [Glucose results in increased secretion of CCL2 protein]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CCL2 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CCL2 mRNA; manganese chloride inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; MIR27B mRNA affects the reaction [Glucose results in increased expression of CCL2 protein]; SNHG1 affects the reaction [Glucose results in increased expression of CCL2 mRNA]; SNHG1 affects the reaction [Glucose results in increased expression of CCL2 protein]; SNHG1 affects the reaction [MIR27B mRNA affects the reaction [Glucose results in increased expression of CCL2 protein]] 		CTD PMID:16143069 PMID:16600694 PMID:17178593 PMID:17607302 PMID:17655880 More... NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Ccl28 C-C motif chemokine ligand 28 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CCL28 mRNA CTD PMID:37567420 NCBI chr 2:53,334,071...53,358,709
Ensembl chr 2:53,334,071...53,358,709 		JBrowse link
G Ccl5 C-C motif chemokine ligand 5 increases expression
multiple interactions
decreases expression 		ISO Glucose results in increased expression of CCL5 mRNA
[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA
Glucose results in decreased expression of CCL5 mRNA 		CTD PMID:17178593 PMID:31655124 PMID:32613381 PMID:32942007 NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884 		JBrowse link
G Ccl7 C-C motif chemokine ligand 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CCL7 mRNA CTD PMID:37567420 NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,514,091...67,515,947 		JBrowse link
G Ccn1 cellular communication network factor 1 increases expression ISO Glucose results in increased expression of CCN1 mRNA CTD PMID:17178593 NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883 		JBrowse link
G Ccn2 cellular communication network factor 2 multiple interactions
increases expression 		ISO
EXP 		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CCN2 protein]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of CCN2 mRNA]; Cadmium inhibits the reaction [Glucose results in increased expression of CCN2 protein]; CCL2 mRNA affects the reaction [Glucose results in increased expression of CCN2 protein]; SB 203580 inhibits the reaction [Glucose results in increased expression of CCN2 protein]; Zinc inhibits the reaction [Glucose results in increased expression of CCN2 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [Glucose results in increased expression of CCN2 mRNA]]; SMARCA4A protein inhibits the reaction [Glucose results in increased expression of CCN2 mRNA]
Aspirin inhibits the reaction [Glucose results in increased expression of CCN2 mRNA]; CCN2 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]; fatostatin inhibits the reaction [Glucose results in increased expression of CCN2 protein]; HIF1A protein affects the reaction [Glucose results in increased expression of CCN2 protein]; MIR217 mRNA affects the reaction [Glucose results in increased expression of CCN2 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of CCN2 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CCN2 protein]]
Glucose results in increased expression of CCN2 mRNA; Glucose results in increased expression of CCN2 protein 		CTD PMID:10026205 PMID:14586741 PMID:19369054 PMID:21124846 PMID:21367880 More... NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976 		JBrowse link
G Ccna1 cyclin A1 multiple interactions ISO [imeglimin co-treated with Glucose] results in increased expression of CCNA1 mRNA CTD PMID:34588186 NCBI chr 2:141,383,352...141,428,205
Ensembl chr 2:141,382,468...141,393,300 		JBrowse link
G Ccnb1 cyclin B1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CCNB1 mRNA CTD PMID:37567420 NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225 		JBrowse link
G Ccnd1 cyclin D1 increases expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of CCND1; Glucose results in increased expression of CCND1 mRNA
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND1 mRNA; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND1 mRNA]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND1 mRNA]]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND1 mRNA]
resveratrol inhibits the reaction [Glucose results in increased expression of CCND1 protein]
[Glucose co-treated with resveratrol] results in decreased expression of CCND1 mRNA; resveratrol inhibits the reaction [Glucose results in increased expression of CCND1 mRNA] 		CTD PMID:23690508 PMID:24064760 PMID:24971582 PMID:27049278 PMID:27481074 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Ccnd2 cyclin D2 multiple interactions
increases expression 		ISO [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND2 mRNA; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND2 mRNA]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND2 mRNA]]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND2 mRNA]
Glucose results in increased expression of CCND2 mRNA 		CTD PMID:27481074 PMID:34588186 NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:161,653,048...161,680,301
Ensembl chr 4:161,653,048...161,680,301 		JBrowse link
G Ccne1 cyclin E1 increases expression
multiple interactions 		EXP Glucose results in increased expression of CCNE1 protein
resveratrol inhibits the reaction [Glucose results in increased expression of CCNE1 protein] 		CTD PMID:24971582 NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822 		JBrowse link
G Ccnl1 cyclin L1 increases expression ISO Glucose results in increased expression of CCNL1 mRNA CTD PMID:17178593 NCBI chr 2:152,495,169...152,508,855
Ensembl chr 2:152,495,172...152,507,468 		JBrowse link
G Ccr10 C-C motif chemokine receptor 10 multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of CCR10 mRNA] CTD PMID:33448797 NCBI chr10:86,608,836...86,611,273
Ensembl chr10:86,608,836...86,611,273 		JBrowse link
G Ccr6 C-C motif chemokine receptor 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CCR6 mRNA CTD PMID:37567420 NCBI chr 1:55,022,037...55,055,857
Ensembl chr 1:55,021,833...55,046,059 		JBrowse link
G Ccr7 C-C motif chemokine receptor 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CCR7 mRNA CTD PMID:37567420 NCBI chr10:84,594,399...84,604,514
Ensembl chr10:84,593,594...84,604,501 		JBrowse link
G Ccs copper chaperone for superoxide dismutase multiple interactions EXP [Glucose co-treated with Lycopene] results in increased expression of CCS mRNA CTD PMID:38444079 NCBI chr 1:211,543,192...211,564,354
Ensembl chr 1:211,542,701...211,564,260 		JBrowse link
G Cd14 CD14 molecule multiple interactions ISO CD14 protein affects the reaction [Glucose promotes the reaction [Lipopolysaccharides results in increased secretion of MMP1 protein]]; Curcumin inhibits the reaction [Glucose promotes the reaction [Lipopolysaccharides results in increased expression of CD14 protein]]; Glucose promotes the reaction [Lipopolysaccharides results in increased expression of CD14 protein] CTD PMID:18180316 NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292 		JBrowse link
G Cd151 CD151 molecule (Raph blood group) multiple interactions EXP CD151 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 1:205,994,300...205,998,307
Ensembl chr 1:205,994,738...205,998,784 		JBrowse link
G Cd160 CD160 molecule decreases expression ISO Glucose results in decreased expression of CD160 mRNA CTD PMID:31525975 NCBI chr 2:187,029,654...187,042,447
Ensembl chr 2:187,033,140...187,064,587 		JBrowse link
G Cd163 CD163 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CD163 mRNA CTD PMID:37567420 NCBI chr 4:158,770,751...158,804,146
Ensembl chr 4:158,770,749...158,804,146 		JBrowse link
G Cd164l2 CD164 molecule like 2 increases expression ISO Glucose results in increased expression of CD164L2 mRNA CTD PMID:39922521 NCBI chr 5:150,698,662...150,711,622
Ensembl chr 5:150,707,667...150,711,631 		JBrowse link
G Cd19 CD19 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of CD19 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CD19 mRNA CTD PMID:37567420 NCBI chr 1:190,417,853...190,424,494
Ensembl chr 1:190,417,853...190,424,355 		JBrowse link
G Cd1d1 CD1d1 molecule multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of CD1D1 mRNA] CTD PMID:33448797 NCBI chr 2:174,721,522...174,725,029
Ensembl chr 2:174,721,522...174,725,029 		JBrowse link
G Cd226 CD226 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CD226 mRNA CTD PMID:37567420 NCBI chr18:84,723,330...84,819,836
Ensembl chr18:84,725,242...84,819,835 		JBrowse link
G Cd247 Cd247 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CD247 mRNA CTD PMID:37567420 NCBI chr13:80,576,264...80,651,422
Ensembl chr13:80,576,202...80,655,248 		JBrowse link
G Cd300a Cd300a molecule increases expression
multiple interactions 		ISO Glucose results in increased expression of CD300A mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CD300A mRNA 		CTD PMID:31525975 PMID:37567420 NCBI chr10:100,428,826...100,441,693
Ensembl chr10:100,428,826...100,442,958 		JBrowse link
G Cd300lb CD300 molecule-like family member b multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CD300LB mRNA CTD PMID:37567420 NCBI chr10:100,463,815...100,473,804
Ensembl chr10:100,463,815...100,473,804 		JBrowse link
G Cd36 CD36 molecule multiple interactions
increases expression 		ISO (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]
Glucose results in increased expression of CD36 mRNA 		CTD PMID:32613381 PMID:36156098 NCBI chr 4:18,209,088...18,302,142 JBrowse link
G Cd3e CD3 epsilon subunit of T-cell receptor complex multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CD3E mRNA CTD PMID:37567420 NCBI chr 8:54,200,617...54,211,770
Ensembl chr 8:54,200,617...54,211,876 		JBrowse link
G Cd40lg CD40 ligand multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CD40LG mRNA CTD PMID:37567420 NCBI chr  X:140,164,341...140,176,057
Ensembl chr  X:140,164,302...140,176,475 		JBrowse link
G Cd44 CD44 molecule increases expression
multiple interactions 		ISO Glucose results in increased expression of CD44 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CD44 mRNA 		CTD PMID:17178593 PMID:37567420 NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424 		JBrowse link
G Cd48 Cd48 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CD48 mRNA CTD PMID:37567420 NCBI chr13:86,717,960...86,741,540
Ensembl chr13:86,717,961...86,742,942 		JBrowse link
G Cd5 Cd5 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CD5 mRNA CTD PMID:37567420 NCBI chr 1:216,790,245...216,811,209
Ensembl chr 1:216,790,245...216,811,209 		JBrowse link
G Cd52 CD52 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CD52 mRNA CTD PMID:37567420 NCBI chr 5:151,603,537...151,605,096
Ensembl chr 5:151,603,524...151,605,086 		JBrowse link
G Cd6 Cd6 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CD6 mRNA CTD PMID:37567420 NCBI chr 1:216,867,767...216,906,642
Ensembl chr 1:216,867,771...216,879,432 		JBrowse link
G Cd74 CD74 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CD74 mRNA CTD PMID:37567420 NCBI chr18:56,527,071...56,536,406
Ensembl chr18:56,527,132...56,536,410 		JBrowse link
G Cd8b CD8 subunit beta multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CD8B1 mRNA CTD PMID:37567420 NCBI chr 4:104,870,911...104,886,838
Ensembl chr 4:104,870,893...104,886,868 		JBrowse link
G Cd96 CD96 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CD96 mRNA CTD PMID:37567420 NCBI chr11:68,164,926...68,239,266
Ensembl chr11:68,164,872...68,241,937 		JBrowse link
G Cdc42 cell division cycle 42 increases expression
multiple interactions 		ISO Glucose results in increased expression of CDC42 mRNA; Glucose results in increased expression of CDC42 protein
Eucalyptol inhibits the reaction [Glucose results in increased expression of CDC42 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of CDC42 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of CDC42 protein] 		CTD PMID:24659233 PMID:31483951 NCBI chr 5:154,838,478...154,876,629
Ensembl chr 5:154,839,631...154,876,627 		JBrowse link
G Cdc7 cell division cycle 7 increases expression ISO Glucose results in increased expression of CDC7 mRNA CTD PMID:39922521 NCBI chr14:2,949,538...2,969,656
Ensembl chr14:2,949,539...2,969,656 		JBrowse link
G Cdh1 cadherin 1 multiple interactions
decreases expression 		ISO 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [Glucose results in decreased expression of CDH1 protein]; [Glucose co-treated with TGFB1 protein] results in decreased expression of CDH1 protein; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in decreased expression of CDH1 protein]; DKK1 protein inhibits the reaction [Glucose results in decreased expression of CDH1 mRNA]; DKK1 protein inhibits the reaction [Glucose results in decreased expression of CDH1 protein]; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in decreased expression of CDH1 protein]; MAPK14 protein promotes the reaction [Glucose results in decreased expression of CDH1 protein]
Glucose results in decreased expression of CDH1 mRNA; Glucose results in decreased expression of CDH1 protein 		CTD PMID:21829520 PMID:26045780 PMID:29163160 PMID:33992720 PMID:35445903 More... NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565 		JBrowse link
G Cdh5 cadherin 5 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of CDH5 mRNA
[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of and affects the localization of CDH5 protein; [Glucose deficiency co-treated with Oxygen deficiency] results in increased localization of CDH5 protein; nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased localization of CDH5 protein]; Wortmannin inhibits the reaction [nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased localization of CDH5 protein]] 		CTD PMID:31655124 PMID:38528077 NCBI chr19:821,875...860,931
Ensembl chr19:822,464...860,822 		JBrowse link
G Cdk1 cyclin-dependent kinase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CDK1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CDK1 mRNA CTD PMID:37567420 NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455 		JBrowse link
G Cdk9 cyclin-dependent kinase 9 increases phosphorylation
multiple interactions 		ISO Glucose results in increased phosphorylation of CDK9 protein
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased phosphorylation of CDK9 protein]; CDK9 protein affects the reaction [Glucose results in increased expression of COL4A4 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of IL1B mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of IL6 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of NOS2 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of TGFB1 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of TNF mRNA]; CDK9 protein affects the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; CDK9 protein affects the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; CDK9 protein affects the reaction [Glucose results in increased secretion of IL6 protein]; CDK9 protein affects the reaction [Glucose results in increased secretion of TNF protein] 		CTD PMID:33631230 NCBI chr 3:36,394,168...36,399,016
Ensembl chr 3:36,394,169...36,399,528 		JBrowse link
G Cdkl5 cyclin-dependent kinase-like 5 increases expression ISO Glucose results in increased expression of CDKL5 mRNA CTD PMID:39922521 NCBI chr  X:37,566,320...37,796,766
Ensembl chr  X:37,566,378...37,796,760 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression
multiple interactions
decreases expression 		ISO
EXP 		Glucose results in increased expression of CDKN1A mRNA
[imeglimin co-treated with Glucose] results in increased expression of CDKN1A mRNA
Glucose results in decreased expression of CDKN1A protein
Glucose promotes the reaction [SETD7 protein binds to CDKN1A promoter]; NAD inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; Niacinamide inhibits the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; SIRT1 protein promotes the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; TGFB1 protein promotes the reaction [Glucose promotes the reaction [SETD7 protein binds to CDKN1A promoter]]; TGFB1 protein promotes the reaction [Glucose results in increased expression of CDKN1A mRNA]
Glucose results in increased expression of CDKN1A mRNA; Glucose results in increased expression of CDKN1A protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased expression of CDKN1A mRNA]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; [Glucose co-treated with Deferoxamine] results in increased expression of CDKN1A mRNA; [Palmitic Acid co-treated with Glucose] results in increased expression of CDKN1A mRNA; CDKN1A protein affects the reaction [Glucose results in increased expression of GLB1 protein]; Fluorometholone inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CDKN1A mRNA]; Melatonin inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; Phytic Acid inhibits the reaction [Glucose results in increased expression of CDKN1A mRNA]; Phytic Acid inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1A mRNA]; SIRT1 protein mutant form inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased expression of CDKN1A mRNA]; TAS1R1 protein affects the reaction [Glucose results in decreased expression of CDKN1A protein] 		CTD PMID:17178593 PMID:22561310 PMID:24451382 PMID:27049278 PMID:27652271 More... NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B increases expression
multiple interactions 		EXP
ISO 		Glucose results in increased expression of CDKN1B protein
[Glucose co-treated with Deferoxamine] results in increased expression of CDKN1B mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CDKN1B mRNA]
NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein]; Niacinamide inhibits the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein]]; Resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1B protein]; Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein]; SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1B protein]]; SIRT1 protein promotes the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein]] 		CTD PMID:22561310 PMID:33962019 PMID:33992720 NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498 		JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A increases expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of CDKN2A protein; Glucose results in increased expression of CDKN2A protein alternative form
CDKN2A protein affects the reaction [Glucose results in increased expression of GLB1 protein]; SIRT3 protein inhibits the reaction [Glucose results in increased expression of CDKN2A protein alternative form] 		CTD PMID:23494737 PMID:38483099 NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248 		JBrowse link
G Ceacam1 CEA cell adhesion molecule 1 multiple interactions
decreases expression
decreases secretion 		ISO cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of CEACAM1 mRNA]; cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased secretion of CEACAM1 protein] CTD PMID:19924377 NCBI chr 1:90,171,401...90,187,810
Ensembl chr 1:90,171,401...90,187,798 		JBrowse link
G Ceacam19 CEA cell adhesion molecule 19 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CEACAM19 mRNA CTD PMID:37567420 NCBI chr 1:88,670,054...88,678,900
Ensembl chr 1:88,670,054...88,678,874 		JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha multiple interactions ISO CEBPA protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]; CEBPA protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]; Glucose promotes the reaction [CEBPA protein binds to EDN1 promoter]; Glucose results in increased localization of and results in increased activity of CEBPA protein; pyrazolanthrone inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPA protein]; SB 203580 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPA protein]; U 0126 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPA protein] CTD PMID:24376792 NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309 		JBrowse link
G Cebpb CCAAT/enhancer binding protein beta multiple interactions
decreases expression 		ISO CEBPB protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]; CEBPB protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]; Glucose promotes the reaction [CEBPB protein binds to EDN1 promoter]; Glucose results in increased localization of and results in increased activity of CEBPB protein; pyrazolanthrone inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPB protein]; SB 203580 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPB protein]; U 0126 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPB protein]
Glucose results in decreased expression of CEBPB protein
CEBPB protein inhibits the reaction [Glucose results in decreased expression of ACE2 protein]; CEBPB protein inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of MMP2 protein]; CEBPB protein inhibits the reaction [Glucose results in decreased expression of MAS1 protein]; CEBPB protein inhibits the reaction [Glucose results in decreased expression of PPARGC1A protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of ACE protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of AGTR1 protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of AGTR2 protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of BAX protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of COL3A1 protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; Glucose inhibits the reaction [CEBPB protein binds to ACE2 promoter] 		CTD PMID:24376792 PMID:28482072 PMID:29266779 NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072 		JBrowse link
G Cebpd CCAAT/enhancer binding protein delta multiple interactions ISO CEBPD protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]; CEBPD protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]; Glucose promotes the reaction [CEBPD protein binds to EDN1 promoter]; Glucose results in increased localization of and results in increased activity of CEBPD protein; pyrazolanthrone inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPD protein]; SB 203580 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPD protein]; U 0126 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPD protein] CTD PMID:24376792 NCBI chr11:98,268,856...98,269,994
Ensembl chr11:98,265,651...98,280,824 		JBrowse link
G Celf3 CUGBP, Elav-like family member 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of CELF3 mRNA CTD PMID:37567420 NCBI chr 2:184,805,078...184,819,189
Ensembl chr 2:184,805,081...184,819,187 		JBrowse link
G Celf4 CUGBP, Elav-like family member 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CELF4 mRNA CTD PMID:37567420 NCBI chr18:17,061,284...17,339,747
Ensembl chr18:17,061,293...17,339,571 		JBrowse link
G Celsr1 cadherin, EGF LAG seven-pass G-type receptor 1 multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of CELSR1 mRNA] CTD PMID:33448797 NCBI chr 7:118,867,450...119,004,859
Ensembl chr 7:118,867,450...119,004,856 		JBrowse link
G Celsr2 cadherin, EGF LAG seven-pass G-type receptor 2 increases expression ISO Glucose results in increased expression of CELSR2 mRNA CTD PMID:39922521 NCBI chr 2:198,717,333...198,741,689
Ensembl chr 2:198,717,896...198,741,581 		JBrowse link
G Celsr3 cadherin, EGF LAG seven-pass G-type receptor 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of CELSR3 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CELSR3 mRNA CTD PMID:37567420 NCBI chr 8:118,409,136...118,438,593
Ensembl chr 8:118,409,136...118,436,847 		JBrowse link
G Cemip cell migration inducing hyaluronidase 1 multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of CEMIP mRNA] CTD PMID:33448797 NCBI chr 1:147,316,052...147,471,552
Ensembl chr 1:147,316,052...147,471,768 		JBrowse link
G Cenpa centromere protein A multiple interactions ISO [imeglimin co-treated with Glucose] results in increased expression of CENPA mRNA CTD PMID:34588186 NCBI chr 6:31,420,062...31,431,703 JBrowse link
G Cenpf centromere protein F multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CENPF mRNA CTD PMID:37567420 NCBI chr13:103,715,344...103,760,931
Ensembl chr13:103,715,344...103,760,886 		JBrowse link
G Cert1 ceramide transporter 1 multiple interactions
increases expression 		EXP rhodioloside inhibits the reaction [Glucose results in increased expression of CERT1 mRNA]; TXNIP protein affects the reaction [Glucose results in increased expression of CERT1 mRNA] CTD PMID:29031534 NCBI chr 2:29,617,202...29,721,734
Ensembl chr 2:29,617,023...29,721,729 		JBrowse link
G Ces2f carboxylesterase 2F increases expression ISO Glucose results in increased expression of CES2F mRNA CTD PMID:31525975 NCBI chr19:11,245...21,395
Ensembl chr19:13,987...21,358 		JBrowse link
G Ces2h carboxylesterase 2H multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CES2H mRNA CTD PMID:37567420 NCBI chr19:49,884,164...49,898,764
Ensembl chr19:49,884,164...49,898,752 		JBrowse link
G Cfap45 cilia and flagella associated protein 45 increases expression ISO Glucose results in increased expression of CFAP45 mRNA CTD PMID:31525975 NCBI chr13:87,521,831...87,545,236
Ensembl chr13:87,521,518...87,545,234 		JBrowse link
G Cfap74 cilia and flagella associated protein 74 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CFAP74 mRNA CTD PMID:37567420 NCBI chr 5:171,252,907...171,328,351
Ensembl chr 5:171,262,113...171,328,349 		JBrowse link
G Cfap97d1 CFAP97 domain containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CFAP97D1 mRNA CTD PMID:37567420 NCBI chr10:87,432,559...87,444,711
Ensembl chr10:87,434,008...87,441,577 		JBrowse link
G Cfd complement factor D decreases expression
multiple interactions 		EXP
ISO 		Glucose results in decreased expression of CFD mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CFD mRNA 		CTD PMID:3299706 PMID:37567420 NCBI chr 7:10,463,773...10,465,496
Ensembl chr 7:10,463,775...10,465,572 		JBrowse link
G Cfl1 cofilin 1 increases secretion ISO Glucose deficiency results in increased secretion of CFL1 protein CTD PMID:24802182 NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:212,226,121...212,231,353 		JBrowse link
G Cfp complement factor properdin decreases expression
multiple interactions 		ISO Glucose results in decreased expression of CFP mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of CFP mRNA] 		CTD PMID:33448797 NCBI chr  X:3,715,551...3,721,113
Ensembl chr  X:3,710,425...3,721,112 		JBrowse link
G Chac1 ChaC glutathione-specific gamma-glutamylcyclotransferase 1 multiple interactions
decreases expression 		EXP
ISO 		CHAC1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
Glucose results in decreased expression of CHAC1 mRNA 		CTD PMID:21124846 PMID:39613055 NCBI chr 3:126,796,131...126,799,352
Ensembl chr 3:126,796,024...126,799,361 		JBrowse link
G Chd2 chromodomain helicase DNA binding protein 2 multiple interactions ISO Glucose promotes the reaction [TCF19 protein binds to CHD2 protein] CTD PMID:29042441 NCBI chr 1:136,597,993...136,726,874
Ensembl chr 1:136,599,900...136,710,335 		JBrowse link
G Chgb chromogranin B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CHGB mRNA CTD PMID:37567420 NCBI chr 3:140,496,712...140,510,057
Ensembl chr 3:140,495,951...140,510,054 		JBrowse link
G Chkb choline kinase beta multiple interactions EXP CHKB protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 7:122,380,592...122,385,102
Ensembl chr 7:122,380,594...122,383,949 		JBrowse link
G Chn1 chimerin 1 increases expression ISO Glucose results in increased expression of CHN1 mRNA CTD PMID:39922521 NCBI chr 3:78,917,329...79,084,040
Ensembl chr 3:78,917,329...79,084,197 		JBrowse link
G Chrdl2 chordin-like 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CHRDL2 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CHRDL2 mRNA CTD PMID:37567420 NCBI chr 1:163,755,316...163,782,758
Ensembl chr 1:163,755,316...163,782,757 		JBrowse link
G Chrm2 cholinergic receptor, muscarinic 2 increases expression EXP Glucose results in increased expression of CHRM2 mRNA CTD PMID:18715473 NCBI chr 4:65,981,136...66,116,128
Ensembl chr 4:65,981,006...66,126,464 		JBrowse link
G Chrna2 cholinergic receptor nicotinic alpha 2 subunit multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CHRNA2 mRNA CTD PMID:37567420 NCBI chr15:44,517,862...44,534,144
Ensembl chr15:44,517,862...44,534,144 		JBrowse link
G Cidea cell death-inducing DFFA-like effector a increases expression ISO Glucose results in increased expression of CIDEA mRNA CTD PMID:39922521 NCBI chr18:63,164,817...63,190,384
Ensembl chr18:63,164,099...63,190,382 		JBrowse link
G Cimap1c ciliary microtubule associated protein 1C multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of CIMAP1C mRNA CTD PMID:37567420 NCBI chr 8:66,144,726...66,176,985
Ensembl chr 8:66,144,726...66,181,546 		JBrowse link
G Ckap2 cytoskeleton associated protein 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CKAP2 mRNA CTD PMID:37567420 NCBI chr16:76,542,114...76,567,297
Ensembl chr16:76,542,104...76,567,352 		JBrowse link
G Ckb creatine kinase B multiple interactions
increases activity 		ISO Glucose inhibits the reaction [daidzein results in increased activity of CKB protein]; Glucose inhibits the reaction [Dihydrotestosterone results in increased activity of CKB protein]; Glucose inhibits the reaction [Estradiol results in increased activity of CKB protein]; Glucose inhibits the reaction [Genistein results in increased activity of CKB protein]
Glucose results in increased activity of CKB protein 		CTD PMID:16621514 NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478 		JBrowse link
G Ckm creatine kinase, M-type increases expression ISO Glucose results in increased expression of CKM mRNA CTD PMID:39922521 NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:88,189,485...88,199,719 		JBrowse link
G Cks2 CDC28 protein kinase regulatory subunit 2 increases expression ISO Glucose results in increased expression of CKS2 mRNA CTD PMID:17178593 NCBI chr17:13,722,360...13,727,519
Ensembl chr17:13,722,361...13,727,519 		JBrowse link
G Clcnkb chloride voltage-gated channel Kb increases expression ISO Glucose results in increased expression of CLCNKB mRNA CTD PMID:39922521 NCBI chr 5:158,993,073...159,005,618
Ensembl chr 5:158,993,074...159,004,900 		JBrowse link
G Cldn4 claudin 4 increases expression ISO Glucose results in increased expression of CLDN4 mRNA CTD PMID:39922521 NCBI chr12:27,388,160...27,389,958
Ensembl chr12:27,387,981...27,389,958 		JBrowse link
G Clec4a C-type lectin domain family 4, member A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CLEC4N mRNA CTD PMID:37567420 NCBI chr 4:158,026,138...158,119,904
Ensembl chr 4:158,100,615...158,118,094 		JBrowse link
G Clec4e C-type lectin domain family 4, member E multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CLEC4E mRNA CTD PMID:37567420 NCBI chr 4:158,292,624...158,298,607
Ensembl chr 4:158,293,311...158,298,467 		JBrowse link
G Clec7a C-type lectin domain containing 7A increases expression ISO Glucose results in increased expression of CLEC7A mRNA CTD PMID:39922521 NCBI chr 4:164,588,737...164,599,953
Ensembl chr 4:164,588,754...164,599,919 		JBrowse link
G Clhc1 clathrin heavy chain linker domain containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CLHC1 mRNA CTD PMID:37567420 NCBI chr14:107,488,983...107,529,667
Ensembl chr14:107,488,643...107,529,669 		JBrowse link
G Clic6 chloride intracellular channel 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CLIC6 mRNA CTD PMID:37567420 NCBI chr11:45,223,715...45,266,261
Ensembl chr11:45,223,669...45,267,344 		JBrowse link
G Clspn claspin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CLSPN mRNA CTD PMID:37567420 NCBI chr 5:144,134,619...144,169,531
Ensembl chr 5:144,134,632...144,169,530 		JBrowse link
G Clstn3 calsyntenin 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CLSTN3 mRNA CTD PMID:37567420 NCBI chr 4:159,017,795...159,051,069
Ensembl chr 4:159,017,795...159,051,069 		JBrowse link
G Cma1 chymase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CMA1 mRNA CTD PMID:37567420 NCBI chr15:33,387,351...33,390,133
Ensembl chr15:33,387,351...33,390,133 		JBrowse link
G Cnga3 cyclic nucleotide gated channel subunit alpha 3 increases expression ISO Glucose results in increased expression of CNGA3 mRNA CTD PMID:39922521 NCBI chr 9:46,943,353...46,989,862
Ensembl chr 9:46,928,810...46,989,862 		JBrowse link
G Cnga4 cyclic nucleotide gated channel subunit alpha 4 increases expression ISO Glucose results in increased expression of CNGA4 mRNA CTD PMID:39922521 NCBI chr 1:169,134,332...169,168,317
Ensembl chr 1:169,164,206...169,168,224 		JBrowse link
G Cnih2 cornichon family AMPA receptor auxiliary protein 2 increases expression ISO Glucose results in increased expression of CNIH2 mRNA CTD PMID:17178593 NCBI chr 1:211,828,791...211,834,474
Ensembl chr 1:211,828,794...211,834,437 		JBrowse link
G Cnn1 calponin 1 increases methylation
decreases expression
multiple interactions 		ISO Glucose results in increased methylation of CNN1 gene
Glucose results in decreased expression of CNN1 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of CNN1 mRNA] 		CTD PMID:33448797 NCBI chr 8:28,908,437...28,917,099
Ensembl chr 8:28,908,330...28,919,482 		JBrowse link
G Cnr1 cannabinoid receptor 1 decreases expression
increases expression
multiple interactions 		EXP Glucose results in decreased expression of CNR1 mRNA
Glucose results in increased expression of CNR1 mRNA; Glucose results in increased expression of CNR1 protein
MIR29A mRNA inhibits the reaction [Glucose results in increased expression of CNR1 mRNA]; MIR29A mRNA inhibits the reaction [Glucose results in increased expression of CNR1 protein] 		CTD PMID:19501110 PMID:30642005 NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:53,204,260...53,239,252 		JBrowse link
G Cntn4 contactin 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CNTN4 mRNA CTD PMID:37567420 NCBI chr 4:140,180,696...141,177,771
Ensembl chr 4:140,596,284...141,177,766 		JBrowse link
G Cntnap2 contactin associated protein 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CNTNAP2 mRNA CTD PMID:37567420 NCBI chr 4:75,109,358...77,366,258
Ensembl chr 4:75,109,858...77,366,258 		JBrowse link
G Cntnap5b contactin associated protein family member 5B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CNTNAP5A mRNA CTD PMID:37567420 NCBI chr13:18,378,255...19,281,711
Ensembl chr13:18,378,368...19,281,711 		JBrowse link
G Col11a2 collagen type XI alpha 2 chain increases expression ISO Glucose results in increased expression of COL11A2 mRNA CTD PMID:39922521 NCBI chr20:4,788,829...4,818,492
Ensembl chr20:4,788,829...4,817,648 		JBrowse link
G Col19a1 collagen type XIX alpha 1 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of COL19A1 mRNA CTD PMID:37567420 NCBI chr 9:34,170,248...34,518,478
Ensembl chr 9:34,170,248...34,518,350 		JBrowse link
G Col1a1 collagen type I alpha 1 chain affects secretion
decreases expression
increases expression
multiple interactions 		ISO
EXP 		Glucose deficiency affects the secretion of COL1A1 protein
Glucose results in decreased expression of COL1A1 mRNA
Glucose results in increased expression of COL1A1 mRNA; Glucose results in increased expression of COL1A1 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in decreased expression of COL1A1 mRNA]]; DKK1 protein inhibits the reaction [Glucose results in increased expression of COL1A1 mRNA]; Melatonin inhibits the reaction [Glucose results in decreased expression of COL1A1 mRNA]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of COL1A1 protein]]; MIR142 inhibits the reaction [Glucose results in increased expression of COL1A1 protein]; Phytic Acid inhibits the reaction [Glucose results in decreased expression of COL1A1 mRNA]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased expression of COL1A1 protein]]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of COL1A1 protein]
Curcumin analog inhibits the reaction [Glucose results in increased expression of COL1A1 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of COL1A1 mRNA] 		CTD PMID:24802182 PMID:28700904 PMID:29163160 PMID:38000455 PMID:38124441 NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460 		JBrowse link
G Col1a2 collagen type I alpha 2 chain multiple interactions
increases secretion
increases expression 		ISO troglitazone inhibits the reaction [Glucose results in increased expression of COL1A2 mRNA]
Glucose deficiency results in increased secretion of COL1A2 protein 		CTD PMID:17199790 PMID:24802182 NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995 		JBrowse link
G Col20a1 collagen type XX alpha 1 chain increases expression ISO Glucose results in increased expression of COL20A1 mRNA CTD PMID:39922521 NCBI chr 3:188,477,663...188,512,326
Ensembl chr 3:188,465,648...188,511,078 		JBrowse link
G Col27a1 collagen type XXVII alpha 1 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of COL27A1 mRNA CTD PMID:37567420 NCBI chr 5:81,662,822...81,781,502
Ensembl chr 5:81,661,685...81,781,502 		JBrowse link
G Col3a1 collagen type III alpha 1 chain affects secretion
increases expression
multiple interactions 		ISO Glucose deficiency affects the secretion of COL3A1 protein
Glucose results in increased expression of COL3A1 protein
CEBPB protein inhibits the reaction [Glucose results in increased expression of COL3A1 protein]; Valsartan inhibits the reaction [Glucose results in increased expression of COL3A1 protein] 		CTD PMID:24802182 PMID:29266779 NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232 		JBrowse link
G Col4a1 collagen type IV alpha 1 chain multiple interactions
increases expression 		EXP
ISO 		[eplerenone co-treated with Enalapril] inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of COL4A1 mRNA]]; Aldosterone promotes the reaction [Glucose results in increased expression of COL4A1 mRNA]; Curcumin analog inhibits the reaction [Glucose results in increased expression of COL4A1 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of COL4A1 mRNA]; Enalapril inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of COL4A1 mRNA]]; eplerenone inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of COL4A1 mRNA]]
MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of COL4A1 protein]]; MIR142 inhibits the reaction [Glucose results in increased expression of COL4A1 protein]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased expression of COL4A1 protein]]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of COL4A1 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [Glucose results in increased expression of COL4A1 mRNA]]; SMARCA4A protein inhibits the reaction [Glucose results in increased expression of COL4A1 mRNA] 		CTD PMID:18682491 PMID:28700904 PMID:33270355 PMID:38124441 NCBI chr16:84,885,597...84,996,482
Ensembl chr16:84,885,597...84,996,482 		JBrowse link
G Col4a2 collagen type IV alpha 2 chain affects secretion ISO Glucose deficiency affects the secretion of COL4A2 protein CTD PMID:24802182 NCBI chr16:84,749,672...84,885,520
Ensembl chr16:84,749,672...84,885,520 		JBrowse link
G Col4a4 collagen type IV alpha 4 chain increases expression
multiple interactions 		ISO Glucose results in increased expression of COL4A4 mRNA
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased expression of COL4A4 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of COL4A4 mRNA] 		CTD PMID:33631230 NCBI chr 9:91,281,324...91,323,577
Ensembl chr 9:91,203,670...91,323,577 		JBrowse link
G Col5a1 collagen type V alpha 1 chain affects secretion ISO Glucose deficiency affects the secretion of COL5A1 protein CTD PMID:24802182 NCBI chr 3:31,606,475...31,755,097
Ensembl chr 3:31,606,486...31,753,020 		JBrowse link
G Col5a2 collagen type V alpha 2 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of COL5A2 mRNA CTD PMID:37567420 NCBI chr 9:54,940,768...55,090,151
Ensembl chr 9:54,940,764...55,090,150 		JBrowse link
G Col6a1 collagen type VI alpha 1 chain affects secretion ISO Glucose deficiency affects the secretion of COL6A1 protein CTD PMID:24802182 NCBI chr20:11,905,690...11,924,111
Ensembl chr20:11,905,457...11,924,107 		JBrowse link
G Col6a2 collagen type VI alpha 2 chain affects secretion ISO Glucose deficiency affects the secretion of COL6A2 protein CTD PMID:24802182 NCBI chr20:12,021,182...12,048,932
Ensembl chr20:12,021,265...12,057,042 		JBrowse link
G Col6a5 collagen type VI alpha 5 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of COL6A5 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of COL6A5 mRNA CTD PMID:37567420 NCBI chr 8:115,362,532...115,462,844
Ensembl chr 8:115,361,906...115,462,859 		JBrowse link
G Col6a6 collagen type VI alpha 6 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of COL6A6 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of COL6A6 mRNA CTD PMID:37567420 NCBI chr 8:115,196,833...115,352,161
Ensembl chr 8:115,197,464...115,352,136 		JBrowse link
G Col7a1 collagen type VII alpha 1 chain multiple interactions
decreases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of COL7A1 mRNA] CTD PMID:33448797 NCBI chr 8:118,483,364...118,515,736
Ensembl chr 8:118,483,364...118,517,439 		JBrowse link
G Col8a2 collagen type VIII alpha 2 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of COL8A2 mRNA CTD PMID:37567420 NCBI chr 5:143,870,754...143,897,372
Ensembl chr 5:143,870,742...143,897,884 		JBrowse link
G Commd9 COMM domain containing 9 multiple interactions EXP COMMD9 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 3:108,630,903...108,645,427
Ensembl chr 3:108,630,980...108,666,091 		JBrowse link
G Coq8a coenzyme Q8A increases expression ISO Glucose results in increased expression of COQ8A mRNA CTD PMID:39922521 NCBI chr13:94,436,680...94,465,535
Ensembl chr13:94,436,546...94,463,378 		JBrowse link
G Cox4i1 cytochrome c oxidase subunit 4i1 increases expression
multiple interactions 		ISO Glucose deficiency results in increased expression of COX4I1 mRNA
[Glucose co-treated with Palmitic Acid] results in decreased expression of COX4I1 mRNA 		CTD PMID:26811028 PMID:39265716 NCBI chr19:65,630,383...65,636,623
Ensembl chr19:65,630,432...65,636,624 		JBrowse link
G Cox5b cytochrome c oxidase subunit 5B multiple interactions EXP COX5B protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 9:46,417,735...46,419,664
Ensembl chr 9:46,417,838...46,420,403 		JBrowse link
G Cox6a2 cytochrome c oxidase subunit 6A2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of COX6A2 mRNA CTD PMID:37567420 NCBI chr 1:192,218,970...192,221,188
Ensembl chr 1:192,218,970...192,219,716 		JBrowse link
G Cpe carboxypeptidase E multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CPE mRNA CTD PMID:37567420 NCBI chr16:29,796,707...29,908,647
Ensembl chr16:29,796,689...29,909,524 		JBrowse link
G Cpeb2 cytoplasmic polyadenylation element binding protein 2 increases expression ISO Glucose results in increased expression of CPEB2 mRNA CTD PMID:39922521 NCBI chr14:71,999,958...72,056,012
Ensembl chr14:72,002,072...72,052,263 		JBrowse link
G Cpne7 copine 7 increases expression ISO Glucose results in increased expression of CPNE7 mRNA CTD PMID:39922521 NCBI chr19:68,072,165...68,091,197
Ensembl chr19:68,074,545...68,091,197 		JBrowse link
G Cpne9 copine family member 9 increases expression ISO Glucose results in increased expression of CPNE9 mRNA CTD PMID:39922521 NCBI chr 4:147,985,900...148,009,987
Ensembl chr 4:147,986,452...148,009,986 		JBrowse link
G Cpq carboxypeptidase Q multiple interactions
decreases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of CPQ mRNA] CTD PMID:33448797 NCBI chr 7:66,148,973...66,719,189
Ensembl chr 7:66,149,377...66,716,137 		JBrowse link
G Cpt1a carnitine palmitoyltransferase 1A decreases expression
multiple interactions 		ISO Glucose results in decreased expression of CPT1A protein
Glucose results in decreased expression of CPT1A mRNA; Glucose results in decreased expression of CPT1A protein
(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Ditiocarb inhibits the reaction [YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of CPT1A protein]]]]; Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of CPT1A protein]; Fenofibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of CPT1A protein]]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of CPT1A protein]]] 		CTD PMID:23090186 PMID:32613381 PMID:36156098 PMID:39059604 NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326 		JBrowse link
G Cpt2 carnitine palmitoyltransferase 2 affects expression
multiple interactions 		EXP
ISO 		Glucose affects the expression of CPT2 mRNA
[Glucose co-treated with Palmitic Acid] results in decreased expression of CPT2 mRNA 		CTD PMID:24349266 PMID:39265716 NCBI chr 5:127,893,450...127,911,347
Ensembl chr 5:127,893,207...127,910,818 		JBrowse link
G Crabp2 cellular retinoic acid binding protein 2 increases expression ISO Glucose results in increased expression of CRABP2 mRNA CTD PMID:39922521 NCBI chr 2:175,714,862...175,719,208
Ensembl chr 2:175,707,312...175,728,385 		JBrowse link
G Creb1 cAMP responsive element binding protein 1 increases activity
multiple interactions 		ISO
EXP 		Glucose results in increased activity of CREB1 protein
[Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased phosphorylation of CREB1 protein; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased phosphorylation of CREB1 protein] 		CTD PMID:15767253 PMID:24726522 NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339 		JBrowse link
G Creb3l3 cAMP responsive element binding protein 3-like 3 multiple interactions
increases expression 		ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CREB3L3 mRNA
Glucose results in increased expression of CREB3L3 mRNA 		CTD PMID:37567420 PMID:39922521 NCBI chr 7:9,273,320...9,281,755
Ensembl chr 7:9,273,338...9,281,778 		JBrowse link
G Crlf1 cytokine receptor-like factor 1 multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of CRLF1 mRNA] CTD PMID:33448797 NCBI chr16:18,958,695...18,970,026
Ensembl chr16:18,957,956...18,969,970 		JBrowse link
G Crmp1 collapsin response mediator protein 1 multiple interactions EXP CRMP1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr14:77,734,675...77,780,916
Ensembl chr14:77,734,675...77,780,916 		JBrowse link
G Crtac1 cartilage acidic protein 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CRTAC1 mRNA CTD PMID:37567420 NCBI chr 1:251,040,963...251,182,920
Ensembl chr 1:251,028,143...251,182,689 		JBrowse link
G Cryaa crystallin, alpha A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CRYAA mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CRYAA mRNA CTD PMID:37567420 NCBI chr20:9,784,872...9,788,656
Ensembl chr20:9,784,857...9,788,654 		JBrowse link
G Crybg2 crystallin beta-gamma domain containing 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CRYBG2 mRNA CTD PMID:37567420 NCBI chr 5:151,570,154...151,602,164
Ensembl chr 5:151,570,540...151,602,163 		JBrowse link
G Cs citrate synthase increases activity
multiple interactions 		ISO Glucose results in increased activity of CS protein
Desipramine inhibits the reaction [Glucose results in increased activity of CS protein] 		CTD PMID:32481596 NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:1,342,942...1,375,938 		JBrowse link
G Csn3 casein kappa increases expression
multiple interactions 		ISO Glucose results in increased expression of CSN3 mRNA
Dichloroacetic Acid inhibits the reaction [Glucose results in increased expression of CSN3 mRNA]; Oxamic Acid inhibits the reaction [Glucose results in increased expression of CSN3 mRNA] 		CTD PMID:39922521 NCBI chr14:20,433,277...20,439,830
Ensembl chr14:20,433,277...20,439,832 		JBrowse link
G Csrnp1 cysteine and serine rich nuclear protein 1 increases expression ISO Glucose results in increased expression of CSRNP1 mRNA CTD PMID:17178593 NCBI chr 8:128,582,364...128,594,163
Ensembl chr 8:128,582,365...128,588,469 		JBrowse link
G Cst6 cystatin E/M multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of CST6 mRNA CTD PMID:37567420 NCBI chr 1:212,084,676...212,086,384
Ensembl chr 1:212,084,676...212,086,384 		JBrowse link
G Cth cystathionine gamma-lyase decreases expression
increases expression 		EXP
ISO 		Glucose deficiency results in decreased expression of CTH mRNA; Glucose deficiency results in decreased expression of CTH protein
Glucose results in increased expression of CTH mRNA 		CTD PMID:35577173 PMID:39613055 NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:249,634,731...249,661,066 		JBrowse link
G Ctnnb1 catenin beta 1 decreases expression
affects localization
multiple interactions
increases expression 		EXP
ISO 		Glucose results in decreased expression of CTNNB1 mRNA; Glucose results in decreased expression of CTNNB1 protein
Glucose affects the localization of CTNNB1 protein
[Glucose co-treated with ICG 001] results in decreased expression of CTNNB1 protein; [ICG 001 co-treated with Glucose] affects the localization of CTNNB1 protein; DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 mRNA]; DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 protein]; Panax notoginseng extract inhibits the reaction [[Glucose co-treated with ICG 001] results in decreased expression of CTNNB1 protein]; Panax notoginseng extract inhibits the reaction [[ICG 001 co-treated with Glucose] affects the localization of CTNNB1 protein]; Panax notoginseng extract inhibits the reaction [Glucose affects the localization of CTNNB1 protein]; Panax notoginseng extract inhibits the reaction [Glucose results in decreased expression of CTNNB1 protein]
Glucose results in increased expression of CTNNB1 mRNA; Glucose results in increased expression of CTNNB1 protein
Simvastatin inhibits the reaction [Glucose results in decreased expression of CTNNB1 protein] 		CTD PMID:18004065 PMID:21818840 PMID:29163160 PMID:35385194 NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662 		JBrowse link
G Ctsb cathepsin B multiple interactions
increases expression 		ISO [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CTSB protein; Melatonin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CTSB protein]
Glucose results in increased expression of CTSB mRNA 		CTD PMID:17178593 PMID:21392095 NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478 		JBrowse link
G Ctsl cathepsin L increases secretion ISO Glucose deficiency results in increased secretion of CTSL protein CTD PMID:24802182 NCBI chr17:770,104...776,266
Ensembl chr17:770,093...777,113 		JBrowse link
G Ctsw cathepsin W multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CTSW mRNA CTD PMID:37567420 NCBI chr 1:212,201,904...212,208,028
Ensembl chr 1:212,201,904...212,205,292 		JBrowse link
G Cttn cortactin decreases expression
multiple interactions 		ISO Glucose results in decreased expression of CTTN protein
Eucalyptol inhibits the reaction [Glucose results in decreased expression of CTTN protein] 		CTD PMID:31483951 NCBI chr 1:209,029,048...209,064,577
Ensembl chr 1:209,029,048...209,058,211 		JBrowse link
G Ctu1 cytosolic thiouridylase subunit 1 decreases expression ISO Glucose results in decreased expression of CTU1 mRNA CTD PMID:39613055 NCBI chr 1:103,251,983...103,257,778
Ensembl chr 1:103,251,995...103,257,775 		JBrowse link
G Cuzd1 CUB and zona pellucida-like domains 1 increases expression ISO Glucose results in increased expression of CUZD1 mRNA CTD PMID:39922521 NCBI chr 1:195,519,609...195,532,733
Ensembl chr 1:195,519,609...195,532,733 		JBrowse link
G Cx3cl1 C-X3-C motif chemokine ligand 1 multiple interactions
increases expression 		ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CX3CL1 protein]; Clofibrate inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA]; Clofibrate inhibits the reaction [Glucose results in increased expression of CX3CL1 protein]; Fenofibrate inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA]; Fenofibrate inhibits the reaction [Glucose results in increased expression of CX3CL1 protein]; SB 203580 inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA]; SB 203580 inhibits the reaction [Glucose results in increased expression of CX3CL1 protein]
Glucose results in increased expression of CX3CL1 mRNA; Glucose results in increased expression of CX3CL1 protein 		CTD PMID:19132243 PMID:31655124 NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,233,329...10,242,999 		JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 increases expression
multiple interactions 		ISO Glucose results in increased expression of CXCL10 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CXCL10 mRNA 		CTD PMID:17178593 PMID:37567420 NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261 		JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 increases expression ISO Glucose results in increased expression of CXCL2 mRNA CTD PMID:17178593 NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255 		JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 increases expression
multiple interactions 		ISO Glucose results in increased expression of CXCL1 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CXCL1 mRNA 		CTD PMID:17178593 PMID:37567420 NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624 		JBrowse link
G Cxcl9 C-X-C motif chemokine ligand 9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CXCL9 mRNA CTD PMID:37567420 NCBI chr14:16,007,166...16,012,077
Ensembl chr14:16,007,204...16,014,299 		JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 multiple interactions ISO [Glucose co-treated with Oxygen deficiency] results in decreased expression of CXCR4 mRNA; [Glucose co-treated with Oxygen deficiency] results in decreased expression of CXCR4 protein CTD PMID:18227068 NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459 		JBrowse link
G Cyba cytochrome b-245 alpha chain increases expression
decreases expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of CYBA protein
Glucose results in decreased expression of CYBA mRNA
Glucose results in increased expression of CYBA mRNA; Glucose results in increased expression of CYBA protein
[[[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1 protein; [[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species; CYBA protein promotes the reaction [Glucose results in increased chemical synthesis of Reactive Oxygen Species]; CYBA protein promotes the reaction [Glucose results in increased expression of FN1 protein]; farrerol inhibits the reaction [Glucose results in increased expression of CYBA mRNA]; farrerol inhibits the reaction [Glucose results in increased expression of CYBA protein]; pyrazolanthrone inhibits the reaction [Glucose results in increased expression of CYBA protein]; Resveratrol inhibits the reaction [[[[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of CYBA mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of CYBA protein]
dorsomorphin inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in increased expression of CYBA protein]]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of CYBA protein]; Rosiglitazone inhibits the reaction [Glucose results in increased expression of CYBA protein] 		CTD PMID:17916771 PMID:18088078 PMID:22245600 PMID:31838053 PMID:32942007 NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214 		JBrowse link
G Cybb cytochrome b-245 beta chain multiple interactions
increases expression
increases localization 		ISO
EXP 		acetovanillone inhibits the reaction [Glucose results in increased expression of and results in increased activity of CYBB protein]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of CYBB protein]; Glucose results in increased expression of and results in increased activity of CYBB protein; Telmisartan inhibits the reaction [Glucose results in increased expression of CYBB mRNA]; Telmisartan inhibits the reaction [Glucose results in increased expression of CYBB protein]
Glucose results in increased expression of CYBB mRNA; Glucose results in increased expression of CYBB protein
dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CYBB protein]]; Resveratrol inhibits the reaction [Glucose results in increased expression of CYBB protein]
Glucose results in increased localization of CYBB protein
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CYBB protein; Prodigiosin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CYBB protein]; prolinedithiocarbamate inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CYBB protein] 		CTD PMID:19878672 PMID:21925195 PMID:22253932 PMID:26054749 PMID:31494106 More... NCBI chr  X:16,030,596...16,065,065
Ensembl chr  X:16,030,596...16,065,065 		JBrowse link
G Cycs cytochrome c, somatic affects localization
increases expression
multiple interactions 		EXP
ISO 		Glucose affects the localization of CYCS protein
Glucose results in increased expression of CYCS protein
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in increased expression of CYCS protein]]; [Glucose co-treated with Deferoxamine] results in increased expression of CYCS mRNA; diallyl trisulfide inhibits the reaction [Glucose results in increased expression of CYCS protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in increased expression of CYCS protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CYCS mRNA]; MitoTEMPO inhibits the reaction [Glucose results in increased expression of CYCS protein]
Glucose results in increased expression of CYCS mRNA; Glucose results in increased expression of CYCS protein
naringenin inhibits the reaction [Glucose affects the localization of CYCS protein]; Scopoletin inhibits the reaction [Glucose results in increased expression of CYCS protein] 		CTD PMID:23192364 PMID:31115753 PMID:33962019 PMID:37619648 PMID:39579577 NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816
Ensembl chr18:80,982,668...80,984,816 		JBrowse link
G Cyfip2 cytoplasmic FMR1 interacting protein 2 increases expression ISO Glucose results in increased expression of CYFIP2 mRNA CTD PMID:39922521 NCBI chr10:31,122,653...31,242,440
Ensembl chr10:31,122,653...31,242,440 		JBrowse link
G Cygb cytoglobin decreases expression ISO Glucose results in decreased expression of CYGB mRNA CTD PMID:32942007 NCBI chr10:102,376,506...102,386,272
Ensembl chr10:102,376,507...102,386,272 		JBrowse link
G Cym chymosin multiple interactions
increases expression 		ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CYM mRNA
Glucose results in increased expression of PGA5 mRNA 		CTD PMID:31525975 PMID:37567420 NCBI chr 2:197,516,947...197,527,307
Ensembl chr 2:197,516,950...197,527,837 		JBrowse link
G Cyp11b3 cytochrome P450, family 11, subfamily b, polypeptide 3 decreases expression EXP Glucose results in decreased expression of CYP11B2 mRNA CTD PMID:15017115 NCBI chr 7:108,689,319...108,694,808
Ensembl chr 7:108,689,165...108,694,921 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
increases expression 		ISO Polyphenols promotes the reaction [Glucose results in increased expression of CYP1A1 mRNA]
CYP1A1 protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased secretion of INS1 protein]] 		CTD PMID:21682256 PMID:31776611 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions ISO CYP1A2 protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased secretion of INS1 protein]] CTD PMID:31776611 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 multiple interactions
increases expression 		ISO [Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of CYP1B1 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of CYP1B1 protein
Glucose results in increased expression of CYP1B1 mRNA 		CTD PMID:28400208 PMID:39613055 NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142 		JBrowse link
G Cyp26b1 cytochrome P450, family 26, subfamily b, polypeptide 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CYP26B1 mRNA CTD PMID:37567420 NCBI chr 4:118,599,356...118,616,176
Ensembl chr 4:118,599,356...118,616,176 		JBrowse link
G Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 multiple interactions
increases expression 		ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CYP27B1 mRNA
Glucose results in increased expression of CYP27B1 mRNA 		CTD PMID:37567420 PMID:39922521 NCBI chr 7:64,756,626...64,761,570
Ensembl chr 7:64,756,626...64,761,570 		JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CYP2B10 mRNA CTD PMID:37567420 NCBI chr 1:90,780,468...90,859,852 JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of CYP2E1 mRNA]
Fatty Acids, Nonesterified promotes the reaction [Glucose results in increased expression of CYP2E1 protein]; jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in increased expression of CYP2E1 protein]] 		CTD PMID:33448797 PMID:39059604 NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495 		JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CYP3A13 mRNA CTD PMID:37567420 NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154 		JBrowse link
G Cyp7b1 cytochrome P450 family 7 subfamily B member 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CYP7B1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CYP7B1 mRNA CTD PMID:37567420 NCBI chr 2:102,419,011...102,586,047
Ensembl chr 2:102,419,011...102,451,804 		JBrowse link
G Cysrt1 cysteine rich tail 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CYSRT1 mRNA CTD PMID:37567420 NCBI chr 3:28,452,359...28,456,006
Ensembl chr 3:28,451,219...28,456,118 		JBrowse link
G Dach1 dachshund family transcription factor 1 increases expression ISO Glucose results in increased expression of DACH1 mRNA CTD PMID:39922521 NCBI chr15:80,936,063...81,317,746
Ensembl chr15:80,936,063...81,317,627 		JBrowse link
G Dact1 dishevelled-binding antagonist of beta-catenin 1 increases expression ISO Glucose results in increased expression of DACT1 mRNA CTD PMID:39922521 NCBI chr 6:95,526,645...95,538,625
Ensembl chr 6:95,526,690...95,551,053 		JBrowse link
G Daxx death-domain associated protein multiple interactions
affects localization 		ISO Glucose deficiency promotes the reaction [DAXX protein binds to MAP3K5 protein]
Glucose deficiency affects the localization of DAXX protein 		CTD PMID:14505347 NCBI chr20:4,971,973...4,978,062
Ensembl chr20:4,971,941...4,977,720 		JBrowse link
G Dbi diazepam binding inhibitor increases expression ISO Glucose results in increased expression of DBI mRNA CTD PMID:17178593 NCBI chr13:33,794,231...33,802,632
Ensembl chr13:33,759,845...33,821,450 		JBrowse link
G Dbn1 drebrin 1 decreases expression
multiple interactions 		EXP Glucose results in decreased expression of DBN1 mRNA; Glucose results in decreased expression of DBN1 protein
Curcumin inhibits the reaction [Glucose results in decreased expression of DBN1 mRNA] 		CTD PMID:23333261 NCBI chr17:9,155,729...9,170,121
Ensembl chr17:9,155,787...9,170,122 		JBrowse link
G Dbp D-box binding PAR bZIP transcription factor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of DBP mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DBP mRNA CTD PMID:37567420 NCBI chr 1:105,312,256...105,317,205
Ensembl chr 1:105,312,108...105,317,205 		JBrowse link
G Dclk1 doublecortin-like kinase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DCLK1 mRNA CTD PMID:37567420 NCBI chr 2:141,567,215...141,861,088
Ensembl chr 2:141,571,983...141,861,090 		JBrowse link
G Dcx doublecortin increases expression ISO Glucose results in increased expression of DCX protein CTD PMID:23776576 NCBI chr  X:112,227,455...112,370,291
Ensembl chr  X:112,227,455...112,304,161 		JBrowse link
G Ddias DNA damage-induced apoptosis suppressor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of DDIAS mRNA CTD PMID:37567420 NCBI chr 1:156,318,559...156,342,869
Ensembl chr 1:156,318,563...156,342,869 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 decreases expression
increases expression
multiple interactions 		ISO
EXP 		Glucose results in decreased expression of DDIT3 mRNA
Glucose results in increased expression of DDIT3 mRNA; Glucose results in increased expression of DDIT3 protein
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of DDIT3 protein]; Metformin inhibits the reaction [Glucose results in increased expression of DDIT3 protein]
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in increased expression of DDIT3 protein]]; [Galactose co-treated with Glucose deficiency] promotes the reaction [Leflunomide results in increased expression of DDIT3 protein]; [ginsenoside Rg3 co-treated with Acetylcysteine] inhibits the reaction [Glucose results in increased expression of DDIT3 protein]; [imeglimin co-treated with Glucose] promotes the reaction [Thapsigargin results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [Glucose results in increased expression of DDIT3 protein]; DDIT3 protein inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; DDIT3 protein inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; DDIT3 protein inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of BAX protein]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of DDIT3 mRNA]]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of DDIT3 mRNA]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of DDIT3 protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in increased expression of DDIT3 protein]
2-aminoethoxydiphenyl borate inhibits the reaction [Glucose results in increased expression of DDIT3 protein]; [imeglimin co-treated with Glucose] results in increased expression of DDIT3 mRNA; [imeglimin co-treated with Glucose] results in increased expression of DDIT3 protein; DDIT3 affects the reaction [Glucose results in decreased expression of PPARGC1A mRNA]; Gadolinium inhibits the reaction [Glucose results in increased expression of DDIT3 protein]; Glucose inhibits the reaction [DDIT3 protein binds to PPARGC1A promoter]; TRPM7 protein affects the reaction [Glucose results in increased expression of DDIT3 protein]; waixenicin A inhibits the reaction [Glucose results in increased expression of DDIT3 protein]
Glucose deficiency results in increased expression of DDIT3 mRNA; Glucose results in increased expression of DDIT3 mRNA; Glucose results in increased expression of DDIT3 protein
Glucose deficiency results in increased expression of DDIT3 protein; Glucose results in increased expression of DDIT3 protein 		CTD PMID:17178593 PMID:21337367 PMID:24349266 PMID:27226639 PMID:28482072 More... NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509 		JBrowse link
G Ddx3x DEAD-box helicase 3, X-linked increases degradation ISO Glucose deficiency results in increased degradation of DDX3X protein CTD PMID:30821613 NCBI chr  X:12,152,346...12,165,983
Ensembl chr  X:12,152,346...12,165,983 		JBrowse link
G Ddx4 DEAD-box helicase 4 increases expression ISO Glucose results in increased expression of DDX4 mRNA CTD PMID:39922521 NCBI chr 2:45,961,174...46,016,097
Ensembl chr 2:45,961,174...46,015,951 		JBrowse link
G Defb24 defensin beta 24 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of DEFB19 mRNA CTD PMID:37567420 NCBI chr 3:161,506,850...161,512,983
Ensembl chr 3:161,506,851...161,512,983 		JBrowse link
G Dek DEK proto-oncogene multiple interactions ISO DEK protein affects the chemical synthesis of and affects the uptake of Glucose CTD PMID:28558019 NCBI chr17:17,786,989...17,809,096
Ensembl chr17:17,787,139...17,810,122 		JBrowse link
G Dennd2c DENN domain containing 2C increases expression ISO Glucose results in increased expression of DENND2C mRNA CTD PMID:39613055 NCBI chr 2:193,310,822...193,378,986
Ensembl chr 2:193,335,230...193,378,978 		JBrowse link
G Depp1 DEPP autophagy regulator 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of DEPP1 mRNA CTD PMID:37567420 NCBI chr 4:151,583,105...151,585,455
Ensembl chr 4:151,581,502...151,586,233 		JBrowse link
G Derl3 derlin 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DERL3 mRNA CTD PMID:37567420 NCBI chr20:12,753,926...12,766,478
Ensembl chr20:12,762,981...12,766,477 		JBrowse link
G Deup1 deuterosome assembly protein 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of DEUP1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DEUP1 mRNA CTD PMID:37567420 NCBI chr 8:20,661,687...20,724,083
Ensembl chr 8:20,661,689...20,723,585 		JBrowse link
G Dgkd diacylglycerol kinase, delta multiple interactions
affects localization 		ISO 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine inhibits the reaction [Glucose affects the localization of DGKD protein alternative form]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose affects the localization of DGKD protein alternative form] CTD PMID:22974639 NCBI chr 9:95,964,507...96,055,160
Ensembl chr 9:95,964,148...96,055,160 		JBrowse link
G Dhh desert hedgehog signaling molecule increases expression ISO Glucose results in increased expression of DHH mRNA CTD PMID:31525975 NCBI chr 7:131,929,857...131,935,352
Ensembl chr 7:131,929,857...131,935,352 		JBrowse link
G Dhps deoxyhypusine synthase multiple interactions EXP DHPS protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr19:39,987,328...39,991,418
Ensembl chr19:39,987,324...39,991,432 		JBrowse link
G Dhrs9 dehydrogenase/reductase 9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DHRS9 mRNA CTD PMID:37567420 NCBI chr 3:74,553,357...74,579,535
Ensembl chr 3:74,555,606...74,581,376 		JBrowse link
G Dhtkd1 dehydrogenase E1 and transketolase domain containing 1 increases expression ISO Glucose results in increased expression of DHTKD1 mRNA CTD PMID:39922521 NCBI chr17:77,242,512...77,316,074
Ensembl chr17:77,264,514...77,316,071 		JBrowse link
G Dhx58 DEXH-box helicase 58 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of DHX58 mRNA CTD PMID:37567420 NCBI chr10:86,120,677...86,132,095
Ensembl chr10:86,120,677...86,131,844 		JBrowse link
G Diablo diablo, IAP-binding mitochondrial protein multiple interactions
increases expression 		ISO [Glucose co-treated with Deferoxamine] results in increased expression of DIABLO mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of DIABLO mRNA]
Glucose results in increased expression of DIABLO mRNA 		CTD PMID:33962019 NCBI chr12:38,716,668...38,731,285
Ensembl chr12:38,716,668...38,731,265 		JBrowse link
G Diaph3 diaphanous-related formin 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DIAPH3 mRNA CTD PMID:37567420 NCBI chr15:68,951,992...69,421,623
Ensembl chr15:68,951,989...69,421,552 		JBrowse link
G Diras2 DIRAS family GTPase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of DIRAS2 mRNA CTD PMID:37567420 NCBI chr17:12,882,224...12,913,366
Ensembl chr17:12,880,385...12,914,291 		JBrowse link
G Disc1 DISC1 scaffold protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of DISC1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of DISC1 mRNA CTD PMID:37567420 NCBI chr19:69,911,548...70,120,970
Ensembl chr19:69,911,976...70,120,970 		JBrowse link
G Disp2 dispatched RND transporter family member 2 increases expression
multiple interactions 		ISO Glucose results in increased expression of DISP2 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of DISP2 mRNA] 		CTD PMID:33448797 NCBI chr 3:126,216,194...126,231,724
Ensembl chr 3:126,216,218...126,231,711 		JBrowse link
G Dkk1 dickkopf WNT signaling pathway inhibitor 1 multiple interactions ISO DKK1 protein inhibits the reaction [Glucose results in decreased expression of CDH1 mRNA]; DKK1 protein inhibits the reaction [Glucose results in decreased expression of CDH1 protein]; DKK1 protein inhibits the reaction [Glucose results in increased expression of ACTA2 mRNA]; DKK1 protein inhibits the reaction [Glucose results in increased expression of ACTA2 protein]; DKK1 protein inhibits the reaction [Glucose results in increased expression of COL1A1 mRNA]; DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 mRNA]; DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 protein]; DKK1 protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; DKK1 protein inhibits the reaction [Glucose results in increased expression of LEF1 mRNA] CTD PMID:29163160 NCBI chr 1:237,794,969...237,798,650
Ensembl chr 1:237,794,969...237,798,650 		JBrowse link
G Dlk1 delta like non-canonical Notch ligand 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of DLK1 mRNA CTD PMID:37567420 NCBI chr 6:134,192,491...134,199,779
Ensembl chr 6:134,192,518...134,200,529 		JBrowse link
G Dmtn dematin actin binding protein increases methylation
multiple interactions
decreases expression 		ISO Glucose results in increased methylation of DMTN gene
fucoxanthin inhibits the reaction [Glucose results in decreased expression of DMTN mRNA] 		CTD PMID:33448797 NCBI chr15:52,087,667...52,111,956
Ensembl chr15:52,087,667...52,112,128 		JBrowse link
G Dmxl2 Dmx-like 2 increases expression ISO Glucose results in increased expression of DMXL2 mRNA CTD PMID:39922521 NCBI chr 8:63,637,314...63,803,911
Ensembl chr 8:63,637,314...63,781,116 		JBrowse link
G Dnaaf3 dynein, axonemal, assembly factor 3 increases expression ISO Glucose results in increased expression of DNAAF3 mRNA CTD PMID:39922521 NCBI chr 1:78,333,985...78,342,034
Ensembl chr 1:78,333,971...78,342,685 		JBrowse link
G Dnajb11 DnaJ heat shock protein family (Hsp40) member B11 decreases expression ISO Glucose results in decreased expression of DNAJB11 mRNA CTD PMID:17178593 NCBI chr11:91,656,334...91,672,800
Ensembl chr11:91,656,335...91,672,800 		JBrowse link
G Dnajc3 DnaJ heat shock protein family (Hsp40) member C3 decreases expression ISO Glucose results in decreased expression of DNAJC3 mRNA CTD PMID:17178593 NCBI chr15:102,432,667...102,475,643
Ensembl chr15:102,432,663...102,475,643 		JBrowse link
G Dnase1l3 deoxyribonuclease 1L3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of DNASE1L3 mRNA CTD PMID:37567420 NCBI chr15:19,351,683...19,378,536
Ensembl chr15:19,352,493...19,378,531 		JBrowse link
G Dnd1 DND microRNA-mediated repression inhibitor 1 increases expression ISO Glucose results in increased expression of DND1 mRNA CTD PMID:39922521 NCBI chr18:28,652,712...28,655,336
Ensembl chr18:28,652,712...28,655,336 		JBrowse link
G Dner delta/notch-like EGF repeat containing increases expression ISO Glucose results in increased expression of DNER mRNA CTD PMID:39613055 NCBI chr 9:93,035,108...93,350,568
Ensembl chr 9:93,035,108...93,350,568 		JBrowse link
G Dnm1l dynamin 1-like increases expression
multiple interactions 		EXP
ISO 		Glucose results in increased expression of DNM1L protein
[Glucose co-treated with Deferoxamine] results in increased expression of DNM1L mRNA; diallyl trisulfide inhibits the reaction [Glucose results in increased expression of DNM1L protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of DNM1L mRNA]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of DNM1L protein; cinnamic acid inhibits the reaction [Glucose results in increased expression of DNM1L protein]; Metformin inhibits the reaction [Glucose results in increased expression of DNM1L protein]; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of DNM1L protein] 		CTD PMID:27684054 PMID:30144576 PMID:31115753 PMID:33962019 PMID:36806343 NCBI chr11:98,084,049...98,135,663
Ensembl chr11:98,085,397...98,137,420 		JBrowse link
G Dnmt1 DNA methyltransferase 1 increases expression ISO Glucose results in increased expression of DNMT1 mRNA CTD PMID:29854080 NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119 		JBrowse link
G Dok3 docking protein 3 increases expression ISO Glucose results in increased expression of DOK3 mRNA CTD PMID:39922521 NCBI chr17:9,114,763...9,121,781
Ensembl chr17:9,114,762...9,120,335 		JBrowse link
G Dok7 docking protein 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of DOK7 mRNA CTD PMID:37567420 NCBI chr14:79,890,051...79,924,081
Ensembl chr14:79,891,367...79,932,252 		JBrowse link
G Dpep2 dipeptidase 2 increases expression ISO Glucose results in increased expression of DPEP2 mRNA CTD PMID:31525975 NCBI chr19:50,795,322...50,806,320
Ensembl chr19:50,795,327...50,801,757
Ensembl chr19:50,795,327...50,801,757 		JBrowse link
G Dpp6 dipeptidyl peptidase like 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of DPP6 mRNA CTD PMID:37567420 NCBI chr 4:8,323,220...9,242,694
Ensembl chr 4:8,324,843...9,242,209 		JBrowse link
G Dpysl5 dihydropyrimidinase-like 5 increases expression ISO Glucose results in increased expression of DPYSL5 mRNA CTD PMID:39922521 NCBI chr 6:31,295,035...31,379,348
Ensembl chr 6:31,295,035...31,379,348 		JBrowse link
G Dram1 DNA-damage regulated autophagy modulator 1 increases expression ISO Glucose results in increased expression of DRAM1 mRNA CTD PMID:39613055 NCBI chr 7:24,630,233...24,665,270
Ensembl chr 7:24,630,238...24,664,354 		JBrowse link
G Dscaml1 DS cell adhesion molecule-like 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of DSCAML1 mRNA CTD PMID:37567420 NCBI chr 8:54,637,054...54,954,042
Ensembl chr 8:54,636,932...54,954,040 		JBrowse link
G Duox1 dual oxidase 1 decreases expression ISO Glucose results in decreased expression of DUOX1 mRNA CTD PMID:32942007 NCBI chr 3:129,714,125...129,749,186
Ensembl chr 3:129,714,149...129,749,187 		JBrowse link
G Duox2 dual oxidase 2 decreases expression ISO Glucose results in decreased expression of DUOX2 mRNA CTD PMID:32942007 NCBI chr 3:129,680,543...129,698,886
Ensembl chr 3:129,680,546...129,699,203 		JBrowse link
G Dusp1 dual specificity phosphatase 1 increases expression ISO Glucose results in increased expression of DUSP1 mRNA CTD PMID:17178593 PMID:32942007 NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644 		JBrowse link
G Dusp13b dual specificity phosphatase 13B decreases expression
multiple interactions 		ISO Glucose results in decreased expression of DUSP13B mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of DUSP13B mRNA] 		CTD PMID:31525975 PMID:33448797 NCBI chr15:2,616,761...2,624,434
Ensembl chr15:2,609,049...2,624,887 		JBrowse link
G Dusp2 dual specificity phosphatase 2 increases expression ISO Glucose results in increased expression of DUSP2 mRNA CTD PMID:17178593 PMID:39922521 NCBI chr 3:135,009,636...135,011,821
Ensembl chr 3:135,009,590...135,011,809 		JBrowse link
G Dusp5 dual specificity phosphatase 5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of DUSP5 mRNA CTD PMID:37567420 NCBI chr 1:262,543,774...262,557,201
Ensembl chr 1:262,543,738...262,562,417 		JBrowse link
G Dusp6 dual specificity phosphatase 6 increases expression ISO Glucose results in increased expression of DUSP6 mRNA CTD PMID:17178593 NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:35,977,921...35,983,833 		JBrowse link
G Dzank1 double zinc ribbon and ankyrin repeat domains 1 increases expression ISO Glucose results in increased expression of DZANK1 mRNA CTD PMID:39922521 NCBI chr 3:152,309,228...152,361,548
Ensembl chr 3:152,309,228...152,361,548 		JBrowse link
G Ebln1l1 endogenous Bornavirus like nucleoprotein 1 like 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of IGKV8-24 mRNA CTD PMID:37567420 NCBI chr10:79,435,547...79,437,553 JBrowse link
G Ecm2 extracellular matrix protein 2 increases expression ISO Glucose results in increased expression of ECM2 mRNA CTD PMID:39922521 NCBI chr17:15,326,359...15,358,938
Ensembl chr17:15,326,359...15,358,855 		JBrowse link
G Edaradd EDAR associated via death domain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of EDARADD mRNA CTD PMID:37567420 NCBI chr17:92,850,791...92,894,808
Ensembl chr17:92,831,613...92,894,361 		JBrowse link
G Edem1 ER degradation enhancing alpha-mannosidase like protein 1 decreases expression ISO Glucose results in decreased expression of EDEM1 mRNA CTD PMID:17178593 NCBI chr 4:143,350,989...143,385,693
Ensembl chr 4:143,353,624...143,388,060 		JBrowse link
G Edn1 endothelin 1 multiple interactions
decreases expression
increases expression 		ISO
EXP 		carvedilol inhibits the reaction [Glucose results in increased expression of EDN1 mRNA]; carvedilol inhibits the reaction [Glucose results in increased expression of EDN1 protein]; CAT protein inhibits the reaction [Glucose promotes the reaction [EDN1 protein results in increased chemical synthesis of Inositol 1,4,5-Trisphosphate]]; CEBPA protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]; CEBPA protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]; CEBPB protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]; CEBPB protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]; CEBPD protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]; CEBPD protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]; diphenyleneiodonium inhibits the reaction [Glucose promotes the reaction [EDN1 protein results in increased chemical synthesis of Inositol 1,4,5-Trisphosphate]]; Glucose promotes the reaction [CEBPA protein binds to EDN1 promoter]; Glucose promotes the reaction [CEBPB protein binds to EDN1 promoter]; Glucose promotes the reaction [CEBPD protein binds to EDN1 promoter]; Glucose promotes the reaction [EDN1 protein results in increased chemical synthesis of Inositol 1,4,5-Trisphosphate]; pyrazolanthrone inhibits the reaction [Glucose results in increased expression of EDN1 mRNA]; resveratrol inhibits the reaction [Glucose results in increased expression of EDN1 mRNA]; SB 203580 inhibits the reaction [Glucose results in increased expression of EDN1 mRNA]; U 0126 inhibits the reaction [Glucose results in increased expression of EDN1 mRNA]
Glucose results in decreased expression of EDN1 mRNA
Glucose results in increased expression of EDN1 mRNA; Glucose results in increased expression of EDN1 protein
Glucose affects the reaction [EDN1 protein affects the abundance of and affects the localization of Calcium]; HIF1A protein affects the reaction [Glucose results in increased expression of EDN1 protein]; MIR217 mRNA affects the reaction [Glucose results in increased expression of EDN1 protein]; resveratrol inhibits the reaction [Glucose results in increased expression of EDN1 protein]; SIRT1 protein affects the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of EDN1 protein]] 		CTD PMID:12821678 PMID:16428915 PMID:20691780 PMID:20960276 PMID:24376792 More... NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687 		JBrowse link
G Edn3 endothelin 3 multiple interactions EXP EDN3 protein inhibits the reaction [SLC5A2 protein results in increased uptake of Glucose] CTD PMID:15127950 NCBI chr 3:183,980,458...184,004,958
Ensembl chr 3:183,980,668...184,005,329 		JBrowse link
G Ednra endothelin receptor type A increases expression ISO Glucose results in increased expression of EDNRA mRNA CTD PMID:31655124 NCBI chr19:47,137,360...47,207,961
Ensembl chr19:47,137,771...47,201,284 		JBrowse link
G Eef1a1 eukaryotic translation elongation factor 1 alpha 1 multiple interactions EXP EEF1A1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 8:88,221,839...88,225,688
Ensembl chr 8:88,221,843...88,225,072 		JBrowse link
G Eef2 eukaryotic translation elongation factor 2 multiple interactions
decreases phosphorylation 		ISO resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of EEF2 protein] CTD PMID:19765649 NCBI chr 7:9,183,836...9,196,255
Ensembl chr 7:9,183,961...9,189,544 		JBrowse link
G Eef2k eukaryotic elongation factor-2 kinase multiple interactions
increases phosphorylation 		ISO resveratrol inhibits the reaction [Glucose results in increased phosphorylation of EEF2K protein] CTD PMID:19765649 NCBI chr 1:184,824,420...184,888,048
Ensembl chr 1:184,824,420...184,888,048 		JBrowse link
G Efcab8 EF-hand calcium binding domain 8 increases expression ISO Glucose results in increased expression of EFCAB8 mRNA CTD PMID:39922521 NCBI chr 3:162,717,381...162,783,900
Ensembl chr 3:162,717,494...162,783,899 		JBrowse link
G Efhc1 EF-hand domain containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of EFHC1 mRNA CTD PMID:37567420 NCBI chr 9:30,872,238...30,910,703
Ensembl chr 9:30,871,565...30,910,703 		JBrowse link
G Efna3 ephrin A3 increases expression ISO Glucose results in increased expression of EFNA3 mRNA CTD PMID:39922521 NCBI chr 2:177,026,928...177,035,838
Ensembl chr 2:177,026,933...177,044,843 		JBrowse link
G Egf epidermal growth factor multiple interactions ISO EGF protein inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA]; EGF protein promotes the reaction [Glucose results in increased expression of TGFA mRNA]; Glucose promotes the reaction [EGF protein results in increased expression of TGFA mRNA] CTD PMID:8638660 PMID:19816600 NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297 		JBrowse link
G Egfr epidermal growth factor receptor multiple interactions ISO [Palmitic Acid co-treated with Glucose] results in increased phosphorylation of EGFR protein; albiflorin inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased phosphorylation of EGFR protein]; zhenwu decoction inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased phosphorylation of EGFR protein] CTD PMID:37523837 NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358 		JBrowse link
G Egr1 early growth response 1 multiple interactions
increases expression 		ISO Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA]]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of EGR1 mRNA
Glucose results in increased expression of EGR1 mRNA 		CTD PMID:17178593 PMID:19225232 PMID:37567420 NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843 		JBrowse link
G Egr2 early growth response 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of EGR2 mRNA CTD PMID:37567420 NCBI chr20:21,050,149...21,055,201
Ensembl chr20:21,050,149...21,057,748 		JBrowse link
G Ehd3 EH-domain containing 3 multiple interactions EXP EHD3 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 6:27,392,709...27,417,445
Ensembl chr 6:27,392,709...27,417,445 		JBrowse link
G Ehhadh enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EHHADH mRNA CTD PMID:37567420 NCBI chr11:92,746,409...92,779,647
Ensembl chr11:92,746,420...92,779,662 		JBrowse link
G Eif2a eukaryotic translation initiation factor 2A multiple interactions ISO [imeglimin co-treated with Glucose] inhibits the reaction [Thapsigargin results in increased phosphorylation of EIF2A protein] CTD PMID:34588186 NCBI chr 2:144,911,247...144,944,705
Ensembl chr 2:144,911,153...144,945,201 		JBrowse link
G Eif2ak2 eukaryotic translation initiation factor 2-alpha kinase 2 multiple interactions
increases phosphorylation 		ISO acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Glucose results in increased phosphorylation of EIF2AK2 protein]; Glucose promotes the reaction [EIF2AK2 protein results in increased activity of MAPK14 protein] CTD PMID:18973755 NCBI chr 6:21,941,147...21,977,115
Ensembl chr 6:21,952,631...21,977,116 		JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 multiple interactions
increases phosphorylation 		ISO
EXP 		2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in increased phosphorylation of EIF2AK3 protein]]; 4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased phosphorylation of EIF2AK3 protein]; [Acetylcysteine co-treated with ginsenoside Rg3] inhibits the reaction [Glucose results in increased phosphorylation of EIF2AK3 protein]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased phosphorylation of EIF2AK3 protein]]; ginsenoside Re inhibits the reaction [Glucose results in increased phosphorylation of EIF2AK3 protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in increased phosphorylation of EIF2AK3 protein]
Chlorogenic Acid inhibits the reaction [Glucose results in increased phosphorylation of EIF2AK3 protein]; Metformin inhibits the reaction [Glucose results in increased phosphorylation of EIF2AK3 protein]
Glucose deficiency results in increased phosphorylation of EIF2AK3 protein; Glucose results in increased phosphorylation of EIF2AK3 protein 		CTD PMID:31022492 PMID:34801538 PMID:39579577 PMID:39798073 NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268 		JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2 subunit alpha multiple interactions
increases phosphorylation 		ISO
EXP 		acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Glucose results in increased phosphorylation of EIF2S1 protein]
Chlorogenic Acid inhibits the reaction [Glucose results in increased phosphorylation of EIF2S1 protein]; Metformin inhibits the reaction [Glucose results in increased phosphorylation of EIF2S1 protein]
4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased phosphorylation of EIF2S1 protein]; salubrinal inhibits the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased phosphorylation of EIF2S1 protein]] 		CTD PMID:18973755 PMID:31022492 PMID:34801538 NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649 		JBrowse link
G Eif4a1 eukaryotic translation initiation factor 4A1 increases degradation ISO Glucose deficiency results in increased degradation of EIF4A1 protein CTD PMID:30821613 NCBI chr10:54,883,093...54,888,602
Ensembl chr10:54,883,093...54,888,602 		JBrowse link
G Eif4e eukaryotic translation initiation factor 4E increases phosphorylation
multiple interactions 		ISO Glucose results in increased phosphorylation of EIF4E protein
Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]; resveratrol inhibits the reaction [Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]]; resveratrol inhibits the reaction [Glucose results in increased phosphorylation of EIF4E protein] 		CTD PMID:19765649 NCBI chr 2:229,736,309...229,772,628
Ensembl chr 2:229,739,897...229,774,105 		JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 multiple interactions EXP
ISO 		resveratrol inhibits the reaction [Glucose results in increased phosphorylation of EIF4EBP1 protein]
[AKT1 protein mutant form results in increased susceptibility to Glucose deficiency] which results in increased phosphorylation of EIF4EBP1 protein 		CTD PMID:15806154 PMID:20332614 NCBI chr16:71,495,457...71,508,845
Ensembl chr16:71,487,930...71,508,874 		JBrowse link
G Eif4g1 eukaryotic translation initiation factor 4 gamma 1 multiple interactions ISO Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]; resveratrol inhibits the reaction [Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]] CTD PMID:19765649 NCBI chr11:93,726,322...93,746,387
Ensembl chr11:93,726,322...93,746,367 		JBrowse link
G Eif4h eukaryotic translation initiation factor 4H increases degradation ISO Glucose deficiency results in increased degradation of EIF4H protein CTD PMID:30821613 NCBI chr12:27,719,527...27,736,350
Ensembl chr12:27,719,321...27,736,346 		JBrowse link
G Elapor1 endosome-lysosome associated apoptosis and autophagy regulator 1 increases expression
multiple interactions 		ISO Glucose results in increased expression of ELAPOR1 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of ELAPOR1 mRNA] 		CTD PMID:31525975 PMID:33448797 NCBI chr 2:198,777,323...198,856,497
Ensembl chr 2:198,777,323...198,856,497 		JBrowse link
G Elfn2 extracellular leucine-rich repeat and fibronectin type III domain containing 2 decreases expression ISO Glucose results in decreased expression of ELFN2 mRNA CTD PMID:39613055 NCBI chr 7:112,101,998...112,153,280
Ensembl chr 7:112,074,331...112,153,451 		JBrowse link
G Elk3 ETS transcription factor ELK3 increases expression ISO Glucose results in increased expression of ELK3 mRNA CTD PMID:17178593 NCBI chr 7:29,655,676...29,718,163
Ensembl chr 7:29,655,693...29,691,661 		JBrowse link
G Elovl6 ELOVL fatty acid elongase 6 increases expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of ELOVL6 mRNA
(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA] 		CTD PMID:15066988 PMID:16790840 PMID:32613381 NCBI chr 2:220,738,095...220,845,528
Ensembl chr 2:220,738,064...220,845,549 		JBrowse link
G Emc1 ER membrane protein complex subunit 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of EMC1 mRNA CTD PMID:37567420 NCBI chr 5:156,891,773...156,917,092
Ensembl chr 5:156,891,773...156,917,092 		JBrowse link
G Endog endonuclease G multiple interactions
affects localization 		ISO
EXP 		[Glucose deficiency co-treated with Acetylcysteine] affects the localization of ENDOG protein; [Glucose deficiency co-treated with CAT] affects the localization of ENDOG protein; [Glucose deficiency co-treated with Tetradecanoylphorbol Acetate] affects the localization of ENDOG protein
Glucose affects the localization of ENDOG protein 		CTD PMID:17309078 PMID:23192364 NCBI chr 3:33,846,935...33,849,531
Ensembl chr 3:33,846,885...33,849,573 		JBrowse link
G Enkur enkurin, TRPC channel interacting protein multiple interactions
increases expression 		ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ENKUR mRNA
Glucose results in increased expression of ENKUR mRNA 		CTD PMID:37567420 PMID:39922521 NCBI chr17:88,599,057...88,622,668
Ensembl chr17:88,599,057...88,622,668 		JBrowse link
G Eno1 enolase 1 decreases secretion ISO Glucose deficiency results in decreased secretion of ENO1 protein CTD PMID:24802182 NCBI chr 5:166,002,867...166,014,252
Ensembl chr 3:77,946,261...77,986,003
Ensembl chr 5:77,946,261...77,986,003 		JBrowse link
G Eno2 enolase 2 increases secretion ISO Glucose deficiency results in increased secretion of ENO2 protein CTD PMID:24802182 NCBI chr 4:159,258,371...159,267,220
Ensembl chr 4:159,258,371...159,267,220 		JBrowse link
G Enpp1 ectonucleotide pyrophosphatase/phosphodiesterase 1 increases expression ISO Glucose results in increased expression of ENPP1 mRNA CTD PMID:39922521 NCBI chr 1:22,518,051...22,583,044
Ensembl chr 1:22,518,069...22,583,044 		JBrowse link
G Entpd1 ectonucleoside triphosphate diphosphohydrolase 1 increases expression ISO Glucose results in increased expression of ENTPD1 mRNA CTD PMID:31525975 NCBI chr 1:249,374,810...249,502,310
Ensembl chr 1:249,374,836...249,502,317 		JBrowse link
G Entpd4 ectonucleoside triphosphate diphosphohydrolase 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ENTPD4 mRNA CTD PMID:37567420 NCBI chr15:51,040,665...51,068,450
Ensembl chr15:51,040,673...51,068,441 		JBrowse link
G Ep300 E1A binding protein p300 multiple interactions
increases expression 		ISO [cobaltous chloride co-treated with Glucose] promotes the reaction [HIF1A protein binds to EP300 protein]; ERCC1 protein affects the reaction [Glucose results in increased expression of EP300 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of EP300 mRNA]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] promotes the reaction [HIF1A protein binds to EP300 protein]] CTD PMID:22228707 PMID:25192544 PMID:26045780 NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:114,946,982...115,058,574 		JBrowse link
G Epb42 erythrocyte membrane protein band 4.2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EPB42 mRNA CTD PMID:37567420 NCBI chr 3:128,433,460...128,451,683
Ensembl chr 3:128,433,464...128,451,683 		JBrowse link
G Epcam epithelial cell adhesion molecule increases expression ISO Glucose results in increased expression of EPCAM mRNA CTD PMID:39922521 NCBI chr 6:12,633,715...12,649,678
Ensembl chr 6:12,631,611...12,649,702 		JBrowse link
G Epha1 Eph receptor A1 increases expression ISO Glucose results in increased expression of EPHA1 mRNA CTD PMID:39922521 NCBI chr 4:72,213,022...72,227,543
Ensembl chr 4:72,213,037...72,227,474 		JBrowse link
G Ephx4 epoxide hydrolase 4 decreases expression ISO Glucose results in decreased expression of EPHX4 mRNA CTD PMID:31525975 NCBI chr14:2,488,282...2,517,558
Ensembl chr14:2,488,290...2,517,757 		JBrowse link
G Epo erythropoietin multiple interactions ISO [EPO protein co-treated with Glucose] results in increased expression of RUNX2 mRNA; [EPO protein co-treated with Glucose] results in increased expression of RUNX2 protein; [EPO protein co-treated with Glucose] results in increased expression of SP7 mRNA; [EPO protein co-treated with Glucose] results in increased expression of SP7 protein CTD PMID:30894315 NCBI chr12:24,841,285...24,844,725
Ensembl chr12:24,841,285...24,844,725 		JBrowse link
G Epop elongin BC and polycomb repressive complex 2 associated protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EPOP mRNA CTD PMID:37567420 NCBI chr10:83,120,767...83,122,287
Ensembl chr10:83,119,970...83,122,423 		JBrowse link
G Eppk1 epiplakin 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of EPPK1 mRNA CTD PMID:37567420 NCBI chr 7:109,697,607...109,718,468
Ensembl chr 7:109,697,607...109,718,468 		JBrowse link
G Epsti1 epithelial stromal interaction 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of EPSTI1 mRNA CTD PMID:37567420 NCBI chr15:59,692,712...59,791,376
Ensembl chr15:59,693,142...59,791,380 		JBrowse link
G Erbb2 erb-b2 receptor tyrosine kinase 2 multiple interactions ISO [Glucose deficiency co-treated with Quercetin] results in increased ubiquitination of ERBB2 protein; Glucose deficiency inhibits the reaction [Quercetin promotes the reaction [ERBB2 protein binds to HSP90AA1 protein]] CTD PMID:18655187 NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481 		JBrowse link
G Erbb3 erb-b2 receptor tyrosine kinase 3 multiple interactions EXP [NRG1 protein binds to ERBB3 protein] which results in increased transport of Glucose CTD PMID:14711829 NCBI chr 7:1,579,079...1,600,379
Ensembl chr 7:1,579,816...1,601,120 		JBrowse link
G Ercc1 ERCC excision repair 1, endonuclease non-catalytic subunit multiple interactions
increases expression 		ISO 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC1 mRNA]; 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC1 protein]; Curcumin inhibits the reaction [Glucose results in increased expression of ERCC1 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of ERCC1 protein]; ERCC1 protein affects the reaction [Glucose results in increased expression of EP300 mRNA]; ERCC1 protein affects the reaction [Glucose results in increased expression of ERCC4 mRNA]; ERCC1 protein affects the reaction [Glucose results in increased expression of ERCC4 protein]; ERCC1 protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; ERCC1 protein affects the reaction [Glucose results in increased expression of PARP1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of ERCC1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of ERCC1 protein]; trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC1 mRNA]; trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC1 protein]
Glucose results in increased expression of ERCC1 mRNA; Glucose results in increased expression of ERCC1 protein 		CTD PMID:22228707 NCBI chr 1:88,099,308...88,135,966
Ensembl chr 1:88,118,891...88,139,120 		JBrowse link
G Ercc4 ERCC excision repair 4, endonuclease catalytic subunit increases expression
multiple interactions 		ISO Glucose results in increased expression of ERCC4 mRNA; Glucose results in increased expression of ERCC4 protein
3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]; 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC4 protein]; Curcumin inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of ERCC4 protein]; ERCC1 protein affects the reaction [Glucose results in increased expression of ERCC4 mRNA]; ERCC1 protein affects the reaction [Glucose results in increased expression of ERCC4 protein]; ERCC4 protein affects the reaction [Glucose results in increased expression of EP300 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of ERCC1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of ERCC1 protein]; ERCC4 protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of PARP1 mRNA]; trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]; trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC4 protein] 		CTD PMID:22228707 NCBI chr10:2,926,085...2,958,176
Ensembl chr10:2,920,455...2,955,539 		JBrowse link
G Erich5 glutamate-rich 5 increases expression ISO Glucose results in increased expression of ERICH5 mRNA CTD PMID:39922521 NCBI chr 7:67,538,154...67,569,433
Ensembl chr 7:67,536,588...67,563,989 		JBrowse link
G Ern1 endoplasmic reticulum to nucleus signaling 1 increases phosphorylation
multiple interactions 		ISO
EXP 		Glucose deficiency results in increased phosphorylation of ERN1 protein; Glucose results in increased phosphorylation of ERN1 protein
[imeglimin co-treated with Glucose] results in increased expression of ERN1 mRNA
Chlorogenic Acid inhibits the reaction [Glucose results in increased phosphorylation of ERN1 protein]; Metformin inhibits the reaction [Glucose results in increased phosphorylation of ERN1 protein]
4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased phosphorylation of ERN1 protein]; [Glucose co-treated with TGFB1 protein] results in increased phosphorylation of ERN1 protein; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased phosphorylation of ERN1 protein]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased phosphorylation of ERN1 protein]]; ginsenoside Re inhibits the reaction [Glucose results in increased phosphorylation of ERN1 protein] 		CTD PMID:31022492 PMID:34588186 PMID:34801538 PMID:35961541 PMID:39798073 NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,830,428...91,920,791 		JBrowse link
G Ern2 endoplasmic reticulum to nucleus signaling 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ERN2 mRNA CTD PMID:37567420 NCBI chr 1:186,153,115...186,174,521
Ensembl chr 1:186,157,691...186,174,521 		JBrowse link
G Ero1a endoplasmic reticulum oxidoreductase 1 alpha decreases expression
multiple interactions
increases expression 		ISO
EXP 		Glucose results in decreased expression of ERO1A mRNA
[imeglimin co-treated with Glucose] results in increased expression of ERO1A mRNA
Glucose results in increased expression of ERO1A protein
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of ERO1A protein]; Metformin inhibits the reaction [Glucose results in increased expression of ERO1A protein] 		CTD PMID:17178593 PMID:34588186 PMID:34801538 NCBI chr15:20,974,771...21,010,170
Ensembl chr15:20,972,679...21,018,039 		JBrowse link
G Esr1 estrogen receptor 1 increases expression
multiple interactions
increases abundance
increases phosphorylation
decreases expression 		ISO
EXP 		Glucose results in increased expression of ESR1 mRNA
Endosulfan promotes the reaction [ESR1 protein results in increased abundance of Glucose]
Glucose results in increased phosphorylation of ESR1 protein
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of ESR1 mRNA; ESR1 protein promotes the reaction [[Resveratrol results in increased localization of SLC2A4 protein] which results in increased uptake of Glucose]; tetrahydropalmatine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of ESR1 mRNA]
Glucose results in decreased expression of ESR1 mRNA 		CTD PMID:16621514 PMID:18426865 PMID:23690508 PMID:31520823 PMID:37606869 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Esr2 estrogen receptor 2 increases expression
decreases expression 		ISO Glucose results in increased expression of ESR2 mRNA
Glucose results in decreased expression of ESR2 mRNA 		CTD PMID:16621514 NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709 		JBrowse link
G Esrp1 epithelial splicing regulatory protein 1 increases expression
multiple interactions 		ISO Glucose results in increased expression of ESRP1 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of ESRP1 mRNA] 		CTD PMID:33448797 NCBI chr 5:29,224,831...29,279,381
Ensembl chr 5:29,225,360...29,279,278 		JBrowse link
G Esrra estrogen related receptor, alpha decreases expression
multiple interactions 		ISO Glucose results in decreased expression of ESRRA protein
resveratrol inhibits the reaction [Glucose results in decreased expression of ESRRA protein] 		CTD PMID:23090186 NCBI chr 1:213,533,309...213,543,432
Ensembl chr 1:213,533,310...213,543,811 		JBrowse link
G Ezr ezrin multiple interactions
decreases expression 		ISO Eucalyptol inhibits the reaction [Glucose results in decreased expression of EZR protein] CTD PMID:31483951 NCBI chr 1:49,373,033...49,416,573
Ensembl chr 1:49,373,035...49,416,573 		JBrowse link
G F13a1 coagulation factor XIII A1 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of F13A1 mRNA CTD PMID:37567420 NCBI chr17:28,021,197...28,197,960
Ensembl chr17:28,020,845...28,197,948 		JBrowse link
G F2r coagulation factor II (thrombin) receptor decreases expression ISO Glucose results in decreased expression of F2R mRNA CTD PMID:31655124 NCBI chr 2:28,604,066...28,620,579
Ensembl chr 2:28,604,066...28,620,579 		JBrowse link
G F3 coagulation factor III, tissue factor multiple interactions
increases expression 		ISO Fluorometholone inhibits the reaction [Glucose results in increased expression of F3 mRNA]; Fluorometholone inhibits the reaction [Glucose results in increased expression of F3 protein]
Glucose results in increased expression of F3 mRNA; Glucose results in increased expression of F3 protein 		CTD PMID:35264022 NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369 		JBrowse link
G F7 coagulation factor VII multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of F7 mRNA CTD PMID:37567420 NCBI chr16:83,191,896...83,202,775
Ensembl chr16:83,191,914...83,202,738 		JBrowse link
G Fabp1 fatty acid binding protein 1 increases expression ISO Glucose results in increased expression of FABP1 mRNA CTD PMID:36156098 NCBI chr 4:104,744,302...104,753,119
Ensembl chr 4:104,744,309...104,753,113 		JBrowse link
G Fabp4 fatty acid binding protein 4 multiple interactions
increases expression 		ISO
EXP 		[Glucose deficiency co-treated with ALB protein] results in decreased expression of FABP4 mRNA; [Glucose deficiency co-treated with Clofibrate co-treated with Oleic Acid] results in increased expression of FABP4 mRNA; [Glucose deficiency co-treated with Clofibrate] results in increased expression of FABP4 mRNA; [Glucose deficiency co-treated with Oleic Acid] results in increased expression of FABP4 mRNA
[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]; dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]
Glucose results in increased expression of FABP4 mRNA 		CTD PMID:3299706 PMID:8536680 PMID:32407875 NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972 		JBrowse link
G Fam151b family with sequence similarity 151, member B increases expression ISO Glucose results in increased expression of FAM151B mRNA CTD PMID:39922521 NCBI chr 2:25,409,382...25,446,225
Ensembl chr 2:25,409,383...25,445,466 		JBrowse link
G Fam163a family with sequence similarity 163, member A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of FAM163A mRNA CTD PMID:37567420 NCBI chr13:70,813,129...70,891,410
Ensembl chr13:70,813,134...70,891,316 		JBrowse link
G Fam163b family with sequence similarity 163, member B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FAM163B mRNA CTD PMID:37567420 NCBI chr 3:30,834,145...30,865,802
Ensembl chr 3:30,834,146...30,864,530 		JBrowse link
G Fam167a family with sequence similarity 167, member A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FAM167A mRNA CTD PMID:37567420 NCBI chr15:41,861,271...41,891,427
Ensembl chr15:41,861,227...41,891,418 		JBrowse link
G Fam178b family with sequence similarity 178, member B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of FAM178B mRNA CTD PMID:37567420 NCBI chr 9:46,301,734...46,409,571
Ensembl chr 9:46,301,734...46,410,686 		JBrowse link
G Fam184b family with sequence similarity 184, member B increases expression ISO Glucose results in increased expression of FAM184B mRNA CTD PMID:39922521 NCBI chr14:69,688,031...69,803,922
Ensembl chr14:69,688,031...69,803,922 		JBrowse link
G Fam217a family with sequence similarity 217, member A increases expression ISO Glucose results in increased expression of FAM217A mRNA CTD PMID:39922521 NCBI chr17:30,180,403...30,186,833
Ensembl chr17:30,172,057...30,186,825 		JBrowse link
G Fam227a family with sequence similarity 227, member A increases expression ISO Glucose results in increased expression of FAM227A mRNA CTD PMID:39922521 NCBI chr 7:113,054,751...113,096,898
Ensembl chr 7:113,054,751...113,096,868 		JBrowse link
G Fam24a family with sequence similarity 24, member A increases expression ISO Glucose results in increased expression of FAM24A mRNA CTD PMID:39922521 NCBI chr 1:195,550,911...195,553,115
Ensembl chr 1:195,546,211...195,554,086 		JBrowse link
G Fam78b family with sequence similarity 78, member B decreases expression
multiple interactions 		ISO Glucose results in decreased expression of FAM78B mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of FAM78B mRNA] 		CTD PMID:33448797 NCBI chr13:81,695,329...81,783,881
Ensembl chr13:81,695,329...81,781,784 		JBrowse link
G Fam83c family with sequence similarity 83, member C multiple interactions
increases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of FAM83C mRNA] CTD PMID:33448797 NCBI chr 3:164,792,258...164,799,882
Ensembl chr 3:164,793,105...164,799,995 		JBrowse link
G Fam98c family with sequence similarity 98, member C decreases expression
multiple interactions 		ISO Glucose results in decreased expression of FAM98C mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of FAM98C mRNA] 		CTD PMID:33448797 NCBI chr 1:93,580,286...93,583,894
Ensembl chr 1:93,580,287...93,583,831 		JBrowse link
G Fas Fas cell surface death receptor increases expression
decreases expression
multiple interactions 		ISO Glucose results in increased expression of FAS mRNA; Glucose results in increased expression of FAS protein
Glucose results in decreased expression of FAS mRNA
dorsomorphin inhibits the reaction [platycodin D inhibits the reaction [Glucose results in increased expression of FAS mRNA]]; dorsomorphin inhibits the reaction [platycodin D inhibits the reaction [Glucose results in increased expression of FAS protein]]; platycodin D inhibits the reaction [Glucose results in increased expression of FAS mRNA]; platycodin D inhibits the reaction [Glucose results in increased expression of FAS protein]; STO 609 inhibits the reaction [platycodin D inhibits the reaction [Glucose results in increased expression of FAS mRNA]] 		CTD PMID:23319015 PMID:31655124 NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104 		JBrowse link
G Faslg Fas ligand increases expression
multiple interactions 		ISO Glucose results in increased expression of FASLG mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of FASL mRNA 		CTD PMID:31655124 PMID:37567420 NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503 		JBrowse link
G Fasn fatty acid synthase increases expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of FASN mRNA
Allopurinol inhibits the reaction [Glucose results in increased expression of FASN protein]; Glucose promotes the reaction [SREBF1 protein binds to FASN promoter]; Quercetin inhibits the reaction [Glucose results in increased expression of FASN protein]
[Glucose results in increased expression of FASN protein] which results in increased abundance of Triglycerides; [INS protein co-treated with Glucose] results in increased expression of FASN mRNA; [Resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [[Glucose results in increased expression of FASN protein] which results in increased abundance of Triglycerides]; Allopurinol inhibits the reaction [Glucose results in increased expression of FASN protein]; PRKAA2 protein promotes the reaction [SIRT1 protein inhibits the reaction [Glucose results in increased expression of FASN protein]]; Quercetin inhibits the reaction [Glucose results in increased expression of FASN protein]; SIRT1 protein inhibits the reaction [Glucose results in increased expression of FASN protein]; SRT1720 inhibits the reaction [[INS protein co-treated with Glucose] results in increased expression of FASN mRNA] 		CTD PMID:15066988 PMID:18482975 PMID:19724016 PMID:22031849 PMID:23647015 NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583 		JBrowse link
G Fat3 FAT atypical cadherin 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of FAT3 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FAT3 mRNA CTD PMID:37567420 NCBI chr 8:20,972,840...21,555,679
Ensembl chr 8:20,972,840...21,555,240 		JBrowse link
G Faxc failed axon connections homolog, metaxin like GST domain containing multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FAXC mRNA CTD PMID:37567420 NCBI chr 5:40,277,167...40,336,503
Ensembl chr 5:40,277,135...40,344,076 		JBrowse link
G Fbp2 fructose-bisphosphatase 2 multiple interactions
decreases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of FBP2 mRNA] CTD PMID:33448797 NCBI chr17:2,241,767...2,259,371
Ensembl chr17:2,241,975...2,259,366 		JBrowse link
G Fbxl13 F-box and leucine-rich repeat protein 13 increases expression ISO Glucose results in increased expression of FBXL13 mRNA CTD PMID:31525975 NCBI chr 4:14,307,032...14,505,491
Ensembl chr 4:14,307,096...14,499,585 		JBrowse link
G Fbxo10 F-box protein 10 increases expression ISO Glucose results in increased expression of FBXO10 mRNA CTD PMID:39613055 NCBI chr 5:64,092,709...64,139,054
Ensembl chr 5:64,092,709...64,160,923 		JBrowse link
G Fbxo32 F-box protein 32 multiple interactions
increases expression 		ISO FBXO32 protein affects the reaction [Glucose results in decreased expression of KCNN2 protein]
Glucose results in increased expression of FBXO32 protein 		CTD PMID:30635400 NCBI chr 7:91,620,925...91,654,491
Ensembl chr 7:91,620,925...91,654,491 		JBrowse link
G Fbxo43 F-box protein 43 increases expression ISO Glucose results in increased expression of FBXO43 mRNA CTD PMID:39922521 NCBI chr 7:69,218,298...69,231,873
Ensembl chr 7:69,218,299...69,230,310 		JBrowse link
G Fbxo47 F-box protein 47 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FBXO47 mRNA CTD PMID:37567420 NCBI chr10:83,331,750...83,376,669
Ensembl chr10:83,338,060...83,376,781 		JBrowse link
G Fbxo48 F-box protein 48 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of FBXO48 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FBXO48 mRNA CTD PMID:37567420 NCBI chr14:95,582,493...95,583,950
Ensembl chr14:95,581,279...95,587,616 		JBrowse link
G Fbxw12 F-box and WD repeat domain containing 12 increases expression ISO Glucose results in increased expression of FBXW12 CTD PMID:36073553 NCBI chr 8:118,660,777...118,680,565
Ensembl chr 8:118,660,605...118,680,572 		JBrowse link
G Fcer1g Fc epsilon receptor Ig decreases expression ISO Glucose results in decreased expression of FCER1G mRNA CTD PMID:31525975 NCBI chr13:86,181,908...86,186,766
Ensembl chr13:86,181,908...86,186,859 		JBrowse link
G Fcgr3a Fc gamma receptor 3A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of FCGR4 mRNA CTD PMID:37567420 NCBI chr13:85,782,636...85,792,656
Ensembl chr13:85,782,490...85,792,651 		JBrowse link
G Fcho1 FCH and mu domain containing endocytic adaptor 1 multiple interactions
decreases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of FCHO1 mRNA] CTD PMID:33448797 NCBI chr16:18,447,424...18,464,738
Ensembl chr16:18,447,424...18,464,698 		JBrowse link
G Fcrlb Fc receptor-like B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FCRLB mRNA CTD PMID:37567420 NCBI chr13:85,681,403...85,689,880
Ensembl chr13:85,682,472...85,688,707 		JBrowse link
G Fdft1 farnesyl diphosphate farnesyl transferase 1 decreases expression ISO Glucose results in decreased expression of FDFT1 mRNA CTD PMID:39613055 NCBI chr15:41,588,114...41,616,168
Ensembl chr15:41,588,117...41,616,168 		JBrowse link
G Fen1 flap structure-specific endonuclease 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of FEN1 mRNA CTD PMID:37567420 NCBI chr 1:216,270,016...216,274,873
Ensembl chr 1:216,269,163...216,275,016 		JBrowse link
G Fendrr FOXF1 adjacent non-coding developmental regulatory RNA multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of FENDRR mRNA CTD PMID:37567420 NCBI chr19:66,035,910...66,061,466
Ensembl chr19:66,036,856...66,044,268 		JBrowse link
G Ffar1 free fatty acid receptor 1 decreases expression
multiple interactions 		EXP
ISO 		Glucose results in decreased expression of FFAR1 mRNA
[FFAR1 protein affects the susceptibility to Dietary Fats] affects the reaction [Glucose results in increased secretion of INS1 protein]; FFAR1 protein affects the reaction [Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]] 		CTD PMID:24349266 PMID:37217659 NCBI chr 1:95,238,785...95,239,689
Ensembl chr 1:95,238,785...95,239,691 		JBrowse link
G Ffar3 free fatty acid receptor 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of FFAR3 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FFAR3 mRNA CTD PMID:37567420 NCBI chr 1:95,232,804...95,234,144
Ensembl chr 1:95,232,336...95,234,354 		JBrowse link
G Fgf1 fibroblast growth factor 1 increases expression
decreases expression
multiple interactions 		ISO Glucose results in increased expression of FGF1 mRNA
Glucose results in decreased expression of FGF1 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of FGF1 mRNA] 		CTD PMID:31655124 PMID:33448797 NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,939,870...30,961,393 		JBrowse link
G Fgf2 fibroblast growth factor 2 increases expression
decreases expression
multiple interactions 		EXP
ISO 		Glucose results in increased expression of FGF2 mRNA; Glucose results in increased expression of FGF2 protein
Glucose results in decreased expression of FGF2 mRNA
Glucosamine promotes the reaction [Glucose results in increased expression of FGF2 mRNA] 		CTD PMID:1518840 PMID:19759273 PMID:31655124 NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493 		JBrowse link
G Fgf21 fibroblast growth factor 21 affects uptake
increases secretion
multiple interactions
increases expression 		ISO FGF21 protein affects the uptake of Glucose
Glucose results in increased secretion of FGF21 protein
indolo(3,2-b)carbazole inhibits the reaction [Glucose deficiency results in increased expression of FGF21 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Glucose deficiency results in increased expression of FGF21 mRNA]
indolo(3,2-b)carbazole inhibits the reaction [Glucose results in increased expression of FGF21 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased expression of FGF21 mRNA] 		CTD PMID:15902306 PMID:27226639 PMID:28123933 NCBI chr 1:105,219,825...105,221,376
Ensembl chr 1:105,219,825...105,232,056 		JBrowse link
G Fgf7 fibroblast growth factor 7 affects transport ISO FGF7 protein affects the transport of Glucose CTD PMID:12757114 NCBI chr 3:133,734,557...133,786,678
Ensembl chr 3:133,734,673...133,786,328 		JBrowse link
G Fgg fibrinogen gamma chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FGG mRNA CTD PMID:37567420 NCBI chr 2:170,652,929...170,660,372
Ensembl chr 2:170,652,234...170,661,170 		JBrowse link
G Fgl2 fibrinogen-like 2 increases expression
multiple interactions 		ISO Glucose results in increased expression of FGL2 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of FGL2 mRNA] 		CTD PMID:33448797 NCBI chr 4:14,602,762...14,608,405
Ensembl chr 4:14,602,771...14,608,405 		JBrowse link
G Fhad1 forkhead associated phosphopeptide binding domain 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of FHAD1 mRNA CTD PMID:37567420 NCBI chr 5:159,474,111...159,593,455
Ensembl chr 5:159,474,158...159,593,367 		JBrowse link
G Fis1 fission, mitochondrial 1 increases expression
multiple interactions 		EXP
ISO 		Glucose results in increased expression of FIS1 protein
[Glucose co-treated with Deferoxamine] results in increased expression of FIS1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of FIS1 mRNA]
cinnamic acid inhibits the reaction [Glucose results in increased expression of FIS1 protein]; Metformin inhibits the reaction [Glucose results in increased expression of FIS1 protein] 		CTD PMID:27684054 PMID:30144576 PMID:33962019 NCBI chr12:25,345,239...25,360,135
Ensembl chr12:25,345,239...25,349,335 		JBrowse link
G Flg filaggrin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of FLG mRNA CTD PMID:37567420 NCBI chr 2:181,583,801...181,596,464
Ensembl chr 2:181,583,808...181,595,968 		JBrowse link
G Flg2 filaggrin 2 decreases methylation
decreases expression 		ISO Glucose results in decreased methylation of FLG2 promoter
Glucose results in decreased expression of FLG2 mRNA 		CTD PMID:31525975
G Flt1 Fms related receptor tyrosine kinase 1 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of FLT1 mRNA; Glucose results in decreased expression of FLT1 protein
[Glucose co-treated with ICG 001] results in decreased expression of FLT1 protein; Panax notoginseng extract inhibits the reaction [[Glucose co-treated with ICG 001] results in decreased expression of FLT1 protein]; Panax notoginseng extract inhibits the reaction [Glucose results in decreased expression of FLT1 protein] 		CTD PMID:31655124 PMID:35385194 NCBI chr12:12,333,050...12,504,750
Ensembl chr12:12,333,430...12,504,750 		JBrowse link
G Fmo3 flavin containing dimethylaniline monoxygenase 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FMO3 mRNA CTD PMID:37567420 NCBI chr13:77,838,899...77,868,869
Ensembl chr13:77,842,602...77,861,256 		JBrowse link
G Fn1 fibronectin 1 increases expression
decreases expression
decreases secretion
multiple interactions
increases secretion 		ISO
EXP 		Glucose results in increased expression of FN1 mRNA; Glucose results in increased expression of FN1 protein
Glucose results in decreased expression of FN1 mRNA
Glucose deficiency results in decreased secretion of FN1 protein
Glucose results in decreased expression of FN1 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; [[[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1 protein; [Glucose results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1; [JTE 013 binds to and results in decreased activity of S1PR2 protein] inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein]; [sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein; acetovanillone inhibits the reaction [Glucose results in increased expression of FN1 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased expression of FN1 protein]; cinnamaldehyde inhibits the reaction [Glucose results in increased expression of FN1 protein]; CYBA protein promotes the reaction [Glucose results in increased expression of FN1 protein]; diphenyleneiodonium inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; diphenyliodonium inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; farrerol inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; farrerol inhibits the reaction [Glucose results in increased expression of FN1 protein]; HIF1A protein affects the reaction [Glucose results in increased expression of FN1 protein]; LY2109761 inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; manumycin inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; MIR217 mRNA affects the reaction [Glucose results in increased expression of FN1 protein]; N,N-dimethylsphingosine inhibits the reaction [Glucose results in increased expression of FN1 protein]; NCF1 protein promotes the reaction [Glucose results in increased expression of FN1 protein]; Resveratrol inhibits the reaction [[[[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of FN1 protein]; rhodioloside inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; SB 203580 inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of FN1 protein]]; SPHK1 mRNA affects the reaction [Glucose results in increased expression of FN1 protein]; SPHK1 protein inhibits the reaction [Glucose results in increased expression of FN1 protein]; Superoxides affects the reaction [Glucose results in increased expression of FN1 mRNA]; TXNIP protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; TXNIP protein affects the reaction [Glucose results in increased expression of FN1 protein]; Y 27632 inhibits the reaction [Glucose results in increased expression of FN1 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [Glucose results in increased expression of FN1 protein]]; Enalaprilat inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; NFE2L2 protein affects the reaction [SMARCA4A protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]]; Resveratrol inhibits the reaction [Glucose results in increased expression of FN1 protein]; SMARCA4A protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; SMARCA4A protein inhibits the reaction [Glucose results in increased expression of FN1 protein]; TXNIP promotes the reaction [Glucose results in increased expression of FN1 mRNA]
3-aminobenzamide inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [Glucose results in increased expression of FN1 protein]; 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Glucose results in increased secretion of FN1 protein]; [Glucose results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased secretion of FN1 protein; acetovanillone inhibits the reaction [Glucose results in increased secretion of FN1 protein]; AKT activator SC79 inhibits the reaction [FOXP1 protein inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]]; alpha-Tocopherol inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]; Bosentan inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; Bosentan inhibits the reaction [Glucose results in increased expression of FN1 protein]; BQ 788 inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; calphostin C inhibits the reaction [Glucose results in increased secretion of FN1 protein]; chelerythrine inhibits the reaction [Glucose results in increased expression of FN1 protein]; Curcumin inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of FN1 protein]; diphenyleneiodonium inhibits the reaction [Glucose results in increased secretion of FN1 protein]; DKK1 protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; ERCC1 protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; gingerol inhibits the reaction [Glucose results in increased secretion of FN1 protein]; Glucose results in increased expression of and results in increased secretion of FN1 protein; Indomethacin inhibits the reaction [Glucose results in increased secretion of FN1 protein]; MAPK14 protein promotes the reaction [Glucose results in increased secretion of FN1 protein]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of FN1 protein]]; MIR142 inhibits the reaction [Glucose results in increased expression of FN1 protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased expression of FN1 protein]; Rotenone inhibits the reaction [Glucose results in increased secretion of FN1 protein]; sitaxsentan inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; SN50 peptide inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; SN50 peptide inhibits the reaction [Glucose results in increased expression of FN1 protein]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased expression of FN1 protein]]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of FN1 protein]; trichostatin A inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; Troglitazone inhibits the reaction [Glucose results in increased expression of FN1 mRNA] 		CTD PMID:9225831 PMID:12388107 PMID:14520012 PMID:15086456 PMID:16320596 More... NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137 		JBrowse link
G Fn3k fructosamine 3 kinase increases expression ISO Glucose results in increased expression of FN3K mRNA CTD PMID:39922521 NCBI chr10:107,198,566...107,214,176
Ensembl chr10:107,198,892...107,214,175 		JBrowse link
G Folr1 folate receptor alpha decreases expression ISO Glucose results in decreased expression of FOLR1 mRNA CTD PMID:19616087 NCBI chr 1:165,631,462...165,650,430
Ensembl chr 1:165,631,462...165,642,669 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit increases expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of FOS mRNA
Glucose results in increased expression of FOS protein
Dactinomycin inhibits the reaction [Glucose results in increased expression of FOS mRNA]; Glucose affects the reaction [Adenosine Triphosphate results in increased expression of FOS mRNA]
[Glucose co-treated with Lipopolysaccharides] results in increased expression of FOS protein; MIR1231 inhibits the reaction [Glucose results in increased expression of FOS protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of FOS protein] 		CTD PMID:10723097 PMID:11123204 PMID:11557636 PMID:17178593 PMID:18180316 More... NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598 		JBrowse link
G Fosl1 FOS like 1, AP-1 transcription factor subunit increases expression
multiple interactions 		ISO Glucose results in increased expression of FOSL1 mRNA
Glucose promotes the reaction [AGT protein results in increased expression of FOSL1 mRNA] 		CTD PMID:17178593 PMID:19225232 NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:212,183,833...212,192,391 		JBrowse link
G Fosl2 FOS like 2, AP-1 transcription factor subunit increases expression ISO Glucose results in increased expression of FOSL2 mRNA CTD PMID:17178593 NCBI chr 6:30,017,952...30,039,269
Ensembl chr 6:30,021,916...30,039,406 		JBrowse link
G Foxa2 forkhead box A2 multiple interactions ISO [Metformin co-treated with Glucose] affects the localization of FOXA2 protein CTD PMID:16489446 NCBI chr 3:155,923,305...155,927,508
Ensembl chr 3:155,923,307...155,928,757 		JBrowse link
G Foxa3 forkhead box A3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of FOXA3 mRNA CTD PMID:37567420 NCBI chr 1:87,790,111...87,800,259
Ensembl chr 1:87,790,012...87,800,953 		JBrowse link
G Foxd2 forkhead box D2 multiple interactions ISO [imeglimin co-treated with Glucose] results in increased expression of FOXD2 mRNA CTD PMID:34588186 NCBI chr 5:133,664,760...133,667,483
Ensembl chr 5:133,664,760...133,667,483 		JBrowse link
G Foxf2 forkhead box F2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FOXF2 mRNA CTD PMID:37567420 NCBI chr17:33,044,446...33,051,259
Ensembl chr17:32,846,603...33,051,259 		JBrowse link
G Foxm1 forkhead box M1 increases expression ISO Glucose results in increased expression of FOXM1 mRNA CTD PMID:32942007 NCBI chr 4:163,325,628...163,338,100
Ensembl chr 4:163,325,614...163,337,172 		JBrowse link
G Foxo1 forkhead box O1 increases abundance
multiple interactions
decreases response to substance 		EXP
ISO 		FOXO1 protein mutant form results in increased abundance of Glucose; FOXO1 protein results in increased abundance of Glucose
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased phosphorylation of and affects the localization of FOXO1 protein]]; Acetylcysteine inhibits the reaction [Glucose affects the localization of FOXO1 protein]; Calcitriol inhibits the reaction [Glucose results in decreased phosphorylation of and affects the localization of FOXO1 protein]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL mRNA]]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP mRNA]]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 mRNA]]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in increased expression of BECN1 protein]]; Glucose results in decreased phosphorylation of and affects the localization of FOXO1 protein
FOXO1 protein results in decreased susceptibility to Glucose
Glucose results in increased acetylation of and results in decreased activity of FOXO1 protein; SIRT3 protein inhibits the reaction [Glucose results in increased acetylation of FOXO1 protein]
FOXO1 protein inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]; FOXO1 protein inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]; FOXO1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]]; FOXO1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]]; Glucose results in increased phosphorylation of and results in decreased activity of FOXO1 protein; INS1 protein inhibits the reaction [FOXO1 protein results in increased abundance of Glucose]; INS1 protein promotes the reaction [FOXO1 protein mutant form results in increased abundance of Glucose]; resveratrol inhibits the reaction [Glucose results in increased phosphorylation of and results in decreased activity of FOXO1 protein]; resveratrol promotes the reaction [FOXO1 protein results in increased abundance of Glucose] 		CTD PMID:15788402 PMID:23494737 PMID:24413998 PMID:33450223 NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419 		JBrowse link
G Foxo3 forkhead box O3 multiple interactions
decreases expression
increases phosphorylation
increases localization 		ISO
EXP 		[[resveratrol results in increased activity of SIRT1 protein] which results in increased phosphorylation of and results in decreased activity of FOXO3 protein] which results in decreased susceptibility to Glucose; AKT1 protein promotes the reaction [Glucose affects the phosphorylation of and affects the activity of FOXO3 protein]; FOXO3 protein promotes the reaction [Glucose results in increased cleavage of and results in increased activity of CASP1 protein]; FOXO3 protein promotes the reaction [Glucose results in increased cleavage of and results in increased activity of CASP3 protein]; Glucose affects the phosphorylation of and affects the activity of FOXO3 protein; resveratrol inhibits the reaction [Glucose results in increased phosphorylation of FOXO3 protein]
polyethylene glycol loxenatide inhibits the reaction [Glucose results in decreased expression of FOXO3 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose affects the localization of and results in increased phosphorylation of FOXO3 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and affects the localization of FOXO3 protein]]; 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucose affects the localization of and results in increased phosphorylation of FOXO3 protein]; Acetylcysteine inhibits the reaction [Glucose results in decreased phosphorylation of FOXO3 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased phosphorylation of FOXO3 protein]; Berberine inhibits the reaction [Glucose results in decreased expression of and results in increased acetylation of FOXO3 protein]; Berberine inhibits the reaction [Glucose results in decreased expression of FOXO3 protein]; Glucose results in decreased expression of and results in increased acetylation of FOXO3 protein; Glucose results in decreased phosphorylation of and affects the localization of FOXO3 protein; Glucose results in increased phosphorylation of and affects the localization of FOXO3 protein; Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and affects the localization of FOXO3 protein]
Glucose results in increased localization of FOXO3 protein 		CTD PMID:20370652 PMID:23090186 PMID:23159718 PMID:25471227 PMID:37417536 More... NCBI chr20:47,251,968...47,348,254
Ensembl chr20:47,255,878...47,346,845 		JBrowse link
G Foxp1 forkhead box P1 multiple interactions
decreases expression 		ISO AKT activator SC79 inhibits the reaction [FOXP1 protein inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of CYBB protein]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of NOX4 protein]; FOXP1 protein inhibits the reaction [Glucose results in increased phosphorylation of MTOR protein]
Glucose results in decreased expression of FOXP1 mRNA; Glucose results in decreased expression of FOXP1 protein 		CTD PMID:31494106 NCBI chr 4:133,117,346...133,808,647
Ensembl chr 4:133,122,055...133,500,272 		JBrowse link
G Foxp3 forkhead box P3 increases expression ISO Glucose results in increased expression of FOXP3 mRNA CTD PMID:39922521 NCBI chr  X:17,580,380...17,601,181
Ensembl chr  X:17,580,380...17,595,894 		JBrowse link
G Frat2 FRAT regulator of WNT signaling pathway 2 increases expression ISO Glucose results in increased expression of FRAT2 mRNA CTD PMID:39922521 NCBI chr 1:250,603,450...250,605,779
Ensembl chr 1:250,603,088...250,606,921 		JBrowse link
G Frk fyn-related Src family tyrosine kinase multiple interactions ISO FRK protein inhibits the reaction [Glucose results in increased secretion of INS1 protein] CTD PMID:17179392 NCBI chr20:39,820,441...39,926,065
Ensembl chr20:39,820,295...39,926,362 		JBrowse link
G Frmd3 FERM domain containing 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FRMD3 mRNA CTD PMID:37567420 NCBI chr 5:92,810,989...93,077,326
Ensembl chr 5:92,810,736...93,077,325 		JBrowse link
G Frmpd3 FERM and PDZ domain containing 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FRMPD3 mRNA CTD PMID:37567420 NCBI chr  X:108,752,511...108,902,393
Ensembl chr  X:108,752,716...108,901,496 		JBrowse link
G Fsbp fibrinogen silencer binding protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of FSBP mRNA CTD PMID:37567420 NCBI chr 5:29,855,340...29,861,613
Ensembl chr 5:29,855,304...29,901,964 		JBrowse link
G Fsip1 fibrous sheath interacting protein 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of FSIP1 mRNA CTD PMID:37567420 NCBI chr 3:125,528,538...125,671,135
Ensembl chr 3:125,524,528...125,671,135 		JBrowse link
G Fth1 ferritin heavy chain 1 multiple interactions
increases expression 		ISO
EXP 		FTH1 protein inhibits the reaction [Glucose results in increased abundance of Reactive Oxygen Species]
Glucose results in increased expression of FTH1 protein
[[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Oxygen] results in increased expression of [FTH1 protein binds to FTL protein] 		CTD PMID:16135072 PMID:18931039 PMID:38483099 NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:216,051,998...216,055,214 		JBrowse link
G Ftl1 ferritin light chain 1 multiple interactions
increases expression 		EXP
ISO 		[[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Oxygen] results in increased expression of [FTH1 protein binds to FTL protein]
Glucose results in increased expression of FTL protein
Glucose results in increased expression of FTL1 protein 		CTD PMID:16135072 PMID:38483099 NCBI chr 1:105,072,858...105,074,705
Ensembl chr  X:45,399,355...45,399,915
Ensembl chr 2:45,399,355...45,399,915
Ensembl chr 1:45,399,355...45,399,915 		JBrowse link
G Fut1 fucosyltransferase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FUT1 mRNA CTD PMID:37567420 NCBI chr 1:105,223,399...105,226,817
Ensembl chr 1:105,223,390...105,227,513 		JBrowse link
G Fut2 fucosyltransferase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of FUT2 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FUT2 mRNA CTD PMID:37567420 NCBI chr 1:105,256,013...105,276,828
Ensembl chr 1:105,255,390...105,276,647 		JBrowse link
G Fxyd5 FXYD domain-containing ion transport regulator 5 increases expression ISO Glucose results in increased expression of FXYD5 mRNA CTD PMID:17178593 NCBI chr 1:95,395,327...95,404,722
Ensembl chr 1:95,395,146...95,405,364 		JBrowse link
G Fzd5 frizzled class receptor 5 increases expression ISO Glucose results in increased expression of FZD5 mRNA CTD PMID:39922521 NCBI chr 9:73,606,860...73,614,039
Ensembl chr 9:73,606,860...73,618,612 		JBrowse link
G G3bp1 G3BP stress granule assembly factor 1 multiple interactions
increases uptake 		ISO Deoxyglucose inhibits the reaction [G3BP1 protein results in increased uptake of Glucose]; YWHAZ protein affects the reaction [G3BP1 protein results in increased uptake of Glucose] CTD PMID:35945655 NCBI chr10:40,087,533...40,120,931
Ensembl chr10:40,087,533...40,120,931 		JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 multiple interactions
increases expression
increases activity
decreases expression 		ISO
EXP 		Glucose promotes the reaction [[ARNT protein binds to G6PC1 promoter] which results in increased expression of G6PC1 mRNA]; Glucose results in increased stability of and results in increased expression of G6PC1 mRNA
Glucose results in increased expression of G6PC1 mRNA
[Glucose co-treated with S 4048] results in increased expression of G6PC1 mRNA
Metformin inhibits the reaction [Glucose results in increased expression of G6PC1 mRNA]; tungstate inhibits the reaction [Glucose results in increased activity of G6PC1 protein]; Vanadates inhibits the reaction [Glucose results in increased activity of G6PC1 protein]
Glucose results in decreased expression of G6PC1 mRNA 		CTD PMID:14988444 PMID:15767253 PMID:16920846 PMID:19576170 PMID:31974165 More... NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,757,899...86,818,033 		JBrowse link
G Gabbr2 gamma-aminobutyric acid type B receptor subunit 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GABBR2 mRNA CTD PMID:37567420 NCBI chr 5:65,743,073...66,083,695
Ensembl chr 5:65,743,073...66,083,695 		JBrowse link
G Gabrp gamma-aminobutyric acid type A receptor subunit pi multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of GABRP mRNA CTD PMID:37567420 NCBI chr10:18,647,243...18,673,806
Ensembl chr10:18,647,243...18,673,727 		JBrowse link
G Gabrq gamma-aminobutyric acid type A receptor subunit theta multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GABRQ mRNA CTD PMID:37567420 NCBI chr  X:155,737,838...155,755,225
Ensembl chr  X:155,738,436...155,755,223 		JBrowse link
G Gad1 glutamate decarboxylase 1 multiple interactions EXP GAD1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:25966616 NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:75,777,534...75,818,759 		JBrowse link
G Gad2 glutamate decarboxylase 2 increases expression ISO Glucose results in increased expression of GAD2 mRNA CTD PMID:39922521 NCBI chr17:89,671,718...89,734,246
Ensembl chr17:89,671,716...89,941,089 		JBrowse link
G Gadd45g growth arrest and DNA-damage-inducible, gamma increases expression
multiple interactions 		ISO Glucose results in increased expression of GADD45G mRNA
Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of GADD45G protein]] 		CTD PMID:17178593 PMID:39798073 NCBI chr17:13,528,606...13,530,351
Ensembl chr17:13,528,610...13,530,369 		JBrowse link
G Galnt16 polypeptide N-acetylgalactosaminyltransferase 16 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GALNT16 mRNA CTD PMID:37567420 NCBI chr 6:105,900,987...105,982,039
Ensembl chr 6:105,901,153...105,991,350 		JBrowse link
G Galnt2 polypeptide N-acetylgalactosaminyltransferase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of GALNT2 mRNA CTD PMID:37567420 NCBI chr19:69,110,657...69,222,237
Ensembl chr19:69,110,657...69,222,237 		JBrowse link
G Galnt6 polypeptide N-acetylgalactosaminyltransferase 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GALNT6 mRNA CTD PMID:37567420 NCBI chr 7:133,668,612...133,715,909
Ensembl chr 7:133,668,615...133,698,439 		JBrowse link
G Gapdh glyceraldehyde-3-phosphate dehydrogenase multiple interactions
increases ADP-ribosylation
increases expression 		ISO
EXP 		SOD2 protein inhibits the reaction [[Glucose results in increased chemical synthesis of Superoxides] which results in decreased activity of GAPDH protein]; SOD2 protein inhibits the reaction [Glucose results in decreased activity of and results in increased ADP-ribosylation of GAPDH protein]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of GAPDH mRNA; PARP1 protein affects the reaction [Glucose results in increased ADP-ribosylation of GAPDH protein]
[chloroacetaldehyde results in decreased activity of GAPDH protein] which results in decreased chemical synthesis of Glucose; UCP1 protein inhibits the reaction [[Glucose results in increased chemical synthesis of Superoxides] which results in decreased activity of GAPDH protein]; UCP1 protein inhibits the reaction [Glucose results in decreased activity of and results in increased ADP-ribosylation of GAPDH protein]
Glucose results in increased expression of GAPDH mRNA 		CTD PMID:7826318 PMID:11050244 PMID:14523042 PMID:19733226 PMID:37567420 NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377 		JBrowse link
G Gapdhs glyceraldehyde-3-phosphate dehydrogenase, spermatogenic increases expression ISO Glucose results in increased expression of GAPDHS mRNA CTD PMID:39922521 NCBI chr 1:95,106,516...95,125,918
Ensembl chr 1:95,106,518...95,121,055 		JBrowse link
G Gask1b golgi associated kinase 1B decreases expression
multiple interactions 		ISO Glucose results in decreased expression of GASK1B mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of GASK1B mRNA] 		CTD PMID:33448797 NCBI chr 2:167,345,738...167,410,606
Ensembl chr 2:167,345,809...167,410,603 		JBrowse link
G Gast gastrin increases secretion EXP Glucose results in increased secretion of GAST protein CTD PMID:19208342 NCBI chr10:85,765,216...85,767,881
Ensembl chr10:85,765,216...85,767,880 		JBrowse link
G Gata4 GATA binding protein 4 increases metabolic processing ISO GATA4 protein results in increased metabolism of Glucose CTD PMID:34087332 NCBI chr15:41,635,572...41,707,252
Ensembl chr15:41,635,572...41,681,609 		JBrowse link
G Gbp2 guanylate binding protein 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GBP2 mRNA CTD PMID:37567420 NCBI chr 2:234,005,727...234,021,812
Ensembl chr 2:234,008,590...234,021,810 		JBrowse link
G Gbp4 guanylate binding protein 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GBP3 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GBP4 mRNA CTD PMID:37567420 NCBI chr 2:233,978,163...233,992,124
Ensembl chr 2:233,978,486...233,992,120 		JBrowse link
G Gbp7 guanylate binding protein 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GBP7 mRNA CTD PMID:37567420 NCBI chr 2:233,948,774...233,970,532
Ensembl chr 2:233,948,677...233,970,526 		JBrowse link
G Gc GC, vitamin D binding protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of GC mRNA CTD PMID:37567420 NCBI chr14:18,916,255...18,951,670
Ensembl chr14:18,916,246...18,951,673 		JBrowse link
G Gcg glucagon multiple interactions
increases expression
decreases secretion
increases secretion
increases abundance 		ISO
EXP 		Glucose inhibits the reaction [[Niacin results in decreased abundance of Fatty Acids, Nonesterified] which results in increased secretion of GCG protein]
Glucose results in increased expression of GCG protein
Glucose results in decreased secretion of GCG protein
Glucose results in increased secretion of GCG protein
9-phenanthrol inhibits the reaction [[GCG protein co-treated with Glucose] results in increased secretion of INS1 protein]; [GCG protein co-treated with Glucose] results in increased secretion of INS1 protein; [GCG protein modified form binds to and results in increased activity of GLP1R protein] promotes the reaction [Glucose results in increased secretion of INS1 protein]; Metformin inhibits the reaction [GCG results in increased abundance of Glucose]; Troglitazone inhibits the reaction [Glucose results in decreased secretion of GCG protein]; Zinc inhibits the reaction [Glucose results in increased secretion of GCG protein]
[[imeglimin co-treated with Sitagliptin Phosphate] affects the reaction [A mutant form affects the susceptibility to Glucose]] which affects the expression of GCG protein; [GCG protein modified form binds to and results in increased activity of GLP1R protein] promotes the reaction [Glucose results in increased secretion of INS1 protein]; [imeglimin affects the reaction [A mutant form affects the susceptibility to Glucose]] which affects the expression of GCG protein; GCG protein promotes the reaction [imeglimin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; isosteviol inhibits the reaction [Palmitic Acid promotes the reaction [Glucose results in increased secretion of GCG protein]]; Lithocholic Acid promotes the reaction [Glucose results in increased expression of GCG protein]; Palmitic Acid promotes the reaction [Glucose results in increased secretion of GCG protein] 		CTD PMID:838844 PMID:12914525 PMID:15919803 PMID:18669601 PMID:19002567 More... NCBI chr 3:67,522,489...67,531,533
Ensembl chr 3:67,522,489...67,531,533 		JBrowse link
G Gcgr glucagon receptor multiple interactions ISO [imeglimin co-treated with Glucose] results in increased expression of GCGR mRNA CTD PMID:34588186 NCBI chr10:106,306,803...106,314,970
Ensembl chr10:106,306,559...106,314,969 		JBrowse link
G Gch1 GTP cyclohydrolase 1 increases expression ISO Glucose results in increased expression of GCH1 mRNA CTD PMID:39922521 NCBI chr15:22,884,006...22,917,412
Ensembl chr15:22,884,006...22,917,412 		JBrowse link
G Gck glucokinase multiple interactions
decreases expression
increases expression 		ISO
EXP 		[ebselen co-treated with Glucose] results in increased activity of GCK protein; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of GCK mRNA; Glucose inhibits the reaction [Alloxan results in decreased expression of GCK mRNA]
Glucose results in decreased expression of GCK mRNA
Glucose results in decreased expression of and affects the localization of GCK protein; Metformin inhibits the reaction [Glucose results in decreased expression of GCK mRNA]
Glucose results in increased expression of GCK mRNA 		CTD PMID:12137914 PMID:23795780 PMID:24349266 PMID:31974165 PMID:37567420 NCBI chr14:84,999,019...85,041,098
Ensembl chr14:84,999,020...85,040,949 		JBrowse link
G Gckr glucokinase regulator increases expression ISO Glucose results in increased expression of GCKR mRNA CTD PMID:39922521 NCBI chr 6:30,765,071...30,795,627
Ensembl chr 6:30,765,075...30,795,627 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit multiple interactions ISO
EXP 		[Glucose co-treated with gastrodin] affects the expression of GCLC mRNA CTD PMID:33764184 NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893 		JBrowse link
G Gclm glutamate cysteine ligase, modifier subunit multiple interactions EXP
ISO 		[Glucose co-treated with gastrodin] affects the expression of GCLM mRNA CTD PMID:33764184 NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003 		JBrowse link
G Gcsam germinal center-associated, signaling and motility multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of GCSAM mRNA CTD PMID:37567420 NCBI chr11:68,658,350...68,669,598
Ensembl chr11:68,660,438...68,669,584 		JBrowse link
G Gdap1l1 ganglioside-induced differentiation-associated protein 1-like 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GDAP1L1 mRNA CTD PMID:37567420 NCBI chr 3:172,529,523...172,549,128
Ensembl chr 3:172,509,564...172,549,125 		JBrowse link
G Gdf15 growth differentiation factor 15 increases expression
decreases expression 		ISO Glucose results in increased expression of GDF15 mRNA
Glucose results in decreased expression of GDF15 mRNA 		CTD PMID:39613055 NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022 		JBrowse link
G Gdf7 growth differentiation factor 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GDF7 mRNA CTD PMID:37567420 NCBI chr 6:36,890,799...36,901,783
Ensembl chr 6:36,890,799...36,901,783 		JBrowse link
G Gem GTP binding protein overexpressed in skeletal muscle increases expression ISO Glucose results in increased expression of GEM mRNA CTD PMID:17178593 NCBI chr 5:30,011,641...30,022,554
Ensembl chr 5:30,011,592...30,022,542 		JBrowse link
G Gh1 growth hormone 1 multiple interactions ISO GH1 protein promotes the reaction [Glucose results in increased phosphorylation of TBC1D4 protein]; Glucose inhibits the reaction [[Niacin results in decreased abundance of Fatty Acids, Nonesterified] which results in increased secretion of GH1 protein] CTD PMID:838844 PMID:21559284 NCBI chr10:91,727,883...91,729,860
Ensembl chr10:91,727,884...91,729,859 		JBrowse link
G Ghrhr growth hormone releasing hormone receptor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GHRHR mRNA CTD PMID:37567420 NCBI chr 4:85,830,345...85,863,127
Ensembl chr 4:85,830,486...85,863,127 		JBrowse link
G Ghrl ghrelin and obestatin prepropeptide multiple interactions ISO [homoeriodictyol co-treated with Glucose] results in increased secretion of GHRL protein CTD PMID:28834253 NCBI chr 4:148,421,315...148,431,128
Ensembl chr 4:148,421,315...148,425,969 		JBrowse link
G Gip gastric inhibitory polypeptide multiple interactions ISO [imeglimin affects the reaction [A mutant form affects the susceptibility to Glucose]] which affects the expression of GIP protein; GIP protein promotes the reaction [Glucose results in increased secretion of INS1 protein] CTD PMID:36977210 NCBI chr10:81,465,070...81,473,216
Ensembl chr10:81,465,062...81,473,216 		JBrowse link
G Gja1 gap junction protein, alpha 1 decreases expression
multiple interactions
increases expression
increases degradation 		ISO
EXP 		Glucose results in decreased expression of GJA1 protein
Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of GJA1 protein]]; Chloroquine promotes the reaction [Glucose results in increased expression of GJA1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of GJA1 protein]
Glucose results in increased expression of GJA1 mRNA
resveratrol inhibits the reaction [Glucose results in increased degradation of GJA1 protein] 		CTD PMID:17178593 PMID:20578705 PMID:28713934 NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689 		JBrowse link
G Gla galactosidase, alpha increases expression ISO Glucose results in increased expression of GLA mRNA CTD PMID:17178593 NCBI chr  X:102,062,497...102,073,915
Ensembl chr  X:102,056,718...102,073,915 		JBrowse link
G Glb1 galactosidase, beta 1 increases expression
increases activity
multiple interactions 		ISO
EXP 		Glucose results in increased expression of GLB1 protein
Glucose results in increased activity of GLB1 protein
NAD inhibits the reaction [Glucose results in increased expression of GLB1 protein]; Niacinamide inhibits the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of GLB1 protein]]; resveratrol inhibits the reaction [Glucose results in increased expression of GLB1 protein]; Sirolimus inhibits the reaction [Glucose results in increased expression of GLB1 protein]; SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of GLB1 protein]]; SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of GLB1 protein]]; SIRT1 protein promotes the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of GLB1 protein]]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased expression of GLB1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Fluorometholone inhibits the reaction [Glucose results in increased activity of GLB1 protein]]; CDKN1A protein affects the reaction [Glucose results in increased expression of GLB1 protein]; CDKN2A protein affects the reaction [Glucose results in increased expression of GLB1 protein]; Fluorometholone inhibits the reaction [Glucose results in increased activity of GLB1 protein]; Melatonin inhibits the reaction [Glucose results in increased expression of GLB1 protein]; Phytic Acid inhibits the reaction [Glucose results in increased expression of GLB1 protein]; SIRT3 protein inhibits the reaction [Glucose results in increased expression of GLB1 protein] 		CTD PMID:17075048 PMID:22561310 PMID:23494737 PMID:35264022 PMID:38000455 More... NCBI chr 8:122,963,718...123,036,326
Ensembl chr 8:122,963,718...123,036,326 		JBrowse link
G Gli1 GLI family zinc finger 1 multiple interactions
increases expression 		ISO [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased localization of GLI1 protein; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA]; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased localization of GLI1 protein]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA]]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased localization of GLI1 protein]]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased localization of GLI1 protein]
Glucose results in increased expression of GLI1 protein 		CTD PMID:27481074 PMID:33992720 NCBI chr 7:65,042,237...65,054,888
Ensembl chr 7:65,042,237...65,054,540 		JBrowse link
G Gli2 GLI family zinc finger 2 affects localization
multiple interactions 		ISO Glucose affects the localization of GLI2 protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GLI2 mRNA 		CTD PMID:33992720 PMID:37567420 NCBI chr13:32,499,678...32,716,418
Ensembl chr13:32,499,678...32,716,418 		JBrowse link
G Glipr1 GLI pathogenesis-related 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GLIPR1 mRNA CTD PMID:37567420 NCBI chr 7:49,373,579...49,399,190
Ensembl chr 7:49,373,581...49,384,640 		JBrowse link
G Glo1 glyoxalase 1 multiple interactions
decreases expression 		ISO
EXP 		GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to HMGB1 promoter]]; GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to S100A12 promoter]]; GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to S100A8 promoter]]; GLO1 inhibits the reaction [Glucose promotes the reaction [RELA protein binds to AGER promoter]]; GLO1 inhibits the reaction [Glucose results in decreased expression of GLO1 protein]; GLO1 inhibits the reaction [Glucose results in increased expression of AGER mRNA]; GLO1 inhibits the reaction [Glucose results in increased expression of AGER protein]; GLO1 inhibits the reaction [Glucose results in increased expression of and results in increased secretion of HMGB1 protein]; GLO1 inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]; GLO1 inhibits the reaction [Glucose results in increased expression of S100A12 mRNA]; GLO1 inhibits the reaction [Glucose results in increased expression of S100A8 mRNA]; GLO1 inhibits the reaction [Glucose results in increased expression of S100A8 protein]; SOD2 inhibits the reaction [Glucose results in decreased expression of GLO1 protein]; UCP1 inhibits the reaction [Glucose results in decreased expression of GLO1 protein]
Glucose results in decreased expression of GLO1 mRNA
morroniside inhibits the reaction [Glucose results in decreased expression of GLO1 mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of GLO1 protein] 		CTD PMID:19833897 PMID:32643284 NCBI chr20:8,665,061...8,683,095
Ensembl chr20:8,665,061...8,683,191 		JBrowse link
G Glp1r glucagon-like peptide 1 receptor multiple interactions
affects response to substance
increases expression 		ISO
EXP 		[GCG protein modified form binds to and results in increased activity of GLP1R protein] promotes the reaction [Glucose results in increased secretion of INS1 protein]; [imeglimin co-treated with Glucose] results in increased expression of GLP1R mRNA; imeglimin affects the reaction [GLP1R protein affects the susceptibility to Glucose]
Glucose results in increased expression of GLP1R mRNA
[GCG protein modified form binds to and results in increased activity of GLP1R protein] promotes the reaction [Glucose results in increased secretion of INS1 protein]; [Glucose co-treated with Oleic Acid] results in decreased expression of GLP1R protein; exenatide inhibits the reaction [[Glucose co-treated with Oleic Acid] results in decreased expression of GLP1R protein] 		CTD PMID:18669601 PMID:22925809 PMID:34588186 PMID:36977210 PMID:39922521 NCBI chr20:8,973,393...9,011,622
Ensembl chr20:8,973,352...9,011,654 		JBrowse link
G Glrx glutaredoxin multiple interactions ISO GLRX protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] promotes the reaction [Glutathione binds to SIRT1 protein]]; GLRX protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased oxidation of and results in decreased activity of SIRT1 protein] CTD PMID:24451382 NCBI chr 2:7,073,737...7,083,548
Ensembl chr 2:7,073,759...7,083,543 		JBrowse link
G Glt8d2 glycosyltransferase 8 domain containing 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of GLT8D2 mRNA CTD PMID:37567420 NCBI chr 7:22,917,055...22,968,616
Ensembl chr 7:22,917,100...22,968,930 		JBrowse link
G Glud1 glutamate dehydrogenase 1 affects expression EXP Glucose affects the expression of GLUD1 mRNA CTD PMID:24349266 NCBI chr16:9,646,569...9,680,215
Ensembl chr16:9,646,509...9,680,210 		JBrowse link
G Glul glutamate-ammonia ligase multiple interactions
decreases expression 		EXP Glucose results in decreased expression of and results in decreased activity of GLUL protein; Resveratrol inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of GLUL protein]; Resveratrol inhibits the reaction [Glucose results in decreased expression of GLUL mRNA] CTD PMID:26677078 NCBI chr13:68,519,500...68,585,554
Ensembl chr13:68,576,067...68,585,520 		JBrowse link
G Gna11 G protein subunit alpha 11 multiple interactions
increases expression 		EXP acetovanillone inhibits the reaction [Glucose results in increased expression of GNA11 protein]; CAT protein inhibits the reaction [Glucose results in increased expression of GNA11 protein] CTD PMID:20691780 NCBI chr 7:8,814,285...8,828,628
Ensembl chr 7:8,814,327...8,830,558 		JBrowse link
G Gna15 G protein subunit alpha 15 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of GNA15 mRNA CTD PMID:37567420 NCBI chr 7:8,835,396...8,856,269
Ensembl chr 7:8,835,357...8,856,268 		JBrowse link
G Gnai1 G protein subunit alpha i1 decreases expression ISO Glucose results in decreased expression of GNAI1 mRNA CTD PMID:17178593 NCBI chr 4:17,706,061...17,790,176
Ensembl chr 4:17,706,025...17,789,198 		JBrowse link
G Gnai2 G protein subunit alpha i2 multiple interactions
decreases expression 		ISO
EXP 		GNAI2 gene mutant form inhibits the reaction [[Glucose co-treated with Amino Acids] results in increased secretion of INS1 protein]; GNAI2 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]
Glucose results in decreased expression of GNAI2 protein
Acetylcysteine inhibits the reaction [Glucose results in decreased expression of GNAI2 protein]; alpha-Tocopherol inhibits the reaction [Glucose results in decreased expression of GNAI2 protein]; diphenyleneiodonium affects the reaction [Glucose results in decreased expression of GNAI2 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in decreased expression of GNAI2 protein]; Uric Acid inhibits the reaction [Glucose results in decreased expression of GNAI2 protein] 		CTD PMID:18441196 PMID:25205820 NCBI chr 8:117,167,045...117,187,652
Ensembl chr 8:117,167,045...117,187,622 		JBrowse link
G Gnai3 G protein subunit alpha i3 multiple interactions
decreases expression 		EXP Acetylcysteine inhibits the reaction [Glucose results in decreased expression of GNAI3 protein]; alpha-Tocopherol inhibits the reaction [Glucose results in decreased expression of GNAI3 protein]; diphenyleneiodonium affects the reaction [Glucose results in decreased expression of GNAI3 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in decreased expression of GNAI3 protein]; Uric Acid inhibits the reaction [Glucose results in decreased expression of GNAI3 protein] CTD PMID:18441196 NCBI chr 2:198,430,920...198,468,874 JBrowse link
G Gnaq G protein subunit alpha q multiple interactions
increases expression 		EXP
ISO 		acetovanillone inhibits the reaction [Glucose results in increased expression of GNAQ protein]; CAT protein inhibits the reaction [Glucose results in increased expression of GNAQ protein]
GNAQ protein affects the reaction [Glucose results in increased secretion of INS1 protein]; GNAQ protein affects the reaction [Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]] 		CTD PMID:20691780 PMID:37217659 NCBI chr 1:222,852,453...223,098,754
Ensembl chr 1:222,852,097...223,126,742 		JBrowse link
G Gnat2 G protein subunit alpha transducin 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GNAT2 mRNA CTD PMID:37567420 NCBI chr 2:198,414,568...198,431,532
Ensembl chr 2:198,414,920...198,424,022 		JBrowse link
G Gng2 G protein subunit gamma 2 increases expression
multiple interactions 		ISO Glucose results in increased expression of GNG2 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of GNG2 mRNA] 		CTD PMID:33448797 NCBI chr15:4,365,222...4,466,060
Ensembl chr15:4,365,135...4,466,059 		JBrowse link
G Gng3 G protein subunit gamma 3 increases expression ISO Glucose results in increased expression of GNG3 mRNA CTD PMID:39922521 NCBI chr 1:215,160,952...215,162,718
Ensembl chr 1:215,160,952...215,162,718 		JBrowse link
G Gng4 G protein subunit gamma 4 increases expression ISO Glucose results in increased expression of GNG4 mRNA CTD PMID:39922521 NCBI chr17:93,432,791...93,481,709
Ensembl chr17:93,433,195...93,481,709 		JBrowse link
G Gng8 G protein subunit gamma 8 decreases expression ISO Glucose results in decreased expression of GNG8 mRNA CTD PMID:31525975 NCBI chr 1:86,692,609...86,696,463
Ensembl chr 1:86,692,642...86,696,408 		JBrowse link
G Gnrh1 gonadotropin releasing hormone 1 increases expression ISO Glucose results in increased expression of GNRH1 mRNA CTD PMID:39922521 NCBI chr15:46,147,878...46,152,086
Ensembl chr15:46,148,301...46,148,977
Ensembl chr15:46,148,301...46,148,977 		JBrowse link
G Golt1a golgi transport 1A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GOLT1A mRNA CTD PMID:37567420 NCBI chr13:47,312,412...47,325,176
Ensembl chr13:47,322,002...47,325,175 		JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1 increases expression ISO Glucose deficiency results in increased expression of GOT1 mRNA CTD PMID:26811028 NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871 		JBrowse link
G Gp5 glycoprotein V (platelet) multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GP5 mRNA CTD PMID:37567420 NCBI chr11:83,948,507...83,952,362
Ensembl chr11:83,948,507...83,952,367 		JBrowse link
G Gp6 glycoprotein 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of GP6 mRNA CTD PMID:37567420 NCBI chr 1:78,471,900...78,535,374
Ensembl chr 1:78,508,468...78,535,374 		JBrowse link
G Gp9 glycoprotein IX (platelet) multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GP9 mRNA CTD PMID:37567420 NCBI chr 4:121,792,842...121,794,452
Ensembl chr 4:121,792,653...121,794,475 		JBrowse link
G Gpc5 glypican 5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of GPC5 mRNA CTD PMID:37567420 NCBI chr15:98,614,499...100,051,285
Ensembl chr15:98,646,340...100,051,514 		JBrowse link
G Gpd1 glycerol-3-phosphate dehydrogenase 1 increases expression EXP Glucose results in increased expression of GPD1 mRNA CTD PMID:3299706 NCBI chr 7:132,722,982...132,730,373
Ensembl chr 7:132,721,915...132,730,368 		JBrowse link
G Gpd2 glycerol-3-phosphate dehydrogenase 2 multiple interactions ISO [Glucose co-treated with S 4048] results in increased expression of GPD2 mRNA; [GPD2 mutant form co-treated with Aminooxyacetic Acid] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [Potassium Chloride co-treated with Diazoxide] inhibits the reaction [[GPD2 mutant form co-treated with Aminooxyacetic Acid] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; GPD2 protein inhibits the reaction [Glucose results in increased abundance of alpha-glycerophosphoric acid]; GPD2 protein inhibits the reaction [Glucose results in increased abundance of Glucose-6-Phosphate]; GPD2 protein inhibits the reaction [Glucose results in increased expression of TXNIP mRNA] CTD PMID:10199125 PMID:10464266 PMID:31974165 NCBI chr 3:62,209,432...62,346,590
Ensembl chr 3:62,210,814...62,346,593 		JBrowse link
G Gpha2 glycoprotein hormone subunit alpha 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of GPHA2 mRNA CTD PMID:37567420 NCBI chr 1:212,954,579...212,956,536
Ensembl chr 1:212,955,387...212,956,535 		JBrowse link
G Gpm6b glycoprotein m6b decreases expression
multiple interactions 		ISO Glucose results in decreased expression of GPM6B mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of GPM6B mRNA] 		CTD PMID:33448797 NCBI chr  X:31,689,485...31,836,199
Ensembl chr  X:31,690,359...31,733,272 		JBrowse link
G Gpnmb glycoprotein nmb multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of GPNMB mRNA CTD PMID:37567420 NCBI chr 4:79,341,128...79,362,366
Ensembl chr 4:79,341,021...79,380,240 		JBrowse link
G Gpr151 G protein-coupled receptor 151 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GPR151 mRNA CTD PMID:37567420 NCBI chr18:34,819,878...34,821,272
Ensembl chr18:34,819,878...34,821,272 		JBrowse link
G Gpr171 G protein-coupled receptor 171 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of GPR171 mRNA CTD PMID:37567420 NCBI chr 2:145,510,305...145,515,392
Ensembl chr 2:145,505,549...145,515,592 		JBrowse link
G Gpr85 G protein-coupled receptor 85 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GPR85 mRNA CTD PMID:37567420 NCBI chr 4:43,070,194...43,075,662
Ensembl chr 4:43,060,777...43,075,794 		JBrowse link
G Gpr87 G protein-coupled receptor 87 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GPR87 mRNA CTD PMID:37567420 NCBI chr 2:145,589,630...145,608,094
Ensembl chr 2:145,589,569...145,604,442 		JBrowse link
G Gprin1 G protein-regulated inducer of neurite outgrowth 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of GPRIN1 mRNA CTD PMID:37567420 NCBI chr17:9,869,009...9,881,958
Ensembl chr17:9,868,571...9,894,560 		JBrowse link
G Gpt glutamic--pyruvic transaminase multiple interactions
increases expression
increases secretion 		EXP
ISO 		Glucose inhibits the reaction [(5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl)acetic acid results in increased activity of GPT protein]
[Fatty Acids, Nonesterified co-treated with Glucose] results in increased expression of GPT protein; jujuboside A inhibits the reaction [[Fatty Acids, Nonesterified co-treated with Glucose] results in increased expression of GPT protein]
Glucose results in increased expression of GPT protein
Glucose results in increased secretion of GPT protein
Ditiocarb inhibits the reaction [YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in increased expression of GPT protein]]]]; Fatty Acids, Nonesterified promotes the reaction [Glucose results in increased expression of GPT protein]; jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in increased expression of GPT protein]]; solanesol inhibits the reaction [Glucose results in increased secretion of GPT protein]; YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in increased expression of GPT protein]]] 		CTD PMID:29479035 PMID:37586544 PMID:39059604 NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160 		JBrowse link
G Gpx1 glutathione peroxidase 1 decreases expression
multiple interactions 		EXP
ISO 		Glucose results in decreased expression of GPX1 mRNA
ebselen inhibits the reaction [GPX1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; GPX1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]
[Glucose co-treated with Lycopene] results in increased expression of GPX1 mRNA; naringenin inhibits the reaction [Glucose results in decreased expression of GPX1 mRNA] 		CTD PMID:21818840 PMID:23192364 PMID:23795780 PMID:32942007 PMID:38444079 NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581 		JBrowse link
G Gpx2 glutathione peroxidase 2 increases expression
multiple interactions 		EXP
ISO 		Glucose results in increased expression of GPX2 mRNA
Glucose inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of GPX2 protein] 		CTD PMID:28027979 PMID:32942007 NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862 		JBrowse link
G Gpx4 glutathione peroxidase 4 multiple interactions
decreases expression
increases expression 		ISO
EXP 		4-Nitroquinoline-1-oxide promotes the reaction [Glucose results in increased expression of GPX4 protein]; Resveratrol inhibits the reaction [Glucose results in decreased expression of GPX4 protein]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of GPX4 protein]]
[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of GPX4 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of GPX4 protein; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of GPX4 mRNA]; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of GPX4 protein] 		CTD PMID:32942007 PMID:36806343 PMID:39719253 NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629 		JBrowse link
G Grap2 GRB2-related adaptor protein 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GRAP2 mRNA CTD PMID:37567420 NCBI chr 7:113,997,356...114,071,073
Ensembl chr 7:113,997,307...114,075,367 		JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 increases expression ISO Glucose results in increased expression of GREB1 mRNA CTD PMID:39922521 NCBI chr 6:45,169,289...45,321,973
Ensembl chr 6:45,169,289...45,291,126 		JBrowse link
G Grem1 gremlin 1, DAN family BMP antagonist increases expression
multiple interactions 		ISO Glucose results in increased expression of GREM1 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of GREM1 mRNA 		CTD PMID:10026205 PMID:10744662 PMID:37567420 NCBI chr 3:120,966,639...120,978,319
Ensembl chr 3:120,966,623...120,979,089 		JBrowse link
G Grem2 gremlin 2, DAN family BMP antagonist multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of GREM2 mRNA CTD PMID:37567420 NCBI chr13:89,310,897...89,403,856
Ensembl chr13:89,310,662...89,404,312 		JBrowse link
G Grhl2 grainyhead-like transcription factor 2 increases expression ISO Glucose results in increased expression of GRHL2 mRNA CTD PMID:39922521 NCBI chr 7:70,280,360...70,415,277
Ensembl chr 7:70,285,310...70,415,274 		JBrowse link
G Gria2 glutamate ionotropic receptor AMPA type subunit 2 multiple interactions EXP [Dithionite co-treated with Glucose deficiency] results in decreased expression of GRIA2 protein; Genistein inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of GRIA2 protein] CTD PMID:27238724 NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:168,247,496...168,367,616 		JBrowse link
G Grin1 glutamate ionotropic receptor NMDA type subunit 1 decreases expression
multiple interactions 		ISO Glucose results in decreased expression of GRIN1 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of GRIN1 mRNA] 		CTD PMID:31525975 PMID:33448797 NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:28,501,836...28,528,754 		JBrowse link
G Grin3a glutamate ionotropic receptor NMDA type subunit 3A increases expression ISO Glucose results in increased expression of GRIN3A mRNA CTD PMID:39922521 NCBI chr 5:68,802,333...69,001,880
Ensembl chr 5:68,804,970...69,001,558 		JBrowse link
G Gsdmd gasdermin D multiple interactions
increases expression
increases cleavage 		ISO Glucose results in increased expression of and results in increased cleavage of GSDMD protein; GSDMD protein affects the reaction [Glucose results in increased secretion of IL18 protein]; GSDMD protein affects the reaction [Glucose results in increased secretion of IL1B protein]; Hirudins inhibits the reaction [Glucose results in increased expression of and results in increased cleavage of GSDMD protein]; IRF2 protein affects the reaction [Glucose results in increased expression of and results in increased cleavage of GSDMD protein]; IRF2 protein affects the reaction [Glucose results in increased expression of GSDMD mRNA]
Glucose results in increased expression of GSDMD mRNA; Glucose results in increased expression of GSDMD protein
[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of GSDMD protein alternative form; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSDMD protein; bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of GSDMD protein alternative form]; bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSDMD protein]; HAGLR protein affects the reaction [Glucose results in increased expression of GSDMD protein]; HAGLR protein promotes the reaction [Glucose results in increased expression of GSDMD protein]; loganin inhibits the reaction [Glucose results in increased expression of GSDMD mRNA]; loganin inhibits the reaction [Glucose results in increased expression of GSDMD protein]; MIR200C mRNA affects the reaction [Glucose results in increased cleavage of GSDMD protein]; PTEN protein affects the reaction [HAGLR protein affects the reaction [Glucose results in increased expression of GSDMD protein]]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased cleavage of GSDMD protein]] 		CTD PMID:34212273 PMID:35607288 PMID:37127800 PMID:37473909 PMID:38088496 NCBI chr 7:109,423,209...109,427,771
Ensembl chr 7:109,422,910...109,430,722 		JBrowse link
G Gsk3b glycogen synthase kinase 3 beta multiple interactions
decreases phosphorylation
increases expression
increases phosphorylation 		ISO
EXP 		[[ginsenoside Rg2 results in increased phosphorylation of GSK3B protein] co-treated with [ginsenoside Rg2 results in increased expression of NR0B2 mRNA]] results in decreased chemical synthesis of Glucose; [Glucose co-treated with ICG 001] results in decreased phosphorylation of GSK3B protein; Berberine inhibits the reaction [Glucose results in decreased phosphorylation of GSK3B protein]; Glucose inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; Panax notoginseng extract inhibits the reaction [[Glucose co-treated with ICG 001] results in decreased phosphorylation of GSK3B protein]; Panax notoginseng extract inhibits the reaction [Glucose results in decreased phosphorylation of GSK3B protein]; Panax notoginseng extract inhibits the reaction [Glucose results in increased expression of GSK3B protein]
Glucose results in increased phosphorylation of GSK3B protein
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSK3B mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSK3B protein; gastrodin inhibits the reaction [Glucose results in decreased phosphorylation of GSK3B protein]; Glucose results in decreased phosphorylation of and results in increased activity of GSK3B protein; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of HMOX1 mRNA]]; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]]; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NQO1 mRNA]]; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSK3B mRNA]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSK3B protein]; Simvastatin inhibits the reaction [Glucose results in decreased phosphorylation of and results in increased activity of GSK3B protein]
[Resveratrol results in increased phosphorylation of GSK3B protein] which results in increased uptake of Glucose; dorsomorphin inhibits the reaction [[Resveratrol results in increased phosphorylation of GSK3B protein] which results in increased uptake of Glucose]; Eucalyptol inhibits the reaction [Glucose results in increased expression of GSK3B protein]; gastrodin inhibits the reaction [Glucose results in decreased phosphorylation of GSK3B protein]; RHOA protein inhibits the reaction [Eucalyptol inhibits the reaction [Glucose results in increased expression of GSK3B protein]]; RHOA protein promotes the reaction [Glucose results in increased expression of GSK3B protein] 		CTD PMID:18004065 PMID:21031461 PMID:22062806 PMID:22180358 PMID:23690508 More... NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249 		JBrowse link
G Gsn gelsolin decreases secretion ISO Glucose deficiency results in decreased secretion of GSN protein CTD PMID:24802182 NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:38,982,671...39,035,850 		JBrowse link
G Gsr glutathione-disulfide reductase multiple interactions
decreases activity
decreases expression 		ISO
EXP 		[Ascorbic Acid co-treated with GSR protein] affects the metabolism of Glucose; [Doxorubicin co-treated with GSR protein] affects the metabolism of Glucose; [Nitrofurantoin co-treated with GSR protein] affects the metabolism of Glucose; Furans analog inhibits the reaction [Glucose results in decreased activity of GSR protein]
naringenin inhibits the reaction [Glucose results in decreased expression of GSR mRNA] 		CTD PMID:1901343 PMID:23192364 PMID:28911973 NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 multiple interactions EXP [Glucose co-treated with Lycopene] results in increased expression of GSTP1 mRNA CTD PMID:38444079 NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705 		JBrowse link
G Gtf2i general transcription factor II I increases expression ISO Glucose results in increased expression of GTF2I mRNA CTD PMID:32942007 NCBI chr12:28,037,344...28,112,677
Ensembl chr12:28,037,853...28,112,677 		JBrowse link
G Gucy2e guanylate cyclase 2E multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GUCY2E mRNA CTD PMID:37567420 NCBI chr10:54,453,753...54,478,639
Ensembl chr10:54,457,844...54,472,898 		JBrowse link
G Gypc glycophorin C increases expression
multiple interactions 		ISO Glucose results in increased expression of GYPC mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of GYPC mRNA] 		CTD PMID:33448797 NCBI chr18:24,434,921...24,467,592
Ensembl chr18:24,434,922...24,440,053 		JBrowse link
G Gys1 glycogen synthase 1 increases phosphorylation
multiple interactions 		EXP Glucose results in increased phosphorylation of GYS1 protein
3,4-Dihydroxyphenylacetic Acid inhibits the reaction [Glucose results in increased phosphorylation of GYS1 protein]; Catechin inhibits the reaction [Glucose results in increased phosphorylation of GYS1 protein] 		CTD PMID:29981789 NCBI chr 1:105,051,916...105,071,763
Ensembl chr 1:105,051,961...105,072,419 		JBrowse link
G Gzmb granzyme B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GZMB mRNA CTD PMID:37567420 NCBI chr15:34,459,007...34,462,469
Ensembl chr15:34,459,007...34,462,469 		JBrowse link
G Gzmm granzyme M decreases expression ISO Glucose results in decreased expression of GZMM mRNA CTD PMID:39613055 NCBI chr 7:10,661,683...10,667,448
Ensembl chr 7:10,661,684...10,667,504 		JBrowse link
G H1f2 H1.2 linker histone, cluster member increases expression ISO Glucose results in increased expression of H1F2 mRNA CTD PMID:17178593 NCBI chr17:41,818,962...41,820,453
Ensembl chr17:41,779,051...41,822,317 		JBrowse link
G H2ax H2A.X variant histone multiple interactions
increases expression 		ISO Glucose promotes the reaction [Bupivacaine results in increased expression of H2AX protein]
Glucose results in increased expression of H2AX protein 		CTD PMID:31672611 NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079 		JBrowse link
G H2bc18 H2B clustered histone 18 decreases expression ISO Glucose results in decreased expression of H2BC18 mRNA CTD PMID:31525975 NCBI chr 2:186,527,197...186,531,634 JBrowse link
G H2bc4 H2B clustered histone 4 increases expression ISO Glucose results in increased expression of H2BC4 mRNA CTD PMID:17178593 NCBI chr17:47,388,085...47,392,349
Ensembl chr17:47,404,375...47,419,020 		JBrowse link
G H3f4 H3.4 histone, cluster member multiple interactions EXP Glucose promotes the reaction [H3F4 protein modified form binds to PKLR promoter] CTD PMID:16644726 NCBI chr10:44,240,282...44,240,842 JBrowse link
G H4c8 H4 clustered histone 8 multiple interactions EXP Glucose promotes the reaction [H4C16 protein modified form binds to PKLR promoter] CTD PMID:16644726 NCBI chr17:47,176,246...47,180,690
Ensembl chr17:41,797,152...41,806,539
Ensembl chr17:41,797,152...41,806,539
Ensembl chr17:41,797,152...41,806,539
Ensembl chr 4:41,797,152...41,806,539 		JBrowse link
G Hamp hepcidin antimicrobial peptide multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of HAMP mRNA CTD PMID:37567420 NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:95,298,307...95,300,297 		JBrowse link
G Hapln1 hyaluronan and proteoglycan link protein 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of HAPLN1 mRNA CTD PMID:37567420 NCBI chr 2:22,366,967...22,431,709
Ensembl chr 2:22,366,967...22,429,098 		JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of HAVCR1 mRNA CTD PMID:37567420 NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,619,897...31,653,268 		JBrowse link
G Hba-a2 hemoglobin alpha, adult chain 2 increases glycation ISO Glucose results in increased glycation of HBA1 protein CTD PMID:26163454 NCBI chr10:15,828,291...15,829,138
Ensembl chr10:15,828,377...15,829,141 		JBrowse link
G Hbb hemoglobin subunit beta multiple interactions
affects binding 		ISO
EXP 		Furans analog inhibits the reaction [Glucose binds to HBB protein]
Fructose promotes the reaction [Glucose binds to HBB protein]; geraniol inhibits the reaction [Fructose promotes the reaction [Glucose binds to HBB protein]]; Pioglitazone inhibits the reaction [Fructose promotes the reaction [Glucose binds to HBB protein]] 		CTD PMID:25679220 PMID:28911973 NCBI chr 1:167,662,310...167,663,721
Ensembl chr 1:167,630,245...167,663,873 		JBrowse link
G Hbegf heparin-binding EGF-like growth factor increases expression ISO Glucose results in increased expression of HBEGF mRNA CTD PMID:17178593 NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,380,337...28,390,220 		JBrowse link
G Hcrt hypocretin neuropeptide precursor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of HCRT mRNA CTD PMID:37567420 NCBI chr10:86,190,289...86,191,524
Ensembl chr10:86,189,775...86,191,524 		JBrowse link
G Hdac1 histone deacetylase 1 multiple interactions ISO Glucose promotes the reaction [HDAC1 protein binds to TUG1 promoter] CTD PMID:32467232 NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:147,138,156...147,165,387 		JBrowse link
G Hdc histidine decarboxylase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of HDC mRNA CTD PMID:37567420 NCBI chr 3:134,300,628...134,318,704
Ensembl chr 3:134,300,632...134,318,711 		JBrowse link
G Hepacam hepatic and glial cell adhesion molecule increases expression ISO Glucose results in increased expression of HEPACAM mRNA CTD PMID:39922521 NCBI chr 8:45,276,594...45,294,006
Ensembl chr 8:45,276,683...45,295,548 		JBrowse link
G Herpud1 homocysteine inducible ER protein with ubiquitin like domain 1 decreases expression ISO Glucose results in decreased expression of HERPUD1 mRNA CTD PMID:17178593 NCBI chr19:10,604,360...10,624,168
Ensembl chr19:10,604,362...10,624,081 		JBrowse link
G Hhat hedgehog acyltransferase decreases expression
multiple interactions 		ISO Glucose results in decreased expression of HHAT mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of HHAT mRNA] 		CTD PMID:33448797 NCBI chr13:106,558,635...106,814,723
Ensembl chr13:106,541,866...106,811,563 		JBrowse link
G Hhipl1 HHIP-like 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of HHIPL1 mRNA CTD PMID:37567420 NCBI chr 6:132,984,028...133,008,248
Ensembl chr 6:132,984,032...133,006,947 		JBrowse link
G Hibch 3-hydroxyisobutyryl-CoA hydrolase decreases secretion ISO Glucose deficiency results in decreased secretion of HIBCH protein CTD PMID:24802182 NCBI chr 9:56,082,082...56,161,796
Ensembl chr 9:56,082,091...56,161,886 		JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha multiple interactions
increases expression
decreases expression 		ISO
EXP 		2-Methoxyestradiol inhibits the reaction [Glucose results in increased expression of HIF1A protein]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Glucose results in increased expression of HIF1A protein]; [3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole results in decreased activity of HIF1A protein] results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]; [Glucose co-treated with Oxygen deficiency] inhibits the reaction [ARNT protein binds to HIF1A protein]; [Glucose co-treated with Oxygen deficiency] promotes the reaction [Pyruvaldehyde binds to and results in decreased activity of HIF1A protein]; [Glucose co-treated with SOD2 gene mutant form] results in decreased expression of HIF1A protein; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HIF1A protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HIF1A mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HIF1A protein; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HIF1A protein]
Glucose results in increased expression of HIF1A mRNA
Glucose results in decreased expression of HIF1A mRNA
Glucose results in increased expression of HIF1A mRNA; Glucose results in increased expression of HIF1A protein
[cobaltous chloride co-treated with Glucose] promotes the reaction [HIF1A protein binds to EP300 protein]; [cobaltous chloride co-treated with Glucose] results in increased expression of and results in decreased ubiquitination of HIF1A protein; [Glucose co-treated with Deferoxamine] results in increased expression of HIF1A mRNA; [Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HIF1A protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HIF1A protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of HIF1A protein]]; Cycloheximide inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of HIF1A protein]; epoxomicin inhibits the reaction [scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of HIF1A protein]]; Glucose affects the reaction [Fusaric Acid affects the expression of HIF1A protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of HIF1A mRNA]; MG 262 inhibits the reaction [scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of HIF1A protein]]; Particulate Matter inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HIF1A protein]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose co-treated with Cycloheximide] results in decreased expression of HIF1A protein]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] promotes the reaction [HIF1A protein binds to EP300 protein]]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of and results in decreased ubiquitination of HIF1A protein]; scutellarin promotes the reaction [Cycloheximide inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of HIF1A protein]]; Vehicle Emissions inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HIF1A protein]
[[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HIF1A protein] which results in increased expression of SLC8A1 mRNA; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HIF1A protein; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HIF1A mRNA; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HIF1A protein; HIF1A protein affects the reaction [Glucose results in increased expression of CCN2 protein]; HIF1A protein affects the reaction [Glucose results in increased expression of EDN1 protein]; HIF1A protein affects the reaction [Glucose results in increased expression of FN1 protein]; HIF1A protein affects the reaction [Glucose results in increased expression of TGFB1 protein]; HIF1A protein affects the reaction [Glucose results in increased expression of VEGFA protein]; MIR217 mRNA affects the reaction [Glucose results in increased expression of HIF1A mRNA]; MIR217 mRNA affects the reaction [Glucose results in increased expression of HIF1A protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HIF1A mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HIF1A protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of HIF1A mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of HIF1A protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of HIF1A protein]] 		CTD PMID:18227068 PMID:19228841 PMID:19429140 PMID:21293012 PMID:21617913 More... NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323 		JBrowse link
G Hipk4 homeodomain interacting protein kinase 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of HIPK4 mRNA CTD PMID:37567420 NCBI chr 1:91,938,308...91,948,680
Ensembl chr 1:91,938,278...91,948,683 		JBrowse link
G Hjurp Holliday junction recognition protein increases expression ISO Glucose results in increased expression of HJURP mRNA CTD PMID:39922521 NCBI chr 9:96,301,183...96,315,587
Ensembl chr 9:96,302,530...96,315,657 		JBrowse link
G Hk1 hexokinase 1 increases expression ISO Glucose results in increased expression of HK1 mRNA CTD PMID:17178593 NCBI chr20:30,773,222...30,874,814
Ensembl chr20:30,773,220...30,874,814 		JBrowse link
G Hk3 hexokinase 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of HK3 mRNA CTD PMID:37567420 NCBI chr17:9,602,119...9,620,038
Ensembl chr17:9,605,016...9,620,037 		JBrowse link
G Hkdc1 hexokinase domain containing 1 increases expression ISO Glucose results in increased expression of HKDC1 mRNA CTD PMID:39613055 NCBI chr20:30,878,037...30,917,044
Ensembl chr20:30,878,319...30,916,704 		JBrowse link
G Hmga2 high mobility group AT-hook 2 increases expression ISO Glucose results in increased expression of HMGA2 mRNA CTD PMID:17178593 NCBI chr 7:57,762,710...57,884,555
Ensembl chr 7:57,765,675...57,880,341 		JBrowse link
G Hmgb1 high mobility group box 1 multiple interactions
increases expression
increases secretion 		ISO GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to HMGB1 promoter]]; GLO1 inhibits the reaction [Glucose results in increased expression of and results in increased secretion of HMGB1 protein]; GLO1 inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]; Glucose promotes the reaction [JUN protein binds to HMGB1 promoter]; Glucose results in increased expression of and results in increased acetylation of HMGB1 protein; Glucose results in increased expression of and results in increased secretion of HMGB1 protein; JUN promotes the reaction [Glucose results in increased expression of HMGB1 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of and results in increased acetylation of HMGB1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of and results in increased acetylation of HMGB1 protein]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]]; SOD2 inhibits the reaction [Glucose results in increased expression of and results in increased secretion of HMGB1 protein]; SOD2 inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]; UCP1 inhibits the reaction [Glucose results in increased expression of and results in increased secretion of HMGB1 protein]; UCP1 inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]
Glucose results in increased expression of HMGB1 mRNA; Glucose results in increased expression of HMGB1 protein
Glucose results in increased secretion of HMGB1 protein
imeglimin inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]; imeglimin inhibits the reaction [Glucose results in increased expression of HMGB1 protein]; NLRP3 protein promotes the reaction [Glucose results in increased secretion of HMGB1 protein] 		CTD PMID:19833897 PMID:27783111 PMID:38334676 PMID:39719253 NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327
Ensembl chr12:39,039,050...39,041,327 		JBrowse link
G Hmgcs1 3-hydroxy-3-methylglutaryl-CoA synthase 1 increases expression ISO Glucose results in increased expression of HMGCS1 mRNA CTD PMID:39613055 NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:53,382,643...53,399,802 		JBrowse link
G Hmmr hyaluronan-mediated motility receptor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of HMMR mRNA CTD PMID:37567420 NCBI chr10:25,635,249...25,665,389
Ensembl chr10:25,635,915...25,665,390 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions
affects expression
decreases expression
increases expression
decreases activity 		ISO
EXP 		2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]]; 4-Nitroquinoline-1-oxide inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]; [4-Nitroquinoline-1-oxide results in increased susceptibility to Glucose] which results in increased expression of HMOX1 protein; [Oxygen co-treated with Glucose] promotes the reaction [Vehicle Emissions promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein]]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein; Acetylcysteine inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]; Acetylcysteine promotes the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]]; Berberine promotes the reaction [Glucose results in increased expression of HMOX1 protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]; Glucose inhibits the reaction [4-Nitroquinoline-1-oxide affects the expression of HMOX1 protein]; Glucose promotes the reaction [cobaltiprotoporphyrin results in increased expression of HMOX1 mRNA]; Glucose promotes the reaction [tin mesoporphyrin results in increased expression of HMOX1 mRNA]; Particulate Matter promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein]; Rosiglitazone inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]; solanesol inhibits the reaction [Glucose results in decreased expression of HMOX1 mRNA]; solanesol inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]; spiraeoside inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]; Vehicle Emissions promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein]
Glucose affects the expression of HMOX1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[diallyl trisulfide co-treated with Glucose] results in increased expression of HMOX1 protein]; [cobaltiprotoporphyrin results in increased expression of HMOX1 protein] which results in decreased susceptibility to Glucose; [diallyl trisulfide co-treated with Glucose] results in increased expression of HMOX1 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of HMOX1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein; Acetylcysteine affects the reaction [Glucose affects the expression of HMOX1 mRNA]; Antioxidants inhibits the reaction [Glucose results in increased expression of HMOX1]; cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased activity of HMOX1 protein]; cobaltiprotoporphyrin promotes the reaction [Glucose results in increased expression of HMOX1 protein]; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 mRNA]; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein]; formononetin inhibits the reaction [Glucose results in decreased expression of HMOX1 mRNA]; Glucose results in decreased activity of and results in increased expression of HMOX1 protein; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of HMOX1 mRNA]]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in decreased phosphorylation of STAT3 protein]]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of NPPA mRNA]]; HMOX1 protein promotes the reaction [diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; manganese(III)-tetrakis(4-benzoic acid)porphyrin affects the reaction [Glucose affects the expression of HMOX1 mRNA]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of HMOX1 mRNA]; Propofol inhibits the reaction [Glucose results in decreased activity of HMOX1 protein]; Propofol promotes the reaction [Glucose results in increased expression of HMOX1 protein]; Quercetin inhibits the reaction [Glucose results in decreased expression of HMOX1 mRNA]; Quercetin inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased activity of HMOX1 protein]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin promotes the reaction [Glucose results in increased expression of HMOX1 protein]]; zinc protoporphyrin inhibits the reaction [Propofol inhibits the reaction [Glucose results in decreased activity of HMOX1 protein]]; zinc protoporphyrin inhibits the reaction [Propofol promotes the reaction [Glucose results in increased expression of HMOX1 protein]]
Glucose results in decreased expression of HMOX1 mRNA; Glucose results in decreased expression of HMOX1 protein
Glucose results in increased expression of HMOX1 mRNA; Glucose results in increased expression of HMOX1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein promotes the reaction [Glucose results in increased expression of HMOX1 protein]]; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of HMOX1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 mRNA; Antioxidants inhibits the reaction [Glucose results in increased expression of HMOX1 mRNA]; Glucose deficiency promotes the reaction [Simvastatin results in increased expression of HMOX1 mRNA]; Glucose deficiency promotes the reaction [Simvastatin results in increased expression of HMOX1 protein]; MIR144 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 mRNA]; NFE2L2 mutant form inhibits the reaction [Glucose deficiency promotes the reaction [Simvastatin results in increased expression of HMOX1 mRNA]]; SMARCA4A protein promotes the reaction [Glucose results in increased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [Glucose deficiency promotes the reaction [Simvastatin results in increased expression of HMOX1 protein]]
Glucose deficiency results in increased expression of HMOX1 mRNA; Glucose results in increased expression of HMOX1 protein
Glucose results in decreased activity of HMOX1 promoter 		CTD PMID:14766238 PMID:16464909 PMID:17928392 PMID:19489000 PMID:19924377 More... NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818 		JBrowse link
G Hnf1a HNF1 homeobox A affects response to substance ISO HNF1A gene mutant form affects the susceptibility to Glucose CTD PMID:15787664 NCBI chr12:47,299,171...47,333,457
Ensembl chr12:47,306,245...47,332,755 		JBrowse link
G Hnf1b HNF1 homeobox B multiple interactions ISO HNF1B protein inhibits the reaction [bisphenol A inhibits the reaction [INS protein results in increased uptake of Glucose]] CTD PMID:32623698 NCBI chr10:69,233,377...69,287,360
Ensembl chr10:69,233,131...69,287,361 		JBrowse link
G Hnf4a hepatocyte nuclear factor 4, alpha multiple interactions
increases expression
decreases expression 		ISO Cerulenin inhibits the reaction [Glucose results in decreased expression of HNF4A mRNA]; Glucose affects the reaction [HNF4A protein binds to SHBG promoter]
Glucose results in increased expression of HNF4A mRNA 		CTD PMID:17992261 PMID:31525975 NCBI chr 3:172,606,220...172,667,758
Ensembl chr 3:172,606,220...172,667,758 		JBrowse link
G Hnrnpk heterogeneous nuclear ribonucleoprotein K decreases expression EXP Glucose results in decreased expression of HNRNPK mRNA; Glucose results in decreased expression of HNRNPK protein CTD PMID:16837467 NCBI chr17:6,269,302...6,280,429
Ensembl chr17:6,268,385...6,280,565 		JBrowse link
G Hoxa2 homeobox A2 increases expression
multiple interactions 		EXP
ISO 		Glucose results in increased expression of HOXA2 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of HOXA2 mRNA 		CTD PMID:21818840 PMID:37567420 NCBI chr 4:82,593,389...82,597,589
Ensembl chr 4:82,593,389...82,595,692 		JBrowse link
G Hp haptoglobin affects secretion
multiple interactions 		ISO Glucose deficiency affects the secretion of HP protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of HP mRNA 		CTD PMID:24802182 PMID:37567420 NCBI chr19:54,449,151...54,453,701
Ensembl chr19:54,446,217...54,467,518 		JBrowse link
G Hpgds hematopoietic prostaglandin D synthase increases expression ISO Glucose results in increased expression of HPGDS mRNA CTD PMID:31525975 NCBI chr 4:95,698,265...95,727,733
Ensembl chr 4:95,702,392...95,938,501 		JBrowse link
G Hprt1 hypoxanthine phosphoribosyltransferase 1 decreases expression ISO Glucose results in decreased expression of HPRT1 mRNA CTD PMID:31655124 NCBI chr  X:137,655,744...137,687,718
Ensembl chr  X:137,655,680...137,687,712 		JBrowse link
G Hras HRas proto-oncogene, GTPase multiple interactions
increases activity 		EXP manumycin inhibits the reaction [Glucose results in increased activity of HRAS protein] CTD PMID:16572112 NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:205,725,975...205,729,590 		JBrowse link
G Hrg histidine-rich glycoprotein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of HRG mRNA CTD PMID:37567420 NCBI chr11:91,559,087...91,573,982
Ensembl chr11:91,559,091...91,573,982 		JBrowse link
G Hrk harakiri, BCL2 interacting protein increases expression ISO Glucose results in increased expression of HRK mRNA CTD PMID:39922521 NCBI chr12:44,048,402...44,070,561
Ensembl chr12:44,048,402...44,070,561 		JBrowse link
G Hs6st2 heparan sulfate 6-O-sulfotransferase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of HS6ST2 mRNA CTD PMID:37567420 NCBI chr  X:135,887,224...136,182,388
Ensembl chr  X:135,888,472...136,182,353 		JBrowse link
G Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 decreases expression EXP Glucose results in decreased expression of HSD11B2 mRNA CTD PMID:15017115 NCBI chr19:50,307,569...50,312,812
Ensembl chr19:50,307,569...50,312,812 		JBrowse link
G Hsd3b1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 increases expression ISO Glucose results in increased expression of HSD3B1 mRNA CTD PMID:31525975 NCBI chr 2:188,858,574...188,864,694 JBrowse link
G Hsf1 heat shock transcription factor 1 decreases activity ISO Glucose results in decreased activity of HSF1 protein CTD PMID:34170685 NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:110,076,710...110,103,665 		JBrowse link
G Hsf2bp heat shock transcription factor 2 binding protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of HSF2BP mRNA CTD PMID:37567420 NCBI chr20:10,035,263...10,121,262
Ensembl chr20:10,035,263...10,121,826 		JBrowse link
G Hsp90aa1 heat shock protein 90 alpha family class A member 1 multiple interactions ISO Glucose deficiency inhibits the reaction [Quercetin promotes the reaction [ERBB2 protein binds to HSP90AA1 protein]] CTD PMID:18655187 NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:135,523,616...135,528,499 		JBrowse link
G Hsp90b1 heat shock protein 90 beta family member 1 decreases expression
increases secretion 		ISO Glucose results in decreased expression of HSP90B1 mRNA
Glucose deficiency results in increased secretion of HSP90B1 protein 		CTD PMID:17178593 PMID:24802182 NCBI chr 7:22,997,962...23,012,293
Ensembl chr 7:22,997,962...23,012,293 		JBrowse link
G Hspa12a heat shock protein family A (Hsp70) member 12A decreases expression
multiple interactions 		EXP Glucose results in decreased expression of HSPA12A protein
KU-32 compound inhibits the reaction [Glucose results in decreased expression of HSPA12A protein] 		CTD PMID:22413817 NCBI chr 1:267,921,780...268,083,171
Ensembl chr 1:267,921,782...268,082,794 		JBrowse link
G Hspa13 heat shock protein family A (Hsp70) member 13 decreases expression ISO Glucose results in decreased expression of HSPA13 mRNA CTD PMID:17178593 NCBI chr11:27,862,717...27,876,898
Ensembl chr11:27,862,593...27,876,898 		JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A multiple interactions ISO [imeglimin co-treated with Glucose] results in increased expression of HSPA1A mRNA CTD PMID:34588186 NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979 		JBrowse link
G Hspa1b heat shock protein family A (Hsp70) member 1B multiple interactions ISO [imeglimin co-treated with Glucose] results in increased expression of HSPA1B mRNA CTD PMID:34588186 NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,855,780...3,877,979 		JBrowse link
G Hspa1l heat shock protein family A (Hsp70) member 1 like multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of HSPA1L mRNA CTD PMID:37567420 NCBI chr20:3,853,496...3,860,223
Ensembl chr20:3,853,331...3,876,877 		JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 increases expression
multiple interactions
decreases expression 		ISO
EXP 		Glucose deficiency results in increased expression of HSPA5 mRNA; Glucose deficiency results in increased expression of HSPA5 protein; Glucose results in increased expression of HSPA5 mRNA; Glucose results in increased expression of HSPA5 protein
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of HSPA5 protein]; Metformin inhibits the reaction [Glucose results in increased expression of HSPA5 protein]
2-aminoethoxydiphenyl borate inhibits the reaction [Glucose results in increased expression of HSPA5 protein]; Gadolinium inhibits the reaction [Glucose results in increased expression of HSPA5 protein]; Glucose affects the reaction [bisphenol A results in decreased expression of HSPA5 protein]; waixenicin A inhibits the reaction [Glucose results in increased expression of HSPA5 protein]
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in increased expression of HSPA5 protein]]; 4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 mRNA]; 4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]; [Acetylcysteine co-treated with ginsenoside Rg3] inhibits the reaction [Glucose results in increased expression of HSPA5 protein]; [Glucose co-treated with TGFB1 protein] results in increased expression of HSPA5 protein; ATF6 protein modified form promotes the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of HSPA5 protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in increased expression of HSPA5 protein]; glucogallin inhibits the reaction [Glucose results in increased expression of HSPA5 protein]; salubrinal inhibits the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]; XBP1 mRNA alternative form promotes the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]
Glucose results in decreased expression of HSPA5 mRNA
Glucose deficiency results in increased expression of HSPA5 protein; Glucose results in increased expression of HSPA5 protein 		CTD PMID:12147617 PMID:16380481 PMID:17178593 PMID:21337367 PMID:21705745 More... NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790 		JBrowse link
G Hspa9 heat shock protein family A (Hsp70) member 9 increases expression
decreases expression
multiple interactions 		ISO
EXP 		Glucose results in increased expression of HSPA9 protein
Glucose results in decreased expression of HSPA9 protein
KU-32 compound inhibits the reaction [Glucose results in decreased expression of HSPA9 protein]
resveratrol inhibits the reaction [Glucose results in increased expression of HSPA9 protein] 		CTD PMID:22413817 PMID:24218232 NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,804,774...26,828,398 		JBrowse link
G Hspb1 heat shock protein family B (small) member 1 multiple interactions
increases phosphorylation
increases secretion 		EXP
ISO 		[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HSPB1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HSPB1 protein; resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HSPB1 mRNA]; resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HSPB1 protein]
Glucose results in increased phosphorylation of HSPB1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased phosphorylation of HSPB1 protein]; U 0126 inhibits the reaction [Glucose results in increased phosphorylation of HSPB1 protein]
Glucose deficiency results in increased secretion of HSPB1 protein 		CTD PMID:23421680 PMID:24802182 PMID:25373458 NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301 		JBrowse link
G Hspd1 heat shock protein family D (Hsp60) member 1 decreases expression
multiple interactions 		ISO Glucose deficiency results in decreased expression of HSPD1 protein
[Glucose co-treated with Palmitic Acid] results in decreased expression of HSPD1 mRNA; Nitroprusside inhibits the reaction [Glucose deficiency results in decreased expression of HSPD1 protein] 		CTD PMID:17855661 PMID:39265716 NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037 		JBrowse link
G Htra3 HtrA serine peptidase 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of HTRA3 mRNA CTD PMID:37567420 NCBI chr14:79,293,535...79,321,936
Ensembl chr14:79,293,541...79,321,936 		JBrowse link
G Hunk hormonally upregulated Neu-associated kinase multiple interactions
decreases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of HUNK mRNA] CTD PMID:33448797 NCBI chr11:43,127,244...43,244,502
Ensembl chr11:43,127,244...43,244,502 		JBrowse link
G Hyal4 hyaluronidase 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of HYAL4 mRNA CTD PMID:37567420 NCBI chr 4:54,221,728...54,240,364
Ensembl chr 4:54,221,728...54,240,364 		JBrowse link
G Hydin Hydin, axonemal central pair apparatus protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of HYDIN mRNA CTD PMID:37567420 NCBI chr19:55,146,382...55,492,660
Ensembl chr19:55,146,466...55,492,660 		JBrowse link
G Hyou1 hypoxia up-regulated 1 decreases expression ISO Glucose results in decreased expression of HYOU1 mRNA CTD PMID:17178593 NCBI chr 8:53,602,882...53,614,998
Ensembl chr 8:53,602,604...53,614,997 		JBrowse link
G Iapp islet amyloid polypeptide multiple interactions
increases expression 		ISO
EXP 		IAPP protein inhibits the reaction [Glucose results in increased secretion of INS protein]; Rosiglitazone inhibits the reaction [IAPP protein inhibits the reaction [Glucose results in increased secretion of INS protein]]
Glucose results in increased expression of IAPP mRNA
Diazoxide inhibits the reaction [Glucose results in increased expression of IAPP mRNA]; Mannoheptulose inhibits the reaction [Glucose results in increased expression of IAPP mRNA]; Verapamil inhibits the reaction [Glucose results in increased expression of IAPP mRNA] 		CTD PMID:9142872 PMID:16204373 NCBI chr 4:176,968,097...176,975,363
Ensembl chr 4:176,968,097...176,975,363 		JBrowse link
G Ica1l islet cell autoantigen 1-like multiple interactions
decreases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of ICA1L mRNA] CTD PMID:33448797 NCBI chr 9:68,906,148...68,964,078
Ensembl chr 9:68,906,148...68,963,692 		JBrowse link
G Icam1 intercellular adhesion molecule 1 increases expression
increases secretion
multiple interactions 		ISO
EXP 		Glucose results in increased expression of ICAM1; Glucose results in increased expression of ICAM1 mRNA; Glucose results in increased expression of ICAM1 protein
Glucose results in increased secretion of ICAM1 protein
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Glucose results in increased expression of ICAM1]; 5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; 5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; aspalathin inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; Hesperidin inhibits the reaction [Glucose results in increased expression of ICAM1]; HTS 466284 inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; isoangustone A inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; manganese chloride inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; Mannitol inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; Mannitol inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased secretion of ICAM1 protein]; naringin inhibits the reaction [Glucose results in increased expression of ICAM1]; nothofagin inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; Polyphenols inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of ICAM1]; Rimonabant inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; sarpogrelate inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of ICAM1 protein]
Curcumin analog inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; Y 27632 inhibits the reaction [Glucose results in increased expression of ICAM1 protein] 		CTD PMID:15304054 PMID:16285992 PMID:21367880 PMID:21373835 PMID:21682256 More... NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617 		JBrowse link
G Icam5 intercellular adhesion molecule 5 multiple interactions
decreases expression 		ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of ICAM5 mRNA] CTD PMID:33448797 NCBI chr 8:27,843,563...27,851,767
Ensembl chr 8:27,844,780...27,857,104 		JBrowse link
G Id1 inhibitor of DNA binding 1 increases expression
decreases expression
affects expression 		ISO Glucose results in increased expression of ID1 mRNA
Glucose results in decreased expression of ID1 mRNA
Glucose affects the expression of ID1 mRNA 		CTD PMID:17178593 PMID:39613055 NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:161,671,538...161,672,685 		JBrowse link
G Id3 inhibitor of DNA binding 3 increases expression
decreases expression 		ISO Glucose results in increased expression of ID3 mRNA
Glucose results in decreased expression of ID3 mRNA 		CTD PMID:17178593 PMID:39613055 NCBI chr 5:153,656,253...153,657,860
Ensembl chr 5:153,630,498...153,657,856 		JBrowse link
G Ide insulin degrading enzyme decreases expression ISO Glucose results in decreased expression of IDE mRNA CTD PMID:17178593 NCBI chr 1:244,415,495...244,516,925
Ensembl chr 1:244,416,343...244,514,526 		JBrowse link
G Idi1 isopentenyl-diphosphate delta isomerase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of IDI1 mRNA CTD PMID:37567420 NCBI chr17:66,539,761...66,547,524
Ensembl chr17:66,539,763...66,547,524 		JBrowse link
G Idi2 isopentenyl-diphosphate delta isomerase 2 increases expression ISO Glucose results in increased expression of IDI2 mRNA CTD PMID:39922521 NCBI chr17:66,022,731...66,026,333 JBrowse link
G Ido1 indoleamine 2,3-dioxygenase 1 multiple interactions ISO IDO1 protein affects the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in increased abundance of Glucose] CTD PMID:39172838 NCBI chr16:74,133,259...74,145,328
Ensembl chr16:74,133,259...74,145,328 		JBrowse link
G Ier5l immediate early response 5-like decreases expression ISO Glucose results in decreased expression of IER5L mRNA CTD PMID:39613055 NCBI chr 3:34,141,866...34,143,457
Ensembl chr 3:34,139,672...34,144,452 		JBrowse link
G Ifi27l2a interferon, alpha-inducible protein 27 like 2A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IFI27L2A mRNA CTD PMID:37567420 NCBI chr 6:128,363,658...128,365,144
Ensembl chr 6:128,363,658...128,365,146 		JBrowse link
G Ifi44 interferon-induced protein 44 increases expression
multiple interactions 		ISO Glucose results in increased expression of IFI44 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of IFI44 mRNA] 		CTD PMID:33448797 NCBI chr 2:243,286,050...243,303,869
Ensembl chr 2:243,286,052...243,306,877 		JBrowse link
G Ifi44l interferon-induced protein 44-like increases expression ISO Glucose results in increased expression of IFI44L mRNA CTD PMID:39613055 NCBI chr 2:243,328,629...243,366,404
Ensembl chr 2:243,328,723...243,366,404 		JBrowse link
G Ifit1 interferon-induced protein with tetratricopeptide repeats 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IFIT1 mRNA CTD PMID:37567420 NCBI chr 1:241,565,197...241,567,262
Ensembl chr 1:241,543,184...241,568,148 		JBrowse link
G Ifit2 interferon-induced protein with tetratricopeptide repeats 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IFIT2 mRNA CTD PMID:37567420 NCBI chr 1:241,515,735...241,521,799
Ensembl chr 1:241,515,709...241,521,798 		JBrowse link
G Ifit3 interferon-induced protein with tetratricopeptide repeats 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IFIT3 mRNA CTD PMID:37567420 NCBI chr 1:241,527,326...241,532,469
Ensembl chr 1:241,526,880...241,532,521 		JBrowse link
G Ifng interferon gamma multiple interactions ISO
EXP 		[IL1B protein co-treated with IFNG protein] promotes the reaction [Glucose results in increased secretion of INS protein]
[TNF protein co-treated with IFNG protein co-treated with IL1B protein] inhibits the reaction [Glucose results in increased secretion of INS protein alternative form]; Quercetin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]
[IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]] 		CTD PMID:10967106 PMID:19071154 PMID:23138875 PMID:31776611 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216 		JBrowse link
G Igf1 insulin-like growth factor 1 increases uptake
multiple interactions
increases expression 		ISO IGF1 protein results in increased uptake of Glucose
MIR1231 inhibits the reaction [Glucose results in increased expression of IGF1 mRNA]; MIR1231 inhibits the reaction [Glucose results in increased expression of IGF1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of IGF1 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of IGF1 protein]
Glucose results in increased expression of IGF1 mRNA; Glucose results in increased expression of IGF1 protein 		CTD PMID:29330302 PMID:38156429 NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764 		JBrowse link
G Igf1r insulin-like growth factor 1 receptor decreases expression
multiple interactions
increases expression 		ISO Glucose results in decreased expression of IGF1R protein
[imeglimin co-treated with Glucose] results in increased expression of IGF1R mRNA
Glucose results in increased expression of IGF1R mRNA; Glucose results in increased expression of IGF1R protein
Berberine inhibits the reaction [Glucose results in decreased expression of IGF1R protein] 		CTD PMID:7826318 PMID:23954465 PMID:34588186 PMID:38069837 NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664 		JBrowse link
G Igf2bp1 insulin-like growth factor 2 mRNA binding protein 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of IGF2BP1 mRNA CTD PMID:37567420 NCBI chr10:81,405,021...81,447,814
Ensembl chr10:81,404,797...81,447,846 		JBrowse link
G Igf2r insulin-like growth factor 2 receptor multiple interactions EXP [Glucose co-treated with IGF2R protein modified form] results in decreased expression of IL6 protein; [Glucose co-treated with IGF2R protein modified form] results in decreased expression of NFKBIA protein; [Glucose co-treated with IGF2R protein modified form] results in decreased expression of NFKBIA protein modified form; [Glucose co-treated with IGF2R protein modified form] results in decreased expression of NOS2 protein; [Glucose co-treated with IGF2R protein modified form] results in increased expression of CASP9 protein; [Glucose co-treated with IGF2R protein modified form] results in increased expression of TNF protein; IGF2R protein modified form inhibits the reaction [Glucose results in increased expression of CASP3 protein modified form]; IGF2R protein modified form inhibits the reaction [Glucose results in increased expression of CASP3 protein] CTD PMID:36462176 NCBI chr 1:50,526,878...50,615,265
Ensembl chr 1:50,526,878...50,615,265 		JBrowse link
G Igfbp4 insulin-like growth factor binding protein 4 decreases expression ISO Glucose results in decreased expression of IGFBP4 mRNA CTD PMID:17178593 NCBI chr10:84,491,471...84,503,487
Ensembl chr10:84,485,775...84,503,473 		JBrowse link
G Igfn1 immunoglobulin-like and fibronectin type III domain containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of IGFN1 mRNA CTD PMID:37567420 NCBI chr13:49,947,330...49,979,203
Ensembl chr13:49,947,330...49,989,601 		JBrowse link
G Igkvl-ps13 immunoglobulin kappa variable like, pseudogene 13 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of IGKV1-133 mRNA CTD PMID:37567420 NCBI chr 4:98,298,232...98,299,135 JBrowse link
G Ikbkb inhibitor of nuclear factor kappa B kinase subunit beta multiple interactions EXP
ISO 		IKBKB affects the reaction [IL1B protein inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]]; IKBKB affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]]
IKBKB protein affects the reaction [Particulate Matter promotes the reaction [Glucose results in increased secretion of INS1 protein]] 		CTD PMID:22558381 PMID:31095431 NCBI chr16:76,021,968...76,075,717
Ensembl chr16:76,022,008...76,081,911 		JBrowse link
G Ikzf4 IKAROS family zinc finger 4 increases expression ISO Glucose results in increased expression of IKZF4 mRNA CTD PMID:39922521 NCBI chr 7:1,643,379...1,687,524
Ensembl chr 7:1,644,799...1,687,094 		JBrowse link
G Il10 interleukin 10 increases expression ISO Glucose results in increased expression of IL10 mRNA CTD PMID:39922521 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580 		JBrowse link
G Il12b interleukin 12B multiple interactions
increases expression 		ISO 2-chloro-4'-methoxychalcone inhibits the reaction [Glucose results in increased expression of IL12B mRNA]; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of IL12B mRNA CTD PMID:21988173 PMID:37567420 NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194 		JBrowse link
G Il12rb2 interleukin 12 receptor subunit beta 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of IL12RB2 mRNA CTD PMID:37567420 NCBI chr 4:97,756,089...97,844,937
Ensembl chr 4:97,756,089...97,844,937 		JBrowse link
G Il17a interleukin 17A multiple interactions
increases expression
increases secretion 		ISO Cycloheximide inhibits the reaction [Glucose results in increased secretion of IL17A protein]; Dactinomycin inhibits the reaction [Glucose results in increased secretion of IL17A protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of IL17A mRNA]; Resveratrol inhibits the reaction [Glucose results in increased secretion of IL17A protein]
Glucose results in increased expression of IL17A protein 		CTD PMID:18310510 PMID:39613055 NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331 		JBrowse link
G Il17ra interleukin 17 receptor A increases expression ISO Glucose results in increased expression of IL17RA mRNA CTD PMID:18310510 NCBI chr 4:155,339,742...155,362,382
Ensembl chr 4:155,339,400...155,362,382 		JBrowse link
G Il18 interleukin 18 increases expression
multiple interactions
increases secretion 		ISO
EXP 		Glucose results in increased expression of IL18 mRNA
Glucose results in increased expression of IL18 mRNA; Glucose results in increased expression of IL18 protein
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL18 protein; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL18 protein]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased secretion of IL18 protein; bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased secretion of IL18 protein]; HAGLR protein affects the reaction [Glucose results in increased expression of IL18 protein]; HAGLR protein promotes the reaction [Glucose results in increased expression of IL18 protein]; Lipopolysaccharides inhibits the reaction [swietenine inhibits the reaction [Glucose results in increased expression of IL18 protein]]; Lipopolysaccharides promotes the reaction [Glucose results in increased expression of IL18 protein]; loganin inhibits the reaction [Glucose results in increased expression of IL18 mRNA]; loganin inhibits the reaction [Glucose results in increased expression of IL18 protein]; MIR200C mRNA affects the reaction [Glucose results in increased secretion of IL18 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Glucose results in increased expression of IL18 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide promotes the reaction [swietenine inhibits the reaction [Glucose results in increased expression of IL18 protein]]; PTEN protein affects the reaction [HAGLR protein affects the reaction [Glucose results in increased expression of IL18 protein]]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased secretion of IL18 protein]]; swietenine inhibits the reaction [Glucose results in increased expression of IL18 protein]
GSDMD protein affects the reaction [Glucose results in increased secretion of IL18 protein]; Hirudins inhibits the reaction [Glucose results in increased secretion of IL18 protein] 		CTD PMID:34212273 PMID:35191607 PMID:35607288 PMID:36066211 PMID:37127800 More... NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286 		JBrowse link
G Il18rap interleukin 18 receptor accessory protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IL18RAP mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of IL18RAP mRNA CTD PMID:37567420 NCBI chr 9:50,263,723...50,296,583
Ensembl chr 9:50,263,733...50,296,583 		JBrowse link
G Il1b interleukin 1 beta multiple interactions
increases secretion
increases expression 		ISO
EXP 		2-chloro-4'-methoxychalcone inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; [cobaltiprotoporphyrin co-treated with IL1B protein] affects the susceptibility to Glucose; [Glucose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased secretion of IL1B protein; [IL1B protein co-treated with IFNG protein] promotes the reaction [Glucose results in increased secretion of INS protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL1B protein; Acetylcysteine inhibits the reaction [Glucose results in increased expression of IL1B protein]; atractylenolide III inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL1B protein]; CDK9 protein affects the reaction [Glucose results in increased expression of IL1B mRNA]; diphenyleneiodonium inhibits the reaction [Glucose promotes the reaction [Particulate Matter results in increased expression of and results in increased cleavage of IL1B protein]]; Edaravone inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL1B protein]; Glucose inhibits the reaction [IL1B protein results in increased expression of MMP1 mRNA]; Glucose inhibits the reaction [IL1B protein results in increased expression of MMP1 protein]; Glucose inhibits the reaction [IL1B protein results in increased phosphorylation of JUN protein]; Glucose inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK1 protein]; Glucose inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK3 protein]; Glucose inhibits the reaction [IL1B protein results in increased phosphorylation of PTK2 protein]; Glucose promotes the reaction [Fatty Acids, Nonesterified results in increased expression of IL1B protein]; Glucose promotes the reaction [Particulate Matter results in increased expression of and results in increased cleavage of IL1B protein]; Glucose promotes the reaction [Particulate Matter results in increased expression of IL1B mRNA]; GSDMD protein affects the reaction [Glucose results in increased secretion of IL1B protein]; Hirudins inhibits the reaction [Glucose results in increased secretion of IL1B protein]; IL1B protein inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]; IL1B protein inhibits the reaction [Glucose results in increased expression of MAFA mRNA]; IL1B protein inhibits the reaction [Glucose results in increased expression of PDX1 mRNA]; imeglimin inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; imeglimin inhibits the reaction [Glucose results in increased secretion of IL1B protein]; jujuboside A inhibits the reaction [Glucose promotes the reaction [Fatty Acids, Nonesterified results in increased expression of IL1B protein]]; Silymarin inhibits the reaction [[Glucose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased secretion of IL1B protein]
Glucose results in increased expression of IL1B mRNA; Glucose results in increased expression of IL1B protein
(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; [Carnosine co-treated with asiatic acid] inhibits the reaction [Glucose results in increased secretion of IL1B protein]; [Fatty Acids, Nonesterified co-treated with Glucose] results in increased expression of IL1B protein; [Glucose co-treated with Lipopolysaccharides] results in decreased expression of IL1B protein; [Glucose co-treated with Pam(3)CSK(4) peptide] results in decreased expression of IL1B protein; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of PPARG mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of PPARA mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL2 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CXCL5 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NFKB1 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of PPARD mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of RELA mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased secretion of IL1B protein; [TNF protein co-treated with IFNG protein co-treated with IL1B protein] inhibits the reaction [Glucose results in increased secretion of INS protein alternative form]; Allopurinol inhibits the reaction [Glucose results in increased expression of IL1B protein]; Anisomycin inhibits the reaction [rutecarpine inhibits the reaction [Glucose results in increased expression of IL1B protein]]; asiatic acid inhibits the reaction [Glucose results in increased secretion of IL1B protein]; bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased secretion of IL1B protein]; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Carnosine inhibits the reaction [Glucose results in increased secretion of IL1B protein]; Catechin inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; Catechin inhibits the reaction [Glucose results in increased expression of IL1B protein]; Ditiocarb inhibits the reaction [YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [[Fatty Acids, Nonesterified co-treated with Glucose] results in increased expression of IL1B protein]]]; epigallocatechin gallate inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; epigallocatechin gallate inhibits the reaction [Glucose results in increased expression of IL1B protein]; Fenofibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Glucose promotes the reaction [Particulate Matter results in increased expression of IL1B mRNA]; HAGLR protein affects the reaction [Glucose results in increased expression of IL1B protein]; HAGLR protein promotes the reaction [Glucose results in increased expression of IL1B protein]; jujuboside A inhibits the reaction [[Fatty Acids, Nonesterified co-treated with Glucose] results in increased expression of IL1B protein]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Lipopolysaccharides inhibits the reaction [swietenine inhibits the reaction [Glucose results in increased expression of IL1B protein]]; Lipopolysaccharides promotes the reaction [Glucose results in increased expression of IL1B protein]; loganin inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; loganin inhibits the reaction [Glucose results in increased expression of IL1B protein]; Luteolin inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; Luteolin inhibits the reaction [Glucose results in increased expression of IL1B protein]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased secretion of IL1B protein]]; MIR142 inhibits the reaction [Glucose results in increased secretion of IL1B protein]; MIR200C mRNA affects the reaction [Glucose results in increased secretion of IL1B protein]; MIR217 mRNA inhibits the reaction [Glucose results in increased secretion of IL1B protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Glucose results in increased expression of IL1B protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide promotes the reaction [swietenine inhibits the reaction [Glucose results in increased expression of IL1B protein]]; Phytic Acid inhibits the reaction [Glucose results in increased expression of IL1B protein]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; PTEN protein affects the reaction [HAGLR protein affects the reaction [Glucose results in increased expression of IL1B protein]]; Quercetin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Quercetin inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of IL1B protein]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; rutecarpine inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; rutecarpine inhibits the reaction [Glucose results in increased expression of IL1B protein]; Rutin inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; Rutin inhibits the reaction [Glucose results in increased expression of IL1B protein]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of IL1B protein]]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased secretion of IL1B protein]]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased secretion of IL1B protein]]; swietenine inhibits the reaction [Glucose results in increased expression of IL1B protein]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased secretion of IL1B protein]; YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [[Fatty Acids, Nonesterified co-treated with Glucose] results in increased expression of IL1B protein]]
[IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL1B protein; [TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Allopurinol inhibits the reaction [Glucose results in increased expression of IL1B protein]; Artesunate inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; Artesunate inhibits the reaction [Glucose results in increased secretion of IL1B protein]; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL1B protein]; Ellagic Acid inhibits the reaction [Glucose results in increased expression of IL1B protein]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Glucose results in increased secretion of IL1B protein]; farrerol inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; farrerol inhibits the reaction [Glucose results in increased secretion of IL1B protein]; Gallic Acid inhibits the reaction [Glucose results in increased secretion of IL1B protein]; IKBKB affects the reaction [IL1B protein inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]]; IL1B protein inhibits the reaction [Glucose results in increased abundance of Proteoglycans]; IL1B protein inhibits the reaction [Glucose results in increased expression of B3GAT3 mRNA]; IL1B protein inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]; morroniside inhibits the reaction [Glucose results in increased secretion of IL1B protein]; prolinedithiocarbamate inhibits the reaction [Glucose results in increased secretion of IL1B protein]; Quercetin inhibits the reaction [Glucose results in increased expression of IL1B protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; S-4-bromobenzylglutathione cyclopentyl diester inhibits the reaction [morroniside inhibits the reaction [Glucose results in increased secretion of IL1B protein]]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL1B protein] 		CTD PMID:10967106 PMID:11801247 PMID:15194409 PMID:19071154 PMID:19557821 More... NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il1rn interleukin 1 receptor antagonist multiple interactions EXP
ISO 		IL1RN protein inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; IL1RN protein inhibits the reaction [Glucose results in increased expression of PTGS2 protein]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expr